data_1yop_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1yop _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 13.7 p . . . . . 0 C--O 1.234 0.257 0 CA-C-O 120.784 0.325 . . . . 0.0 111.342 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 12.1 m-85 -109.6 -38.45 5.42 Favored 'General case' 0 C--O 1.232 0.173 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.158 179.487 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 1.8 t0 -158.54 174.84 14.46 Favored 'General case' 0 C--O 1.236 0.352 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.047 179.888 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 34.0 mt-10 -130.45 127.5 39.38 Favored 'General case' 0 C--O 1.232 0.164 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.872 179.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 3.7 mp -109.88 155.45 11.08 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.181 -179.807 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 11.9 mp0 -111.49 146.88 36.48 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.257 -179.833 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 3.6 tt -62.64 -34.29 64.44 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.247 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.28 179.615 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 5.0 pt-20 -64.08 -32.4 73.94 Favored 'General case' 0 CA--C 1.531 0.239 0 CA-C-N 116.559 -0.291 . . . . 0.0 111.129 179.731 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 11.6 m-20 -96.7 37.62 1.27 Allowed 'General case' 0 CA--C 1.531 0.234 0 CA-C-O 120.839 0.352 . . . . 0.0 111.083 179.704 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -131.63 152.6 50.71 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.075 -179.952 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -81.05 166.07 21.09 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.935 179.925 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 3.1 m-85 -119.9 138.41 53.45 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.975 -179.765 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -107.89 90.05 6.04 Favored Pre-proline 0 C--O 1.234 0.265 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.718 179.685 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -73.1 64.44 4.22 Favored 'Trans proline' 0 C--N 1.35 0.614 0 C-N-CA 122.745 2.297 . . . . 0.0 112.937 -179.528 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 6.3 pt-20 -141.95 -46.45 0.35 Allowed 'General case' 0 CA--C 1.531 0.223 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.22 179.698 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 3.5 m120 -139.36 29.49 2.2 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-N 116.572 -0.286 . . . . 0.0 111.449 179.692 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' GLN . . . . . 0.41 ' NE2' ' HA ' ' A' ' 68' ' ' TYR . 28.2 mt-30 56.52 68.62 0.83 Allowed 'General case' 0 C--O 1.234 0.244 0 CA-C-O 121.043 0.449 . . . . 0.0 111.664 179.448 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 3.8 ptt? -148.23 158.61 44.18 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.01 179.54 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -110.13 159.44 17.34 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.685 179.91 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 34.4 p -134.35 150.06 50.9 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-O 120.941 0.401 . . . . 0.0 111.303 179.827 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 31.5 t80 -155.69 102.07 2.17 Favored Pre-proline 0 C--N 1.333 -0.152 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.565 -179.87 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 62.6 Cg_exo -50.95 99.35 0.04 OUTLIER 'Trans proline' 0 C--N 1.349 0.574 0 C-N-CA 122.53 2.153 . . . . 0.0 112.116 -179.975 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 48.5 t -60.89 138.67 93.84 Favored Pre-proline 0 C--O 1.233 0.231 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.743 -179.618 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 80.2 Cg_exo -48.99 -26.45 10.24 Favored 'Trans proline' 0 C--N 1.351 0.667 0 C-N-CA 122.925 2.417 . . . . 0.0 113.025 179.796 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 4.3 p -59.5 -29.49 67.89 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-O 120.601 0.239 . . . . 0.0 111.352 179.661 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 123.2 7.5 7.02 Favored Glycine 0 CA--C 1.523 0.576 0 C-N-CA 121.207 -0.52 . . . . 0.0 113.445 179.94 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -114.09 -168.24 1.33 Allowed 'General case' 0 CA--C 1.532 0.262 0 CA-C-N 117.379 0.59 . . . . 0.0 111.158 -179.986 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 1.1 tpt180 -117.11 106.43 13.34 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-O 120.75 0.31 . . . . 0.0 110.91 -179.836 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -73.42 113.24 10.29 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.706 179.899 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 25.6 mt-30 -102.89 150.85 23.11 Favored 'General case' 0 N--CA 1.463 0.186 0 CA-C-N 116.435 -0.348 . . . . 0.0 111.146 -179.802 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -154.16 121.57 0.63 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.246 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.005 179.896 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 28.8 m-85 -81.92 148.14 28.9 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-N 116.374 -0.375 . . . . 0.0 111.144 -179.865 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 6.3 mt -67.85 -35.5 78.67 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.969 179.672 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 1.9 p-10 -66.22 -43.13 87.58 Favored 'General case' 0 CA--C 1.531 0.216 0 CA-C-N 116.372 -0.377 . . . . 0.0 110.825 179.481 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -62.81 -52.18 64.18 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-O 120.704 0.288 . . . . 0.0 111.053 -179.855 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 24.1 ptm -61.62 -27.67 68.82 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.36 179.97 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -55.58 -32.4 63.02 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 116.516 -0.311 . . . . 0.0 111.16 179.578 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 13.7 mt-10 -90.96 41.04 1.05 Allowed 'General case' 0 CA--C 1.532 0.285 0 CA-C-O 120.782 0.325 . . . . 0.0 111.484 179.9 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 60.09 64.81 3.84 Favored Glycine 0 C--N 1.334 0.434 0 C-N-CA 121.162 -0.542 . . . . 0.0 113.316 179.41 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 4.3 tt0 -121.62 98.93 6.19 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-O 120.927 0.394 . . . . 0.0 110.979 179.694 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -112.88 -33.78 5.97 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.804 179.856 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 10.3 m -89.18 82.0 2.0 Favored 'Isoleucine or valine' 0 C--O 1.234 0.272 0 CA-C-O 121.037 0.446 . . . . 0.0 110.94 -179.977 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -91.09 147.0 23.38 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.274 -179.79 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 21.4 t -104.87 121.08 56.35 Favored 'Isoleucine or valine' 0 C--O 1.233 0.189 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.804 179.939 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 53.7 t -61.87 135.76 94.67 Favored Pre-proline 0 N--CA 1.463 0.223 0 CA-C-N 116.365 -0.379 . . . . 0.0 110.886 179.972 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 85.0 Cg_endo -84.32 20.25 1.24 Allowed 'Trans proline' 0 CA--C 1.534 0.495 0 C-N-CA 122.724 2.283 . . . . 0.0 113.167 179.926 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -129.81 -59.53 1.06 Allowed 'General case' 0 C--O 1.233 0.194 0 CA-C-O 120.516 0.198 . . . . 0.0 110.74 179.767 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 20.4 p -100.84 -17.29 16.94 Favored 'General case' 0 CA--C 1.532 0.261 0 CA-C-N 116.553 -0.294 . . . . 0.0 111.669 179.683 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER 67.43 36.56 3.8 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-O 120.911 0.386 . . . . 0.0 111.021 -179.889 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 9.8 tp -85.57 133.35 34.07 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.669 179.849 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' MET . . . . . . . . . . . . . 27.9 mtt -82.01 122.44 27.8 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.875 -179.801 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 2.8 pp -131.33 143.34 40.93 Favored 'Isoleucine or valine' 0 C--O 1.234 0.26 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.008 179.884 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -109.39 92.21 3.96 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.622 -179.692 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 12.5 p -86.05 130.03 37.19 Favored 'Isoleucine or valine' 0 C--O 1.234 0.272 0 CA-C-N 116.099 -0.501 . . . . 0.0 111.002 -179.85 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 13.4 p -94.09 145.57 7.76 Favored 'Isoleucine or valine' 0 C--O 1.234 0.268 0 CA-C-N 116.057 -0.519 . . . . 0.0 111.103 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 22.3 p90 -131.89 146.77 52.31 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.153 179.879 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -89.26 -18.92 26.06 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.173 179.382 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 10.5 tttp 68.51 26.2 6.55 Favored 'General case' 0 CA--C 1.532 0.261 0 CA-C-O 120.835 0.35 . . . . 0.0 111.099 -179.688 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 4.4 tt0 -99.69 -62.52 1.23 Allowed 'General case' 0 C--O 1.232 0.165 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.351 179.644 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -62.03 -25.28 67.57 Favored 'General case' 0 N--CA 1.463 0.183 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.976 179.269 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -53.69 -38.31 64.09 Favored 'General case' 0 CA--C 1.53 0.203 0 CA-C-N 116.7 -0.227 . . . . 0.0 111.054 179.701 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -91.66 -37.64 12.92 Favored 'General case' 0 CA--C 1.53 0.208 0 CA-C-N 116.519 -0.309 . . . . 0.0 111.327 179.777 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 19.7 tt0 -66.22 -42.75 88.24 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-N 116.542 -0.299 . . . . 0.0 111.289 -179.937 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 23.3 t80 -57.92 -30.84 66.25 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.34 179.881 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . 0.41 ' HA ' ' NE2' ' A' ' 20' ' ' GLN . 4.2 m-85 -58.52 -35.29 72.05 Favored 'General case' 0 CA--C 1.528 0.117 0 CA-C-O 120.599 0.237 . . . . 0.0 110.725 179.745 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 18.4 mt-10 -81.88 -32.03 31.22 Favored 'General case' 0 C--O 1.232 0.152 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.888 179.394 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -69.4 -51.51 35.81 Favored 'General case' 0 N--CA 1.461 0.109 0 CA-C-N 116.486 -0.324 . . . . 0.0 111.208 179.921 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.233 0.203 0 CA-C-N 116.363 -0.38 . . . . 0.0 111.358 -179.882 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 2.8 p . . . . . 0 N--CA 1.47 0.561 0 CA-C-O 120.975 0.417 . . . . 0.0 111.487 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 17.1 m-85 -116.08 -38.11 3.69 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.707 -179.624 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 1.4 p30 -159.61 174.85 13.96 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-O 120.671 0.272 . . . . 0.0 111.015 -179.697 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -143.67 121.36 11.86 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.072 179.761 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 3.6 mp -115.36 151.99 17.05 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.178 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.271 -179.8 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . 0.417 ' HA ' HG11 ' A' ' 58' ' ' VAL . 1.4 pm0 -91.12 156.14 18.11 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.359 -179.947 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 11.6 tt -63.78 -31.2 52.18 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.251 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.406 179.707 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 12.9 mt-10 -59.78 -33.58 71.88 Favored 'General case' 0 CA--C 1.531 0.249 0 CA-C-N 116.552 -0.295 . . . . 0.0 111.095 179.69 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -96.46 37.29 1.28 Allowed 'General case' 0 CA--C 1.534 0.335 0 CA-C-O 120.798 0.332 . . . . 0.0 111.211 179.815 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -131.65 134.19 45.7 Favored 'General case' 0 C--O 1.232 0.161 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.581 179.889 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 3.6 m -72.16 144.1 48.69 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-O 120.674 0.273 . . . . 0.0 110.782 179.977 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 13.5 p90 -111.84 141.92 44.87 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.001 179.923 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 29.3 mt-10 -117.75 82.9 17.1 Favored Pre-proline 0 C--O 1.233 0.224 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.741 179.916 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -54.76 -24.79 39.51 Favored 'Trans proline' 0 C--N 1.348 0.509 0 C-N-CA 122.814 2.342 . . . . 0.0 112.701 179.692 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -51.37 -38.09 51.51 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-N 116.55 -0.295 . . . . 0.0 111.32 179.729 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 46.3 m-20 -136.3 18.6 3.16 Favored 'General case' 0 CA--C 1.537 0.455 0 N-CA-C 111.927 0.343 . . . . 0.0 111.927 179.881 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 39.7 mt-30 52.27 73.75 0.31 Allowed 'General case' 0 N--CA 1.467 0.392 0 N-CA-C 112.043 0.386 . . . . 0.0 112.043 179.399 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' MET . . . . . 0.404 ' HB3' ' CD2' ' A' ' 35' ' ' TYR . 3.7 ptt? -166.54 146.15 5.78 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.52 179.583 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 27.4 m-85 -90.16 157.05 17.92 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.808 179.548 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 19.1 p -147.46 136.52 22.27 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.19 179.762 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 58.3 t80 -139.82 136.02 17.07 Favored Pre-proline 0 C--N 1.332 -0.161 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.802 179.626 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo -67.48 101.7 0.66 Allowed 'Trans proline' 0 C--N 1.348 0.544 0 C-N-CA 122.528 2.152 . . . . 0.0 112.231 179.907 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . 0.422 ' SG ' ' HD2' ' A' ' 27' ' ' PRO . 37.2 t -61.95 137.6 95.48 Favored Pre-proline 0 C--O 1.233 0.197 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.696 179.868 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . 0.422 ' HD2' ' SG ' ' A' ' 26' ' ' CYS . 12.0 Cg_endo -56.46 -21.65 38.63 Favored 'Trans proline' 0 C--N 1.348 0.523 0 C-N-CA 122.611 2.207 . . . . 0.0 112.686 179.739 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -65.51 -37.88 88.07 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-O 120.507 0.194 . . . . 0.0 111.191 179.932 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 153.05 -44.13 0.62 Allowed Glycine 0 C--N 1.335 0.474 0 C-N-CA 120.692 -0.766 . . . . 0.0 113.13 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -84.36 179.43 7.44 Favored 'General case' 0 CA--C 1.532 0.256 0 CA-C-O 120.785 0.326 . . . . 0.0 111.253 -179.727 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 27.8 ttm180 -113.06 117.69 32.7 Favored 'General case' 0 C--O 1.232 0.159 0 CA-C-N 116.387 -0.369 . . . . 0.0 110.844 179.873 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 30.6 t80 -65.52 156.39 32.7 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.423 -179.838 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 15.8 pt20 -143.57 131.78 21.94 Favored 'General case' 0 CA--C 1.53 0.205 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.16 -179.971 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 7.0 tt -139.09 125.76 24.39 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.185 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.927 179.53 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . 0.404 ' CD2' ' HB3' ' A' ' 21' ' ' MET . 55.4 m-85 -80.24 151.2 29.76 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.345 -179.83 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 45.2 mt -61.34 -40.08 92.91 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.815 179.694 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 2.5 p-10 -63.02 -34.06 76.76 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.199 179.605 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -65.65 -58.94 4.52 Favored 'General case' 0 C--O 1.231 0.083 0 CA-C-O 120.799 0.333 . . . . 0.0 110.728 179.997 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 5.9 ptm -63.69 -34.38 77.73 Favored 'General case' 0 CA--C 1.53 0.202 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.277 179.991 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 46.4 t80 -57.44 -40.68 78.96 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 116.506 -0.316 . . . . 0.0 110.911 179.542 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 4.0 mt-10 -61.71 -35.4 77.94 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 116.538 -0.301 . . . . 0.0 110.982 179.541 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 137.45 46.6 0.08 OUTLIER Glycine 0 C--N 1.332 0.348 0 C-N-CA 120.95 -0.643 . . . . 0.0 112.625 179.86 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -104.07 115.96 31.36 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-O 120.669 0.271 . . . . 0.0 111.042 -179.954 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 2.4 ptpt -117.26 -40.37 3.09 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.216 179.943 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 5.0 m -101.71 101.13 11.68 Favored 'Isoleucine or valine' 0 C--O 1.232 0.172 0 CA-C-O 120.922 0.391 . . . . 0.0 111.249 -179.953 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -99.5 167.77 10.4 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-N 115.987 -0.551 . . . . 0.0 111.404 -179.716 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 5.6 m -136.51 128.33 43.86 Favored 'Isoleucine or valine' 0 C--O 1.232 0.182 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.354 -179.83 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 46.1 t -66.22 136.1 95.17 Favored Pre-proline 0 N--CA 1.463 0.214 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.903 179.865 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_endo -83.57 20.11 1.24 Allowed 'Trans proline' 0 C--N 1.348 0.548 0 C-N-CA 122.692 2.262 . . . . 0.0 113.262 179.859 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -128.45 -56.25 1.23 Allowed 'General case' 0 C--O 1.232 0.156 0 CA-C-O 120.574 0.226 . . . . 0.0 110.502 179.658 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 20.1 p -100.83 -20.08 15.67 Favored 'General case' 0 CA--C 1.534 0.356 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.729 179.846 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 68.24 39.58 2.3 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-O 120.989 0.423 . . . . 0.0 110.896 -179.751 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 6.6 tp -86.44 129.77 34.74 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.816 179.948 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' MET . . . . . . . . . . . . . 28.0 mtm -83.02 131.08 35.19 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.845 -179.934 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 2.6 pp -142.27 145.88 23.16 Favored 'Isoleucine or valine' 0 C--O 1.233 0.204 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.62 -179.731 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -104.6 105.15 15.13 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.757 179.572 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 12.9 p -105.51 118.23 52.62 Favored 'Isoleucine or valine' 0 C--O 1.233 0.213 0 CA-C-O 120.952 0.406 . . . . 0.0 111.101 179.793 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.417 HG11 ' HA ' ' A' ' 9' ' ' GLU . 14.6 p -86.22 139.32 17.55 Favored 'Isoleucine or valine' 0 C--O 1.233 0.232 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.045 -179.839 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 30.5 p90 -129.82 165.75 21.33 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.16 -179.649 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -128.43 178.83 6.01 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-N 116.024 -0.535 . . . . 0.0 111.039 -179.752 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 26.4 mttp -111.1 29.5 7.73 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.206 179.671 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 5.6 mt-10 -99.15 -70.27 0.73 Allowed 'General case' 0 C--O 1.232 0.147 0 CA-C-N 116.492 -0.322 . . . . 0.0 110.604 179.504 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 3.0 p30 -68.3 -37.7 80.88 Favored 'General case' 0 N--CA 1.463 0.175 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.6 179.432 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -56.11 -41.33 75.11 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-N 116.456 -0.338 . . . . 0.0 110.877 179.872 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -73.76 -38.64 64.65 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.35 179.654 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 10.3 mt-10 -71.94 -35.33 69.58 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 116.416 -0.356 . . . . 0.0 111.765 -179.678 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 7.4 m-85 -55.59 -28.32 54.38 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 116.623 -0.262 . . . . 0.0 111.345 -179.794 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 23.4 m-85 -60.66 -34.27 74.05 Favored 'General case' 0 CA--C 1.528 0.117 0 CA-C-N 116.651 -0.25 . . . . 0.0 110.562 179.707 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -90.55 -36.51 14.43 Favored 'General case' 0 CA--C 1.531 0.213 0 CA-C-N 116.284 -0.417 . . . . 0.0 110.993 179.445 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -71.12 -34.71 71.32 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 116.464 -0.335 . . . . 0.0 111.785 -179.648 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.233 0.214 0 CA-C-O 120.895 0.379 . . . . 0.0 111.295 -179.85 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.464 0.264 0 CA-C-O 120.985 0.421 . . . . 0.0 111.511 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 85.0 m-85 -105.04 -37.3 6.99 Favored 'General case' 0 CA--C 1.531 0.232 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.409 -179.945 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -157.14 175.67 13.75 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-N 116.534 -0.303 . . . . 0.0 111.247 -179.792 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 21.5 mt-10 -126.2 143.26 51.2 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 116.108 -0.497 . . . . 0.0 111.033 -179.921 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 22.8 mt -127.19 151.82 34.49 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.29 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.173 -179.886 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 8.5 tt0 -104.97 142.89 33.98 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-N 116.515 -0.311 . . . . 0.0 110.953 179.756 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 41.2 pt -61.15 -32.81 53.82 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.305 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.34 179.82 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 16.8 tt0 -59.44 -33.19 70.97 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.841 179.613 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -97.01 36.89 1.36 Allowed 'General case' 0 CA--C 1.533 0.307 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.191 179.855 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 13.0 mtp -131.32 148.29 52.66 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.639 179.678 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 20.0 m -61.96 129.79 42.55 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.14 -179.816 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 21.1 p90 -93.53 124.39 37.49 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.716 179.593 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 -112.07 86.02 7.25 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.793 -179.881 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo -69.23 -16.99 40.18 Favored 'Trans proline' 0 C--N 1.347 0.499 0 C-N-CA 122.743 2.295 . . . . 0.0 112.942 -179.865 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -53.24 -37.49 62.12 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-N 116.712 -0.222 . . . . 0.0 111.15 179.739 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 25.8 m-20 -143.17 25.32 1.74 Allowed 'General case' 0 CA--C 1.533 0.303 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.718 179.902 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 6.2 tt0 53.35 72.25 0.44 Allowed 'General case' 0 CA--C 1.534 0.329 0 CA-C-O 120.992 0.425 . . . . 0.0 111.648 179.513 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' MET . . . . . 0.418 ' HB3' ' CD2' ' A' ' 35' ' ' TYR . 5.7 ptt? -154.08 175.11 13.82 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.046 179.928 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 27.2 m-85 -137.4 138.65 40.08 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.131 179.879 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 79.6 p -130.82 156.64 44.66 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.273 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 45.7 t80 -156.53 136.01 8.22 Favored Pre-proline 0 N--CA 1.463 0.176 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.863 179.781 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -64.71 100.29 0.34 Allowed 'Trans proline' 0 C--N 1.35 0.616 0 C-N-CA 122.678 2.252 . . . . 0.0 112.37 179.839 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . 0.407 ' SG ' ' HD2' ' A' ' 27' ' ' PRO . 42.0 t -59.68 139.26 89.76 Favored Pre-proline 0 C--O 1.233 0.19 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.69 179.817 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . 0.407 ' HD2' ' SG ' ' A' ' 26' ' ' CYS . 75.2 Cg_exo -51.17 -26.09 18.87 Favored 'Trans proline' 0 C--N 1.348 0.548 0 C-N-CA 122.739 2.293 . . . . 0.0 112.951 179.887 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -68.53 -38.88 81.23 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-O 120.553 0.216 . . . . 0.0 111.279 -179.858 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 152.43 -45.95 0.59 Allowed Glycine 0 C--N 1.334 0.459 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.959 -179.904 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.3 t0 -73.17 -173.81 1.41 Allowed 'General case' 0 CA--C 1.533 0.303 0 CA-C-O 120.748 0.309 . . . . 0.0 111.156 -179.807 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 27.4 ttt180 -123.3 129.67 51.66 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-N 116.444 -0.343 . . . . 0.0 110.886 179.855 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 7.4 m-85 -65.09 161.98 17.8 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.987 179.822 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -151.76 127.92 10.49 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.221 179.8 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 3.6 tt -150.87 144.38 16.87 Favored 'Isoleucine or valine' 0 C--O 1.233 0.219 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.175 179.785 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . 0.418 ' CD2' ' HB3' ' A' ' 21' ' ' MET . 86.0 m-85 -105.29 157.47 17.28 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.869 -179.913 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -61.3 -33.85 74.25 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.936 179.768 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 8.2 t70 -68.13 -39.4 82.74 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.991 179.598 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -59.63 -56.43 22.04 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.1 -179.817 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 36.4 mtm -63.58 -31.27 72.39 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.947 179.618 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 17.0 t80 -58.4 -46.32 86.64 Favored 'General case' 0 CA--C 1.529 0.148 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.912 179.604 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -58.18 -35.49 71.65 Favored 'General case' 0 N--CA 1.463 0.185 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.887 179.685 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 138.65 48.45 0.06 OUTLIER Glycine 0 C--N 1.333 0.386 0 C-N-CA 120.992 -0.623 . . . . 0.0 112.64 179.671 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -102.16 124.89 48.55 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-O 120.791 0.329 . . . . 0.0 110.946 -179.989 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 16.2 mttt -122.83 -43.91 2.23 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.968 179.897 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 11.1 p -112.58 113.58 44.54 Favored 'Isoleucine or valine' 0 C--O 1.233 0.236 0 CA-C-O 121.001 0.429 . . . . 0.0 110.967 179.811 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -99.0 160.28 14.37 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.2 -179.648 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 7.5 m -116.81 124.42 72.86 Favored 'Isoleucine or valine' 0 C--O 1.233 0.2 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.367 -179.894 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 51.3 t -69.99 135.66 87.39 Favored Pre-proline 0 C--N 1.33 -0.252 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.868 179.875 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_endo -84.6 20.78 1.17 Allowed 'Trans proline' 0 CA--C 1.535 0.527 0 C-N-CA 122.714 2.276 . . . . 0.0 112.967 179.747 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -128.01 -57.67 1.24 Allowed 'General case' 0 CA--C 1.529 0.147 0 CA-C-O 120.587 0.232 . . . . 0.0 110.578 179.788 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 20.2 p -99.69 -20.45 16.28 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.817 179.946 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 2.1 t 67.29 40.02 2.86 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-O 120.921 0.391 . . . . 0.0 111.022 -179.857 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 8.5 tt -95.94 135.93 37.05 Favored 'General case' 0 C--O 1.232 0.178 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.625 179.805 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' MET . . . . . . . . . . . . . 12.3 mtt -89.39 128.45 35.92 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.128 -179.578 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 2.1 pp -135.14 132.09 52.72 Favored 'Isoleucine or valine' 0 C--O 1.233 0.221 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.474 179.922 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 74.1 m-20 -87.21 99.46 11.97 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.769 179.61 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 13.3 p -93.18 113.38 27.97 Favored 'Isoleucine or valine' 0 C--O 1.233 0.228 0 CA-C-O 121.114 0.483 . . . . 0.0 111.126 179.943 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 11.7 p -81.64 135.5 24.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.867 -179.955 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 53.5 p90 -131.47 178.57 6.63 Favored 'General case' 0 CA--C 1.532 0.252 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.174 -179.722 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 1.6 t0 -126.29 159.91 31.8 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.893 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -79.99 -36.21 36.31 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.612 179.464 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -60.83 -36.73 79.83 Favored 'General case' 0 CA--C 1.528 0.114 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.088 179.967 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -55.16 -45.76 75.73 Favored 'General case' 0 N--CA 1.462 0.137 0 CA-C-N 116.474 -0.33 . . . . 0.0 111.145 179.747 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 3.7 mp -61.54 -55.89 26.03 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.626 -0.261 . . . . 0.0 110.915 179.812 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -56.73 -40.75 76.27 Favored 'General case' 0 N--CA 1.462 0.156 0 CA-C-N 116.484 -0.326 . . . . 0.0 111.083 179.736 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 30.0 mt-10 -67.43 -43.45 81.13 Favored 'General case' 0 CA--C 1.528 0.115 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.93 179.542 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -70.67 -40.15 73.13 Favored 'General case' 0 N--CA 1.463 0.183 0 CA-C-N 116.531 -0.304 . . . . 0.0 111.438 179.939 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 9.7 m-85 -59.21 -40.17 84.96 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 116.659 -0.246 . . . . 0.0 111.075 -179.744 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 16.8 mt-10 -81.24 -33.75 32.59 Favored 'General case' 0 CA--C 1.529 0.158 0 CA-C-N 116.577 -0.283 . . . . 0.0 111.101 179.886 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 29.1 mt-10 -73.44 -50.19 22.97 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-N 116.587 -0.279 . . . . 0.0 111.192 179.945 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.169 0 CA-C-N 116.323 -0.398 . . . . 0.0 111.519 -179.572 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 1.8 t . . . . . 0 N--CA 1.465 0.277 0 CA-C-O 120.879 0.371 . . . . 0.0 111.229 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 27.1 m-85 -103.88 -31.21 9.88 Favored 'General case' 0 CA--C 1.532 0.252 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.275 179.732 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 5.7 t70 -158.73 165.63 33.88 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-O 120.769 0.319 . . . . 0.0 111.566 -179.855 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 11.2 tt0 -136.41 115.05 11.98 Favored 'General case' 0 CA--C 1.53 0.195 0 CA-C-N 116.035 -0.529 . . . . 0.0 111.177 -179.774 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.431 HG22 ' CE2' ' A' ' 24' ' ' TYR . 3.9 mp -113.56 151.29 15.43 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.277 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.199 179.917 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 4.7 mt-10 -97.92 148.45 23.44 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.273 -179.927 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 14.3 tt -58.55 -31.43 43.63 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.305 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.36 179.668 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 26.4 mt-10 -63.13 -27.56 69.47 Favored 'General case' 0 CA--C 1.532 0.274 0 CA-C-N 116.597 -0.274 . . . . 0.0 111.302 179.634 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -95.09 36.14 1.23 Allowed 'General case' 0 CA--C 1.533 0.325 0 CA-C-O 120.696 0.284 . . . . 0.0 111.313 179.95 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -119.0 177.31 4.91 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-O 120.843 0.354 . . . . 0.0 110.959 179.715 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 1.6 m -108.49 85.69 2.15 Favored 'General case' 0 C--O 1.232 0.15 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.575 179.911 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 30.3 p90 -86.28 139.51 30.95 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.891 179.958 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 25.3 mt-10 -138.69 157.91 71.11 Favored Pre-proline 0 C--O 1.234 0.246 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.633 -179.606 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 25.8 Cg_exo -63.36 -11.95 28.16 Favored 'Trans proline' 0 C--N 1.351 0.686 0 C-N-CA 123.257 2.638 . . . . 0.0 112.914 179.391 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 3.1 pt-20 -66.17 82.99 0.08 Allowed 'General case' 0 C--O 1.233 0.197 0 CA-C-O 121.076 0.465 . . . . 0.0 110.843 -179.731 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 6.0 m-80 62.12 22.9 13.45 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-N 115.799 -0.637 . . . . 0.0 111.668 -179.503 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER 53.49 78.07 0.16 Allowed 'General case' 0 C--O 1.234 0.281 0 CA-C-O 121.067 0.461 . . . . 0.0 111.286 179.921 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 1.9 ppp? -133.71 143.5 48.54 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.674 179.842 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . 0.412 ' CD1' ' N ' ' A' ' 22' ' ' PHE . 0.9 OUTLIER -127.7 132.32 49.65 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.656 179.618 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 40.6 p -122.14 158.74 28.66 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.815 -178.929 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' TYR . . . . . 0.431 ' CE2' HG22 ' A' ' 8' ' ' ILE . 61.1 t80 -139.9 137.22 18.05 Favored Pre-proline 0 CA--C 1.53 0.186 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.225 179.878 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 65.5 Cg_endo -73.44 100.94 1.3 Allowed 'Trans proline' 0 C--N 1.35 0.627 0 C-N-CA 122.768 2.312 . . . . 0.0 112.442 179.587 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . 0.432 ' SG ' ' HD2' ' A' ' 27' ' ' PRO . 53.1 t -68.69 140.21 91.76 Favored Pre-proline 0 C--O 1.233 0.229 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.705 179.786 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . 0.432 ' HD2' ' SG ' ' A' ' 26' ' ' CYS . 86.7 Cg_exo -48.89 -26.98 10.73 Favored 'Trans proline' 0 C--N 1.351 0.666 0 C-N-CA 122.916 2.411 . . . . 0.0 113.175 179.962 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 9.0 p -58.49 -28.92 65.83 Favored 'General case' 0 CA--C 1.533 0.321 0 CA-C-O 120.642 0.258 . . . . 0.0 111.433 -179.949 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 120.93 9.87 7.22 Favored Glycine 0 CA--C 1.523 0.57 0 C-N-CA 121.134 -0.555 . . . . 0.0 113.337 -179.823 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -122.42 -165.2 1.25 Allowed 'General case' 0 CA--C 1.535 0.375 0 CA-C-N 117.145 0.472 . . . . 0.0 110.935 179.972 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 3.8 ttt85 -137.85 117.16 12.73 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-O 120.515 0.198 . . . . 0.0 111.186 -179.73 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . 0.446 ' CZ ' ' HB1' ' A' ' 46' ' ' ALA . 76.4 t80 -70.63 151.96 44.4 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.225 179.896 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 3.6 pt20 -126.28 139.66 53.14 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.449 -179.939 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 12.0 tt -155.0 148.89 12.61 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.346 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.21 179.69 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 60.3 m-85 -100.67 155.77 17.7 Favored 'General case' 0 C--O 1.236 0.357 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.516 -179.695 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . 0.423 HD12 ' HG ' ' A' ' 64' ' ' LEU . 3.2 mm? -61.67 -46.88 87.85 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.775 179.734 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -60.27 -36.55 78.08 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 116.495 -0.321 . . . . 0.0 110.995 179.647 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -57.19 -46.12 83.14 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.41 179.709 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 2.6 mtt -66.23 -28.81 69.02 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.321 179.582 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -56.53 -45.77 80.98 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-O 120.573 0.225 . . . . 0.0 111.046 179.906 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 10.6 mt-10 -59.91 -32.51 70.83 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 116.461 -0.336 . . . . 0.0 110.975 179.586 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 131.74 46.61 0.13 Allowed Glycine 0 C--N 1.333 0.394 0 C-N-CA 121.145 -0.55 . . . . 0.0 112.498 179.981 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -83.35 92.89 7.63 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-O 120.993 0.425 . . . . 0.0 110.888 -179.948 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 10.8 ptpt -107.33 -32.43 7.76 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.831 -0.622 . . . . 0.0 111.218 179.881 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 7.6 p -121.58 108.98 23.47 Favored 'Isoleucine or valine' 0 C--O 1.233 0.214 0 CA-C-O 121.109 0.48 . . . . 0.0 110.874 179.796 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . 0.446 ' HB1' ' CZ ' ' A' ' 32' ' ' PHE . . . -109.63 171.81 7.22 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.589 -179.361 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 19.1 t -128.91 119.43 49.48 Favored 'Isoleucine or valine' 0 C--O 1.232 0.145 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.036 -179.935 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 41.7 t -62.33 112.19 5.99 Favored Pre-proline 0 N--CA 1.463 0.199 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.452 179.683 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 31.1 Cg_exo -60.33 -17.82 49.2 Favored 'Trans proline' 0 C--N 1.347 0.484 0 C-N-CA 122.645 2.23 . . . . 0.0 113.346 -179.569 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 4.6 t -77.05 -65.17 0.98 Allowed 'General case' 0 CA--C 1.53 0.206 0 CA-C-O 120.416 0.15 . . . . 0.0 111.397 -179.738 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 22.6 p -92.18 -19.55 22.13 Favored 'General case' 0 N--CA 1.465 0.324 0 N-CA-C 112.195 0.442 . . . . 0.0 112.195 -179.426 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 72.96 36.4 0.88 Allowed 'General case' 0 CA--C 1.533 0.302 0 CA-C-O 120.886 0.374 . . . . 0.0 110.905 -179.609 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 6.4 tt -94.94 149.51 21.17 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.736 179.792 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' MET . . . . . . . . . . . . . 38.7 mtt -93.14 129.75 39.03 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-N 116.462 -0.335 . . . . 0.0 111.357 -179.487 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 2.5 pp -137.99 152.47 26.27 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.343 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.47 179.783 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 42.5 m-20 -108.7 107.63 18.16 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.64 179.067 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 14.5 p -99.43 125.63 52.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-O 120.967 0.413 . . . . 0.0 111.026 179.835 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 13.3 p -93.74 142.66 12.98 Favored 'Isoleucine or valine' 0 C--O 1.234 0.258 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.194 -179.88 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 3.0 p90 -131.03 144.39 51.42 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.623 -179.386 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -95.13 -22.67 17.72 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-N 115.997 -0.547 . . . . 0.0 112.028 -179.93 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 3.3 mttt 65.82 27.49 11.05 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-O 120.603 0.24 . . . . 0.0 111.412 -179.575 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 12.5 tt0 -95.47 -49.64 5.33 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-O 120.919 0.39 . . . . 0.0 110.104 179.474 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -66.51 -33.78 76.45 Favored 'General case' 0 N--CA 1.462 0.169 0 CA-C-N 115.746 -0.661 . . . . 0.0 111.129 179.577 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.423 ' HG ' HD12 ' A' ' 36' ' ' LEU . 0.2 OUTLIER -52.86 -34.62 55.17 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 116.679 -0.237 . . . . 0.0 111.495 -179.711 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -86.44 -48.73 8.17 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-N 116.663 -0.244 . . . . 0.0 111.56 -179.981 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 23.5 mt-10 -65.8 -54.17 30.54 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-O 120.664 0.268 . . . . 0.0 111.256 -179.674 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 2.6 t80 -59.64 -23.69 63.25 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.3 179.412 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -57.27 -54.88 41.76 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-O 120.665 0.269 . . . . 0.0 110.962 179.834 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 37.1 mt-10 -79.97 -35.57 37.35 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.763 179.771 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 25.0 mt-10 -62.84 -37.27 86.14 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.188 179.868 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.234 0.269 0 CA-C-O 120.893 0.378 . . . . 0.0 111.353 -179.935 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 3.1 p . . . . . 0 N--CA 1.472 0.661 0 CA-C-O 120.781 0.324 . . . . 0.0 111.306 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -111.64 -41.59 4.03 Favored 'General case' 0 CA--C 1.53 0.186 0 CA-C-N 116.517 -0.31 . . . . 0.0 111.311 -179.955 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -155.56 176.09 13.05 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-O 120.697 0.284 . . . . 0.0 111.207 -179.991 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 3.9 pt-20 -130.22 131.22 45.45 Favored 'General case' 0 CA--C 1.531 0.234 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.15 179.798 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 26.5 mm -130.03 154.16 39.98 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.281 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.455 -179.812 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 9.7 mt-10 -103.78 148.22 26.36 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.062 179.843 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 33.8 pt -58.76 -32.43 46.72 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.325 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.347 179.537 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 4.4 mt-10 -60.45 -30.39 69.62 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.223 179.726 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 5.6 t0 -98.52 39.0 1.28 Allowed 'General case' 0 CA--C 1.532 0.278 0 CA-C-O 120.902 0.382 . . . . 0.0 111.038 179.727 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -132.98 143.39 49.41 Favored 'General case' 0 C--O 1.232 0.172 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.585 179.833 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 1.2 m -62.18 121.12 12.3 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-O 120.734 0.302 . . . . 0.0 111.172 -179.582 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 20.8 p90 -87.76 125.44 34.43 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.695 179.597 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 -112.22 86.38 7.84 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.405 179.852 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 40.0 Cg_endo -67.45 -20.09 48.41 Favored 'Trans proline' 0 C--N 1.347 0.487 0 C-N-CA 122.673 2.248 . . . . 0.0 112.786 -179.989 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -53.33 -36.15 60.96 Favored 'General case' 0 CA--C 1.53 0.2 0 CA-C-N 116.591 -0.277 . . . . 0.0 111.337 179.884 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 3.0 t-20 -138.54 22.73 2.71 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-N 116.534 -0.303 . . . . 0.0 111.652 179.867 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' GLN . . . . . 0.409 ' NE2' ' HA ' ' A' ' 68' ' ' TYR . 15.8 tt0 50.32 65.35 1.47 Allowed 'General case' 0 CA--C 1.534 0.347 0 CA-C-O 120.975 0.416 . . . . 0.0 111.454 179.916 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' MET . . . . . 0.449 ' HB3' ' CD1' ' A' ' 35' ' ' TYR . 23.3 ptt? -149.62 172.65 14.7 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.137 179.86 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 16.1 m-85 -130.3 134.29 47.1 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.026 179.86 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 11.8 p -130.53 136.29 48.8 Favored 'General case' 0 N--CA 1.462 0.162 0 CA-C-N 116.389 -0.368 . . . . 0.0 111.269 -179.893 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 32.7 t80 -139.38 137.46 19.02 Favored Pre-proline 0 C--N 1.333 -0.137 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.982 179.895 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -72.06 103.68 1.53 Allowed 'Trans proline' 0 C--N 1.348 0.517 0 C-N-CA 122.685 2.256 . . . . 0.0 112.507 179.924 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . 0.408 ' SG ' ' HD2' ' A' ' 27' ' ' PRO . 48.7 t -64.31 139.29 97.67 Favored Pre-proline 0 C--O 1.233 0.23 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.696 179.75 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . 0.408 ' HD2' ' SG ' ' A' ' 26' ' ' CYS . 71.0 Cg_exo -50.06 -26.01 13.82 Favored 'Trans proline' 0 C--N 1.352 0.713 0 C-N-CA 122.932 2.422 . . . . 0.0 113.237 179.844 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 7.7 p -57.94 -28.65 64.5 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-O 120.578 0.228 . . . . 0.0 111.434 179.944 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 122.84 6.79 7.62 Favored Glycine 0 CA--C 1.524 0.629 0 C-N-CA 121.096 -0.573 . . . . 0.0 113.513 -179.995 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -122.37 -173.33 2.65 Favored 'General case' 0 CA--C 1.532 0.252 0 CA-C-N 117.237 0.519 . . . . 0.0 111.001 179.954 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 7.1 ttm-85 -118.94 130.11 55.53 Favored 'General case' 0 N--CA 1.463 0.183 0 CA-C-O 120.807 0.337 . . . . 0.0 111.378 -179.854 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . 0.457 ' CZ ' ' HB2' ' A' ' 46' ' ' ALA . 64.6 t80 -91.84 157.48 16.85 Favored 'General case' 0 CA--C 1.529 0.164 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.917 179.673 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -140.13 129.3 23.72 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.067 179.749 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 3.1 tt -139.06 115.65 10.24 Favored 'Isoleucine or valine' 0 C--O 1.234 0.254 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.986 179.626 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . 0.449 ' CD1' ' HB3' ' A' ' 21' ' ' MET . 41.6 m-85 -74.5 141.63 44.88 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.996 -179.88 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -59.54 -38.29 80.65 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.006 179.686 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 1.2 p30 -60.88 -40.22 92.19 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 116.477 -0.329 . . . . 0.0 110.849 179.524 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 2.5 t70 -63.17 -39.56 95.02 Favored 'General case' 0 N--CA 1.462 0.134 0 CA-C-N 116.493 -0.321 . . . . 0.0 110.895 179.73 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 5.0 mtt -61.99 -29.49 70.29 Favored 'General case' 0 N--CA 1.463 0.187 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.115 179.604 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -57.13 -35.99 70.14 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 116.536 -0.302 . . . . 0.0 111.035 179.662 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 8.3 mt-10 -66.99 -34.4 77.67 Favored 'General case' 0 CA--C 1.531 0.234 0 CA-C-N 116.511 -0.313 . . . . 0.0 110.835 179.628 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 124.56 64.02 0.19 Allowed Glycine 0 C--N 1.335 0.49 0 C-N-CA 120.982 -0.628 . . . . 0.0 112.557 179.631 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 2.1 tp10 -104.25 105.93 16.25 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-O 120.729 0.3 . . . . 0.0 111.084 179.955 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -111.44 -33.79 6.3 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.044 179.431 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 18.8 t -115.96 87.68 1.07 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.273 0 CA-C-O 120.905 0.383 . . . . 0.0 110.659 179.752 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . 0.457 ' HB2' ' CZ ' ' A' ' 32' ' ' PHE . . . -82.94 162.65 21.44 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.21 -179.796 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 11.6 p -121.38 122.95 68.63 Favored 'Isoleucine or valine' 0 C--O 1.233 0.206 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.083 179.926 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 49.3 t -63.04 135.43 96.22 Favored Pre-proline 0 C--N 1.331 -0.217 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.724 179.96 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 93.6 Cg_endo -83.3 19.76 1.28 Allowed 'Trans proline' 0 CA--C 1.535 0.555 0 C-N-CA 122.623 2.215 . . . . 0.0 113.307 -179.855 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -129.15 -57.19 1.16 Allowed 'General case' 0 C--O 1.233 0.188 0 CA-C-O 120.459 0.171 . . . . 0.0 110.628 179.661 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 17.9 p -101.68 -10.92 19.57 Favored 'General case' 0 N--CA 1.465 0.319 0 N-CA-C 111.956 0.354 . . . . 0.0 111.956 179.881 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 5.8 p 61.0 35.64 18.88 Favored 'General case' 0 CA--C 1.535 0.403 0 CA-C-O 120.842 0.354 . . . . 0.0 111.502 179.842 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 7.7 tt -89.07 134.6 33.94 Favored 'General case' 0 CA--C 1.53 0.2 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.534 179.748 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' MET . . . . . . . . . . . . . 20.4 mtt -84.6 135.79 34.04 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.062 -179.773 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 2.7 pt -138.81 137.56 42.68 Favored 'Isoleucine or valine' 0 C--O 1.234 0.261 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.751 -179.778 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 55.5 m-20 -87.13 88.67 7.76 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.675 179.305 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 14.2 p -88.38 112.47 23.86 Favored 'Isoleucine or valine' 0 C--O 1.234 0.263 0 CA-C-O 121.003 0.43 . . . . 0.0 111.004 179.901 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 14.4 p -86.72 127.72 40.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.935 179.997 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 29.1 p90 -124.82 177.76 5.84 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.936 -0.575 . . . . 0.0 111.114 -179.606 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -133.1 144.38 49.91 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.169 -179.807 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 8.1 tttt -74.88 -40.76 60.76 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.84 179.585 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 6.3 tt0 -58.03 -48.8 78.98 Favored 'General case' 0 N--CA 1.462 0.131 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.559 179.587 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -55.03 -50.15 69.78 Favored 'General case' 0 C--O 1.232 0.153 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.033 179.691 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -56.88 -40.32 75.98 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.132 179.976 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -61.27 -38.29 86.22 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-N 116.451 -0.34 . . . . 0.0 111.163 179.645 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -76.05 -47.46 24.62 Favored 'General case' 0 C--O 1.231 0.125 0 CA-C-N 116.474 -0.33 . . . . 0.0 111.075 179.639 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 6.5 m-85 -55.75 -32.75 63.68 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 116.468 -0.333 . . . . 0.0 111.384 179.876 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . 0.409 ' HA ' ' NE2' ' A' ' 20' ' ' GLN . 1.8 t80 -59.09 -41.31 87.75 Favored 'General case' 0 C--O 1.232 0.184 0 CA-C-O 120.695 0.284 . . . . 0.0 110.713 179.644 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 6.4 tt0 -84.82 -38.94 18.94 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.803 179.447 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 4.9 tt0 -62.29 -39.69 93.79 Favored 'General case' 0 CA--C 1.529 0.169 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.252 -179.958 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.233 0.194 0 CA-C-N 116.597 -0.274 . . . . 0.0 111.132 179.729 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 2.4 p . . . . . 0 N--CA 1.469 0.505 0 CA-C-O 121.201 0.524 . . . . 0.0 111.432 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 7.9 m-85 -114.8 -37.33 4.24 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.747 -0.66 . . . . 0.0 111.381 -179.844 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -157.53 176.72 12.27 Favored 'General case' 0 C--O 1.236 0.344 0 CA-C-O 120.698 0.285 . . . . 0.0 111.094 179.752 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -122.7 140.94 52.31 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.966 179.802 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 25.0 mt -125.83 154.62 34.91 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.17 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.196 -179.811 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 17.1 mt-10 -109.04 150.62 27.52 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-N 116.345 -0.388 . . . . 0.0 111.108 179.957 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 16.5 tt -59.01 -28.88 39.93 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.292 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.58 179.697 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 20.5 mt-10 -58.26 -31.13 67.14 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-N 116.528 -0.305 . . . . 0.0 111.285 179.666 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -94.36 28.48 2.54 Favored 'General case' 0 CA--C 1.536 0.41 0 CA-C-N 116.695 -0.23 . . . . 0.0 111.41 179.643 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 1.4 ttp -122.75 167.56 13.33 Favored 'General case' 0 CA--C 1.53 0.176 0 CA-C-O 120.648 0.261 . . . . 0.0 111.234 -179.736 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -105.36 117.24 33.52 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.77 179.891 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . 0.493 ' HB3' ' CE2' ' A' ' 22' ' ' PHE . 37.2 p90 -96.0 147.78 23.34 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.974 179.826 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -144.43 150.25 47.13 Favored Pre-proline 0 N--CA 1.463 0.211 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.398 179.875 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 70.2 Cg_endo -73.8 -14.74 24.17 Favored 'Trans proline' 0 C--N 1.348 0.55 0 C-N-CA 123.056 2.504 . . . . 0.0 113.098 179.613 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -69.03 82.53 0.32 Allowed 'General case' 0 CA--C 1.53 0.185 0 CA-C-O 121.179 0.514 . . . . 0.0 110.868 -179.824 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 6.8 m-80 67.51 20.7 9.73 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 115.564 -0.744 . . . . 0.0 111.797 -179.556 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 16.7 mt-30 54.14 77.54 0.19 Allowed 'General case' 0 CA--C 1.532 0.257 0 CA-C-O 120.854 0.359 . . . . 0.0 111.428 179.596 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -116.62 145.25 43.53 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.034 179.967 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . 0.493 ' CE2' ' HB3' ' A' ' 15' ' ' PHE . 12.3 m-85 -125.92 94.86 4.23 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.654 -179.901 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 32.2 p -91.79 146.14 24.0 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.419 -179.49 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 23.0 t80 -142.59 137.18 15.09 Favored Pre-proline 0 CA--C 1.53 0.184 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.036 -179.942 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -65.32 100.02 0.37 Allowed 'Trans proline' 0 C--N 1.349 0.596 0 C-N-CA 122.694 2.263 . . . . 0.0 112.272 179.604 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 48.1 t -65.94 139.01 96.56 Favored Pre-proline 0 C--O 1.233 0.229 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.699 179.903 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 54.8 Cg_exo -53.25 -25.41 30.21 Favored 'Trans proline' 0 C--N 1.35 0.649 0 C-N-CA 122.82 2.346 . . . . 0.0 112.83 179.666 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -68.26 -38.54 81.86 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-O 120.451 0.167 . . . . 0.0 111.268 179.985 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 152.16 -47.47 0.56 Allowed Glycine 0 C--N 1.335 0.477 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.962 -179.987 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -76.74 -174.69 3.11 Favored 'General case' 0 CA--C 1.531 0.223 0 CA-C-O 120.694 0.283 . . . . 0.0 111.12 -179.783 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 12.3 mtt180 -122.36 137.41 54.87 Favored 'General case' 0 C--O 1.232 0.164 0 CA-C-O 120.829 0.347 . . . . 0.0 111.097 -179.853 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 9.1 m-85 -66.47 167.85 10.03 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.004 179.774 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 12.6 pt20 -154.18 97.64 2.06 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.114 -179.985 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 10.7 tt -123.97 151.52 28.94 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.216 0 CA-C-N 116.29 -0.413 . . . . 0.0 111.293 179.996 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 6.3 m-85 -102.53 152.69 20.86 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.839 -179.961 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 25.6 mt -61.6 -43.04 99.6 Favored 'General case' 0 N--CA 1.463 0.175 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.032 179.798 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -60.25 -38.13 82.53 Favored 'General case' 0 CA--C 1.53 0.187 0 CA-C-N 116.405 -0.362 . . . . 0.0 111.032 179.65 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -59.19 -57.04 14.79 Favored 'General case' 0 N--CA 1.462 0.158 0 CA-C-O 120.769 0.319 . . . . 0.0 110.81 179.711 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 47.6 mtm -61.32 -37.77 84.46 Favored 'General case' 0 N--CA 1.462 0.157 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.024 179.589 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 17.7 t80 -58.11 -38.7 76.96 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.999 179.586 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 1.3 tp10 -62.05 -45.13 94.9 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-N 116.507 -0.315 . . . . 0.0 110.761 179.576 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 152.29 48.34 0.02 OUTLIER Glycine 0 C--N 1.332 0.34 0 C-N-CA 120.979 -0.629 . . . . 0.0 112.694 179.627 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 1.1 tp10 -99.53 147.61 25.14 Favored 'General case' 0 C--O 1.231 0.106 0 CA-C-O 120.754 0.311 . . . . 0.0 110.99 179.921 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 7.9 mttt -149.37 -47.99 0.14 Allowed 'General case' 0 C--O 1.233 0.217 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.133 179.752 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 24.3 t -106.86 104.52 17.18 Favored 'Isoleucine or valine' 0 C--O 1.234 0.257 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.862 179.957 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -92.7 174.64 7.16 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.076 179.813 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 10.7 p -134.9 123.57 41.22 Favored 'Isoleucine or valine' 0 C--O 1.233 0.214 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.205 -179.954 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 48.3 t -70.31 135.77 86.66 Favored Pre-proline 0 C--N 1.332 -0.186 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.807 179.869 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_endo -84.13 20.94 1.13 Allowed 'Trans proline' 0 CA--C 1.536 0.581 0 C-N-CA 122.762 2.308 . . . . 0.0 113.077 179.682 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -128.71 -55.72 1.22 Allowed 'General case' 0 C--O 1.232 0.155 0 CA-C-N 116.67 -0.241 . . . . 0.0 110.626 179.903 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 18.6 p -98.31 -17.69 18.76 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.848 179.906 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 5.6 p 63.93 37.15 9.65 Favored 'General case' 0 CA--C 1.535 0.382 0 CA-C-O 120.987 0.422 . . . . 0.0 111.438 179.865 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 1.3 tm? -101.99 130.62 48.57 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.491 179.7 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' MET . . . . . . . . . . . . . 60.6 mtm -83.95 135.18 34.56 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.836 179.997 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 2.5 pp -137.51 134.35 46.42 Favored 'Isoleucine or valine' 0 C--O 1.233 0.23 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.564 -179.89 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 20.1 m-20 -82.41 100.95 10.32 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.766 179.597 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 13.5 p -104.02 116.66 48.22 Favored 'Isoleucine or valine' 0 C--O 1.233 0.227 0 CA-C-O 121.133 0.492 . . . . 0.0 111.179 179.9 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 12.4 p -87.55 137.53 20.82 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.939 -179.94 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 44.3 p90 -124.66 175.98 6.85 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.072 -179.67 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -114.02 155.94 24.99 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.144 -179.881 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 56.6 mttt -92.96 -44.44 8.43 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.742 179.674 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 16.2 pt-20 -57.84 -36.04 71.73 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 116.473 -0.33 . . . . 0.0 110.927 179.61 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -55.68 -53.3 58.3 Favored 'General case' 0 N--CA 1.461 0.125 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.67 179.523 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 3.0 mp -55.43 -39.35 70.14 Favored 'General case' 0 N--CA 1.462 0.159 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.211 179.631 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -58.76 -60.15 4.29 Favored 'General case' 0 CA--C 1.528 0.11 0 CA-C-N 116.507 -0.315 . . . . 0.0 111.173 179.885 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -63.72 -40.6 97.15 Favored 'General case' 0 N--CA 1.464 0.225 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.221 179.708 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -63.16 -55.51 24.57 Favored 'General case' 0 C--O 1.227 -0.129 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.233 -179.82 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 3.0 t80 -61.56 -43.98 97.87 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 116.592 -0.276 . . . . 0.0 110.89 179.998 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 4.0 tt0 -58.11 -30.42 66.28 Favored 'General case' 0 CA--C 1.53 0.21 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.975 179.541 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -130.74 59.55 1.66 Allowed 'General case' 0 C--O 1.234 0.26 0 CA-C-O 120.839 0.352 . . . . 0.0 111.107 -179.927 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.234 0.251 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.536 179.926 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' THR . . . . . 0.413 HG23 ' HB3' ' A' ' 54' ' ' MET . 0.2 OUTLIER . . . . . 0 N--CA 1.467 0.384 0 CA-C-O 120.747 0.308 . . . . 0.0 110.982 . . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 21.4 m-85 -105.58 -76.4 0.61 Allowed 'General case' 0 C--O 1.232 0.167 0 CA-C-N 116.48 -0.327 . . . . 0.0 111.176 -179.739 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -126.66 171.77 10.87 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.002 -179.813 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 4.6 pt-20 -132.64 136.31 46.41 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-N 116.405 -0.361 . . . . 0.0 111.014 179.654 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 3.7 mp -118.48 150.4 20.72 Favored 'Isoleucine or valine' 0 C--O 1.233 0.226 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.375 -179.605 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . 0.404 ' HA ' ' CG1' ' A' ' 58' ' ' VAL . 12.2 mt-10 -98.97 153.55 18.76 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.366 -179.905 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 1.1 tp -59.25 -32.61 48.65 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.286 0 CA-C-N 115.989 -0.55 . . . . 0.0 111.223 179.551 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -61.21 -33.17 73.04 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-N 116.551 -0.295 . . . . 0.0 110.998 179.514 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -96.91 37.37 1.31 Allowed 'General case' 0 C--O 1.234 0.27 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.177 179.816 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' MET . . . . . 0.499 ' HG2' ' CD1' ' A' ' 24' ' ' TYR . 3.3 mtp -125.75 150.09 48.02 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-N 116.407 -0.361 . . . . 0.0 110.887 179.798 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 7.3 m -96.7 113.57 25.14 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.766 179.679 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 24.2 p90 -80.38 130.18 35.0 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.517 179.632 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 3.9 tt0 -107.23 95.83 14.18 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.625 -179.949 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -72.87 60.84 3.72 Favored 'Trans proline' 0 C--N 1.347 0.492 0 C-N-CA 122.69 2.26 . . . . 0.0 112.58 -179.734 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 15.1 pt-20 -126.67 -45.27 1.63 Allowed 'General case' 0 C--O 1.233 0.189 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.876 179.915 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 2.2 t-20 -146.55 33.64 0.95 Allowed 'General case' 0 CA--C 1.532 0.276 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.066 179.636 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 10.1 mt-30 57.9 57.75 3.98 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.222 179.851 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 21.8 ptm -136.62 151.44 49.33 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.672 179.658 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 7.6 m-85 -130.24 124.85 33.44 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.388 -179.899 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 64.3 p -120.24 137.5 54.18 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.952 -179.581 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' TYR . . . . . 0.499 ' CD1' ' HG2' ' A' ' 13' ' ' MET . 1.9 p90 -131.54 148.17 68.97 Favored Pre-proline 0 C--O 1.233 0.195 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.133 179.867 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_exo -52.52 124.72 15.81 Favored 'Trans proline' 0 C--N 1.349 0.584 0 C-N-CA 122.872 2.381 . . . . 0.0 112.774 -179.671 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . 0.48 ' SG ' ' HD2' ' A' ' 27' ' ' PRO . 50.5 t -94.9 141.21 22.98 Favored Pre-proline 0 C--N 1.33 -0.244 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.342 179.587 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . 0.48 ' HD2' ' SG ' ' A' ' 26' ' ' CYS . 87.6 Cg_exo -48.08 -30.11 13.63 Favored 'Trans proline' 0 C--N 1.349 0.578 0 C-N-CA 122.846 2.364 . . . . 0.0 113.192 179.914 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . 0.404 ' CB ' ' HB3' ' A' ' 51' ' ' CYS . 0.8 OUTLIER -76.96 -40.36 47.2 Favored 'General case' 0 CA--C 1.532 0.267 0 CA-C-N 116.818 -0.174 . . . . 0.0 111.32 179.986 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 151.77 -45.07 0.63 Allowed Glycine 0 C--N 1.335 0.516 0 C-N-CA 120.49 -0.862 . . . . 0.0 113.175 179.753 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 50.6 m-20 -67.33 -177.74 0.74 Allowed 'General case' 0 CA--C 1.532 0.271 0 CA-C-O 120.912 0.387 . . . . 0.0 111.123 -179.808 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -110.97 128.15 55.74 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.875 -179.716 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 15.0 m-85 -64.66 91.46 0.08 Allowed 'General case' 0 C--O 1.233 0.227 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.7 179.816 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 2.9 pt20 -80.13 125.86 30.36 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.228 -179.65 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 2.5 tt -161.26 133.77 1.09 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.207 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.066 179.723 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 71.3 m-85 -88.11 145.52 25.9 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.775 -179.947 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 4.1 pp -58.01 -33.38 68.88 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.215 179.74 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 1.2 p30 -65.3 -39.07 92.03 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 116.567 -0.288 . . . . 0.0 110.785 179.493 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -61.87 -46.95 87.19 Favored 'General case' 0 CA--C 1.528 0.116 0 CA-C-N 116.422 -0.353 . . . . 0.0 110.839 179.781 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 55.6 mtm -74.37 -33.1 62.98 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.176 179.825 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 18.4 t80 -57.09 -38.27 73.09 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.029 -179.931 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 21.6 mt-10 -60.71 -37.18 80.83 Favored 'General case' 0 N--CA 1.462 0.147 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.889 179.548 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 145.56 47.62 0.03 OUTLIER Glycine 0 C--N 1.333 0.391 0 C-N-CA 120.94 -0.647 . . . . 0.0 112.69 179.794 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -112.56 148.2 35.02 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-O 120.741 0.305 . . . . 0.0 111.161 -179.845 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 22.8 mtmt -148.09 -48.24 0.16 Allowed 'General case' 0 CA--C 1.531 0.219 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.076 179.815 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 23.7 t -89.87 94.79 5.03 Favored 'Isoleucine or valine' 0 C--O 1.232 0.178 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.805 -179.985 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -91.6 159.18 16.03 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.188 -179.884 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 11.6 p -126.04 128.45 71.84 Favored 'Isoleucine or valine' 0 C--O 1.232 0.169 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.371 -179.904 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 42.0 t -71.21 136.73 84.32 Favored Pre-proline 0 CA--C 1.53 0.201 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.884 179.714 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 92.9 Cg_endo -82.8 20.35 1.16 Allowed 'Trans proline' 0 C--N 1.35 0.629 0 C-N-CA 122.751 2.301 . . . . 0.0 113.136 179.742 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 38.9 t -128.59 -58.11 1.18 Allowed 'General case' 0 C--O 1.232 0.153 0 N-CA-C 110.265 -0.272 . . . . 0.0 110.265 179.539 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' CYS . . . . . 0.454 ' SG ' ' HB2' ' A' ' 53' ' ' LEU . 20.7 p -94.26 -27.0 16.38 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.483 179.711 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 1.5 t 70.92 42.92 0.73 Allowed 'General case' 0 CA--C 1.532 0.275 0 CA-C-O 120.931 0.396 . . . . 0.0 110.968 -179.838 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.454 ' HB2' ' SG ' ' A' ' 51' ' ' CYS . 3.6 mm? -92.34 150.69 20.69 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.63 179.64 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' MET . . . . . 0.413 ' HB3' HG23 ' A' ' 4' ' ' THR . 9.7 mtt -104.66 123.05 46.92 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.904 -179.791 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 2.6 pp -134.99 148.3 29.1 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.313 0 CA-C-N 116.363 -0.38 . . . . 0.0 111.842 -179.883 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 32.1 m-20 -102.4 92.36 4.66 Favored 'General case' 0 CA--C 1.531 0.223 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.95 179.657 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 13.1 p -88.97 127.83 41.46 Favored 'Isoleucine or valine' 0 C--O 1.234 0.256 0 CA-C-O 120.851 0.357 . . . . 0.0 110.986 179.72 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.404 ' CG1' ' HA ' ' A' ' 9' ' ' GLU . 12.5 p -97.97 136.53 28.52 Favored 'Isoleucine or valine' 0 C--O 1.234 0.251 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.398 -179.837 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 16.1 p90 -123.82 170.12 10.88 Favored 'General case' 0 CA--C 1.53 0.184 0 CA-C-N 115.899 -0.591 . . . . 0.0 111.073 -179.966 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -107.63 160.13 15.93 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.106 179.734 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -89.17 -37.85 14.73 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.032 179.691 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -72.21 -38.83 68.91 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-N 116.618 -0.265 . . . . 0.0 111.171 179.944 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 88.7 m-20 -52.71 -41.65 64.11 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.001 -179.988 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -63.7 -52.35 60.97 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.979 -179.933 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -57.47 -39.26 75.97 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-N 116.489 -0.323 . . . . 0.0 110.736 179.57 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -73.83 -46.43 45.15 Favored 'General case' 0 N--CA 1.461 0.124 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.273 179.67 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 9.3 t80 -60.61 -37.67 82.18 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 116.713 -0.221 . . . . 0.0 111.237 -179.946 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 13.9 t80 -58.29 -41.34 84.17 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-O 120.55 0.214 . . . . 0.0 110.813 179.742 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 9.5 mt-10 -87.93 -35.38 17.71 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.496 -179.801 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 -72.18 -33.37 67.63 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 116.65 -0.25 . . . . 0.0 111.583 -179.843 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.233 0.232 0 CA-C-O 120.819 0.342 . . . . 0.0 111.329 -179.939 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.464 0.262 0 CA-C-O 120.906 0.384 . . . . 0.0 111.36 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 15.3 m-85 -103.6 -36.2 8.01 Favored 'General case' 0 CA--C 1.53 0.194 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.381 179.849 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -158.78 171.45 20.05 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-O 120.701 0.286 . . . . 0.0 111.322 -179.97 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -127.54 140.5 52.09 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.005 -179.897 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 27.1 mm -120.48 156.01 23.61 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.254 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.926 -179.865 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 10.0 mt-10 -119.63 159.82 23.67 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-O 120.739 0.304 . . . . 0.0 111.323 179.848 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 11.5 tt -65.39 -30.95 51.77 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.351 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.481 179.37 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -60.02 -42.33 94.14 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-O 120.45 0.166 . . . . 0.0 111.331 -179.878 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 8.4 p-10 -98.09 37.05 1.47 Allowed 'General case' 0 CA--C 1.535 0.378 0 CA-C-O 120.824 0.345 . . . . 0.0 111.329 179.589 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -114.43 139.74 49.26 Favored 'General case' 0 C--O 1.233 0.236 0 N-CA-C 109.655 -0.498 . . . . 0.0 109.655 179.182 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 2.9 m -66.87 89.84 0.17 Allowed 'General case' 0 C--O 1.233 0.207 0 CA-C-O 120.86 0.362 . . . . 0.0 110.651 -179.649 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 52.1 p90 -80.2 127.71 32.66 Favored 'General case' 0 C--O 1.232 0.159 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.752 -179.979 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 5.8 mt-10 -109.1 93.92 13.93 Favored Pre-proline 0 C--O 1.236 0.346 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.347 179.845 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -71.64 64.77 3.05 Favored 'Trans proline' 0 C--N 1.346 0.398 0 C-N-CA 122.943 2.429 . . . . 0.0 112.351 -179.794 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 17.1 pt-20 -140.29 -45.86 0.42 Allowed 'General case' 0 CA--C 1.531 0.226 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.916 179.934 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 44.9 p30 -134.69 24.11 3.67 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.557 -179.998 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER 60.79 47.05 8.27 Favored 'General case' 0 C--O 1.235 0.325 0 CA-C-O 120.944 0.402 . . . . 0.0 111.053 179.983 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 20.2 ttt -114.77 143.13 45.56 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.919 -179.917 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 4.1 m-85 -127.92 104.34 7.75 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.702 179.649 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 22.5 p -107.88 179.27 4.27 Favored 'General case' 0 CA--C 1.531 0.216 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.01 -179.962 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 63.1 t80 -173.09 135.27 0.7 Allowed Pre-proline 0 N--CA 1.466 0.338 0 CA-C-N 116.63 -0.259 . . . . 0.0 111.211 179.712 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_endo -66.92 108.05 1.42 Allowed 'Trans proline' 0 C--N 1.349 0.6 0 C-N-CA 122.611 2.207 . . . . 0.0 112.447 179.832 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . 0.424 ' SG ' ' HD2' ' A' ' 27' ' ' PRO . 42.8 t -69.36 139.64 89.7 Favored Pre-proline 0 C--N 1.332 -0.187 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.517 179.704 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . 0.424 ' HD2' ' SG ' ' A' ' 26' ' ' CYS . 77.7 Cg_exo -51.59 -26.95 23.93 Favored 'Trans proline' 0 C--N 1.349 0.599 0 C-N-CA 122.92 2.413 . . . . 0.0 113.072 179.833 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . 0.401 ' CB ' ' HB3' ' A' ' 51' ' ' CYS . 0.8 OUTLIER -70.1 -38.59 75.7 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-N 116.894 -0.139 . . . . 0.0 111.36 -179.868 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 150.86 -43.31 0.71 Allowed Glycine 0 C--N 1.335 0.483 0 C-N-CA 120.869 -0.682 . . . . 0.0 112.91 -179.842 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -70.83 -174.44 0.92 Allowed 'General case' 0 CA--C 1.535 0.383 0 CA-C-O 120.668 0.271 . . . . 0.0 111.187 -179.77 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 18.6 ttm180 -126.96 122.37 34.35 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-O 120.706 0.289 . . . . 0.0 111.385 -179.689 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 4.4 m-85 -61.86 154.14 26.9 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.849 179.527 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 32.9 mt-30 -143.02 122.04 12.83 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-N 116.455 -0.338 . . . . 0.0 111.478 179.993 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 3.9 tt -151.2 123.12 1.12 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.24 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.896 179.451 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 44.5 m-85 -81.52 158.78 24.35 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.887 -179.916 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -59.53 -39.39 83.75 Favored 'General case' 0 N--CA 1.463 0.225 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.847 179.829 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -59.76 -42.59 93.58 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 116.468 -0.333 . . . . 0.0 110.98 179.543 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 33.9 m-20 -58.72 -46.11 88.09 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-O 120.857 0.36 . . . . 0.0 110.475 179.696 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 5.2 mmm -61.18 -35.71 77.88 Favored 'General case' 0 CA--C 1.529 0.17 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.808 179.518 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -54.35 -45.6 72.77 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 116.491 -0.322 . . . . 0.0 111.293 179.933 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 6.3 mt-10 -61.43 -46.47 89.96 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 116.585 -0.28 . . . . 0.0 110.892 179.875 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 132.09 52.63 0.09 OUTLIER Glycine 0 C--N 1.333 0.376 0 C-N-CA 120.977 -0.63 . . . . 0.0 112.609 179.807 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -106.32 95.88 6.08 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-O 120.941 0.401 . . . . 0.0 111.175 -179.938 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 5.0 ptpt -105.77 -32.92 8.18 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-N 115.843 -0.617 . . . . 0.0 111.064 179.62 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 9.5 p -86.89 74.07 1.05 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.295 0 CA-C-O 121.456 0.646 . . . . 0.0 111.001 -179.915 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -81.5 136.32 35.63 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.718 -0.674 . . . . 0.0 111.101 -179.896 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 6.4 m -109.8 125.59 66.98 Favored 'Isoleucine or valine' 0 C--O 1.232 0.18 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.337 -179.985 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 50.3 t -68.8 135.68 90.05 Favored Pre-proline 0 C--O 1.233 0.229 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.84 179.893 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_endo -84.14 20.59 1.18 Allowed 'Trans proline' 0 C--N 1.349 0.59 0 C-N-CA 122.716 2.278 . . . . 0.0 113.217 179.698 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -128.55 -57.58 1.2 Allowed 'General case' 0 C--O 1.232 0.151 0 CA-C-O 120.59 0.233 . . . . 0.0 110.582 179.712 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' CYS . . . . . 0.401 ' HB3' ' CB ' ' A' ' 28' ' ' CYS . 19.1 p -95.35 -22.51 17.69 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-N 116.352 -0.386 . . . . 0.0 111.658 179.828 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 1.1 t 67.53 41.37 2.36 Favored 'General case' 0 CA--C 1.533 0.314 0 CA-C-O 120.981 0.42 . . . . 0.0 110.948 -179.841 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 7.0 tp -95.66 134.32 38.7 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.846 179.86 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' MET . . . . . . . . . . . . . 37.7 mtt -86.07 132.3 34.07 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.0 -179.94 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 2.5 pp -142.18 139.64 29.87 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.205 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.314 -179.899 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 67.3 m-20 -102.07 97.28 7.63 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.68 179.362 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 12.7 p -86.39 138.01 19.84 Favored 'Isoleucine or valine' 0 C--O 1.234 0.282 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.12 179.885 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 13.4 p -104.92 133.21 49.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.876 179.89 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 37.6 p90 -132.46 176.51 8.36 Favored 'General case' 0 CA--C 1.532 0.274 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.054 -179.397 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 2.5 t70 -122.3 147.69 45.93 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.457 179.968 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 15.0 tttm -83.68 -39.0 20.73 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.82 179.435 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 20.3 mt-10 -60.0 -42.29 93.94 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-N 116.481 -0.327 . . . . 0.0 110.397 179.514 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -64.6 -44.43 90.62 Favored 'General case' 0 CA--C 1.527 0.072 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.795 179.396 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -58.25 -43.64 87.94 Favored 'General case' 0 N--CA 1.463 0.207 0 CA-C-N 116.679 -0.237 . . . . 0.0 110.946 179.841 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -65.11 -40.94 95.22 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-N 116.409 -0.359 . . . . 0.0 110.814 179.527 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 2.3 tp10 -72.35 -43.8 63.52 Favored 'General case' 0 CA--C 1.532 0.251 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.165 179.617 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 1.4 t80 -62.48 -36.56 82.88 Favored 'General case' 0 N--CA 1.464 0.273 0 N-CA-C 111.945 0.35 . . . . 0.0 111.945 -179.589 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -59.47 -38.73 81.56 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-O 120.676 0.274 . . . . 0.0 110.624 179.963 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 -86.69 -38.6 16.84 Favored 'General case' 0 CA--C 1.53 0.205 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.048 179.766 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 73.2 mt-10 -69.15 -38.81 78.99 Favored 'General case' 0 N--CA 1.465 0.306 0 N-CA-C 111.867 0.321 . . . . 0.0 111.867 -179.394 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.157 0 C-N-CA 121.245 -0.182 . . . . 0.0 111.401 -179.749 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--O 1.233 0.221 0 CA-C-O 120.722 0.296 . . . . 0.0 111.027 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 25.7 m-85 -106.72 -74.04 0.67 Allowed 'General case' 0 C--O 1.232 0.166 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.325 -179.843 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -131.78 169.22 16.52 Favored 'General case' 0 C--O 1.234 0.279 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.152 -179.695 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 1.5 pt-20 -105.88 138.22 42.44 Favored 'General case' 0 C--O 1.232 0.166 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.234 179.987 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 31.3 mm -101.38 154.96 4.7 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.196 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.053 179.916 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . 0.416 ' HA ' HG11 ' A' ' 58' ' ' VAL . 16.0 tt0 -109.18 130.3 55.49 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.947 179.94 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 18.7 tt -60.58 -31.3 48.65 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.262 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.244 179.632 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 3.1 tt0 -59.98 -31.81 70.25 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.107 179.543 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -96.26 37.12 1.27 Allowed 'General case' 0 CA--C 1.533 0.312 0 CA-C-O 120.81 0.338 . . . . 0.0 111.112 179.823 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 32.4 mtt -127.89 137.0 52.16 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-N 116.478 -0.328 . . . . 0.0 110.653 179.733 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 2.6 m -61.17 116.97 4.99 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.765 -179.847 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 23.5 p90 -86.44 134.05 33.72 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.904 -179.946 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -118.96 94.1 47.67 Favored Pre-proline 0 C--O 1.234 0.256 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.646 179.946 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_endo -68.34 -12.83 36.09 Favored 'Trans proline' 0 C--N 1.346 0.413 0 C-N-CA 122.76 2.307 . . . . 0.0 113.122 -179.926 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -54.75 -44.18 73.37 Favored 'General case' 0 CA--C 1.53 0.191 0 CA-C-N 116.812 -0.176 . . . . 0.0 111.138 -179.942 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 14.7 m-20 -144.85 24.3 1.51 Allowed 'General case' 0 CA--C 1.534 0.337 0 CA-C-N 116.435 -0.348 . . . . 0.0 111.555 179.723 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 2.3 tp60 56.86 69.01 0.78 Allowed 'General case' 0 CA--C 1.532 0.285 0 CA-C-O 120.827 0.346 . . . . 0.0 111.7 179.561 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 11.7 ptp -141.89 150.15 41.15 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.352 -0.386 . . . . 0.0 111.139 179.662 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 7.7 m-85 -120.2 143.9 48.0 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.79 -179.941 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 58.0 p -126.68 146.69 50.1 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.232 -179.897 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 4.6 t80 -135.73 95.07 14.32 Favored Pre-proline 0 C--N 1.332 -0.177 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.605 179.815 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_exo -52.13 94.31 0.03 OUTLIER 'Trans proline' 0 C--N 1.349 0.59 0 C-N-CA 122.867 2.378 . . . . 0.0 112.309 -179.932 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 29.5 t -65.38 135.63 96.03 Favored Pre-proline 0 C--O 1.233 0.224 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.792 -179.778 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -60.17 -17.49 46.16 Favored 'Trans proline' 0 C--N 1.349 0.564 0 C-N-CA 122.731 2.288 . . . . 0.0 112.861 179.684 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 3.6 p -58.72 -30.33 67.37 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-O 120.556 0.217 . . . . 0.0 111.346 179.769 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 138.64 -15.28 3.37 Favored Glycine 0 CA--C 1.523 0.577 0 C-N-CA 120.945 -0.645 . . . . 0.0 113.28 -179.897 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 3.2 t0 -113.83 -166.55 1.1 Allowed 'General case' 0 CA--C 1.534 0.333 0 CA-C-N 117.036 0.418 . . . . 0.0 111.216 -179.804 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 16.2 ttp-105 -129.32 153.62 47.67 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.059 -179.804 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -91.27 167.02 12.62 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-N 116.09 -0.504 . . . . 0.0 111.074 179.754 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -157.58 113.76 2.87 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.885 179.608 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.401 HD12 ' HG3' ' A' ' 39' ' ' MET . 5.3 tt -144.37 126.54 10.43 Favored 'Isoleucine or valine' 0 C--O 1.234 0.238 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.134 -179.876 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 37.2 m-85 -81.3 155.53 25.98 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.759 -179.994 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 24.2 mt -58.19 -37.33 74.55 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.055 179.762 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -59.57 -40.99 89.17 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 116.387 -0.37 . . . . 0.0 110.861 179.598 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 2.7 t0 -64.08 -39.16 93.45 Favored 'General case' 0 CA--C 1.528 0.112 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.565 179.525 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' MET . . . . . 0.401 ' HG3' HD12 ' A' ' 34' ' ' ILE . 28.2 mtm -93.1 30.94 1.52 Allowed 'General case' 0 CA--C 1.532 0.279 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.115 179.467 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 16.9 t80 -131.42 -47.32 0.98 Allowed 'General case' 0 C--O 1.232 0.181 0 CA-C-N 116.547 -0.297 . . . . 0.0 110.799 179.793 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 13.5 mt-10 -58.0 -36.95 73.39 Favored 'General case' 0 CA--C 1.53 0.179 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.17 179.731 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 151.87 68.26 0.01 OUTLIER Glycine 0 C--N 1.336 0.534 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.849 179.709 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 12.8 tt0 -130.37 157.91 41.28 Favored 'General case' 0 N--CA 1.462 0.152 0 CA-C-O 120.787 0.327 . . . . 0.0 111.436 179.966 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 1.8 mtmt -154.98 -45.98 0.08 Allowed 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.016 179.873 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 5.4 m -99.32 115.27 39.64 Favored 'Isoleucine or valine' 0 C--O 1.233 0.216 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.089 -179.99 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -109.15 149.99 28.53 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.152 -179.912 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 12.8 m -109.68 135.33 48.96 Favored 'Isoleucine or valine' 0 C--O 1.233 0.207 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.388 -179.898 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 50.8 t -75.94 135.96 70.29 Favored Pre-proline 0 C--O 1.233 0.229 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.018 -179.918 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 83.7 Cg_endo -83.91 19.17 1.4 Allowed 'Trans proline' 0 CA--C 1.535 0.573 0 C-N-CA 122.719 2.279 . . . . 0.0 113.127 179.639 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 36.3 t -128.41 -58.31 1.19 Allowed 'General case' 0 C--O 1.232 0.162 0 CA-C-N 116.746 -0.206 . . . . 0.0 110.572 179.789 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 21.0 p -103.39 -18.99 14.59 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 116.398 -0.364 . . . . 0.0 111.695 179.879 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER 70.03 37.13 1.78 Allowed 'General case' 0 CA--C 1.533 0.304 0 CA-C-O 120.788 0.328 . . . . 0.0 111.106 -179.802 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 7.6 mt -75.38 142.35 43.12 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-N 116.396 -0.366 . . . . 0.0 110.643 179.712 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' MET . . . . . . . . . . . . . 22.5 mtt -96.01 113.85 25.5 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.972 -179.58 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 2.7 pp -131.56 162.37 39.53 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.285 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.608 -179.538 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -119.5 95.74 4.91 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.032 179.995 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 15.0 p -89.31 128.82 41.13 Favored 'Isoleucine or valine' 0 C--O 1.234 0.251 0 CA-C-O 120.937 0.399 . . . . 0.0 111.251 179.728 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.416 HG11 ' HA ' ' A' ' 9' ' ' GLU . 14.0 p -91.68 152.7 3.34 Favored 'Isoleucine or valine' 0 C--O 1.234 0.239 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.142 179.93 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 15.8 p90 -136.58 174.96 10.05 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.116 -179.651 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -133.43 142.77 48.47 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.321 179.939 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.74 -41.78 62.05 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.746 179.559 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -59.44 -41.03 88.66 Favored 'General case' 0 N--CA 1.462 0.139 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.624 179.427 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -70.42 -46.68 63.44 Favored 'General case' 0 CA--C 1.528 0.121 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.988 179.695 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -56.93 -39.36 74.35 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.187 179.882 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -76.41 -46.44 27.15 Favored 'General case' 0 C--O 1.232 0.142 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.264 179.923 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 31.4 mt-10 -58.61 -47.05 85.66 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 116.43 -0.35 . . . . 0.0 110.924 179.817 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 3.3 m-85 -58.06 -32.62 68.19 Favored 'General case' 0 C--N 1.334 -0.105 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.299 179.742 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -59.57 -34.92 73.3 Favored 'General case' 0 CA--C 1.528 0.128 0 CA-C-O 120.626 0.251 . . . . 0.0 110.988 179.666 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -91.99 -35.42 13.98 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.028 179.719 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 13.9 mt-10 -68.92 -35.59 77.0 Favored 'General case' 0 CA--C 1.53 0.197 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.134 179.774 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.233 0.193 0 CA-C-O 120.859 0.362 . . . . 0.0 111.182 179.965 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.465 0.317 0 CA-C-O 120.98 0.419 . . . . 0.0 111.348 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . 0.405 ' HB2' HD22 ' A' ' 53' ' ' LEU . 92.2 m-85 -107.87 -37.47 6.1 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-N 115.873 -0.603 . . . . 0.0 111.359 179.841 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -144.94 161.45 39.31 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-O 120.814 0.34 . . . . 0.0 111.393 179.923 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . 0.431 ' HG2' ' HB2' ' A' ' 56' ' ' ASP . 28.5 mt-10 -141.1 143.73 34.49 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.146 -179.888 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 3.8 mp -137.84 152.33 26.46 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.424 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.11 179.83 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -97.97 154.06 17.94 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 116.442 -0.345 . . . . 0.0 110.921 179.389 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . 0.439 HD11 HG21 ' A' ' 10' ' ' ILE . 0.2 OUTLIER -54.65 -29.6 21.03 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.588 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.626 179.747 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 9.6 tt0 -56.25 -39.0 71.88 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-N 116.58 -0.282 . . . . 0.0 111.041 179.529 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -94.93 29.63 2.33 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-N 116.455 -0.339 . . . . 0.0 111.561 -179.817 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -114.71 136.69 52.79 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-O 120.577 0.227 . . . . 0.0 110.904 -179.961 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 25.6 m -71.8 102.54 2.87 Favored 'General case' 0 C--O 1.232 0.138 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.487 179.609 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 30.6 p90 -80.57 132.0 35.59 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.017 -179.788 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 53.2 mm-40 -108.95 95.08 16.17 Favored Pre-proline 0 C--O 1.234 0.28 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.618 179.916 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 67.0 Cg_endo -74.53 59.46 4.82 Favored 'Trans proline' 0 C--N 1.347 0.491 0 C-N-CA 122.615 2.21 . . . . 0.0 112.366 179.945 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -128.23 -49.19 1.31 Allowed 'General case' 0 CA--C 1.53 0.196 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.906 -179.914 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 16.0 m-80 -139.11 28.94 2.27 Favored 'General case' 0 CA--C 1.534 0.356 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.009 179.582 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 3.9 mm-40 58.88 61.91 2.03 Favored 'General case' 0 CA--C 1.535 0.401 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.609 179.489 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 20.8 ptp -134.7 141.18 46.46 Favored 'General case' 0 CA--C 1.531 0.227 0 CA-C-N 116.33 -0.396 . . . . 0.0 110.992 179.755 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 3.9 m-85 -111.23 125.68 54.06 Favored 'General case' 0 N--CA 1.463 0.176 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.492 179.713 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 29.6 p -117.27 160.85 20.44 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.329 -179.715 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 29.6 t80 -157.4 136.36 8.0 Favored Pre-proline 0 N--CA 1.463 0.175 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.018 -179.971 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -70.41 93.0 0.58 Allowed 'Trans proline' 0 C--N 1.347 0.448 0 C-N-CA 122.405 2.07 . . . . 0.0 111.989 179.421 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . 0.459 ' SG ' ' HD2' ' A' ' 27' ' ' PRO . 42.3 t -56.6 139.27 75.92 Favored Pre-proline 0 C--O 1.234 0.243 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.664 -179.968 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . 0.459 ' HD2' ' SG ' ' A' ' 26' ' ' CYS . 9.9 Cg_endo -53.23 -25.96 32.16 Favored 'Trans proline' 0 C--N 1.347 0.497 0 C-N-CA 122.926 2.418 . . . . 0.0 113.031 179.997 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . 0.41 ' CB ' ' HB3' ' A' ' 51' ' ' CYS . 0.6 OUTLIER -74.72 -39.43 61.9 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-O 120.461 0.172 . . . . 0.0 111.352 -179.898 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 150.04 -38.33 0.91 Allowed Glycine 0 C--N 1.334 0.467 0 C-N-CA 120.859 -0.686 . . . . 0.0 113.004 -179.802 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -72.04 -176.66 1.8 Allowed 'General case' 0 CA--C 1.533 0.321 0 CA-C-O 120.818 0.342 . . . . 0.0 111.215 -179.861 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 5.4 ttp-105 -116.7 123.67 47.8 Favored 'General case' 0 C--O 1.232 0.173 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.282 -179.375 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -73.65 99.95 3.23 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.643 179.534 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 9.7 mt-30 -92.98 136.39 33.3 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-N 116.474 -0.33 . . . . 0.0 111.208 -179.731 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -155.69 119.04 0.44 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.294 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.868 179.849 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 79.9 m-85 -81.86 159.07 23.8 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 116.444 -0.344 . . . . 0.0 110.934 -179.749 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . 0.408 ' HA ' ' HG2' ' A' ' 39' ' ' MET . 62.8 mt -55.16 -40.28 70.47 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.071 179.857 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 22.1 m-20 -60.38 -45.58 93.05 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-O 120.57 0.224 . . . . 0.0 110.555 179.395 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 64.5 m-20 -60.31 -43.52 96.28 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.139 179.132 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' MET . . . . . 0.408 ' HG2' ' HA ' ' A' ' 36' ' ' LEU . 1.8 ptm -90.77 36.79 0.91 Allowed 'General case' 0 CA--C 1.536 0.434 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.2 179.475 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 18.2 t80 -139.84 -49.89 0.48 Allowed 'General case' 0 CA--C 1.53 0.192 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.71 179.42 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 2.2 mm-40 -59.74 -35.88 75.47 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 116.526 -0.306 . . . . 0.0 110.911 179.613 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 140.59 52.28 0.04 OUTLIER Glycine 0 C--N 1.335 0.491 0 C-N-CA 120.951 -0.642 . . . . 0.0 113.015 179.568 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -129.03 102.3 6.44 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-O 120.796 0.332 . . . . 0.0 111.287 179.969 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . 0.451 ' HG2' ' CE2' ' A' ' 59' ' ' PHE . 12.8 mttt -113.74 -34.98 5.31 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.02 179.723 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 29.7 t -79.12 79.11 0.9 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.238 0 CA-C-O 120.986 0.422 . . . . 0.0 110.565 179.849 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -87.56 151.54 22.91 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.333 -179.802 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 11.8 p -133.24 130.03 57.31 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.026 179.88 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . 0.41 ' O ' ' N ' ' A' ' 52' ' ' SER . 37.7 t -73.64 115.32 40.62 Favored Pre-proline 0 C--N 1.331 -0.238 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.312 179.859 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_exo -57.2 -21.63 44.32 Favored 'Trans proline' 0 CA--C 1.533 0.455 0 C-N-CA 122.703 2.269 . . . . 0.0 113.049 -179.996 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -76.25 -66.99 0.73 Allowed 'General case' 0 CA--C 1.533 0.294 0 N-CA-C 111.236 0.087 . . . . 0.0 111.236 -179.814 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' CYS . . . . . 0.41 ' HB3' ' CB ' ' A' ' 28' ' ' CYS . 27.4 p -81.7 -22.02 37.67 Favored 'General case' 0 N--CA 1.469 0.491 0 N-CA-C 111.991 0.367 . . . . 0.0 111.991 -179.826 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' SER . . . . . 0.41 ' N ' ' O ' ' A' ' 48' ' ' CYS . 1.3 t 69.65 37.88 1.81 Allowed 'General case' 0 CA--C 1.534 0.347 0 CA-C-O 120.802 0.334 . . . . 0.0 111.204 -179.762 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.405 HD22 ' HB2' ' A' ' 5' ' ' TYR . 2.8 tt -106.27 127.21 53.07 Favored 'General case' 0 CA--C 1.53 0.183 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.894 179.832 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' MET . . . . . . . . . . . . . 24.6 mtt -84.12 142.18 30.56 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.428 -179.467 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 2.8 pp -142.78 163.77 17.24 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.298 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.595 179.917 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . 0.431 ' HB2' ' HG2' ' A' ' 7' ' ' GLU . 75.3 m-20 -115.9 106.91 14.34 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.704 179.03 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 11.2 p -97.78 115.11 36.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-O 120.992 0.425 . . . . 0.0 110.624 179.59 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 14.4 p -81.95 125.46 39.75 Favored 'Isoleucine or valine' 0 C--O 1.233 0.199 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.032 -179.646 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . 0.451 ' CE2' ' HG2' ' A' ' 44' ' ' LYS . 11.3 p90 -136.7 167.61 21.09 Favored 'General case' 0 CA--C 1.531 0.218 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.465 -179.494 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 3.4 t0 -113.63 175.69 5.35 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.054 179.708 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 3.1 ttmt -100.23 -41.0 7.27 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.229 -179.958 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -59.36 -35.48 73.97 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 116.461 -0.336 . . . . 0.0 111.076 179.794 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 2.8 t0 -54.24 -43.27 70.76 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.168 -179.913 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 4.3 mp -60.22 -51.81 67.97 Favored 'General case' 0 N--CA 1.462 0.146 0 CA-C-N 116.444 -0.344 . . . . 0.0 110.903 179.877 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -53.84 -42.04 68.07 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-N 116.4 -0.363 . . . . 0.0 111.092 179.69 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 16.9 mm-40 -72.53 -41.28 66.03 Favored 'General case' 0 CA--C 1.528 0.132 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.018 179.579 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -61.0 -35.09 75.92 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 116.524 -0.307 . . . . 0.0 111.636 -179.877 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 3.8 m-85 -56.82 -52.19 66.03 Favored 'General case' 0 N--CA 1.462 0.154 0 CA-C-N 116.704 -0.226 . . . . 0.0 110.829 -179.967 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -75.59 -35.16 60.63 Favored 'General case' 0 CA--C 1.53 0.196 0 CA-C-N 116.542 -0.299 . . . . 0.0 111.013 179.711 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 1.8 mm-40 -61.0 -47.77 84.92 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-N 116.481 -0.327 . . . . 0.0 111.2 -179.958 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.233 0.186 0 CA-C-O 120.842 0.353 . . . . 0.0 111.146 179.914 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 81.8 p . . . . . 0 C--O 1.234 0.259 0 CA-C-O 120.719 0.295 . . . . 0.0 111.377 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 18.7 m-85 -109.13 -38.89 5.43 Favored 'General case' 0 CA--C 1.531 0.217 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.198 179.702 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -157.02 175.14 14.49 Favored 'General case' 0 C--O 1.234 0.284 0 CA-C-N 116.484 -0.325 . . . . 0.0 111.244 179.881 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 2.6 pt-20 -135.24 125.98 27.25 Favored 'General case' 0 CA--C 1.53 0.189 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.122 179.856 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 4.6 mt -119.86 152.4 22.55 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.241 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.182 -179.745 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . 0.4 ' HA ' ' CG1' ' A' ' 58' ' ' VAL . 16.5 mt-10 -97.94 147.71 24.2 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.254 -179.998 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 8.0 tp -58.38 -31.37 42.74 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.238 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.138 179.476 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -59.32 -32.81 70.41 Favored 'General case' 0 CA--C 1.531 0.218 0 CA-C-N 116.551 -0.295 . . . . 0.0 110.934 179.603 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 5.5 t0 -97.57 36.09 1.55 Allowed 'General case' 0 CA--C 1.532 0.276 0 CA-C-O 120.914 0.387 . . . . 0.0 110.964 179.65 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -121.01 156.93 31.08 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.688 179.831 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 24.4 m -81.44 150.09 28.49 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.586 179.839 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 16.0 p90 -120.87 144.8 48.19 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.819 179.851 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -118.17 88.71 33.16 Favored Pre-proline 0 C--O 1.235 0.309 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.743 179.91 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 16.8 Cg_exo -68.27 72.47 0.85 Allowed 'Trans proline' 0 C--N 1.35 0.634 0 C-N-CA 122.98 2.453 . . . . 0.0 112.387 -179.711 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 1.1 pp20? -151.85 -50.39 0.11 Allowed 'General case' 0 C--O 1.233 0.212 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.992 179.907 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 20.8 m-20 -129.74 26.95 5.26 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-O 120.666 0.269 . . . . 0.0 111.223 179.495 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 56.82 54.64 6.96 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-O 120.992 0.425 . . . . 0.0 111.439 179.82 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 10.2 ptm -133.71 154.12 51.19 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.919 179.619 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 5.9 m-85 -119.06 147.69 43.85 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.081 -0.508 . . . . 0.0 111.052 -179.727 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' THR . . . . . 0.401 ' HA ' ' O ' ' A' ' 32' ' ' PHE . 20.5 p -123.35 173.79 7.74 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.141 -0.482 . . . . 0.0 111.209 179.918 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 60.8 t80 -172.12 99.83 0.37 Allowed Pre-proline 0 C--O 1.232 0.136 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.683 179.962 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_exo -51.21 99.76 0.04 OUTLIER 'Trans proline' 0 C--N 1.349 0.572 0 C-N-CA 122.684 2.256 . . . . 0.0 112.094 -179.905 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 45.9 t -60.53 138.38 92.63 Favored Pre-proline 0 C--N 1.331 -0.218 0 CA-C-N 116.053 -0.522 . . . . 0.0 110.776 -179.761 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 70.3 Cg_exo -51.84 -24.78 19.45 Favored 'Trans proline' 0 C--N 1.348 0.542 0 C-N-CA 122.695 2.263 . . . . 0.0 112.818 179.828 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 1.1 p -66.96 -37.96 85.24 Favored 'General case' 0 CA--C 1.533 0.305 0 CA-C-O 120.526 0.203 . . . . 0.0 111.221 179.902 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 151.88 -44.61 0.64 Allowed Glycine 0 C--N 1.335 0.498 0 C-N-CA 120.8 -0.714 . . . . 0.0 112.955 -179.996 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -72.34 -173.0 1.01 Allowed 'General case' 0 CA--C 1.532 0.278 0 CA-C-O 120.687 0.279 . . . . 0.0 111.337 -179.799 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 33.0 ttm180 -129.5 124.15 33.27 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-O 120.698 0.285 . . . . 0.0 111.052 -179.813 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . 0.401 ' O ' ' HA ' ' A' ' 23' ' ' THR . 1.8 m-85 -61.18 155.64 20.29 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.878 179.664 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 3.8 pt20 -147.16 112.02 5.38 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-N 116.376 -0.375 . . . . 0.0 111.15 179.763 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 2.4 tt -140.48 134.91 35.0 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.955 179.904 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 8.5 m-85 -87.92 161.91 17.19 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.939 -179.811 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -60.63 -46.05 91.76 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.136 -179.991 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -60.57 -36.59 78.88 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-O 120.717 0.294 . . . . 0.0 110.769 179.425 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -60.68 -41.38 94.99 Favored 'General case' 0 C--N 1.334 -0.075 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.535 179.635 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 4.6 mmm -91.78 29.64 1.52 Allowed 'General case' 0 CA--C 1.535 0.401 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.089 179.303 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 16.9 t80 -126.26 -43.54 1.78 Allowed 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 116.499 -0.318 . . . . 0.0 111.174 179.734 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -59.4 -68.13 0.31 Allowed 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 116.519 -0.31 . . . . 0.0 111.477 -179.467 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -169.62 55.76 0.2 Allowed Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.544 -0.836 . . . . 0.0 112.508 -179.761 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -110.15 160.31 16.59 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.834 0.35 . . . . 0.0 111.073 -179.866 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -163.83 -45.13 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.912 -0.585 . . . . 0.0 111.656 179.953 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 8.9 p -116.67 112.68 40.36 Favored 'Isoleucine or valine' 0 C--O 1.233 0.224 0 CA-C-O 120.977 0.418 . . . . 0.0 111.101 -179.876 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -95.31 168.23 10.86 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.53 -179.589 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 18.6 t -139.74 125.79 22.29 Favored 'Isoleucine or valine' 0 C--O 1.232 0.173 0 CA-C-N 115.98 -0.554 . . . . 0.0 111.205 -179.855 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 42.5 t -73.73 114.58 33.7 Favored Pre-proline 0 C--N 1.331 -0.207 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.267 179.573 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_exo -59.24 -20.5 55.44 Favored 'Trans proline' 0 C--N 1.346 0.414 0 C-N-CA 122.569 2.179 . . . . 0.0 112.875 179.946 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -75.75 -67.32 0.68 Allowed 'General case' 0 CA--C 1.531 0.226 0 CA-C-N 116.789 -0.187 . . . . 0.0 111.316 -179.711 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 23.9 p -83.62 -22.42 32.23 Favored 'General case' 0 N--CA 1.466 0.37 0 N-CA-C 111.933 0.346 . . . . 0.0 111.933 -179.706 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER 70.79 39.42 1.08 Allowed 'General case' 0 CA--C 1.533 0.292 0 CA-C-O 120.891 0.377 . . . . 0.0 110.863 -179.678 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 7.4 tp -100.98 143.57 30.96 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.958 179.982 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' MET . . . . . . . . . . . . . 42.2 mtt -95.19 138.09 33.37 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.089 -179.827 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 2.5 pp -148.08 145.07 18.86 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.259 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.653 -179.884 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -92.77 104.89 17.11 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.688 179.411 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 13.4 p -108.42 112.96 42.61 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-O 121.036 0.446 . . . . 0.0 111.167 179.717 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.4 ' CG1' ' HA ' ' A' ' 9' ' ' GLU . 14.5 p -83.61 150.42 4.18 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.28 -179.759 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 47.2 p90 -119.36 177.84 4.76 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.224 -179.846 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -121.96 172.83 7.92 Favored 'General case' 0 C--O 1.232 0.159 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.109 179.793 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 16.1 mmtt -105.6 -46.32 4.2 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.789 179.647 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -66.44 -40.75 89.66 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.894 179.774 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -57.94 -37.63 74.46 Favored 'General case' 0 N--CA 1.462 0.156 0 CA-C-N 116.554 -0.294 . . . . 0.0 111.203 179.913 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -60.53 -41.0 93.53 Favored 'General case' 0 CA--C 1.53 0.189 0 CA-C-N 116.664 -0.244 . . . . 0.0 111.022 179.896 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -82.5 -42.96 17.77 Favored 'General case' 0 C--O 1.232 0.173 0 CA-C-N 116.485 -0.325 . . . . 0.0 111.015 179.687 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -61.18 -50.55 72.67 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.653 179.836 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 55.3 t80 -63.2 -31.86 73.12 Favored 'General case' 0 CA--C 1.53 0.196 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.331 179.649 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 2.0 t80 -61.93 -59.73 4.67 Favored 'General case' 0 C--O 1.232 0.143 0 CA-C-O 120.545 0.212 . . . . 0.0 110.851 179.918 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 2.1 tp10 -63.56 -35.33 80.14 Favored 'General case' 0 N--CA 1.462 0.17 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.388 -179.977 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 25.4 mt-10 -71.65 -36.47 70.69 Favored 'General case' 0 CA--C 1.53 0.179 0 CA-C-N 116.544 -0.298 . . . . 0.0 111.371 -179.893 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.332 -0.176 0 CA-C-O 120.589 0.233 . . . . 0.0 111.353 180.0 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.465 0.32 0 CA-C-O 120.847 0.356 . . . . 0.0 111.277 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . 0.4 ' HB2' HD23 ' A' ' 53' ' ' LEU . 58.9 m-85 -98.95 -35.81 9.95 Favored 'General case' 0 CA--C 1.531 0.241 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.49 -179.891 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -158.85 173.55 16.36 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-O 120.759 0.314 . . . . 0.0 111.323 -179.92 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 2.7 tm-20 -138.58 122.72 18.03 Favored 'General case' 0 CA--C 1.531 0.24 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.879 -179.886 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 4.8 mt -126.21 152.36 33.5 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.338 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.114 -179.747 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 3.0 pt-20 -96.95 153.17 18.06 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.622 -179.99 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 1.2 tp -62.99 -34.66 67.73 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.313 0 CA-C-N 115.947 -0.569 . . . . 0.0 111.36 179.58 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -58.74 -32.87 69.63 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-N 116.609 -0.269 . . . . 0.0 111.157 179.681 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -97.28 36.1 1.51 Allowed 'General case' 0 CA--C 1.537 0.47 0 CA-C-O 120.81 0.338 . . . . 0.0 111.311 179.783 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 1.7 ttt -121.54 148.83 43.98 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.888 179.787 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -69.33 126.93 31.3 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-O 120.826 0.346 . . . . 0.0 110.873 179.971 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 14.4 t80 -94.59 123.97 38.33 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.509 179.596 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 1.4 tp10 -108.96 92.1 10.2 Favored Pre-proline 0 C--O 1.234 0.256 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.314 179.499 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 64.3 Cg_endo -73.6 61.27 4.4 Favored 'Trans proline' 0 C--N 1.351 0.677 0 C-N-CA 122.793 2.329 . . . . 0.0 112.72 -179.44 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 19.1 pt-20 -131.44 -45.82 0.99 Allowed 'General case' 0 CA--C 1.533 0.302 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.885 179.772 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -141.71 32.13 1.63 Allowed 'General case' 0 CA--C 1.534 0.363 0 CA-C-N 116.515 -0.311 . . . . 0.0 111.057 179.406 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 91.3 mt-30 55.15 59.88 3.75 Favored 'General case' 0 C--O 1.236 0.363 0 CA-C-O 120.955 0.407 . . . . 0.0 111.413 179.931 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 9.6 ptp -130.41 148.72 52.25 Favored 'General case' 0 C--O 1.235 0.307 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.343 179.909 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . 0.41 ' CE1' HD22 ' A' ' 36' ' ' LEU . 25.4 m-85 -124.6 102.89 7.84 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.896 179.994 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 66.9 p -101.54 166.83 10.5 Favored 'General case' 0 CA--C 1.532 0.261 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.84 -179.827 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 62.3 t80 -164.7 139.6 4.42 Favored Pre-proline 0 CA--C 1.531 0.235 0 CA-C-O 120.599 0.237 . . . . 0.0 111.377 179.774 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -53.2 121.79 10.03 Favored 'Trans proline' 0 C--N 1.352 0.724 0 C-N-CA 122.994 2.462 . . . . 0.0 113.144 -179.979 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . 0.448 ' SG ' ' HD2' ' A' ' 27' ' ' PRO . 42.1 t -90.64 140.3 26.57 Favored Pre-proline 0 C--N 1.331 -0.218 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.497 179.38 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . 0.448 ' HD2' ' SG ' ' A' ' 26' ' ' CYS . 73.8 Cg_exo -50.7 -27.82 20.92 Favored 'Trans proline' 0 C--N 1.349 0.587 0 C-N-CA 122.898 2.398 . . . . 0.0 113.026 179.536 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . 0.408 ' CB ' ' HB3' ' A' ' 51' ' ' CYS . 0.9 OUTLIER -69.51 -38.89 77.77 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-N 116.799 -0.182 . . . . 0.0 111.446 -179.959 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 151.92 -48.4 0.55 Allowed Glycine 0 C--N 1.336 0.57 0 C-N-CA 120.854 -0.689 . . . . 0.0 112.958 -179.933 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -73.96 -175.11 2.05 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-O 120.665 0.269 . . . . 0.0 110.966 179.984 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 19.5 mtt180 -118.72 134.66 54.98 Favored 'General case' 0 C--O 1.232 0.164 0 CA-C-O 120.677 0.275 . . . . 0.0 110.826 179.924 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 6.8 m-85 -62.23 168.0 3.7 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.811 179.653 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 5.8 tt0 -155.58 121.95 5.21 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-O 120.695 0.283 . . . . 0.0 111.274 179.882 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 5.8 tt -146.04 138.81 20.45 Favored 'Isoleucine or valine' 0 C--O 1.234 0.25 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.085 179.646 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 25.6 m-85 -95.58 155.49 16.72 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.993 179.992 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . 0.41 HD22 ' CE1' ' A' ' 22' ' ' PHE . 87.9 mt -62.63 -39.84 95.11 Favored 'General case' 0 CA--C 1.53 0.199 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.016 179.72 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -66.2 -34.81 78.86 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 116.683 -0.235 . . . . 0.0 111.196 179.409 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -62.7 -57.99 9.06 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-O 120.918 0.389 . . . . 0.0 110.591 179.991 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 5.6 ptm -63.04 -34.62 77.97 Favored 'General case' 0 CA--C 1.534 0.343 0 CA-C-N 115.956 -0.565 . . . . 0.0 111.291 179.764 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . 0.4 ' HB2' ' CD2' ' A' ' 64' ' ' LEU . 31.6 t80 -61.14 -45.06 96.18 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-N 116.551 -0.295 . . . . 0.0 110.882 179.485 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 2.6 tp10 -56.0 -40.8 73.89 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.709 179.471 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 148.47 47.86 0.02 OUTLIER Glycine 0 C--N 1.335 0.49 0 C-N-CA 121.146 -0.55 . . . . 0.0 112.672 179.755 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 4.3 tt0 -112.4 123.19 49.73 Favored 'General case' 0 C--O 1.232 0.159 0 CA-C-O 120.826 0.346 . . . . 0.0 111.149 -179.795 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 19.4 mtmt -122.46 -43.75 2.27 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-N 115.917 -0.583 . . . . 0.0 111.026 179.726 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 12.0 p -108.16 113.21 43.26 Favored 'Isoleucine or valine' 0 C--O 1.233 0.209 0 CA-C-O 121.011 0.434 . . . . 0.0 111.005 179.781 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -102.24 164.66 11.56 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.154 -179.815 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 11.6 p -124.49 129.09 73.93 Favored 'Isoleucine or valine' 0 C--O 1.233 0.207 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.227 -179.909 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 47.9 t -67.86 135.52 92.16 Favored Pre-proline 0 C--O 1.233 0.229 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.79 179.929 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 84.5 Cg_endo -83.54 21.09 1.08 Allowed 'Trans proline' 0 CA--C 1.537 0.639 0 C-N-CA 122.729 2.286 . . . . 0.0 113.056 179.777 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 7.7 t -129.07 -56.82 1.17 Allowed 'General case' 0 C--O 1.233 0.204 0 CA-C-N 116.615 -0.266 . . . . 0.0 110.512 179.768 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' CYS . . . . . 0.408 ' HB3' ' CB ' ' A' ' 28' ' ' CYS . 18.5 p -100.63 -10.59 20.79 Favored 'General case' 0 CA--C 1.538 0.481 0 N-CA-C 112.276 0.473 . . . . 0.0 112.276 179.924 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 6.5 p 60.24 35.85 20.87 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-O 120.863 0.363 . . . . 0.0 111.765 -179.903 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.4 HD23 ' HB2' ' A' ' 5' ' ' TYR . 6.6 tt -94.95 121.34 36.46 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.698 179.394 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' MET . . . . . . . . . . . . . 6.9 mtt -85.94 141.53 29.48 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.171 -179.712 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 3.8 pt -145.19 148.19 17.99 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.295 0 CA-C-N 115.934 -0.575 . . . . 0.0 111.495 179.997 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 72.3 m-20 -93.27 104.74 16.89 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.463 178.918 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 12.5 p -100.22 112.37 32.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 121.057 0.456 . . . . 0.0 110.879 179.72 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 14.2 p -81.04 130.87 35.14 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.172 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.709 -179.852 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 42.1 p90 -133.41 176.96 8.06 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.29 -179.275 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 4.3 t70 -122.38 144.91 48.73 Favored 'General case' 0 N--CA 1.462 0.17 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.4 -179.923 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 11.7 mttp -76.7 -40.01 50.14 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.153 179.699 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 17.7 tt0 -58.43 -37.66 75.86 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 116.617 -0.265 . . . . 0.0 110.595 179.531 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . 0.476 ' HB3' ' CE2' ' A' ' 67' ' ' TYR . 3.4 m-20 -56.03 -43.87 78.2 Favored 'General case' 0 N--CA 1.463 0.19 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.954 179.425 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.4 ' CD2' ' HB2' ' A' ' 40' ' ' PHE . 3.0 mp -53.31 -53.41 51.4 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 116.469 -0.332 . . . . 0.0 111.185 179.987 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -56.24 -39.65 72.88 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 116.512 -0.313 . . . . 0.0 110.846 179.511 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -69.19 -39.74 78.49 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.05 179.367 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . 0.476 ' CE2' ' HB3' ' A' ' 63' ' ' ASP . 20.1 m-85 -69.12 -37.93 78.62 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 116.634 -0.257 . . . . 0.0 111.624 -179.861 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 5.7 m-85 -62.17 -38.25 88.35 Favored 'General case' 0 N--CA 1.463 0.211 0 C-N-CA 121.247 -0.181 . . . . 0.0 110.635 179.966 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -80.96 -36.26 31.13 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-N 116.48 -0.327 . . . . 0.0 111.084 179.262 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 5.7 mt-10 -72.28 -35.68 68.79 Favored 'General case' 0 N--CA 1.467 0.376 0 N-CA-C 111.681 0.252 . . . . 0.0 111.681 -179.834 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.233 0.215 0 N-CA-C 111.517 0.191 . . . . 0.0 111.517 -179.643 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.463 0.22 0 CA-C-O 120.769 0.319 . . . . 0.0 111.477 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 9.3 m-85 -106.68 -43.65 4.66 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.37 179.721 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 12.0 m-20 -151.74 175.53 12.31 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-O 120.782 0.325 . . . . 0.0 111.484 179.791 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 19.5 tt0 -128.0 122.62 32.73 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.443 179.514 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 28.5 mm -120.33 155.04 23.53 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.162 -179.584 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -112.55 150.98 30.56 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-N 116.308 -0.406 . . . . 0.0 111.292 179.867 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 2.8 tt -58.72 -31.89 45.38 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.331 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.239 179.576 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 17.8 mt-10 -66.24 -30.91 71.44 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-N 116.374 -0.375 . . . . 0.0 111.106 179.501 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 3.3 t70 -98.03 38.37 1.32 Allowed 'General case' 0 CA--C 1.533 0.313 0 CA-C-O 120.889 0.376 . . . . 0.0 111.052 179.816 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 1.8 mtp -128.39 156.17 43.56 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.782 179.778 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 8.7 m -87.4 108.2 18.89 Favored 'General case' 0 N--CA 1.462 0.15 0 CA-C-O 120.835 0.35 . . . . 0.0 110.952 -179.923 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 29.8 p90 -85.12 138.12 32.6 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.764 179.754 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 25.1 mt-10 -103.9 96.36 9.16 Favored Pre-proline 0 C--O 1.234 0.263 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.406 179.848 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -71.77 63.62 3.12 Favored 'Trans proline' 0 C--N 1.35 0.654 0 C-N-CA 122.812 2.342 . . . . 0.0 112.721 -179.497 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 7.1 pt-20 -135.14 -53.78 0.79 Allowed 'General case' 0 C--N 1.333 -0.144 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.741 179.535 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 71.6 m-20 -133.08 33.04 3.68 Favored 'General case' 0 CA--C 1.534 0.345 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.999 179.479 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 25.4 mt-30 56.81 49.84 13.52 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-O 120.802 0.334 . . . . 0.0 111.287 179.936 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 9.6 ttp -122.62 157.18 32.72 Favored 'General case' 0 N--CA 1.463 0.176 0 CA-C-O 120.737 0.304 . . . . 0.0 111.161 -179.942 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . 0.42 ' O ' ' HA ' ' A' ' 33' ' ' GLN . 5.8 m-85 -121.28 164.43 17.01 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.852 -179.988 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 25.6 p -144.59 150.93 38.29 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.095 179.487 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 86.5 t80 -145.38 95.91 4.95 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.243 179.282 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -55.05 94.33 0.04 OUTLIER 'Trans proline' 0 C--N 1.349 0.559 0 C-N-CA 122.719 2.279 . . . . 0.0 111.832 179.967 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . 0.437 ' SG ' ' HD2' ' A' ' 27' ' ' PRO . 45.3 t -63.8 137.89 97.23 Favored Pre-proline 0 C--O 1.234 0.243 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.095 -179.306 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . 0.437 ' HD2' ' SG ' ' A' ' 26' ' ' CYS . 10.9 Cg_endo -54.84 -20.33 22.11 Favored 'Trans proline' 0 C--N 1.35 0.626 0 C-N-CA 122.906 2.404 . . . . 0.0 112.831 179.777 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 12.4 p -55.49 -29.31 58.55 Favored 'General case' 0 CA--C 1.535 0.378 0 CA-C-O 120.592 0.234 . . . . 0.0 111.398 179.68 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 125.55 5.43 6.52 Favored Glycine 0 CA--C 1.526 0.737 0 C-N-CA 121.143 -0.551 . . . . 0.0 113.692 179.836 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -126.55 -167.12 1.67 Allowed 'General case' 0 CA--C 1.536 0.408 0 CA-C-N 117.412 0.606 . . . . 0.0 111.324 -179.814 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 8.6 ttm-85 -121.36 150.1 41.96 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-O 120.8 0.333 . . . . 0.0 111.506 -179.596 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 21.7 t80 -103.43 162.27 13.17 Favored 'General case' 0 CA--C 1.529 0.153 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.882 179.368 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . 0.42 ' HA ' ' O ' ' A' ' 22' ' ' PHE . 3.2 pt20 -149.7 115.64 5.66 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.879 179.65 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 3.3 tt -130.71 128.3 62.92 Favored 'Isoleucine or valine' 0 C--O 1.234 0.245 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.062 179.989 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -80.23 123.53 28.02 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.054 -179.667 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 3.7 pp -61.28 -38.59 87.33 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.998 179.601 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 3.7 t70 -56.3 -46.37 79.83 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 116.503 -0.317 . . . . 0.0 110.801 179.538 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -65.92 -45.59 81.33 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.518 179.435 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 1.6 mtm -52.05 -25.62 9.02 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.852 179.687 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -53.97 -35.46 61.81 Favored 'General case' 0 N--CA 1.467 0.397 0 N-CA-C 111.559 0.207 . . . . 0.0 111.559 179.775 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 -58.44 -31.59 67.91 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-N 116.646 -0.252 . . . . 0.0 111.565 179.75 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 125.14 45.54 0.25 Allowed Glycine 0 C--N 1.335 0.509 0 C-N-CA 121.218 -0.515 . . . . 0.0 112.771 179.81 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -84.1 133.31 34.64 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-O 120.687 0.28 . . . . 0.0 110.908 179.996 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 3.4 ptpp? -126.54 -45.26 1.65 Allowed 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.385 -179.9 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 12.2 p -94.55 131.44 41.38 Favored 'Isoleucine or valine' 0 C--O 1.233 0.223 0 CA-C-N 116.418 -0.355 . . . . 0.0 110.715 179.797 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -129.82 144.79 51.48 Favored 'General case' 0 C--O 1.234 0.288 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.109 -179.676 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 11.3 p -110.36 123.88 66.64 Favored 'Isoleucine or valine' 0 C--O 1.233 0.223 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.15 -179.828 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 52.5 t -62.2 134.72 94.72 Favored Pre-proline 0 N--CA 1.463 0.214 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.99 179.905 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 90.7 Cg_endo -84.98 24.55 0.76 Allowed 'Trans proline' 0 C--N 1.349 0.58 0 C-N-CA 122.713 2.275 . . . . 0.0 112.993 179.926 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 1.4 m -132.99 -60.29 0.87 Allowed 'General case' 0 CA--C 1.53 0.191 0 CA-C-N 116.503 -0.317 . . . . 0.0 110.586 -179.83 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 22.6 p -102.35 -13.98 17.1 Favored 'General case' 0 CA--C 1.537 0.462 0 N-CA-C 111.869 0.322 . . . . 0.0 111.869 179.494 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 6.4 t 66.82 34.28 5.6 Favored 'General case' 0 CA--C 1.534 0.365 0 CA-C-O 120.895 0.379 . . . . 0.0 111.286 -179.815 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 8.0 tt -85.21 134.27 34.15 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.604 179.663 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' MET . . . . . . . . . . . . . 40.7 mtm -82.79 133.0 35.15 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.198 -179.635 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 2.7 pt -138.68 151.07 23.85 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.394 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.853 -179.829 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 71.1 m-20 -97.02 88.47 4.52 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.741 179.297 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 12.5 p -94.5 114.52 31.26 Favored 'Isoleucine or valine' 0 C--O 1.234 0.279 0 CA-C-O 121.063 0.458 . . . . 0.0 110.938 179.77 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 12.6 p -91.79 135.24 27.7 Favored 'Isoleucine or valine' 0 C--O 1.233 0.218 0 CA-C-N 115.967 -0.561 . . . . 0.0 110.974 -179.719 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 48.5 p90 -112.51 166.55 11.22 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.885 -179.52 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -131.16 137.74 49.14 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.215 179.774 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 17.0 mttp -68.43 -38.21 80.98 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.733 179.191 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 21.3 mt-10 -58.87 -52.99 63.35 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.427 179.266 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 38.4 m-20 -62.12 -43.04 99.72 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.993 179.505 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -60.16 -53.43 57.77 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-O 120.607 0.242 . . . . 0.0 111.244 179.95 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -63.7 -39.25 93.84 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 116.422 -0.353 . . . . 0.0 111.149 179.867 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 26.7 tt0 -68.27 -41.29 81.26 Favored 'General case' 0 CA--C 1.532 0.285 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.9 179.476 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 19.9 t80 -66.24 -34.79 78.81 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.655 -179.994 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 23.5 t80 -54.26 -41.96 69.41 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-O 120.732 0.301 . . . . 0.0 110.254 179.719 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 4.1 tt0 -83.6 -37.45 22.9 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.292 179.466 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -66.63 -32.96 74.62 Favored 'General case' 0 N--CA 1.467 0.403 0 N-CA-C 112.053 0.39 . . . . 0.0 112.053 -179.608 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.465 0.323 0 N-CA-C 111.863 0.32 . . . . 0.0 111.863 -179.322 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 5.0 p . . . . . 0 CA--C 1.532 0.267 0 CA-C-O 120.875 0.369 . . . . 0.0 111.069 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 11.6 m-85 -164.65 -40.84 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.123 179.755 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -145.83 169.99 17.45 Favored 'General case' 0 C--O 1.237 0.409 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.005 -179.798 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -123.98 112.11 16.81 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.873 -179.882 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.42 ' O ' ' HA ' ' A' ' 57' ' ' VAL . 27.8 mm -88.07 154.62 3.23 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.196 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.954 179.918 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 82.2 mt-10 -121.54 146.77 46.61 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-N 116.374 -0.376 . . . . 0.0 111.211 -179.983 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 8.1 tp -58.11 -34.95 50.67 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.344 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.124 179.501 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 6.6 tt0 -65.66 -34.61 78.6 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-N 116.496 -0.32 . . . . 0.0 110.878 179.46 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 22.1 m-20 -95.94 38.27 1.19 Allowed 'General case' 0 CA--C 1.531 0.238 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.226 179.766 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -133.79 136.73 44.69 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.725 179.785 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 9.7 m -69.64 138.22 52.86 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.015 -179.841 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . 0.405 ' HB3' ' CE2' ' A' ' 22' ' ' PHE . 17.3 p90 -101.54 130.4 47.82 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.556 179.649 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . 0.401 ' HG2' ' HE2' ' A' ' 21' ' ' MET . 2.3 mp0 -109.23 90.82 8.68 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.733 179.795 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 69.9 Cg_endo -74.26 62.31 5.16 Favored 'Trans proline' 0 C--N 1.348 0.512 0 C-N-CA 122.776 2.317 . . . . 0.0 112.954 -179.786 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 4.8 pt-20 -132.68 -50.21 0.9 Allowed 'General case' 0 CA--C 1.531 0.224 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.757 179.47 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 38.0 m-20 -136.46 32.03 2.82 Favored 'General case' 0 CA--C 1.534 0.345 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.23 179.512 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' GLN . . . . . 0.411 ' OE1' ' HA ' ' A' ' 68' ' ' TYR . 15.2 mt-30 56.67 67.38 1.0 Allowed 'General case' 0 CA--C 1.535 0.368 0 CA-C-O 121.06 0.457 . . . . 0.0 111.462 179.447 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' MET . . . . . 0.401 ' HE2' ' HG2' ' A' ' 16' ' ' GLU . 2.5 ptt? -146.99 158.64 43.98 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-N 116.013 -0.54 . . . . 0.0 111.092 179.674 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . 0.405 ' CE2' ' HB3' ' A' ' 15' ' ' PHE . 17.4 m-85 -131.21 127.8 38.65 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.787 -179.967 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' THR . . . . . 0.413 ' HA ' ' O ' ' A' ' 32' ' ' PHE . 18.2 p -116.14 170.21 8.68 Favored 'General case' 0 CA--C 1.532 0.28 0 CA-C-O 120.828 0.347 . . . . 0.0 111.454 -179.877 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 57.8 t80 -163.23 136.29 4.31 Favored Pre-proline 0 N--CA 1.464 0.271 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.042 179.795 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 42.0 Cg_endo -66.59 103.38 0.68 Allowed 'Trans proline' 0 C--N 1.35 0.606 0 C-N-CA 122.555 2.17 . . . . 0.0 112.27 179.649 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . 0.472 ' SG ' ' HD2' ' A' ' 27' ' ' PRO . 42.7 t -66.89 139.63 95.76 Favored Pre-proline 0 C--O 1.233 0.215 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.551 179.786 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . 0.472 ' HD2' ' SG ' ' A' ' 26' ' ' CYS . 9.3 Cg_endo -53.64 -25.56 33.99 Favored 'Trans proline' 0 C--N 1.35 0.617 0 C-N-CA 122.928 2.419 . . . . 0.0 112.927 179.867 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . 0.406 ' CB ' ' HB3' ' A' ' 51' ' ' CYS . 0.8 OUTLIER -69.93 -38.03 76.07 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-O 120.51 0.195 . . . . 0.0 111.299 -179.978 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 150.37 -44.8 0.68 Allowed Glycine 0 C--N 1.336 0.541 0 C-N-CA 120.834 -0.698 . . . . 0.0 112.898 -179.922 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -71.09 -176.51 1.43 Allowed 'General case' 0 CA--C 1.534 0.333 0 CA-C-O 120.779 0.323 . . . . 0.0 111.169 -179.86 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 7.2 ttp180 -122.19 114.06 20.33 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-N 116.515 -0.312 . . . . 0.0 111.085 -179.886 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . 0.413 ' O ' ' HA ' ' A' ' 23' ' ' THR . 73.3 t80 -62.2 154.55 27.07 Favored 'General case' 0 N--CA 1.462 0.168 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.966 179.708 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 1.1 pt20 -147.47 144.12 28.37 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.231 179.994 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 2.8 tt -147.6 132.14 10.25 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.247 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.064 179.497 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 6.0 m-85 -90.41 139.54 30.58 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.944 -179.883 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 13.9 mt -59.57 -47.48 85.41 Favored 'General case' 0 N--CA 1.463 0.19 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.027 179.954 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -59.57 -38.5 81.32 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 116.587 -0.279 . . . . 0.0 110.78 179.339 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -66.73 -58.99 3.97 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.017 179.853 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 6.4 ptm -60.68 -32.58 71.79 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 116.462 -0.335 . . . . 0.0 111.556 -179.878 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 18.7 t80 -58.39 -37.05 74.49 Favored 'General case' 0 CA--C 1.533 0.318 0 CA-C-N 116.499 -0.318 . . . . 0.0 111.15 179.689 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 4.6 mt-10 -57.92 -38.14 75.34 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-O 120.668 0.271 . . . . 0.0 110.98 179.512 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 144.77 52.14 0.03 OUTLIER Glycine 0 C--N 1.334 0.46 0 C-N-CA 121.018 -0.611 . . . . 0.0 112.701 179.785 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -109.98 157.18 19.56 Favored 'General case' 0 C--O 1.232 0.15 0 CA-C-O 120.81 0.338 . . . . 0.0 111.237 -179.943 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -157.1 -47.14 0.07 Allowed 'General case' 0 CA--C 1.532 0.262 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.156 179.815 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 4.8 m -100.02 115.0 40.19 Favored 'Isoleucine or valine' 0 C--O 1.233 0.191 0 CA-C-O 120.84 0.352 . . . . 0.0 110.972 179.78 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -110.47 174.79 5.7 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.204 -179.854 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 11.3 m -133.48 121.18 40.81 Favored 'Isoleucine or valine' 0 C--O 1.233 0.209 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.186 -179.886 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 43.3 t -63.15 135.94 96.46 Favored Pre-proline 0 C--O 1.233 0.215 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.702 179.964 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 91.5 Cg_endo -83.15 19.87 1.26 Allowed 'Trans proline' 0 CA--C 1.537 0.645 0 C-N-CA 122.682 2.255 . . . . 0.0 113.212 179.972 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 29.8 t -128.35 -58.2 1.2 Allowed 'General case' 0 CA--C 1.529 0.152 0 CA-C-O 120.657 0.265 . . . . 0.0 110.521 179.644 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' CYS . . . . . 0.406 ' HB3' ' CB ' ' A' ' 28' ' ' CYS . 20.1 p -98.72 -20.2 17.07 Favored 'General case' 0 CA--C 1.533 0.327 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.826 179.93 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 1.1 t 67.46 39.48 2.88 Favored 'General case' 0 CA--C 1.534 0.327 0 CA-C-O 121.07 0.462 . . . . 0.0 110.904 -179.772 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 6.9 tp -88.08 131.68 34.58 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.711 179.814 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' MET . . . . . . . . . . . . . 41.1 mtt -85.14 123.99 31.29 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.618 -179.877 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 2.6 pp -134.06 142.16 41.89 Favored 'Isoleucine or valine' 0 C--O 1.234 0.249 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.621 -179.749 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -105.81 95.92 6.14 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.656 -179.909 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.42 ' HA ' ' O ' ' A' ' 8' ' ' ILE . 14.8 p -84.18 139.13 18.03 Favored 'Isoleucine or valine' 0 C--O 1.234 0.286 0 CA-C-O 120.941 0.4 . . . . 0.0 111.124 -179.954 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 12.1 p -111.26 123.02 66.75 Favored 'Isoleucine or valine' 0 C--O 1.234 0.264 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.862 179.703 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 32.3 p90 -129.32 176.83 7.63 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.025 -179.675 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -118.02 162.79 17.6 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.556 -179.898 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 22.8 mttt -87.82 -32.1 19.21 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.128 179.568 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -59.73 -54.55 45.05 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 116.587 -0.279 . . . . 0.0 110.835 179.882 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -61.28 -44.48 97.16 Favored 'General case' 0 N--CA 1.463 0.186 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.741 179.655 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -57.96 -41.31 82.64 Favored 'General case' 0 CA--C 1.529 0.157 0 CA-C-N 116.429 -0.35 . . . . 0.0 110.809 179.583 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -70.18 -39.45 75.24 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 116.441 -0.345 . . . . 0.0 111.241 179.763 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 31.1 mt-10 -70.51 -41.06 73.12 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.504 -179.808 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 2.5 t80 -55.94 -30.84 62.3 Favored 'General case' 0 N--CA 1.465 0.275 0 CA-C-N 116.693 -0.231 . . . . 0.0 111.499 -179.958 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . 0.411 ' HA ' ' OE1' ' A' ' 20' ' ' GLN . 3.8 m-85 -58.85 -36.24 74.25 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-O 120.63 0.253 . . . . 0.0 110.589 179.665 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 7.8 tt0 -88.3 -36.32 16.73 Favored 'General case' 0 CA--C 1.531 0.242 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.943 179.334 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 4.5 mm-40 -66.23 -34.57 78.31 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.605 -179.705 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.234 0.248 0 CA-C-O 120.86 0.362 . . . . 0.0 111.251 -179.838 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 58.4 p . . . . . 0 N--CA 1.468 0.449 0 CA-C-O 120.77 0.319 . . . . 0.0 111.249 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 5.7 m-85 -102.83 -50.3 3.57 Favored 'General case' 0 CA--C 1.529 0.163 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.173 179.628 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -154.88 176.49 12.43 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.383 179.702 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 15.3 pt-20 -123.76 135.56 53.9 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.765 179.422 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 3.5 mp -121.75 139.63 48.23 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.305 0 CA-C-N 116.462 -0.336 . . . . 0.0 110.827 -179.977 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 -83.93 145.73 28.42 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.182 -179.871 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 9.7 tp -57.15 -33.81 43.89 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.314 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.184 179.586 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 -58.77 -34.58 71.59 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 116.569 -0.287 . . . . 0.0 111.087 179.307 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 54.2 m-20 -95.76 36.83 1.25 Allowed 'General case' 0 CA--C 1.535 0.367 0 CA-C-O 120.722 0.296 . . . . 0.0 111.342 179.591 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 3.1 ttt -120.2 146.49 45.98 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 116.582 -0.281 . . . . 0.0 110.802 179.779 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 1.5 m -68.95 126.03 28.5 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 116.519 -0.31 . . . . 0.0 110.765 179.876 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 2.8 p90 -105.14 157.58 17.17 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.04 179.885 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 23.6 mt-10 -139.97 83.27 16.33 Favored Pre-proline 0 C--O 1.235 0.292 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.675 179.98 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 70.4 Cg_exo -52.05 -28.75 33.7 Favored 'Trans proline' 0 C--N 1.349 0.554 0 C-N-CA 122.98 2.454 . . . . 0.0 112.731 179.919 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -52.36 -35.94 52.5 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-N 116.454 -0.339 . . . . 0.0 111.577 179.605 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 2.0 t-20 -141.85 29.39 1.7 Allowed 'General case' 0 CA--C 1.538 0.505 0 N-CA-C 111.721 0.267 . . . . 0.0 111.721 -179.92 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 8.3 pt20 41.73 35.87 0.55 Allowed 'General case' 0 N--CA 1.475 0.792 0 N-CA-C 112.245 0.461 . . . . 0.0 112.245 -179.756 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 7.0 ttt -105.67 158.67 16.55 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.475 -179.601 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 23.1 m-85 -129.65 147.07 51.4 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-O 120.777 0.322 . . . . 0.0 111.187 179.587 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 21.2 p -144.19 177.42 8.61 Favored 'General case' 0 CA--C 1.537 0.465 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.953 -179.98 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 38.7 t80 -171.68 134.79 0.89 Allowed Pre-proline 0 N--CA 1.47 0.559 0 CA-C-N 116.699 -0.228 . . . . 0.0 110.961 179.327 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -65.04 101.23 0.39 Allowed 'Trans proline' 0 C--N 1.352 0.724 0 C-N-CA 122.795 2.33 . . . . 0.0 112.902 -179.857 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . 0.425 ' SG ' ' HD2' ' A' ' 27' ' ' PRO . 46.7 t -66.18 139.53 96.5 Favored Pre-proline 0 C--O 1.233 0.232 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.729 179.598 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . 0.425 ' HD2' ' SG ' ' A' ' 26' ' ' CYS . 60.9 Cg_exo -52.61 -27.08 31.61 Favored 'Trans proline' 0 C--N 1.348 0.547 0 C-N-CA 122.748 2.299 . . . . 0.0 112.907 179.625 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -67.6 -38.53 84.11 Favored 'General case' 0 C--O 1.235 0.305 0 N-CA-C 111.61 0.226 . . . . 0.0 111.61 -179.99 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 152.32 -48.19 0.55 Allowed Glycine 0 C--N 1.336 0.571 0 C-N-CA 120.785 -0.721 . . . . 0.0 113.242 -179.788 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -75.89 -173.59 2.34 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-N 116.751 0.276 . . . . 0.0 111.137 -179.812 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 51.5 mtt180 -122.41 138.34 54.57 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-O 120.76 0.314 . . . . 0.0 111.185 -179.989 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 45.0 m-85 -69.06 167.86 15.08 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.864 179.569 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 3.9 pp0? -152.17 138.16 18.16 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.22 179.594 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 3.5 tt -173.98 127.87 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.531 0.238 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.033 179.659 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 76.5 m-85 -82.21 142.9 31.78 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.734 -179.81 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 3.9 pp -55.45 -35.22 65.22 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 116.389 -0.368 . . . . 0.0 111.231 179.645 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -61.49 -45.6 93.55 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 116.534 -0.303 . . . . 0.0 111.016 179.678 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -61.12 -43.43 98.89 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-O 120.762 0.315 . . . . 0.0 110.731 179.453 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 3.6 mtt -59.75 -33.52 71.77 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.029 179.616 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -56.42 -39.88 73.78 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 116.534 -0.303 . . . . 0.0 110.991 179.533 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 21.9 mt-10 -65.57 -48.94 70.67 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 116.665 -0.243 . . . . 0.0 110.863 179.741 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 153.64 74.94 0.01 OUTLIER Glycine 0 C--N 1.336 0.535 0 C-N-CA 120.678 -0.772 . . . . 0.0 113.02 179.696 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 5.0 tp10 -128.66 96.71 4.47 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-O 120.858 0.361 . . . . 0.0 111.299 179.748 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 14.5 ptpt -111.86 -31.81 6.82 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.439 179.803 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 4.4 m -110.87 97.41 5.7 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.264 0 CA-C-O 120.953 0.406 . . . . 0.0 111.075 179.853 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -99.64 154.55 18.19 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.527 -179.574 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 11.2 p -118.56 139.23 46.59 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.244 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.313 -179.958 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 53.5 t -78.52 135.25 60.89 Favored Pre-proline 0 C--O 1.233 0.232 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.917 179.858 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_endo -83.96 19.7 1.32 Allowed 'Trans proline' 0 C--N 1.35 0.628 0 C-N-CA 122.692 2.261 . . . . 0.0 113.171 179.843 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 12.7 t -128.02 -59.26 1.19 Allowed 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 122.301 0.24 . . . . 0.0 110.41 179.607 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 19.4 p -95.76 -20.89 18.51 Favored 'General case' 0 N--CA 1.468 0.444 0 N-CA-C 112.073 0.397 . . . . 0.0 112.073 179.676 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 1.2 t 67.04 39.6 3.15 Favored 'General case' 0 CA--C 1.536 0.434 0 CA-C-O 120.901 0.382 . . . . 0.0 111.353 -179.683 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 8.0 tt -91.81 139.6 30.51 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.852 179.903 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' MET . . . . . . . . . . . . . 53.1 mtp -88.24 128.11 35.46 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 116.396 -0.366 . . . . 0.0 111.3 -179.734 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 2.4 pt -132.26 139.08 50.95 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.259 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.492 179.937 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 22.0 m-20 -96.93 87.13 4.17 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 116.458 -0.337 . . . . 0.0 110.324 179.216 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 12.6 p -93.13 114.15 29.35 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.251 0 CA-C-O 121.004 0.43 . . . . 0.0 111.079 -179.893 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 14.9 p -82.92 146.75 6.59 Favored 'Isoleucine or valine' 0 C--O 1.233 0.208 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.283 -179.539 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 47.5 p90 -121.9 170.1 10.13 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.267 -179.645 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -132.08 165.0 25.01 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.448 -179.914 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -99.83 -33.77 10.42 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.405 179.815 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 1.6 mm-40 -59.35 -60.31 4.06 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-O 120.471 0.176 . . . . 0.0 111.073 179.929 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -59.87 -44.49 94.14 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 116.608 -0.269 . . . . 0.0 110.86 179.733 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -58.38 -45.34 88.49 Favored 'General case' 0 CA--C 1.53 0.211 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.036 179.734 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -62.77 -51.68 66.19 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.176 179.789 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 2.0 tp10 -59.57 -40.91 88.9 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-N 116.459 -0.337 . . . . 0.0 110.761 179.517 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 3.9 t80 -55.11 -36.18 65.45 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.435 179.544 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 1.6 t80 -55.9 -38.69 70.55 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-O 120.637 0.256 . . . . 0.0 110.58 179.791 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 4.2 tt0 -83.04 -37.24 24.17 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.73 179.091 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 8.1 mt-10 -65.76 -36.87 84.79 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 116.526 -0.306 . . . . 0.0 111.621 -179.802 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.233 0.223 0 CA-C-O 120.811 0.338 . . . . 0.0 111.542 -179.893 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 3.1 p . . . . . 0 N--CA 1.464 0.275 0 CA-C-O 120.647 0.26 . . . . 0.0 111.627 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -107.89 -47.56 3.56 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.21 179.622 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -150.32 174.57 12.71 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.339 179.938 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 12.4 mt-10 -121.62 120.71 35.57 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.63 179.691 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.443 ' O ' ' HA ' ' A' ' 57' ' ' VAL . 3.6 mp -115.08 152.09 16.74 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.331 0 CA-C-N 116.441 -0.345 . . . . 0.0 111.33 -179.495 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . 0.416 ' HA ' HG12 ' A' ' 58' ' ' VAL . 10.2 mt-10 -99.24 143.06 29.93 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 116.525 -0.307 . . . . 0.0 111.387 179.986 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 9.0 tp -59.32 -29.42 41.88 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.382 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.467 179.576 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 3.4 pt-20 -60.59 -28.67 68.67 Favored 'General case' 0 CA--C 1.533 0.325 0 CA-C-N 116.669 -0.241 . . . . 0.0 111.357 179.679 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -97.9 36.99 1.46 Allowed 'General case' 0 CA--C 1.535 0.392 0 CA-C-O 120.722 0.296 . . . . 0.0 111.248 179.756 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 3.9 mtt -131.44 140.06 49.52 Favored 'General case' 0 N--CA 1.464 0.225 0 CA-C-N 116.528 -0.305 . . . . 0.0 111.075 179.994 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 2.1 m -67.58 145.91 54.4 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 116.418 -0.355 . . . . 0.0 111.131 179.826 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 1.5 p90 -109.08 158.15 18.04 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.159 179.726 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -135.7 76.9 53.04 Favored Pre-proline 0 CA--C 1.532 0.264 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.587 179.677 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -54.09 -25.02 35.32 Favored 'Trans proline' 0 C--N 1.352 0.736 0 C-N-CA 122.982 2.454 . . . . 0.0 113.133 -179.99 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -52.95 -42.72 65.74 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-N 116.669 -0.241 . . . . 0.0 111.316 179.918 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 3.5 m-80 -133.01 15.69 4.22 Favored 'General case' 0 CA--C 1.541 0.615 0 N-CA-C 112.181 0.438 . . . . 0.0 112.181 -179.758 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 27.7 mt-30 56.08 75.26 0.35 Allowed 'General case' 0 N--CA 1.471 0.591 0 N-CA-C 111.959 0.355 . . . . 0.0 111.959 179.497 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 1.6 ptt? -163.01 147.95 11.58 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-N 116.431 -0.349 . . . . 0.0 111.26 179.191 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 7.5 m-85 -105.09 139.33 39.92 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-O 120.677 0.275 . . . . 0.0 110.973 179.675 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 75.5 p -132.44 158.25 42.51 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.57 -179.488 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 39.0 t80 -162.83 136.45 4.61 Favored Pre-proline 0 N--CA 1.465 0.276 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.908 179.619 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 41.7 Cg_endo -66.14 100.31 0.45 Allowed 'Trans proline' 0 C--N 1.35 0.617 0 C-N-CA 122.461 2.107 . . . . 0.0 112.32 179.725 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . 0.41 ' SG ' ' HD2' ' A' ' 27' ' ' PRO . 42.6 t -58.4 139.3 84.91 Favored Pre-proline 0 C--O 1.233 0.19 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.843 179.843 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . 0.41 ' HD2' ' SG ' ' A' ' 26' ' ' CYS . 65.1 Cg_exo -52.27 -26.53 27.33 Favored 'Trans proline' 0 C--N 1.349 0.596 0 C-N-CA 122.843 2.362 . . . . 0.0 113.038 179.844 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . 0.419 ' CB ' ' HB3' ' A' ' 51' ' ' CYS . 0.8 OUTLIER -68.19 -38.4 81.97 Favored 'General case' 0 CA--C 1.533 0.318 0 CA-C-O 120.472 0.177 . . . . 0.0 111.394 179.924 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 151.12 -45.28 0.64 Allowed Glycine 0 C--N 1.336 0.55 0 C-N-CA 120.827 -0.702 . . . . 0.0 112.999 -179.784 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 2.8 t70 -72.26 -178.21 2.41 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-N 116.677 0.239 . . . . 0.0 111.143 -179.845 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 8.2 ttm180 -118.93 125.37 49.3 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-O 120.673 0.273 . . . . 0.0 111.234 -179.86 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -64.84 154.33 37.48 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.243 179.858 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 20.8 pt20 -150.44 135.93 18.06 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.278 -179.92 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 2.8 tt -149.27 135.39 12.07 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.201 0 CA-C-N 116.425 -0.352 . . . . 0.0 111.219 179.428 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -86.2 140.93 29.71 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.83 179.963 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 9.8 mp -58.03 -49.14 77.89 Favored 'General case' 0 C--O 1.232 0.152 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.676 179.699 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -58.05 -39.4 78.35 Favored 'General case' 0 CA--C 1.532 0.261 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.23 179.48 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -58.54 -46.79 86.09 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 116.571 -0.286 . . . . 0.0 110.834 179.809 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 8.9 mtm -59.82 -35.3 74.44 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.85 179.683 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -55.16 -42.91 73.74 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.923 179.511 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -60.38 -48.23 82.66 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-O 120.68 0.276 . . . . 0.0 110.81 179.712 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 149.62 54.76 0.01 OUTLIER Glycine 0 C--N 1.334 0.472 0 C-N-CA 120.954 -0.641 . . . . 0.0 112.663 179.775 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 2.3 tp10 -99.32 95.94 7.39 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-O 120.775 0.321 . . . . 0.0 111.047 179.971 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 13.4 mtmt -105.39 -36.89 7.03 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.078 179.75 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 9.4 p -117.95 111.11 32.94 Favored 'Isoleucine or valine' 0 C--O 1.233 0.217 0 CA-C-O 121.037 0.446 . . . . 0.0 110.87 179.769 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -109.9 168.8 9.16 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-N 115.816 -0.629 . . . . 0.0 111.338 -179.552 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 12.0 p -130.83 140.44 48.68 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.254 0 CA-C-N 116.432 -0.349 . . . . 0.0 111.75 -179.352 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 40.6 t -76.64 136.82 67.21 Favored Pre-proline 0 N--CA 1.464 0.248 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.737 179.785 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_endo -83.03 20.7 1.12 Allowed 'Trans proline' 0 CA--C 1.537 0.627 0 C-N-CA 122.85 2.367 . . . . 0.0 113.203 179.796 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -129.0 -56.79 1.18 Allowed 'General case' 0 C--O 1.233 0.222 0 CA-C-N 116.682 -0.235 . . . . 0.0 110.419 179.516 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' CYS . . . . . 0.419 ' HB3' ' CB ' ' A' ' 28' ' ' CYS . 22.9 p -95.78 -24.16 16.62 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 116.473 -0.33 . . . . 0.0 111.777 179.49 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER 69.64 39.95 1.45 Allowed 'General case' 0 CA--C 1.534 0.344 0 CA-C-O 120.821 0.343 . . . . 0.0 111.368 -179.666 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 74.4 mt -98.07 127.78 44.21 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-N 116.433 -0.348 . . . . 0.0 110.606 179.62 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' MET . . . . . . . . . . . . . 9.4 mtt -82.61 136.24 34.86 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.963 -179.677 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 9.2 pt -136.75 152.61 29.1 Favored 'Isoleucine or valine' 0 C--O 1.234 0.25 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.908 -179.647 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -102.66 108.78 20.16 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.484 179.285 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.443 ' HA ' ' O ' ' A' ' 8' ' ' ILE . 0.0 OUTLIER -110.13 113.18 43.51 Favored 'Isoleucine or valine' 0 C--O 1.234 0.257 0 CA-C-O 120.793 0.33 . . . . 0.0 111.355 179.726 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.416 HG12 ' HA ' ' A' ' 9' ' ' GLU . 8.1 p -81.88 88.2 1.84 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.265 0 CA-C-O 121.353 0.597 . . . . 0.0 110.772 179.821 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 51.0 p90 -80.02 155.27 27.68 Favored 'General case' 0 CA--C 1.531 0.249 0 CA-C-N 115.597 -0.729 . . . . 0.0 111.177 -179.568 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -103.54 145.91 29.32 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-O 120.891 0.377 . . . . 0.0 111.375 -179.875 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 5.8 tttp -87.94 -40.22 14.1 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.844 179.67 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 21.1 tt0 -56.42 -44.62 80.56 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.335 179.424 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 77.4 m-20 -63.0 -46.66 86.63 Favored 'General case' 0 N--CA 1.463 0.186 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.813 179.353 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -53.33 -45.89 69.24 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-N 116.635 -0.257 . . . . 0.0 111.327 179.971 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -58.0 -51.54 69.25 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-N 116.471 -0.332 . . . . 0.0 111.024 179.869 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 58.6 mt-10 -67.13 -46.36 74.34 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.889 179.767 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 5.2 m-85 -53.98 -31.91 52.35 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.62 179.637 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 1.7 t80 -59.09 -49.2 78.79 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-O 120.671 0.272 . . . . 0.0 110.804 179.935 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 34.8 mt-10 -83.93 -35.5 23.99 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.006 179.841 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 2.6 mm-40 -66.63 -30.31 70.55 Favored 'General case' 0 CA--C 1.533 0.29 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.67 179.765 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.465 0.285 0 CA-C-O 120.966 0.412 . . . . 0.0 111.991 -179.478 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 1.2 p . . . . . 0 N--CA 1.465 0.305 0 CA-C-O 120.627 0.251 . . . . 0.0 110.794 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 2.8 m-85 -108.03 -73.74 0.68 Allowed 'General case' 0 C--O 1.233 0.226 0 CA-C-N 116.46 -0.337 . . . . 0.0 111.119 -179.968 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 8.9 p-10 -142.29 162.19 36.1 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.44 -179.515 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 -106.58 108.85 20.57 Favored 'General case' 0 CA--C 1.531 0.228 0 CA-C-N 115.857 -0.611 . . . . 0.0 110.976 -179.954 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 3.7 mp -93.73 150.14 4.07 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.23 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.215 179.95 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . 0.456 ' HA ' HG12 ' A' ' 58' ' ' VAL . 4.0 tt0 -95.59 146.87 24.14 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.344 -179.734 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 2.9 tt -60.37 -33.19 53.08 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.296 0 CA-C-N 116.086 -0.507 . . . . 0.0 111.415 179.653 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 27.3 mt-10 -60.18 -35.24 74.93 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 116.464 -0.334 . . . . 0.0 110.892 179.532 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -96.44 37.22 1.28 Allowed 'General case' 0 CA--C 1.533 0.316 0 CA-C-O 120.804 0.335 . . . . 0.0 111.287 179.774 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 2.3 ttt -124.18 144.12 50.11 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.756 179.751 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 21.5 m -64.88 136.86 57.33 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.047 -179.788 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 19.7 p90 -105.89 131.04 53.68 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.009 179.771 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -118.65 91.8 42.82 Favored Pre-proline 0 C--N 1.33 -0.261 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.479 179.843 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 42.3 Cg_endo -70.82 -14.79 32.99 Favored 'Trans proline' 0 C--N 1.347 0.496 0 C-N-CA 122.598 2.199 . . . . 0.0 113.0 -179.932 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 -51.37 -35.26 37.79 Favored 'General case' 0 CA--C 1.533 0.319 0 N-CA-C 111.912 0.338 . . . . 0.0 111.912 -179.759 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 18.6 m-20 -148.71 26.67 0.91 Allowed 'General case' 0 CA--C 1.534 0.36 0 CA-C-N 116.624 -0.262 . . . . 0.0 111.579 -179.78 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 7.1 mt-30 55.02 69.84 0.69 Allowed 'General case' 0 CA--C 1.537 0.472 0 CA-C-O 120.921 0.391 . . . . 0.0 111.566 179.518 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 5.7 ptt? -151.52 167.49 27.87 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.938 179.577 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 17.4 m-85 -128.63 147.49 50.73 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 116.507 -0.315 . . . . 0.0 110.918 179.824 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 71.7 p -138.77 169.52 17.64 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.803 -179.615 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 47.6 t80 -163.54 137.09 4.4 Favored Pre-proline 0 N--CA 1.468 0.432 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.938 179.878 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -67.3 97.08 0.42 Allowed 'Trans proline' 0 C--N 1.352 0.713 0 C-N-CA 122.486 2.124 . . . . 0.0 112.11 179.446 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . 0.454 ' SG ' ' HD2' ' A' ' 27' ' ' PRO . 50.2 t -59.44 140.43 88.5 Favored Pre-proline 0 C--O 1.233 0.193 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.676 179.962 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . 0.454 ' HD2' ' SG ' ' A' ' 26' ' ' CYS . 74.5 Cg_exo -50.86 -27.75 21.54 Favored 'Trans proline' 0 C--N 1.349 0.591 0 C-N-CA 122.942 2.428 . . . . 0.0 113.098 179.928 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -71.48 -38.29 71.23 Favored 'General case' 0 CA--C 1.533 0.326 0 CA-C-O 120.485 0.183 . . . . 0.0 111.269 -179.905 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 149.45 -44.08 0.74 Allowed Glycine 0 C--N 1.337 0.6 0 C-N-CA 120.858 -0.687 . . . . 0.0 113.001 -179.971 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -68.26 176.85 2.55 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-O 120.84 0.352 . . . . 0.0 111.278 -179.716 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -118.43 128.82 54.98 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-N 116.492 -0.322 . . . . 0.0 110.998 -179.927 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 9.6 m-85 -62.54 160.13 14.44 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.859 179.671 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 10.5 pt20 -155.3 130.14 9.31 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-O 120.845 0.355 . . . . 0.0 111.401 -179.982 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 3.2 tt -157.3 124.19 0.56 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.281 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.904 179.707 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 32.0 m-85 -80.15 156.5 26.95 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.746 179.999 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 72.0 mt -58.73 -40.9 85.14 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.836 179.849 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -62.2 -35.22 78.21 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 116.447 -0.342 . . . . 0.0 111.408 179.675 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 18.1 m-20 -64.45 -60.08 3.58 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-O 120.862 0.363 . . . . 0.0 110.77 -179.943 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 13.7 ptp -60.18 -37.26 79.66 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.076 179.874 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . 0.432 ' HB2' ' CD2' ' A' ' 64' ' ' LEU . 23.2 t80 -59.8 -45.35 92.59 Favored 'General case' 0 CA--C 1.53 0.193 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.984 179.581 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -57.97 -42.2 84.53 Favored 'General case' 0 CA--C 1.532 0.251 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.005 179.799 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 149.78 65.73 0.01 OUTLIER Glycine 0 C--N 1.336 0.537 0 C-N-CA 120.773 -0.727 . . . . 0.0 113.086 179.632 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -120.01 156.63 30.51 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-O 120.655 0.264 . . . . 0.0 111.12 179.719 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -162.77 -46.8 0.04 OUTLIER 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.164 179.532 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 22.0 t -96.89 89.22 2.02 Favored 'Isoleucine or valine' 0 C--O 1.234 0.28 0 CA-C-O 120.892 0.377 . . . . 0.0 110.644 179.692 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -80.1 141.54 35.7 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.24 -179.583 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 7.9 m -110.09 127.24 67.14 Favored 'Isoleucine or valine' 0 C--O 1.232 0.174 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.464 -179.879 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 51.0 t -72.13 135.64 82.32 Favored Pre-proline 0 C--N 1.331 -0.227 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.792 179.806 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 87.0 Cg_endo -84.0 19.22 1.4 Allowed 'Trans proline' 0 CA--C 1.537 0.631 0 C-N-CA 122.734 2.289 . . . . 0.0 113.234 179.96 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 2.0 t -127.74 -57.86 1.25 Allowed 'General case' 0 C--O 1.232 0.176 0 CA-C-O 120.558 0.218 . . . . 0.0 110.649 179.538 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 19.6 p -98.7 -19.81 17.29 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-N 116.455 -0.339 . . . . 0.0 111.73 179.888 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER 67.81 39.28 2.68 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-O 121.081 0.467 . . . . 0.0 110.955 -179.895 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 9.1 tt -91.25 132.9 35.83 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.631 179.875 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' MET . . . . . . . . . . . . . 15.1 mtt -87.92 130.49 34.91 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.194 -179.664 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 3.2 pt -133.45 144.51 35.86 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.237 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.456 179.676 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -101.7 107.59 18.87 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.226 179.148 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 11.6 p -107.98 117.1 52.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-O 120.943 0.402 . . . . 0.0 111.01 -179.821 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.456 HG12 ' HA ' ' A' ' 9' ' ' GLU . 13.9 p -79.99 135.54 25.25 Favored 'Isoleucine or valine' 0 C--O 1.236 0.347 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.662 -179.896 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 8.0 p90 -142.96 169.39 17.66 Favored 'General case' 0 C--O 1.235 0.299 0 CA-C-N 115.782 -0.645 . . . . 0.0 110.97 -179.084 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -138.06 171.07 14.95 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.175 179.615 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 7.6 mttp -96.78 23.01 7.47 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.324 179.746 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 4.6 mt-10 -94.35 -47.81 6.43 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.224 179.206 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 3.0 t70 -68.55 -35.95 78.12 Favored 'General case' 0 N--CA 1.462 0.126 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.213 179.529 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.432 ' CD2' ' HB2' ' A' ' 40' ' ' PHE . 0.7 OUTLIER -55.05 -53.61 53.6 Favored 'General case' 0 CA--C 1.532 0.279 0 CA-C-N 116.694 -0.23 . . . . 0.0 111.358 -179.895 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -59.57 -44.6 93.25 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-O 120.811 0.339 . . . . 0.0 110.934 179.573 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -64.45 -45.15 88.67 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-N 115.857 -0.61 . . . . 0.0 111.102 179.884 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 1.2 t80 -72.11 -39.85 68.59 Favored 'General case' 0 CA--C 1.531 0.239 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.899 -179.764 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 15.4 t80 -62.5 -36.96 84.17 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-O 120.577 0.227 . . . . 0.0 110.86 179.924 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 32.4 mt-10 -78.11 -32.82 50.73 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.987 179.471 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 4.8 tt0 -114.23 40.4 2.52 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-N 116.546 -0.297 . . . . 0.0 111.492 -179.79 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.234 0.261 0 CA-C-O 120.986 0.422 . . . . 0.0 111.62 -179.942 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.465 0.301 0 CA-C-O 120.772 0.32 . . . . 0.0 111.172 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 61.2 m-85 -95.07 -35.26 11.99 Favored 'General case' 0 CA--C 1.53 0.197 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.523 179.991 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -155.04 174.1 15.65 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-O 120.812 0.339 . . . . 0.0 111.328 179.887 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 26.5 tt0 -130.8 114.33 15.2 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.649 -179.936 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 27.8 mm -93.2 155.61 3.12 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.178 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.744 179.897 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 4.3 pm0 -119.1 145.97 45.49 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.171 -179.807 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 8.2 tp -59.21 -33.53 50.99 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.328 0 CA-C-N 116.277 -0.419 . . . . 0.0 111.168 179.595 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 8.4 mt-10 -65.68 -32.25 73.71 Favored 'General case' 0 CA--C 1.533 0.318 0 CA-C-N 116.461 -0.336 . . . . 0.0 111.155 179.445 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 11.0 t0 -98.63 40.32 1.2 Allowed 'General case' 0 CA--C 1.533 0.3 0 CA-C-O 120.97 0.414 . . . . 0.0 110.664 179.617 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -131.83 163.96 27.11 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.937 179.803 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 5.8 m -96.62 119.93 36.0 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-N 116.43 -0.35 . . . . 0.0 110.824 -179.809 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 20.8 p90 -98.56 134.14 41.94 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.529 179.618 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 4.5 mt-10 -107.11 94.3 10.75 Favored Pre-proline 0 C--O 1.234 0.239 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.521 179.952 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -73.0 65.24 4.14 Favored 'Trans proline' 0 C--N 1.35 0.629 0 C-N-CA 122.936 2.424 . . . . 0.0 112.5 -179.553 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 5.4 pt-20 -135.92 -49.48 0.69 Allowed 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.676 -0.693 . . . . 0.0 111.062 179.991 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -135.54 32.19 3.07 Favored 'General case' 0 CA--C 1.535 0.382 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.384 179.865 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 55.48 59.29 3.98 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-O 121.037 0.446 . . . . 0.0 111.273 -179.995 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 10.6 ptm -143.14 163.28 33.3 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.989 179.791 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 4.5 p90 -150.82 144.32 24.98 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.09 -179.997 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 76.4 p -134.62 167.35 20.98 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-N 115.987 -0.551 . . . . 0.0 111.689 -179.386 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 31.6 t80 -153.41 136.72 10.06 Favored Pre-proline 0 CA--C 1.531 0.239 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.937 -179.993 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo -66.58 101.94 0.57 Allowed 'Trans proline' 0 C--N 1.35 0.623 0 C-N-CA 122.706 2.27 . . . . 0.0 112.415 179.739 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . 0.411 ' SG ' ' HD2' ' A' ' 27' ' ' PRO . 41.8 t -62.82 139.23 97.21 Favored Pre-proline 0 C--O 1.232 0.184 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.605 179.688 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . 0.411 ' HD2' ' SG ' ' A' ' 26' ' ' CYS . 76.3 Cg_exo -51.44 -27.27 23.9 Favored 'Trans proline' 0 C--N 1.349 0.602 0 C-N-CA 122.847 2.365 . . . . 0.0 113.029 179.858 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . 0.42 ' CB ' ' HB3' ' A' ' 51' ' ' CYS . 0.8 OUTLIER -69.66 -36.88 76.43 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-N 116.849 -0.16 . . . . 0.0 111.425 179.947 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 148.53 -43.54 0.8 Allowed Glycine 0 C--N 1.337 0.599 0 C-N-CA 120.881 -0.676 . . . . 0.0 113.141 179.91 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -69.49 -177.77 1.26 Allowed 'General case' 0 N--CA 1.465 0.315 0 CA-C-O 120.841 0.353 . . . . 0.0 111.442 -179.686 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 1.4 tpp180 -121.74 118.53 29.31 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.033 -179.918 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 34.3 t80 -59.87 142.74 52.96 Favored 'General case' 0 CA--C 1.528 0.103 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.448 179.394 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 1.5 pt20 -135.81 143.97 45.46 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-N 116.539 -0.3 . . . . 0.0 111.214 -179.814 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 8.2 tt -174.79 149.24 0.41 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.343 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.02 -179.953 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 64.9 m-85 -99.14 159.62 14.85 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.05 -179.806 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 7.9 mp -60.69 -44.27 96.73 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.728 179.831 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -57.9 -40.22 79.82 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.678 179.327 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -60.26 -42.37 95.22 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.521 179.292 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 4.5 mtp -91.55 33.41 1.01 Allowed 'General case' 0 CA--C 1.534 0.356 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.253 179.367 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 18.0 t80 -135.95 -47.32 0.66 Allowed 'General case' 0 C--O 1.233 0.207 0 CA-C-N 116.654 -0.248 . . . . 0.0 110.865 179.647 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 12.9 tt0 -58.69 -44.62 90.32 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.884 179.675 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 167.28 68.17 0.03 OUTLIER Glycine 0 C--N 1.335 0.492 0 C-N-CA 120.892 -0.671 . . . . 0.0 112.843 179.713 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -144.08 156.02 44.19 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-O 120.818 0.342 . . . . 0.0 111.439 -179.968 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 4.7 pttp -156.21 -47.35 0.08 Allowed 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 115.886 -0.597 . . . . 0.0 111.107 179.811 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 10.5 p -103.74 120.36 53.72 Favored 'Isoleucine or valine' 0 C--O 1.233 0.211 0 CA-C-O 120.898 0.38 . . . . 0.0 110.797 179.735 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -111.99 173.83 6.17 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.162 -179.844 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 19.9 t -128.48 137.8 56.39 Favored 'Isoleucine or valine' 0 C--O 1.235 0.29 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.441 -179.669 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 43.8 t -78.6 136.12 59.79 Favored Pre-proline 0 C--O 1.233 0.222 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.679 179.624 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_endo -84.31 22.16 0.98 Allowed 'Trans proline' 0 C--N 1.349 0.595 0 C-N-CA 122.828 2.352 . . . . 0.0 113.339 179.951 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 36.4 m -131.26 -57.13 1.02 Allowed 'General case' 0 C--O 1.233 0.219 0 CA-C-O 120.507 0.194 . . . . 0.0 110.674 179.825 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' CYS . . . . . 0.42 ' HB3' ' CB ' ' A' ' 28' ' ' CYS . 19.2 p -95.68 -19.18 19.92 Favored 'General case' 0 CA--C 1.535 0.369 0 CA-C-N 116.489 -0.323 . . . . 0.0 111.615 179.441 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 1.7 m 62.97 40.83 8.96 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-O 121.061 0.457 . . . . 0.0 111.014 -179.728 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 7.1 tp -95.02 142.94 26.91 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.873 179.898 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' MET . . . . . . . . . . . . . 17.3 mtm -91.99 128.39 37.81 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.709 179.817 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 19.0 pt -137.62 139.41 43.25 Favored 'Isoleucine or valine' 0 C--O 1.233 0.227 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.452 -179.659 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 91.5 m-20 -99.06 90.13 4.5 Favored 'General case' 0 C--O 1.231 0.13 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.493 179.417 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 9.4 p -86.79 114.54 26.22 Favored 'Isoleucine or valine' 0 C--O 1.233 0.216 0 CA-C-O 120.993 0.425 . . . . 0.0 110.759 179.697 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 14.3 p -79.71 142.79 13.49 Favored 'Isoleucine or valine' 0 C--O 1.233 0.213 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.269 -179.75 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 36.2 p90 -132.43 177.94 7.21 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.691 -179.827 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -121.87 -167.1 1.48 Allowed 'General case' 0 CA--C 1.534 0.331 0 CA-C-O 120.792 0.33 . . . . 0.0 110.789 179.781 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 4.7 mmtp -113.98 -44.99 3.1 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.288 179.255 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 7.7 mt-10 -61.71 -34.2 75.37 Favored 'General case' 0 CA--C 1.529 0.17 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.206 179.58 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 34.8 p30 -56.73 -32.6 65.7 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 116.843 -0.162 . . . . 0.0 111.25 179.582 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 1.3 mp -79.27 -53.29 7.1 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-O 120.658 0.266 . . . . 0.0 110.612 179.355 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -56.04 -38.92 71.22 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.814 179.473 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 26.9 tt0 -68.73 -40.53 79.86 Favored 'General case' 0 CA--C 1.531 0.242 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.776 179.335 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -68.38 -39.81 81.62 Favored 'General case' 0 CA--C 1.53 0.185 0 CA-C-N 116.525 -0.307 . . . . 0.0 111.628 179.842 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 6.0 m-85 -60.46 -41.81 94.89 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 116.773 -0.194 . . . . 0.0 111.081 -179.858 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 16.9 pt-20 -77.84 -33.56 52.2 Favored 'General case' 0 CA--C 1.533 0.322 0 CA-C-N 116.621 -0.263 . . . . 0.0 111.234 179.698 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -74.17 -51.79 14.46 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-O 120.605 0.24 . . . . 0.0 111.41 -179.951 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.233 0.197 0 CA-C-O 120.816 0.341 . . . . 0.0 111.358 -179.872 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 68.0 p . . . . . 0 N--CA 1.467 0.414 0 CA-C-O 120.756 0.313 . . . . 0.0 111.518 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . 0.446 ' CD1' ' HB2' ' A' ' 6' ' ' ASP . 10.8 t80 -104.93 -41.32 5.65 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.137 -179.992 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . 0.446 ' HB2' ' CD1' ' A' ' 5' ' ' TYR . 5.1 t70 -155.95 161.33 40.53 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-O 120.801 0.334 . . . . 0.0 111.633 -179.565 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -117.12 119.97 36.88 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.861 179.474 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.412 ' O ' ' HA ' ' A' ' 57' ' ' VAL . 3.7 mp -111.53 153.16 13.3 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.226 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.309 -179.581 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 15.7 mt-10 -103.08 152.03 21.86 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.362 -179.841 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 1.1 tp -58.0 -35.35 51.8 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.297 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.253 179.508 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -63.37 -32.75 74.26 Favored 'General case' 0 CA--C 1.53 0.196 0 CA-C-N 116.544 -0.298 . . . . 0.0 111.151 179.544 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -96.18 36.79 1.29 Allowed 'General case' 0 CA--C 1.531 0.243 0 CA-C-O 120.762 0.315 . . . . 0.0 111.266 -179.987 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' MET . . . . . 0.429 ' HG3' ' HB2' ' A' ' 24' ' ' TYR . 7.6 ttt -127.31 140.84 51.93 Favored 'General case' 0 C--N 1.333 -0.128 0 CA-C-N 116.458 -0.337 . . . . 0.0 110.56 179.643 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 19.4 m -61.19 140.08 58.0 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.919 179.999 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 9.1 m-85 -105.14 135.28 46.79 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.772 -179.974 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -117.56 88.77 30.34 Favored Pre-proline 0 C--O 1.234 0.24 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.608 179.572 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 12.9 Cg_exo -70.7 65.16 2.36 Favored 'Trans proline' 0 C--N 1.349 0.556 0 C-N-CA 123.014 2.476 . . . . 0.0 112.47 -179.649 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 5.9 pt-20 -137.05 -51.89 0.67 Allowed 'General case' 0 C--O 1.232 0.177 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.909 179.945 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 70.8 m-20 -137.0 32.14 2.67 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-N 116.407 -0.36 . . . . 0.0 111.088 179.587 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 13.0 mm-40 56.87 61.9 2.45 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-O 120.917 0.389 . . . . 0.0 110.653 -179.861 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 3.8 ptm -134.26 150.41 51.01 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.957 -179.81 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 5.4 m-85 -122.99 126.86 47.97 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.659 -179.731 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 67.4 p -108.98 156.2 20.0 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.163 -179.87 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' TYR . . . . . 0.429 ' HB2' ' HG3' ' A' ' 13' ' ' MET . 64.8 t80 -148.12 107.34 3.65 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.54 179.824 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_exo -54.34 96.18 0.05 OUTLIER 'Trans proline' 0 C--N 1.348 0.551 0 C-N-CA 122.585 2.19 . . . . 0.0 111.95 -179.966 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . 0.461 ' SG ' ' HD2' ' A' ' 27' ' ' PRO . 46.4 t -63.46 139.19 97.55 Favored Pre-proline 0 C--O 1.233 0.225 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.909 -179.584 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . 0.461 ' HD2' ' SG ' ' A' ' 26' ' ' CYS . 10.1 Cg_endo -52.92 -23.3 20.72 Favored 'Trans proline' 0 C--N 1.349 0.554 0 C-N-CA 122.911 2.407 . . . . 0.0 112.834 179.745 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 6.1 p -59.43 -28.89 67.36 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-O 120.626 0.251 . . . . 0.0 111.222 179.839 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 125.11 4.74 7.03 Favored Glycine 0 CA--C 1.523 0.569 0 C-N-CA 120.988 -0.625 . . . . 0.0 113.6 179.976 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -119.91 -164.72 1.1 Allowed 'General case' 0 CA--C 1.534 0.341 0 CA-C-N 117.552 0.676 . . . . 0.0 111.424 -179.903 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 1.4 tpt180 -124.87 138.78 54.24 Favored 'General case' 0 C--O 1.232 0.155 0 CA-C-O 120.837 0.351 . . . . 0.0 111.561 -179.425 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 2.5 m-85 -81.29 165.16 21.66 Favored 'General case' 0 C--O 1.232 0.166 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.641 179.293 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 3.7 pt20 -155.46 122.92 5.56 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.438 -0.347 . . . . 0.0 111.009 179.785 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 4.3 tt -150.02 136.43 12.35 Favored 'Isoleucine or valine' 0 C--O 1.233 0.236 0 CA-C-N 116.308 -0.406 . . . . 0.0 111.141 -179.926 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 9.7 m-85 -96.39 156.5 16.31 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.011 -179.803 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 86.8 mt -63.64 -40.3 96.52 Favored 'General case' 0 N--CA 1.462 0.165 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.061 179.829 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 2.0 t0 -59.06 -35.76 73.89 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 116.499 -0.318 . . . . 0.0 111.361 179.928 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 9.7 m-20 -68.44 -58.53 4.2 Favored 'General case' 0 C--O 1.231 0.109 0 CA-C-O 120.828 0.347 . . . . 0.0 110.879 179.947 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 11.7 ptp -62.26 -34.03 75.75 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.527 -179.78 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . 0.406 ' HB2' ' CD2' ' A' ' 64' ' ' LEU . 22.4 t80 -60.21 -45.77 92.05 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 116.418 -0.355 . . . . 0.0 110.815 179.698 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 11.0 tt0 -57.93 -37.05 73.37 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.836 179.559 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 143.0 68.34 0.02 OUTLIER Glycine 0 C--N 1.334 0.426 0 C-N-CA 120.917 -0.659 . . . . 0.0 112.586 179.675 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -125.93 122.42 35.93 Favored 'General case' 0 N--CA 1.462 0.144 0 CA-C-O 120.7 0.286 . . . . 0.0 111.414 -179.769 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 14.0 mttt -118.68 -45.09 2.61 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.916 179.413 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 10.6 p -104.55 114.52 44.37 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.182 0 CA-C-O 120.983 0.42 . . . . 0.0 110.98 179.904 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -106.92 151.45 25.25 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.947 -0.569 . . . . 0.0 111.433 -179.52 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 20.4 t -105.13 129.63 57.54 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.15 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.351 -179.893 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 50.2 t -69.43 135.35 88.65 Favored Pre-proline 0 N--CA 1.463 0.175 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.919 179.659 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 91.0 Cg_endo -83.9 19.05 1.42 Allowed 'Trans proline' 0 CA--C 1.535 0.537 0 C-N-CA 122.583 2.189 . . . . 0.0 113.118 179.953 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 1.9 m -129.1 -59.5 1.11 Allowed 'General case' 0 C--O 1.232 0.154 0 CA-C-O 120.412 0.148 . . . . 0.0 110.762 179.725 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 20.8 p -101.5 -14.2 17.6 Favored 'General case' 0 CA--C 1.535 0.377 0 N-CA-C 111.746 0.276 . . . . 0.0 111.746 179.789 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER 66.01 34.0 7.31 Favored 'General case' 0 CA--C 1.533 0.302 0 CA-C-O 120.848 0.356 . . . . 0.0 111.151 -179.98 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 16.8 tp -86.47 133.21 33.77 Favored 'General case' 0 C--O 1.232 0.14 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.709 179.76 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' MET . . . . . . . . . . . . . 15.3 mtt -82.72 129.9 35.04 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.696 179.995 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 3.0 pt -135.9 143.26 36.71 Favored 'Isoleucine or valine' 0 C--O 1.233 0.236 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.816 -179.474 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 30.1 m-20 -91.44 99.93 12.79 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.82 179.497 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.412 ' HA ' ' O ' ' A' ' 8' ' ' ILE . 10.2 p -105.19 110.52 31.23 Favored 'Isoleucine or valine' 0 C--O 1.234 0.262 0 CA-C-O 121.105 0.478 . . . . 0.0 110.927 179.723 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 12.3 p -82.05 138.14 19.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.407 -179.466 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 33.9 p90 -117.22 175.37 5.64 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.771 -0.65 . . . . 0.0 111.114 -179.683 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . 0.483 ' HB3' ' HB2' ' A' ' 63' ' ' ASP . 1.9 t70 -134.28 128.37 33.68 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.136 179.897 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 1.9 mptt -61.53 -42.35 98.69 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.638 179.514 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 23.5 mt-10 -63.95 -39.13 93.45 Favored 'General case' 0 C--O 1.232 0.137 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.328 179.187 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . 0.483 ' HB2' ' HB3' ' A' ' 60' ' ' ASP . 12.9 t70 -56.63 -45.02 81.77 Favored 'General case' 0 N--CA 1.462 0.126 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.886 179.331 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.406 ' CD2' ' HB2' ' A' ' 40' ' ' PHE . 1.1 mp -56.89 -55.62 32.18 Favored 'General case' 0 CA--C 1.529 0.151 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.517 -179.56 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -60.11 -46.91 88.02 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-N 116.673 -0.239 . . . . 0.0 111.483 -179.753 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 10.3 mm-40 -63.34 -42.62 98.94 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.901 179.877 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 33.9 t80 -69.91 -36.39 75.33 Favored 'General case' 0 CA--C 1.531 0.239 0 CA-C-N 116.481 -0.327 . . . . 0.0 111.149 179.599 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 2.2 t80 -55.7 -54.47 43.9 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-N 116.674 -0.239 . . . . 0.0 111.045 -179.882 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -69.83 -35.87 75.13 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.231 179.844 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 13.5 mt-10 -64.09 -38.37 90.81 Favored 'General case' 0 CA--C 1.53 0.179 0 CA-C-N 116.398 -0.365 . . . . 0.0 111.733 -179.831 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.233 0.194 0 N-CA-C 111.633 0.235 . . . . 0.0 111.633 -179.315 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 72.8 p . . . . . 0 N--CA 1.464 0.261 0 CA-C-O 120.91 0.386 . . . . 0.0 111.262 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 9.3 m-85 -105.89 -39.56 5.98 Favored 'General case' 0 CA--C 1.531 0.217 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.397 179.887 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -158.6 176.96 11.74 Favored 'General case' 0 C--O 1.235 0.299 0 CA-C-N 116.451 -0.341 . . . . 0.0 111.256 -179.91 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 2.2 pt-20 -123.14 151.37 42.19 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.906 -179.992 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 25.4 mt -133.2 149.59 31.67 Favored 'Isoleucine or valine' 0 C--O 1.232 0.181 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.254 -179.803 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 39.2 mt-10 -88.63 150.52 22.99 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.062 179.714 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . 0.4 HG22 HD11 ' A' ' 10' ' ' ILE . 14.4 tt -56.86 -34.87 44.86 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.327 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.042 179.221 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -71.59 -44.13 65.03 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.106 179.573 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -53.06 -23.25 7.27 Favored 'General case' 0 N--CA 1.469 0.503 0 N-CA-C 112.026 0.38 . . . . 0.0 112.026 -179.973 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 4.8 ttm -88.42 137.53 32.24 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-N 116.791 -0.186 . . . . 0.0 110.708 179.867 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 29.4 m -60.62 145.27 49.65 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-O 120.735 0.302 . . . . 0.0 111.115 -179.945 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 16.3 p90 -104.84 144.27 31.99 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.272 179.992 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 9.0 mp0 -130.55 93.92 30.85 Favored Pre-proline 0 C--O 1.233 0.23 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.667 179.804 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -68.12 -17.0 45.5 Favored 'Trans proline' 0 C--N 1.349 0.576 0 C-N-CA 122.938 2.425 . . . . 0.0 112.86 179.585 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -54.35 -39.13 66.82 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 116.615 -0.266 . . . . 0.0 111.677 -179.96 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 2.1 m120 -144.7 20.03 1.66 Allowed 'General case' 0 CA--C 1.535 0.37 0 CA-C-N 116.431 -0.349 . . . . 0.0 111.839 -179.521 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 55.68 79.32 0.16 Allowed 'General case' 0 C--O 1.234 0.237 0 CA-C-O 121.142 0.496 . . . . 0.0 111.288 179.636 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 3.2 ptt? -159.54 163.69 34.95 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.78 179.912 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 80.3 m-85 -123.58 118.78 28.12 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.617 179.792 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 14.7 p -105.46 152.03 23.52 Favored 'General case' 0 CA--C 1.53 0.184 0 CA-C-O 120.809 0.338 . . . . 0.0 111.145 -179.895 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 38.4 t80 -159.16 136.46 6.99 Favored Pre-proline 0 N--CA 1.463 0.198 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.018 -179.979 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -72.19 110.37 2.93 Favored 'Trans proline' 0 C--N 1.348 0.525 0 C-N-CA 122.496 2.131 . . . . 0.0 112.317 179.699 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . 0.45 ' SG ' ' HD2' ' A' ' 27' ' ' PRO . 51.5 t -77.63 140.14 63.57 Favored Pre-proline 0 C--O 1.233 0.209 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.463 179.56 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . 0.45 ' HD2' ' SG ' ' A' ' 26' ' ' CYS . 81.8 Cg_exo -49.41 -28.71 16.3 Favored 'Trans proline' 0 C--N 1.35 0.642 0 C-N-CA 123.041 2.494 . . . . 0.0 113.124 179.861 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 3.6 p -61.99 -29.83 70.53 Favored 'General case' 0 C--O 1.236 0.36 0 CA-C-O 120.657 0.265 . . . . 0.0 111.286 179.875 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 116.29 15.92 6.87 Favored Glycine 0 CA--C 1.525 0.696 0 C-N-CA 121.364 -0.446 . . . . 0.0 113.291 -179.894 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -120.11 -171.65 2.2 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-N 117.113 0.457 . . . . 0.0 111.056 -179.995 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 3.8 ttt180 -108.56 131.94 54.35 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-O 120.89 0.376 . . . . 0.0 111.367 -179.701 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 5.1 t80 -100.43 102.15 13.28 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.547 179.775 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 9.2 mt-30 -101.41 154.43 18.82 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.076 -179.781 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 2.4 tt -161.98 123.48 0.31 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.254 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.044 179.674 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 1.3 t80 -76.1 145.11 40.26 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.829 -179.905 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 10.1 mp -58.53 -42.78 88.56 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.852 179.714 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -60.21 -37.81 81.39 Favored 'General case' 0 N--CA 1.462 0.134 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.818 179.232 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -57.9 -52.02 67.21 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.866 179.715 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 7.8 mtt -67.61 -36.59 81.12 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 116.066 -0.516 . . . . 0.0 111.03 179.648 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 16.8 t80 -63.6 -42.5 98.23 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.975 179.732 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 3.0 tp10 -55.53 -35.5 65.71 Favored 'General case' 0 CA--C 1.532 0.269 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.195 179.68 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 139.42 54.91 0.05 OUTLIER Glycine 0 C--N 1.334 0.437 0 C-N-CA 121.15 -0.548 . . . . 0.0 112.433 179.669 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -103.65 150.68 23.78 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-O 120.87 0.367 . . . . 0.0 111.451 -179.711 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 87.0 mttt -147.02 -47.51 0.18 Allowed 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 115.894 -0.593 . . . . 0.0 111.226 179.905 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 15.7 t -107.54 99.97 9.72 Favored 'Isoleucine or valine' 0 C--O 1.233 0.21 0 CA-C-O 120.782 0.325 . . . . 0.0 110.799 179.985 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -88.1 148.49 24.43 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.202 -179.985 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 20.4 t -114.37 129.93 69.53 Favored 'Isoleucine or valine' 0 C--O 1.233 0.19 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.927 -179.902 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 48.9 t -68.87 136.48 89.89 Favored Pre-proline 0 N--CA 1.463 0.202 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.822 179.892 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 89.5 Cg_endo -83.5 19.43 1.34 Allowed 'Trans proline' 0 CA--C 1.536 0.58 0 C-N-CA 122.684 2.256 . . . . 0.0 113.084 179.854 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 43.0 t -128.03 -59.62 1.18 Allowed 'General case' 0 C--O 1.233 0.205 0 CA-C-O 120.57 0.224 . . . . 0.0 110.506 179.675 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' CYS . . . . . 0.413 ' SG ' ' HB2' ' A' ' 53' ' ' LEU . 22.9 p -101.16 -19.53 15.7 Favored 'General case' 0 CA--C 1.535 0.377 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.821 179.888 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 1.6 t 72.94 36.31 0.9 Allowed 'General case' 0 CA--C 1.535 0.375 0 CA-C-O 120.869 0.366 . . . . 0.0 111.039 -179.767 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.413 ' HB2' ' SG ' ' A' ' 51' ' ' CYS . 0.3 OUTLIER -67.66 155.59 38.84 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.835 179.742 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' MET . . . . . . . . . . . . . 15.2 mtt -112.01 114.12 26.82 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.697 -179.753 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 2.8 pp -132.63 143.02 40.94 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.285 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.479 -179.658 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 45.8 m-20 -101.71 91.38 4.38 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.898 179.487 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 11.1 p -85.44 127.74 39.76 Favored 'Isoleucine or valine' 0 C--O 1.233 0.233 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.773 179.614 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 12.2 p -90.12 131.85 36.29 Favored 'Isoleucine or valine' 0 C--O 1.234 0.277 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.114 -179.871 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 54.2 p90 -112.22 143.46 43.24 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.818 -0.628 . . . . 0.0 111.103 -179.697 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 59.5 m-20 -104.39 -28.58 11.27 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.5 179.866 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 16.3 ttmt 63.82 26.05 14.24 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-O 120.937 0.399 . . . . 0.0 111.397 -179.777 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 20.4 tt0 -95.75 -39.43 9.87 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.531 179.479 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -74.29 -32.8 63.03 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-N 115.883 -0.598 . . . . 0.0 111.349 179.809 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 3.0 mp -54.85 -45.21 74.51 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-O 120.544 0.212 . . . . 0.0 111.114 -179.9 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -59.53 -38.62 81.48 Favored 'General case' 0 CA--C 1.532 0.28 0 CA-C-N 116.523 -0.308 . . . . 0.0 111.284 179.65 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 1.9 mm-40 -79.21 -40.84 29.73 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.236 179.726 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -64.8 -35.07 79.91 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 116.47 -0.332 . . . . 0.0 111.818 -179.827 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 2.9 m-85 -59.5 -36.07 75.36 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-O 120.582 0.23 . . . . 0.0 110.722 179.885 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 20.8 tt0 -87.54 -37.43 16.89 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.912 179.296 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 34.9 mt-10 -68.55 -40.87 80.49 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.752 -179.55 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 0.205 0 N-CA-C 111.565 0.209 . . . . 0.0 111.565 -179.56 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 6.8 ttt . . . . . 0 N--CA 1.489 1.509 0 CA-C-O 120.656 0.265 . . . . 0.0 111.579 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 15.4 m -109.72 -38.47 3.57 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.237 0 CA-C-N 116.588 -0.278 . . . . 0.0 111.298 179.778 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 1.3 m -130.66 119.08 21.89 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-N 116.591 -0.277 . . . . 0.0 110.682 179.852 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 13.7 p -147.49 143.91 28.19 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-N 116.398 -0.365 . . . . 0.0 111.342 -179.569 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 12.1 m-85 -109.6 -38.45 5.42 Favored 'General case' 0 C--O 1.232 0.173 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.158 179.487 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 1.8 t0 -158.54 174.84 14.46 Favored 'General case' 0 C--O 1.236 0.352 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.047 179.888 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 34.0 mt-10 -130.45 127.5 39.38 Favored 'General case' 0 C--O 1.232 0.164 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.872 179.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 3.7 mp -109.88 155.45 11.08 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.181 -179.807 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 11.9 mp0 -111.49 146.88 36.48 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.257 -179.833 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 3.6 tt -62.64 -34.29 64.44 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.247 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.28 179.615 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 5.0 pt-20 -64.08 -32.4 73.94 Favored 'General case' 0 CA--C 1.531 0.239 0 CA-C-N 116.559 -0.291 . . . . 0.0 111.129 179.731 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 11.6 m-20 -96.7 37.62 1.27 Allowed 'General case' 0 CA--C 1.531 0.234 0 CA-C-O 120.839 0.352 . . . . 0.0 111.083 179.704 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -131.63 152.6 50.71 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.075 -179.952 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -81.05 166.07 21.09 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.935 179.925 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 3.1 m-85 -119.9 138.41 53.45 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.975 -179.765 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -107.89 90.05 6.04 Favored Pre-proline 0 C--O 1.234 0.265 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.718 179.685 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -73.1 64.44 4.22 Favored 'Trans proline' 0 C--N 1.35 0.614 0 C-N-CA 122.745 2.297 . . . . 0.0 112.937 -179.528 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 6.3 pt-20 -141.95 -46.45 0.35 Allowed 'General case' 0 CA--C 1.531 0.223 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.22 179.698 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 3.5 m120 -139.36 29.49 2.2 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-N 116.572 -0.286 . . . . 0.0 111.449 179.692 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . 0.41 ' NE2' ' HA ' ' A' ' 68' ' ' TYR . 28.2 mt-30 56.52 68.62 0.83 Allowed 'General case' 0 C--O 1.234 0.244 0 CA-C-O 121.043 0.449 . . . . 0.0 111.664 179.448 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 3.8 ptt? -148.23 158.61 44.18 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.01 179.54 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -110.13 159.44 17.34 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.685 179.91 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 34.4 p -134.35 150.06 50.9 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-O 120.941 0.401 . . . . 0.0 111.303 179.827 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 31.5 t80 -155.69 102.07 2.17 Favored Pre-proline 0 C--N 1.333 -0.152 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.565 -179.87 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 62.6 Cg_exo -50.95 99.35 0.04 OUTLIER 'Trans proline' 0 C--N 1.349 0.574 0 C-N-CA 122.53 2.153 . . . . 0.0 112.116 -179.975 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 48.5 t -60.89 138.67 93.84 Favored Pre-proline 0 C--O 1.233 0.231 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.743 -179.618 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 80.2 Cg_exo -48.99 -26.45 10.24 Favored 'Trans proline' 0 C--N 1.351 0.667 0 C-N-CA 122.925 2.417 . . . . 0.0 113.025 179.796 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 4.3 p -59.5 -29.49 67.89 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-O 120.601 0.239 . . . . 0.0 111.352 179.661 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 123.2 7.5 7.02 Favored Glycine 0 CA--C 1.523 0.576 0 C-N-CA 121.207 -0.52 . . . . 0.0 113.445 179.94 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -114.09 -168.24 1.33 Allowed 'General case' 0 CA--C 1.532 0.262 0 CA-C-N 117.379 0.59 . . . . 0.0 111.158 -179.986 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 1.1 tpt180 -117.11 106.43 13.34 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-O 120.75 0.31 . . . . 0.0 110.91 -179.836 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -73.42 113.24 10.29 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.706 179.899 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 25.6 mt-30 -102.89 150.85 23.11 Favored 'General case' 0 N--CA 1.463 0.186 0 CA-C-N 116.435 -0.348 . . . . 0.0 111.146 -179.802 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -154.16 121.57 0.63 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.246 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.005 179.896 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 28.8 m-85 -81.92 148.14 28.9 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-N 116.374 -0.375 . . . . 0.0 111.144 -179.865 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 6.3 mt -67.85 -35.5 78.67 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.969 179.672 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 1.9 p-10 -66.22 -43.13 87.58 Favored 'General case' 0 CA--C 1.531 0.216 0 CA-C-N 116.372 -0.377 . . . . 0.0 110.825 179.481 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -62.81 -52.18 64.18 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-O 120.704 0.288 . . . . 0.0 111.053 -179.855 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 24.1 ptm -61.62 -27.67 68.82 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.36 179.97 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -55.58 -32.4 63.02 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 116.516 -0.311 . . . . 0.0 111.16 179.578 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 13.7 mt-10 -90.96 41.04 1.05 Allowed 'General case' 0 CA--C 1.532 0.285 0 CA-C-O 120.782 0.325 . . . . 0.0 111.484 179.9 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 60.09 64.81 3.84 Favored Glycine 0 C--N 1.334 0.434 0 C-N-CA 121.162 -0.542 . . . . 0.0 113.316 179.41 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 4.3 tt0 -121.62 98.93 6.19 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-O 120.927 0.394 . . . . 0.0 110.979 179.694 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -112.88 -33.78 5.97 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.804 179.856 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 10.3 m -89.18 82.0 2.0 Favored 'Isoleucine or valine' 0 C--O 1.234 0.272 0 CA-C-O 121.037 0.446 . . . . 0.0 110.94 -179.977 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -91.09 147.0 23.38 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.274 -179.79 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 21.4 t -104.87 121.08 56.35 Favored 'Isoleucine or valine' 0 C--O 1.233 0.189 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.804 179.939 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 53.7 t -61.87 135.76 94.67 Favored Pre-proline 0 N--CA 1.463 0.223 0 CA-C-N 116.365 -0.379 . . . . 0.0 110.886 179.972 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 85.0 Cg_endo -84.32 20.25 1.24 Allowed 'Trans proline' 0 CA--C 1.534 0.495 0 C-N-CA 122.724 2.283 . . . . 0.0 113.167 179.926 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -129.81 -59.53 1.06 Allowed 'General case' 0 C--O 1.233 0.194 0 CA-C-O 120.516 0.198 . . . . 0.0 110.74 179.767 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 20.4 p -100.84 -17.29 16.94 Favored 'General case' 0 CA--C 1.532 0.261 0 CA-C-N 116.553 -0.294 . . . . 0.0 111.669 179.683 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER 67.43 36.56 3.8 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-O 120.911 0.386 . . . . 0.0 111.021 -179.889 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 9.8 tp -85.57 133.35 34.07 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.669 179.849 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' MET . . . . . . . . . . . . . 27.9 mtt -82.01 122.44 27.8 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.875 -179.801 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 2.8 pp -131.33 143.34 40.93 Favored 'Isoleucine or valine' 0 C--O 1.234 0.26 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.008 179.884 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -109.39 92.21 3.96 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.622 -179.692 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 12.5 p -86.05 130.03 37.19 Favored 'Isoleucine or valine' 0 C--O 1.234 0.272 0 CA-C-N 116.099 -0.501 . . . . 0.0 111.002 -179.85 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 13.4 p -94.09 145.57 7.76 Favored 'Isoleucine or valine' 0 C--O 1.234 0.268 0 CA-C-N 116.057 -0.519 . . . . 0.0 111.103 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 22.3 p90 -131.89 146.77 52.31 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.153 179.879 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -89.26 -18.92 26.06 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.173 179.382 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 10.5 tttp 68.51 26.2 6.55 Favored 'General case' 0 CA--C 1.532 0.261 0 CA-C-O 120.835 0.35 . . . . 0.0 111.099 -179.688 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 4.4 tt0 -99.69 -62.52 1.23 Allowed 'General case' 0 C--O 1.232 0.165 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.351 179.644 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -62.03 -25.28 67.57 Favored 'General case' 0 N--CA 1.463 0.183 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.976 179.269 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -53.69 -38.31 64.09 Favored 'General case' 0 CA--C 1.53 0.203 0 CA-C-N 116.7 -0.227 . . . . 0.0 111.054 179.701 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -91.66 -37.64 12.92 Favored 'General case' 0 CA--C 1.53 0.208 0 CA-C-N 116.519 -0.309 . . . . 0.0 111.327 179.777 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 19.7 tt0 -66.22 -42.75 88.24 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-N 116.542 -0.299 . . . . 0.0 111.289 -179.937 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 23.3 t80 -57.92 -30.84 66.25 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.34 179.881 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . 0.41 ' HA ' ' NE2' ' A' ' 20' ' ' GLN . 4.2 m-85 -58.52 -35.29 72.05 Favored 'General case' 0 CA--C 1.528 0.117 0 CA-C-O 120.599 0.237 . . . . 0.0 110.725 179.745 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 18.4 mt-10 -81.88 -32.03 31.22 Favored 'General case' 0 C--O 1.232 0.152 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.888 179.394 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -69.4 -51.51 35.81 Favored 'General case' 0 N--CA 1.461 0.109 0 CA-C-N 116.486 -0.324 . . . . 0.0 111.208 179.921 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -71.49 154.01 41.81 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-N 116.363 -0.38 . . . . 0.0 111.358 -179.882 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -103.56 34.66 5.6 Favored Glycine 0 C--N 1.333 0.407 0 C-N-CA 120.982 -0.628 . . . . 0.0 112.715 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 16.4 tt -78.37 156.72 5.02 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.188 0 CA-C-O 120.6 0.238 . . . . 0.0 111.095 179.957 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 34.5 t60 -101.66 93.72 3.72 Favored Pre-proline 0 C--O 1.234 0.268 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.81 179.868 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_endo -68.34 160.15 50.26 Favored 'Trans proline' 0 C--N 1.347 0.498 0 C-N-CA 122.707 2.271 . . . . 0.0 112.483 -179.918 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . 0.43 ' O ' ' HB2' ' A' ' 77' ' ' GLU . 56.8 Cg_endo -70.26 168.52 21.97 Favored 'Trans proline' 0 C--N 1.348 0.508 0 C-N-CA 122.715 2.277 . . . . 0.0 112.239 179.869 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . 0.43 ' HB2' ' O ' ' A' ' 76' ' ' PRO . 5.0 mt-10 68.62 149.7 0.12 Allowed Pre-proline 0 N--CA 1.466 0.341 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.258 -179.895 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -71.78 157.63 54.87 Favored 'Trans proline' 0 C--N 1.346 0.432 0 C-N-CA 122.691 2.26 . . . . 0.0 112.523 179.897 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 4.0 mt -113.59 109.67 29.37 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.021 -179.908 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -97.2 126.88 42.69 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.086 179.962 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -104.58 109.25 21.09 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.054 179.9 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -142.93 132.77 24.04 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.078 -179.966 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.332 -0.179 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.125 179.832 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 75.1 mtp . . . . . 0 N--CA 1.489 1.491 0 CA-C-O 120.655 0.264 . . . . 0.0 111.203 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 6.6 m -108.35 133.96 51.7 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.197 0 CA-C-N 116.418 -0.355 . . . . 0.0 110.932 179.83 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 54.7 p -95.46 113.98 25.7 Favored 'General case' 0 CA--C 1.53 0.204 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.811 179.904 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 2.8 p 60.4 172.67 0.09 Allowed 'General case' 0 N--CA 1.47 0.561 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.487 -179.431 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 17.1 m-85 -116.08 -38.11 3.69 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.707 -179.624 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 1.4 p30 -159.61 174.85 13.96 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-O 120.671 0.272 . . . . 0.0 111.015 -179.697 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -143.67 121.36 11.86 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.072 179.761 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 3.6 mp -115.36 151.99 17.05 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.178 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.271 -179.8 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . 0.417 ' HA ' HG11 ' A' ' 58' ' ' VAL . 1.4 pm0 -91.12 156.14 18.11 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.359 -179.947 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 11.6 tt -63.78 -31.2 52.18 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.251 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.406 179.707 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 12.9 mt-10 -59.78 -33.58 71.88 Favored 'General case' 0 CA--C 1.531 0.249 0 CA-C-N 116.552 -0.295 . . . . 0.0 111.095 179.69 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -96.46 37.29 1.28 Allowed 'General case' 0 CA--C 1.534 0.335 0 CA-C-O 120.798 0.332 . . . . 0.0 111.211 179.815 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -131.65 134.19 45.7 Favored 'General case' 0 C--O 1.232 0.161 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.581 179.889 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 3.6 m -72.16 144.1 48.69 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-O 120.674 0.273 . . . . 0.0 110.782 179.977 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 13.5 p90 -111.84 141.92 44.87 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.001 179.923 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 29.3 mt-10 -117.75 82.9 17.1 Favored Pre-proline 0 C--O 1.233 0.224 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.741 179.916 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -54.76 -24.79 39.51 Favored 'Trans proline' 0 C--N 1.348 0.509 0 C-N-CA 122.814 2.342 . . . . 0.0 112.701 179.692 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -51.37 -38.09 51.51 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-N 116.55 -0.295 . . . . 0.0 111.32 179.729 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 46.3 m-20 -136.3 18.6 3.16 Favored 'General case' 0 CA--C 1.537 0.455 0 N-CA-C 111.927 0.343 . . . . 0.0 111.927 179.881 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 39.7 mt-30 52.27 73.75 0.31 Allowed 'General case' 0 N--CA 1.467 0.392 0 N-CA-C 112.043 0.386 . . . . 0.0 112.043 179.399 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' MET . . . . . 0.404 ' HB3' ' CD2' ' A' ' 35' ' ' TYR . 3.7 ptt? -166.54 146.15 5.78 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.52 179.583 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 27.4 m-85 -90.16 157.05 17.92 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.808 179.548 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 19.1 p -147.46 136.52 22.27 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.19 179.762 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 58.3 t80 -139.82 136.02 17.07 Favored Pre-proline 0 C--N 1.332 -0.161 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.802 179.626 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo -67.48 101.7 0.66 Allowed 'Trans proline' 0 C--N 1.348 0.544 0 C-N-CA 122.528 2.152 . . . . 0.0 112.231 179.907 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . 0.422 ' SG ' ' HD2' ' A' ' 27' ' ' PRO . 37.2 t -61.95 137.6 95.48 Favored Pre-proline 0 C--O 1.233 0.197 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.696 179.868 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . 0.422 ' HD2' ' SG ' ' A' ' 26' ' ' CYS . 12.0 Cg_endo -56.46 -21.65 38.63 Favored 'Trans proline' 0 C--N 1.348 0.523 0 C-N-CA 122.611 2.207 . . . . 0.0 112.686 179.739 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -65.51 -37.88 88.07 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-O 120.507 0.194 . . . . 0.0 111.191 179.932 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 153.05 -44.13 0.62 Allowed Glycine 0 C--N 1.335 0.474 0 C-N-CA 120.692 -0.766 . . . . 0.0 113.13 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -84.36 179.43 7.44 Favored 'General case' 0 CA--C 1.532 0.256 0 CA-C-O 120.785 0.326 . . . . 0.0 111.253 -179.727 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 27.8 ttm180 -113.06 117.69 32.7 Favored 'General case' 0 C--O 1.232 0.159 0 CA-C-N 116.387 -0.369 . . . . 0.0 110.844 179.873 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 30.6 t80 -65.52 156.39 32.7 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.423 -179.838 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 15.8 pt20 -143.57 131.78 21.94 Favored 'General case' 0 CA--C 1.53 0.205 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.16 -179.971 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 7.0 tt -139.09 125.76 24.39 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.185 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.927 179.53 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . 0.404 ' CD2' ' HB3' ' A' ' 21' ' ' MET . 55.4 m-85 -80.24 151.2 29.76 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.345 -179.83 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 45.2 mt -61.34 -40.08 92.91 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.815 179.694 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 2.5 p-10 -63.02 -34.06 76.76 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.199 179.605 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -65.65 -58.94 4.52 Favored 'General case' 0 C--O 1.231 0.083 0 CA-C-O 120.799 0.333 . . . . 0.0 110.728 179.997 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 5.9 ptm -63.69 -34.38 77.73 Favored 'General case' 0 CA--C 1.53 0.202 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.277 179.991 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 46.4 t80 -57.44 -40.68 78.96 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 116.506 -0.316 . . . . 0.0 110.911 179.542 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 4.0 mt-10 -61.71 -35.4 77.94 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 116.538 -0.301 . . . . 0.0 110.982 179.541 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 137.45 46.6 0.08 OUTLIER Glycine 0 C--N 1.332 0.348 0 C-N-CA 120.95 -0.643 . . . . 0.0 112.625 179.86 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -104.07 115.96 31.36 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-O 120.669 0.271 . . . . 0.0 111.042 -179.954 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 2.4 ptpt -117.26 -40.37 3.09 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.216 179.943 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 5.0 m -101.71 101.13 11.68 Favored 'Isoleucine or valine' 0 C--O 1.232 0.172 0 CA-C-O 120.922 0.391 . . . . 0.0 111.249 -179.953 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -99.5 167.77 10.4 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-N 115.987 -0.551 . . . . 0.0 111.404 -179.716 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 5.6 m -136.51 128.33 43.86 Favored 'Isoleucine or valine' 0 C--O 1.232 0.182 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.354 -179.83 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 46.1 t -66.22 136.1 95.17 Favored Pre-proline 0 N--CA 1.463 0.214 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.903 179.865 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_endo -83.57 20.11 1.24 Allowed 'Trans proline' 0 C--N 1.348 0.548 0 C-N-CA 122.692 2.262 . . . . 0.0 113.262 179.859 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -128.45 -56.25 1.23 Allowed 'General case' 0 C--O 1.232 0.156 0 CA-C-O 120.574 0.226 . . . . 0.0 110.502 179.658 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 20.1 p -100.83 -20.08 15.67 Favored 'General case' 0 CA--C 1.534 0.356 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.729 179.846 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 68.24 39.58 2.3 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-O 120.989 0.423 . . . . 0.0 110.896 -179.751 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 6.6 tp -86.44 129.77 34.74 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.816 179.948 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' MET . . . . . . . . . . . . . 28.0 mtm -83.02 131.08 35.19 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.845 -179.934 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 2.6 pp -142.27 145.88 23.16 Favored 'Isoleucine or valine' 0 C--O 1.233 0.204 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.62 -179.731 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -104.6 105.15 15.13 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.757 179.572 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 12.9 p -105.51 118.23 52.62 Favored 'Isoleucine or valine' 0 C--O 1.233 0.213 0 CA-C-O 120.952 0.406 . . . . 0.0 111.101 179.793 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.417 HG11 ' HA ' ' A' ' 9' ' ' GLU . 14.6 p -86.22 139.32 17.55 Favored 'Isoleucine or valine' 0 C--O 1.233 0.232 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.045 -179.839 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 30.5 p90 -129.82 165.75 21.33 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.16 -179.649 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -128.43 178.83 6.01 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-N 116.024 -0.535 . . . . 0.0 111.039 -179.752 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 26.4 mttp -111.1 29.5 7.73 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.206 179.671 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 5.6 mt-10 -99.15 -70.27 0.73 Allowed 'General case' 0 C--O 1.232 0.147 0 CA-C-N 116.492 -0.322 . . . . 0.0 110.604 179.504 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 3.0 p30 -68.3 -37.7 80.88 Favored 'General case' 0 N--CA 1.463 0.175 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.6 179.432 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -56.11 -41.33 75.11 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-N 116.456 -0.338 . . . . 0.0 110.877 179.872 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -73.76 -38.64 64.65 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.35 179.654 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 10.3 mt-10 -71.94 -35.33 69.58 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 116.416 -0.356 . . . . 0.0 111.765 -179.678 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 7.4 m-85 -55.59 -28.32 54.38 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 116.623 -0.262 . . . . 0.0 111.345 -179.794 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 23.4 m-85 -60.66 -34.27 74.05 Favored 'General case' 0 CA--C 1.528 0.117 0 CA-C-N 116.651 -0.25 . . . . 0.0 110.562 179.707 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -90.55 -36.51 14.43 Favored 'General case' 0 CA--C 1.531 0.213 0 CA-C-N 116.284 -0.417 . . . . 0.0 110.993 179.445 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -71.12 -34.71 71.32 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 116.464 -0.335 . . . . 0.0 111.785 -179.648 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -92.6 149.03 21.6 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-O 120.895 0.379 . . . . 0.0 111.295 -179.85 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -101.95 55.47 0.72 Allowed Glycine 0 C--N 1.333 0.387 0 C-N-CA 121.002 -0.618 . . . . 0.0 112.856 -179.821 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 1.1 tp -61.65 -32.87 54.99 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.26 0 CA-C-O 120.55 0.214 . . . . 0.0 111.452 179.799 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 4.3 m170 -106.68 87.89 3.1 Favored Pre-proline 0 C--O 1.232 0.172 0 CA-C-N 116.521 -0.308 . . . . 0.0 110.552 179.695 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_endo -69.63 111.32 2.75 Favored 'Trans proline' 0 C--N 1.348 0.54 0 C-N-CA 122.696 2.264 . . . . 0.0 112.576 -179.686 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -71.51 -178.55 3.06 Favored 'Trans proline' 0 C--N 1.348 0.533 0 C-N-CA 122.517 2.145 . . . . 0.0 112.407 179.819 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -167.11 -60.12 0.01 OUTLIER Pre-proline 0 C--N 1.329 -0.287 0 CA-C-N 116.004 -0.543 . . . . 0.0 111.142 179.788 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 68.4 Cg_endo -73.07 65.26 4.21 Favored 'Trans proline' 0 C--N 1.35 0.62 0 C-N-CA 122.562 2.175 . . . . 0.0 112.352 179.885 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 2.0 pt -138.18 86.66 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.922 179.906 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . 57.76 75.27 0.38 Allowed 'General case' 0 C--O 1.234 0.243 0 CA-C-N 115.862 -0.608 . . . . 0.0 111.333 -179.709 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . 62.95 -174.37 0.15 Allowed 'General case' 0 C--O 1.234 0.246 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.454 179.99 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -170.26 136.13 1.36 Allowed 'General case' 0 C--O 1.233 0.211 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.279 -179.785 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.463 0.21 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.563 179.856 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.488 1.449 0 CA-C-O 120.676 0.274 . . . . 0.0 110.977 . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 20.7 t -97.38 142.73 13.76 Favored 'Isoleucine or valine' 0 C--O 1.232 0.183 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.442 -179.507 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 49.1 m -151.96 111.14 3.89 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.307 -179.927 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -152.67 160.37 43.17 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-O 120.985 0.421 . . . . 0.0 111.511 -179.905 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 85.0 m-85 -105.04 -37.3 6.99 Favored 'General case' 0 CA--C 1.531 0.232 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.409 -179.945 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -157.14 175.67 13.75 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-N 116.534 -0.303 . . . . 0.0 111.247 -179.792 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 21.5 mt-10 -126.2 143.26 51.2 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 116.108 -0.497 . . . . 0.0 111.033 -179.921 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 22.8 mt -127.19 151.82 34.49 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.29 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.173 -179.886 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 8.5 tt0 -104.97 142.89 33.98 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-N 116.515 -0.311 . . . . 0.0 110.953 179.756 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 41.2 pt -61.15 -32.81 53.82 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.305 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.34 179.82 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 16.8 tt0 -59.44 -33.19 70.97 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.841 179.613 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -97.01 36.89 1.36 Allowed 'General case' 0 CA--C 1.533 0.307 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.191 179.855 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 13.0 mtp -131.32 148.29 52.66 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.639 179.678 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 20.0 m -61.96 129.79 42.55 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.14 -179.816 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 21.1 p90 -93.53 124.39 37.49 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.716 179.593 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 -112.07 86.02 7.25 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.793 -179.881 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo -69.23 -16.99 40.18 Favored 'Trans proline' 0 C--N 1.347 0.499 0 C-N-CA 122.743 2.295 . . . . 0.0 112.942 -179.865 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -53.24 -37.49 62.12 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-N 116.712 -0.222 . . . . 0.0 111.15 179.739 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 25.8 m-20 -143.17 25.32 1.74 Allowed 'General case' 0 CA--C 1.533 0.303 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.718 179.902 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 6.2 tt0 53.35 72.25 0.44 Allowed 'General case' 0 CA--C 1.534 0.329 0 CA-C-O 120.992 0.425 . . . . 0.0 111.648 179.513 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' MET . . . . . 0.418 ' HB3' ' CD2' ' A' ' 35' ' ' TYR . 5.7 ptt? -154.08 175.11 13.82 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.046 179.928 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 27.2 m-85 -137.4 138.65 40.08 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.131 179.879 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 79.6 p -130.82 156.64 44.66 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.273 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 45.7 t80 -156.53 136.01 8.22 Favored Pre-proline 0 N--CA 1.463 0.176 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.863 179.781 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -64.71 100.29 0.34 Allowed 'Trans proline' 0 C--N 1.35 0.616 0 C-N-CA 122.678 2.252 . . . . 0.0 112.37 179.839 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . 0.407 ' SG ' ' HD2' ' A' ' 27' ' ' PRO . 42.0 t -59.68 139.26 89.76 Favored Pre-proline 0 C--O 1.233 0.19 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.69 179.817 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . 0.407 ' HD2' ' SG ' ' A' ' 26' ' ' CYS . 75.2 Cg_exo -51.17 -26.09 18.87 Favored 'Trans proline' 0 C--N 1.348 0.548 0 C-N-CA 122.739 2.293 . . . . 0.0 112.951 179.887 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -68.53 -38.88 81.23 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-O 120.553 0.216 . . . . 0.0 111.279 -179.858 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 152.43 -45.95 0.59 Allowed Glycine 0 C--N 1.334 0.459 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.959 -179.904 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.3 t0 -73.17 -173.81 1.41 Allowed 'General case' 0 CA--C 1.533 0.303 0 CA-C-O 120.748 0.309 . . . . 0.0 111.156 -179.807 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 27.4 ttt180 -123.3 129.67 51.66 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-N 116.444 -0.343 . . . . 0.0 110.886 179.855 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 7.4 m-85 -65.09 161.98 17.8 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.987 179.822 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -151.76 127.92 10.49 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.221 179.8 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 3.6 tt -150.87 144.38 16.87 Favored 'Isoleucine or valine' 0 C--O 1.233 0.219 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.175 179.785 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . 0.418 ' CD2' ' HB3' ' A' ' 21' ' ' MET . 86.0 m-85 -105.29 157.47 17.28 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.869 -179.913 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -61.3 -33.85 74.25 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.936 179.768 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 8.2 t70 -68.13 -39.4 82.74 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.991 179.598 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -59.63 -56.43 22.04 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.1 -179.817 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 36.4 mtm -63.58 -31.27 72.39 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.947 179.618 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 17.0 t80 -58.4 -46.32 86.64 Favored 'General case' 0 CA--C 1.529 0.148 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.912 179.604 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -58.18 -35.49 71.65 Favored 'General case' 0 N--CA 1.463 0.185 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.887 179.685 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 138.65 48.45 0.06 OUTLIER Glycine 0 C--N 1.333 0.386 0 C-N-CA 120.992 -0.623 . . . . 0.0 112.64 179.671 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -102.16 124.89 48.55 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-O 120.791 0.329 . . . . 0.0 110.946 -179.989 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 16.2 mttt -122.83 -43.91 2.23 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.968 179.897 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 11.1 p -112.58 113.58 44.54 Favored 'Isoleucine or valine' 0 C--O 1.233 0.236 0 CA-C-O 121.001 0.429 . . . . 0.0 110.967 179.811 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -99.0 160.28 14.37 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.2 -179.648 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 7.5 m -116.81 124.42 72.86 Favored 'Isoleucine or valine' 0 C--O 1.233 0.2 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.367 -179.894 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 51.3 t -69.99 135.66 87.39 Favored Pre-proline 0 C--N 1.33 -0.252 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.868 179.875 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_endo -84.6 20.78 1.17 Allowed 'Trans proline' 0 CA--C 1.535 0.527 0 C-N-CA 122.714 2.276 . . . . 0.0 112.967 179.747 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -128.01 -57.67 1.24 Allowed 'General case' 0 CA--C 1.529 0.147 0 CA-C-O 120.587 0.232 . . . . 0.0 110.578 179.788 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 20.2 p -99.69 -20.45 16.28 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.817 179.946 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 2.1 t 67.29 40.02 2.86 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-O 120.921 0.391 . . . . 0.0 111.022 -179.857 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 8.5 tt -95.94 135.93 37.05 Favored 'General case' 0 C--O 1.232 0.178 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.625 179.805 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' MET . . . . . . . . . . . . . 12.3 mtt -89.39 128.45 35.92 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.128 -179.578 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 2.1 pp -135.14 132.09 52.72 Favored 'Isoleucine or valine' 0 C--O 1.233 0.221 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.474 179.922 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 74.1 m-20 -87.21 99.46 11.97 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.769 179.61 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 13.3 p -93.18 113.38 27.97 Favored 'Isoleucine or valine' 0 C--O 1.233 0.228 0 CA-C-O 121.114 0.483 . . . . 0.0 111.126 179.943 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 11.7 p -81.64 135.5 24.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.867 -179.955 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 53.5 p90 -131.47 178.57 6.63 Favored 'General case' 0 CA--C 1.532 0.252 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.174 -179.722 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 1.6 t0 -126.29 159.91 31.8 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.893 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -79.99 -36.21 36.31 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.612 179.464 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -60.83 -36.73 79.83 Favored 'General case' 0 CA--C 1.528 0.114 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.088 179.967 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -55.16 -45.76 75.73 Favored 'General case' 0 N--CA 1.462 0.137 0 CA-C-N 116.474 -0.33 . . . . 0.0 111.145 179.747 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 3.7 mp -61.54 -55.89 26.03 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.626 -0.261 . . . . 0.0 110.915 179.812 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -56.73 -40.75 76.27 Favored 'General case' 0 N--CA 1.462 0.156 0 CA-C-N 116.484 -0.326 . . . . 0.0 111.083 179.736 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 30.0 mt-10 -67.43 -43.45 81.13 Favored 'General case' 0 CA--C 1.528 0.115 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.93 179.542 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -70.67 -40.15 73.13 Favored 'General case' 0 N--CA 1.463 0.183 0 CA-C-N 116.531 -0.304 . . . . 0.0 111.438 179.939 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 9.7 m-85 -59.21 -40.17 84.96 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 116.659 -0.246 . . . . 0.0 111.075 -179.744 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 16.8 mt-10 -81.24 -33.75 32.59 Favored 'General case' 0 CA--C 1.529 0.158 0 CA-C-N 116.577 -0.283 . . . . 0.0 111.101 179.886 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 29.1 mt-10 -73.44 -50.19 22.97 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-N 116.587 -0.279 . . . . 0.0 111.192 179.945 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -83.32 146.51 28.47 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-N 116.323 -0.398 . . . . 0.0 111.519 -179.572 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -101.27 46.5 1.29 Allowed Glycine 0 C--N 1.333 0.379 0 C-N-CA 120.993 -0.622 . . . . 0.0 112.571 179.825 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 8.5 tp -66.65 143.52 15.51 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.173 0 CA-C-O 120.8 0.333 . . . . 0.0 111.095 179.976 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 23.7 m80 -123.0 151.09 60.78 Favored Pre-proline 0 C--O 1.234 0.261 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.037 -179.857 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -54.18 161.3 5.33 Favored 'Trans proline' 0 C--N 1.351 0.69 0 C-N-CA 122.951 2.434 . . . . 0.0 112.698 179.779 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 42.0 Cg_endo -67.51 -38.36 14.77 Favored 'Trans proline' 0 C--N 1.35 0.62 0 C-N-CA 122.821 2.347 . . . . 0.0 112.836 -179.848 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 57.64 82.54 0.23 Allowed Pre-proline 0 N--CA 1.464 0.272 0 CA-C-O 120.952 0.406 . . . . 0.0 111.439 179.968 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.68 178.89 4.07 Favored 'Trans proline' 0 C--N 1.348 0.528 0 C-N-CA 123.013 2.475 . . . . 0.0 112.889 -179.834 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 2.0 pt -102.35 85.9 1.03 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.256 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.512 -179.861 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . 60.32 90.79 0.06 Allowed 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 115.776 -0.647 . . . . 0.0 111.586 179.815 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -103.46 35.25 2.65 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.6 179.832 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . 56.89 80.86 0.15 Allowed 'General case' 0 CA--C 1.533 0.303 0 CA-C-N 116.491 -0.322 . . . . 0.0 111.641 179.633 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.233 0.204 0 CA-C-O 120.985 0.421 . . . . 0.0 111.29 179.985 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 98.2 mtp . . . . . 0 N--CA 1.489 1.511 0 CA-C-O 120.797 0.332 . . . . 0.0 111.266 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 17.9 t -102.31 -41.29 7.81 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.301 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.139 179.984 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 9.0 p -79.22 133.52 36.68 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 116.475 -0.33 . . . . 0.0 111.254 -179.96 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 1.8 t -164.5 159.77 19.7 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.229 179.857 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 27.1 m-85 -103.88 -31.21 9.88 Favored 'General case' 0 CA--C 1.532 0.252 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.275 179.732 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 5.7 t70 -158.73 165.63 33.88 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-O 120.769 0.319 . . . . 0.0 111.566 -179.855 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 11.2 tt0 -136.41 115.05 11.98 Favored 'General case' 0 CA--C 1.53 0.195 0 CA-C-N 116.035 -0.529 . . . . 0.0 111.177 -179.774 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.431 HG22 ' CE2' ' A' ' 24' ' ' TYR . 3.9 mp -113.56 151.29 15.43 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.277 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.199 179.917 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 4.7 mt-10 -97.92 148.45 23.44 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.273 -179.927 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 14.3 tt -58.55 -31.43 43.63 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.305 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.36 179.668 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 26.4 mt-10 -63.13 -27.56 69.47 Favored 'General case' 0 CA--C 1.532 0.274 0 CA-C-N 116.597 -0.274 . . . . 0.0 111.302 179.634 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -95.09 36.14 1.23 Allowed 'General case' 0 CA--C 1.533 0.325 0 CA-C-O 120.696 0.284 . . . . 0.0 111.313 179.95 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -119.0 177.31 4.91 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-O 120.843 0.354 . . . . 0.0 110.959 179.715 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 1.6 m -108.49 85.69 2.15 Favored 'General case' 0 C--O 1.232 0.15 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.575 179.911 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 30.3 p90 -86.28 139.51 30.95 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.891 179.958 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 25.3 mt-10 -138.69 157.91 71.11 Favored Pre-proline 0 C--O 1.234 0.246 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.633 -179.606 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 25.8 Cg_exo -63.36 -11.95 28.16 Favored 'Trans proline' 0 C--N 1.351 0.686 0 C-N-CA 123.257 2.638 . . . . 0.0 112.914 179.391 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 3.1 pt-20 -66.17 82.99 0.08 Allowed 'General case' 0 C--O 1.233 0.197 0 CA-C-O 121.076 0.465 . . . . 0.0 110.843 -179.731 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 6.0 m-80 62.12 22.9 13.45 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-N 115.799 -0.637 . . . . 0.0 111.668 -179.503 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER 53.49 78.07 0.16 Allowed 'General case' 0 C--O 1.234 0.281 0 CA-C-O 121.067 0.461 . . . . 0.0 111.286 179.921 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 1.9 ppp? -133.71 143.5 48.54 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.674 179.842 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.412 ' CD1' ' N ' ' A' ' 22' ' ' PHE . 0.9 OUTLIER -127.7 132.32 49.65 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.656 179.618 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 40.6 p -122.14 158.74 28.66 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.815 -178.929 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . 0.431 ' CE2' HG22 ' A' ' 8' ' ' ILE . 61.1 t80 -139.9 137.22 18.05 Favored Pre-proline 0 CA--C 1.53 0.186 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.225 179.878 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 65.5 Cg_endo -73.44 100.94 1.3 Allowed 'Trans proline' 0 C--N 1.35 0.627 0 C-N-CA 122.768 2.312 . . . . 0.0 112.442 179.587 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . 0.432 ' SG ' ' HD2' ' A' ' 27' ' ' PRO . 53.1 t -68.69 140.21 91.76 Favored Pre-proline 0 C--O 1.233 0.229 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.705 179.786 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . 0.432 ' HD2' ' SG ' ' A' ' 26' ' ' CYS . 86.7 Cg_exo -48.89 -26.98 10.73 Favored 'Trans proline' 0 C--N 1.351 0.666 0 C-N-CA 122.916 2.411 . . . . 0.0 113.175 179.962 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 9.0 p -58.49 -28.92 65.83 Favored 'General case' 0 CA--C 1.533 0.321 0 CA-C-O 120.642 0.258 . . . . 0.0 111.433 -179.949 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 120.93 9.87 7.22 Favored Glycine 0 CA--C 1.523 0.57 0 C-N-CA 121.134 -0.555 . . . . 0.0 113.337 -179.823 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -122.42 -165.2 1.25 Allowed 'General case' 0 CA--C 1.535 0.375 0 CA-C-N 117.145 0.472 . . . . 0.0 110.935 179.972 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 3.8 ttt85 -137.85 117.16 12.73 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-O 120.515 0.198 . . . . 0.0 111.186 -179.73 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . 0.446 ' CZ ' ' HB1' ' A' ' 46' ' ' ALA . 76.4 t80 -70.63 151.96 44.4 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.225 179.896 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 3.6 pt20 -126.28 139.66 53.14 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.449 -179.939 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 12.0 tt -155.0 148.89 12.61 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.346 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.21 179.69 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 60.3 m-85 -100.67 155.77 17.7 Favored 'General case' 0 C--O 1.236 0.357 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.516 -179.695 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . 0.423 HD12 ' HG ' ' A' ' 64' ' ' LEU . 3.2 mm? -61.67 -46.88 87.85 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.775 179.734 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -60.27 -36.55 78.08 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 116.495 -0.321 . . . . 0.0 110.995 179.647 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -57.19 -46.12 83.14 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.41 179.709 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 2.6 mtt -66.23 -28.81 69.02 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.321 179.582 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -56.53 -45.77 80.98 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-O 120.573 0.225 . . . . 0.0 111.046 179.906 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 10.6 mt-10 -59.91 -32.51 70.83 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 116.461 -0.336 . . . . 0.0 110.975 179.586 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 131.74 46.61 0.13 Allowed Glycine 0 C--N 1.333 0.394 0 C-N-CA 121.145 -0.55 . . . . 0.0 112.498 179.981 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -83.35 92.89 7.63 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-O 120.993 0.425 . . . . 0.0 110.888 -179.948 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 10.8 ptpt -107.33 -32.43 7.76 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.831 -0.622 . . . . 0.0 111.218 179.881 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 7.6 p -121.58 108.98 23.47 Favored 'Isoleucine or valine' 0 C--O 1.233 0.214 0 CA-C-O 121.109 0.48 . . . . 0.0 110.874 179.796 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.446 ' HB1' ' CZ ' ' A' ' 32' ' ' PHE . . . -109.63 171.81 7.22 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.589 -179.361 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 19.1 t -128.91 119.43 49.48 Favored 'Isoleucine or valine' 0 C--O 1.232 0.145 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.036 -179.935 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 41.7 t -62.33 112.19 5.99 Favored Pre-proline 0 N--CA 1.463 0.199 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.452 179.683 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 31.1 Cg_exo -60.33 -17.82 49.2 Favored 'Trans proline' 0 C--N 1.347 0.484 0 C-N-CA 122.645 2.23 . . . . 0.0 113.346 -179.569 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 4.6 t -77.05 -65.17 0.98 Allowed 'General case' 0 CA--C 1.53 0.206 0 CA-C-O 120.416 0.15 . . . . 0.0 111.397 -179.738 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 22.6 p -92.18 -19.55 22.13 Favored 'General case' 0 N--CA 1.465 0.324 0 N-CA-C 112.195 0.442 . . . . 0.0 112.195 -179.426 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 72.96 36.4 0.88 Allowed 'General case' 0 CA--C 1.533 0.302 0 CA-C-O 120.886 0.374 . . . . 0.0 110.905 -179.609 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 6.4 tt -94.94 149.51 21.17 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.736 179.792 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' MET . . . . . . . . . . . . . 38.7 mtt -93.14 129.75 39.03 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-N 116.462 -0.335 . . . . 0.0 111.357 -179.487 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 2.5 pp -137.99 152.47 26.27 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.343 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.47 179.783 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 42.5 m-20 -108.7 107.63 18.16 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.64 179.067 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 14.5 p -99.43 125.63 52.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-O 120.967 0.413 . . . . 0.0 111.026 179.835 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 13.3 p -93.74 142.66 12.98 Favored 'Isoleucine or valine' 0 C--O 1.234 0.258 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.194 -179.88 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 3.0 p90 -131.03 144.39 51.42 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.623 -179.386 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -95.13 -22.67 17.72 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-N 115.997 -0.547 . . . . 0.0 112.028 -179.93 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 3.3 mttt 65.82 27.49 11.05 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-O 120.603 0.24 . . . . 0.0 111.412 -179.575 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 12.5 tt0 -95.47 -49.64 5.33 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-O 120.919 0.39 . . . . 0.0 110.104 179.474 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -66.51 -33.78 76.45 Favored 'General case' 0 N--CA 1.462 0.169 0 CA-C-N 115.746 -0.661 . . . . 0.0 111.129 179.577 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.423 ' HG ' HD12 ' A' ' 36' ' ' LEU . 0.2 OUTLIER -52.86 -34.62 55.17 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 116.679 -0.237 . . . . 0.0 111.495 -179.711 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -86.44 -48.73 8.17 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-N 116.663 -0.244 . . . . 0.0 111.56 -179.981 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 23.5 mt-10 -65.8 -54.17 30.54 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-O 120.664 0.268 . . . . 0.0 111.256 -179.674 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 2.6 t80 -59.64 -23.69 63.25 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.3 179.412 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -57.27 -54.88 41.76 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-O 120.665 0.269 . . . . 0.0 110.962 179.834 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 37.1 mt-10 -79.97 -35.57 37.35 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.763 179.771 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 25.0 mt-10 -62.84 -37.27 86.14 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.188 179.868 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -91.82 156.66 17.36 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-O 120.893 0.378 . . . . 0.0 111.353 -179.935 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -110.77 47.31 1.06 Allowed Glycine 0 C--N 1.332 0.345 0 CA-C-N 115.868 -0.605 . . . . 0.0 112.242 179.785 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 2.7 pp -72.68 -28.51 27.8 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.214 0 N-CA-C 111.5 0.185 . . . . 0.0 111.5 -179.897 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 4.5 m170 -56.86 -60.32 9.83 Favored Pre-proline 0 CA--C 1.531 0.239 0 CA-C-N 116.769 -0.196 . . . . 0.0 111.045 179.896 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -72.1 109.27 2.66 Favored 'Trans proline' 0 C--N 1.351 0.676 0 C-N-CA 122.442 2.094 . . . . 0.0 112.263 179.662 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -61.48 -68.3 0.04 OUTLIER 'Trans proline' 0 C--N 1.35 0.645 0 C-N-CA 122.645 2.23 . . . . 0.0 112.633 -179.592 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 3.4 pt-20 -179.26 156.02 0.82 Allowed Pre-proline 0 N--CA 1.465 0.28 0 CA-C-N 116.628 -0.26 . . . . 0.0 110.476 179.759 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_exo -57.62 85.37 0.05 OUTLIER 'Trans proline' 0 C--N 1.351 0.662 0 C-N-CA 122.935 2.424 . . . . 0.0 112.566 -179.715 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 24.2 mm -134.97 123.64 41.14 Favored 'Isoleucine or valine' 0 C--O 1.233 0.197 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.147 -179.705 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -119.75 -42.6 2.61 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.419 179.512 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -60.8 -53.43 57.48 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.727 -179.454 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -68.57 101.34 1.26 Allowed 'General case' 0 C--O 1.232 0.176 0 CA-C-O 120.822 0.344 . . . . 0.0 111.05 -179.841 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.33 -0.254 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.084 -179.889 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.646 0 N-CA-C 112.183 0.438 . . . . 0.0 112.183 . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 21.5 t -103.12 116.26 46.56 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.143 0 CA-C-O 120.59 0.233 . . . . 0.0 111.426 -179.694 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 1.2 m -167.79 80.25 0.18 Allowed 'General case' 0 CA--C 1.532 0.284 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.747 179.678 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 3.1 p 56.61 -171.51 0.08 Allowed 'General case' 0 N--CA 1.472 0.661 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.306 -179.353 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -111.64 -41.59 4.03 Favored 'General case' 0 CA--C 1.53 0.186 0 CA-C-N 116.517 -0.31 . . . . 0.0 111.311 -179.955 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -155.56 176.09 13.05 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-O 120.697 0.284 . . . . 0.0 111.207 -179.991 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 3.9 pt-20 -130.22 131.22 45.45 Favored 'General case' 0 CA--C 1.531 0.234 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.15 179.798 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 26.5 mm -130.03 154.16 39.98 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.281 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.455 -179.812 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 9.7 mt-10 -103.78 148.22 26.36 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.062 179.843 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 33.8 pt -58.76 -32.43 46.72 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.325 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.347 179.537 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 4.4 mt-10 -60.45 -30.39 69.62 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.223 179.726 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 5.6 t0 -98.52 39.0 1.28 Allowed 'General case' 0 CA--C 1.532 0.278 0 CA-C-O 120.902 0.382 . . . . 0.0 111.038 179.727 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -132.98 143.39 49.41 Favored 'General case' 0 C--O 1.232 0.172 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.585 179.833 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 1.2 m -62.18 121.12 12.3 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-O 120.734 0.302 . . . . 0.0 111.172 -179.582 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 20.8 p90 -87.76 125.44 34.43 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.695 179.597 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 -112.22 86.38 7.84 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.405 179.852 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 40.0 Cg_endo -67.45 -20.09 48.41 Favored 'Trans proline' 0 C--N 1.347 0.487 0 C-N-CA 122.673 2.248 . . . . 0.0 112.786 -179.989 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -53.33 -36.15 60.96 Favored 'General case' 0 CA--C 1.53 0.2 0 CA-C-N 116.591 -0.277 . . . . 0.0 111.337 179.884 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 3.0 t-20 -138.54 22.73 2.71 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-N 116.534 -0.303 . . . . 0.0 111.652 179.867 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . 0.409 ' NE2' ' HA ' ' A' ' 68' ' ' TYR . 15.8 tt0 50.32 65.35 1.47 Allowed 'General case' 0 CA--C 1.534 0.347 0 CA-C-O 120.975 0.416 . . . . 0.0 111.454 179.916 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' MET . . . . . 0.449 ' HB3' ' CD1' ' A' ' 35' ' ' TYR . 23.3 ptt? -149.62 172.65 14.7 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.137 179.86 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 16.1 m-85 -130.3 134.29 47.1 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.026 179.86 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 11.8 p -130.53 136.29 48.8 Favored 'General case' 0 N--CA 1.462 0.162 0 CA-C-N 116.389 -0.368 . . . . 0.0 111.269 -179.893 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 32.7 t80 -139.38 137.46 19.02 Favored Pre-proline 0 C--N 1.333 -0.137 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.982 179.895 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -72.06 103.68 1.53 Allowed 'Trans proline' 0 C--N 1.348 0.517 0 C-N-CA 122.685 2.256 . . . . 0.0 112.507 179.924 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . 0.408 ' SG ' ' HD2' ' A' ' 27' ' ' PRO . 48.7 t -64.31 139.29 97.67 Favored Pre-proline 0 C--O 1.233 0.23 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.696 179.75 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . 0.408 ' HD2' ' SG ' ' A' ' 26' ' ' CYS . 71.0 Cg_exo -50.06 -26.01 13.82 Favored 'Trans proline' 0 C--N 1.352 0.713 0 C-N-CA 122.932 2.422 . . . . 0.0 113.237 179.844 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 7.7 p -57.94 -28.65 64.5 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-O 120.578 0.228 . . . . 0.0 111.434 179.944 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 122.84 6.79 7.62 Favored Glycine 0 CA--C 1.524 0.629 0 C-N-CA 121.096 -0.573 . . . . 0.0 113.513 -179.995 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -122.37 -173.33 2.65 Favored 'General case' 0 CA--C 1.532 0.252 0 CA-C-N 117.237 0.519 . . . . 0.0 111.001 179.954 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 7.1 ttm-85 -118.94 130.11 55.53 Favored 'General case' 0 N--CA 1.463 0.183 0 CA-C-O 120.807 0.337 . . . . 0.0 111.378 -179.854 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . 0.457 ' CZ ' ' HB2' ' A' ' 46' ' ' ALA . 64.6 t80 -91.84 157.48 16.85 Favored 'General case' 0 CA--C 1.529 0.164 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.917 179.673 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -140.13 129.3 23.72 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.067 179.749 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 3.1 tt -139.06 115.65 10.24 Favored 'Isoleucine or valine' 0 C--O 1.234 0.254 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.986 179.626 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . 0.449 ' CD1' ' HB3' ' A' ' 21' ' ' MET . 41.6 m-85 -74.5 141.63 44.88 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.996 -179.88 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -59.54 -38.29 80.65 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.006 179.686 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 1.2 p30 -60.88 -40.22 92.19 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 116.477 -0.329 . . . . 0.0 110.849 179.524 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 2.5 t70 -63.17 -39.56 95.02 Favored 'General case' 0 N--CA 1.462 0.134 0 CA-C-N 116.493 -0.321 . . . . 0.0 110.895 179.73 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 5.0 mtt -61.99 -29.49 70.29 Favored 'General case' 0 N--CA 1.463 0.187 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.115 179.604 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -57.13 -35.99 70.14 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 116.536 -0.302 . . . . 0.0 111.035 179.662 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 8.3 mt-10 -66.99 -34.4 77.67 Favored 'General case' 0 CA--C 1.531 0.234 0 CA-C-N 116.511 -0.313 . . . . 0.0 110.835 179.628 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 124.56 64.02 0.19 Allowed Glycine 0 C--N 1.335 0.49 0 C-N-CA 120.982 -0.628 . . . . 0.0 112.557 179.631 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 2.1 tp10 -104.25 105.93 16.25 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-O 120.729 0.3 . . . . 0.0 111.084 179.955 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -111.44 -33.79 6.3 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.044 179.431 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 18.8 t -115.96 87.68 1.07 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.273 0 CA-C-O 120.905 0.383 . . . . 0.0 110.659 179.752 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.457 ' HB2' ' CZ ' ' A' ' 32' ' ' PHE . . . -82.94 162.65 21.44 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.21 -179.796 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 11.6 p -121.38 122.95 68.63 Favored 'Isoleucine or valine' 0 C--O 1.233 0.206 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.083 179.926 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 49.3 t -63.04 135.43 96.22 Favored Pre-proline 0 C--N 1.331 -0.217 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.724 179.96 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 93.6 Cg_endo -83.3 19.76 1.28 Allowed 'Trans proline' 0 CA--C 1.535 0.555 0 C-N-CA 122.623 2.215 . . . . 0.0 113.307 -179.855 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -129.15 -57.19 1.16 Allowed 'General case' 0 C--O 1.233 0.188 0 CA-C-O 120.459 0.171 . . . . 0.0 110.628 179.661 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 17.9 p -101.68 -10.92 19.57 Favored 'General case' 0 N--CA 1.465 0.319 0 N-CA-C 111.956 0.354 . . . . 0.0 111.956 179.881 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 5.8 p 61.0 35.64 18.88 Favored 'General case' 0 CA--C 1.535 0.403 0 CA-C-O 120.842 0.354 . . . . 0.0 111.502 179.842 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 7.7 tt -89.07 134.6 33.94 Favored 'General case' 0 CA--C 1.53 0.2 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.534 179.748 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' MET . . . . . . . . . . . . . 20.4 mtt -84.6 135.79 34.04 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.062 -179.773 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 2.7 pt -138.81 137.56 42.68 Favored 'Isoleucine or valine' 0 C--O 1.234 0.261 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.751 -179.778 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 55.5 m-20 -87.13 88.67 7.76 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.675 179.305 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 14.2 p -88.38 112.47 23.86 Favored 'Isoleucine or valine' 0 C--O 1.234 0.263 0 CA-C-O 121.003 0.43 . . . . 0.0 111.004 179.901 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 14.4 p -86.72 127.72 40.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.935 179.997 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 29.1 p90 -124.82 177.76 5.84 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.936 -0.575 . . . . 0.0 111.114 -179.606 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -133.1 144.38 49.91 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.169 -179.807 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 8.1 tttt -74.88 -40.76 60.76 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.84 179.585 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 6.3 tt0 -58.03 -48.8 78.98 Favored 'General case' 0 N--CA 1.462 0.131 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.559 179.587 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -55.03 -50.15 69.78 Favored 'General case' 0 C--O 1.232 0.153 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.033 179.691 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -56.88 -40.32 75.98 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.132 179.976 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -61.27 -38.29 86.22 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-N 116.451 -0.34 . . . . 0.0 111.163 179.645 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -76.05 -47.46 24.62 Favored 'General case' 0 C--O 1.231 0.125 0 CA-C-N 116.474 -0.33 . . . . 0.0 111.075 179.639 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 6.5 m-85 -55.75 -32.75 63.68 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 116.468 -0.333 . . . . 0.0 111.384 179.876 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . 0.409 ' HA ' ' NE2' ' A' ' 20' ' ' GLN . 1.8 t80 -59.09 -41.31 87.75 Favored 'General case' 0 C--O 1.232 0.184 0 CA-C-O 120.695 0.284 . . . . 0.0 110.713 179.644 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 6.4 tt0 -84.82 -38.94 18.94 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.803 179.447 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 4.9 tt0 -62.29 -39.69 93.79 Favored 'General case' 0 CA--C 1.529 0.169 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.252 -179.958 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -85.03 -39.22 18.28 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-N 116.597 -0.274 . . . . 0.0 111.132 179.729 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 64.12 62.04 5.53 Favored Glycine 0 C--N 1.336 0.573 0 C-N-CA 121.031 -0.604 . . . . 0.0 112.583 179.805 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 9.6 tp -56.28 -34.1 39.25 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.259 0 N-CA-C 111.886 0.328 . . . . 0.0 111.886 -179.881 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 35.0 m80 59.98 85.9 0.17 Allowed Pre-proline 0 N--CA 1.463 0.176 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.131 179.996 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 43.3 Cg_endo -68.22 109.98 2.12 Favored 'Trans proline' 0 C--N 1.346 0.436 0 C-N-CA 122.657 2.238 . . . . 0.0 112.42 -179.944 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 49.1 Cg_endo -69.41 138.12 38.16 Favored 'Trans proline' 0 C--N 1.351 0.675 0 C-N-CA 122.544 2.163 . . . . 0.0 111.933 179.755 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER 58.8 59.88 5.42 Favored Pre-proline 0 C--O 1.233 0.222 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.599 -179.547 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -71.69 58.0 2.53 Favored 'Trans proline' 0 C--N 1.35 0.615 0 C-N-CA 122.656 2.237 . . . . 0.0 112.535 -179.786 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 14.2 pt -151.04 30.47 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.53 0.184 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.311 179.953 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -88.8 92.86 9.38 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-O 120.808 0.337 . . . . 0.0 111.343 -179.581 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . 67.22 159.0 0.14 Allowed 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.669 179.828 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -166.86 169.9 12.76 Favored 'General case' 0 CA--C 1.53 0.206 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.744 -179.841 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.463 0.213 0 CA-C-N 115.88 -0.6 . . . . 0.0 111.558 179.764 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.489 1.519 0 CA-C-O 120.623 0.249 . . . . 0.0 111.204 . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 10.6 t -106.86 43.58 0.18 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.316 0 CA-C-O 120.984 0.421 . . . . 0.0 110.911 179.798 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 56.05 82.71 0.1 Allowed 'General case' 0 CA--C 1.531 0.23 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.034 -179.964 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 2.4 p 63.13 173.11 0.15 Allowed 'General case' 0 N--CA 1.469 0.505 0 CA-C-N 115.599 -0.728 . . . . 0.0 111.432 -179.316 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 7.9 m-85 -114.8 -37.33 4.24 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.747 -0.66 . . . . 0.0 111.381 -179.844 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -157.53 176.72 12.27 Favored 'General case' 0 C--O 1.236 0.344 0 CA-C-O 120.698 0.285 . . . . 0.0 111.094 179.752 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -122.7 140.94 52.31 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.966 179.802 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 25.0 mt -125.83 154.62 34.91 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.17 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.196 -179.811 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 17.1 mt-10 -109.04 150.62 27.52 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-N 116.345 -0.388 . . . . 0.0 111.108 179.957 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 16.5 tt -59.01 -28.88 39.93 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.292 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.58 179.697 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 20.5 mt-10 -58.26 -31.13 67.14 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-N 116.528 -0.305 . . . . 0.0 111.285 179.666 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -94.36 28.48 2.54 Favored 'General case' 0 CA--C 1.536 0.41 0 CA-C-N 116.695 -0.23 . . . . 0.0 111.41 179.643 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 1.4 ttp -122.75 167.56 13.33 Favored 'General case' 0 CA--C 1.53 0.176 0 CA-C-O 120.648 0.261 . . . . 0.0 111.234 -179.736 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -105.36 117.24 33.52 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.77 179.891 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . 0.493 ' HB3' ' CE2' ' A' ' 22' ' ' PHE . 37.2 p90 -96.0 147.78 23.34 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.974 179.826 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -144.43 150.25 47.13 Favored Pre-proline 0 N--CA 1.463 0.211 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.398 179.875 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 70.2 Cg_endo -73.8 -14.74 24.17 Favored 'Trans proline' 0 C--N 1.348 0.55 0 C-N-CA 123.056 2.504 . . . . 0.0 113.098 179.613 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -69.03 82.53 0.32 Allowed 'General case' 0 CA--C 1.53 0.185 0 CA-C-O 121.179 0.514 . . . . 0.0 110.868 -179.824 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 6.8 m-80 67.51 20.7 9.73 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 115.564 -0.744 . . . . 0.0 111.797 -179.556 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 16.7 mt-30 54.14 77.54 0.19 Allowed 'General case' 0 CA--C 1.532 0.257 0 CA-C-O 120.854 0.359 . . . . 0.0 111.428 179.596 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -116.62 145.25 43.53 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.034 179.967 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.493 ' CE2' ' HB3' ' A' ' 15' ' ' PHE . 12.3 m-85 -125.92 94.86 4.23 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.654 -179.901 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 32.2 p -91.79 146.14 24.0 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.419 -179.49 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 23.0 t80 -142.59 137.18 15.09 Favored Pre-proline 0 CA--C 1.53 0.184 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.036 -179.942 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -65.32 100.02 0.37 Allowed 'Trans proline' 0 C--N 1.349 0.596 0 C-N-CA 122.694 2.263 . . . . 0.0 112.272 179.604 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 48.1 t -65.94 139.01 96.56 Favored Pre-proline 0 C--O 1.233 0.229 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.699 179.903 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 54.8 Cg_exo -53.25 -25.41 30.21 Favored 'Trans proline' 0 C--N 1.35 0.649 0 C-N-CA 122.82 2.346 . . . . 0.0 112.83 179.666 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -68.26 -38.54 81.86 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-O 120.451 0.167 . . . . 0.0 111.268 179.985 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 152.16 -47.47 0.56 Allowed Glycine 0 C--N 1.335 0.477 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.962 -179.987 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -76.74 -174.69 3.11 Favored 'General case' 0 CA--C 1.531 0.223 0 CA-C-O 120.694 0.283 . . . . 0.0 111.12 -179.783 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 12.3 mtt180 -122.36 137.41 54.87 Favored 'General case' 0 C--O 1.232 0.164 0 CA-C-O 120.829 0.347 . . . . 0.0 111.097 -179.853 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 9.1 m-85 -66.47 167.85 10.03 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.004 179.774 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 12.6 pt20 -154.18 97.64 2.06 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.114 -179.985 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 10.7 tt -123.97 151.52 28.94 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.216 0 CA-C-N 116.29 -0.413 . . . . 0.0 111.293 179.996 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 6.3 m-85 -102.53 152.69 20.86 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.839 -179.961 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 25.6 mt -61.6 -43.04 99.6 Favored 'General case' 0 N--CA 1.463 0.175 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.032 179.798 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -60.25 -38.13 82.53 Favored 'General case' 0 CA--C 1.53 0.187 0 CA-C-N 116.405 -0.362 . . . . 0.0 111.032 179.65 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -59.19 -57.04 14.79 Favored 'General case' 0 N--CA 1.462 0.158 0 CA-C-O 120.769 0.319 . . . . 0.0 110.81 179.711 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 47.6 mtm -61.32 -37.77 84.46 Favored 'General case' 0 N--CA 1.462 0.157 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.024 179.589 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 17.7 t80 -58.11 -38.7 76.96 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.999 179.586 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 1.3 tp10 -62.05 -45.13 94.9 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-N 116.507 -0.315 . . . . 0.0 110.761 179.576 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 152.29 48.34 0.02 OUTLIER Glycine 0 C--N 1.332 0.34 0 C-N-CA 120.979 -0.629 . . . . 0.0 112.694 179.627 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 1.1 tp10 -99.53 147.61 25.14 Favored 'General case' 0 C--O 1.231 0.106 0 CA-C-O 120.754 0.311 . . . . 0.0 110.99 179.921 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 7.9 mttt -149.37 -47.99 0.14 Allowed 'General case' 0 C--O 1.233 0.217 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.133 179.752 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 24.3 t -106.86 104.52 17.18 Favored 'Isoleucine or valine' 0 C--O 1.234 0.257 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.862 179.957 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -92.7 174.64 7.16 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.076 179.813 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 10.7 p -134.9 123.57 41.22 Favored 'Isoleucine or valine' 0 C--O 1.233 0.214 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.205 -179.954 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 48.3 t -70.31 135.77 86.66 Favored Pre-proline 0 C--N 1.332 -0.186 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.807 179.869 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_endo -84.13 20.94 1.13 Allowed 'Trans proline' 0 CA--C 1.536 0.581 0 C-N-CA 122.762 2.308 . . . . 0.0 113.077 179.682 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -128.71 -55.72 1.22 Allowed 'General case' 0 C--O 1.232 0.155 0 CA-C-N 116.67 -0.241 . . . . 0.0 110.626 179.903 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 18.6 p -98.31 -17.69 18.76 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.848 179.906 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 5.6 p 63.93 37.15 9.65 Favored 'General case' 0 CA--C 1.535 0.382 0 CA-C-O 120.987 0.422 . . . . 0.0 111.438 179.865 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 1.3 tm? -101.99 130.62 48.57 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.491 179.7 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' MET . . . . . . . . . . . . . 60.6 mtm -83.95 135.18 34.56 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.836 179.997 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 2.5 pp -137.51 134.35 46.42 Favored 'Isoleucine or valine' 0 C--O 1.233 0.23 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.564 -179.89 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 20.1 m-20 -82.41 100.95 10.32 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.766 179.597 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 13.5 p -104.02 116.66 48.22 Favored 'Isoleucine or valine' 0 C--O 1.233 0.227 0 CA-C-O 121.133 0.492 . . . . 0.0 111.179 179.9 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 12.4 p -87.55 137.53 20.82 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.939 -179.94 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 44.3 p90 -124.66 175.98 6.85 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.072 -179.67 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -114.02 155.94 24.99 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.144 -179.881 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 56.6 mttt -92.96 -44.44 8.43 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.742 179.674 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 16.2 pt-20 -57.84 -36.04 71.73 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 116.473 -0.33 . . . . 0.0 110.927 179.61 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -55.68 -53.3 58.3 Favored 'General case' 0 N--CA 1.461 0.125 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.67 179.523 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 3.0 mp -55.43 -39.35 70.14 Favored 'General case' 0 N--CA 1.462 0.159 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.211 179.631 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -58.76 -60.15 4.29 Favored 'General case' 0 CA--C 1.528 0.11 0 CA-C-N 116.507 -0.315 . . . . 0.0 111.173 179.885 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -63.72 -40.6 97.15 Favored 'General case' 0 N--CA 1.464 0.225 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.221 179.708 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -63.16 -55.51 24.57 Favored 'General case' 0 C--O 1.227 -0.129 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.233 -179.82 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 3.0 t80 -61.56 -43.98 97.87 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 116.592 -0.276 . . . . 0.0 110.89 179.998 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 4.0 tt0 -58.11 -30.42 66.28 Favored 'General case' 0 CA--C 1.53 0.21 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.975 179.541 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -130.74 59.55 1.66 Allowed 'General case' 0 C--O 1.234 0.26 0 CA-C-O 120.839 0.352 . . . . 0.0 111.107 -179.927 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -135.54 139.38 43.89 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.536 179.926 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -97.02 48.23 1.6 Allowed Glycine 0 C--N 1.333 0.406 0 C-N-CA 121.081 -0.58 . . . . 0.0 112.309 179.515 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 36.4 pt -69.48 176.76 0.49 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.175 0 CA-C-O 120.671 0.272 . . . . 0.0 111.156 179.987 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -53.13 -59.85 8.15 Favored Pre-proline 0 CA--C 1.531 0.215 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.216 -179.987 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -73.74 111.15 3.23 Favored 'Trans proline' 0 C--N 1.352 0.739 0 C-N-CA 122.361 2.041 . . . . 0.0 112.342 179.605 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -71.54 -178.53 3.06 Favored 'Trans proline' 0 C--N 1.348 0.548 0 C-N-CA 122.68 2.254 . . . . 0.0 112.507 -179.912 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 5.6 tt0 -127.58 90.83 47.31 Favored Pre-proline 0 CA--C 1.531 0.237 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.089 179.989 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 41.1 Cg_endo -68.31 95.69 0.45 Allowed 'Trans proline' 0 C--N 1.346 0.43 0 C-N-CA 122.647 2.232 . . . . 0.0 112.424 179.987 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 1.8 pt -140.84 90.47 0.53 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.21 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.292 -179.722 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . 60.12 90.8 0.06 Allowed 'General case' 0 N--CA 1.465 0.302 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.504 179.934 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -106.47 163.13 13.11 Favored 'General case' 0 N--CA 1.463 0.207 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.548 -179.862 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -109.29 156.63 19.73 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.241 179.904 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.139 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.133 179.611 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 5.7 mtt . . . . . 0 N--CA 1.49 1.54 0 CA-C-O 120.525 0.202 . . . . 0.0 111.371 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 30.9 m -66.8 113.52 2.98 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.275 0 CA-C-O 120.811 0.339 . . . . 0.0 111.17 -179.924 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 1.4 p -149.52 137.46 20.41 Favored 'General case' 0 CA--C 1.53 0.194 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.904 -179.538 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' THR . . . . . 0.413 HG23 ' HB3' ' A' ' 54' ' ' MET . 0.2 OUTLIER 63.23 177.48 0.15 Allowed 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.982 -179.891 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 21.4 m-85 -105.58 -76.4 0.61 Allowed 'General case' 0 C--O 1.232 0.167 0 CA-C-N 116.48 -0.327 . . . . 0.0 111.176 -179.739 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -126.66 171.77 10.87 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.002 -179.813 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 4.6 pt-20 -132.64 136.31 46.41 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-N 116.405 -0.361 . . . . 0.0 111.014 179.654 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 3.7 mp -118.48 150.4 20.72 Favored 'Isoleucine or valine' 0 C--O 1.233 0.226 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.375 -179.605 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . 0.404 ' HA ' ' CG1' ' A' ' 58' ' ' VAL . 12.2 mt-10 -98.97 153.55 18.76 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.366 -179.905 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 1.1 tp -59.25 -32.61 48.65 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.286 0 CA-C-N 115.989 -0.55 . . . . 0.0 111.223 179.551 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -61.21 -33.17 73.04 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-N 116.551 -0.295 . . . . 0.0 110.998 179.514 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -96.91 37.37 1.31 Allowed 'General case' 0 C--O 1.234 0.27 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.177 179.816 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' MET . . . . . 0.499 ' HG2' ' CD1' ' A' ' 24' ' ' TYR . 3.3 mtp -125.75 150.09 48.02 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-N 116.407 -0.361 . . . . 0.0 110.887 179.798 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 7.3 m -96.7 113.57 25.14 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.766 179.679 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 24.2 p90 -80.38 130.18 35.0 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.517 179.632 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 3.9 tt0 -107.23 95.83 14.18 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.625 -179.949 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -72.87 60.84 3.72 Favored 'Trans proline' 0 C--N 1.347 0.492 0 C-N-CA 122.69 2.26 . . . . 0.0 112.58 -179.734 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 15.1 pt-20 -126.67 -45.27 1.63 Allowed 'General case' 0 C--O 1.233 0.189 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.876 179.915 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 2.2 t-20 -146.55 33.64 0.95 Allowed 'General case' 0 CA--C 1.532 0.276 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.066 179.636 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . 0.418 ' CG ' HG12 ' A' ' 73' ' ' ILE . 10.1 mt-30 57.9 57.75 3.98 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.222 179.851 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 21.8 ptm -136.62 151.44 49.33 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.672 179.658 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 7.6 m-85 -130.24 124.85 33.44 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.388 -179.899 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 64.3 p -120.24 137.5 54.18 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.952 -179.581 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . 0.499 ' CD1' ' HG2' ' A' ' 13' ' ' MET . 1.9 p90 -131.54 148.17 68.97 Favored Pre-proline 0 C--O 1.233 0.195 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.133 179.867 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_exo -52.52 124.72 15.81 Favored 'Trans proline' 0 C--N 1.349 0.584 0 C-N-CA 122.872 2.381 . . . . 0.0 112.774 -179.671 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . 0.48 ' SG ' ' HD2' ' A' ' 27' ' ' PRO . 50.5 t -94.9 141.21 22.98 Favored Pre-proline 0 C--N 1.33 -0.244 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.342 179.587 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . 0.48 ' HD2' ' SG ' ' A' ' 26' ' ' CYS . 87.6 Cg_exo -48.08 -30.11 13.63 Favored 'Trans proline' 0 C--N 1.349 0.578 0 C-N-CA 122.846 2.364 . . . . 0.0 113.192 179.914 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . 0.404 ' CB ' ' HB3' ' A' ' 51' ' ' CYS . 0.8 OUTLIER -76.96 -40.36 47.2 Favored 'General case' 0 CA--C 1.532 0.267 0 CA-C-N 116.818 -0.174 . . . . 0.0 111.32 179.986 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 151.77 -45.07 0.63 Allowed Glycine 0 C--N 1.335 0.516 0 C-N-CA 120.49 -0.862 . . . . 0.0 113.175 179.753 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 50.6 m-20 -67.33 -177.74 0.74 Allowed 'General case' 0 CA--C 1.532 0.271 0 CA-C-O 120.912 0.387 . . . . 0.0 111.123 -179.808 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -110.97 128.15 55.74 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.875 -179.716 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 15.0 m-85 -64.66 91.46 0.08 Allowed 'General case' 0 C--O 1.233 0.227 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.7 179.816 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 2.9 pt20 -80.13 125.86 30.36 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.228 -179.65 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 2.5 tt -161.26 133.77 1.09 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.207 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.066 179.723 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 71.3 m-85 -88.11 145.52 25.9 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.775 -179.947 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 4.1 pp -58.01 -33.38 68.88 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.215 179.74 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 1.2 p30 -65.3 -39.07 92.03 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 116.567 -0.288 . . . . 0.0 110.785 179.493 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -61.87 -46.95 87.19 Favored 'General case' 0 CA--C 1.528 0.116 0 CA-C-N 116.422 -0.353 . . . . 0.0 110.839 179.781 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 55.6 mtm -74.37 -33.1 62.98 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.176 179.825 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 18.4 t80 -57.09 -38.27 73.09 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.029 -179.931 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 21.6 mt-10 -60.71 -37.18 80.83 Favored 'General case' 0 N--CA 1.462 0.147 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.889 179.548 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 145.56 47.62 0.03 OUTLIER Glycine 0 C--N 1.333 0.391 0 C-N-CA 120.94 -0.647 . . . . 0.0 112.69 179.794 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -112.56 148.2 35.02 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-O 120.741 0.305 . . . . 0.0 111.161 -179.845 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 22.8 mtmt -148.09 -48.24 0.16 Allowed 'General case' 0 CA--C 1.531 0.219 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.076 179.815 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 23.7 t -89.87 94.79 5.03 Favored 'Isoleucine or valine' 0 C--O 1.232 0.178 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.805 -179.985 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -91.6 159.18 16.03 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.188 -179.884 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 11.6 p -126.04 128.45 71.84 Favored 'Isoleucine or valine' 0 C--O 1.232 0.169 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.371 -179.904 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 42.0 t -71.21 136.73 84.32 Favored Pre-proline 0 CA--C 1.53 0.201 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.884 179.714 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 92.9 Cg_endo -82.8 20.35 1.16 Allowed 'Trans proline' 0 C--N 1.35 0.629 0 C-N-CA 122.751 2.301 . . . . 0.0 113.136 179.742 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 38.9 t -128.59 -58.11 1.18 Allowed 'General case' 0 C--O 1.232 0.153 0 N-CA-C 110.265 -0.272 . . . . 0.0 110.265 179.539 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' CYS . . . . . 0.454 ' SG ' ' HB2' ' A' ' 53' ' ' LEU . 20.7 p -94.26 -27.0 16.38 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.483 179.711 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 1.5 t 70.92 42.92 0.73 Allowed 'General case' 0 CA--C 1.532 0.275 0 CA-C-O 120.931 0.396 . . . . 0.0 110.968 -179.838 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.454 ' HB2' ' SG ' ' A' ' 51' ' ' CYS . 3.6 mm? -92.34 150.69 20.69 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.63 179.64 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' MET . . . . . 0.413 ' HB3' HG23 ' A' ' 4' ' ' THR . 9.7 mtt -104.66 123.05 46.92 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.904 -179.791 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 2.6 pp -134.99 148.3 29.1 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.313 0 CA-C-N 116.363 -0.38 . . . . 0.0 111.842 -179.883 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 32.1 m-20 -102.4 92.36 4.66 Favored 'General case' 0 CA--C 1.531 0.223 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.95 179.657 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 13.1 p -88.97 127.83 41.46 Favored 'Isoleucine or valine' 0 C--O 1.234 0.256 0 CA-C-O 120.851 0.357 . . . . 0.0 110.986 179.72 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.404 ' CG1' ' HA ' ' A' ' 9' ' ' GLU . 12.5 p -97.97 136.53 28.52 Favored 'Isoleucine or valine' 0 C--O 1.234 0.251 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.398 -179.837 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 16.1 p90 -123.82 170.12 10.88 Favored 'General case' 0 CA--C 1.53 0.184 0 CA-C-N 115.899 -0.591 . . . . 0.0 111.073 -179.966 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -107.63 160.13 15.93 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.106 179.734 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -89.17 -37.85 14.73 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.032 179.691 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -72.21 -38.83 68.91 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-N 116.618 -0.265 . . . . 0.0 111.171 179.944 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 88.7 m-20 -52.71 -41.65 64.11 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.001 -179.988 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -63.7 -52.35 60.97 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.979 -179.933 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -57.47 -39.26 75.97 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-N 116.489 -0.323 . . . . 0.0 110.736 179.57 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -73.83 -46.43 45.15 Favored 'General case' 0 N--CA 1.461 0.124 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.273 179.67 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 9.3 t80 -60.61 -37.67 82.18 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 116.713 -0.221 . . . . 0.0 111.237 -179.946 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 13.9 t80 -58.29 -41.34 84.17 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-O 120.55 0.214 . . . . 0.0 110.813 179.742 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 9.5 mt-10 -87.93 -35.38 17.71 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.496 -179.801 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 -72.18 -33.37 67.63 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 116.65 -0.25 . . . . 0.0 111.583 -179.843 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -75.08 140.47 43.49 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-O 120.819 0.342 . . . . 0.0 111.329 -179.939 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -96.05 33.28 5.68 Favored Glycine 0 C--N 1.333 0.372 0 C-N-CA 121.027 -0.606 . . . . 0.0 112.297 179.475 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.418 HG12 ' CG ' ' A' ' 20' ' ' GLN . 1.7 pp -69.13 176.33 0.51 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.168 0 CA-C-O 120.841 0.353 . . . . 0.0 111.339 -179.851 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 57.4 m-70 -119.79 147.54 44.28 Favored Pre-proline 0 C--O 1.233 0.21 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.192 -179.729 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_endo -69.59 148.17 65.56 Favored 'Trans proline' 0 C--N 1.348 0.526 0 C-N-CA 122.717 2.278 . . . . 0.0 112.48 179.875 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 68.2 Cg_endo -73.88 84.84 1.41 Allowed 'Trans proline' 0 C--N 1.347 0.498 0 C-N-CA 122.789 2.326 . . . . 0.0 112.495 -179.845 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . 0.406 ' HB3' ' HD2' ' A' ' 78' ' ' PRO . 10.7 mt-10 67.52 164.51 0.13 Allowed Pre-proline 0 N--CA 1.467 0.377 0 CA-C-N 115.844 -0.616 . . . . 0.0 111.402 179.926 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . 0.406 ' HD2' ' HB3' ' A' ' 77' ' ' GLU . 46.9 Cg_exo -56.56 157.66 18.28 Favored 'Trans proline' 0 C--N 1.349 0.594 0 C-N-CA 122.833 2.355 . . . . 0.0 112.486 179.947 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 2.2 pp -141.2 -46.43 0.23 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.206 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.86 179.974 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -144.65 30.92 1.19 Allowed 'General case' 0 N--CA 1.463 0.208 0 CA-C-O 120.771 0.32 . . . . 0.0 111.261 179.907 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -86.99 -33.87 19.45 Favored 'General case' 0 C--O 1.232 0.143 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.236 179.877 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -61.53 -38.31 86.94 Favored 'General case' 0 C--O 1.232 0.133 0 CA-C-N 116.42 -0.355 . . . . 0.0 111.339 179.929 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.174 0 CA-C-N 116.496 -0.32 . . . . 0.0 111.242 -179.999 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 19.0 mtt . . . . . 0 N--CA 1.49 1.549 0 CA-C-O 120.446 0.165 . . . . 0.0 111.333 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 9.9 m -128.56 147.6 33.05 Favored 'Isoleucine or valine' 0 C--O 1.233 0.232 0 CA-C-O 120.748 0.308 . . . . 0.0 111.675 179.974 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 8.9 p -140.74 34.84 1.79 Allowed 'General case' 0 CA--C 1.535 0.398 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.158 179.921 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -101.47 171.89 7.31 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-O 120.906 0.384 . . . . 0.0 111.36 -179.963 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 15.3 m-85 -103.6 -36.2 8.01 Favored 'General case' 0 CA--C 1.53 0.194 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.381 179.849 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -158.78 171.45 20.05 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-O 120.701 0.286 . . . . 0.0 111.322 -179.97 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -127.54 140.5 52.09 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.005 -179.897 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 27.1 mm -120.48 156.01 23.61 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.254 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.926 -179.865 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 10.0 mt-10 -119.63 159.82 23.67 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-O 120.739 0.304 . . . . 0.0 111.323 179.848 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 11.5 tt -65.39 -30.95 51.77 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.351 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.481 179.37 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -60.02 -42.33 94.14 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-O 120.45 0.166 . . . . 0.0 111.331 -179.878 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 8.4 p-10 -98.09 37.05 1.47 Allowed 'General case' 0 CA--C 1.535 0.378 0 CA-C-O 120.824 0.345 . . . . 0.0 111.329 179.589 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -114.43 139.74 49.26 Favored 'General case' 0 C--O 1.233 0.236 0 N-CA-C 109.655 -0.498 . . . . 0.0 109.655 179.182 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 2.9 m -66.87 89.84 0.17 Allowed 'General case' 0 C--O 1.233 0.207 0 CA-C-O 120.86 0.362 . . . . 0.0 110.651 -179.649 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 52.1 p90 -80.2 127.71 32.66 Favored 'General case' 0 C--O 1.232 0.159 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.752 -179.979 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 5.8 mt-10 -109.1 93.92 13.93 Favored Pre-proline 0 C--O 1.236 0.346 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.347 179.845 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -71.64 64.77 3.05 Favored 'Trans proline' 0 C--N 1.346 0.398 0 C-N-CA 122.943 2.429 . . . . 0.0 112.351 -179.794 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 17.1 pt-20 -140.29 -45.86 0.42 Allowed 'General case' 0 CA--C 1.531 0.226 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.916 179.934 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 44.9 p30 -134.69 24.11 3.67 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.557 -179.998 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER 60.79 47.05 8.27 Favored 'General case' 0 C--O 1.235 0.325 0 CA-C-O 120.944 0.402 . . . . 0.0 111.053 179.983 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 20.2 ttt -114.77 143.13 45.56 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.919 -179.917 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 4.1 m-85 -127.92 104.34 7.75 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.702 179.649 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 22.5 p -107.88 179.27 4.27 Favored 'General case' 0 CA--C 1.531 0.216 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.01 -179.962 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 63.1 t80 -173.09 135.27 0.7 Allowed Pre-proline 0 N--CA 1.466 0.338 0 CA-C-N 116.63 -0.259 . . . . 0.0 111.211 179.712 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_endo -66.92 108.05 1.42 Allowed 'Trans proline' 0 C--N 1.349 0.6 0 C-N-CA 122.611 2.207 . . . . 0.0 112.447 179.832 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . 0.424 ' SG ' ' HD2' ' A' ' 27' ' ' PRO . 42.8 t -69.36 139.64 89.7 Favored Pre-proline 0 C--N 1.332 -0.187 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.517 179.704 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . 0.424 ' HD2' ' SG ' ' A' ' 26' ' ' CYS . 77.7 Cg_exo -51.59 -26.95 23.93 Favored 'Trans proline' 0 C--N 1.349 0.599 0 C-N-CA 122.92 2.413 . . . . 0.0 113.072 179.833 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . 0.401 ' CB ' ' HB3' ' A' ' 51' ' ' CYS . 0.8 OUTLIER -70.1 -38.59 75.7 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-N 116.894 -0.139 . . . . 0.0 111.36 -179.868 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 150.86 -43.31 0.71 Allowed Glycine 0 C--N 1.335 0.483 0 C-N-CA 120.869 -0.682 . . . . 0.0 112.91 -179.842 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -70.83 -174.44 0.92 Allowed 'General case' 0 CA--C 1.535 0.383 0 CA-C-O 120.668 0.271 . . . . 0.0 111.187 -179.77 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 18.6 ttm180 -126.96 122.37 34.35 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-O 120.706 0.289 . . . . 0.0 111.385 -179.689 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 4.4 m-85 -61.86 154.14 26.9 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.849 179.527 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 32.9 mt-30 -143.02 122.04 12.83 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-N 116.455 -0.338 . . . . 0.0 111.478 179.993 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 3.9 tt -151.2 123.12 1.12 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.24 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.896 179.451 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 44.5 m-85 -81.52 158.78 24.35 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.887 -179.916 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -59.53 -39.39 83.75 Favored 'General case' 0 N--CA 1.463 0.225 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.847 179.829 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -59.76 -42.59 93.58 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 116.468 -0.333 . . . . 0.0 110.98 179.543 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 33.9 m-20 -58.72 -46.11 88.09 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-O 120.857 0.36 . . . . 0.0 110.475 179.696 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 5.2 mmm -61.18 -35.71 77.88 Favored 'General case' 0 CA--C 1.529 0.17 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.808 179.518 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -54.35 -45.6 72.77 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 116.491 -0.322 . . . . 0.0 111.293 179.933 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 6.3 mt-10 -61.43 -46.47 89.96 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 116.585 -0.28 . . . . 0.0 110.892 179.875 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 132.09 52.63 0.09 OUTLIER Glycine 0 C--N 1.333 0.376 0 C-N-CA 120.977 -0.63 . . . . 0.0 112.609 179.807 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -106.32 95.88 6.08 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-O 120.941 0.401 . . . . 0.0 111.175 -179.938 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 5.0 ptpt -105.77 -32.92 8.18 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-N 115.843 -0.617 . . . . 0.0 111.064 179.62 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 9.5 p -86.89 74.07 1.05 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.295 0 CA-C-O 121.456 0.646 . . . . 0.0 111.001 -179.915 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -81.5 136.32 35.63 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.718 -0.674 . . . . 0.0 111.101 -179.896 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 6.4 m -109.8 125.59 66.98 Favored 'Isoleucine or valine' 0 C--O 1.232 0.18 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.337 -179.985 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 50.3 t -68.8 135.68 90.05 Favored Pre-proline 0 C--O 1.233 0.229 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.84 179.893 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_endo -84.14 20.59 1.18 Allowed 'Trans proline' 0 C--N 1.349 0.59 0 C-N-CA 122.716 2.278 . . . . 0.0 113.217 179.698 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -128.55 -57.58 1.2 Allowed 'General case' 0 C--O 1.232 0.151 0 CA-C-O 120.59 0.233 . . . . 0.0 110.582 179.712 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' CYS . . . . . 0.401 ' HB3' ' CB ' ' A' ' 28' ' ' CYS . 19.1 p -95.35 -22.51 17.69 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-N 116.352 -0.386 . . . . 0.0 111.658 179.828 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 1.1 t 67.53 41.37 2.36 Favored 'General case' 0 CA--C 1.533 0.314 0 CA-C-O 120.981 0.42 . . . . 0.0 110.948 -179.841 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 7.0 tp -95.66 134.32 38.7 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.846 179.86 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' MET . . . . . . . . . . . . . 37.7 mtt -86.07 132.3 34.07 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.0 -179.94 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 2.5 pp -142.18 139.64 29.87 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.205 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.314 -179.899 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 67.3 m-20 -102.07 97.28 7.63 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.68 179.362 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 12.7 p -86.39 138.01 19.84 Favored 'Isoleucine or valine' 0 C--O 1.234 0.282 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.12 179.885 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 13.4 p -104.92 133.21 49.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.876 179.89 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 37.6 p90 -132.46 176.51 8.36 Favored 'General case' 0 CA--C 1.532 0.274 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.054 -179.397 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 2.5 t70 -122.3 147.69 45.93 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.457 179.968 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 15.0 tttm -83.68 -39.0 20.73 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.82 179.435 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 20.3 mt-10 -60.0 -42.29 93.94 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-N 116.481 -0.327 . . . . 0.0 110.397 179.514 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -64.6 -44.43 90.62 Favored 'General case' 0 CA--C 1.527 0.072 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.795 179.396 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -58.25 -43.64 87.94 Favored 'General case' 0 N--CA 1.463 0.207 0 CA-C-N 116.679 -0.237 . . . . 0.0 110.946 179.841 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -65.11 -40.94 95.22 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-N 116.409 -0.359 . . . . 0.0 110.814 179.527 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 2.3 tp10 -72.35 -43.8 63.52 Favored 'General case' 0 CA--C 1.532 0.251 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.165 179.617 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 1.4 t80 -62.48 -36.56 82.88 Favored 'General case' 0 N--CA 1.464 0.273 0 N-CA-C 111.945 0.35 . . . . 0.0 111.945 -179.589 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -59.47 -38.73 81.56 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-O 120.676 0.274 . . . . 0.0 110.624 179.963 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 -86.69 -38.6 16.84 Favored 'General case' 0 CA--C 1.53 0.205 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.048 179.766 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 73.2 mt-10 -69.15 -38.81 78.99 Favored 'General case' 0 N--CA 1.465 0.306 0 N-CA-C 111.867 0.321 . . . . 0.0 111.867 -179.394 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -70.92 -47.06 61.17 Favored 'General case' 0 C--O 1.232 0.157 0 C-N-CA 121.245 -0.182 . . . . 0.0 111.401 -179.749 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 60.4 42.0 98.75 Favored Glycine 0 C--N 1.336 0.541 0 C-N-CA 120.852 -0.69 . . . . 0.0 112.573 -179.93 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 2.8 pt -63.41 -31.59 53.43 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.258 0 N-CA-C 111.723 0.268 . . . . 0.0 111.723 -179.815 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 3.6 m-70 -73.13 -59.64 2.06 Favored Pre-proline 0 CA--C 1.532 0.287 0 CA-C-N 116.743 -0.208 . . . . 0.0 110.862 179.673 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 64.5 Cg_endo -73.81 110.64 3.12 Favored 'Trans proline' 0 C--N 1.352 0.743 0 C-N-CA 122.509 2.139 . . . . 0.0 112.7 179.843 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . 0.4 ' O ' ' HB2' ' A' ' 77' ' ' GLU . 57.1 Cg_endo -70.5 116.68 4.74 Favored 'Trans proline' 0 C--N 1.348 0.545 0 C-N-CA 122.708 2.272 . . . . 0.0 112.279 179.924 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . 0.4 ' HB2' ' O ' ' A' ' 76' ' ' PRO . 36.7 mt-10 67.33 163.55 0.13 Allowed Pre-proline 0 N--CA 1.468 0.427 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.288 -179.766 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -53.92 127.35 25.26 Favored 'Trans proline' 0 C--N 1.353 0.773 0 C-N-CA 122.853 2.369 . . . . 0.0 112.484 -179.861 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 15.5 tt -126.91 150.29 32.67 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.299 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.666 -179.513 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -151.87 170.87 18.75 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.346 -179.999 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -147.66 105.47 3.71 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-N 116.286 -0.416 . . . . 0.0 111.073 179.855 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -134.33 126.98 30.79 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.079 -179.998 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.156 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.948 179.762 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.488 1.469 0 CA-C-O 120.467 0.175 . . . . 0.0 111.304 . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 11.5 p -82.46 117.89 29.21 Favored 'Isoleucine or valine' 0 C--O 1.233 0.189 0 CA-C-O 120.956 0.408 . . . . 0.0 111.246 -179.979 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 60.5 p -99.7 167.52 10.51 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.846 179.87 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -153.9 156.01 36.75 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.027 -179.97 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 25.7 m-85 -106.72 -74.04 0.67 Allowed 'General case' 0 C--O 1.232 0.166 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.325 -179.843 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -131.78 169.22 16.52 Favored 'General case' 0 C--O 1.234 0.279 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.152 -179.695 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 1.5 pt-20 -105.88 138.22 42.44 Favored 'General case' 0 C--O 1.232 0.166 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.234 179.987 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 31.3 mm -101.38 154.96 4.7 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.196 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.053 179.916 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . 0.416 ' HA ' HG11 ' A' ' 58' ' ' VAL . 16.0 tt0 -109.18 130.3 55.49 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.947 179.94 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 18.7 tt -60.58 -31.3 48.65 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.262 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.244 179.632 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 3.1 tt0 -59.98 -31.81 70.25 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.107 179.543 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -96.26 37.12 1.27 Allowed 'General case' 0 CA--C 1.533 0.312 0 CA-C-O 120.81 0.338 . . . . 0.0 111.112 179.823 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 32.4 mtt -127.89 137.0 52.16 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-N 116.478 -0.328 . . . . 0.0 110.653 179.733 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 2.6 m -61.17 116.97 4.99 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.765 -179.847 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 23.5 p90 -86.44 134.05 33.72 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.904 -179.946 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -118.96 94.1 47.67 Favored Pre-proline 0 C--O 1.234 0.256 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.646 179.946 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_endo -68.34 -12.83 36.09 Favored 'Trans proline' 0 C--N 1.346 0.413 0 C-N-CA 122.76 2.307 . . . . 0.0 113.122 -179.926 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -54.75 -44.18 73.37 Favored 'General case' 0 CA--C 1.53 0.191 0 CA-C-N 116.812 -0.176 . . . . 0.0 111.138 -179.942 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 14.7 m-20 -144.85 24.3 1.51 Allowed 'General case' 0 CA--C 1.534 0.337 0 CA-C-N 116.435 -0.348 . . . . 0.0 111.555 179.723 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 2.3 tp60 56.86 69.01 0.78 Allowed 'General case' 0 CA--C 1.532 0.285 0 CA-C-O 120.827 0.346 . . . . 0.0 111.7 179.561 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 11.7 ptp -141.89 150.15 41.15 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.352 -0.386 . . . . 0.0 111.139 179.662 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 7.7 m-85 -120.2 143.9 48.0 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.79 -179.941 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 58.0 p -126.68 146.69 50.1 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.232 -179.897 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 4.6 t80 -135.73 95.07 14.32 Favored Pre-proline 0 C--N 1.332 -0.177 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.605 179.815 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_exo -52.13 94.31 0.03 OUTLIER 'Trans proline' 0 C--N 1.349 0.59 0 C-N-CA 122.867 2.378 . . . . 0.0 112.309 -179.932 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 29.5 t -65.38 135.63 96.03 Favored Pre-proline 0 C--O 1.233 0.224 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.792 -179.778 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -60.17 -17.49 46.16 Favored 'Trans proline' 0 C--N 1.349 0.564 0 C-N-CA 122.731 2.288 . . . . 0.0 112.861 179.684 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 3.6 p -58.72 -30.33 67.37 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-O 120.556 0.217 . . . . 0.0 111.346 179.769 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 138.64 -15.28 3.37 Favored Glycine 0 CA--C 1.523 0.577 0 C-N-CA 120.945 -0.645 . . . . 0.0 113.28 -179.897 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 3.2 t0 -113.83 -166.55 1.1 Allowed 'General case' 0 CA--C 1.534 0.333 0 CA-C-N 117.036 0.418 . . . . 0.0 111.216 -179.804 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 16.2 ttp-105 -129.32 153.62 47.67 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.059 -179.804 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -91.27 167.02 12.62 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-N 116.09 -0.504 . . . . 0.0 111.074 179.754 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -157.58 113.76 2.87 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.885 179.608 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.401 HD12 ' HG3' ' A' ' 39' ' ' MET . 5.3 tt -144.37 126.54 10.43 Favored 'Isoleucine or valine' 0 C--O 1.234 0.238 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.134 -179.876 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 37.2 m-85 -81.3 155.53 25.98 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.759 -179.994 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 24.2 mt -58.19 -37.33 74.55 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.055 179.762 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -59.57 -40.99 89.17 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 116.387 -0.37 . . . . 0.0 110.861 179.598 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 2.7 t0 -64.08 -39.16 93.45 Favored 'General case' 0 CA--C 1.528 0.112 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.565 179.525 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' MET . . . . . 0.401 ' HG3' HD12 ' A' ' 34' ' ' ILE . 28.2 mtm -93.1 30.94 1.52 Allowed 'General case' 0 CA--C 1.532 0.279 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.115 179.467 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 16.9 t80 -131.42 -47.32 0.98 Allowed 'General case' 0 C--O 1.232 0.181 0 CA-C-N 116.547 -0.297 . . . . 0.0 110.799 179.793 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 13.5 mt-10 -58.0 -36.95 73.39 Favored 'General case' 0 CA--C 1.53 0.179 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.17 179.731 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 151.87 68.26 0.01 OUTLIER Glycine 0 C--N 1.336 0.534 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.849 179.709 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 12.8 tt0 -130.37 157.91 41.28 Favored 'General case' 0 N--CA 1.462 0.152 0 CA-C-O 120.787 0.327 . . . . 0.0 111.436 179.966 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 1.8 mtmt -154.98 -45.98 0.08 Allowed 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.016 179.873 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 5.4 m -99.32 115.27 39.64 Favored 'Isoleucine or valine' 0 C--O 1.233 0.216 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.089 -179.99 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -109.15 149.99 28.53 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.152 -179.912 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 12.8 m -109.68 135.33 48.96 Favored 'Isoleucine or valine' 0 C--O 1.233 0.207 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.388 -179.898 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 50.8 t -75.94 135.96 70.29 Favored Pre-proline 0 C--O 1.233 0.229 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.018 -179.918 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 83.7 Cg_endo -83.91 19.17 1.4 Allowed 'Trans proline' 0 CA--C 1.535 0.573 0 C-N-CA 122.719 2.279 . . . . 0.0 113.127 179.639 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 36.3 t -128.41 -58.31 1.19 Allowed 'General case' 0 C--O 1.232 0.162 0 CA-C-N 116.746 -0.206 . . . . 0.0 110.572 179.789 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 21.0 p -103.39 -18.99 14.59 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 116.398 -0.364 . . . . 0.0 111.695 179.879 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER 70.03 37.13 1.78 Allowed 'General case' 0 CA--C 1.533 0.304 0 CA-C-O 120.788 0.328 . . . . 0.0 111.106 -179.802 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 7.6 mt -75.38 142.35 43.12 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-N 116.396 -0.366 . . . . 0.0 110.643 179.712 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' MET . . . . . . . . . . . . . 22.5 mtt -96.01 113.85 25.5 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.972 -179.58 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 2.7 pp -131.56 162.37 39.53 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.285 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.608 -179.538 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -119.5 95.74 4.91 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.032 179.995 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 15.0 p -89.31 128.82 41.13 Favored 'Isoleucine or valine' 0 C--O 1.234 0.251 0 CA-C-O 120.937 0.399 . . . . 0.0 111.251 179.728 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.416 HG11 ' HA ' ' A' ' 9' ' ' GLU . 14.0 p -91.68 152.7 3.34 Favored 'Isoleucine or valine' 0 C--O 1.234 0.239 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.142 179.93 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 15.8 p90 -136.58 174.96 10.05 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.116 -179.651 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -133.43 142.77 48.47 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.321 179.939 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.74 -41.78 62.05 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.746 179.559 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -59.44 -41.03 88.66 Favored 'General case' 0 N--CA 1.462 0.139 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.624 179.427 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -70.42 -46.68 63.44 Favored 'General case' 0 CA--C 1.528 0.121 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.988 179.695 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -56.93 -39.36 74.35 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.187 179.882 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -76.41 -46.44 27.15 Favored 'General case' 0 C--O 1.232 0.142 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.264 179.923 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 31.4 mt-10 -58.61 -47.05 85.66 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 116.43 -0.35 . . . . 0.0 110.924 179.817 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 3.3 m-85 -58.06 -32.62 68.19 Favored 'General case' 0 C--N 1.334 -0.105 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.299 179.742 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -59.57 -34.92 73.3 Favored 'General case' 0 CA--C 1.528 0.128 0 CA-C-O 120.626 0.251 . . . . 0.0 110.988 179.666 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -91.99 -35.42 13.98 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.028 179.719 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 13.9 mt-10 -68.92 -35.59 77.0 Favored 'General case' 0 CA--C 1.53 0.197 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.134 179.774 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -98.77 152.38 19.76 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-O 120.859 0.362 . . . . 0.0 111.182 179.965 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -87.95 78.46 1.79 Allowed Glycine 0 C--N 1.334 0.427 0 C-N-CA 121.052 -0.594 . . . . 0.0 112.53 -179.928 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -137.9 140.17 41.31 Favored 'Isoleucine or valine' 0 C--O 1.233 0.225 0 CA-C-O 120.835 0.35 . . . . 0.0 111.298 -179.858 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 5.7 m-70 -104.03 160.04 27.35 Favored Pre-proline 0 C--N 1.33 -0.246 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.838 179.844 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_endo -69.5 110.85 2.6 Favored 'Trans proline' 0 C--N 1.348 0.533 0 C-N-CA 122.569 2.179 . . . . 0.0 112.371 179.988 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -70.39 166.59 27.88 Favored 'Trans proline' 0 C--N 1.347 0.462 0 C-N-CA 122.45 2.1 . . . . 0.0 112.201 179.799 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 3.2 mt-10 -114.96 86.42 13.46 Favored Pre-proline 0 C--N 1.331 -0.217 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.531 179.84 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -54.66 87.93 0.03 OUTLIER 'Trans proline' 0 C--N 1.352 0.731 0 C-N-CA 123.034 2.49 . . . . 0.0 112.446 -179.844 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 3.3 tt -111.37 -40.68 3.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 115.87 -0.604 . . . . 0.0 111.343 -179.71 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . 66.44 157.25 0.11 Allowed 'General case' 0 C--O 1.233 0.232 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.403 179.94 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -89.57 95.69 10.37 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.849 179.85 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . 62.0 76.49 0.37 Allowed 'General case' 0 C--O 1.234 0.271 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.269 -179.867 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.166 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.968 179.928 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 47.3 mtt . . . . . 0 N--CA 1.491 1.612 0 CA-C-O 120.398 0.142 . . . . 0.0 111.3 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 18.4 m -86.66 154.43 3.36 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.309 0 CA-C-O 120.664 0.269 . . . . 0.0 111.507 179.972 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 50.7 m -149.74 123.04 8.98 Favored 'General case' 0 CA--C 1.53 0.208 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.925 179.936 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -110.02 160.95 15.98 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-O 120.98 0.419 . . . . 0.0 111.348 -179.814 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . 0.405 ' HB2' HD22 ' A' ' 53' ' ' LEU . 92.2 m-85 -107.87 -37.47 6.1 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-N 115.873 -0.603 . . . . 0.0 111.359 179.841 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -144.94 161.45 39.31 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-O 120.814 0.34 . . . . 0.0 111.393 179.923 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . 0.431 ' HG2' ' HB2' ' A' ' 56' ' ' ASP . 28.5 mt-10 -141.1 143.73 34.49 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.146 -179.888 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 3.8 mp -137.84 152.33 26.46 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.424 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.11 179.83 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -97.97 154.06 17.94 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 116.442 -0.345 . . . . 0.0 110.921 179.389 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.439 HD11 HG21 ' A' ' 10' ' ' ILE . 0.2 OUTLIER -54.65 -29.6 21.03 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.588 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.626 179.747 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 9.6 tt0 -56.25 -39.0 71.88 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-N 116.58 -0.282 . . . . 0.0 111.041 179.529 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -94.93 29.63 2.33 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-N 116.455 -0.339 . . . . 0.0 111.561 -179.817 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -114.71 136.69 52.79 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-O 120.577 0.227 . . . . 0.0 110.904 -179.961 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 25.6 m -71.8 102.54 2.87 Favored 'General case' 0 C--O 1.232 0.138 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.487 179.609 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 30.6 p90 -80.57 132.0 35.59 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.017 -179.788 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 53.2 mm-40 -108.95 95.08 16.17 Favored Pre-proline 0 C--O 1.234 0.28 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.618 179.916 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 67.0 Cg_endo -74.53 59.46 4.82 Favored 'Trans proline' 0 C--N 1.347 0.491 0 C-N-CA 122.615 2.21 . . . . 0.0 112.366 179.945 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -128.23 -49.19 1.31 Allowed 'General case' 0 CA--C 1.53 0.196 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.906 -179.914 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 16.0 m-80 -139.11 28.94 2.27 Favored 'General case' 0 CA--C 1.534 0.356 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.009 179.582 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 3.9 mm-40 58.88 61.91 2.03 Favored 'General case' 0 CA--C 1.535 0.401 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.609 179.489 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 20.8 ptp -134.7 141.18 46.46 Favored 'General case' 0 CA--C 1.531 0.227 0 CA-C-N 116.33 -0.396 . . . . 0.0 110.992 179.755 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 3.9 m-85 -111.23 125.68 54.06 Favored 'General case' 0 N--CA 1.463 0.176 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.492 179.713 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 29.6 p -117.27 160.85 20.44 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.329 -179.715 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 29.6 t80 -157.4 136.36 8.0 Favored Pre-proline 0 N--CA 1.463 0.175 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.018 -179.971 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -70.41 93.0 0.58 Allowed 'Trans proline' 0 C--N 1.347 0.448 0 C-N-CA 122.405 2.07 . . . . 0.0 111.989 179.421 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . 0.459 ' SG ' ' HD2' ' A' ' 27' ' ' PRO . 42.3 t -56.6 139.27 75.92 Favored Pre-proline 0 C--O 1.234 0.243 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.664 -179.968 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . 0.459 ' HD2' ' SG ' ' A' ' 26' ' ' CYS . 9.9 Cg_endo -53.23 -25.96 32.16 Favored 'Trans proline' 0 C--N 1.347 0.497 0 C-N-CA 122.926 2.418 . . . . 0.0 113.031 179.997 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . 0.41 ' CB ' ' HB3' ' A' ' 51' ' ' CYS . 0.6 OUTLIER -74.72 -39.43 61.9 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-O 120.461 0.172 . . . . 0.0 111.352 -179.898 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 150.04 -38.33 0.91 Allowed Glycine 0 C--N 1.334 0.467 0 C-N-CA 120.859 -0.686 . . . . 0.0 113.004 -179.802 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -72.04 -176.66 1.8 Allowed 'General case' 0 CA--C 1.533 0.321 0 CA-C-O 120.818 0.342 . . . . 0.0 111.215 -179.861 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 5.4 ttp-105 -116.7 123.67 47.8 Favored 'General case' 0 C--O 1.232 0.173 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.282 -179.375 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -73.65 99.95 3.23 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.643 179.534 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 9.7 mt-30 -92.98 136.39 33.3 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-N 116.474 -0.33 . . . . 0.0 111.208 -179.731 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -155.69 119.04 0.44 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.294 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.868 179.849 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 79.9 m-85 -81.86 159.07 23.8 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 116.444 -0.344 . . . . 0.0 110.934 -179.749 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . 0.408 ' HA ' ' HG2' ' A' ' 39' ' ' MET . 62.8 mt -55.16 -40.28 70.47 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.071 179.857 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 22.1 m-20 -60.38 -45.58 93.05 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-O 120.57 0.224 . . . . 0.0 110.555 179.395 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 64.5 m-20 -60.31 -43.52 96.28 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.139 179.132 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' MET . . . . . 0.408 ' HG2' ' HA ' ' A' ' 36' ' ' LEU . 1.8 ptm -90.77 36.79 0.91 Allowed 'General case' 0 CA--C 1.536 0.434 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.2 179.475 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 18.2 t80 -139.84 -49.89 0.48 Allowed 'General case' 0 CA--C 1.53 0.192 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.71 179.42 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 2.2 mm-40 -59.74 -35.88 75.47 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 116.526 -0.306 . . . . 0.0 110.911 179.613 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 140.59 52.28 0.04 OUTLIER Glycine 0 C--N 1.335 0.491 0 C-N-CA 120.951 -0.642 . . . . 0.0 113.015 179.568 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -129.03 102.3 6.44 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-O 120.796 0.332 . . . . 0.0 111.287 179.969 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . 0.451 ' HG2' ' CE2' ' A' ' 59' ' ' PHE . 12.8 mttt -113.74 -34.98 5.31 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.02 179.723 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 29.7 t -79.12 79.11 0.9 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.238 0 CA-C-O 120.986 0.422 . . . . 0.0 110.565 179.849 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -87.56 151.54 22.91 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.333 -179.802 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 11.8 p -133.24 130.03 57.31 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.026 179.88 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . 0.41 ' O ' ' N ' ' A' ' 52' ' ' SER . 37.7 t -73.64 115.32 40.62 Favored Pre-proline 0 C--N 1.331 -0.238 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.312 179.859 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_exo -57.2 -21.63 44.32 Favored 'Trans proline' 0 CA--C 1.533 0.455 0 C-N-CA 122.703 2.269 . . . . 0.0 113.049 -179.996 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -76.25 -66.99 0.73 Allowed 'General case' 0 CA--C 1.533 0.294 0 N-CA-C 111.236 0.087 . . . . 0.0 111.236 -179.814 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' CYS . . . . . 0.41 ' HB3' ' CB ' ' A' ' 28' ' ' CYS . 27.4 p -81.7 -22.02 37.67 Favored 'General case' 0 N--CA 1.469 0.491 0 N-CA-C 111.991 0.367 . . . . 0.0 111.991 -179.826 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' SER . . . . . 0.41 ' N ' ' O ' ' A' ' 48' ' ' CYS . 1.3 t 69.65 37.88 1.81 Allowed 'General case' 0 CA--C 1.534 0.347 0 CA-C-O 120.802 0.334 . . . . 0.0 111.204 -179.762 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.405 HD22 ' HB2' ' A' ' 5' ' ' TYR . 2.8 tt -106.27 127.21 53.07 Favored 'General case' 0 CA--C 1.53 0.183 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.894 179.832 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' MET . . . . . . . . . . . . . 24.6 mtt -84.12 142.18 30.56 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.428 -179.467 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 2.8 pp -142.78 163.77 17.24 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.298 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.595 179.917 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . 0.431 ' HB2' ' HG2' ' A' ' 7' ' ' GLU . 75.3 m-20 -115.9 106.91 14.34 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.704 179.03 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 11.2 p -97.78 115.11 36.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-O 120.992 0.425 . . . . 0.0 110.624 179.59 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 14.4 p -81.95 125.46 39.75 Favored 'Isoleucine or valine' 0 C--O 1.233 0.199 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.032 -179.646 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . 0.451 ' CE2' ' HG2' ' A' ' 44' ' ' LYS . 11.3 p90 -136.7 167.61 21.09 Favored 'General case' 0 CA--C 1.531 0.218 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.465 -179.494 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 3.4 t0 -113.63 175.69 5.35 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.054 179.708 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 3.1 ttmt -100.23 -41.0 7.27 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.229 -179.958 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -59.36 -35.48 73.97 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 116.461 -0.336 . . . . 0.0 111.076 179.794 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 2.8 t0 -54.24 -43.27 70.76 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.168 -179.913 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 4.3 mp -60.22 -51.81 67.97 Favored 'General case' 0 N--CA 1.462 0.146 0 CA-C-N 116.444 -0.344 . . . . 0.0 110.903 179.877 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -53.84 -42.04 68.07 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-N 116.4 -0.363 . . . . 0.0 111.092 179.69 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 16.9 mm-40 -72.53 -41.28 66.03 Favored 'General case' 0 CA--C 1.528 0.132 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.018 179.579 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -61.0 -35.09 75.92 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 116.524 -0.307 . . . . 0.0 111.636 -179.877 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 3.8 m-85 -56.82 -52.19 66.03 Favored 'General case' 0 N--CA 1.462 0.154 0 CA-C-N 116.704 -0.226 . . . . 0.0 110.829 -179.967 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -75.59 -35.16 60.63 Favored 'General case' 0 CA--C 1.53 0.196 0 CA-C-N 116.542 -0.299 . . . . 0.0 111.013 179.711 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 1.8 mm-40 -61.0 -47.77 84.92 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-N 116.481 -0.327 . . . . 0.0 111.2 -179.958 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -81.91 149.8 28.06 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-O 120.842 0.353 . . . . 0.0 111.146 179.914 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -95.74 31.37 7.28 Favored Glycine 0 C--N 1.332 0.336 0 C-N-CA 121.127 -0.558 . . . . 0.0 112.499 179.7 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 2.2 pp -63.53 130.46 28.35 Favored 'Isoleucine or valine' 0 C--O 1.233 0.196 0 CA-C-O 120.718 0.294 . . . . 0.0 111.005 179.964 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -120.35 88.43 42.13 Favored Pre-proline 0 C--N 1.33 -0.242 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.93 -179.675 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -53.7 151.26 25.95 Favored 'Trans proline' 0 C--N 1.347 0.452 0 C-N-CA 122.859 2.373 . . . . 0.0 112.806 -179.873 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_endo -69.46 101.19 0.84 Allowed 'Trans proline' 0 C--N 1.349 0.596 0 C-N-CA 122.87 2.38 . . . . 0.0 112.585 -179.747 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 15.8 mt-10 -146.7 88.66 5.97 Favored Pre-proline 0 CA--C 1.534 0.347 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.139 -179.911 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_exo -56.55 153.97 32.83 Favored 'Trans proline' 0 C--N 1.35 0.654 0 C-N-CA 123.128 2.552 . . . . 0.0 113.004 -179.774 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 3.5 pt -137.1 30.69 0.65 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.433 0 CA-C-N 116.12 -0.491 . . . . 0.0 112.171 -179.856 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -162.21 130.73 4.16 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-O 120.673 0.273 . . . . 0.0 111.731 179.76 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -143.85 34.47 1.26 Allowed 'General case' 0 C--O 1.233 0.224 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.332 179.493 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -140.46 -58.07 0.53 Allowed 'General case' 0 CA--C 1.528 0.129 0 CA-C-N 116.499 -0.319 . . . . 0.0 111.108 179.712 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.106 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.019 179.839 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 13.0 mtm . . . . . 0 N--CA 1.491 1.582 0 CA-C-O 120.667 0.27 . . . . 0.0 111.178 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 11.1 p -132.22 130.98 60.95 Favored 'Isoleucine or valine' 0 C--O 1.233 0.225 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.146 -179.967 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 4.8 t -94.59 158.15 15.66 Favored 'General case' 0 C--O 1.232 0.184 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.873 179.944 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 81.8 p -149.65 144.02 25.88 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.377 -179.74 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 18.7 m-85 -109.13 -38.89 5.43 Favored 'General case' 0 CA--C 1.531 0.217 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.198 179.702 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -157.02 175.14 14.49 Favored 'General case' 0 C--O 1.234 0.284 0 CA-C-N 116.484 -0.325 . . . . 0.0 111.244 179.881 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 2.6 pt-20 -135.24 125.98 27.25 Favored 'General case' 0 CA--C 1.53 0.189 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.122 179.856 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 4.6 mt -119.86 152.4 22.55 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.241 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.182 -179.745 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . 0.4 ' HA ' ' CG1' ' A' ' 58' ' ' VAL . 16.5 mt-10 -97.94 147.71 24.2 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.254 -179.998 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 8.0 tp -58.38 -31.37 42.74 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.238 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.138 179.476 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -59.32 -32.81 70.41 Favored 'General case' 0 CA--C 1.531 0.218 0 CA-C-N 116.551 -0.295 . . . . 0.0 110.934 179.603 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 5.5 t0 -97.57 36.09 1.55 Allowed 'General case' 0 CA--C 1.532 0.276 0 CA-C-O 120.914 0.387 . . . . 0.0 110.964 179.65 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -121.01 156.93 31.08 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.688 179.831 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 24.4 m -81.44 150.09 28.49 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.586 179.839 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 16.0 p90 -120.87 144.8 48.19 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.819 179.851 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -118.17 88.71 33.16 Favored Pre-proline 0 C--O 1.235 0.309 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.743 179.91 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 16.8 Cg_exo -68.27 72.47 0.85 Allowed 'Trans proline' 0 C--N 1.35 0.634 0 C-N-CA 122.98 2.453 . . . . 0.0 112.387 -179.711 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 1.1 pp20? -151.85 -50.39 0.11 Allowed 'General case' 0 C--O 1.233 0.212 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.992 179.907 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 20.8 m-20 -129.74 26.95 5.26 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-O 120.666 0.269 . . . . 0.0 111.223 179.495 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 56.82 54.64 6.96 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-O 120.992 0.425 . . . . 0.0 111.439 179.82 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 10.2 ptm -133.71 154.12 51.19 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.919 179.619 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 5.9 m-85 -119.06 147.69 43.85 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.081 -0.508 . . . . 0.0 111.052 -179.727 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' THR . . . . . 0.401 ' HA ' ' O ' ' A' ' 32' ' ' PHE . 20.5 p -123.35 173.79 7.74 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.141 -0.482 . . . . 0.0 111.209 179.918 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 60.8 t80 -172.12 99.83 0.37 Allowed Pre-proline 0 C--O 1.232 0.136 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.683 179.962 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_exo -51.21 99.76 0.04 OUTLIER 'Trans proline' 0 C--N 1.349 0.572 0 C-N-CA 122.684 2.256 . . . . 0.0 112.094 -179.905 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 45.9 t -60.53 138.38 92.63 Favored Pre-proline 0 C--N 1.331 -0.218 0 CA-C-N 116.053 -0.522 . . . . 0.0 110.776 -179.761 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 70.3 Cg_exo -51.84 -24.78 19.45 Favored 'Trans proline' 0 C--N 1.348 0.542 0 C-N-CA 122.695 2.263 . . . . 0.0 112.818 179.828 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 1.1 p -66.96 -37.96 85.24 Favored 'General case' 0 CA--C 1.533 0.305 0 CA-C-O 120.526 0.203 . . . . 0.0 111.221 179.902 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 151.88 -44.61 0.64 Allowed Glycine 0 C--N 1.335 0.498 0 C-N-CA 120.8 -0.714 . . . . 0.0 112.955 -179.996 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -72.34 -173.0 1.01 Allowed 'General case' 0 CA--C 1.532 0.278 0 CA-C-O 120.687 0.279 . . . . 0.0 111.337 -179.799 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 33.0 ttm180 -129.5 124.15 33.27 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-O 120.698 0.285 . . . . 0.0 111.052 -179.813 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . 0.401 ' O ' ' HA ' ' A' ' 23' ' ' THR . 1.8 m-85 -61.18 155.64 20.29 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.878 179.664 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 3.8 pt20 -147.16 112.02 5.38 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-N 116.376 -0.375 . . . . 0.0 111.15 179.763 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 2.4 tt -140.48 134.91 35.0 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.955 179.904 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 8.5 m-85 -87.92 161.91 17.19 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.939 -179.811 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -60.63 -46.05 91.76 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.136 -179.991 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -60.57 -36.59 78.88 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-O 120.717 0.294 . . . . 0.0 110.769 179.425 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -60.68 -41.38 94.99 Favored 'General case' 0 C--N 1.334 -0.075 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.535 179.635 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 4.6 mmm -91.78 29.64 1.52 Allowed 'General case' 0 CA--C 1.535 0.401 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.089 179.303 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 16.9 t80 -126.26 -43.54 1.78 Allowed 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 116.499 -0.318 . . . . 0.0 111.174 179.734 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -59.4 -68.13 0.31 Allowed 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 116.519 -0.31 . . . . 0.0 111.477 -179.467 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -169.62 55.76 0.2 Allowed Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.544 -0.836 . . . . 0.0 112.508 -179.761 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -110.15 160.31 16.59 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.834 0.35 . . . . 0.0 111.073 -179.866 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -163.83 -45.13 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.912 -0.585 . . . . 0.0 111.656 179.953 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 8.9 p -116.67 112.68 40.36 Favored 'Isoleucine or valine' 0 C--O 1.233 0.224 0 CA-C-O 120.977 0.418 . . . . 0.0 111.101 -179.876 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -95.31 168.23 10.86 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.53 -179.589 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 18.6 t -139.74 125.79 22.29 Favored 'Isoleucine or valine' 0 C--O 1.232 0.173 0 CA-C-N 115.98 -0.554 . . . . 0.0 111.205 -179.855 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 42.5 t -73.73 114.58 33.7 Favored Pre-proline 0 C--N 1.331 -0.207 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.267 179.573 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_exo -59.24 -20.5 55.44 Favored 'Trans proline' 0 C--N 1.346 0.414 0 C-N-CA 122.569 2.179 . . . . 0.0 112.875 179.946 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -75.75 -67.32 0.68 Allowed 'General case' 0 CA--C 1.531 0.226 0 CA-C-N 116.789 -0.187 . . . . 0.0 111.316 -179.711 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 23.9 p -83.62 -22.42 32.23 Favored 'General case' 0 N--CA 1.466 0.37 0 N-CA-C 111.933 0.346 . . . . 0.0 111.933 -179.706 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER 70.79 39.42 1.08 Allowed 'General case' 0 CA--C 1.533 0.292 0 CA-C-O 120.891 0.377 . . . . 0.0 110.863 -179.678 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 7.4 tp -100.98 143.57 30.96 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.958 179.982 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' MET . . . . . . . . . . . . . 42.2 mtt -95.19 138.09 33.37 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.089 -179.827 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 2.5 pp -148.08 145.07 18.86 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.259 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.653 -179.884 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -92.77 104.89 17.11 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.688 179.411 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 13.4 p -108.42 112.96 42.61 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-O 121.036 0.446 . . . . 0.0 111.167 179.717 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.4 ' CG1' ' HA ' ' A' ' 9' ' ' GLU . 14.5 p -83.61 150.42 4.18 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.28 -179.759 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 47.2 p90 -119.36 177.84 4.76 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.224 -179.846 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -121.96 172.83 7.92 Favored 'General case' 0 C--O 1.232 0.159 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.109 179.793 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 16.1 mmtt -105.6 -46.32 4.2 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.789 179.647 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -66.44 -40.75 89.66 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.894 179.774 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -57.94 -37.63 74.46 Favored 'General case' 0 N--CA 1.462 0.156 0 CA-C-N 116.554 -0.294 . . . . 0.0 111.203 179.913 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -60.53 -41.0 93.53 Favored 'General case' 0 CA--C 1.53 0.189 0 CA-C-N 116.664 -0.244 . . . . 0.0 111.022 179.896 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -82.5 -42.96 17.77 Favored 'General case' 0 C--O 1.232 0.173 0 CA-C-N 116.485 -0.325 . . . . 0.0 111.015 179.687 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -61.18 -50.55 72.67 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.653 179.836 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 55.3 t80 -63.2 -31.86 73.12 Favored 'General case' 0 CA--C 1.53 0.196 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.331 179.649 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 2.0 t80 -61.93 -59.73 4.67 Favored 'General case' 0 C--O 1.232 0.143 0 CA-C-O 120.545 0.212 . . . . 0.0 110.851 179.918 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 2.1 tp10 -63.56 -35.33 80.14 Favored 'General case' 0 N--CA 1.462 0.17 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.388 -179.977 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 25.4 mt-10 -71.65 -36.47 70.69 Favored 'General case' 0 CA--C 1.53 0.179 0 CA-C-N 116.544 -0.298 . . . . 0.0 111.371 -179.893 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -79.61 -40.72 28.66 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 120.589 0.233 . . . . 0.0 111.353 180.0 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 66.1 62.22 4.86 Favored Glycine 0 C--N 1.335 0.528 0 C-N-CA 120.985 -0.626 . . . . 0.0 112.724 179.844 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 9.1 tp -58.08 -35.14 51.32 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.229 0 CA-C-O 120.556 0.217 . . . . 0.0 111.547 -179.991 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 9.7 m80 -98.41 149.41 35.71 Favored Pre-proline 0 C--O 1.234 0.237 0 CA-C-N 116.502 -0.317 . . . . 0.0 110.698 179.601 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo -53.83 152.72 21.94 Favored 'Trans proline' 0 C--N 1.35 0.635 0 C-N-CA 122.873 2.382 . . . . 0.0 112.665 -179.999 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 41.0 Cg_endo -67.02 -31.7 36.51 Favored 'Trans proline' 0 C--N 1.348 0.506 0 C-N-CA 122.526 2.15 . . . . 0.0 112.504 179.768 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -141.67 87.16 10.32 Favored Pre-proline 0 C--O 1.232 0.168 0 CA-C-N 116.544 -0.298 . . . . 0.0 111.018 -179.981 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -69.98 -178.59 2.5 Favored 'Trans proline' 0 C--N 1.347 0.486 0 C-N-CA 122.576 2.184 . . . . 0.0 112.348 179.994 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 33.7 mt 68.44 102.35 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.339 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.618 -179.745 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . 60.08 37.6 20.96 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.075 -179.204 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -95.7 131.05 42.38 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.154 -179.965 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -80.23 164.67 23.06 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.114 179.893 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.331 -0.197 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.069 179.929 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 14.5 mtt . . . . . 0 N--CA 1.492 1.657 0 CA-C-O 120.654 0.264 . . . . 0.0 111.362 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 11.7 p -147.91 147.65 17.01 Favored 'Isoleucine or valine' 0 C--O 1.234 0.275 0 CA-C-N 116.558 -0.292 . . . . 0.0 111.28 -179.885 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 1.3 m -164.06 156.65 17.42 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.279 -179.918 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -102.8 176.87 5.01 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.277 179.889 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . 0.4 ' HB2' HD23 ' A' ' 53' ' ' LEU . 58.9 m-85 -98.95 -35.81 9.95 Favored 'General case' 0 CA--C 1.531 0.241 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.49 -179.891 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -158.85 173.55 16.36 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-O 120.759 0.314 . . . . 0.0 111.323 -179.92 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 2.7 tm-20 -138.58 122.72 18.03 Favored 'General case' 0 CA--C 1.531 0.24 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.879 -179.886 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 4.8 mt -126.21 152.36 33.5 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.338 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.114 -179.747 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 3.0 pt-20 -96.95 153.17 18.06 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.622 -179.99 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 1.2 tp -62.99 -34.66 67.73 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.313 0 CA-C-N 115.947 -0.569 . . . . 0.0 111.36 179.58 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -58.74 -32.87 69.63 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-N 116.609 -0.269 . . . . 0.0 111.157 179.681 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -97.28 36.1 1.51 Allowed 'General case' 0 CA--C 1.537 0.47 0 CA-C-O 120.81 0.338 . . . . 0.0 111.311 179.783 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 1.7 ttt -121.54 148.83 43.98 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.888 179.787 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -69.33 126.93 31.3 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-O 120.826 0.346 . . . . 0.0 110.873 179.971 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 14.4 t80 -94.59 123.97 38.33 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.509 179.596 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 1.4 tp10 -108.96 92.1 10.2 Favored Pre-proline 0 C--O 1.234 0.256 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.314 179.499 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 64.3 Cg_endo -73.6 61.27 4.4 Favored 'Trans proline' 0 C--N 1.351 0.677 0 C-N-CA 122.793 2.329 . . . . 0.0 112.72 -179.44 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 19.1 pt-20 -131.44 -45.82 0.99 Allowed 'General case' 0 CA--C 1.533 0.302 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.885 179.772 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -141.71 32.13 1.63 Allowed 'General case' 0 CA--C 1.534 0.363 0 CA-C-N 116.515 -0.311 . . . . 0.0 111.057 179.406 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 91.3 mt-30 55.15 59.88 3.75 Favored 'General case' 0 C--O 1.236 0.363 0 CA-C-O 120.955 0.407 . . . . 0.0 111.413 179.931 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 9.6 ptp -130.41 148.72 52.25 Favored 'General case' 0 C--O 1.235 0.307 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.343 179.909 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.41 ' CE1' HD22 ' A' ' 36' ' ' LEU . 25.4 m-85 -124.6 102.89 7.84 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.896 179.994 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 66.9 p -101.54 166.83 10.5 Favored 'General case' 0 CA--C 1.532 0.261 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.84 -179.827 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 62.3 t80 -164.7 139.6 4.42 Favored Pre-proline 0 CA--C 1.531 0.235 0 CA-C-O 120.599 0.237 . . . . 0.0 111.377 179.774 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -53.2 121.79 10.03 Favored 'Trans proline' 0 C--N 1.352 0.724 0 C-N-CA 122.994 2.462 . . . . 0.0 113.144 -179.979 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . 0.448 ' SG ' ' HD2' ' A' ' 27' ' ' PRO . 42.1 t -90.64 140.3 26.57 Favored Pre-proline 0 C--N 1.331 -0.218 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.497 179.38 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . 0.448 ' HD2' ' SG ' ' A' ' 26' ' ' CYS . 73.8 Cg_exo -50.7 -27.82 20.92 Favored 'Trans proline' 0 C--N 1.349 0.587 0 C-N-CA 122.898 2.398 . . . . 0.0 113.026 179.536 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . 0.408 ' CB ' ' HB3' ' A' ' 51' ' ' CYS . 0.9 OUTLIER -69.51 -38.89 77.77 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-N 116.799 -0.182 . . . . 0.0 111.446 -179.959 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 151.92 -48.4 0.55 Allowed Glycine 0 C--N 1.336 0.57 0 C-N-CA 120.854 -0.689 . . . . 0.0 112.958 -179.933 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -73.96 -175.11 2.05 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-O 120.665 0.269 . . . . 0.0 110.966 179.984 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 19.5 mtt180 -118.72 134.66 54.98 Favored 'General case' 0 C--O 1.232 0.164 0 CA-C-O 120.677 0.275 . . . . 0.0 110.826 179.924 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 6.8 m-85 -62.23 168.0 3.7 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.811 179.653 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 5.8 tt0 -155.58 121.95 5.21 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-O 120.695 0.283 . . . . 0.0 111.274 179.882 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 5.8 tt -146.04 138.81 20.45 Favored 'Isoleucine or valine' 0 C--O 1.234 0.25 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.085 179.646 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 25.6 m-85 -95.58 155.49 16.72 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.993 179.992 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . 0.41 HD22 ' CE1' ' A' ' 22' ' ' PHE . 87.9 mt -62.63 -39.84 95.11 Favored 'General case' 0 CA--C 1.53 0.199 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.016 179.72 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -66.2 -34.81 78.86 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 116.683 -0.235 . . . . 0.0 111.196 179.409 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -62.7 -57.99 9.06 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-O 120.918 0.389 . . . . 0.0 110.591 179.991 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 5.6 ptm -63.04 -34.62 77.97 Favored 'General case' 0 CA--C 1.534 0.343 0 CA-C-N 115.956 -0.565 . . . . 0.0 111.291 179.764 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . 0.4 ' HB2' ' CD2' ' A' ' 64' ' ' LEU . 31.6 t80 -61.14 -45.06 96.18 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-N 116.551 -0.295 . . . . 0.0 110.882 179.485 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 2.6 tp10 -56.0 -40.8 73.89 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.709 179.471 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 148.47 47.86 0.02 OUTLIER Glycine 0 C--N 1.335 0.49 0 C-N-CA 121.146 -0.55 . . . . 0.0 112.672 179.755 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 4.3 tt0 -112.4 123.19 49.73 Favored 'General case' 0 C--O 1.232 0.159 0 CA-C-O 120.826 0.346 . . . . 0.0 111.149 -179.795 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 19.4 mtmt -122.46 -43.75 2.27 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-N 115.917 -0.583 . . . . 0.0 111.026 179.726 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 12.0 p -108.16 113.21 43.26 Favored 'Isoleucine or valine' 0 C--O 1.233 0.209 0 CA-C-O 121.011 0.434 . . . . 0.0 111.005 179.781 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -102.24 164.66 11.56 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.154 -179.815 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 11.6 p -124.49 129.09 73.93 Favored 'Isoleucine or valine' 0 C--O 1.233 0.207 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.227 -179.909 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 47.9 t -67.86 135.52 92.16 Favored Pre-proline 0 C--O 1.233 0.229 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.79 179.929 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 84.5 Cg_endo -83.54 21.09 1.08 Allowed 'Trans proline' 0 CA--C 1.537 0.639 0 C-N-CA 122.729 2.286 . . . . 0.0 113.056 179.777 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 7.7 t -129.07 -56.82 1.17 Allowed 'General case' 0 C--O 1.233 0.204 0 CA-C-N 116.615 -0.266 . . . . 0.0 110.512 179.768 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' CYS . . . . . 0.408 ' HB3' ' CB ' ' A' ' 28' ' ' CYS . 18.5 p -100.63 -10.59 20.79 Favored 'General case' 0 CA--C 1.538 0.481 0 N-CA-C 112.276 0.473 . . . . 0.0 112.276 179.924 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 6.5 p 60.24 35.85 20.87 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-O 120.863 0.363 . . . . 0.0 111.765 -179.903 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.4 HD23 ' HB2' ' A' ' 5' ' ' TYR . 6.6 tt -94.95 121.34 36.46 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.698 179.394 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' MET . . . . . . . . . . . . . 6.9 mtt -85.94 141.53 29.48 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.171 -179.712 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 3.8 pt -145.19 148.19 17.99 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.295 0 CA-C-N 115.934 -0.575 . . . . 0.0 111.495 179.997 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 72.3 m-20 -93.27 104.74 16.89 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.463 178.918 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 12.5 p -100.22 112.37 32.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 121.057 0.456 . . . . 0.0 110.879 179.72 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 14.2 p -81.04 130.87 35.14 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.172 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.709 -179.852 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 42.1 p90 -133.41 176.96 8.06 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.29 -179.275 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 4.3 t70 -122.38 144.91 48.73 Favored 'General case' 0 N--CA 1.462 0.17 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.4 -179.923 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 11.7 mttp -76.7 -40.01 50.14 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.153 179.699 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 17.7 tt0 -58.43 -37.66 75.86 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 116.617 -0.265 . . . . 0.0 110.595 179.531 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . 0.476 ' HB3' ' CE2' ' A' ' 67' ' ' TYR . 3.4 m-20 -56.03 -43.87 78.2 Favored 'General case' 0 N--CA 1.463 0.19 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.954 179.425 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.4 ' CD2' ' HB2' ' A' ' 40' ' ' PHE . 3.0 mp -53.31 -53.41 51.4 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 116.469 -0.332 . . . . 0.0 111.185 179.987 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -56.24 -39.65 72.88 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 116.512 -0.313 . . . . 0.0 110.846 179.511 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -69.19 -39.74 78.49 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.05 179.367 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . 0.476 ' CE2' ' HB3' ' A' ' 63' ' ' ASP . 20.1 m-85 -69.12 -37.93 78.62 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 116.634 -0.257 . . . . 0.0 111.624 -179.861 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 5.7 m-85 -62.17 -38.25 88.35 Favored 'General case' 0 N--CA 1.463 0.211 0 C-N-CA 121.247 -0.181 . . . . 0.0 110.635 179.966 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -80.96 -36.26 31.13 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-N 116.48 -0.327 . . . . 0.0 111.084 179.262 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 5.7 mt-10 -72.28 -35.68 68.79 Favored 'General case' 0 N--CA 1.467 0.376 0 N-CA-C 111.681 0.252 . . . . 0.0 111.681 -179.834 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -87.42 -56.68 3.25 Favored 'General case' 0 C--O 1.233 0.215 0 N-CA-C 111.517 0.191 . . . . 0.0 111.517 -179.643 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 79.9 57.5 3.03 Favored Glycine 0 C--N 1.334 0.447 0 C-N-CA 120.89 -0.671 . . . . 0.0 112.782 179.98 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 10.7 tp -60.9 146.01 11.96 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.33 0 CA-C-O 120.753 0.311 . . . . 0.0 111.554 -179.932 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 55.4 m80 -99.15 160.83 26.64 Favored Pre-proline 0 C--O 1.234 0.262 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.796 179.511 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_exo -52.6 152.17 17.14 Favored 'Trans proline' 0 C--N 1.352 0.725 0 C-N-CA 122.928 2.418 . . . . 0.0 112.933 -179.779 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_endo -68.89 134.21 29.26 Favored 'Trans proline' 0 C--N 1.35 0.643 0 C-N-CA 122.685 2.257 . . . . 0.0 112.314 179.86 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER 61.18 86.11 0.16 Allowed Pre-proline 0 N--CA 1.466 0.327 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.258 -179.78 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_endo -68.61 111.32 2.53 Favored 'Trans proline' 0 C--N 1.349 0.563 0 C-N-CA 122.684 2.256 . . . . 0.0 112.312 179.949 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 21.4 mt 65.19 81.53 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.308 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.777 -179.651 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -104.78 92.91 4.46 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-N 115.801 -0.636 . . . . 0.0 111.281 -179.545 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . 69.29 151.83 0.09 Allowed 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.752 179.901 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . 63.61 100.78 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.511 -179.997 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.095 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.162 179.924 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 6.9 mtt . . . . . 0 N--CA 1.49 1.575 0 CA-C-O 120.68 0.276 . . . . 0.0 111.289 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 21.0 t -75.35 139.65 18.7 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.219 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.121 179.931 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 2.0 m -105.84 107.48 18.5 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.487 179.578 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -153.35 178.73 9.46 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-N 116.262 -0.427 . . . . 0.0 111.477 -179.284 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 9.3 m-85 -106.68 -43.65 4.66 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.37 179.721 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 12.0 m-20 -151.74 175.53 12.31 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-O 120.782 0.325 . . . . 0.0 111.484 179.791 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 19.5 tt0 -128.0 122.62 32.73 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.443 179.514 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 28.5 mm -120.33 155.04 23.53 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.162 -179.584 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -112.55 150.98 30.56 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-N 116.308 -0.406 . . . . 0.0 111.292 179.867 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 2.8 tt -58.72 -31.89 45.38 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.331 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.239 179.576 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 17.8 mt-10 -66.24 -30.91 71.44 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-N 116.374 -0.375 . . . . 0.0 111.106 179.501 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 3.3 t70 -98.03 38.37 1.32 Allowed 'General case' 0 CA--C 1.533 0.313 0 CA-C-O 120.889 0.376 . . . . 0.0 111.052 179.816 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 1.8 mtp -128.39 156.17 43.56 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.782 179.778 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 8.7 m -87.4 108.2 18.89 Favored 'General case' 0 N--CA 1.462 0.15 0 CA-C-O 120.835 0.35 . . . . 0.0 110.952 -179.923 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 29.8 p90 -85.12 138.12 32.6 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.764 179.754 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 25.1 mt-10 -103.9 96.36 9.16 Favored Pre-proline 0 C--O 1.234 0.263 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.406 179.848 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -71.77 63.62 3.12 Favored 'Trans proline' 0 C--N 1.35 0.654 0 C-N-CA 122.812 2.342 . . . . 0.0 112.721 -179.497 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 7.1 pt-20 -135.14 -53.78 0.79 Allowed 'General case' 0 C--N 1.333 -0.144 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.741 179.535 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 71.6 m-20 -133.08 33.04 3.68 Favored 'General case' 0 CA--C 1.534 0.345 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.999 179.479 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 25.4 mt-30 56.81 49.84 13.52 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-O 120.802 0.334 . . . . 0.0 111.287 179.936 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 9.6 ttp -122.62 157.18 32.72 Favored 'General case' 0 N--CA 1.463 0.176 0 CA-C-O 120.737 0.304 . . . . 0.0 111.161 -179.942 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.42 ' O ' ' HA ' ' A' ' 33' ' ' GLN . 5.8 m-85 -121.28 164.43 17.01 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.852 -179.988 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 25.6 p -144.59 150.93 38.29 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.095 179.487 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 86.5 t80 -145.38 95.91 4.95 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.243 179.282 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -55.05 94.33 0.04 OUTLIER 'Trans proline' 0 C--N 1.349 0.559 0 C-N-CA 122.719 2.279 . . . . 0.0 111.832 179.967 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . 0.437 ' SG ' ' HD2' ' A' ' 27' ' ' PRO . 45.3 t -63.8 137.89 97.23 Favored Pre-proline 0 C--O 1.234 0.243 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.095 -179.306 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . 0.437 ' HD2' ' SG ' ' A' ' 26' ' ' CYS . 10.9 Cg_endo -54.84 -20.33 22.11 Favored 'Trans proline' 0 C--N 1.35 0.626 0 C-N-CA 122.906 2.404 . . . . 0.0 112.831 179.777 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 12.4 p -55.49 -29.31 58.55 Favored 'General case' 0 CA--C 1.535 0.378 0 CA-C-O 120.592 0.234 . . . . 0.0 111.398 179.68 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 125.55 5.43 6.52 Favored Glycine 0 CA--C 1.526 0.737 0 C-N-CA 121.143 -0.551 . . . . 0.0 113.692 179.836 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -126.55 -167.12 1.67 Allowed 'General case' 0 CA--C 1.536 0.408 0 CA-C-N 117.412 0.606 . . . . 0.0 111.324 -179.814 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 8.6 ttm-85 -121.36 150.1 41.96 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-O 120.8 0.333 . . . . 0.0 111.506 -179.596 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 21.7 t80 -103.43 162.27 13.17 Favored 'General case' 0 CA--C 1.529 0.153 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.882 179.368 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . 0.42 ' HA ' ' O ' ' A' ' 22' ' ' PHE . 3.2 pt20 -149.7 115.64 5.66 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.879 179.65 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 3.3 tt -130.71 128.3 62.92 Favored 'Isoleucine or valine' 0 C--O 1.234 0.245 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.062 179.989 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -80.23 123.53 28.02 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.054 -179.667 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 3.7 pp -61.28 -38.59 87.33 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.998 179.601 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 3.7 t70 -56.3 -46.37 79.83 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 116.503 -0.317 . . . . 0.0 110.801 179.538 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -65.92 -45.59 81.33 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.518 179.435 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 1.6 mtm -52.05 -25.62 9.02 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.852 179.687 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -53.97 -35.46 61.81 Favored 'General case' 0 N--CA 1.467 0.397 0 N-CA-C 111.559 0.207 . . . . 0.0 111.559 179.775 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 -58.44 -31.59 67.91 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-N 116.646 -0.252 . . . . 0.0 111.565 179.75 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 125.14 45.54 0.25 Allowed Glycine 0 C--N 1.335 0.509 0 C-N-CA 121.218 -0.515 . . . . 0.0 112.771 179.81 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -84.1 133.31 34.64 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-O 120.687 0.28 . . . . 0.0 110.908 179.996 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 3.4 ptpp? -126.54 -45.26 1.65 Allowed 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.385 -179.9 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 12.2 p -94.55 131.44 41.38 Favored 'Isoleucine or valine' 0 C--O 1.233 0.223 0 CA-C-N 116.418 -0.355 . . . . 0.0 110.715 179.797 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -129.82 144.79 51.48 Favored 'General case' 0 C--O 1.234 0.288 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.109 -179.676 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 11.3 p -110.36 123.88 66.64 Favored 'Isoleucine or valine' 0 C--O 1.233 0.223 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.15 -179.828 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 52.5 t -62.2 134.72 94.72 Favored Pre-proline 0 N--CA 1.463 0.214 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.99 179.905 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 90.7 Cg_endo -84.98 24.55 0.76 Allowed 'Trans proline' 0 C--N 1.349 0.58 0 C-N-CA 122.713 2.275 . . . . 0.0 112.993 179.926 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 1.4 m -132.99 -60.29 0.87 Allowed 'General case' 0 CA--C 1.53 0.191 0 CA-C-N 116.503 -0.317 . . . . 0.0 110.586 -179.83 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 22.6 p -102.35 -13.98 17.1 Favored 'General case' 0 CA--C 1.537 0.462 0 N-CA-C 111.869 0.322 . . . . 0.0 111.869 179.494 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 6.4 t 66.82 34.28 5.6 Favored 'General case' 0 CA--C 1.534 0.365 0 CA-C-O 120.895 0.379 . . . . 0.0 111.286 -179.815 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 8.0 tt -85.21 134.27 34.15 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.604 179.663 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' MET . . . . . . . . . . . . . 40.7 mtm -82.79 133.0 35.15 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.198 -179.635 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 2.7 pt -138.68 151.07 23.85 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.394 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.853 -179.829 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 71.1 m-20 -97.02 88.47 4.52 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.741 179.297 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 12.5 p -94.5 114.52 31.26 Favored 'Isoleucine or valine' 0 C--O 1.234 0.279 0 CA-C-O 121.063 0.458 . . . . 0.0 110.938 179.77 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 12.6 p -91.79 135.24 27.7 Favored 'Isoleucine or valine' 0 C--O 1.233 0.218 0 CA-C-N 115.967 -0.561 . . . . 0.0 110.974 -179.719 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 48.5 p90 -112.51 166.55 11.22 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.885 -179.52 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -131.16 137.74 49.14 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.215 179.774 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 17.0 mttp -68.43 -38.21 80.98 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.733 179.191 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 21.3 mt-10 -58.87 -52.99 63.35 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.427 179.266 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 38.4 m-20 -62.12 -43.04 99.72 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.993 179.505 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -60.16 -53.43 57.77 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-O 120.607 0.242 . . . . 0.0 111.244 179.95 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -63.7 -39.25 93.84 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 116.422 -0.353 . . . . 0.0 111.149 179.867 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 26.7 tt0 -68.27 -41.29 81.26 Favored 'General case' 0 CA--C 1.532 0.285 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.9 179.476 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 19.9 t80 -66.24 -34.79 78.81 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.655 -179.994 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 23.5 t80 -54.26 -41.96 69.41 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-O 120.732 0.301 . . . . 0.0 110.254 179.719 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 4.1 tt0 -83.6 -37.45 22.9 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.292 179.466 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -66.63 -32.96 74.62 Favored 'General case' 0 N--CA 1.467 0.403 0 N-CA-C 112.053 0.39 . . . . 0.0 112.053 -179.608 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -60.44 -63.18 1.39 Allowed 'General case' 0 N--CA 1.465 0.323 0 N-CA-C 111.863 0.32 . . . . 0.0 111.863 -179.322 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 90.65 35.78 7.17 Favored Glycine 0 C--N 1.334 0.418 0 C-N-CA 120.915 -0.659 . . . . 0.0 112.842 -179.816 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 17.9 tt -64.26 153.35 7.65 Favored 'Isoleucine or valine' 0 C--O 1.232 0.179 0 CA-C-O 120.623 0.249 . . . . 0.0 111.099 179.75 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 1.5 t-80 65.07 84.12 0.18 Allowed Pre-proline 0 C--O 1.233 0.23 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.328 -179.693 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -53.52 163.74 2.49 Favored 'Trans proline' 0 C--N 1.351 0.674 0 C-N-CA 123.023 2.482 . . . . 0.0 112.809 -179.607 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_exo -60.45 179.55 0.33 Allowed 'Trans proline' 0 C--N 1.35 0.631 0 C-N-CA 122.849 2.366 . . . . 0.0 112.495 179.858 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . 0.419 ' H ' ' HD2' ' A' ' 78' ' ' PRO . 2.3 mt-10 -160.94 -60.3 0.02 OUTLIER Pre-proline 0 C--N 1.33 -0.273 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.242 -179.874 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . 0.419 ' HD2' ' H ' ' A' ' 77' ' ' GLU . 57.8 Cg_endo -70.56 82.44 0.92 Allowed 'Trans proline' 0 C--N 1.352 0.762 0 C-N-CA 122.588 2.192 . . . . 0.0 112.633 -179.799 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 15.0 tt -66.37 150.32 11.04 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.247 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.249 179.886 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -65.4 -64.5 0.85 Allowed 'General case' 0 CA--C 1.531 0.229 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.052 179.871 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . 61.82 102.89 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.401 0 CA-C-N 116.387 -0.37 . . . . 0.0 111.796 179.574 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -130.86 -76.04 0.53 Allowed 'General case' 0 N--CA 1.464 0.227 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.434 179.758 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.128 0 CA-C-O 120.812 0.339 . . . . 0.0 111.132 -179.943 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.491 1.584 0 CA-C-O 120.599 0.238 . . . . 0.0 111.077 . . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 11.2 p -61.54 -32.46 53.57 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.219 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.273 179.55 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 5.1 m 61.83 177.43 0.12 Allowed 'General case' 0 C--O 1.233 0.219 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.672 -179.547 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 5.0 p 55.72 -173.44 0.06 Allowed 'General case' 0 CA--C 1.532 0.267 0 CA-C-O 120.875 0.369 . . . . 0.0 111.069 -179.838 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 11.6 m-85 -164.65 -40.84 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.123 179.755 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -145.83 169.99 17.45 Favored 'General case' 0 C--O 1.237 0.409 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.005 -179.798 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -123.98 112.11 16.81 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.873 -179.882 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.42 ' O ' ' HA ' ' A' ' 57' ' ' VAL . 27.8 mm -88.07 154.62 3.23 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.196 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.954 179.918 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 82.2 mt-10 -121.54 146.77 46.61 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-N 116.374 -0.376 . . . . 0.0 111.211 -179.983 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 8.1 tp -58.11 -34.95 50.67 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.344 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.124 179.501 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 6.6 tt0 -65.66 -34.61 78.6 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-N 116.496 -0.32 . . . . 0.0 110.878 179.46 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 22.1 m-20 -95.94 38.27 1.19 Allowed 'General case' 0 CA--C 1.531 0.238 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.226 179.766 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -133.79 136.73 44.69 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.725 179.785 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 9.7 m -69.64 138.22 52.86 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.015 -179.841 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . 0.405 ' HB3' ' CE2' ' A' ' 22' ' ' PHE . 17.3 p90 -101.54 130.4 47.82 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.556 179.649 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . 0.401 ' HG2' ' HE2' ' A' ' 21' ' ' MET . 2.3 mp0 -109.23 90.82 8.68 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.733 179.795 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 69.9 Cg_endo -74.26 62.31 5.16 Favored 'Trans proline' 0 C--N 1.348 0.512 0 C-N-CA 122.776 2.317 . . . . 0.0 112.954 -179.786 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 4.8 pt-20 -132.68 -50.21 0.9 Allowed 'General case' 0 CA--C 1.531 0.224 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.757 179.47 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 38.0 m-20 -136.46 32.03 2.82 Favored 'General case' 0 CA--C 1.534 0.345 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.23 179.512 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . 0.411 ' OE1' ' HA ' ' A' ' 68' ' ' TYR . 15.2 mt-30 56.67 67.38 1.0 Allowed 'General case' 0 CA--C 1.535 0.368 0 CA-C-O 121.06 0.457 . . . . 0.0 111.462 179.447 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' MET . . . . . 0.401 ' HE2' ' HG2' ' A' ' 16' ' ' GLU . 2.5 ptt? -146.99 158.64 43.98 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-N 116.013 -0.54 . . . . 0.0 111.092 179.674 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.405 ' CE2' ' HB3' ' A' ' 15' ' ' PHE . 17.4 m-85 -131.21 127.8 38.65 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.787 -179.967 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' THR . . . . . 0.413 ' HA ' ' O ' ' A' ' 32' ' ' PHE . 18.2 p -116.14 170.21 8.68 Favored 'General case' 0 CA--C 1.532 0.28 0 CA-C-O 120.828 0.347 . . . . 0.0 111.454 -179.877 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 57.8 t80 -163.23 136.29 4.31 Favored Pre-proline 0 N--CA 1.464 0.271 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.042 179.795 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 42.0 Cg_endo -66.59 103.38 0.68 Allowed 'Trans proline' 0 C--N 1.35 0.606 0 C-N-CA 122.555 2.17 . . . . 0.0 112.27 179.649 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . 0.472 ' SG ' ' HD2' ' A' ' 27' ' ' PRO . 42.7 t -66.89 139.63 95.76 Favored Pre-proline 0 C--O 1.233 0.215 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.551 179.786 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . 0.472 ' HD2' ' SG ' ' A' ' 26' ' ' CYS . 9.3 Cg_endo -53.64 -25.56 33.99 Favored 'Trans proline' 0 C--N 1.35 0.617 0 C-N-CA 122.928 2.419 . . . . 0.0 112.927 179.867 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . 0.406 ' CB ' ' HB3' ' A' ' 51' ' ' CYS . 0.8 OUTLIER -69.93 -38.03 76.07 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-O 120.51 0.195 . . . . 0.0 111.299 -179.978 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 150.37 -44.8 0.68 Allowed Glycine 0 C--N 1.336 0.541 0 C-N-CA 120.834 -0.698 . . . . 0.0 112.898 -179.922 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -71.09 -176.51 1.43 Allowed 'General case' 0 CA--C 1.534 0.333 0 CA-C-O 120.779 0.323 . . . . 0.0 111.169 -179.86 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 7.2 ttp180 -122.19 114.06 20.33 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-N 116.515 -0.312 . . . . 0.0 111.085 -179.886 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . 0.413 ' O ' ' HA ' ' A' ' 23' ' ' THR . 73.3 t80 -62.2 154.55 27.07 Favored 'General case' 0 N--CA 1.462 0.168 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.966 179.708 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 1.1 pt20 -147.47 144.12 28.37 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.231 179.994 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 2.8 tt -147.6 132.14 10.25 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.247 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.064 179.497 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 6.0 m-85 -90.41 139.54 30.58 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.944 -179.883 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 13.9 mt -59.57 -47.48 85.41 Favored 'General case' 0 N--CA 1.463 0.19 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.027 179.954 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -59.57 -38.5 81.32 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 116.587 -0.279 . . . . 0.0 110.78 179.339 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -66.73 -58.99 3.97 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.017 179.853 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 6.4 ptm -60.68 -32.58 71.79 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 116.462 -0.335 . . . . 0.0 111.556 -179.878 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 18.7 t80 -58.39 -37.05 74.49 Favored 'General case' 0 CA--C 1.533 0.318 0 CA-C-N 116.499 -0.318 . . . . 0.0 111.15 179.689 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 4.6 mt-10 -57.92 -38.14 75.34 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-O 120.668 0.271 . . . . 0.0 110.98 179.512 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 144.77 52.14 0.03 OUTLIER Glycine 0 C--N 1.334 0.46 0 C-N-CA 121.018 -0.611 . . . . 0.0 112.701 179.785 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -109.98 157.18 19.56 Favored 'General case' 0 C--O 1.232 0.15 0 CA-C-O 120.81 0.338 . . . . 0.0 111.237 -179.943 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -157.1 -47.14 0.07 Allowed 'General case' 0 CA--C 1.532 0.262 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.156 179.815 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 4.8 m -100.02 115.0 40.19 Favored 'Isoleucine or valine' 0 C--O 1.233 0.191 0 CA-C-O 120.84 0.352 . . . . 0.0 110.972 179.78 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -110.47 174.79 5.7 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.204 -179.854 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 11.3 m -133.48 121.18 40.81 Favored 'Isoleucine or valine' 0 C--O 1.233 0.209 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.186 -179.886 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 43.3 t -63.15 135.94 96.46 Favored Pre-proline 0 C--O 1.233 0.215 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.702 179.964 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 91.5 Cg_endo -83.15 19.87 1.26 Allowed 'Trans proline' 0 CA--C 1.537 0.645 0 C-N-CA 122.682 2.255 . . . . 0.0 113.212 179.972 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 29.8 t -128.35 -58.2 1.2 Allowed 'General case' 0 CA--C 1.529 0.152 0 CA-C-O 120.657 0.265 . . . . 0.0 110.521 179.644 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' CYS . . . . . 0.406 ' HB3' ' CB ' ' A' ' 28' ' ' CYS . 20.1 p -98.72 -20.2 17.07 Favored 'General case' 0 CA--C 1.533 0.327 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.826 179.93 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 1.1 t 67.46 39.48 2.88 Favored 'General case' 0 CA--C 1.534 0.327 0 CA-C-O 121.07 0.462 . . . . 0.0 110.904 -179.772 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 6.9 tp -88.08 131.68 34.58 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.711 179.814 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' MET . . . . . . . . . . . . . 41.1 mtt -85.14 123.99 31.29 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.618 -179.877 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 2.6 pp -134.06 142.16 41.89 Favored 'Isoleucine or valine' 0 C--O 1.234 0.249 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.621 -179.749 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -105.81 95.92 6.14 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.656 -179.909 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.42 ' HA ' ' O ' ' A' ' 8' ' ' ILE . 14.8 p -84.18 139.13 18.03 Favored 'Isoleucine or valine' 0 C--O 1.234 0.286 0 CA-C-O 120.941 0.4 . . . . 0.0 111.124 -179.954 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 12.1 p -111.26 123.02 66.75 Favored 'Isoleucine or valine' 0 C--O 1.234 0.264 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.862 179.703 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 32.3 p90 -129.32 176.83 7.63 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.025 -179.675 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -118.02 162.79 17.6 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.556 -179.898 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 22.8 mttt -87.82 -32.1 19.21 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.128 179.568 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -59.73 -54.55 45.05 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 116.587 -0.279 . . . . 0.0 110.835 179.882 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -61.28 -44.48 97.16 Favored 'General case' 0 N--CA 1.463 0.186 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.741 179.655 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -57.96 -41.31 82.64 Favored 'General case' 0 CA--C 1.529 0.157 0 CA-C-N 116.429 -0.35 . . . . 0.0 110.809 179.583 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -70.18 -39.45 75.24 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 116.441 -0.345 . . . . 0.0 111.241 179.763 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 31.1 mt-10 -70.51 -41.06 73.12 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.504 -179.808 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 2.5 t80 -55.94 -30.84 62.3 Favored 'General case' 0 N--CA 1.465 0.275 0 CA-C-N 116.693 -0.231 . . . . 0.0 111.499 -179.958 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . 0.411 ' HA ' ' OE1' ' A' ' 20' ' ' GLN . 3.8 m-85 -58.85 -36.24 74.25 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-O 120.63 0.253 . . . . 0.0 110.589 179.665 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 7.8 tt0 -88.3 -36.32 16.73 Favored 'General case' 0 CA--C 1.531 0.242 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.943 179.334 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 4.5 mm-40 -66.23 -34.57 78.31 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.605 -179.705 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -67.63 143.88 55.81 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-O 120.86 0.362 . . . . 0.0 111.251 -179.838 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -96.06 28.24 13.58 Favored Glycine 0 CA--C 1.521 0.423 0 C-N-CA 121.05 -0.595 . . . . 0.0 112.804 179.959 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 11.7 tt -78.56 -34.52 17.94 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.314 0 CA-C-O 120.532 0.206 . . . . 0.0 111.364 179.971 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 10.6 m-70 -133.5 88.45 34.38 Favored Pre-proline 0 C--O 1.234 0.261 0 CA-C-O 120.79 0.329 . . . . 0.0 110.879 179.715 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.58 155.74 65.72 Favored 'Trans proline' 0 C--N 1.349 0.563 0 C-N-CA 122.842 2.362 . . . . 0.0 112.531 179.963 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -70.5 137.05 32.47 Favored 'Trans proline' 0 C--N 1.35 0.643 0 C-N-CA 122.826 2.351 . . . . 0.0 112.66 -179.9 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -169.18 152.61 5.14 Favored Pre-proline 0 CA--C 1.532 0.27 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.882 179.772 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -54.97 95.69 0.05 OUTLIER 'Trans proline' 0 C--N 1.352 0.75 0 C-N-CA 122.985 2.457 . . . . 0.0 112.565 -179.985 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 7.6 pt -105.43 -34.06 3.0 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.328 0 CA-C-N 116.022 -0.535 . . . . 0.0 111.825 -179.745 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -145.05 148.87 34.18 Favored 'General case' 0 C--O 1.234 0.284 0 CA-C-O 120.59 0.233 . . . . 0.0 111.135 -179.939 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -111.38 159.71 17.75 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.479 -179.757 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -135.44 148.57 49.34 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.139 179.925 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.463 0.219 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.59 179.882 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.3 mtp . . . . . 0 N--CA 1.49 1.549 0 CA-C-O 120.415 0.15 . . . . 0.0 111.379 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 11.6 p -64.73 -42.09 94.01 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.318 0 CA-C-N 116.787 -0.188 . . . . 0.0 111.429 179.93 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 22.9 m -109.58 -179.69 3.89 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-N 116.55 -0.295 . . . . 0.0 111.144 179.995 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 58.4 p -64.48 168.04 6.31 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.249 179.915 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 5.7 m-85 -102.83 -50.3 3.57 Favored 'General case' 0 CA--C 1.529 0.163 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.173 179.628 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -154.88 176.49 12.43 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.383 179.702 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 15.3 pt-20 -123.76 135.56 53.9 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.765 179.422 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 3.5 mp -121.75 139.63 48.23 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.305 0 CA-C-N 116.462 -0.336 . . . . 0.0 110.827 -179.977 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 -83.93 145.73 28.42 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.182 -179.871 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 9.7 tp -57.15 -33.81 43.89 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.314 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.184 179.586 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 -58.77 -34.58 71.59 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 116.569 -0.287 . . . . 0.0 111.087 179.307 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 54.2 m-20 -95.76 36.83 1.25 Allowed 'General case' 0 CA--C 1.535 0.367 0 CA-C-O 120.722 0.296 . . . . 0.0 111.342 179.591 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 3.1 ttt -120.2 146.49 45.98 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 116.582 -0.281 . . . . 0.0 110.802 179.779 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 1.5 m -68.95 126.03 28.5 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 116.519 -0.31 . . . . 0.0 110.765 179.876 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 2.8 p90 -105.14 157.58 17.17 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.04 179.885 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 23.6 mt-10 -139.97 83.27 16.33 Favored Pre-proline 0 C--O 1.235 0.292 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.675 179.98 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 70.4 Cg_exo -52.05 -28.75 33.7 Favored 'Trans proline' 0 C--N 1.349 0.554 0 C-N-CA 122.98 2.454 . . . . 0.0 112.731 179.919 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -52.36 -35.94 52.5 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-N 116.454 -0.339 . . . . 0.0 111.577 179.605 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 2.0 t-20 -141.85 29.39 1.7 Allowed 'General case' 0 CA--C 1.538 0.505 0 N-CA-C 111.721 0.267 . . . . 0.0 111.721 -179.92 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . 0.423 ' HG2' HD12 ' A' ' 73' ' ' ILE . 8.3 pt20 41.73 35.87 0.55 Allowed 'General case' 0 N--CA 1.475 0.792 0 N-CA-C 112.245 0.461 . . . . 0.0 112.245 -179.756 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 7.0 ttt -105.67 158.67 16.55 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.475 -179.601 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 23.1 m-85 -129.65 147.07 51.4 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-O 120.777 0.322 . . . . 0.0 111.187 179.587 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 21.2 p -144.19 177.42 8.61 Favored 'General case' 0 CA--C 1.537 0.465 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.953 -179.98 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 38.7 t80 -171.68 134.79 0.89 Allowed Pre-proline 0 N--CA 1.47 0.559 0 CA-C-N 116.699 -0.228 . . . . 0.0 110.961 179.327 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -65.04 101.23 0.39 Allowed 'Trans proline' 0 C--N 1.352 0.724 0 C-N-CA 122.795 2.33 . . . . 0.0 112.902 -179.857 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . 0.425 ' SG ' ' HD2' ' A' ' 27' ' ' PRO . 46.7 t -66.18 139.53 96.5 Favored Pre-proline 0 C--O 1.233 0.232 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.729 179.598 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . 0.425 ' HD2' ' SG ' ' A' ' 26' ' ' CYS . 60.9 Cg_exo -52.61 -27.08 31.61 Favored 'Trans proline' 0 C--N 1.348 0.547 0 C-N-CA 122.748 2.299 . . . . 0.0 112.907 179.625 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -67.6 -38.53 84.11 Favored 'General case' 0 C--O 1.235 0.305 0 N-CA-C 111.61 0.226 . . . . 0.0 111.61 -179.99 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 152.32 -48.19 0.55 Allowed Glycine 0 C--N 1.336 0.571 0 C-N-CA 120.785 -0.721 . . . . 0.0 113.242 -179.788 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -75.89 -173.59 2.34 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-N 116.751 0.276 . . . . 0.0 111.137 -179.812 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 51.5 mtt180 -122.41 138.34 54.57 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-O 120.76 0.314 . . . . 0.0 111.185 -179.989 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 45.0 m-85 -69.06 167.86 15.08 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.864 179.569 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 3.9 pp0? -152.17 138.16 18.16 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.22 179.594 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 3.5 tt -173.98 127.87 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.531 0.238 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.033 179.659 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 76.5 m-85 -82.21 142.9 31.78 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.734 -179.81 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 3.9 pp -55.45 -35.22 65.22 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 116.389 -0.368 . . . . 0.0 111.231 179.645 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -61.49 -45.6 93.55 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 116.534 -0.303 . . . . 0.0 111.016 179.678 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -61.12 -43.43 98.89 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-O 120.762 0.315 . . . . 0.0 110.731 179.453 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 3.6 mtt -59.75 -33.52 71.77 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.029 179.616 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -56.42 -39.88 73.78 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 116.534 -0.303 . . . . 0.0 110.991 179.533 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 21.9 mt-10 -65.57 -48.94 70.67 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 116.665 -0.243 . . . . 0.0 110.863 179.741 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 153.64 74.94 0.01 OUTLIER Glycine 0 C--N 1.336 0.535 0 C-N-CA 120.678 -0.772 . . . . 0.0 113.02 179.696 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 5.0 tp10 -128.66 96.71 4.47 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-O 120.858 0.361 . . . . 0.0 111.299 179.748 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 14.5 ptpt -111.86 -31.81 6.82 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.439 179.803 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 4.4 m -110.87 97.41 5.7 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.264 0 CA-C-O 120.953 0.406 . . . . 0.0 111.075 179.853 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -99.64 154.55 18.19 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.527 -179.574 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 11.2 p -118.56 139.23 46.59 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.244 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.313 -179.958 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 53.5 t -78.52 135.25 60.89 Favored Pre-proline 0 C--O 1.233 0.232 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.917 179.858 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_endo -83.96 19.7 1.32 Allowed 'Trans proline' 0 C--N 1.35 0.628 0 C-N-CA 122.692 2.261 . . . . 0.0 113.171 179.843 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 12.7 t -128.02 -59.26 1.19 Allowed 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 122.301 0.24 . . . . 0.0 110.41 179.607 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 19.4 p -95.76 -20.89 18.51 Favored 'General case' 0 N--CA 1.468 0.444 0 N-CA-C 112.073 0.397 . . . . 0.0 112.073 179.676 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 1.2 t 67.04 39.6 3.15 Favored 'General case' 0 CA--C 1.536 0.434 0 CA-C-O 120.901 0.382 . . . . 0.0 111.353 -179.683 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 8.0 tt -91.81 139.6 30.51 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.852 179.903 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' MET . . . . . . . . . . . . . 53.1 mtp -88.24 128.11 35.46 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 116.396 -0.366 . . . . 0.0 111.3 -179.734 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 2.4 pt -132.26 139.08 50.95 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.259 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.492 179.937 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 22.0 m-20 -96.93 87.13 4.17 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 116.458 -0.337 . . . . 0.0 110.324 179.216 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 12.6 p -93.13 114.15 29.35 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.251 0 CA-C-O 121.004 0.43 . . . . 0.0 111.079 -179.893 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 14.9 p -82.92 146.75 6.59 Favored 'Isoleucine or valine' 0 C--O 1.233 0.208 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.283 -179.539 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 47.5 p90 -121.9 170.1 10.13 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.267 -179.645 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -132.08 165.0 25.01 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.448 -179.914 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -99.83 -33.77 10.42 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.405 179.815 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 1.6 mm-40 -59.35 -60.31 4.06 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-O 120.471 0.176 . . . . 0.0 111.073 179.929 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -59.87 -44.49 94.14 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 116.608 -0.269 . . . . 0.0 110.86 179.733 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -58.38 -45.34 88.49 Favored 'General case' 0 CA--C 1.53 0.211 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.036 179.734 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -62.77 -51.68 66.19 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.176 179.789 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 2.0 tp10 -59.57 -40.91 88.9 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-N 116.459 -0.337 . . . . 0.0 110.761 179.517 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 3.9 t80 -55.11 -36.18 65.45 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.435 179.544 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 1.6 t80 -55.9 -38.69 70.55 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-O 120.637 0.256 . . . . 0.0 110.58 179.791 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 4.2 tt0 -83.04 -37.24 24.17 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.73 179.091 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 8.1 mt-10 -65.76 -36.87 84.79 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 116.526 -0.306 . . . . 0.0 111.621 -179.802 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -75.82 142.72 42.18 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-O 120.811 0.338 . . . . 0.0 111.542 -179.893 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -92.57 26.81 12.36 Favored Glycine 0 CA--C 1.524 0.627 0 C-N-CA 121.032 -0.604 . . . . 0.0 113.077 179.705 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.423 HD12 ' HG2' ' A' ' 20' ' ' GLN . 2.6 tt -87.21 -33.19 6.66 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.274 0 CA-C-N 116.891 0.345 . . . . 0.0 111.574 179.931 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 5.5 t60 -113.3 91.64 20.13 Favored Pre-proline 0 CA--C 1.533 0.312 0 CA-C-O 120.66 0.267 . . . . 0.0 111.002 179.853 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_endo -68.59 152.36 74.71 Favored 'Trans proline' 0 C--N 1.352 0.74 0 C-N-CA 122.808 2.339 . . . . 0.0 112.636 -179.906 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 41.3 Cg_endo -68.61 -43.72 3.7 Favored 'Trans proline' 0 C--N 1.352 0.722 0 C-N-CA 122.627 2.218 . . . . 0.0 112.868 -179.864 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -106.95 147.94 36.03 Favored Pre-proline 0 C--O 1.233 0.215 0 CA-C-N 116.64 -0.254 . . . . 0.0 110.859 -179.997 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -70.89 116.53 4.71 Favored 'Trans proline' 0 C--N 1.351 0.66 0 C-N-CA 122.7 2.267 . . . . 0.0 112.476 -179.909 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 2.7 pp -133.96 23.47 1.19 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.486 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.962 179.979 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -142.68 146.53 34.5 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-O 120.648 0.261 . . . . 0.0 111.642 179.614 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -147.51 172.6 13.72 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.384 179.839 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -73.55 128.23 34.91 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-N 116.495 -0.32 . . . . 0.0 111.382 179.941 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.115 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.272 179.922 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 6.0 ptp . . . . . 0 N--CA 1.491 1.611 0 CA-C-O 120.709 0.29 . . . . 0.0 111.356 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 28.7 m -136.07 170.58 18.49 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.292 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.321 -179.869 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 3.5 m -129.05 31.36 4.91 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.025 179.647 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 3.1 p -91.8 150.11 21.25 Favored 'General case' 0 N--CA 1.464 0.275 0 CA-C-N 116.442 -0.345 . . . . 0.0 111.627 -179.797 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -107.89 -47.56 3.56 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.21 179.622 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -150.32 174.57 12.71 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.339 179.938 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 12.4 mt-10 -121.62 120.71 35.57 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.63 179.691 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.443 ' O ' ' HA ' ' A' ' 57' ' ' VAL . 3.6 mp -115.08 152.09 16.74 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.331 0 CA-C-N 116.441 -0.345 . . . . 0.0 111.33 -179.495 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . 0.416 ' HA ' HG12 ' A' ' 58' ' ' VAL . 10.2 mt-10 -99.24 143.06 29.93 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 116.525 -0.307 . . . . 0.0 111.387 179.986 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 9.0 tp -59.32 -29.42 41.88 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.382 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.467 179.576 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 3.4 pt-20 -60.59 -28.67 68.67 Favored 'General case' 0 CA--C 1.533 0.325 0 CA-C-N 116.669 -0.241 . . . . 0.0 111.357 179.679 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -97.9 36.99 1.46 Allowed 'General case' 0 CA--C 1.535 0.392 0 CA-C-O 120.722 0.296 . . . . 0.0 111.248 179.756 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 3.9 mtt -131.44 140.06 49.52 Favored 'General case' 0 N--CA 1.464 0.225 0 CA-C-N 116.528 -0.305 . . . . 0.0 111.075 179.994 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 2.1 m -67.58 145.91 54.4 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 116.418 -0.355 . . . . 0.0 111.131 179.826 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 1.5 p90 -109.08 158.15 18.04 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.159 179.726 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -135.7 76.9 53.04 Favored Pre-proline 0 CA--C 1.532 0.264 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.587 179.677 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -54.09 -25.02 35.32 Favored 'Trans proline' 0 C--N 1.352 0.736 0 C-N-CA 122.982 2.454 . . . . 0.0 113.133 -179.99 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -52.95 -42.72 65.74 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-N 116.669 -0.241 . . . . 0.0 111.316 179.918 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 3.5 m-80 -133.01 15.69 4.22 Favored 'General case' 0 CA--C 1.541 0.615 0 N-CA-C 112.181 0.438 . . . . 0.0 112.181 -179.758 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 27.7 mt-30 56.08 75.26 0.35 Allowed 'General case' 0 N--CA 1.471 0.591 0 N-CA-C 111.959 0.355 . . . . 0.0 111.959 179.497 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 1.6 ptt? -163.01 147.95 11.58 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-N 116.431 -0.349 . . . . 0.0 111.26 179.191 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 7.5 m-85 -105.09 139.33 39.92 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-O 120.677 0.275 . . . . 0.0 110.973 179.675 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 75.5 p -132.44 158.25 42.51 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.57 -179.488 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 39.0 t80 -162.83 136.45 4.61 Favored Pre-proline 0 N--CA 1.465 0.276 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.908 179.619 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 41.7 Cg_endo -66.14 100.31 0.45 Allowed 'Trans proline' 0 C--N 1.35 0.617 0 C-N-CA 122.461 2.107 . . . . 0.0 112.32 179.725 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . 0.41 ' SG ' ' HD2' ' A' ' 27' ' ' PRO . 42.6 t -58.4 139.3 84.91 Favored Pre-proline 0 C--O 1.233 0.19 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.843 179.843 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . 0.41 ' HD2' ' SG ' ' A' ' 26' ' ' CYS . 65.1 Cg_exo -52.27 -26.53 27.33 Favored 'Trans proline' 0 C--N 1.349 0.596 0 C-N-CA 122.843 2.362 . . . . 0.0 113.038 179.844 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . 0.419 ' CB ' ' HB3' ' A' ' 51' ' ' CYS . 0.8 OUTLIER -68.19 -38.4 81.97 Favored 'General case' 0 CA--C 1.533 0.318 0 CA-C-O 120.472 0.177 . . . . 0.0 111.394 179.924 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 151.12 -45.28 0.64 Allowed Glycine 0 C--N 1.336 0.55 0 C-N-CA 120.827 -0.702 . . . . 0.0 112.999 -179.784 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 2.8 t70 -72.26 -178.21 2.41 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-N 116.677 0.239 . . . . 0.0 111.143 -179.845 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 8.2 ttm180 -118.93 125.37 49.3 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-O 120.673 0.273 . . . . 0.0 111.234 -179.86 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -64.84 154.33 37.48 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.243 179.858 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 20.8 pt20 -150.44 135.93 18.06 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.278 -179.92 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 2.8 tt -149.27 135.39 12.07 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.201 0 CA-C-N 116.425 -0.352 . . . . 0.0 111.219 179.428 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -86.2 140.93 29.71 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.83 179.963 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 9.8 mp -58.03 -49.14 77.89 Favored 'General case' 0 C--O 1.232 0.152 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.676 179.699 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -58.05 -39.4 78.35 Favored 'General case' 0 CA--C 1.532 0.261 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.23 179.48 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -58.54 -46.79 86.09 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 116.571 -0.286 . . . . 0.0 110.834 179.809 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 8.9 mtm -59.82 -35.3 74.44 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.85 179.683 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -55.16 -42.91 73.74 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.923 179.511 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -60.38 -48.23 82.66 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-O 120.68 0.276 . . . . 0.0 110.81 179.712 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 149.62 54.76 0.01 OUTLIER Glycine 0 C--N 1.334 0.472 0 C-N-CA 120.954 -0.641 . . . . 0.0 112.663 179.775 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 2.3 tp10 -99.32 95.94 7.39 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-O 120.775 0.321 . . . . 0.0 111.047 179.971 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 13.4 mtmt -105.39 -36.89 7.03 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.078 179.75 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 9.4 p -117.95 111.11 32.94 Favored 'Isoleucine or valine' 0 C--O 1.233 0.217 0 CA-C-O 121.037 0.446 . . . . 0.0 110.87 179.769 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -109.9 168.8 9.16 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-N 115.816 -0.629 . . . . 0.0 111.338 -179.552 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 12.0 p -130.83 140.44 48.68 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.254 0 CA-C-N 116.432 -0.349 . . . . 0.0 111.75 -179.352 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 40.6 t -76.64 136.82 67.21 Favored Pre-proline 0 N--CA 1.464 0.248 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.737 179.785 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_endo -83.03 20.7 1.12 Allowed 'Trans proline' 0 CA--C 1.537 0.627 0 C-N-CA 122.85 2.367 . . . . 0.0 113.203 179.796 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -129.0 -56.79 1.18 Allowed 'General case' 0 C--O 1.233 0.222 0 CA-C-N 116.682 -0.235 . . . . 0.0 110.419 179.516 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' CYS . . . . . 0.419 ' HB3' ' CB ' ' A' ' 28' ' ' CYS . 22.9 p -95.78 -24.16 16.62 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 116.473 -0.33 . . . . 0.0 111.777 179.49 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER 69.64 39.95 1.45 Allowed 'General case' 0 CA--C 1.534 0.344 0 CA-C-O 120.821 0.343 . . . . 0.0 111.368 -179.666 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 74.4 mt -98.07 127.78 44.21 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-N 116.433 -0.348 . . . . 0.0 110.606 179.62 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' MET . . . . . . . . . . . . . 9.4 mtt -82.61 136.24 34.86 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.963 -179.677 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 9.2 pt -136.75 152.61 29.1 Favored 'Isoleucine or valine' 0 C--O 1.234 0.25 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.908 -179.647 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -102.66 108.78 20.16 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.484 179.285 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.443 ' HA ' ' O ' ' A' ' 8' ' ' ILE . 0.0 OUTLIER -110.13 113.18 43.51 Favored 'Isoleucine or valine' 0 C--O 1.234 0.257 0 CA-C-O 120.793 0.33 . . . . 0.0 111.355 179.726 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.416 HG12 ' HA ' ' A' ' 9' ' ' GLU . 8.1 p -81.88 88.2 1.84 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.265 0 CA-C-O 121.353 0.597 . . . . 0.0 110.772 179.821 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 51.0 p90 -80.02 155.27 27.68 Favored 'General case' 0 CA--C 1.531 0.249 0 CA-C-N 115.597 -0.729 . . . . 0.0 111.177 -179.568 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -103.54 145.91 29.32 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-O 120.891 0.377 . . . . 0.0 111.375 -179.875 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 5.8 tttp -87.94 -40.22 14.1 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.844 179.67 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 21.1 tt0 -56.42 -44.62 80.56 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.335 179.424 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 77.4 m-20 -63.0 -46.66 86.63 Favored 'General case' 0 N--CA 1.463 0.186 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.813 179.353 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -53.33 -45.89 69.24 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-N 116.635 -0.257 . . . . 0.0 111.327 179.971 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -58.0 -51.54 69.25 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-N 116.471 -0.332 . . . . 0.0 111.024 179.869 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 58.6 mt-10 -67.13 -46.36 74.34 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.889 179.767 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 5.2 m-85 -53.98 -31.91 52.35 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.62 179.637 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 1.7 t80 -59.09 -49.2 78.79 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-O 120.671 0.272 . . . . 0.0 110.804 179.935 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 34.8 mt-10 -83.93 -35.5 23.99 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.006 179.841 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 2.6 mm-40 -66.63 -30.31 70.55 Favored 'General case' 0 CA--C 1.533 0.29 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.67 179.765 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -62.71 167.2 4.7 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-O 120.966 0.412 . . . . 0.0 111.991 -179.478 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -108.36 38.67 3.22 Favored Glycine 0 C--N 1.334 0.469 0 C-N-CA 121.115 -0.564 . . . . 0.0 112.632 179.885 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 7.6 tt -66.59 140.36 19.61 Favored 'Isoleucine or valine' 0 C--O 1.232 0.17 0 CA-C-O 120.925 0.393 . . . . 0.0 111.379 -179.883 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 10.6 m-70 -72.02 -62.92 1.42 Allowed Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.097 -179.729 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 65.6 Cg_endo -72.93 110.41 3.03 Favored 'Trans proline' 0 C--N 1.351 0.691 0 C-N-CA 122.469 2.113 . . . . 0.0 112.613 179.864 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_endo -67.13 -56.57 0.23 Allowed 'Trans proline' 0 C--N 1.351 0.672 0 C-N-CA 122.421 2.081 . . . . 0.0 111.957 179.892 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -153.11 151.86 26.85 Favored Pre-proline 0 CA--C 1.532 0.26 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.22 179.247 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -54.74 146.92 52.63 Favored 'Trans proline' 0 C--N 1.349 0.576 0 C-N-CA 123.053 2.502 . . . . 0.0 112.702 -179.794 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 7.9 pt -102.84 -34.8 3.66 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.293 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.932 -179.843 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -105.42 112.16 25.16 Favored 'General case' 0 C--O 1.232 0.172 0 CA-C-O 120.746 0.308 . . . . 0.0 111.305 -179.884 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -81.11 172.38 13.76 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.561 -179.902 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -161.36 -50.54 0.04 OUTLIER 'General case' 0 CA--C 1.531 0.223 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.445 179.887 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.463 0.196 0 CA-C-O 120.903 0.383 . . . . 0.0 111.192 -179.901 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.9 ttt . . . . . 0 N--CA 1.488 1.466 0 CA-C-O 120.677 0.275 . . . . 0.0 111.047 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 11.8 p -75.59 147.24 8.27 Favored 'Isoleucine or valine' 0 C--O 1.234 0.241 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.268 -179.877 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 72.7 m -93.44 74.39 4.48 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.353 -179.621 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 1.2 p -151.96 163.41 39.33 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.794 179.711 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 2.8 m-85 -108.03 -73.74 0.68 Allowed 'General case' 0 C--O 1.233 0.226 0 CA-C-N 116.46 -0.337 . . . . 0.0 111.119 -179.968 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 8.9 p-10 -142.29 162.19 36.1 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.44 -179.515 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 -106.58 108.85 20.57 Favored 'General case' 0 CA--C 1.531 0.228 0 CA-C-N 115.857 -0.611 . . . . 0.0 110.976 -179.954 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 3.7 mp -93.73 150.14 4.07 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.23 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.215 179.95 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . 0.456 ' HA ' HG12 ' A' ' 58' ' ' VAL . 4.0 tt0 -95.59 146.87 24.14 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.344 -179.734 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 2.9 tt -60.37 -33.19 53.08 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.296 0 CA-C-N 116.086 -0.507 . . . . 0.0 111.415 179.653 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 27.3 mt-10 -60.18 -35.24 74.93 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 116.464 -0.334 . . . . 0.0 110.892 179.532 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -96.44 37.22 1.28 Allowed 'General case' 0 CA--C 1.533 0.316 0 CA-C-O 120.804 0.335 . . . . 0.0 111.287 179.774 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 2.3 ttt -124.18 144.12 50.11 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.756 179.751 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 21.5 m -64.88 136.86 57.33 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.047 -179.788 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 19.7 p90 -105.89 131.04 53.68 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.009 179.771 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -118.65 91.8 42.82 Favored Pre-proline 0 C--N 1.33 -0.261 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.479 179.843 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 42.3 Cg_endo -70.82 -14.79 32.99 Favored 'Trans proline' 0 C--N 1.347 0.496 0 C-N-CA 122.598 2.199 . . . . 0.0 113.0 -179.932 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 -51.37 -35.26 37.79 Favored 'General case' 0 CA--C 1.533 0.319 0 N-CA-C 111.912 0.338 . . . . 0.0 111.912 -179.759 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 18.6 m-20 -148.71 26.67 0.91 Allowed 'General case' 0 CA--C 1.534 0.36 0 CA-C-N 116.624 -0.262 . . . . 0.0 111.579 -179.78 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 7.1 mt-30 55.02 69.84 0.69 Allowed 'General case' 0 CA--C 1.537 0.472 0 CA-C-O 120.921 0.391 . . . . 0.0 111.566 179.518 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 5.7 ptt? -151.52 167.49 27.87 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.938 179.577 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 17.4 m-85 -128.63 147.49 50.73 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 116.507 -0.315 . . . . 0.0 110.918 179.824 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 71.7 p -138.77 169.52 17.64 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.803 -179.615 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 47.6 t80 -163.54 137.09 4.4 Favored Pre-proline 0 N--CA 1.468 0.432 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.938 179.878 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -67.3 97.08 0.42 Allowed 'Trans proline' 0 C--N 1.352 0.713 0 C-N-CA 122.486 2.124 . . . . 0.0 112.11 179.446 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . 0.454 ' SG ' ' HD2' ' A' ' 27' ' ' PRO . 50.2 t -59.44 140.43 88.5 Favored Pre-proline 0 C--O 1.233 0.193 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.676 179.962 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . 0.454 ' HD2' ' SG ' ' A' ' 26' ' ' CYS . 74.5 Cg_exo -50.86 -27.75 21.54 Favored 'Trans proline' 0 C--N 1.349 0.591 0 C-N-CA 122.942 2.428 . . . . 0.0 113.098 179.928 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -71.48 -38.29 71.23 Favored 'General case' 0 CA--C 1.533 0.326 0 CA-C-O 120.485 0.183 . . . . 0.0 111.269 -179.905 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 149.45 -44.08 0.74 Allowed Glycine 0 C--N 1.337 0.6 0 C-N-CA 120.858 -0.687 . . . . 0.0 113.001 -179.971 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -68.26 176.85 2.55 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-O 120.84 0.352 . . . . 0.0 111.278 -179.716 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -118.43 128.82 54.98 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-N 116.492 -0.322 . . . . 0.0 110.998 -179.927 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 9.6 m-85 -62.54 160.13 14.44 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.859 179.671 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 10.5 pt20 -155.3 130.14 9.31 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-O 120.845 0.355 . . . . 0.0 111.401 -179.982 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 3.2 tt -157.3 124.19 0.56 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.281 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.904 179.707 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 32.0 m-85 -80.15 156.5 26.95 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.746 179.999 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 72.0 mt -58.73 -40.9 85.14 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.836 179.849 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -62.2 -35.22 78.21 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 116.447 -0.342 . . . . 0.0 111.408 179.675 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 18.1 m-20 -64.45 -60.08 3.58 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-O 120.862 0.363 . . . . 0.0 110.77 -179.943 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 13.7 ptp -60.18 -37.26 79.66 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.076 179.874 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . 0.432 ' HB2' ' CD2' ' A' ' 64' ' ' LEU . 23.2 t80 -59.8 -45.35 92.59 Favored 'General case' 0 CA--C 1.53 0.193 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.984 179.581 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -57.97 -42.2 84.53 Favored 'General case' 0 CA--C 1.532 0.251 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.005 179.799 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 149.78 65.73 0.01 OUTLIER Glycine 0 C--N 1.336 0.537 0 C-N-CA 120.773 -0.727 . . . . 0.0 113.086 179.632 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -120.01 156.63 30.51 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-O 120.655 0.264 . . . . 0.0 111.12 179.719 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -162.77 -46.8 0.04 OUTLIER 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.164 179.532 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 22.0 t -96.89 89.22 2.02 Favored 'Isoleucine or valine' 0 C--O 1.234 0.28 0 CA-C-O 120.892 0.377 . . . . 0.0 110.644 179.692 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -80.1 141.54 35.7 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.24 -179.583 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 7.9 m -110.09 127.24 67.14 Favored 'Isoleucine or valine' 0 C--O 1.232 0.174 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.464 -179.879 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 51.0 t -72.13 135.64 82.32 Favored Pre-proline 0 C--N 1.331 -0.227 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.792 179.806 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 87.0 Cg_endo -84.0 19.22 1.4 Allowed 'Trans proline' 0 CA--C 1.537 0.631 0 C-N-CA 122.734 2.289 . . . . 0.0 113.234 179.96 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 2.0 t -127.74 -57.86 1.25 Allowed 'General case' 0 C--O 1.232 0.176 0 CA-C-O 120.558 0.218 . . . . 0.0 110.649 179.538 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 19.6 p -98.7 -19.81 17.29 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-N 116.455 -0.339 . . . . 0.0 111.73 179.888 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER 67.81 39.28 2.68 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-O 121.081 0.467 . . . . 0.0 110.955 -179.895 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 9.1 tt -91.25 132.9 35.83 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.631 179.875 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' MET . . . . . . . . . . . . . 15.1 mtt -87.92 130.49 34.91 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.194 -179.664 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 3.2 pt -133.45 144.51 35.86 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.237 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.456 179.676 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -101.7 107.59 18.87 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.226 179.148 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 11.6 p -107.98 117.1 52.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-O 120.943 0.402 . . . . 0.0 111.01 -179.821 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.456 HG12 ' HA ' ' A' ' 9' ' ' GLU . 13.9 p -79.99 135.54 25.25 Favored 'Isoleucine or valine' 0 C--O 1.236 0.347 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.662 -179.896 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 8.0 p90 -142.96 169.39 17.66 Favored 'General case' 0 C--O 1.235 0.299 0 CA-C-N 115.782 -0.645 . . . . 0.0 110.97 -179.084 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -138.06 171.07 14.95 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.175 179.615 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 7.6 mttp -96.78 23.01 7.47 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.324 179.746 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 4.6 mt-10 -94.35 -47.81 6.43 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.224 179.206 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 3.0 t70 -68.55 -35.95 78.12 Favored 'General case' 0 N--CA 1.462 0.126 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.213 179.529 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.432 ' CD2' ' HB2' ' A' ' 40' ' ' PHE . 0.7 OUTLIER -55.05 -53.61 53.6 Favored 'General case' 0 CA--C 1.532 0.279 0 CA-C-N 116.694 -0.23 . . . . 0.0 111.358 -179.895 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -59.57 -44.6 93.25 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-O 120.811 0.339 . . . . 0.0 110.934 179.573 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -64.45 -45.15 88.67 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-N 115.857 -0.61 . . . . 0.0 111.102 179.884 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 1.2 t80 -72.11 -39.85 68.59 Favored 'General case' 0 CA--C 1.531 0.239 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.899 -179.764 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 15.4 t80 -62.5 -36.96 84.17 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-O 120.577 0.227 . . . . 0.0 110.86 179.924 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 32.4 mt-10 -78.11 -32.82 50.73 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.987 179.471 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 4.8 tt0 -114.23 40.4 2.52 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-N 116.546 -0.297 . . . . 0.0 111.492 -179.79 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -79.07 151.48 31.41 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-O 120.986 0.422 . . . . 0.0 111.62 -179.942 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -95.05 32.73 5.89 Favored Glycine 0 C--N 1.335 0.477 0 CA-C-N 115.694 -0.685 . . . . 0.0 112.82 179.693 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 4.6 tt -83.28 -35.7 12.1 Favored 'Isoleucine or valine' 0 C--O 1.233 0.236 0 CA-C-O 120.725 0.298 . . . . 0.0 111.143 179.862 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 22.4 p80 -87.14 146.61 40.68 Favored Pre-proline 0 CA--C 1.53 0.21 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.626 179.454 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -71.08 116.43 4.69 Favored 'Trans proline' 0 C--N 1.349 0.583 0 C-N-CA 122.741 2.294 . . . . 0.0 112.337 -179.747 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -60.18 171.59 3.03 Favored 'Trans proline' 0 C--N 1.351 0.667 0 C-N-CA 122.883 2.389 . . . . 0.0 112.772 -179.644 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -94.17 148.36 35.0 Favored Pre-proline 0 C--O 1.232 0.156 0 CA-C-N 115.872 -0.604 . . . . 0.0 111.388 -179.873 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 39.3 Cg_exo -56.87 87.84 0.04 OUTLIER 'Trans proline' 0 C--N 1.352 0.755 0 C-N-CA 123.053 2.502 . . . . 0.0 112.725 179.926 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 3.7 mp 66.86 133.93 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.338 0 CA-C-N 115.781 -0.645 . . . . 0.0 111.724 -179.971 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -130.83 -65.9 0.77 Allowed 'General case' 0 CA--C 1.53 0.21 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.478 179.89 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -101.75 -31.55 10.72 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 116.538 -0.301 . . . . 0.0 111.633 -179.717 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -60.23 115.2 3.33 Favored 'General case' 0 C--O 1.232 0.162 0 CA-C-N 116.463 -0.335 . . . . 0.0 111.272 -179.828 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.161 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.96 179.861 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 19.6 ptp . . . . . 0 N--CA 1.49 1.569 0 CA-C-O 120.703 0.287 . . . . 0.0 111.45 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 5.0 m -149.59 33.75 0.1 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.429 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.285 -179.952 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 61.75 -164.21 0.25 Allowed 'General case' 0 CA--C 1.536 0.419 0 CA-C-N 116.635 -0.257 . . . . 0.0 110.841 -179.665 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -67.17 158.15 31.96 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-O 120.772 0.32 . . . . 0.0 111.172 179.963 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 61.2 m-85 -95.07 -35.26 11.99 Favored 'General case' 0 CA--C 1.53 0.197 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.523 179.991 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -155.04 174.1 15.65 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-O 120.812 0.339 . . . . 0.0 111.328 179.887 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 26.5 tt0 -130.8 114.33 15.2 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.649 -179.936 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 27.8 mm -93.2 155.61 3.12 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.178 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.744 179.897 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 4.3 pm0 -119.1 145.97 45.49 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.171 -179.807 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 8.2 tp -59.21 -33.53 50.99 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.328 0 CA-C-N 116.277 -0.419 . . . . 0.0 111.168 179.595 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 8.4 mt-10 -65.68 -32.25 73.71 Favored 'General case' 0 CA--C 1.533 0.318 0 CA-C-N 116.461 -0.336 . . . . 0.0 111.155 179.445 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 11.0 t0 -98.63 40.32 1.2 Allowed 'General case' 0 CA--C 1.533 0.3 0 CA-C-O 120.97 0.414 . . . . 0.0 110.664 179.617 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -131.83 163.96 27.11 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.937 179.803 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 5.8 m -96.62 119.93 36.0 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-N 116.43 -0.35 . . . . 0.0 110.824 -179.809 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 20.8 p90 -98.56 134.14 41.94 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.529 179.618 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 4.5 mt-10 -107.11 94.3 10.75 Favored Pre-proline 0 C--O 1.234 0.239 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.521 179.952 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -73.0 65.24 4.14 Favored 'Trans proline' 0 C--N 1.35 0.629 0 C-N-CA 122.936 2.424 . . . . 0.0 112.5 -179.553 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 5.4 pt-20 -135.92 -49.48 0.69 Allowed 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.676 -0.693 . . . . 0.0 111.062 179.991 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -135.54 32.19 3.07 Favored 'General case' 0 CA--C 1.535 0.382 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.384 179.865 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 55.48 59.29 3.98 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-O 121.037 0.446 . . . . 0.0 111.273 -179.995 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 10.6 ptm -143.14 163.28 33.3 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.989 179.791 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 4.5 p90 -150.82 144.32 24.98 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.09 -179.997 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 76.4 p -134.62 167.35 20.98 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-N 115.987 -0.551 . . . . 0.0 111.689 -179.386 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 31.6 t80 -153.41 136.72 10.06 Favored Pre-proline 0 CA--C 1.531 0.239 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.937 -179.993 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo -66.58 101.94 0.57 Allowed 'Trans proline' 0 C--N 1.35 0.623 0 C-N-CA 122.706 2.27 . . . . 0.0 112.415 179.739 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . 0.411 ' SG ' ' HD2' ' A' ' 27' ' ' PRO . 41.8 t -62.82 139.23 97.21 Favored Pre-proline 0 C--O 1.232 0.184 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.605 179.688 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . 0.411 ' HD2' ' SG ' ' A' ' 26' ' ' CYS . 76.3 Cg_exo -51.44 -27.27 23.9 Favored 'Trans proline' 0 C--N 1.349 0.602 0 C-N-CA 122.847 2.365 . . . . 0.0 113.029 179.858 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . 0.42 ' CB ' ' HB3' ' A' ' 51' ' ' CYS . 0.8 OUTLIER -69.66 -36.88 76.43 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-N 116.849 -0.16 . . . . 0.0 111.425 179.947 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 148.53 -43.54 0.8 Allowed Glycine 0 C--N 1.337 0.599 0 C-N-CA 120.881 -0.676 . . . . 0.0 113.141 179.91 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -69.49 -177.77 1.26 Allowed 'General case' 0 N--CA 1.465 0.315 0 CA-C-O 120.841 0.353 . . . . 0.0 111.442 -179.686 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 1.4 tpp180 -121.74 118.53 29.31 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.033 -179.918 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 34.3 t80 -59.87 142.74 52.96 Favored 'General case' 0 CA--C 1.528 0.103 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.448 179.394 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 1.5 pt20 -135.81 143.97 45.46 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-N 116.539 -0.3 . . . . 0.0 111.214 -179.814 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 8.2 tt -174.79 149.24 0.41 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.343 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.02 -179.953 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 64.9 m-85 -99.14 159.62 14.85 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.05 -179.806 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 7.9 mp -60.69 -44.27 96.73 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.728 179.831 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -57.9 -40.22 79.82 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.678 179.327 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -60.26 -42.37 95.22 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.521 179.292 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 4.5 mtp -91.55 33.41 1.01 Allowed 'General case' 0 CA--C 1.534 0.356 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.253 179.367 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 18.0 t80 -135.95 -47.32 0.66 Allowed 'General case' 0 C--O 1.233 0.207 0 CA-C-N 116.654 -0.248 . . . . 0.0 110.865 179.647 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 12.9 tt0 -58.69 -44.62 90.32 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.884 179.675 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 167.28 68.17 0.03 OUTLIER Glycine 0 C--N 1.335 0.492 0 C-N-CA 120.892 -0.671 . . . . 0.0 112.843 179.713 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -144.08 156.02 44.19 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-O 120.818 0.342 . . . . 0.0 111.439 -179.968 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 4.7 pttp -156.21 -47.35 0.08 Allowed 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 115.886 -0.597 . . . . 0.0 111.107 179.811 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 10.5 p -103.74 120.36 53.72 Favored 'Isoleucine or valine' 0 C--O 1.233 0.211 0 CA-C-O 120.898 0.38 . . . . 0.0 110.797 179.735 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -111.99 173.83 6.17 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.162 -179.844 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 19.9 t -128.48 137.8 56.39 Favored 'Isoleucine or valine' 0 C--O 1.235 0.29 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.441 -179.669 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 43.8 t -78.6 136.12 59.79 Favored Pre-proline 0 C--O 1.233 0.222 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.679 179.624 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_endo -84.31 22.16 0.98 Allowed 'Trans proline' 0 C--N 1.349 0.595 0 C-N-CA 122.828 2.352 . . . . 0.0 113.339 179.951 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 36.4 m -131.26 -57.13 1.02 Allowed 'General case' 0 C--O 1.233 0.219 0 CA-C-O 120.507 0.194 . . . . 0.0 110.674 179.825 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' CYS . . . . . 0.42 ' HB3' ' CB ' ' A' ' 28' ' ' CYS . 19.2 p -95.68 -19.18 19.92 Favored 'General case' 0 CA--C 1.535 0.369 0 CA-C-N 116.489 -0.323 . . . . 0.0 111.615 179.441 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 1.7 m 62.97 40.83 8.96 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-O 121.061 0.457 . . . . 0.0 111.014 -179.728 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 7.1 tp -95.02 142.94 26.91 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.873 179.898 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' MET . . . . . . . . . . . . . 17.3 mtm -91.99 128.39 37.81 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.709 179.817 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 19.0 pt -137.62 139.41 43.25 Favored 'Isoleucine or valine' 0 C--O 1.233 0.227 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.452 -179.659 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 91.5 m-20 -99.06 90.13 4.5 Favored 'General case' 0 C--O 1.231 0.13 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.493 179.417 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 9.4 p -86.79 114.54 26.22 Favored 'Isoleucine or valine' 0 C--O 1.233 0.216 0 CA-C-O 120.993 0.425 . . . . 0.0 110.759 179.697 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 14.3 p -79.71 142.79 13.49 Favored 'Isoleucine or valine' 0 C--O 1.233 0.213 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.269 -179.75 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 36.2 p90 -132.43 177.94 7.21 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.691 -179.827 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -121.87 -167.1 1.48 Allowed 'General case' 0 CA--C 1.534 0.331 0 CA-C-O 120.792 0.33 . . . . 0.0 110.789 179.781 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 4.7 mmtp -113.98 -44.99 3.1 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.288 179.255 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 7.7 mt-10 -61.71 -34.2 75.37 Favored 'General case' 0 CA--C 1.529 0.17 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.206 179.58 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 34.8 p30 -56.73 -32.6 65.7 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 116.843 -0.162 . . . . 0.0 111.25 179.582 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 1.3 mp -79.27 -53.29 7.1 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-O 120.658 0.266 . . . . 0.0 110.612 179.355 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -56.04 -38.92 71.22 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.814 179.473 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 26.9 tt0 -68.73 -40.53 79.86 Favored 'General case' 0 CA--C 1.531 0.242 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.776 179.335 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -68.38 -39.81 81.62 Favored 'General case' 0 CA--C 1.53 0.185 0 CA-C-N 116.525 -0.307 . . . . 0.0 111.628 179.842 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 6.0 m-85 -60.46 -41.81 94.89 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 116.773 -0.194 . . . . 0.0 111.081 -179.858 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 16.9 pt-20 -77.84 -33.56 52.2 Favored 'General case' 0 CA--C 1.533 0.322 0 CA-C-N 116.621 -0.263 . . . . 0.0 111.234 179.698 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -74.17 -51.79 14.46 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-O 120.605 0.24 . . . . 0.0 111.41 -179.951 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -76.93 136.86 38.81 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-O 120.816 0.341 . . . . 0.0 111.358 -179.872 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -89.83 49.17 3.33 Favored Glycine 0 C--N 1.334 0.437 0 C-N-CA 121.09 -0.576 . . . . 0.0 112.935 179.995 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 1.1 tp -76.65 -36.72 27.84 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.234 0 CA-C-O 120.585 0.231 . . . . 0.0 111.128 179.7 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 1.8 t-80 -140.58 85.88 12.7 Favored Pre-proline 0 CA--C 1.531 0.237 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.889 179.78 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -70.07 154.7 66.25 Favored 'Trans proline' 0 C--N 1.348 0.515 0 C-N-CA 122.696 2.264 . . . . 0.0 112.438 179.918 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -54.09 133.54 55.79 Favored 'Trans proline' 0 C--N 1.351 0.706 0 C-N-CA 122.915 2.41 . . . . 0.0 112.641 -179.9 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 8.9 tt0 -168.09 85.91 0.73 Allowed Pre-proline 0 CA--C 1.534 0.328 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.245 -179.97 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_exo -58.53 171.98 1.67 Allowed 'Trans proline' 0 C--N 1.351 0.675 0 C-N-CA 123.006 2.47 . . . . 0.0 112.802 -179.966 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 24.7 mm -86.27 -42.88 16.07 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.232 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.408 -179.951 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -170.03 43.37 0.03 OUTLIER 'General case' 0 CA--C 1.533 0.322 0 CA-C-O 120.765 0.317 . . . . 0.0 111.194 179.531 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . 53.38 34.53 18.24 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.257 -179.621 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -86.59 -64.35 1.17 Allowed 'General case' 0 CA--C 1.531 0.25 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.578 -179.539 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.255 0 CA-C-O 120.976 0.417 . . . . 0.0 111.154 -179.98 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.488 1.459 0 CA-C-O 120.767 0.318 . . . . 0.0 111.376 . . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 28.6 m -104.06 165.58 3.29 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.186 0 CA-C-N 116.328 -0.397 . . . . 0.0 111.157 179.662 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 19.6 m -125.15 148.12 48.72 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.783 179.844 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 68.0 p -141.19 157.64 44.98 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-O 120.756 0.313 . . . . 0.0 111.518 -179.896 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . 0.446 ' CD1' ' HB2' ' A' ' 6' ' ' ASP . 10.8 t80 -104.93 -41.32 5.65 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.137 -179.992 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . 0.446 ' HB2' ' CD1' ' A' ' 5' ' ' TYR . 5.1 t70 -155.95 161.33 40.53 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-O 120.801 0.334 . . . . 0.0 111.633 -179.565 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -117.12 119.97 36.88 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.861 179.474 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.412 ' O ' ' HA ' ' A' ' 57' ' ' VAL . 3.7 mp -111.53 153.16 13.3 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.226 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.309 -179.581 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 15.7 mt-10 -103.08 152.03 21.86 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.362 -179.841 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 1.1 tp -58.0 -35.35 51.8 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.297 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.253 179.508 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -63.37 -32.75 74.26 Favored 'General case' 0 CA--C 1.53 0.196 0 CA-C-N 116.544 -0.298 . . . . 0.0 111.151 179.544 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -96.18 36.79 1.29 Allowed 'General case' 0 CA--C 1.531 0.243 0 CA-C-O 120.762 0.315 . . . . 0.0 111.266 -179.987 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' MET . . . . . 0.429 ' HG3' ' HB2' ' A' ' 24' ' ' TYR . 7.6 ttt -127.31 140.84 51.93 Favored 'General case' 0 C--N 1.333 -0.128 0 CA-C-N 116.458 -0.337 . . . . 0.0 110.56 179.643 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 19.4 m -61.19 140.08 58.0 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.919 179.999 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 9.1 m-85 -105.14 135.28 46.79 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.772 -179.974 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -117.56 88.77 30.34 Favored Pre-proline 0 C--O 1.234 0.24 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.608 179.572 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 12.9 Cg_exo -70.7 65.16 2.36 Favored 'Trans proline' 0 C--N 1.349 0.556 0 C-N-CA 123.014 2.476 . . . . 0.0 112.47 -179.649 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 5.9 pt-20 -137.05 -51.89 0.67 Allowed 'General case' 0 C--O 1.232 0.177 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.909 179.945 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . 0.408 ' HA ' HD12 ' A' ' 73' ' ' ILE . 70.8 m-20 -137.0 32.14 2.67 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-N 116.407 -0.36 . . . . 0.0 111.088 179.587 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 13.0 mm-40 56.87 61.9 2.45 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-O 120.917 0.389 . . . . 0.0 110.653 -179.861 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 3.8 ptm -134.26 150.41 51.01 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.957 -179.81 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 5.4 m-85 -122.99 126.86 47.97 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.659 -179.731 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 67.4 p -108.98 156.2 20.0 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.163 -179.87 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . 0.429 ' HB2' ' HG3' ' A' ' 13' ' ' MET . 64.8 t80 -148.12 107.34 3.65 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.54 179.824 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_exo -54.34 96.18 0.05 OUTLIER 'Trans proline' 0 C--N 1.348 0.551 0 C-N-CA 122.585 2.19 . . . . 0.0 111.95 -179.966 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . 0.461 ' SG ' ' HD2' ' A' ' 27' ' ' PRO . 46.4 t -63.46 139.19 97.55 Favored Pre-proline 0 C--O 1.233 0.225 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.909 -179.584 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . 0.461 ' HD2' ' SG ' ' A' ' 26' ' ' CYS . 10.1 Cg_endo -52.92 -23.3 20.72 Favored 'Trans proline' 0 C--N 1.349 0.554 0 C-N-CA 122.911 2.407 . . . . 0.0 112.834 179.745 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 6.1 p -59.43 -28.89 67.36 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-O 120.626 0.251 . . . . 0.0 111.222 179.839 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 125.11 4.74 7.03 Favored Glycine 0 CA--C 1.523 0.569 0 C-N-CA 120.988 -0.625 . . . . 0.0 113.6 179.976 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -119.91 -164.72 1.1 Allowed 'General case' 0 CA--C 1.534 0.341 0 CA-C-N 117.552 0.676 . . . . 0.0 111.424 -179.903 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 1.4 tpt180 -124.87 138.78 54.24 Favored 'General case' 0 C--O 1.232 0.155 0 CA-C-O 120.837 0.351 . . . . 0.0 111.561 -179.425 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 2.5 m-85 -81.29 165.16 21.66 Favored 'General case' 0 C--O 1.232 0.166 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.641 179.293 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 3.7 pt20 -155.46 122.92 5.56 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.438 -0.347 . . . . 0.0 111.009 179.785 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 4.3 tt -150.02 136.43 12.35 Favored 'Isoleucine or valine' 0 C--O 1.233 0.236 0 CA-C-N 116.308 -0.406 . . . . 0.0 111.141 -179.926 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 9.7 m-85 -96.39 156.5 16.31 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.011 -179.803 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 86.8 mt -63.64 -40.3 96.52 Favored 'General case' 0 N--CA 1.462 0.165 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.061 179.829 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 2.0 t0 -59.06 -35.76 73.89 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 116.499 -0.318 . . . . 0.0 111.361 179.928 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 9.7 m-20 -68.44 -58.53 4.2 Favored 'General case' 0 C--O 1.231 0.109 0 CA-C-O 120.828 0.347 . . . . 0.0 110.879 179.947 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 11.7 ptp -62.26 -34.03 75.75 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.527 -179.78 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . 0.406 ' HB2' ' CD2' ' A' ' 64' ' ' LEU . 22.4 t80 -60.21 -45.77 92.05 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 116.418 -0.355 . . . . 0.0 110.815 179.698 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 11.0 tt0 -57.93 -37.05 73.37 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.836 179.559 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 143.0 68.34 0.02 OUTLIER Glycine 0 C--N 1.334 0.426 0 C-N-CA 120.917 -0.659 . . . . 0.0 112.586 179.675 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -125.93 122.42 35.93 Favored 'General case' 0 N--CA 1.462 0.144 0 CA-C-O 120.7 0.286 . . . . 0.0 111.414 -179.769 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 14.0 mttt -118.68 -45.09 2.61 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.916 179.413 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 10.6 p -104.55 114.52 44.37 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.182 0 CA-C-O 120.983 0.42 . . . . 0.0 110.98 179.904 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -106.92 151.45 25.25 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.947 -0.569 . . . . 0.0 111.433 -179.52 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 20.4 t -105.13 129.63 57.54 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.15 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.351 -179.893 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 50.2 t -69.43 135.35 88.65 Favored Pre-proline 0 N--CA 1.463 0.175 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.919 179.659 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 91.0 Cg_endo -83.9 19.05 1.42 Allowed 'Trans proline' 0 CA--C 1.535 0.537 0 C-N-CA 122.583 2.189 . . . . 0.0 113.118 179.953 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 1.9 m -129.1 -59.5 1.11 Allowed 'General case' 0 C--O 1.232 0.154 0 CA-C-O 120.412 0.148 . . . . 0.0 110.762 179.725 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 20.8 p -101.5 -14.2 17.6 Favored 'General case' 0 CA--C 1.535 0.377 0 N-CA-C 111.746 0.276 . . . . 0.0 111.746 179.789 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER 66.01 34.0 7.31 Favored 'General case' 0 CA--C 1.533 0.302 0 CA-C-O 120.848 0.356 . . . . 0.0 111.151 -179.98 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 16.8 tp -86.47 133.21 33.77 Favored 'General case' 0 C--O 1.232 0.14 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.709 179.76 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' MET . . . . . . . . . . . . . 15.3 mtt -82.72 129.9 35.04 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.696 179.995 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 3.0 pt -135.9 143.26 36.71 Favored 'Isoleucine or valine' 0 C--O 1.233 0.236 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.816 -179.474 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 30.1 m-20 -91.44 99.93 12.79 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.82 179.497 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.412 ' HA ' ' O ' ' A' ' 8' ' ' ILE . 10.2 p -105.19 110.52 31.23 Favored 'Isoleucine or valine' 0 C--O 1.234 0.262 0 CA-C-O 121.105 0.478 . . . . 0.0 110.927 179.723 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 12.3 p -82.05 138.14 19.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.407 -179.466 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 33.9 p90 -117.22 175.37 5.64 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.771 -0.65 . . . . 0.0 111.114 -179.683 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . 0.483 ' HB3' ' HB2' ' A' ' 63' ' ' ASP . 1.9 t70 -134.28 128.37 33.68 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.136 179.897 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 1.9 mptt -61.53 -42.35 98.69 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.638 179.514 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 23.5 mt-10 -63.95 -39.13 93.45 Favored 'General case' 0 C--O 1.232 0.137 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.328 179.187 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . 0.483 ' HB2' ' HB3' ' A' ' 60' ' ' ASP . 12.9 t70 -56.63 -45.02 81.77 Favored 'General case' 0 N--CA 1.462 0.126 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.886 179.331 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.406 ' CD2' ' HB2' ' A' ' 40' ' ' PHE . 1.1 mp -56.89 -55.62 32.18 Favored 'General case' 0 CA--C 1.529 0.151 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.517 -179.56 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -60.11 -46.91 88.02 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-N 116.673 -0.239 . . . . 0.0 111.483 -179.753 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 10.3 mm-40 -63.34 -42.62 98.94 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.901 179.877 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 33.9 t80 -69.91 -36.39 75.33 Favored 'General case' 0 CA--C 1.531 0.239 0 CA-C-N 116.481 -0.327 . . . . 0.0 111.149 179.599 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 2.2 t80 -55.7 -54.47 43.9 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-N 116.674 -0.239 . . . . 0.0 111.045 -179.882 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -69.83 -35.87 75.13 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.231 179.844 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 13.5 mt-10 -64.09 -38.37 90.81 Favored 'General case' 0 CA--C 1.53 0.179 0 CA-C-N 116.398 -0.365 . . . . 0.0 111.733 -179.831 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -64.95 -61.57 2.08 Favored 'General case' 0 C--O 1.233 0.194 0 N-CA-C 111.633 0.235 . . . . 0.0 111.633 -179.315 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 91.3 37.54 6.21 Favored Glycine 0 C--N 1.334 0.429 0 C-N-CA 120.806 -0.711 . . . . 0.0 112.868 179.742 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.408 HD12 ' HA ' ' A' ' 19' ' ' ASN . 14.1 tt -73.38 141.48 16.23 Favored 'Isoleucine or valine' 0 C--O 1.233 0.226 0 CA-C-O 120.823 0.344 . . . . 0.0 111.201 179.944 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 27.6 t-80 -173.09 79.49 0.41 Allowed Pre-proline 0 C--N 1.33 -0.245 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.007 -179.909 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_exo -51.68 106.56 0.14 Allowed 'Trans proline' 0 C--N 1.35 0.631 0 C-N-CA 122.778 2.319 . . . . 0.0 112.366 179.948 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -68.73 -50.61 0.59 Allowed 'Trans proline' 0 C--N 1.349 0.567 0 C-N-CA 122.386 2.057 . . . . 0.0 112.442 -179.591 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -173.04 150.44 1.96 Allowed Pre-proline 0 C--O 1.234 0.251 0 CA-C-N 116.473 -0.331 . . . . 0.0 110.812 179.87 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 69.8 Cg_endo -73.41 179.62 5.35 Favored 'Trans proline' 0 C--N 1.349 0.555 0 C-N-CA 122.734 2.29 . . . . 0.0 112.539 -179.877 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 13.7 mt -136.86 39.25 0.53 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.446 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.293 179.992 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -137.86 148.15 45.15 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-N 116.519 -0.31 . . . . 0.0 110.821 179.634 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -69.8 -69.22 0.36 Allowed 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 116.59 -0.277 . . . . 0.0 111.267 -179.862 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -109.58 -53.76 2.63 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 116.53 -0.305 . . . . 0.0 110.956 179.729 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.125 0 CA-C-O 121.002 0.43 . . . . 0.0 111.138 179.806 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.49 1.535 0 CA-C-O 120.658 0.266 . . . . 0.0 111.197 . . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 11.8 m -132.28 29.59 1.19 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.373 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.631 179.776 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 87.2 p -130.43 -179.32 5.2 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-O 120.625 0.25 . . . . 0.0 110.964 179.978 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 72.8 p -76.02 165.47 24.91 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-O 120.91 0.386 . . . . 0.0 111.262 -179.878 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 9.3 m-85 -105.89 -39.56 5.98 Favored 'General case' 0 CA--C 1.531 0.217 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.397 179.887 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -158.6 176.96 11.74 Favored 'General case' 0 C--O 1.235 0.299 0 CA-C-N 116.451 -0.341 . . . . 0.0 111.256 -179.91 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 2.2 pt-20 -123.14 151.37 42.19 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.906 -179.992 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 25.4 mt -133.2 149.59 31.67 Favored 'Isoleucine or valine' 0 C--O 1.232 0.181 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.254 -179.803 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 39.2 mt-10 -88.63 150.52 22.99 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.062 179.714 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.4 HG22 HD11 ' A' ' 10' ' ' ILE . 14.4 tt -56.86 -34.87 44.86 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.327 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.042 179.221 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -71.59 -44.13 65.03 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.106 179.573 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -53.06 -23.25 7.27 Favored 'General case' 0 N--CA 1.469 0.503 0 N-CA-C 112.026 0.38 . . . . 0.0 112.026 -179.973 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 4.8 ttm -88.42 137.53 32.24 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-N 116.791 -0.186 . . . . 0.0 110.708 179.867 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 29.4 m -60.62 145.27 49.65 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-O 120.735 0.302 . . . . 0.0 111.115 -179.945 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 16.3 p90 -104.84 144.27 31.99 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.272 179.992 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 9.0 mp0 -130.55 93.92 30.85 Favored Pre-proline 0 C--O 1.233 0.23 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.667 179.804 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -68.12 -17.0 45.5 Favored 'Trans proline' 0 C--N 1.349 0.576 0 C-N-CA 122.938 2.425 . . . . 0.0 112.86 179.585 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -54.35 -39.13 66.82 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 116.615 -0.266 . . . . 0.0 111.677 -179.96 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 2.1 m120 -144.7 20.03 1.66 Allowed 'General case' 0 CA--C 1.535 0.37 0 CA-C-N 116.431 -0.349 . . . . 0.0 111.839 -179.521 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . 0.446 ' OE1' ' HB ' ' A' ' 73' ' ' ILE . 0.0 OUTLIER 55.68 79.32 0.16 Allowed 'General case' 0 C--O 1.234 0.237 0 CA-C-O 121.142 0.496 . . . . 0.0 111.288 179.636 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 3.2 ptt? -159.54 163.69 34.95 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.78 179.912 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 80.3 m-85 -123.58 118.78 28.12 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.617 179.792 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 14.7 p -105.46 152.03 23.52 Favored 'General case' 0 CA--C 1.53 0.184 0 CA-C-O 120.809 0.338 . . . . 0.0 111.145 -179.895 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 38.4 t80 -159.16 136.46 6.99 Favored Pre-proline 0 N--CA 1.463 0.198 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.018 -179.979 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -72.19 110.37 2.93 Favored 'Trans proline' 0 C--N 1.348 0.525 0 C-N-CA 122.496 2.131 . . . . 0.0 112.317 179.699 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . 0.45 ' SG ' ' HD2' ' A' ' 27' ' ' PRO . 51.5 t -77.63 140.14 63.57 Favored Pre-proline 0 C--O 1.233 0.209 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.463 179.56 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . 0.45 ' HD2' ' SG ' ' A' ' 26' ' ' CYS . 81.8 Cg_exo -49.41 -28.71 16.3 Favored 'Trans proline' 0 C--N 1.35 0.642 0 C-N-CA 123.041 2.494 . . . . 0.0 113.124 179.861 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 3.6 p -61.99 -29.83 70.53 Favored 'General case' 0 C--O 1.236 0.36 0 CA-C-O 120.657 0.265 . . . . 0.0 111.286 179.875 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 116.29 15.92 6.87 Favored Glycine 0 CA--C 1.525 0.696 0 C-N-CA 121.364 -0.446 . . . . 0.0 113.291 -179.894 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -120.11 -171.65 2.2 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-N 117.113 0.457 . . . . 0.0 111.056 -179.995 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 3.8 ttt180 -108.56 131.94 54.35 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-O 120.89 0.376 . . . . 0.0 111.367 -179.701 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 5.1 t80 -100.43 102.15 13.28 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.547 179.775 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 9.2 mt-30 -101.41 154.43 18.82 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.076 -179.781 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 2.4 tt -161.98 123.48 0.31 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.254 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.044 179.674 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 1.3 t80 -76.1 145.11 40.26 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.829 -179.905 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 10.1 mp -58.53 -42.78 88.56 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.852 179.714 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -60.21 -37.81 81.39 Favored 'General case' 0 N--CA 1.462 0.134 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.818 179.232 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -57.9 -52.02 67.21 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.866 179.715 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 7.8 mtt -67.61 -36.59 81.12 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 116.066 -0.516 . . . . 0.0 111.03 179.648 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 16.8 t80 -63.6 -42.5 98.23 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.975 179.732 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 3.0 tp10 -55.53 -35.5 65.71 Favored 'General case' 0 CA--C 1.532 0.269 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.195 179.68 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 139.42 54.91 0.05 OUTLIER Glycine 0 C--N 1.334 0.437 0 C-N-CA 121.15 -0.548 . . . . 0.0 112.433 179.669 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -103.65 150.68 23.78 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-O 120.87 0.367 . . . . 0.0 111.451 -179.711 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 87.0 mttt -147.02 -47.51 0.18 Allowed 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 115.894 -0.593 . . . . 0.0 111.226 179.905 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 15.7 t -107.54 99.97 9.72 Favored 'Isoleucine or valine' 0 C--O 1.233 0.21 0 CA-C-O 120.782 0.325 . . . . 0.0 110.799 179.985 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -88.1 148.49 24.43 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.202 -179.985 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 20.4 t -114.37 129.93 69.53 Favored 'Isoleucine or valine' 0 C--O 1.233 0.19 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.927 -179.902 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 48.9 t -68.87 136.48 89.89 Favored Pre-proline 0 N--CA 1.463 0.202 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.822 179.892 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 89.5 Cg_endo -83.5 19.43 1.34 Allowed 'Trans proline' 0 CA--C 1.536 0.58 0 C-N-CA 122.684 2.256 . . . . 0.0 113.084 179.854 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 43.0 t -128.03 -59.62 1.18 Allowed 'General case' 0 C--O 1.233 0.205 0 CA-C-O 120.57 0.224 . . . . 0.0 110.506 179.675 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' CYS . . . . . 0.413 ' SG ' ' HB2' ' A' ' 53' ' ' LEU . 22.9 p -101.16 -19.53 15.7 Favored 'General case' 0 CA--C 1.535 0.377 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.821 179.888 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 1.6 t 72.94 36.31 0.9 Allowed 'General case' 0 CA--C 1.535 0.375 0 CA-C-O 120.869 0.366 . . . . 0.0 111.039 -179.767 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.413 ' HB2' ' SG ' ' A' ' 51' ' ' CYS . 0.3 OUTLIER -67.66 155.59 38.84 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.835 179.742 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' MET . . . . . . . . . . . . . 15.2 mtt -112.01 114.12 26.82 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.697 -179.753 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 2.8 pp -132.63 143.02 40.94 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.285 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.479 -179.658 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 45.8 m-20 -101.71 91.38 4.38 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.898 179.487 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 11.1 p -85.44 127.74 39.76 Favored 'Isoleucine or valine' 0 C--O 1.233 0.233 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.773 179.614 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 12.2 p -90.12 131.85 36.29 Favored 'Isoleucine or valine' 0 C--O 1.234 0.277 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.114 -179.871 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 54.2 p90 -112.22 143.46 43.24 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.818 -0.628 . . . . 0.0 111.103 -179.697 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 59.5 m-20 -104.39 -28.58 11.27 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.5 179.866 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 16.3 ttmt 63.82 26.05 14.24 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-O 120.937 0.399 . . . . 0.0 111.397 -179.777 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 20.4 tt0 -95.75 -39.43 9.87 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.531 179.479 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -74.29 -32.8 63.03 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-N 115.883 -0.598 . . . . 0.0 111.349 179.809 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 3.0 mp -54.85 -45.21 74.51 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-O 120.544 0.212 . . . . 0.0 111.114 -179.9 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -59.53 -38.62 81.48 Favored 'General case' 0 CA--C 1.532 0.28 0 CA-C-N 116.523 -0.308 . . . . 0.0 111.284 179.65 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 1.9 mm-40 -79.21 -40.84 29.73 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.236 179.726 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -64.8 -35.07 79.91 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 116.47 -0.332 . . . . 0.0 111.818 -179.827 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 2.9 m-85 -59.5 -36.07 75.36 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-O 120.582 0.23 . . . . 0.0 110.722 179.885 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 20.8 tt0 -87.54 -37.43 16.89 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.912 179.296 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 34.9 mt-10 -68.55 -40.87 80.49 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.752 -179.55 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -89.77 -66.85 0.88 Allowed 'General case' 0 CA--C 1.53 0.205 0 N-CA-C 111.565 0.209 . . . . 0.0 111.565 -179.56 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 91.53 49.96 2.86 Favored Glycine 0 C--N 1.337 0.59 0 C-N-CA 121.033 -0.603 . . . . 0.0 112.94 -179.973 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.446 ' HB ' ' OE1' ' A' ' 20' ' ' GLN . 7.4 tp -66.37 144.03 15.07 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.246 0 CA-C-O 120.72 0.295 . . . . 0.0 111.115 179.86 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 32.1 m80 -81.22 157.58 70.62 Favored Pre-proline 0 C--O 1.234 0.268 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.127 179.97 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 38.6 Cg_endo -66.85 136.44 41.7 Favored 'Trans proline' 0 C--N 1.351 0.665 0 C-N-CA 122.682 2.255 . . . . 0.0 112.45 179.984 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -74.87 -170.97 0.85 Allowed 'Trans proline' 0 C--N 1.349 0.556 0 C-N-CA 122.732 2.288 . . . . 0.0 112.282 179.844 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 18.5 mt-10 -112.12 90.39 13.64 Favored Pre-proline 0 C--O 1.233 0.204 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.66 179.69 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_exo -52.93 100.92 0.06 OUTLIER 'Trans proline' 0 C--N 1.35 0.63 0 C-N-CA 123.167 2.578 . . . . 0.0 112.903 -179.676 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 2.1 pp -148.05 -45.2 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.532 0.255 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.682 179.62 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -122.51 122.79 39.74 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.642 -0.254 . . . . 0.0 110.88 -179.948 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -69.75 -69.98 0.31 Allowed 'General case' 0 N--CA 1.462 0.163 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.386 -179.605 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -145.79 151.54 38.11 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-O 120.729 0.299 . . . . 0.0 111.168 -179.984 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.233 0.21 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.427 -179.749 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 13.7 p . . . . . 0 C--O 1.234 0.257 0 CA-C-O 120.784 0.325 . . . . 0.0 111.342 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 5' ' ' TYR . . . . . 0.597 ' CG ' HD11 ' A' ' 53' ' ' LEU . 12.1 m-85 -109.6 -38.45 5.42 Favored 'General case' 0 C--O 1.232 0.173 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.158 179.487 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 1.8 t0 -158.54 174.84 14.46 Favored 'General case' 0 C--O 1.236 0.352 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.047 179.888 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 34.0 mt-10 -130.45 127.5 39.38 Favored 'General case' 0 C--O 1.232 0.164 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.872 179.991 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.407 HG12 ' CE2' ' A' ' 24' ' ' TYR . 3.7 mp -109.88 155.45 11.08 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.181 -179.807 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 11.9 mp0 -111.49 146.88 36.48 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.257 -179.833 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 3.6 tt -62.64 -34.29 64.44 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.247 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.28 179.615 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 5.0 pt-20 -64.08 -32.4 73.94 Favored 'General case' 0 CA--C 1.531 0.239 0 CA-C-N 116.559 -0.291 . . . . 0.0 111.129 179.731 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 11.6 m-20 -96.7 37.62 1.27 Allowed 'General case' 0 CA--C 1.531 0.234 0 CA-C-O 120.839 0.352 . . . . 0.0 111.083 179.704 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -131.63 152.6 50.71 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.075 -179.952 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -81.05 166.07 21.09 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.935 179.925 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 3.1 m-85 -119.9 138.41 53.45 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.975 -179.765 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -107.89 90.05 6.04 Favored Pre-proline 0 C--O 1.234 0.265 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.718 179.685 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -73.1 64.44 4.22 Favored 'Trans proline' 0 C--N 1.35 0.614 0 C-N-CA 122.745 2.297 . . . . 0.0 112.937 -179.528 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' GLU . . . . . 0.401 ' HG3' ' HE2' ' A' ' 21' ' ' MET . 6.3 pt-20 -141.95 -46.45 0.35 Allowed 'General case' 0 CA--C 1.531 0.223 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.22 179.698 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 3.5 m120 -139.36 29.49 2.2 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-N 116.572 -0.286 . . . . 0.0 111.449 179.692 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' GLN . . . . . 0.708 ' HB3' HD12 ' A' ' 36' ' ' LEU . 28.2 mt-30 56.52 68.62 0.83 Allowed 'General case' 0 C--O 1.234 0.244 0 CA-C-O 121.043 0.449 . . . . 0.0 111.664 179.448 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 21' ' ' MET . . . . . 0.401 ' HE2' ' HG3' ' A' ' 18' ' ' GLU . 3.8 ptt? -148.23 158.61 44.18 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.01 179.54 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.478 ' CE1' HD21 ' A' ' 36' ' ' LEU . 3.3 m-85 -110.13 159.44 17.34 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.685 179.91 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 34.4 p -134.35 150.06 50.9 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-O 120.941 0.401 . . . . 0.0 111.303 179.827 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' TYR . . . . . 0.407 ' CE2' HG12 ' A' ' 8' ' ' ILE . 31.5 t80 -155.69 102.07 2.17 Favored Pre-proline 0 C--N 1.333 -0.152 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.565 -179.87 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 62.6 Cg_exo -50.95 99.35 0.04 OUTLIER 'Trans proline' 0 C--N 1.349 0.574 0 C-N-CA 122.53 2.153 . . . . 0.0 112.116 -179.975 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 48.5 t -60.89 138.67 93.84 Favored Pre-proline 0 C--O 1.233 0.231 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.743 -179.618 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 80.2 Cg_exo -48.99 -26.45 10.24 Favored 'Trans proline' 0 C--N 1.351 0.667 0 C-N-CA 122.925 2.417 . . . . 0.0 113.025 179.796 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 4.3 p -59.5 -29.49 67.89 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-O 120.601 0.239 . . . . 0.0 111.352 179.661 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 123.2 7.5 7.02 Favored Glycine 0 CA--C 1.523 0.576 0 C-N-CA 121.207 -0.52 . . . . 0.0 113.445 179.94 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -114.09 -168.24 1.33 Allowed 'General case' 0 CA--C 1.532 0.262 0 CA-C-N 117.379 0.59 . . . . 0.0 111.158 -179.986 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 1.1 tpt180 -117.11 106.43 13.34 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-O 120.75 0.31 . . . . 0.0 110.91 -179.836 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -73.42 113.24 10.29 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.706 179.899 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 25.6 mt-30 -102.89 150.85 23.11 Favored 'General case' 0 N--CA 1.463 0.186 0 CA-C-N 116.435 -0.348 . . . . 0.0 111.146 -179.802 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.435 ' O ' HG23 ' A' ' 34' ' ' ILE . 0.9 OUTLIER -154.16 121.57 0.63 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.246 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.005 179.896 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 28.8 m-85 -81.92 148.14 28.9 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-N 116.374 -0.375 . . . . 0.0 111.144 -179.865 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.708 HD12 ' HB3' ' A' ' 20' ' ' GLN . 6.3 mt -67.85 -35.5 78.67 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.969 179.672 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 1.9 p-10 -66.22 -43.13 87.58 Favored 'General case' 0 CA--C 1.531 0.216 0 CA-C-N 116.372 -0.377 . . . . 0.0 110.825 179.481 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -62.81 -52.18 64.18 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-O 120.704 0.288 . . . . 0.0 111.053 -179.855 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 39' ' ' MET . . . . . 0.562 ' HG3' HD11 ' A' ' 64' ' ' LEU . 24.1 ptm -61.62 -27.67 68.82 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.36 179.97 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 40' ' ' PHE . . . . . 0.534 ' CD2' HD22 ' A' ' 64' ' ' LEU . 0.4 OUTLIER -55.58 -32.4 63.02 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 116.516 -0.311 . . . . 0.0 111.16 179.578 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 13.7 mt-10 -90.96 41.04 1.05 Allowed 'General case' 0 CA--C 1.532 0.285 0 CA-C-O 120.782 0.325 . . . . 0.0 111.484 179.9 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 60.09 64.81 3.84 Favored Glycine 0 C--N 1.334 0.434 0 C-N-CA 121.162 -0.542 . . . . 0.0 113.316 179.41 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 4.3 tt0 -121.62 98.93 6.19 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-O 120.927 0.394 . . . . 0.0 110.979 179.694 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -112.88 -33.78 5.97 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.804 179.856 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.431 HG23 ' O ' ' A' ' 45' ' ' VAL . 10.3 m -89.18 82.0 2.0 Favored 'Isoleucine or valine' 0 C--O 1.234 0.272 0 CA-C-O 121.037 0.446 . . . . 0.0 110.94 -179.977 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -91.09 147.0 23.38 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.274 -179.79 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 21.4 t -104.87 121.08 56.35 Favored 'Isoleucine or valine' 0 C--O 1.233 0.189 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.804 179.939 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 53.7 t -61.87 135.76 94.67 Favored Pre-proline 0 N--CA 1.463 0.223 0 CA-C-N 116.365 -0.379 . . . . 0.0 110.886 179.972 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 85.0 Cg_endo -84.32 20.25 1.24 Allowed 'Trans proline' 0 CA--C 1.534 0.495 0 C-N-CA 122.724 2.283 . . . . 0.0 113.167 179.926 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -129.81 -59.53 1.06 Allowed 'General case' 0 C--O 1.233 0.194 0 CA-C-O 120.516 0.198 . . . . 0.0 110.74 179.767 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 20.4 p -100.84 -17.29 16.94 Favored 'General case' 0 CA--C 1.532 0.261 0 CA-C-N 116.553 -0.294 . . . . 0.0 111.669 179.683 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER 67.43 36.56 3.8 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-O 120.911 0.386 . . . . 0.0 111.021 -179.889 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.597 HD11 ' CG ' ' A' ' 5' ' ' TYR . 9.8 tp -85.57 133.35 34.07 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.669 179.849 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 54' ' ' MET . . . . . . . . . . . . . 27.9 mtt -82.01 122.44 27.8 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.875 -179.801 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.486 ' O ' HD12 ' A' ' 55' ' ' ILE . 2.8 pp -131.33 143.34 40.93 Favored 'Isoleucine or valine' 0 C--O 1.234 0.26 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.008 179.884 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -109.39 92.21 3.96 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.622 -179.692 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 12.5 p -86.05 130.03 37.19 Favored 'Isoleucine or valine' 0 C--O 1.234 0.272 0 CA-C-N 116.099 -0.501 . . . . 0.0 111.002 -179.85 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 13.4 p -94.09 145.57 7.76 Favored 'Isoleucine or valine' 0 C--O 1.234 0.268 0 CA-C-N 116.057 -0.519 . . . . 0.0 111.103 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 22.3 p90 -131.89 146.77 52.31 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.153 179.879 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -89.26 -18.92 26.06 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.173 179.382 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 10.5 tttp 68.51 26.2 6.55 Favored 'General case' 0 CA--C 1.532 0.261 0 CA-C-O 120.835 0.35 . . . . 0.0 111.099 -179.688 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 4.4 tt0 -99.69 -62.52 1.23 Allowed 'General case' 0 C--O 1.232 0.165 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.351 179.644 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -62.03 -25.28 67.57 Favored 'General case' 0 N--CA 1.463 0.183 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.976 179.269 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.562 HD11 ' HG3' ' A' ' 39' ' ' MET . 0.2 OUTLIER -53.69 -38.31 64.09 Favored 'General case' 0 CA--C 1.53 0.203 0 CA-C-N 116.7 -0.227 . . . . 0.0 111.054 179.701 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -91.66 -37.64 12.92 Favored 'General case' 0 CA--C 1.53 0.208 0 CA-C-N 116.519 -0.309 . . . . 0.0 111.327 179.777 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 19.7 tt0 -66.22 -42.75 88.24 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-N 116.542 -0.299 . . . . 0.0 111.289 -179.937 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 23.3 t80 -57.92 -30.84 66.25 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.34 179.881 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 68' ' ' TYR . . . . . 0.423 ' HA ' ' NE2' ' A' ' 20' ' ' GLN . 4.2 m-85 -58.52 -35.29 72.05 Favored 'General case' 0 CA--C 1.528 0.117 0 CA-C-O 120.599 0.237 . . . . 0.0 110.725 179.745 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 18.4 mt-10 -81.88 -32.03 31.22 Favored 'General case' 0 C--O 1.232 0.152 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.888 179.394 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -69.4 -51.51 35.81 Favored 'General case' 0 N--CA 1.461 0.109 0 CA-C-N 116.486 -0.324 . . . . 0.0 111.208 179.921 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.233 0.203 0 CA-C-N 116.363 -0.38 . . . . 0.0 111.358 -179.882 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 2.8 p . . . . . 0 N--CA 1.47 0.561 0 CA-C-O 120.975 0.417 . . . . 0.0 111.487 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 5' ' ' TYR . . . . . 0.577 ' CG ' HD11 ' A' ' 53' ' ' LEU . 17.1 m-85 -116.08 -38.11 3.69 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.707 -179.624 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 1.4 p30 -159.61 174.85 13.96 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-O 120.671 0.272 . . . . 0.0 111.015 -179.697 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -143.67 121.36 11.86 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.072 179.761 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 3.6 mp -115.36 151.99 17.05 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.178 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.271 -179.8 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 1.4 pm0 -91.12 156.14 18.11 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.359 -179.947 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 11.6 tt -63.78 -31.2 52.18 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.251 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.406 179.707 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 12.9 mt-10 -59.78 -33.58 71.88 Favored 'General case' 0 CA--C 1.531 0.249 0 CA-C-N 116.552 -0.295 . . . . 0.0 111.095 179.69 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -96.46 37.29 1.28 Allowed 'General case' 0 CA--C 1.534 0.335 0 CA-C-O 120.798 0.332 . . . . 0.0 111.211 179.815 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -131.65 134.19 45.7 Favored 'General case' 0 C--O 1.232 0.161 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.581 179.889 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 3.6 m -72.16 144.1 48.69 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-O 120.674 0.273 . . . . 0.0 110.782 179.977 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 13.5 p90 -111.84 141.92 44.87 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.001 179.923 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 29.3 mt-10 -117.75 82.9 17.1 Favored Pre-proline 0 C--O 1.233 0.224 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.741 179.916 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -54.76 -24.79 39.51 Favored 'Trans proline' 0 C--N 1.348 0.509 0 C-N-CA 122.814 2.342 . . . . 0.0 112.701 179.692 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -51.37 -38.09 51.51 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-N 116.55 -0.295 . . . . 0.0 111.32 179.729 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 46.3 m-20 -136.3 18.6 3.16 Favored 'General case' 0 CA--C 1.537 0.455 0 N-CA-C 111.927 0.343 . . . . 0.0 111.927 179.881 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 10.7 mt-30 52.27 73.75 0.31 Allowed 'General case' 0 N--CA 1.467 0.392 0 N-CA-C 112.043 0.386 . . . . 0.0 112.043 179.399 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' MET . . . . . 0.416 ' HB3' ' CD2' ' A' ' 35' ' ' TYR . 3.7 ptt? -166.54 146.15 5.78 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.52 179.583 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 27.4 m-85 -90.16 157.05 17.92 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.808 179.548 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 19.1 p -147.46 136.52 22.27 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.19 179.762 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 58.3 t80 -139.82 136.02 17.07 Favored Pre-proline 0 C--N 1.332 -0.161 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.802 179.626 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo -67.48 101.7 0.66 Allowed 'Trans proline' 0 C--N 1.348 0.544 0 C-N-CA 122.528 2.152 . . . . 0.0 112.231 179.907 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' CYS . . . . . 0.412 ' SG ' ' HD2' ' A' ' 27' ' ' PRO . 37.2 t -61.95 137.6 95.48 Favored Pre-proline 0 C--O 1.233 0.197 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.696 179.868 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 27' ' ' PRO . . . . . 0.412 ' HD2' ' SG ' ' A' ' 26' ' ' CYS . 12.0 Cg_endo -56.46 -21.65 38.63 Favored 'Trans proline' 0 C--N 1.348 0.523 0 C-N-CA 122.611 2.207 . . . . 0.0 112.686 179.739 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -65.51 -37.88 88.07 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-O 120.507 0.194 . . . . 0.0 111.191 179.932 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 153.05 -44.13 0.62 Allowed Glycine 0 C--N 1.335 0.474 0 C-N-CA 120.692 -0.766 . . . . 0.0 113.13 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -84.36 179.43 7.44 Favored 'General case' 0 CA--C 1.532 0.256 0 CA-C-O 120.785 0.326 . . . . 0.0 111.253 -179.727 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 27.8 ttm180 -113.06 117.69 32.7 Favored 'General case' 0 C--O 1.232 0.159 0 CA-C-N 116.387 -0.369 . . . . 0.0 110.844 179.873 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' PHE . . . . . 0.548 ' HZ ' ' HB1' ' A' ' 46' ' ' ALA . 30.6 t80 -65.52 156.39 32.7 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.423 -179.838 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 15.8 pt20 -143.57 131.78 21.94 Favored 'General case' 0 CA--C 1.53 0.205 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.16 -179.971 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 7.0 tt -139.09 125.76 24.39 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.185 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.927 179.53 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 35' ' ' TYR . . . . . 0.416 ' CD2' ' HB3' ' A' ' 21' ' ' MET . 55.4 m-85 -80.24 151.2 29.76 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.345 -179.83 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 45.2 mt -61.34 -40.08 92.91 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.815 179.694 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 2.5 p-10 -63.02 -34.06 76.76 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.199 179.605 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -65.65 -58.94 4.52 Favored 'General case' 0 C--O 1.231 0.083 0 CA-C-O 120.799 0.333 . . . . 0.0 110.728 179.997 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 39' ' ' MET . . . . . 0.654 ' HG3' HD11 ' A' ' 64' ' ' LEU . 5.9 ptm -63.69 -34.38 77.73 Favored 'General case' 0 CA--C 1.53 0.202 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.277 179.991 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 46.4 t80 -57.44 -40.68 78.96 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 116.506 -0.316 . . . . 0.0 110.911 179.542 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 4.0 mt-10 -61.71 -35.4 77.94 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 116.538 -0.301 . . . . 0.0 110.982 179.541 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 137.45 46.6 0.08 OUTLIER Glycine 0 C--N 1.332 0.348 0 C-N-CA 120.95 -0.643 . . . . 0.0 112.625 179.86 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -104.07 115.96 31.36 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-O 120.669 0.271 . . . . 0.0 111.042 -179.954 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 2.4 ptpt -117.26 -40.37 3.09 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.216 179.943 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 5.0 m -101.71 101.13 11.68 Favored 'Isoleucine or valine' 0 C--O 1.232 0.172 0 CA-C-O 120.922 0.391 . . . . 0.0 111.249 -179.953 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.548 ' HB1' ' HZ ' ' A' ' 32' ' ' PHE . . . -99.5 167.77 10.4 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-N 115.987 -0.551 . . . . 0.0 111.404 -179.716 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 5.6 m -136.51 128.33 43.86 Favored 'Isoleucine or valine' 0 C--O 1.232 0.182 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.354 -179.83 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 46.1 t -66.22 136.1 95.17 Favored Pre-proline 0 N--CA 1.463 0.214 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.903 179.865 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_endo -83.57 20.11 1.24 Allowed 'Trans proline' 0 C--N 1.348 0.548 0 C-N-CA 122.692 2.262 . . . . 0.0 113.262 179.859 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -128.45 -56.25 1.23 Allowed 'General case' 0 C--O 1.232 0.156 0 CA-C-O 120.574 0.226 . . . . 0.0 110.502 179.658 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 20.1 p -100.83 -20.08 15.67 Favored 'General case' 0 CA--C 1.534 0.356 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.729 179.846 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 68.24 39.58 2.3 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-O 120.989 0.423 . . . . 0.0 110.896 -179.751 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.577 HD11 ' CG ' ' A' ' 5' ' ' TYR . 6.6 tp -86.44 129.77 34.74 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.816 179.948 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 54' ' ' MET . . . . . . . . . . . . . 28.0 mtm -83.02 131.08 35.19 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.845 -179.934 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 2.6 pp -142.27 145.88 23.16 Favored 'Isoleucine or valine' 0 C--O 1.233 0.204 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.62 -179.731 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -104.6 105.15 15.13 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.757 179.572 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.436 ' O ' HG13 ' A' ' 57' ' ' VAL . 12.9 p -105.51 118.23 52.62 Favored 'Isoleucine or valine' 0 C--O 1.233 0.213 0 CA-C-O 120.952 0.406 . . . . 0.0 111.101 179.793 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 14.6 p -86.22 139.32 17.55 Favored 'Isoleucine or valine' 0 C--O 1.233 0.232 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.045 -179.839 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 30.5 p90 -129.82 165.75 21.33 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.16 -179.649 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -128.43 178.83 6.01 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-N 116.024 -0.535 . . . . 0.0 111.039 -179.752 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 26.4 mttp -111.1 29.5 7.73 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.206 179.671 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 5.6 mt-10 -99.15 -70.27 0.73 Allowed 'General case' 0 C--O 1.232 0.147 0 CA-C-N 116.492 -0.322 . . . . 0.0 110.604 179.504 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 3.0 p30 -68.3 -37.7 80.88 Favored 'General case' 0 N--CA 1.463 0.175 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.6 179.432 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.654 HD11 ' HG3' ' A' ' 39' ' ' MET . 0.2 OUTLIER -56.11 -41.33 75.11 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-N 116.456 -0.338 . . . . 0.0 110.877 179.872 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -73.76 -38.64 64.65 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.35 179.654 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 10.3 mt-10 -71.94 -35.33 69.58 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 116.416 -0.356 . . . . 0.0 111.765 -179.678 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 7.4 m-85 -55.59 -28.32 54.38 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 116.623 -0.262 . . . . 0.0 111.345 -179.794 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 23.4 m-85 -60.66 -34.27 74.05 Favored 'General case' 0 CA--C 1.528 0.117 0 CA-C-N 116.651 -0.25 . . . . 0.0 110.562 179.707 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -90.55 -36.51 14.43 Favored 'General case' 0 CA--C 1.531 0.213 0 CA-C-N 116.284 -0.417 . . . . 0.0 110.993 179.445 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -71.12 -34.71 71.32 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 116.464 -0.335 . . . . 0.0 111.785 -179.648 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.233 0.214 0 CA-C-O 120.895 0.379 . . . . 0.0 111.295 -179.85 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 4' ' ' THR . . . . . 0.64 HG21 ' CG ' ' A' ' 56' ' ' ASP . 0.9 OUTLIER . . . . . 0 N--CA 1.464 0.264 0 CA-C-O 120.985 0.421 . . . . 0.0 111.511 . . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 85.0 m-85 -105.04 -37.3 6.99 Favored 'General case' 0 CA--C 1.531 0.232 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.409 -179.945 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -157.14 175.67 13.75 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-N 116.534 -0.303 . . . . 0.0 111.247 -179.792 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 21.5 mt-10 -126.2 143.26 51.2 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 116.108 -0.497 . . . . 0.0 111.033 -179.921 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 22.8 mt -127.19 151.82 34.49 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.29 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.173 -179.886 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 9' ' ' GLU . . . . . 0.441 ' HG3' HG13 ' A' ' 58' ' ' VAL . 8.5 tt0 -104.97 142.89 33.98 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-N 116.515 -0.311 . . . . 0.0 110.953 179.756 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 41.2 pt -61.15 -32.81 53.82 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.305 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.34 179.82 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 16.8 tt0 -59.44 -33.19 70.97 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.841 179.613 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -97.01 36.89 1.36 Allowed 'General case' 0 CA--C 1.533 0.307 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.191 179.855 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 13.0 mtp -131.32 148.29 52.66 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.639 179.678 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 20.0 m -61.96 129.79 42.55 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.14 -179.816 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 21.1 p90 -93.53 124.39 37.49 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.716 179.593 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 -112.07 86.02 7.25 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.793 -179.881 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo -69.23 -16.99 40.18 Favored 'Trans proline' 0 C--N 1.347 0.499 0 C-N-CA 122.743 2.295 . . . . 0.0 112.942 -179.865 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -53.24 -37.49 62.12 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-N 116.712 -0.222 . . . . 0.0 111.15 179.739 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 25.8 m-20 -143.17 25.32 1.74 Allowed 'General case' 0 CA--C 1.533 0.303 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.718 179.902 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' GLN . . . . . 0.442 ' HG2' HD23 ' A' ' 36' ' ' LEU . 6.2 tt0 53.35 72.25 0.44 Allowed 'General case' 0 CA--C 1.534 0.329 0 CA-C-O 120.992 0.425 . . . . 0.0 111.648 179.513 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 21' ' ' MET . . . . . 0.434 ' HB3' ' CD2' ' A' ' 35' ' ' TYR . 5.7 ptt? -154.08 175.11 13.82 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.046 179.928 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 27.2 m-85 -137.4 138.65 40.08 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.131 179.879 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 79.6 p -130.82 156.64 44.66 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.273 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 45.7 t80 -156.53 136.01 8.22 Favored Pre-proline 0 N--CA 1.463 0.176 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.863 179.781 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -64.71 100.29 0.34 Allowed 'Trans proline' 0 C--N 1.35 0.616 0 C-N-CA 122.678 2.252 . . . . 0.0 112.37 179.839 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' CYS . . . . . 0.419 ' SG ' ' HD2' ' A' ' 27' ' ' PRO . 42.0 t -59.68 139.26 89.76 Favored Pre-proline 0 C--O 1.233 0.19 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.69 179.817 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 27' ' ' PRO . . . . . 0.419 ' HD2' ' SG ' ' A' ' 26' ' ' CYS . 75.2 Cg_exo -51.17 -26.09 18.87 Favored 'Trans proline' 0 C--N 1.348 0.548 0 C-N-CA 122.739 2.293 . . . . 0.0 112.951 179.887 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -68.53 -38.88 81.23 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-O 120.553 0.216 . . . . 0.0 111.279 -179.858 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 152.43 -45.95 0.59 Allowed Glycine 0 C--N 1.334 0.459 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.959 -179.904 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.3 t0 -73.17 -173.81 1.41 Allowed 'General case' 0 CA--C 1.533 0.303 0 CA-C-O 120.748 0.309 . . . . 0.0 111.156 -179.807 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 27.4 ttt180 -123.3 129.67 51.66 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-N 116.444 -0.343 . . . . 0.0 110.886 179.855 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 7.4 m-85 -65.09 161.98 17.8 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.987 179.822 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -151.76 127.92 10.49 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.221 179.8 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 3.6 tt -150.87 144.38 16.87 Favored 'Isoleucine or valine' 0 C--O 1.233 0.219 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.175 179.785 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' TYR . . . . . 0.434 ' CD2' ' HB3' ' A' ' 21' ' ' MET . 86.0 m-85 -105.29 157.47 17.28 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.869 -179.913 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.573 HD12 ' HG ' ' A' ' 64' ' ' LEU . 4.0 mm? -61.3 -33.85 74.25 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.936 179.768 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 8.2 t70 -68.13 -39.4 82.74 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.991 179.598 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -59.63 -56.43 22.04 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.1 -179.817 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 36.4 mtm -63.58 -31.27 72.39 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.947 179.618 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' PHE . . . . . 0.656 ' HB2' HD21 ' A' ' 64' ' ' LEU . 17.0 t80 -58.4 -46.32 86.64 Favored 'General case' 0 CA--C 1.529 0.148 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.912 179.604 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -58.18 -35.49 71.65 Favored 'General case' 0 N--CA 1.463 0.185 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.887 179.685 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 138.65 48.45 0.06 OUTLIER Glycine 0 C--N 1.333 0.386 0 C-N-CA 120.992 -0.623 . . . . 0.0 112.64 179.671 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -102.16 124.89 48.55 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-O 120.791 0.329 . . . . 0.0 110.946 -179.989 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 16.2 mttt -122.83 -43.91 2.23 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.968 179.897 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.486 HG13 ' O ' ' A' ' 45' ' ' VAL . 11.1 p -112.58 113.58 44.54 Favored 'Isoleucine or valine' 0 C--O 1.233 0.236 0 CA-C-O 121.001 0.429 . . . . 0.0 110.967 179.811 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -99.0 160.28 14.37 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.2 -179.648 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 7.5 m -116.81 124.42 72.86 Favored 'Isoleucine or valine' 0 C--O 1.233 0.2 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.367 -179.894 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 51.3 t -69.99 135.66 87.39 Favored Pre-proline 0 C--N 1.33 -0.252 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.868 179.875 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_endo -84.6 20.78 1.17 Allowed 'Trans proline' 0 CA--C 1.535 0.527 0 C-N-CA 122.714 2.276 . . . . 0.0 112.967 179.747 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -128.01 -57.67 1.24 Allowed 'General case' 0 CA--C 1.529 0.147 0 CA-C-O 120.587 0.232 . . . . 0.0 110.578 179.788 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 20.2 p -99.69 -20.45 16.28 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.817 179.946 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 2.1 t 67.29 40.02 2.86 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-O 120.921 0.391 . . . . 0.0 111.022 -179.857 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.52 ' CD2' HG23 ' A' ' 55' ' ' ILE . 8.5 tt -95.94 135.93 37.05 Favored 'General case' 0 C--O 1.232 0.178 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.625 179.805 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 54' ' ' MET . . . . . . . . . . . . . 12.3 mtt -89.39 128.45 35.92 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.128 -179.578 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.52 HG23 ' CD2' ' A' ' 53' ' ' LEU . 2.1 pp -135.14 132.09 52.72 Favored 'Isoleucine or valine' 0 C--O 1.233 0.221 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.474 179.922 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 56' ' ' ASP . . . . . 0.64 ' CG ' HG21 ' A' ' 4' ' ' THR . 74.1 m-20 -87.21 99.46 11.97 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.769 179.61 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.505 ' O ' HG13 ' A' ' 57' ' ' VAL . 13.3 p -93.18 113.38 27.97 Favored 'Isoleucine or valine' 0 C--O 1.233 0.228 0 CA-C-O 121.114 0.483 . . . . 0.0 111.126 179.943 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.441 HG13 ' HG3' ' A' ' 9' ' ' GLU . 11.7 p -81.64 135.5 24.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.867 -179.955 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 53.5 p90 -131.47 178.57 6.63 Favored 'General case' 0 CA--C 1.532 0.252 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.174 -179.722 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 1.6 t0 -126.29 159.91 31.8 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.893 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -79.99 -36.21 36.31 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.612 179.464 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -60.83 -36.73 79.83 Favored 'General case' 0 CA--C 1.528 0.114 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.088 179.967 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -55.16 -45.76 75.73 Favored 'General case' 0 N--CA 1.462 0.137 0 CA-C-N 116.474 -0.33 . . . . 0.0 111.145 179.747 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.656 HD21 ' HB2' ' A' ' 40' ' ' PHE . 3.7 mp -61.54 -55.89 26.03 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.626 -0.261 . . . . 0.0 110.915 179.812 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -56.73 -40.75 76.27 Favored 'General case' 0 N--CA 1.462 0.156 0 CA-C-N 116.484 -0.326 . . . . 0.0 111.083 179.736 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 30.0 mt-10 -67.43 -43.45 81.13 Favored 'General case' 0 CA--C 1.528 0.115 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.93 179.542 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 67' ' ' TYR . . . . . 0.405 ' CD1' ' HG3' ' A' ' 20' ' ' GLN . 0.3 OUTLIER -70.67 -40.15 73.13 Favored 'General case' 0 N--CA 1.463 0.183 0 CA-C-N 116.531 -0.304 . . . . 0.0 111.438 179.939 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 9.7 m-85 -59.21 -40.17 84.96 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 116.659 -0.246 . . . . 0.0 111.075 -179.744 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 16.8 mt-10 -81.24 -33.75 32.59 Favored 'General case' 0 CA--C 1.529 0.158 0 CA-C-N 116.577 -0.283 . . . . 0.0 111.101 179.886 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 29.1 mt-10 -73.44 -50.19 22.97 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-N 116.587 -0.279 . . . . 0.0 111.192 179.945 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.169 0 CA-C-N 116.323 -0.398 . . . . 0.0 111.519 -179.572 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 1.8 t . . . . . 0 N--CA 1.465 0.277 0 CA-C-O 120.879 0.371 . . . . 0.0 111.229 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 27.1 m-85 -103.88 -31.21 9.88 Favored 'General case' 0 CA--C 1.532 0.252 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.275 179.732 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 5.7 t70 -158.73 165.63 33.88 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-O 120.769 0.319 . . . . 0.0 111.566 -179.855 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 11.2 tt0 -136.41 115.05 11.98 Favored 'General case' 0 CA--C 1.53 0.195 0 CA-C-N 116.035 -0.529 . . . . 0.0 111.177 -179.774 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 3.9 mp -113.56 151.29 15.43 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.277 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.199 179.917 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 4.7 mt-10 -97.92 148.45 23.44 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.273 -179.927 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 14.3 tt -58.55 -31.43 43.63 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.305 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.36 179.668 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 26.4 mt-10 -63.13 -27.56 69.47 Favored 'General case' 0 CA--C 1.532 0.274 0 CA-C-N 116.597 -0.274 . . . . 0.0 111.302 179.634 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -95.09 36.14 1.23 Allowed 'General case' 0 CA--C 1.533 0.325 0 CA-C-O 120.696 0.284 . . . . 0.0 111.313 179.95 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -119.0 177.31 4.91 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-O 120.843 0.354 . . . . 0.0 110.959 179.715 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 1.6 m -108.49 85.69 2.15 Favored 'General case' 0 C--O 1.232 0.15 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.575 179.911 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 30.3 p90 -86.28 139.51 30.95 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.891 179.958 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 25.3 mt-10 -138.69 157.91 71.11 Favored Pre-proline 0 C--O 1.234 0.246 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.633 -179.606 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 25.8 Cg_exo -63.36 -11.95 28.16 Favored 'Trans proline' 0 C--N 1.351 0.686 0 C-N-CA 123.257 2.638 . . . . 0.0 112.914 179.391 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 3.1 pt-20 -66.17 82.99 0.08 Allowed 'General case' 0 C--O 1.233 0.197 0 CA-C-O 121.076 0.465 . . . . 0.0 110.843 -179.731 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 6.0 m-80 62.12 22.9 13.45 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-N 115.799 -0.637 . . . . 0.0 111.668 -179.503 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' GLN . . . . . 0.493 ' O ' HD23 ' A' ' 36' ' ' LEU . 0.8 OUTLIER 53.49 78.07 0.16 Allowed 'General case' 0 C--O 1.234 0.281 0 CA-C-O 121.067 0.461 . . . . 0.0 111.286 179.921 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 1.9 ppp? -133.71 143.5 48.54 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.674 179.842 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.546 ' CE1' HD22 ' A' ' 36' ' ' LEU . 0.9 OUTLIER -127.7 132.32 49.65 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.656 179.618 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 23' ' ' THR . . . . . 0.616 HG22 ' HA ' ' A' ' 33' ' ' GLN . 40.6 p -122.14 158.74 28.66 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.815 -178.929 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 61.1 t80 -139.9 137.22 18.05 Favored Pre-proline 0 CA--C 1.53 0.186 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.225 179.878 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 65.5 Cg_endo -73.44 100.94 1.3 Allowed 'Trans proline' 0 C--N 1.35 0.627 0 C-N-CA 122.768 2.312 . . . . 0.0 112.442 179.587 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' CYS . . . . . 0.44 ' SG ' ' HD2' ' A' ' 27' ' ' PRO . 53.1 t -68.69 140.21 91.76 Favored Pre-proline 0 C--O 1.233 0.229 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.705 179.786 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 27' ' ' PRO . . . . . 0.44 ' HD2' ' SG ' ' A' ' 26' ' ' CYS . 86.7 Cg_exo -48.89 -26.98 10.73 Favored 'Trans proline' 0 C--N 1.351 0.666 0 C-N-CA 122.916 2.411 . . . . 0.0 113.175 179.962 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 9.0 p -58.49 -28.92 65.83 Favored 'General case' 0 CA--C 1.533 0.321 0 CA-C-O 120.642 0.258 . . . . 0.0 111.433 -179.949 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 120.93 9.87 7.22 Favored Glycine 0 CA--C 1.523 0.57 0 C-N-CA 121.134 -0.555 . . . . 0.0 113.337 -179.823 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -122.42 -165.2 1.25 Allowed 'General case' 0 CA--C 1.535 0.375 0 CA-C-N 117.145 0.472 . . . . 0.0 110.935 179.972 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 3.8 ttt85 -137.85 117.16 12.73 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-O 120.515 0.198 . . . . 0.0 111.186 -179.73 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 32' ' ' PHE . . . . . 0.542 ' CZ ' ' HB1' ' A' ' 46' ' ' ALA . 76.4 t80 -70.63 151.96 44.4 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.225 179.896 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 33' ' ' GLN . . . . . 0.616 ' HA ' HG22 ' A' ' 23' ' ' THR . 3.6 pt20 -126.28 139.66 53.14 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.449 -179.939 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 12.0 tt -155.0 148.89 12.61 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.346 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.21 179.69 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 60.3 m-85 -100.67 155.77 17.7 Favored 'General case' 0 C--O 1.236 0.357 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.516 -179.695 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.82 HD12 ' HG ' ' A' ' 64' ' ' LEU . 3.2 mm? -61.67 -46.88 87.85 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.775 179.734 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -60.27 -36.55 78.08 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 116.495 -0.321 . . . . 0.0 110.995 179.647 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -57.19 -46.12 83.14 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.41 179.709 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 2.6 mtt -66.23 -28.81 69.02 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.321 179.582 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' PHE . . . . . 0.671 ' CE1' HD22 ' A' ' 64' ' ' LEU . 0.0 OUTLIER -56.53 -45.77 80.98 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-O 120.573 0.225 . . . . 0.0 111.046 179.906 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 10.6 mt-10 -59.91 -32.51 70.83 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 116.461 -0.336 . . . . 0.0 110.975 179.586 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 131.74 46.61 0.13 Allowed Glycine 0 C--N 1.333 0.394 0 C-N-CA 121.145 -0.55 . . . . 0.0 112.498 179.981 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -83.35 92.89 7.63 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-O 120.993 0.425 . . . . 0.0 110.888 -179.948 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 10.8 ptpt -107.33 -32.43 7.76 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.831 -0.622 . . . . 0.0 111.218 179.881 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.49 HG13 ' O ' ' A' ' 45' ' ' VAL . 7.6 p -121.58 108.98 23.47 Favored 'Isoleucine or valine' 0 C--O 1.233 0.214 0 CA-C-O 121.109 0.48 . . . . 0.0 110.874 179.796 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.542 ' HB1' ' CZ ' ' A' ' 32' ' ' PHE . . . -109.63 171.81 7.22 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.589 -179.361 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 19.1 t -128.91 119.43 49.48 Favored 'Isoleucine or valine' 0 C--O 1.232 0.145 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.036 -179.935 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 41.7 t -62.33 112.19 5.99 Favored Pre-proline 0 N--CA 1.463 0.199 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.452 179.683 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 31.1 Cg_exo -60.33 -17.82 49.2 Favored 'Trans proline' 0 C--N 1.347 0.484 0 C-N-CA 122.645 2.23 . . . . 0.0 113.346 -179.569 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 4.6 t -77.05 -65.17 0.98 Allowed 'General case' 0 CA--C 1.53 0.206 0 CA-C-O 120.416 0.15 . . . . 0.0 111.397 -179.738 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 22.6 p -92.18 -19.55 22.13 Favored 'General case' 0 N--CA 1.465 0.324 0 N-CA-C 112.195 0.442 . . . . 0.0 112.195 -179.426 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 72.96 36.4 0.88 Allowed 'General case' 0 CA--C 1.533 0.302 0 CA-C-O 120.886 0.374 . . . . 0.0 110.905 -179.609 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.604 HD23 HG23 ' A' ' 55' ' ' ILE . 6.4 tt -94.94 149.51 21.17 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.736 179.792 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 54' ' ' MET . . . . . . . . . . . . . 38.7 mtt -93.14 129.75 39.03 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-N 116.462 -0.335 . . . . 0.0 111.357 -179.487 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.604 HG23 HD23 ' A' ' 53' ' ' LEU . 2.5 pp -137.99 152.47 26.27 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.343 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.47 179.783 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 42.5 m-20 -108.7 107.63 18.16 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.64 179.067 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 14.5 p -99.43 125.63 52.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-O 120.967 0.413 . . . . 0.0 111.026 179.835 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 13.3 p -93.74 142.66 12.98 Favored 'Isoleucine or valine' 0 C--O 1.234 0.258 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.194 -179.88 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 3.0 p90 -131.03 144.39 51.42 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.623 -179.386 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -95.13 -22.67 17.72 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-N 115.997 -0.547 . . . . 0.0 112.028 -179.93 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 3.3 mttt 65.82 27.49 11.05 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-O 120.603 0.24 . . . . 0.0 111.412 -179.575 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 12.5 tt0 -95.47 -49.64 5.33 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-O 120.919 0.39 . . . . 0.0 110.104 179.474 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -66.51 -33.78 76.45 Favored 'General case' 0 N--CA 1.462 0.169 0 CA-C-N 115.746 -0.661 . . . . 0.0 111.129 179.577 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.82 ' HG ' HD12 ' A' ' 36' ' ' LEU . 0.2 OUTLIER -52.86 -34.62 55.17 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 116.679 -0.237 . . . . 0.0 111.495 -179.711 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -86.44 -48.73 8.17 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-N 116.663 -0.244 . . . . 0.0 111.56 -179.981 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 23.5 mt-10 -65.8 -54.17 30.54 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-O 120.664 0.268 . . . . 0.0 111.256 -179.674 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 67' ' ' TYR . . . . . 0.411 ' HA ' ' HB2' ' A' ' 70' ' ' GLU . 2.6 t80 -59.64 -23.69 63.25 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.3 179.412 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -57.27 -54.88 41.76 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-O 120.665 0.269 . . . . 0.0 110.962 179.834 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 37.1 mt-10 -79.97 -35.57 37.35 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.763 179.771 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 70' ' ' GLU . . . . . 0.411 ' HB2' ' HA ' ' A' ' 67' ' ' TYR . 25.0 mt-10 -62.84 -37.27 86.14 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.188 179.868 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.234 0.269 0 CA-C-O 120.893 0.378 . . . . 0.0 111.353 -179.935 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 4' ' ' THR . . . . . 0.413 HG21 ' CG ' ' A' ' 56' ' ' ASP . 3.1 p . . . . . 0 N--CA 1.472 0.661 0 CA-C-O 120.781 0.324 . . . . 0.0 111.306 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 5' ' ' TYR . . . . . 0.444 ' CG ' HD11 ' A' ' 53' ' ' LEU . 0.2 OUTLIER -111.64 -41.59 4.03 Favored 'General case' 0 CA--C 1.53 0.186 0 CA-C-N 116.517 -0.31 . . . . 0.0 111.311 -179.955 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -155.56 176.09 13.05 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-O 120.697 0.284 . . . . 0.0 111.207 -179.991 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 7' ' ' GLU . . . . . 0.562 ' O ' HD13 ' A' ' 8' ' ' ILE . 3.9 pt-20 -130.22 131.22 45.45 Favored 'General case' 0 CA--C 1.531 0.234 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.15 179.798 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.562 HD13 ' O ' ' A' ' 7' ' ' GLU . 26.5 mm -130.03 154.16 39.98 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.281 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.455 -179.812 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 9.7 mt-10 -103.78 148.22 26.36 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.062 179.843 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 33.8 pt -58.76 -32.43 46.72 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.325 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.347 179.537 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 4.4 mt-10 -60.45 -30.39 69.62 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.223 179.726 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 5.6 t0 -98.52 39.0 1.28 Allowed 'General case' 0 CA--C 1.532 0.278 0 CA-C-O 120.902 0.382 . . . . 0.0 111.038 179.727 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' MET . . . . . 0.415 ' HG2' ' HB2' ' A' ' 24' ' ' TYR . 0.1 OUTLIER -132.98 143.39 49.41 Favored 'General case' 0 C--O 1.232 0.172 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.585 179.833 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 1.2 m -62.18 121.12 12.3 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-O 120.734 0.302 . . . . 0.0 111.172 -179.582 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 20.8 p90 -87.76 125.44 34.43 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.695 179.597 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 -112.22 86.38 7.84 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.405 179.852 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 40.0 Cg_endo -67.45 -20.09 48.41 Favored 'Trans proline' 0 C--N 1.347 0.487 0 C-N-CA 122.673 2.248 . . . . 0.0 112.786 -179.989 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -53.33 -36.15 60.96 Favored 'General case' 0 CA--C 1.53 0.2 0 CA-C-N 116.591 -0.277 . . . . 0.0 111.337 179.884 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 3.0 t-20 -138.54 22.73 2.71 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-N 116.534 -0.303 . . . . 0.0 111.652 179.867 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 8.4 tt0 50.32 65.35 1.47 Allowed 'General case' 0 CA--C 1.534 0.347 0 CA-C-O 120.975 0.416 . . . . 0.0 111.454 179.916 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' MET . . . . . 0.467 ' HB3' ' CD1' ' A' ' 35' ' ' TYR . 23.3 ptt? -149.62 172.65 14.7 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.137 179.86 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.415 ' CD1' HD21 ' A' ' 36' ' ' LEU . 16.1 m-85 -130.3 134.29 47.1 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.026 179.86 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 11.8 p -130.53 136.29 48.8 Favored 'General case' 0 N--CA 1.462 0.162 0 CA-C-N 116.389 -0.368 . . . . 0.0 111.269 -179.893 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' TYR . . . . . 0.415 ' HB2' ' HG2' ' A' ' 13' ' ' MET . 32.7 t80 -139.38 137.46 19.02 Favored Pre-proline 0 C--N 1.333 -0.137 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.982 179.895 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -72.06 103.68 1.53 Allowed 'Trans proline' 0 C--N 1.348 0.517 0 C-N-CA 122.685 2.256 . . . . 0.0 112.507 179.924 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' CYS . . . . . 0.415 ' SG ' ' HD2' ' A' ' 27' ' ' PRO . 48.7 t -64.31 139.29 97.67 Favored Pre-proline 0 C--O 1.233 0.23 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.696 179.75 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 27' ' ' PRO . . . . . 0.415 ' HD2' ' SG ' ' A' ' 26' ' ' CYS . 71.0 Cg_exo -50.06 -26.01 13.82 Favored 'Trans proline' 0 C--N 1.352 0.713 0 C-N-CA 122.932 2.422 . . . . 0.0 113.237 179.844 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 7.7 p -57.94 -28.65 64.5 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-O 120.578 0.228 . . . . 0.0 111.434 179.944 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 122.84 6.79 7.62 Favored Glycine 0 CA--C 1.524 0.629 0 C-N-CA 121.096 -0.573 . . . . 0.0 113.513 -179.995 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -122.37 -173.33 2.65 Favored 'General case' 0 CA--C 1.532 0.252 0 CA-C-N 117.237 0.519 . . . . 0.0 111.001 179.954 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 7.1 ttm-85 -118.94 130.11 55.53 Favored 'General case' 0 N--CA 1.463 0.183 0 CA-C-O 120.807 0.337 . . . . 0.0 111.378 -179.854 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 32' ' ' PHE . . . . . 0.424 ' CZ ' ' HB1' ' A' ' 46' ' ' ALA . 64.6 t80 -91.84 157.48 16.85 Favored 'General case' 0 CA--C 1.529 0.164 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.917 179.673 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -140.13 129.3 23.72 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.067 179.749 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.47 ' O ' HG23 ' A' ' 34' ' ' ILE . 3.1 tt -139.06 115.65 10.24 Favored 'Isoleucine or valine' 0 C--O 1.234 0.254 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.986 179.626 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 35' ' ' TYR . . . . . 0.467 ' CD1' ' HB3' ' A' ' 21' ' ' MET . 41.6 m-85 -74.5 141.63 44.88 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.996 -179.88 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.624 ' O ' HD11 ' A' ' 64' ' ' LEU . 3.9 mm? -59.54 -38.29 80.65 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.006 179.686 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 1.2 p30 -60.88 -40.22 92.19 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 116.477 -0.329 . . . . 0.0 110.849 179.524 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 2.5 t70 -63.17 -39.56 95.02 Favored 'General case' 0 N--CA 1.462 0.134 0 CA-C-N 116.493 -0.321 . . . . 0.0 110.895 179.73 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 39' ' ' MET . . . . . 0.47 ' SD ' HD13 ' A' ' 36' ' ' LEU . 5.0 mtt -61.99 -29.49 70.29 Favored 'General case' 0 N--CA 1.463 0.187 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.115 179.604 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -57.13 -35.99 70.14 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 116.536 -0.302 . . . . 0.0 111.035 179.662 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 8.3 mt-10 -66.99 -34.4 77.67 Favored 'General case' 0 CA--C 1.531 0.234 0 CA-C-N 116.511 -0.313 . . . . 0.0 110.835 179.628 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 124.56 64.02 0.19 Allowed Glycine 0 C--N 1.335 0.49 0 C-N-CA 120.982 -0.628 . . . . 0.0 112.557 179.631 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 2.1 tp10 -104.25 105.93 16.25 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-O 120.729 0.3 . . . . 0.0 111.084 179.955 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -111.44 -33.79 6.3 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.044 179.431 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.446 HG22 ' OD1' ' A' ' 56' ' ' ASP . 18.8 t -115.96 87.68 1.07 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.273 0 CA-C-O 120.905 0.383 . . . . 0.0 110.659 179.752 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.424 ' HB1' ' CZ ' ' A' ' 32' ' ' PHE . . . -82.94 162.65 21.44 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.21 -179.796 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 11.6 p -121.38 122.95 68.63 Favored 'Isoleucine or valine' 0 C--O 1.233 0.206 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.083 179.926 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 49.3 t -63.04 135.43 96.22 Favored Pre-proline 0 C--N 1.331 -0.217 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.724 179.96 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 93.6 Cg_endo -83.3 19.76 1.28 Allowed 'Trans proline' 0 CA--C 1.535 0.555 0 C-N-CA 122.623 2.215 . . . . 0.0 113.307 -179.855 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -129.15 -57.19 1.16 Allowed 'General case' 0 C--O 1.233 0.188 0 CA-C-O 120.459 0.171 . . . . 0.0 110.628 179.661 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 17.9 p -101.68 -10.92 19.57 Favored 'General case' 0 N--CA 1.465 0.319 0 N-CA-C 111.956 0.354 . . . . 0.0 111.956 179.881 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 5.8 p 61.0 35.64 18.88 Favored 'General case' 0 CA--C 1.535 0.403 0 CA-C-O 120.842 0.354 . . . . 0.0 111.502 179.842 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.618 HD23 HG23 ' A' ' 55' ' ' ILE . 7.7 tt -89.07 134.6 33.94 Favored 'General case' 0 CA--C 1.53 0.2 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.534 179.748 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 54' ' ' MET . . . . . . . . . . . . . 20.4 mtt -84.6 135.79 34.04 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.062 -179.773 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.618 HG23 HD23 ' A' ' 53' ' ' LEU . 2.7 pt -138.81 137.56 42.68 Favored 'Isoleucine or valine' 0 C--O 1.234 0.261 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.751 -179.778 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 56' ' ' ASP . . . . . 0.446 ' OD1' HG22 ' A' ' 45' ' ' VAL . 55.5 m-20 -87.13 88.67 7.76 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.675 179.305 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.517 ' O ' HG13 ' A' ' 57' ' ' VAL . 14.2 p -88.38 112.47 23.86 Favored 'Isoleucine or valine' 0 C--O 1.234 0.263 0 CA-C-O 121.003 0.43 . . . . 0.0 111.004 179.901 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 14.4 p -86.72 127.72 40.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.935 179.997 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 29.1 p90 -124.82 177.76 5.84 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.936 -0.575 . . . . 0.0 111.114 -179.606 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -133.1 144.38 49.91 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.169 -179.807 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 8.1 tttt -74.88 -40.76 60.76 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.84 179.585 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 6.3 tt0 -58.03 -48.8 78.98 Favored 'General case' 0 N--CA 1.462 0.131 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.559 179.587 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -55.03 -50.15 69.78 Favored 'General case' 0 C--O 1.232 0.153 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.033 179.691 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.624 HD11 ' O ' ' A' ' 36' ' ' LEU . 0.3 OUTLIER -56.88 -40.32 75.98 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.132 179.976 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -61.27 -38.29 86.22 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-N 116.451 -0.34 . . . . 0.0 111.163 179.645 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -76.05 -47.46 24.62 Favored 'General case' 0 C--O 1.231 0.125 0 CA-C-N 116.474 -0.33 . . . . 0.0 111.075 179.639 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 6.5 m-85 -55.75 -32.75 63.68 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 116.468 -0.333 . . . . 0.0 111.384 179.876 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 1.8 t80 -59.09 -41.31 87.75 Favored 'General case' 0 C--O 1.232 0.184 0 CA-C-O 120.695 0.284 . . . . 0.0 110.713 179.644 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 6.4 tt0 -84.82 -38.94 18.94 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.803 179.447 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 4.9 tt0 -62.29 -39.69 93.79 Favored 'General case' 0 CA--C 1.529 0.169 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.252 -179.958 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.233 0.194 0 CA-C-N 116.597 -0.274 . . . . 0.0 111.132 179.729 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 2.4 p . . . . . 0 N--CA 1.469 0.505 0 CA-C-O 121.201 0.524 . . . . 0.0 111.432 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 5' ' ' TYR . . . . . 0.414 ' CE1' HD21 ' A' ' 53' ' ' LEU . 7.9 m-85 -114.8 -37.33 4.24 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.747 -0.66 . . . . 0.0 111.381 -179.844 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -157.53 176.72 12.27 Favored 'General case' 0 C--O 1.236 0.344 0 CA-C-O 120.698 0.285 . . . . 0.0 111.094 179.752 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -122.7 140.94 52.31 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.966 179.802 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 25.0 mt -125.83 154.62 34.91 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.17 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.196 -179.811 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 17.1 mt-10 -109.04 150.62 27.52 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-N 116.345 -0.388 . . . . 0.0 111.108 179.957 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.665 HD11 ' CE2' ' A' ' 22' ' ' PHE . 16.5 tt -59.01 -28.88 39.93 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.292 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.58 179.697 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 20.5 mt-10 -58.26 -31.13 67.14 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-N 116.528 -0.305 . . . . 0.0 111.285 179.666 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -94.36 28.48 2.54 Favored 'General case' 0 CA--C 1.536 0.41 0 CA-C-N 116.695 -0.23 . . . . 0.0 111.41 179.643 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 1.4 ttp -122.75 167.56 13.33 Favored 'General case' 0 CA--C 1.53 0.176 0 CA-C-O 120.648 0.261 . . . . 0.0 111.234 -179.736 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -105.36 117.24 33.52 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.77 179.891 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 15' ' ' PHE . . . . . 0.513 ' HB3' ' CE2' ' A' ' 22' ' ' PHE . 37.2 p90 -96.0 147.78 23.34 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.974 179.826 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -144.43 150.25 47.13 Favored Pre-proline 0 N--CA 1.463 0.211 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.398 179.875 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 70.2 Cg_endo -73.8 -14.74 24.17 Favored 'Trans proline' 0 C--N 1.348 0.55 0 C-N-CA 123.056 2.504 . . . . 0.0 113.098 179.613 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -69.03 82.53 0.32 Allowed 'General case' 0 CA--C 1.53 0.185 0 CA-C-O 121.179 0.514 . . . . 0.0 110.868 -179.824 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 6.8 m-80 67.51 20.7 9.73 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 115.564 -0.744 . . . . 0.0 111.797 -179.556 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' GLN . . . . . 0.619 ' HG2' HD12 ' A' ' 36' ' ' LEU . 16.7 mt-30 54.14 77.54 0.19 Allowed 'General case' 0 CA--C 1.532 0.257 0 CA-C-O 120.854 0.359 . . . . 0.0 111.428 179.596 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -116.62 145.25 43.53 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.034 179.967 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.665 ' CE2' HD11 ' A' ' 10' ' ' ILE . 12.3 m-85 -125.92 94.86 4.23 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.654 -179.901 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 32.2 p -91.79 146.14 24.0 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.419 -179.49 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 23.0 t80 -142.59 137.18 15.09 Favored Pre-proline 0 CA--C 1.53 0.184 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.036 -179.942 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -65.32 100.02 0.37 Allowed 'Trans proline' 0 C--N 1.349 0.596 0 C-N-CA 122.694 2.263 . . . . 0.0 112.272 179.604 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' CYS . . . . . 0.403 ' SG ' ' HD2' ' A' ' 27' ' ' PRO . 48.1 t -65.94 139.01 96.56 Favored Pre-proline 0 C--O 1.233 0.229 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.699 179.903 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 27' ' ' PRO . . . . . 0.403 ' HD2' ' SG ' ' A' ' 26' ' ' CYS . 54.8 Cg_exo -53.25 -25.41 30.21 Favored 'Trans proline' 0 C--N 1.35 0.649 0 C-N-CA 122.82 2.346 . . . . 0.0 112.83 179.666 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -68.26 -38.54 81.86 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-O 120.451 0.167 . . . . 0.0 111.268 179.985 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 152.16 -47.47 0.56 Allowed Glycine 0 C--N 1.335 0.477 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.962 -179.987 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -76.74 -174.69 3.11 Favored 'General case' 0 CA--C 1.531 0.223 0 CA-C-O 120.694 0.283 . . . . 0.0 111.12 -179.783 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 12.3 mtt180 -122.36 137.41 54.87 Favored 'General case' 0 C--O 1.232 0.164 0 CA-C-O 120.829 0.347 . . . . 0.0 111.097 -179.853 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 9.1 m-85 -66.47 167.85 10.03 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.004 179.774 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 12.6 pt20 -154.18 97.64 2.06 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.114 -179.985 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 10.7 tt -123.97 151.52 28.94 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.216 0 CA-C-N 116.29 -0.413 . . . . 0.0 111.293 179.996 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 6.3 m-85 -102.53 152.69 20.86 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.839 -179.961 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.619 HD12 ' HG2' ' A' ' 20' ' ' GLN . 25.6 mt -61.6 -43.04 99.6 Favored 'General case' 0 N--CA 1.463 0.175 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.032 179.798 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -60.25 -38.13 82.53 Favored 'General case' 0 CA--C 1.53 0.187 0 CA-C-N 116.405 -0.362 . . . . 0.0 111.032 179.65 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -59.19 -57.04 14.79 Favored 'General case' 0 N--CA 1.462 0.158 0 CA-C-O 120.769 0.319 . . . . 0.0 110.81 179.711 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 47.6 mtm -61.32 -37.77 84.46 Favored 'General case' 0 N--CA 1.462 0.157 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.024 179.589 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 17.7 t80 -58.11 -38.7 76.96 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.999 179.586 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 1.3 tp10 -62.05 -45.13 94.9 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-N 116.507 -0.315 . . . . 0.0 110.761 179.576 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 152.29 48.34 0.02 OUTLIER Glycine 0 C--N 1.332 0.34 0 C-N-CA 120.979 -0.629 . . . . 0.0 112.694 179.627 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 1.1 tp10 -99.53 147.61 25.14 Favored 'General case' 0 C--O 1.231 0.106 0 CA-C-O 120.754 0.311 . . . . 0.0 110.99 179.921 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 7.9 mttt -149.37 -47.99 0.14 Allowed 'General case' 0 C--O 1.233 0.217 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.133 179.752 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.432 HG22 ' OD1' ' A' ' 56' ' ' ASP . 24.3 t -106.86 104.52 17.18 Favored 'Isoleucine or valine' 0 C--O 1.234 0.257 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.862 179.957 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -92.7 174.64 7.16 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.076 179.813 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 10.7 p -134.9 123.57 41.22 Favored 'Isoleucine or valine' 0 C--O 1.233 0.214 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.205 -179.954 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 48.3 t -70.31 135.77 86.66 Favored Pre-proline 0 C--N 1.332 -0.186 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.807 179.869 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_endo -84.13 20.94 1.13 Allowed 'Trans proline' 0 CA--C 1.536 0.581 0 C-N-CA 122.762 2.308 . . . . 0.0 113.077 179.682 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -128.71 -55.72 1.22 Allowed 'General case' 0 C--O 1.232 0.155 0 CA-C-N 116.67 -0.241 . . . . 0.0 110.626 179.903 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 18.6 p -98.31 -17.69 18.76 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.848 179.906 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 5.6 p 63.93 37.15 9.65 Favored 'General case' 0 CA--C 1.535 0.382 0 CA-C-O 120.987 0.422 . . . . 0.0 111.438 179.865 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.496 HD13 ' N ' ' A' ' 54' ' ' MET . 1.3 tm? -101.99 130.62 48.57 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.491 179.7 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 54' ' ' MET . . . . . 0.496 ' N ' HD13 ' A' ' 53' ' ' LEU . 60.6 mtm -83.95 135.18 34.56 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.836 179.997 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.463 ' O ' HD12 ' A' ' 55' ' ' ILE . 2.5 pp -137.51 134.35 46.42 Favored 'Isoleucine or valine' 0 C--O 1.233 0.23 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.564 -179.89 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 56' ' ' ASP . . . . . 0.432 ' OD1' HG22 ' A' ' 45' ' ' VAL . 20.1 m-20 -82.41 100.95 10.32 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.766 179.597 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.468 ' O ' HG13 ' A' ' 57' ' ' VAL . 13.5 p -104.02 116.66 48.22 Favored 'Isoleucine or valine' 0 C--O 1.233 0.227 0 CA-C-O 121.133 0.492 . . . . 0.0 111.179 179.9 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 12.4 p -87.55 137.53 20.82 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.939 -179.94 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 44.3 p90 -124.66 175.98 6.85 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.072 -179.67 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -114.02 155.94 24.99 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.144 -179.881 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 56.6 mttt -92.96 -44.44 8.43 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.742 179.674 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 16.2 pt-20 -57.84 -36.04 71.73 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 116.473 -0.33 . . . . 0.0 110.927 179.61 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -55.68 -53.3 58.3 Favored 'General case' 0 N--CA 1.461 0.125 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.67 179.523 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 3.0 mp -55.43 -39.35 70.14 Favored 'General case' 0 N--CA 1.462 0.159 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.211 179.631 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -58.76 -60.15 4.29 Favored 'General case' 0 CA--C 1.528 0.11 0 CA-C-N 116.507 -0.315 . . . . 0.0 111.173 179.885 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -63.72 -40.6 97.15 Favored 'General case' 0 N--CA 1.464 0.225 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.221 179.708 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 67' ' ' TYR . . . . . 0.617 ' O ' ' HB2' ' A' ' 71' ' ' ALA . 3.2 m-85 -63.16 -55.51 24.57 Favored 'General case' 0 C--O 1.227 -0.129 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.233 -179.82 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 3.0 t80 -61.56 -43.98 97.87 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 116.592 -0.276 . . . . 0.0 110.89 179.998 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 4.0 tt0 -58.11 -30.42 66.28 Favored 'General case' 0 CA--C 1.53 0.21 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.975 179.541 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -130.74 59.55 1.66 Allowed 'General case' 0 C--O 1.234 0.26 0 CA-C-O 120.839 0.352 . . . . 0.0 111.107 -179.927 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 71' ' ' ALA . . . . . 0.617 ' HB2' ' O ' ' A' ' 67' ' ' TYR . . . . . . . . 0 C--O 1.234 0.251 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.536 179.926 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 4' ' ' THR . . . . . 0.48 HG22 ' O ' ' A' ' 54' ' ' MET . 0.2 OUTLIER . . . . . 0 N--CA 1.467 0.384 0 CA-C-O 120.747 0.308 . . . . 0.0 110.982 . . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 21.4 m-85 -105.58 -76.4 0.61 Allowed 'General case' 0 C--O 1.232 0.167 0 CA-C-N 116.48 -0.327 . . . . 0.0 111.176 -179.739 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -126.66 171.77 10.87 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.002 -179.813 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 4.6 pt-20 -132.64 136.31 46.41 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-N 116.405 -0.361 . . . . 0.0 111.014 179.654 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 3.7 mp -118.48 150.4 20.72 Favored 'Isoleucine or valine' 0 C--O 1.233 0.226 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.375 -179.605 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 9' ' ' GLU . . . . . 0.446 ' HA ' HG12 ' A' ' 58' ' ' VAL . 12.2 mt-10 -98.97 153.55 18.76 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.366 -179.905 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 1.1 tp -59.25 -32.61 48.65 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.286 0 CA-C-N 115.989 -0.55 . . . . 0.0 111.223 179.551 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -61.21 -33.17 73.04 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-N 116.551 -0.295 . . . . 0.0 110.998 179.514 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -96.91 37.37 1.31 Allowed 'General case' 0 C--O 1.234 0.27 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.177 179.816 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 13' ' ' MET . . . . . 0.516 ' HG2' ' CD1' ' A' ' 24' ' ' TYR . 3.3 mtp -125.75 150.09 48.02 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-N 116.407 -0.361 . . . . 0.0 110.887 179.798 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 7.3 m -96.7 113.57 25.14 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.766 179.679 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 24.2 p90 -80.38 130.18 35.0 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.517 179.632 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 3.9 tt0 -107.23 95.83 14.18 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.625 -179.949 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -72.87 60.84 3.72 Favored 'Trans proline' 0 C--N 1.347 0.492 0 C-N-CA 122.69 2.26 . . . . 0.0 112.58 -179.734 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 15.1 pt-20 -126.67 -45.27 1.63 Allowed 'General case' 0 C--O 1.233 0.189 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.876 179.915 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 2.2 t-20 -146.55 33.64 0.95 Allowed 'General case' 0 CA--C 1.532 0.276 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.066 179.636 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 10.1 mt-30 57.9 57.75 3.98 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.222 179.851 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 21.8 ptm -136.62 151.44 49.33 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.672 179.658 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.611 ' HE1' HD23 ' A' ' 36' ' ' LEU . 7.6 m-85 -130.24 124.85 33.44 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.388 -179.899 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 23' ' ' THR . . . . . 0.767 HG22 ' HA ' ' A' ' 33' ' ' GLN . 64.3 p -120.24 137.5 54.18 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.952 -179.581 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 24' ' ' TYR . . . . . 0.516 ' CD1' ' HG2' ' A' ' 13' ' ' MET . 1.9 p90 -131.54 148.17 68.97 Favored Pre-proline 0 C--O 1.233 0.195 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.133 179.867 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_exo -52.52 124.72 15.81 Favored 'Trans proline' 0 C--N 1.349 0.584 0 C-N-CA 122.872 2.381 . . . . 0.0 112.774 -179.671 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' CYS . . . . . 0.491 ' SG ' ' HD2' ' A' ' 27' ' ' PRO . 50.5 t -94.9 141.21 22.98 Favored Pre-proline 0 C--N 1.33 -0.244 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.342 179.587 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 27' ' ' PRO . . . . . 0.491 ' HD2' ' SG ' ' A' ' 26' ' ' CYS . 87.6 Cg_exo -48.08 -30.11 13.63 Favored 'Trans proline' 0 C--N 1.349 0.578 0 C-N-CA 122.846 2.364 . . . . 0.0 113.192 179.914 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 28' ' ' CYS . . . . . 0.405 ' CB ' ' HB3' ' A' ' 51' ' ' CYS . 0.8 OUTLIER -76.96 -40.36 47.2 Favored 'General case' 0 CA--C 1.532 0.267 0 CA-C-N 116.818 -0.174 . . . . 0.0 111.32 179.986 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 151.77 -45.07 0.63 Allowed Glycine 0 C--N 1.335 0.516 0 C-N-CA 120.49 -0.862 . . . . 0.0 113.175 179.753 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 50.6 m-20 -67.33 -177.74 0.74 Allowed 'General case' 0 CA--C 1.532 0.271 0 CA-C-O 120.912 0.387 . . . . 0.0 111.123 -179.808 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -110.97 128.15 55.74 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.875 -179.716 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 15.0 m-85 -64.66 91.46 0.08 Allowed 'General case' 0 C--O 1.233 0.227 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.7 179.816 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 33' ' ' GLN . . . . . 0.767 ' HA ' HG22 ' A' ' 23' ' ' THR . 2.9 pt20 -80.13 125.86 30.36 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.228 -179.65 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 2.5 tt -161.26 133.77 1.09 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.207 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.066 179.723 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 71.3 m-85 -88.11 145.52 25.9 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.775 -179.947 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.611 HD23 ' HE1' ' A' ' 22' ' ' PHE . 4.1 pp -58.01 -33.38 68.88 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.215 179.74 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 37' ' ' ASP . . . . . 0.55 ' N ' HD12 ' A' ' 36' ' ' LEU . 1.2 p30 -65.3 -39.07 92.03 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 116.567 -0.288 . . . . 0.0 110.785 179.493 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -61.87 -46.95 87.19 Favored 'General case' 0 CA--C 1.528 0.116 0 CA-C-N 116.422 -0.353 . . . . 0.0 110.839 179.781 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 55.6 mtm -74.37 -33.1 62.98 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.176 179.825 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 40' ' ' PHE . . . . . 0.417 ' HB2' HD21 ' A' ' 64' ' ' LEU . 18.4 t80 -57.09 -38.27 73.09 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.029 -179.931 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 21.6 mt-10 -60.71 -37.18 80.83 Favored 'General case' 0 N--CA 1.462 0.147 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.889 179.548 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 145.56 47.62 0.03 OUTLIER Glycine 0 C--N 1.333 0.391 0 C-N-CA 120.94 -0.647 . . . . 0.0 112.69 179.794 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -112.56 148.2 35.02 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-O 120.741 0.305 . . . . 0.0 111.161 -179.845 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 22.8 mtmt -148.09 -48.24 0.16 Allowed 'General case' 0 CA--C 1.531 0.219 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.076 179.815 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.45 HG22 ' OD1' ' A' ' 56' ' ' ASP . 23.7 t -89.87 94.79 5.03 Favored 'Isoleucine or valine' 0 C--O 1.232 0.178 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.805 -179.985 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -91.6 159.18 16.03 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.188 -179.884 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 11.6 p -126.04 128.45 71.84 Favored 'Isoleucine or valine' 0 C--O 1.232 0.169 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.371 -179.904 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 42.0 t -71.21 136.73 84.32 Favored Pre-proline 0 CA--C 1.53 0.201 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.884 179.714 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 92.9 Cg_endo -82.8 20.35 1.16 Allowed 'Trans proline' 0 C--N 1.35 0.629 0 C-N-CA 122.751 2.301 . . . . 0.0 113.136 179.742 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 38.9 t -128.59 -58.11 1.18 Allowed 'General case' 0 C--O 1.232 0.153 0 N-CA-C 110.265 -0.272 . . . . 0.0 110.265 179.539 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 51' ' ' CYS . . . . . 0.816 ' SG ' HD23 ' A' ' 53' ' ' LEU . 20.7 p -94.26 -27.0 16.38 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.483 179.711 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 1.5 t 70.92 42.92 0.73 Allowed 'General case' 0 CA--C 1.532 0.275 0 CA-C-O 120.931 0.396 . . . . 0.0 110.968 -179.838 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.816 HD23 ' SG ' ' A' ' 51' ' ' CYS . 3.6 mm? -92.34 150.69 20.69 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.63 179.64 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 54' ' ' MET . . . . . 0.48 ' O ' HG22 ' A' ' 4' ' ' THR . 9.7 mtt -104.66 123.05 46.92 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.904 -179.791 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 2.6 pp -134.99 148.3 29.1 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.313 0 CA-C-N 116.363 -0.38 . . . . 0.0 111.842 -179.883 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 56' ' ' ASP . . . . . 0.45 ' OD1' HG22 ' A' ' 45' ' ' VAL . 32.1 m-20 -102.4 92.36 4.66 Favored 'General case' 0 CA--C 1.531 0.223 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.95 179.657 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 13.1 p -88.97 127.83 41.46 Favored 'Isoleucine or valine' 0 C--O 1.234 0.256 0 CA-C-O 120.851 0.357 . . . . 0.0 110.986 179.72 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.446 HG12 ' HA ' ' A' ' 9' ' ' GLU . 12.5 p -97.97 136.53 28.52 Favored 'Isoleucine or valine' 0 C--O 1.234 0.251 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.398 -179.837 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 16.1 p90 -123.82 170.12 10.88 Favored 'General case' 0 CA--C 1.53 0.184 0 CA-C-N 115.899 -0.591 . . . . 0.0 111.073 -179.966 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -107.63 160.13 15.93 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.106 179.734 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -89.17 -37.85 14.73 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.032 179.691 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -72.21 -38.83 68.91 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-N 116.618 -0.265 . . . . 0.0 111.171 179.944 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 88.7 m-20 -52.71 -41.65 64.11 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.001 -179.988 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.417 HD21 ' HB2' ' A' ' 40' ' ' PHE . 0.8 OUTLIER -63.7 -52.35 60.97 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.979 -179.933 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -57.47 -39.26 75.97 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-N 116.489 -0.323 . . . . 0.0 110.736 179.57 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -73.83 -46.43 45.15 Favored 'General case' 0 N--CA 1.461 0.124 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.273 179.67 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 9.3 t80 -60.61 -37.67 82.18 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 116.713 -0.221 . . . . 0.0 111.237 -179.946 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 13.9 t80 -58.29 -41.34 84.17 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-O 120.55 0.214 . . . . 0.0 110.813 179.742 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 9.5 mt-10 -87.93 -35.38 17.71 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.496 -179.801 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 -72.18 -33.37 67.63 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 116.65 -0.25 . . . . 0.0 111.583 -179.843 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.233 0.232 0 CA-C-O 120.819 0.342 . . . . 0.0 111.329 -179.939 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 4' ' ' THR . . . . . 0.408 HG21 ' CG ' ' A' ' 56' ' ' ASP . 0.8 OUTLIER . . . . . 0 N--CA 1.464 0.262 0 CA-C-O 120.906 0.384 . . . . 0.0 111.36 . . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 15.3 m-85 -103.6 -36.2 8.01 Favored 'General case' 0 CA--C 1.53 0.194 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.381 179.849 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -158.78 171.45 20.05 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-O 120.701 0.286 . . . . 0.0 111.322 -179.97 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -127.54 140.5 52.09 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.005 -179.897 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 27.1 mm -120.48 156.01 23.61 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.254 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.926 -179.865 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 10.0 mt-10 -119.63 159.82 23.67 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-O 120.739 0.304 . . . . 0.0 111.323 179.848 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 11.5 tt -65.39 -30.95 51.77 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.351 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.481 179.37 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -60.02 -42.33 94.14 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-O 120.45 0.166 . . . . 0.0 111.331 -179.878 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 8.4 p-10 -98.09 37.05 1.47 Allowed 'General case' 0 CA--C 1.535 0.378 0 CA-C-O 120.824 0.345 . . . . 0.0 111.329 179.589 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -114.43 139.74 49.26 Favored 'General case' 0 C--O 1.233 0.236 0 N-CA-C 109.655 -0.498 . . . . 0.0 109.655 179.182 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 2.9 m -66.87 89.84 0.17 Allowed 'General case' 0 C--O 1.233 0.207 0 CA-C-O 120.86 0.362 . . . . 0.0 110.651 -179.649 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 52.1 p90 -80.2 127.71 32.66 Favored 'General case' 0 C--O 1.232 0.159 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.752 -179.979 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 5.8 mt-10 -109.1 93.92 13.93 Favored Pre-proline 0 C--O 1.236 0.346 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.347 179.845 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -71.64 64.77 3.05 Favored 'Trans proline' 0 C--N 1.346 0.398 0 C-N-CA 122.943 2.429 . . . . 0.0 112.351 -179.794 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 17.1 pt-20 -140.29 -45.86 0.42 Allowed 'General case' 0 CA--C 1.531 0.226 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.916 179.934 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 44.9 p30 -134.69 24.11 3.67 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.557 -179.998 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' GLN . . . . . 0.4 ' HG2' ' HB2' ' A' ' 36' ' ' LEU . 0.2 OUTLIER 60.79 47.05 8.27 Favored 'General case' 0 C--O 1.235 0.325 0 CA-C-O 120.944 0.402 . . . . 0.0 111.053 179.983 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 20.2 ttt -114.77 143.13 45.56 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.919 -179.917 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.488 ' CD1' HD21 ' A' ' 36' ' ' LEU . 4.1 m-85 -127.92 104.34 7.75 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.702 179.649 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 23' ' ' THR . . . . . 0.412 HG22 ' HG2' ' A' ' 33' ' ' GLN . 22.5 p -107.88 179.27 4.27 Favored 'General case' 0 CA--C 1.531 0.216 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.01 -179.962 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 63.1 t80 -173.09 135.27 0.7 Allowed Pre-proline 0 N--CA 1.466 0.338 0 CA-C-N 116.63 -0.259 . . . . 0.0 111.211 179.712 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_endo -66.92 108.05 1.42 Allowed 'Trans proline' 0 C--N 1.349 0.6 0 C-N-CA 122.611 2.207 . . . . 0.0 112.447 179.832 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' CYS . . . . . 0.438 ' SG ' ' HD2' ' A' ' 27' ' ' PRO . 42.8 t -69.36 139.64 89.7 Favored Pre-proline 0 C--N 1.332 -0.187 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.517 179.704 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 27' ' ' PRO . . . . . 0.438 ' HD2' ' SG ' ' A' ' 26' ' ' CYS . 77.7 Cg_exo -51.59 -26.95 23.93 Favored 'Trans proline' 0 C--N 1.349 0.599 0 C-N-CA 122.92 2.413 . . . . 0.0 113.072 179.833 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 28' ' ' CYS . . . . . 0.403 ' CB ' ' HB3' ' A' ' 51' ' ' CYS . 0.8 OUTLIER -70.1 -38.59 75.7 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-N 116.894 -0.139 . . . . 0.0 111.36 -179.868 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 150.86 -43.31 0.71 Allowed Glycine 0 C--N 1.335 0.483 0 C-N-CA 120.869 -0.682 . . . . 0.0 112.91 -179.842 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -70.83 -174.44 0.92 Allowed 'General case' 0 CA--C 1.535 0.383 0 CA-C-O 120.668 0.271 . . . . 0.0 111.187 -179.77 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 18.6 ttm180 -126.96 122.37 34.35 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-O 120.706 0.289 . . . . 0.0 111.385 -179.689 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 4.4 m-85 -61.86 154.14 26.9 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.849 179.527 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' GLN . . . . . 0.412 ' HG2' HG22 ' A' ' 23' ' ' THR . 32.9 mt-30 -143.02 122.04 12.83 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-N 116.455 -0.338 . . . . 0.0 111.478 179.993 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 3.9 tt -151.2 123.12 1.12 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.24 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.896 179.451 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 44.5 m-85 -81.52 158.78 24.35 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.887 -179.916 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.84 HD12 ' HG ' ' A' ' 64' ' ' LEU . 4.0 mm? -59.53 -39.39 83.75 Favored 'General case' 0 N--CA 1.463 0.225 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.847 179.829 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -59.76 -42.59 93.58 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 116.468 -0.333 . . . . 0.0 110.98 179.543 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 33.9 m-20 -58.72 -46.11 88.09 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-O 120.857 0.36 . . . . 0.0 110.475 179.696 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 5.2 mmm -61.18 -35.71 77.88 Favored 'General case' 0 CA--C 1.529 0.17 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.808 179.518 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 40' ' ' PHE . . . . . 0.595 ' CD2' HD22 ' A' ' 64' ' ' LEU . 0.3 OUTLIER -54.35 -45.6 72.77 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 116.491 -0.322 . . . . 0.0 111.293 179.933 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 6.3 mt-10 -61.43 -46.47 89.96 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 116.585 -0.28 . . . . 0.0 110.892 179.875 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 132.09 52.63 0.09 OUTLIER Glycine 0 C--N 1.333 0.376 0 C-N-CA 120.977 -0.63 . . . . 0.0 112.609 179.807 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -106.32 95.88 6.08 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-O 120.941 0.401 . . . . 0.0 111.175 -179.938 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 5.0 ptpt -105.77 -32.92 8.18 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-N 115.843 -0.617 . . . . 0.0 111.064 179.62 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.547 HG13 ' O ' ' A' ' 45' ' ' VAL . 9.5 p -86.89 74.07 1.05 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.295 0 CA-C-O 121.456 0.646 . . . . 0.0 111.001 -179.915 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -81.5 136.32 35.63 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.718 -0.674 . . . . 0.0 111.101 -179.896 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 6.4 m -109.8 125.59 66.98 Favored 'Isoleucine or valine' 0 C--O 1.232 0.18 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.337 -179.985 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 50.3 t -68.8 135.68 90.05 Favored Pre-proline 0 C--O 1.233 0.229 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.84 179.893 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_endo -84.14 20.59 1.18 Allowed 'Trans proline' 0 C--N 1.349 0.59 0 C-N-CA 122.716 2.278 . . . . 0.0 113.217 179.698 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -128.55 -57.58 1.2 Allowed 'General case' 0 C--O 1.232 0.151 0 CA-C-O 120.59 0.233 . . . . 0.0 110.582 179.712 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 51' ' ' CYS . . . . . 0.403 ' HB3' ' CB ' ' A' ' 28' ' ' CYS . 19.1 p -95.35 -22.51 17.69 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-N 116.352 -0.386 . . . . 0.0 111.658 179.828 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 1.1 t 67.53 41.37 2.36 Favored 'General case' 0 CA--C 1.533 0.314 0 CA-C-O 120.981 0.42 . . . . 0.0 110.948 -179.841 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 7.0 tp -95.66 134.32 38.7 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.846 179.86 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 54' ' ' MET . . . . . . . . . . . . . 37.7 mtt -86.07 132.3 34.07 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.0 -179.94 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 2.5 pp -142.18 139.64 29.87 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.205 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.314 -179.899 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 56' ' ' ASP . . . . . 0.408 ' CG ' HG21 ' A' ' 4' ' ' THR . 67.3 m-20 -102.07 97.28 7.63 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.68 179.362 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 12.7 p -86.39 138.01 19.84 Favored 'Isoleucine or valine' 0 C--O 1.234 0.282 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.12 179.885 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 13.4 p -104.92 133.21 49.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.876 179.89 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 37.6 p90 -132.46 176.51 8.36 Favored 'General case' 0 CA--C 1.532 0.274 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.054 -179.397 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 2.5 t70 -122.3 147.69 45.93 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.457 179.968 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 15.0 tttm -83.68 -39.0 20.73 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.82 179.435 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 20.3 mt-10 -60.0 -42.29 93.94 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-N 116.481 -0.327 . . . . 0.0 110.397 179.514 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -64.6 -44.43 90.62 Favored 'General case' 0 CA--C 1.527 0.072 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.795 179.396 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.84 ' HG ' HD12 ' A' ' 36' ' ' LEU . 0.3 OUTLIER -58.25 -43.64 87.94 Favored 'General case' 0 N--CA 1.463 0.207 0 CA-C-N 116.679 -0.237 . . . . 0.0 110.946 179.841 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -65.11 -40.94 95.22 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-N 116.409 -0.359 . . . . 0.0 110.814 179.527 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 2.3 tp10 -72.35 -43.8 63.52 Favored 'General case' 0 CA--C 1.532 0.251 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.165 179.617 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 1.4 t80 -62.48 -36.56 82.88 Favored 'General case' 0 N--CA 1.464 0.273 0 N-CA-C 111.945 0.35 . . . . 0.0 111.945 -179.589 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -59.47 -38.73 81.56 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-O 120.676 0.274 . . . . 0.0 110.624 179.963 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 -86.69 -38.6 16.84 Favored 'General case' 0 CA--C 1.53 0.205 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.048 179.766 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 73.2 mt-10 -69.15 -38.81 78.99 Favored 'General case' 0 N--CA 1.465 0.306 0 N-CA-C 111.867 0.321 . . . . 0.0 111.867 -179.394 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.157 0 C-N-CA 121.245 -0.182 . . . . 0.0 111.401 -179.749 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--O 1.233 0.221 0 CA-C-O 120.722 0.296 . . . . 0.0 111.027 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 25.7 m-85 -106.72 -74.04 0.67 Allowed 'General case' 0 C--O 1.232 0.166 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.325 -179.843 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -131.78 169.22 16.52 Favored 'General case' 0 C--O 1.234 0.279 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.152 -179.695 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 1.5 pt-20 -105.88 138.22 42.44 Favored 'General case' 0 C--O 1.232 0.166 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.234 179.987 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 31.3 mm -101.38 154.96 4.7 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.196 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.053 179.916 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 16.0 tt0 -109.18 130.3 55.49 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.947 179.94 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 18.7 tt -60.58 -31.3 48.65 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.262 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.244 179.632 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 3.1 tt0 -59.98 -31.81 70.25 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.107 179.543 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -96.26 37.12 1.27 Allowed 'General case' 0 CA--C 1.533 0.312 0 CA-C-O 120.81 0.338 . . . . 0.0 111.112 179.823 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' MET . . . . . 0.463 ' HE3' HG21 ' A' ' 57' ' ' VAL . 32.4 mtt -127.89 137.0 52.16 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-N 116.478 -0.328 . . . . 0.0 110.653 179.733 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 2.6 m -61.17 116.97 4.99 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.765 -179.847 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 23.5 p90 -86.44 134.05 33.72 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.904 -179.946 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -118.96 94.1 47.67 Favored Pre-proline 0 C--O 1.234 0.256 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.646 179.946 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_endo -68.34 -12.83 36.09 Favored 'Trans proline' 0 C--N 1.346 0.413 0 C-N-CA 122.76 2.307 . . . . 0.0 113.122 -179.926 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -54.75 -44.18 73.37 Favored 'General case' 0 CA--C 1.53 0.191 0 CA-C-N 116.812 -0.176 . . . . 0.0 111.138 -179.942 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 14.7 m-20 -144.85 24.3 1.51 Allowed 'General case' 0 CA--C 1.534 0.337 0 CA-C-N 116.435 -0.348 . . . . 0.0 111.555 179.723 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' GLN . . . . . 0.638 ' CG ' HD12 ' A' ' 36' ' ' LEU . 2.3 tp60 56.86 69.01 0.78 Allowed 'General case' 0 CA--C 1.532 0.285 0 CA-C-O 120.827 0.346 . . . . 0.0 111.7 179.561 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 11.7 ptp -141.89 150.15 41.15 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.352 -0.386 . . . . 0.0 111.139 179.662 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 7.7 m-85 -120.2 143.9 48.0 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.79 -179.941 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 58.0 p -126.68 146.69 50.1 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.232 -179.897 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 4.6 t80 -135.73 95.07 14.32 Favored Pre-proline 0 C--N 1.332 -0.177 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.605 179.815 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' PRO . . . . . 0.415 ' HA ' ' HA ' ' A' ' 31' ' ' ARG . 54.4 Cg_exo -52.13 94.31 0.03 OUTLIER 'Trans proline' 0 C--N 1.349 0.59 0 C-N-CA 122.867 2.378 . . . . 0.0 112.309 -179.932 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 29.5 t -65.38 135.63 96.03 Favored Pre-proline 0 C--O 1.233 0.224 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.792 -179.778 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -60.17 -17.49 46.16 Favored 'Trans proline' 0 C--N 1.349 0.564 0 C-N-CA 122.731 2.288 . . . . 0.0 112.861 179.684 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 3.6 p -58.72 -30.33 67.37 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-O 120.556 0.217 . . . . 0.0 111.346 179.769 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 138.64 -15.28 3.37 Favored Glycine 0 CA--C 1.523 0.577 0 C-N-CA 120.945 -0.645 . . . . 0.0 113.28 -179.897 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 3.2 t0 -113.83 -166.55 1.1 Allowed 'General case' 0 CA--C 1.534 0.333 0 CA-C-N 117.036 0.418 . . . . 0.0 111.216 -179.804 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 31' ' ' ARG . . . . . 0.415 ' HA ' ' HA ' ' A' ' 25' ' ' PRO . 16.2 ttp-105 -129.32 153.62 47.67 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.059 -179.804 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -91.27 167.02 12.62 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-N 116.09 -0.504 . . . . 0.0 111.074 179.754 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -157.58 113.76 2.87 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.885 179.608 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.408 ' CD1' ' HG3' ' A' ' 39' ' ' MET . 5.3 tt -144.37 126.54 10.43 Favored 'Isoleucine or valine' 0 C--O 1.234 0.238 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.134 -179.876 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 37.2 m-85 -81.3 155.53 25.98 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.759 -179.994 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.638 HD12 ' CG ' ' A' ' 20' ' ' GLN . 24.2 mt -58.19 -37.33 74.55 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.055 179.762 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -59.57 -40.99 89.17 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 116.387 -0.37 . . . . 0.0 110.861 179.598 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 2.7 t0 -64.08 -39.16 93.45 Favored 'General case' 0 CA--C 1.528 0.112 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.565 179.525 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 39' ' ' MET . . . . . 0.408 ' HG3' ' CD1' ' A' ' 34' ' ' ILE . 28.2 mtm -93.1 30.94 1.52 Allowed 'General case' 0 CA--C 1.532 0.279 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.115 179.467 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 16.9 t80 -131.42 -47.32 0.98 Allowed 'General case' 0 C--O 1.232 0.181 0 CA-C-N 116.547 -0.297 . . . . 0.0 110.799 179.793 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 13.5 mt-10 -58.0 -36.95 73.39 Favored 'General case' 0 CA--C 1.53 0.179 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.17 179.731 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 151.87 68.26 0.01 OUTLIER Glycine 0 C--N 1.336 0.534 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.849 179.709 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 12.8 tt0 -130.37 157.91 41.28 Favored 'General case' 0 N--CA 1.462 0.152 0 CA-C-O 120.787 0.327 . . . . 0.0 111.436 179.966 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 1.8 mtmt -154.98 -45.98 0.08 Allowed 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.016 179.873 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 5.4 m -99.32 115.27 39.64 Favored 'Isoleucine or valine' 0 C--O 1.233 0.216 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.089 -179.99 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -109.15 149.99 28.53 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.152 -179.912 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 12.8 m -109.68 135.33 48.96 Favored 'Isoleucine or valine' 0 C--O 1.233 0.207 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.388 -179.898 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 50.8 t -75.94 135.96 70.29 Favored Pre-proline 0 C--O 1.233 0.229 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.018 -179.918 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 83.7 Cg_endo -83.91 19.17 1.4 Allowed 'Trans proline' 0 CA--C 1.535 0.573 0 C-N-CA 122.719 2.279 . . . . 0.0 113.127 179.639 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 36.3 t -128.41 -58.31 1.19 Allowed 'General case' 0 C--O 1.232 0.162 0 CA-C-N 116.746 -0.206 . . . . 0.0 110.572 179.789 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 21.0 p -103.39 -18.99 14.59 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 116.398 -0.364 . . . . 0.0 111.695 179.879 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER 70.03 37.13 1.78 Allowed 'General case' 0 CA--C 1.533 0.304 0 CA-C-O 120.788 0.328 . . . . 0.0 111.106 -179.802 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 7.6 mt -75.38 142.35 43.12 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-N 116.396 -0.366 . . . . 0.0 110.643 179.712 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 54' ' ' MET . . . . . . . . . . . . . 22.5 mtt -96.01 113.85 25.5 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.972 -179.58 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 2.7 pp -131.56 162.37 39.53 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.285 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.608 -179.538 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -119.5 95.74 4.91 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.032 179.995 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.463 HG21 ' HE3' ' A' ' 13' ' ' MET . 15.0 p -89.31 128.82 41.13 Favored 'Isoleucine or valine' 0 C--O 1.234 0.251 0 CA-C-O 120.937 0.399 . . . . 0.0 111.251 179.728 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 14.0 p -91.68 152.7 3.34 Favored 'Isoleucine or valine' 0 C--O 1.234 0.239 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.142 179.93 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 15.8 p90 -136.58 174.96 10.05 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.116 -179.651 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -133.43 142.77 48.47 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.321 179.939 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.74 -41.78 62.05 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.746 179.559 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -59.44 -41.03 88.66 Favored 'General case' 0 N--CA 1.462 0.139 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.624 179.427 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -70.42 -46.68 63.44 Favored 'General case' 0 CA--C 1.528 0.121 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.988 179.695 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.497 ' HG ' HD22 ' A' ' 36' ' ' LEU . 0.2 OUTLIER -56.93 -39.36 74.35 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.187 179.882 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -76.41 -46.44 27.15 Favored 'General case' 0 C--O 1.232 0.142 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.264 179.923 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 31.4 mt-10 -58.61 -47.05 85.66 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 116.43 -0.35 . . . . 0.0 110.924 179.817 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 3.3 m-85 -58.06 -32.62 68.19 Favored 'General case' 0 C--N 1.334 -0.105 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.299 179.742 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -59.57 -34.92 73.3 Favored 'General case' 0 CA--C 1.528 0.128 0 CA-C-O 120.626 0.251 . . . . 0.0 110.988 179.666 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -91.99 -35.42 13.98 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.028 179.719 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 13.9 mt-10 -68.92 -35.59 77.0 Favored 'General case' 0 CA--C 1.53 0.197 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.134 179.774 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.233 0.193 0 CA-C-O 120.859 0.362 . . . . 0.0 111.182 179.965 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 4' ' ' THR . . . . . 0.428 HG21 ' CG ' ' A' ' 56' ' ' ASP . 0.9 OUTLIER . . . . . 0 N--CA 1.465 0.317 0 CA-C-O 120.98 0.419 . . . . 0.0 111.348 . . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 5' ' ' TYR . . . . . 0.488 ' HB2' HD21 ' A' ' 53' ' ' LEU . 92.2 m-85 -107.87 -37.47 6.1 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-N 115.873 -0.603 . . . . 0.0 111.359 179.841 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -144.94 161.45 39.31 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-O 120.814 0.34 . . . . 0.0 111.393 179.923 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 7' ' ' GLU . . . . . 0.427 ' HG2' ' HB2' ' A' ' 56' ' ' ASP . 28.5 mt-10 -141.1 143.73 34.49 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.146 -179.888 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 3.8 mp -137.84 152.33 26.46 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.424 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.11 179.83 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -97.97 154.06 17.94 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 116.442 -0.345 . . . . 0.0 110.921 179.389 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.47 HD12 ' HA ' ' A' ' 59' ' ' PHE . 0.2 OUTLIER -54.65 -29.6 21.03 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.588 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.626 179.747 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 9.6 tt0 -56.25 -39.0 71.88 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-N 116.58 -0.282 . . . . 0.0 111.041 179.529 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -94.93 29.63 2.33 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-N 116.455 -0.339 . . . . 0.0 111.561 -179.817 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -114.71 136.69 52.79 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-O 120.577 0.227 . . . . 0.0 110.904 -179.961 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 25.6 m -71.8 102.54 2.87 Favored 'General case' 0 C--O 1.232 0.138 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.487 179.609 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 30.6 p90 -80.57 132.0 35.59 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.017 -179.788 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' GLU . . . . . 0.415 ' HB2' ' HG3' ' A' ' 21' ' ' MET . 53.2 mm-40 -108.95 95.08 16.17 Favored Pre-proline 0 C--O 1.234 0.28 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.618 179.916 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 67.0 Cg_endo -74.53 59.46 4.82 Favored 'Trans proline' 0 C--N 1.347 0.491 0 C-N-CA 122.615 2.21 . . . . 0.0 112.366 179.945 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -128.23 -49.19 1.31 Allowed 'General case' 0 CA--C 1.53 0.196 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.906 -179.914 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 16.0 m-80 -139.11 28.94 2.27 Favored 'General case' 0 CA--C 1.534 0.356 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.009 179.582 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 3.6 mm100 58.88 61.91 2.03 Favored 'General case' 0 CA--C 1.535 0.401 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.609 179.489 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' MET . . . . . 0.415 ' HG3' ' HB2' ' A' ' 16' ' ' GLU . 20.8 ptp -134.7 141.18 46.46 Favored 'General case' 0 CA--C 1.531 0.227 0 CA-C-N 116.33 -0.396 . . . . 0.0 110.992 179.755 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 3.9 m-85 -111.23 125.68 54.06 Favored 'General case' 0 N--CA 1.463 0.176 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.492 179.713 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 29.6 p -117.27 160.85 20.44 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.329 -179.715 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 29.6 t80 -157.4 136.36 8.0 Favored Pre-proline 0 N--CA 1.463 0.175 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.018 -179.971 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -70.41 93.0 0.58 Allowed 'Trans proline' 0 C--N 1.347 0.448 0 C-N-CA 122.405 2.07 . . . . 0.0 111.989 179.421 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' CYS . . . . . 0.447 ' SG ' ' HD2' ' A' ' 27' ' ' PRO . 42.3 t -56.6 139.27 75.92 Favored Pre-proline 0 C--O 1.234 0.243 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.664 -179.968 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 27' ' ' PRO . . . . . 0.447 ' HD2' ' SG ' ' A' ' 26' ' ' CYS . 9.9 Cg_endo -53.23 -25.96 32.16 Favored 'Trans proline' 0 C--N 1.347 0.497 0 C-N-CA 122.926 2.418 . . . . 0.0 113.031 179.997 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 28' ' ' CYS . . . . . 0.411 ' CB ' ' HB3' ' A' ' 51' ' ' CYS . 0.6 OUTLIER -74.72 -39.43 61.9 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-O 120.461 0.172 . . . . 0.0 111.352 -179.898 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 150.04 -38.33 0.91 Allowed Glycine 0 C--N 1.334 0.467 0 C-N-CA 120.859 -0.686 . . . . 0.0 113.004 -179.802 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -72.04 -176.66 1.8 Allowed 'General case' 0 CA--C 1.533 0.321 0 CA-C-O 120.818 0.342 . . . . 0.0 111.215 -179.861 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 5.4 ttp-105 -116.7 123.67 47.8 Favored 'General case' 0 C--O 1.232 0.173 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.282 -179.375 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -73.65 99.95 3.23 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.643 179.534 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 9.7 mt-30 -92.98 136.39 33.3 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-N 116.474 -0.33 . . . . 0.0 111.208 -179.731 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.454 ' O ' HG23 ' A' ' 34' ' ' ILE . 1.0 OUTLIER -155.69 119.04 0.44 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.294 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.868 179.849 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 79.9 m-85 -81.86 159.07 23.8 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 116.444 -0.344 . . . . 0.0 110.934 -179.749 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.562 HD22 ' HG ' ' A' ' 64' ' ' LEU . 62.8 mt -55.16 -40.28 70.47 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.071 179.857 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 22.1 m-20 -60.38 -45.58 93.05 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-O 120.57 0.224 . . . . 0.0 110.555 179.395 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 64.5 m-20 -60.31 -43.52 96.28 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.139 179.132 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 39' ' ' MET . . . . . 0.424 ' HG2' ' HA ' ' A' ' 36' ' ' LEU . 1.8 ptm -90.77 36.79 0.91 Allowed 'General case' 0 CA--C 1.536 0.434 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.2 179.475 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 18.2 t80 -139.84 -49.89 0.48 Allowed 'General case' 0 CA--C 1.53 0.192 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.71 179.42 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 2.2 mm-40 -59.74 -35.88 75.47 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 116.526 -0.306 . . . . 0.0 110.911 179.613 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 140.59 52.28 0.04 OUTLIER Glycine 0 C--N 1.335 0.491 0 C-N-CA 120.951 -0.642 . . . . 0.0 113.015 179.568 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -129.03 102.3 6.44 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-O 120.796 0.332 . . . . 0.0 111.287 179.969 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 44' ' ' LYS . . . . . 0.448 ' HG2' ' CE2' ' A' ' 59' ' ' PHE . 12.8 mttt -113.74 -34.98 5.31 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.02 179.723 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 29.7 t -79.12 79.11 0.9 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.238 0 CA-C-O 120.986 0.422 . . . . 0.0 110.565 179.849 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -87.56 151.54 22.91 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.333 -179.802 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 11.8 p -133.24 130.03 57.31 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.026 179.88 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 37.7 t -73.64 115.32 40.62 Favored Pre-proline 0 C--N 1.331 -0.238 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.312 179.859 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_exo -57.2 -21.63 44.32 Favored 'Trans proline' 0 CA--C 1.533 0.455 0 C-N-CA 122.703 2.269 . . . . 0.0 113.049 -179.996 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -76.25 -66.99 0.73 Allowed 'General case' 0 CA--C 1.533 0.294 0 N-CA-C 111.236 0.087 . . . . 0.0 111.236 -179.814 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 51' ' ' CYS . . . . . 0.411 ' HB3' ' CB ' ' A' ' 28' ' ' CYS . 27.4 p -81.7 -22.02 37.67 Favored 'General case' 0 N--CA 1.469 0.491 0 N-CA-C 111.991 0.367 . . . . 0.0 111.991 -179.826 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 1.3 t 69.65 37.88 1.81 Allowed 'General case' 0 CA--C 1.534 0.347 0 CA-C-O 120.802 0.334 . . . . 0.0 111.204 -179.762 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.488 HD21 ' HB2' ' A' ' 5' ' ' TYR . 2.8 tt -106.27 127.21 53.07 Favored 'General case' 0 CA--C 1.53 0.183 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.894 179.832 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 54' ' ' MET . . . . . . . . . . . . . 24.6 mtt -84.12 142.18 30.56 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.428 -179.467 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 2.8 pp -142.78 163.77 17.24 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.298 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.595 179.917 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 56' ' ' ASP . . . . . 0.428 ' CG ' HG21 ' A' ' 4' ' ' THR . 75.3 m-20 -115.9 106.91 14.34 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.704 179.03 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.462 ' O ' HG13 ' A' ' 57' ' ' VAL . 11.2 p -97.78 115.11 36.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-O 120.992 0.425 . . . . 0.0 110.624 179.59 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 14.4 p -81.95 125.46 39.75 Favored 'Isoleucine or valine' 0 C--O 1.233 0.199 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.032 -179.646 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 59' ' ' PHE . . . . . 0.47 ' HA ' HD12 ' A' ' 10' ' ' ILE . 11.3 p90 -136.7 167.61 21.09 Favored 'General case' 0 CA--C 1.531 0.218 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.465 -179.494 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 3.4 t0 -113.63 175.69 5.35 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.054 179.708 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 3.1 ttmt -100.23 -41.0 7.27 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.229 -179.958 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -59.36 -35.48 73.97 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 116.461 -0.336 . . . . 0.0 111.076 179.794 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 2.8 t0 -54.24 -43.27 70.76 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.168 -179.913 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.562 ' HG ' HD22 ' A' ' 36' ' ' LEU . 4.3 mp -60.22 -51.81 67.97 Favored 'General case' 0 N--CA 1.462 0.146 0 CA-C-N 116.444 -0.344 . . . . 0.0 110.903 179.877 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -53.84 -42.04 68.07 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-N 116.4 -0.363 . . . . 0.0 111.092 179.69 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 16.9 mm-40 -72.53 -41.28 66.03 Favored 'General case' 0 CA--C 1.528 0.132 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.018 179.579 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -61.0 -35.09 75.92 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 116.524 -0.307 . . . . 0.0 111.636 -179.877 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 3.8 m-85 -56.82 -52.19 66.03 Favored 'General case' 0 N--CA 1.462 0.154 0 CA-C-N 116.704 -0.226 . . . . 0.0 110.829 -179.967 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -75.59 -35.16 60.63 Favored 'General case' 0 CA--C 1.53 0.196 0 CA-C-N 116.542 -0.299 . . . . 0.0 111.013 179.711 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 1.8 mm-40 -61.0 -47.77 84.92 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-N 116.481 -0.327 . . . . 0.0 111.2 -179.958 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.233 0.186 0 CA-C-O 120.842 0.353 . . . . 0.0 111.146 179.914 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 81.8 p . . . . . 0 C--O 1.234 0.259 0 CA-C-O 120.719 0.295 . . . . 0.0 111.377 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 5' ' ' TYR . . . . . 0.517 ' CD1' HD11 ' A' ' 53' ' ' LEU . 18.7 m-85 -109.13 -38.89 5.43 Favored 'General case' 0 CA--C 1.531 0.217 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.198 179.702 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -157.02 175.14 14.49 Favored 'General case' 0 C--O 1.234 0.284 0 CA-C-N 116.484 -0.325 . . . . 0.0 111.244 179.881 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 2.6 pt-20 -135.24 125.98 27.25 Favored 'General case' 0 CA--C 1.53 0.189 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.122 179.856 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 4.6 mt -119.86 152.4 22.55 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.241 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.182 -179.745 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 9' ' ' GLU . . . . . 0.556 ' HA ' HG12 ' A' ' 58' ' ' VAL . 16.5 mt-10 -97.94 147.71 24.2 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.254 -179.998 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 8.0 tp -58.38 -31.37 42.74 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.238 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.138 179.476 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -59.32 -32.81 70.41 Favored 'General case' 0 CA--C 1.531 0.218 0 CA-C-N 116.551 -0.295 . . . . 0.0 110.934 179.603 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 5.5 t0 -97.57 36.09 1.55 Allowed 'General case' 0 CA--C 1.532 0.276 0 CA-C-O 120.914 0.387 . . . . 0.0 110.964 179.65 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -121.01 156.93 31.08 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.688 179.831 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 24.4 m -81.44 150.09 28.49 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.586 179.839 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 16.0 p90 -120.87 144.8 48.19 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.819 179.851 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -118.17 88.71 33.16 Favored Pre-proline 0 C--O 1.235 0.309 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.743 179.91 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 16.8 Cg_exo -68.27 72.47 0.85 Allowed 'Trans proline' 0 C--N 1.35 0.634 0 C-N-CA 122.98 2.453 . . . . 0.0 112.387 -179.711 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 1.1 pp20? -151.85 -50.39 0.11 Allowed 'General case' 0 C--O 1.233 0.212 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.992 179.907 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 20.8 m-20 -129.74 26.95 5.26 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-O 120.666 0.269 . . . . 0.0 111.223 179.495 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 20' ' ' GLN . . . . . 0.505 ' HG3' HD23 ' A' ' 36' ' ' LEU . 0.0 OUTLIER 56.82 54.64 6.96 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-O 120.992 0.425 . . . . 0.0 111.439 179.82 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 10.2 ptm -133.71 154.12 51.19 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.919 179.619 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 5.9 m-85 -119.06 147.69 43.85 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.081 -0.508 . . . . 0.0 111.052 -179.727 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 23' ' ' THR . . . . . 0.411 ' HA ' ' O ' ' A' ' 32' ' ' PHE . 20.5 p -123.35 173.79 7.74 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.141 -0.482 . . . . 0.0 111.209 179.918 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 60.8 t80 -172.12 99.83 0.37 Allowed Pre-proline 0 C--O 1.232 0.136 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.683 179.962 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_exo -51.21 99.76 0.04 OUTLIER 'Trans proline' 0 C--N 1.349 0.572 0 C-N-CA 122.684 2.256 . . . . 0.0 112.094 -179.905 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 45.9 t -60.53 138.38 92.63 Favored Pre-proline 0 C--N 1.331 -0.218 0 CA-C-N 116.053 -0.522 . . . . 0.0 110.776 -179.761 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 70.3 Cg_exo -51.84 -24.78 19.45 Favored 'Trans proline' 0 C--N 1.348 0.542 0 C-N-CA 122.695 2.263 . . . . 0.0 112.818 179.828 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 1.1 p -66.96 -37.96 85.24 Favored 'General case' 0 CA--C 1.533 0.305 0 CA-C-O 120.526 0.203 . . . . 0.0 111.221 179.902 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 151.88 -44.61 0.64 Allowed Glycine 0 C--N 1.335 0.498 0 C-N-CA 120.8 -0.714 . . . . 0.0 112.955 -179.996 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -72.34 -173.0 1.01 Allowed 'General case' 0 CA--C 1.532 0.278 0 CA-C-O 120.687 0.279 . . . . 0.0 111.337 -179.799 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 33.0 ttm180 -129.5 124.15 33.27 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-O 120.698 0.285 . . . . 0.0 111.052 -179.813 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 32' ' ' PHE . . . . . 0.411 ' O ' ' HA ' ' A' ' 23' ' ' THR . 1.8 m-85 -61.18 155.64 20.29 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.878 179.664 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 3.8 pt20 -147.16 112.02 5.38 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-N 116.376 -0.375 . . . . 0.0 111.15 179.763 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.404 ' CD1' ' HG2' ' A' ' 39' ' ' MET . 2.4 tt -140.48 134.91 35.0 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.955 179.904 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 8.5 m-85 -87.92 161.91 17.19 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.939 -179.811 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.505 HD23 ' HG3' ' A' ' 20' ' ' GLN . 4.0 mm? -60.63 -46.05 91.76 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.136 -179.991 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -60.57 -36.59 78.88 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-O 120.717 0.294 . . . . 0.0 110.769 179.425 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -60.68 -41.38 94.99 Favored 'General case' 0 C--N 1.334 -0.075 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.535 179.635 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 39' ' ' MET . . . . . 0.404 ' HG2' ' CD1' ' A' ' 34' ' ' ILE . 4.6 mmm -91.78 29.64 1.52 Allowed 'General case' 0 CA--C 1.535 0.401 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.089 179.303 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 40' ' ' PHE . . . . . 0.66 ' HB2' HD21 ' A' ' 64' ' ' LEU . 16.9 t80 -126.26 -43.54 1.78 Allowed 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 116.499 -0.318 . . . . 0.0 111.174 179.734 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -59.4 -68.13 0.31 Allowed 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 116.519 -0.31 . . . . 0.0 111.477 -179.467 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -169.62 55.76 0.2 Allowed Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.544 -0.836 . . . . 0.0 112.508 -179.761 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -110.15 160.31 16.59 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.834 0.35 . . . . 0.0 111.073 -179.866 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -163.83 -45.13 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.912 -0.585 . . . . 0.0 111.656 179.953 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.482 HG13 ' O ' ' A' ' 45' ' ' VAL . 8.9 p -116.67 112.68 40.36 Favored 'Isoleucine or valine' 0 C--O 1.233 0.224 0 CA-C-O 120.977 0.418 . . . . 0.0 111.101 -179.876 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -95.31 168.23 10.86 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.53 -179.589 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 18.6 t -139.74 125.79 22.29 Favored 'Isoleucine or valine' 0 C--O 1.232 0.173 0 CA-C-N 115.98 -0.554 . . . . 0.0 111.205 -179.855 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 42.5 t -73.73 114.58 33.7 Favored Pre-proline 0 C--N 1.331 -0.207 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.267 179.573 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_exo -59.24 -20.5 55.44 Favored 'Trans proline' 0 C--N 1.346 0.414 0 C-N-CA 122.569 2.179 . . . . 0.0 112.875 179.946 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -75.75 -67.32 0.68 Allowed 'General case' 0 CA--C 1.531 0.226 0 CA-C-N 116.789 -0.187 . . . . 0.0 111.316 -179.711 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 23.9 p -83.62 -22.42 32.23 Favored 'General case' 0 N--CA 1.466 0.37 0 N-CA-C 111.933 0.346 . . . . 0.0 111.933 -179.706 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER 70.79 39.42 1.08 Allowed 'General case' 0 CA--C 1.533 0.292 0 CA-C-O 120.891 0.377 . . . . 0.0 110.863 -179.678 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.517 HD11 ' CD1' ' A' ' 5' ' ' TYR . 7.4 tp -100.98 143.57 30.96 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.958 179.982 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 54' ' ' MET . . . . . . . . . . . . . 42.2 mtt -95.19 138.09 33.37 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.089 -179.827 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.426 ' O ' HG23 ' A' ' 45' ' ' VAL . 2.5 pp -148.08 145.07 18.86 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.259 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.653 -179.884 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -92.77 104.89 17.11 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.688 179.411 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.494 ' O ' HG13 ' A' ' 57' ' ' VAL . 13.4 p -108.42 112.96 42.61 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-O 121.036 0.446 . . . . 0.0 111.167 179.717 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.556 HG12 ' HA ' ' A' ' 9' ' ' GLU . 14.5 p -83.61 150.42 4.18 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.28 -179.759 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 47.2 p90 -119.36 177.84 4.76 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.224 -179.846 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 60' ' ' ASP . . . . . 0.426 ' O ' HD13 ' A' ' 64' ' ' LEU . 4.7 m-20 -121.96 172.83 7.92 Favored 'General case' 0 C--O 1.232 0.159 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.109 179.793 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 16.1 mmtt -105.6 -46.32 4.2 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.789 179.647 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -66.44 -40.75 89.66 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.894 179.774 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -57.94 -37.63 74.46 Favored 'General case' 0 N--CA 1.462 0.156 0 CA-C-N 116.554 -0.294 . . . . 0.0 111.203 179.913 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.66 HD21 ' HB2' ' A' ' 40' ' ' PHE . 0.4 OUTLIER -60.53 -41.0 93.53 Favored 'General case' 0 CA--C 1.53 0.189 0 CA-C-N 116.664 -0.244 . . . . 0.0 111.022 179.896 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -82.5 -42.96 17.77 Favored 'General case' 0 C--O 1.232 0.173 0 CA-C-N 116.485 -0.325 . . . . 0.0 111.015 179.687 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -61.18 -50.55 72.67 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.653 179.836 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 55.3 t80 -63.2 -31.86 73.12 Favored 'General case' 0 CA--C 1.53 0.196 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.331 179.649 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 2.0 t80 -61.93 -59.73 4.67 Favored 'General case' 0 C--O 1.232 0.143 0 CA-C-O 120.545 0.212 . . . . 0.0 110.851 179.918 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 2.1 tp10 -63.56 -35.33 80.14 Favored 'General case' 0 N--CA 1.462 0.17 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.388 -179.977 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 25.4 mt-10 -71.65 -36.47 70.69 Favored 'General case' 0 CA--C 1.53 0.179 0 CA-C-N 116.544 -0.298 . . . . 0.0 111.371 -179.893 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.332 -0.176 0 CA-C-O 120.589 0.233 . . . . 0.0 111.353 180.0 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 4' ' ' THR . . . . . 0.437 HG21 ' CG ' ' A' ' 56' ' ' ASP . 0.8 OUTLIER . . . . . 0 N--CA 1.465 0.32 0 CA-C-O 120.847 0.356 . . . . 0.0 111.277 . . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 58.9 m-85 -98.95 -35.81 9.95 Favored 'General case' 0 CA--C 1.531 0.241 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.49 -179.891 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -158.85 173.55 16.36 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-O 120.759 0.314 . . . . 0.0 111.323 -179.92 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 2.7 tm-20 -138.58 122.72 18.03 Favored 'General case' 0 CA--C 1.531 0.24 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.879 -179.886 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 4.8 mt -126.21 152.36 33.5 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.338 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.114 -179.747 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 3.0 pt-20 -96.95 153.17 18.06 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.622 -179.99 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.464 HD13 ' CE ' ' A' ' 39' ' ' MET . 1.2 tp -62.99 -34.66 67.73 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.313 0 CA-C-N 115.947 -0.569 . . . . 0.0 111.36 179.58 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -58.74 -32.87 69.63 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-N 116.609 -0.269 . . . . 0.0 111.157 179.681 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -97.28 36.1 1.51 Allowed 'General case' 0 CA--C 1.537 0.47 0 CA-C-O 120.81 0.338 . . . . 0.0 111.311 179.783 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 13' ' ' MET . . . . . 0.409 ' HG3' ' HB2' ' A' ' 24' ' ' TYR . 1.7 ttt -121.54 148.83 43.98 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.888 179.787 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -69.33 126.93 31.3 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-O 120.826 0.346 . . . . 0.0 110.873 179.971 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 14.4 t80 -94.59 123.97 38.33 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.509 179.596 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 1.4 tp10 -108.96 92.1 10.2 Favored Pre-proline 0 C--O 1.234 0.256 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.314 179.499 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 64.3 Cg_endo -73.6 61.27 4.4 Favored 'Trans proline' 0 C--N 1.351 0.677 0 C-N-CA 122.793 2.329 . . . . 0.0 112.72 -179.44 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 19.1 pt-20 -131.44 -45.82 0.99 Allowed 'General case' 0 CA--C 1.533 0.302 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.885 179.772 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -141.71 32.13 1.63 Allowed 'General case' 0 CA--C 1.534 0.363 0 CA-C-N 116.515 -0.311 . . . . 0.0 111.057 179.406 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 91.3 mt-30 55.15 59.88 3.75 Favored 'General case' 0 C--O 1.236 0.363 0 CA-C-O 120.955 0.407 . . . . 0.0 111.413 179.931 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 9.6 ptp -130.41 148.72 52.25 Favored 'General case' 0 C--O 1.235 0.307 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.343 179.909 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 25.4 m-85 -124.6 102.89 7.84 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.896 179.994 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 23' ' ' THR . . . . . 0.415 HG22 ' HA ' ' A' ' 33' ' ' GLN . 66.9 p -101.54 166.83 10.5 Favored 'General case' 0 CA--C 1.532 0.261 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.84 -179.827 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 24' ' ' TYR . . . . . 0.409 ' HB2' ' HG3' ' A' ' 13' ' ' MET . 62.3 t80 -164.7 139.6 4.42 Favored Pre-proline 0 CA--C 1.531 0.235 0 CA-C-O 120.599 0.237 . . . . 0.0 111.377 179.774 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -53.2 121.79 10.03 Favored 'Trans proline' 0 C--N 1.352 0.724 0 C-N-CA 122.994 2.462 . . . . 0.0 113.144 -179.979 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 26' ' ' CYS . . . . . 0.461 ' SG ' ' HD2' ' A' ' 27' ' ' PRO . 42.1 t -90.64 140.3 26.57 Favored Pre-proline 0 C--N 1.331 -0.218 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.497 179.38 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 27' ' ' PRO . . . . . 0.461 ' HD2' ' SG ' ' A' ' 26' ' ' CYS . 73.8 Cg_exo -50.7 -27.82 20.92 Favored 'Trans proline' 0 C--N 1.349 0.587 0 C-N-CA 122.898 2.398 . . . . 0.0 113.026 179.536 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 28' ' ' CYS . . . . . 0.402 ' CB ' ' HB3' ' A' ' 51' ' ' CYS . 0.9 OUTLIER -69.51 -38.89 77.77 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-N 116.799 -0.182 . . . . 0.0 111.446 -179.959 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 151.92 -48.4 0.55 Allowed Glycine 0 C--N 1.336 0.57 0 C-N-CA 120.854 -0.689 . . . . 0.0 112.958 -179.933 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -73.96 -175.11 2.05 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-O 120.665 0.269 . . . . 0.0 110.966 179.984 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 19.5 mtt180 -118.72 134.66 54.98 Favored 'General case' 0 C--O 1.232 0.164 0 CA-C-O 120.677 0.275 . . . . 0.0 110.826 179.924 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 6.8 m-85 -62.23 168.0 3.7 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.811 179.653 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 33' ' ' GLN . . . . . 0.415 ' HA ' HG22 ' A' ' 23' ' ' THR . 5.8 tt0 -155.58 121.95 5.21 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-O 120.695 0.283 . . . . 0.0 111.274 179.882 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 5.8 tt -146.04 138.81 20.45 Favored 'Isoleucine or valine' 0 C--O 1.234 0.25 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.085 179.646 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 25.6 m-85 -95.58 155.49 16.72 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.993 179.992 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.838 HD22 ' HG ' ' A' ' 64' ' ' LEU . 87.9 mt -62.63 -39.84 95.11 Favored 'General case' 0 CA--C 1.53 0.199 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.016 179.72 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -66.2 -34.81 78.86 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 116.683 -0.235 . . . . 0.0 111.196 179.409 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -62.7 -57.99 9.06 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-O 120.918 0.389 . . . . 0.0 110.591 179.991 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 39' ' ' MET . . . . . 0.464 ' CE ' HD13 ' A' ' 10' ' ' ILE . 5.6 ptm -63.04 -34.62 77.97 Favored 'General case' 0 CA--C 1.534 0.343 0 CA-C-N 115.956 -0.565 . . . . 0.0 111.291 179.764 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 40' ' ' PHE . . . . . 0.405 ' HB2' ' CD2' ' A' ' 64' ' ' LEU . 31.6 t80 -61.14 -45.06 96.18 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-N 116.551 -0.295 . . . . 0.0 110.882 179.485 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 2.6 tp10 -56.0 -40.8 73.89 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.709 179.471 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 148.47 47.86 0.02 OUTLIER Glycine 0 C--N 1.335 0.49 0 C-N-CA 121.146 -0.55 . . . . 0.0 112.672 179.755 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 4.3 tt0 -112.4 123.19 49.73 Favored 'General case' 0 C--O 1.232 0.159 0 CA-C-O 120.826 0.346 . . . . 0.0 111.149 -179.795 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 19.4 mtmt -122.46 -43.75 2.27 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-N 115.917 -0.583 . . . . 0.0 111.026 179.726 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.483 HG13 ' O ' ' A' ' 45' ' ' VAL . 12.0 p -108.16 113.21 43.26 Favored 'Isoleucine or valine' 0 C--O 1.233 0.209 0 CA-C-O 121.011 0.434 . . . . 0.0 111.005 179.781 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -102.24 164.66 11.56 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.154 -179.815 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 11.6 p -124.49 129.09 73.93 Favored 'Isoleucine or valine' 0 C--O 1.233 0.207 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.227 -179.909 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 47.9 t -67.86 135.52 92.16 Favored Pre-proline 0 C--O 1.233 0.229 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.79 179.929 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 84.5 Cg_endo -83.54 21.09 1.08 Allowed 'Trans proline' 0 CA--C 1.537 0.639 0 C-N-CA 122.729 2.286 . . . . 0.0 113.056 179.777 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 7.7 t -129.07 -56.82 1.17 Allowed 'General case' 0 C--O 1.233 0.204 0 CA-C-N 116.615 -0.266 . . . . 0.0 110.512 179.768 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 51' ' ' CYS . . . . . 0.402 ' HB3' ' CB ' ' A' ' 28' ' ' CYS . 18.5 p -100.63 -10.59 20.79 Favored 'General case' 0 CA--C 1.538 0.481 0 N-CA-C 112.276 0.473 . . . . 0.0 112.276 179.924 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 6.5 p 60.24 35.85 20.87 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-O 120.863 0.363 . . . . 0.0 111.765 -179.903 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.599 HD23 HG23 ' A' ' 55' ' ' ILE . 6.6 tt -94.95 121.34 36.46 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.698 179.394 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 54' ' ' MET . . . . . . . . . . . . . 6.9 mtt -85.94 141.53 29.48 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.171 -179.712 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.599 HG23 HD23 ' A' ' 53' ' ' LEU . 3.8 pt -145.19 148.19 17.99 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.295 0 CA-C-N 115.934 -0.575 . . . . 0.0 111.495 179.997 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 56' ' ' ASP . . . . . 0.437 ' CG ' HG21 ' A' ' 4' ' ' THR . 72.3 m-20 -93.27 104.74 16.89 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.463 178.918 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.485 ' O ' HG13 ' A' ' 57' ' ' VAL . 12.5 p -100.22 112.37 32.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 121.057 0.456 . . . . 0.0 110.879 179.72 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 14.2 p -81.04 130.87 35.14 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.172 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.709 -179.852 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 42.1 p90 -133.41 176.96 8.06 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.29 -179.275 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 4.3 t70 -122.38 144.91 48.73 Favored 'General case' 0 N--CA 1.462 0.17 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.4 -179.923 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 11.7 mttp -76.7 -40.01 50.14 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.153 179.699 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 17.7 tt0 -58.43 -37.66 75.86 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 116.617 -0.265 . . . . 0.0 110.595 179.531 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 63' ' ' ASP . . . . . 0.478 ' HB3' ' CE2' ' A' ' 67' ' ' TYR . 3.4 m-20 -56.03 -43.87 78.2 Favored 'General case' 0 N--CA 1.463 0.19 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.954 179.425 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.838 ' HG ' HD22 ' A' ' 36' ' ' LEU . 3.0 mp -53.31 -53.41 51.4 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 116.469 -0.332 . . . . 0.0 111.185 179.987 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -56.24 -39.65 72.88 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 116.512 -0.313 . . . . 0.0 110.846 179.511 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -69.19 -39.74 78.49 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.05 179.367 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 67' ' ' TYR . . . . . 0.478 ' CE2' ' HB3' ' A' ' 63' ' ' ASP . 20.1 m-85 -69.12 -37.93 78.62 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 116.634 -0.257 . . . . 0.0 111.624 -179.861 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 5.7 m-85 -62.17 -38.25 88.35 Favored 'General case' 0 N--CA 1.463 0.211 0 C-N-CA 121.247 -0.181 . . . . 0.0 110.635 179.966 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -80.96 -36.26 31.13 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-N 116.48 -0.327 . . . . 0.0 111.084 179.262 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 5.7 mt-10 -72.28 -35.68 68.79 Favored 'General case' 0 N--CA 1.467 0.376 0 N-CA-C 111.681 0.252 . . . . 0.0 111.681 -179.834 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.233 0.215 0 N-CA-C 111.517 0.191 . . . . 0.0 111.517 -179.643 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 4' ' ' THR . . . . . 0.493 HG22 ' HA ' ' A' ' 55' ' ' ILE . 0.2 OUTLIER . . . . . 0 N--CA 1.463 0.22 0 CA-C-O 120.769 0.319 . . . . 0.0 111.477 . . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 9.3 m-85 -106.68 -43.65 4.66 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.37 179.721 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 12.0 m-20 -151.74 175.53 12.31 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-O 120.782 0.325 . . . . 0.0 111.484 179.791 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 19.5 tt0 -128.0 122.62 32.73 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.443 179.514 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 28.5 mm -120.33 155.04 23.53 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.162 -179.584 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -112.55 150.98 30.56 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-N 116.308 -0.406 . . . . 0.0 111.292 179.867 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 2.8 tt -58.72 -31.89 45.38 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.331 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.239 179.576 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 17.8 mt-10 -66.24 -30.91 71.44 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-N 116.374 -0.375 . . . . 0.0 111.106 179.501 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 3.3 t70 -98.03 38.37 1.32 Allowed 'General case' 0 CA--C 1.533 0.313 0 CA-C-O 120.889 0.376 . . . . 0.0 111.052 179.816 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 1.8 mtp -128.39 156.17 43.56 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.782 179.778 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 8.7 m -87.4 108.2 18.89 Favored 'General case' 0 N--CA 1.462 0.15 0 CA-C-O 120.835 0.35 . . . . 0.0 110.952 -179.923 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 15' ' ' PHE . . . . . 0.419 ' HB3' ' CZ ' ' A' ' 22' ' ' PHE . 29.8 p90 -85.12 138.12 32.6 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.764 179.754 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 25.1 mt-10 -103.9 96.36 9.16 Favored Pre-proline 0 C--O 1.234 0.263 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.406 179.848 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -71.77 63.62 3.12 Favored 'Trans proline' 0 C--N 1.35 0.654 0 C-N-CA 122.812 2.342 . . . . 0.0 112.721 -179.497 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 7.1 pt-20 -135.14 -53.78 0.79 Allowed 'General case' 0 C--N 1.333 -0.144 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.741 179.535 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 71.6 m-20 -133.08 33.04 3.68 Favored 'General case' 0 CA--C 1.534 0.345 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.999 179.479 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 20' ' ' GLN . . . . . 0.546 ' OE1' HD11 ' A' ' 36' ' ' LEU . 25.4 mt-30 56.81 49.84 13.52 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-O 120.802 0.334 . . . . 0.0 111.287 179.936 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 9.6 ttp -122.62 157.18 32.72 Favored 'General case' 0 N--CA 1.463 0.176 0 CA-C-O 120.737 0.304 . . . . 0.0 111.161 -179.942 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.433 ' O ' ' HA ' ' A' ' 33' ' ' GLN . 5.8 m-85 -121.28 164.43 17.01 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.852 -179.988 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 25.6 p -144.59 150.93 38.29 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.095 179.487 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 86.5 t80 -145.38 95.91 4.95 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.243 179.282 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 25' ' ' PRO . . . . . 0.403 ' HA ' ' HA ' ' A' ' 31' ' ' ARG . 53.1 Cg_exo -55.05 94.33 0.04 OUTLIER 'Trans proline' 0 C--N 1.349 0.559 0 C-N-CA 122.719 2.279 . . . . 0.0 111.832 179.967 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 26' ' ' CYS . . . . . 0.422 ' SG ' ' HD2' ' A' ' 27' ' ' PRO . 45.3 t -63.8 137.89 97.23 Favored Pre-proline 0 C--O 1.234 0.243 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.095 -179.306 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 27' ' ' PRO . . . . . 0.422 ' HD2' ' SG ' ' A' ' 26' ' ' CYS . 10.9 Cg_endo -54.84 -20.33 22.11 Favored 'Trans proline' 0 C--N 1.35 0.626 0 C-N-CA 122.906 2.404 . . . . 0.0 112.831 179.777 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 12.4 p -55.49 -29.31 58.55 Favored 'General case' 0 CA--C 1.535 0.378 0 CA-C-O 120.592 0.234 . . . . 0.0 111.398 179.68 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 125.55 5.43 6.52 Favored Glycine 0 CA--C 1.526 0.737 0 C-N-CA 121.143 -0.551 . . . . 0.0 113.692 179.836 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -126.55 -167.12 1.67 Allowed 'General case' 0 CA--C 1.536 0.408 0 CA-C-N 117.412 0.606 . . . . 0.0 111.324 -179.814 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 31' ' ' ARG . . . . . 0.403 ' HA ' ' HA ' ' A' ' 25' ' ' PRO . 8.6 ttm-85 -121.36 150.1 41.96 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-O 120.8 0.333 . . . . 0.0 111.506 -179.596 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 32' ' ' PHE . . . . . 0.474 ' HZ ' ' HB1' ' A' ' 46' ' ' ALA . 21.7 t80 -103.43 162.27 13.17 Favored 'General case' 0 CA--C 1.529 0.153 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.882 179.368 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 33' ' ' GLN . . . . . 0.433 ' HA ' ' O ' ' A' ' 22' ' ' PHE . 3.2 pt20 -149.7 115.64 5.66 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.879 179.65 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.427 HG21 ' HE2' ' A' ' 39' ' ' MET . 3.3 tt -130.71 128.3 62.92 Favored 'Isoleucine or valine' 0 C--O 1.234 0.245 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.062 179.989 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -80.23 123.53 28.02 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.054 -179.667 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.546 HD11 ' OE1' ' A' ' 20' ' ' GLN . 3.7 pp -61.28 -38.59 87.33 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.998 179.601 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 37' ' ' ASP . . . . . 0.537 ' N ' HD12 ' A' ' 36' ' ' LEU . 3.7 t70 -56.3 -46.37 79.83 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 116.503 -0.317 . . . . 0.0 110.801 179.538 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -65.92 -45.59 81.33 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.518 179.435 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 39' ' ' MET . . . . . 0.427 ' HE2' HG21 ' A' ' 34' ' ' ILE . 1.6 mtm -52.05 -25.62 9.02 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.852 179.687 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -53.97 -35.46 61.81 Favored 'General case' 0 N--CA 1.467 0.397 0 N-CA-C 111.559 0.207 . . . . 0.0 111.559 179.775 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 -58.44 -31.59 67.91 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-N 116.646 -0.252 . . . . 0.0 111.565 179.75 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 125.14 45.54 0.25 Allowed Glycine 0 C--N 1.335 0.509 0 C-N-CA 121.218 -0.515 . . . . 0.0 112.771 179.81 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -84.1 133.31 34.64 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-O 120.687 0.28 . . . . 0.0 110.908 179.996 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 3.4 ptpp? -126.54 -45.26 1.65 Allowed 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.385 -179.9 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 12.2 p -94.55 131.44 41.38 Favored 'Isoleucine or valine' 0 C--O 1.233 0.223 0 CA-C-N 116.418 -0.355 . . . . 0.0 110.715 179.797 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.474 ' HB1' ' HZ ' ' A' ' 32' ' ' PHE . . . -129.82 144.79 51.48 Favored 'General case' 0 C--O 1.234 0.288 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.109 -179.676 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 11.3 p -110.36 123.88 66.64 Favored 'Isoleucine or valine' 0 C--O 1.233 0.223 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.15 -179.828 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 52.5 t -62.2 134.72 94.72 Favored Pre-proline 0 N--CA 1.463 0.214 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.99 179.905 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 90.7 Cg_endo -84.98 24.55 0.76 Allowed 'Trans proline' 0 C--N 1.349 0.58 0 C-N-CA 122.713 2.275 . . . . 0.0 112.993 179.926 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 1.4 m -132.99 -60.29 0.87 Allowed 'General case' 0 CA--C 1.53 0.191 0 CA-C-N 116.503 -0.317 . . . . 0.0 110.586 -179.83 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 22.6 p -102.35 -13.98 17.1 Favored 'General case' 0 CA--C 1.537 0.462 0 N-CA-C 111.869 0.322 . . . . 0.0 111.869 179.494 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 6.4 t 66.82 34.28 5.6 Favored 'General case' 0 CA--C 1.534 0.365 0 CA-C-O 120.895 0.379 . . . . 0.0 111.286 -179.815 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.65 HD23 HG23 ' A' ' 55' ' ' ILE . 8.0 tt -85.21 134.27 34.15 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.604 179.663 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 54' ' ' MET . . . . . . . . . . . . . 40.7 mtm -82.79 133.0 35.15 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.198 -179.635 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.65 HG23 HD23 ' A' ' 53' ' ' LEU . 2.7 pt -138.68 151.07 23.85 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.394 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.853 -179.829 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 71.1 m-20 -97.02 88.47 4.52 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.741 179.297 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.472 ' O ' HG13 ' A' ' 57' ' ' VAL . 12.5 p -94.5 114.52 31.26 Favored 'Isoleucine or valine' 0 C--O 1.234 0.279 0 CA-C-O 121.063 0.458 . . . . 0.0 110.938 179.77 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 12.6 p -91.79 135.24 27.7 Favored 'Isoleucine or valine' 0 C--O 1.233 0.218 0 CA-C-N 115.967 -0.561 . . . . 0.0 110.974 -179.719 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 48.5 p90 -112.51 166.55 11.22 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.885 -179.52 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -131.16 137.74 49.14 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.215 179.774 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 17.0 mttp -68.43 -38.21 80.98 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.733 179.191 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 21.3 mt-10 -58.87 -52.99 63.35 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.427 179.266 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 38.4 m-20 -62.12 -43.04 99.72 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.993 179.505 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.464 HD23 HD13 ' A' ' 36' ' ' LEU . 0.8 OUTLIER -60.16 -53.43 57.77 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-O 120.607 0.242 . . . . 0.0 111.244 179.95 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -63.7 -39.25 93.84 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 116.422 -0.353 . . . . 0.0 111.149 179.867 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 26.7 tt0 -68.27 -41.29 81.26 Favored 'General case' 0 CA--C 1.532 0.285 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.9 179.476 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 19.9 t80 -66.24 -34.79 78.81 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.655 -179.994 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 68' ' ' TYR . . . . . 0.403 ' HA ' ' OE1' ' A' ' 20' ' ' GLN . 23.5 t80 -54.26 -41.96 69.41 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-O 120.732 0.301 . . . . 0.0 110.254 179.719 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 4.1 tt0 -83.6 -37.45 22.9 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.292 179.466 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -66.63 -32.96 74.62 Favored 'General case' 0 N--CA 1.467 0.403 0 N-CA-C 112.053 0.39 . . . . 0.0 112.053 -179.608 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.465 0.323 0 N-CA-C 111.863 0.32 . . . . 0.0 111.863 -179.322 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 5.0 p . . . . . 0 CA--C 1.532 0.267 0 CA-C-O 120.875 0.369 . . . . 0.0 111.069 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 11.6 m-85 -164.65 -40.84 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.123 179.755 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -145.83 169.99 17.45 Favored 'General case' 0 C--O 1.237 0.409 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.005 -179.798 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -123.98 112.11 16.81 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.873 -179.882 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.466 HG21 ' SD ' ' A' ' 13' ' ' MET . 27.8 mm -88.07 154.62 3.23 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.196 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.954 179.918 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 82.2 mt-10 -121.54 146.77 46.61 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-N 116.374 -0.376 . . . . 0.0 111.211 -179.983 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 8.1 tp -58.11 -34.95 50.67 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.344 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.124 179.501 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 6.6 tt0 -65.66 -34.61 78.6 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-N 116.496 -0.32 . . . . 0.0 110.878 179.46 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 22.1 m-20 -95.94 38.27 1.19 Allowed 'General case' 0 CA--C 1.531 0.238 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.226 179.766 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 13' ' ' MET . . . . . 0.466 ' SD ' HG21 ' A' ' 8' ' ' ILE . 0.6 OUTLIER -133.79 136.73 44.69 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.725 179.785 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 9.7 m -69.64 138.22 52.86 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.015 -179.841 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 15' ' ' PHE . . . . . 0.426 ' HB3' ' CE2' ' A' ' 22' ' ' PHE . 17.3 p90 -101.54 130.4 47.82 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.556 179.649 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 -109.23 90.82 8.68 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.733 179.795 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 69.9 Cg_endo -74.26 62.31 5.16 Favored 'Trans proline' 0 C--N 1.348 0.512 0 C-N-CA 122.776 2.317 . . . . 0.0 112.954 -179.786 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 4.8 pt-20 -132.68 -50.21 0.9 Allowed 'General case' 0 CA--C 1.531 0.224 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.757 179.47 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 38.0 m-20 -136.46 32.03 2.82 Favored 'General case' 0 CA--C 1.534 0.345 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.23 179.512 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 20' ' ' GLN . . . . . 0.688 ' HB3' HD12 ' A' ' 36' ' ' LEU . 15.2 mt-30 56.67 67.38 1.0 Allowed 'General case' 0 CA--C 1.535 0.368 0 CA-C-O 121.06 0.457 . . . . 0.0 111.462 179.447 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 2.5 ptt? -146.99 158.64 43.98 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-N 116.013 -0.54 . . . . 0.0 111.092 179.674 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.509 ' CE1' HD21 ' A' ' 36' ' ' LEU . 17.4 m-85 -131.21 127.8 38.65 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.787 -179.967 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 23' ' ' THR . . . . . 0.42 ' HA ' ' O ' ' A' ' 32' ' ' PHE . 18.2 p -116.14 170.21 8.68 Favored 'General case' 0 CA--C 1.532 0.28 0 CA-C-O 120.828 0.347 . . . . 0.0 111.454 -179.877 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 57.8 t80 -163.23 136.29 4.31 Favored Pre-proline 0 N--CA 1.464 0.271 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.042 179.795 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 42.0 Cg_endo -66.59 103.38 0.68 Allowed 'Trans proline' 0 C--N 1.35 0.606 0 C-N-CA 122.555 2.17 . . . . 0.0 112.27 179.649 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 26' ' ' CYS . . . . . 0.461 ' SG ' ' HD2' ' A' ' 27' ' ' PRO . 42.7 t -66.89 139.63 95.76 Favored Pre-proline 0 C--O 1.233 0.215 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.551 179.786 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 27' ' ' PRO . . . . . 0.461 ' HD2' ' SG ' ' A' ' 26' ' ' CYS . 9.3 Cg_endo -53.64 -25.56 33.99 Favored 'Trans proline' 0 C--N 1.35 0.617 0 C-N-CA 122.928 2.419 . . . . 0.0 112.927 179.867 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 28' ' ' CYS . . . . . 0.401 ' CB ' ' HB3' ' A' ' 51' ' ' CYS . 0.8 OUTLIER -69.93 -38.03 76.07 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-O 120.51 0.195 . . . . 0.0 111.299 -179.978 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 150.37 -44.8 0.68 Allowed Glycine 0 C--N 1.336 0.541 0 C-N-CA 120.834 -0.698 . . . . 0.0 112.898 -179.922 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -71.09 -176.51 1.43 Allowed 'General case' 0 CA--C 1.534 0.333 0 CA-C-O 120.779 0.323 . . . . 0.0 111.169 -179.86 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 7.2 ttp180 -122.19 114.06 20.33 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-N 116.515 -0.312 . . . . 0.0 111.085 -179.886 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 32' ' ' PHE . . . . . 0.42 ' O ' ' HA ' ' A' ' 23' ' ' THR . 73.3 t80 -62.2 154.55 27.07 Favored 'General case' 0 N--CA 1.462 0.168 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.966 179.708 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 1.1 pt20 -147.47 144.12 28.37 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.231 179.994 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 2.8 tt -147.6 132.14 10.25 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.247 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.064 179.497 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 6.0 m-85 -90.41 139.54 30.58 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.944 -179.883 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.688 HD12 ' HB3' ' A' ' 20' ' ' GLN . 13.9 mt -59.57 -47.48 85.41 Favored 'General case' 0 N--CA 1.463 0.19 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.027 179.954 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -59.57 -38.5 81.32 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 116.587 -0.279 . . . . 0.0 110.78 179.339 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -66.73 -58.99 3.97 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.017 179.853 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 39' ' ' MET . . . . . 0.709 ' HG3' HD11 ' A' ' 64' ' ' LEU . 6.4 ptm -60.68 -32.58 71.79 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 116.462 -0.335 . . . . 0.0 111.556 -179.878 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 18.7 t80 -58.39 -37.05 74.49 Favored 'General case' 0 CA--C 1.533 0.318 0 CA-C-N 116.499 -0.318 . . . . 0.0 111.15 179.689 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 4.6 mt-10 -57.92 -38.14 75.34 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-O 120.668 0.271 . . . . 0.0 110.98 179.512 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 144.77 52.14 0.03 OUTLIER Glycine 0 C--N 1.334 0.46 0 C-N-CA 121.018 -0.611 . . . . 0.0 112.701 179.785 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -109.98 157.18 19.56 Favored 'General case' 0 C--O 1.232 0.15 0 CA-C-O 120.81 0.338 . . . . 0.0 111.237 -179.943 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -157.1 -47.14 0.07 Allowed 'General case' 0 CA--C 1.532 0.262 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.156 179.815 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 4.8 m -100.02 115.0 40.19 Favored 'Isoleucine or valine' 0 C--O 1.233 0.191 0 CA-C-O 120.84 0.352 . . . . 0.0 110.972 179.78 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -110.47 174.79 5.7 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.204 -179.854 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 11.3 m -133.48 121.18 40.81 Favored 'Isoleucine or valine' 0 C--O 1.233 0.209 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.186 -179.886 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 43.3 t -63.15 135.94 96.46 Favored Pre-proline 0 C--O 1.233 0.215 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.702 179.964 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 91.5 Cg_endo -83.15 19.87 1.26 Allowed 'Trans proline' 0 CA--C 1.537 0.645 0 C-N-CA 122.682 2.255 . . . . 0.0 113.212 179.972 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 29.8 t -128.35 -58.2 1.2 Allowed 'General case' 0 CA--C 1.529 0.152 0 CA-C-O 120.657 0.265 . . . . 0.0 110.521 179.644 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 51' ' ' CYS . . . . . 0.401 ' HB3' ' CB ' ' A' ' 28' ' ' CYS . 20.1 p -98.72 -20.2 17.07 Favored 'General case' 0 CA--C 1.533 0.327 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.826 179.93 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 1.1 t 67.46 39.48 2.88 Favored 'General case' 0 CA--C 1.534 0.327 0 CA-C-O 121.07 0.462 . . . . 0.0 110.904 -179.772 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 6.9 tp -88.08 131.68 34.58 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.711 179.814 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 54' ' ' MET . . . . . . . . . . . . . 41.1 mtt -85.14 123.99 31.29 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.618 -179.877 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 2.6 pp -134.06 142.16 41.89 Favored 'Isoleucine or valine' 0 C--O 1.234 0.249 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.621 -179.749 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -105.81 95.92 6.14 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.656 -179.909 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.415 ' HA ' ' O ' ' A' ' 8' ' ' ILE . 14.8 p -84.18 139.13 18.03 Favored 'Isoleucine or valine' 0 C--O 1.234 0.286 0 CA-C-O 120.941 0.4 . . . . 0.0 111.124 -179.954 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 12.1 p -111.26 123.02 66.75 Favored 'Isoleucine or valine' 0 C--O 1.234 0.264 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.862 179.703 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 32.3 p90 -129.32 176.83 7.63 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.025 -179.675 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -118.02 162.79 17.6 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.556 -179.898 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 22.8 mttt -87.82 -32.1 19.21 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.128 179.568 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -59.73 -54.55 45.05 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 116.587 -0.279 . . . . 0.0 110.835 179.882 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -61.28 -44.48 97.16 Favored 'General case' 0 N--CA 1.463 0.186 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.741 179.655 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.709 HD11 ' HG3' ' A' ' 39' ' ' MET . 0.2 OUTLIER -57.96 -41.31 82.64 Favored 'General case' 0 CA--C 1.529 0.157 0 CA-C-N 116.429 -0.35 . . . . 0.0 110.809 179.583 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -70.18 -39.45 75.24 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 116.441 -0.345 . . . . 0.0 111.241 179.763 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 31.1 mt-10 -70.51 -41.06 73.12 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.504 -179.808 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 67' ' ' TYR . . . . . 0.561 ' CD2' HD11 ' A' ' 36' ' ' LEU . 2.5 t80 -55.94 -30.84 62.3 Favored 'General case' 0 N--CA 1.465 0.275 0 CA-C-N 116.693 -0.231 . . . . 0.0 111.499 -179.958 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 68' ' ' TYR . . . . . 0.419 ' HA ' ' OE1' ' A' ' 20' ' ' GLN . 3.8 m-85 -58.85 -36.24 74.25 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-O 120.63 0.253 . . . . 0.0 110.589 179.665 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 7.8 tt0 -88.3 -36.32 16.73 Favored 'General case' 0 CA--C 1.531 0.242 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.943 179.334 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 4.5 mm-40 -66.23 -34.57 78.31 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.605 -179.705 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.234 0.248 0 CA-C-O 120.86 0.362 . . . . 0.0 111.251 -179.838 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 4' ' ' THR . . . . . 0.602 HG22 ' HB3' ' A' ' 54' ' ' MET . 58.4 p . . . . . 0 N--CA 1.468 0.449 0 CA-C-O 120.77 0.319 . . . . 0.0 111.249 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 5.7 m-85 -102.83 -50.3 3.57 Favored 'General case' 0 CA--C 1.529 0.163 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.173 179.628 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -154.88 176.49 12.43 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.383 179.702 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 15.3 pt-20 -123.76 135.56 53.9 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.765 179.422 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 3.5 mp -121.75 139.63 48.23 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.305 0 CA-C-N 116.462 -0.336 . . . . 0.0 110.827 -179.977 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 9' ' ' GLU . . . . . 0.48 ' HG3' HG13 ' A' ' 58' ' ' VAL . 3.2 tt0 -83.93 145.73 28.42 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.182 -179.871 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 9.7 tp -57.15 -33.81 43.89 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.314 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.184 179.586 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 -58.77 -34.58 71.59 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 116.569 -0.287 . . . . 0.0 111.087 179.307 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 54.2 m-20 -95.76 36.83 1.25 Allowed 'General case' 0 CA--C 1.535 0.367 0 CA-C-O 120.722 0.296 . . . . 0.0 111.342 179.591 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 3.1 ttt -120.2 146.49 45.98 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 116.582 -0.281 . . . . 0.0 110.802 179.779 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 1.5 m -68.95 126.03 28.5 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 116.519 -0.31 . . . . 0.0 110.765 179.876 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 2.8 p90 -105.14 157.58 17.17 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.04 179.885 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 23.6 mt-10 -139.97 83.27 16.33 Favored Pre-proline 0 C--O 1.235 0.292 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.675 179.98 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 70.4 Cg_exo -52.05 -28.75 33.7 Favored 'Trans proline' 0 C--N 1.349 0.554 0 C-N-CA 122.98 2.454 . . . . 0.0 112.731 179.919 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -52.36 -35.94 52.5 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-N 116.454 -0.339 . . . . 0.0 111.577 179.605 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 2.0 t-20 -141.85 29.39 1.7 Allowed 'General case' 0 CA--C 1.538 0.505 0 N-CA-C 111.721 0.267 . . . . 0.0 111.721 -179.92 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 20' ' ' GLN . . . . . 0.487 ' HB2' HD21 ' A' ' 36' ' ' LEU . 24.5 pt20 41.73 35.87 0.55 Allowed 'General case' 0 N--CA 1.475 0.792 0 N-CA-C 112.245 0.461 . . . . 0.0 112.245 -179.756 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 7.0 ttt -105.67 158.67 16.55 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.475 -179.601 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 23.1 m-85 -129.65 147.07 51.4 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-O 120.777 0.322 . . . . 0.0 111.187 179.587 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 23' ' ' THR . . . . . 0.427 HG22 ' O ' ' A' ' 32' ' ' PHE . 21.2 p -144.19 177.42 8.61 Favored 'General case' 0 CA--C 1.537 0.465 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.953 -179.98 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 38.7 t80 -171.68 134.79 0.89 Allowed Pre-proline 0 N--CA 1.47 0.559 0 CA-C-N 116.699 -0.228 . . . . 0.0 110.961 179.327 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -65.04 101.23 0.39 Allowed 'Trans proline' 0 C--N 1.352 0.724 0 C-N-CA 122.795 2.33 . . . . 0.0 112.902 -179.857 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 26' ' ' CYS . . . . . 0.435 ' SG ' ' HD2' ' A' ' 27' ' ' PRO . 46.7 t -66.18 139.53 96.5 Favored Pre-proline 0 C--O 1.233 0.232 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.729 179.598 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 27' ' ' PRO . . . . . 0.435 ' HD2' ' SG ' ' A' ' 26' ' ' CYS . 60.9 Cg_exo -52.61 -27.08 31.61 Favored 'Trans proline' 0 C--N 1.348 0.547 0 C-N-CA 122.748 2.299 . . . . 0.0 112.907 179.625 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -67.6 -38.53 84.11 Favored 'General case' 0 C--O 1.235 0.305 0 N-CA-C 111.61 0.226 . . . . 0.0 111.61 -179.99 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 152.32 -48.19 0.55 Allowed Glycine 0 C--N 1.336 0.571 0 C-N-CA 120.785 -0.721 . . . . 0.0 113.242 -179.788 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -75.89 -173.59 2.34 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-N 116.751 0.276 . . . . 0.0 111.137 -179.812 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 51.5 mtt180 -122.41 138.34 54.57 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-O 120.76 0.314 . . . . 0.0 111.185 -179.989 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 32' ' ' PHE . . . . . 0.427 ' O ' HG22 ' A' ' 23' ' ' THR . 45.0 m-85 -69.06 167.86 15.08 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.864 179.569 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 3.9 pp0? -152.17 138.16 18.16 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.22 179.594 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.445 HD13 ' HE2' ' A' ' 39' ' ' MET . 3.5 tt -173.98 127.87 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.531 0.238 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.033 179.659 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 76.5 m-85 -82.21 142.9 31.78 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.734 -179.81 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.514 HD13 HD23 ' A' ' 64' ' ' LEU . 3.9 pp -55.45 -35.22 65.22 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 116.389 -0.368 . . . . 0.0 111.231 179.645 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 37' ' ' ASP . . . . . 0.42 ' N ' HD12 ' A' ' 36' ' ' LEU . 0.9 OUTLIER -61.49 -45.6 93.55 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 116.534 -0.303 . . . . 0.0 111.016 179.678 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -61.12 -43.43 98.89 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-O 120.762 0.315 . . . . 0.0 110.731 179.453 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 39' ' ' MET . . . . . 0.445 ' HE2' HD13 ' A' ' 34' ' ' ILE . 3.6 mtt -59.75 -33.52 71.77 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.029 179.616 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -56.42 -39.88 73.78 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 116.534 -0.303 . . . . 0.0 110.991 179.533 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 21.9 mt-10 -65.57 -48.94 70.67 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 116.665 -0.243 . . . . 0.0 110.863 179.741 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 153.64 74.94 0.01 OUTLIER Glycine 0 C--N 1.336 0.535 0 C-N-CA 120.678 -0.772 . . . . 0.0 113.02 179.696 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 5.0 tp10 -128.66 96.71 4.47 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-O 120.858 0.361 . . . . 0.0 111.299 179.748 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 14.5 ptpt -111.86 -31.81 6.82 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.439 179.803 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 4.4 m -110.87 97.41 5.7 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.264 0 CA-C-O 120.953 0.406 . . . . 0.0 111.075 179.853 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -99.64 154.55 18.19 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.527 -179.574 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 11.2 p -118.56 139.23 46.59 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.244 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.313 -179.958 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 53.5 t -78.52 135.25 60.89 Favored Pre-proline 0 C--O 1.233 0.232 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.917 179.858 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_endo -83.96 19.7 1.32 Allowed 'Trans proline' 0 C--N 1.35 0.628 0 C-N-CA 122.692 2.261 . . . . 0.0 113.171 179.843 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 12.7 t -128.02 -59.26 1.19 Allowed 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 122.301 0.24 . . . . 0.0 110.41 179.607 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 19.4 p -95.76 -20.89 18.51 Favored 'General case' 0 N--CA 1.468 0.444 0 N-CA-C 112.073 0.397 . . . . 0.0 112.073 179.676 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 1.2 t 67.04 39.6 3.15 Favored 'General case' 0 CA--C 1.536 0.434 0 CA-C-O 120.901 0.382 . . . . 0.0 111.353 -179.683 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.585 HD23 HG23 ' A' ' 55' ' ' ILE . 8.0 tt -91.81 139.6 30.51 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.852 179.903 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 54' ' ' MET . . . . . 0.602 ' HB3' HG22 ' A' ' 4' ' ' THR . 53.1 mtp -88.24 128.11 35.46 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 116.396 -0.366 . . . . 0.0 111.3 -179.734 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.585 HG23 HD23 ' A' ' 53' ' ' LEU . 2.4 pt -132.26 139.08 50.95 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.259 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.492 179.937 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 22.0 m-20 -96.93 87.13 4.17 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 116.458 -0.337 . . . . 0.0 110.324 179.216 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.429 ' O ' HG13 ' A' ' 57' ' ' VAL . 12.6 p -93.13 114.15 29.35 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.251 0 CA-C-O 121.004 0.43 . . . . 0.0 111.079 -179.893 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.48 HG13 ' HG3' ' A' ' 9' ' ' GLU . 14.9 p -82.92 146.75 6.59 Favored 'Isoleucine or valine' 0 C--O 1.233 0.208 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.283 -179.539 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 47.5 p90 -121.9 170.1 10.13 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.267 -179.645 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -132.08 165.0 25.01 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.448 -179.914 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -99.83 -33.77 10.42 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.405 179.815 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 1.6 mm-40 -59.35 -60.31 4.06 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-O 120.471 0.176 . . . . 0.0 111.073 179.929 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -59.87 -44.49 94.14 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 116.608 -0.269 . . . . 0.0 110.86 179.733 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.514 HD23 HD13 ' A' ' 36' ' ' LEU . 0.7 OUTLIER -58.38 -45.34 88.49 Favored 'General case' 0 CA--C 1.53 0.211 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.036 179.734 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -62.77 -51.68 66.19 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.176 179.789 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 2.0 tp10 -59.57 -40.91 88.9 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-N 116.459 -0.337 . . . . 0.0 110.761 179.517 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 3.9 t80 -55.11 -36.18 65.45 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.435 179.544 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 1.6 t80 -55.9 -38.69 70.55 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-O 120.637 0.256 . . . . 0.0 110.58 179.791 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 4.2 tt0 -83.04 -37.24 24.17 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.73 179.091 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 8.1 mt-10 -65.76 -36.87 84.79 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 116.526 -0.306 . . . . 0.0 111.621 -179.802 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.233 0.223 0 CA-C-O 120.811 0.338 . . . . 0.0 111.542 -179.893 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 3.1 p . . . . . 0 N--CA 1.464 0.275 0 CA-C-O 120.647 0.26 . . . . 0.0 111.627 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -107.89 -47.56 3.56 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.21 179.622 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -150.32 174.57 12.71 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.339 179.938 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 12.4 mt-10 -121.62 120.71 35.57 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.63 179.691 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.447 ' O ' ' HA ' ' A' ' 57' ' ' VAL . 3.6 mp -115.08 152.09 16.74 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.331 0 CA-C-N 116.441 -0.345 . . . . 0.0 111.33 -179.495 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 10.2 mt-10 -99.24 143.06 29.93 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 116.525 -0.307 . . . . 0.0 111.387 179.986 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 9.0 tp -59.32 -29.42 41.88 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.382 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.467 179.576 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 3.4 pt-20 -60.59 -28.67 68.67 Favored 'General case' 0 CA--C 1.533 0.325 0 CA-C-N 116.669 -0.241 . . . . 0.0 111.357 179.679 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -97.9 36.99 1.46 Allowed 'General case' 0 CA--C 1.535 0.392 0 CA-C-O 120.722 0.296 . . . . 0.0 111.248 179.756 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 13' ' ' MET . . . . . 0.607 ' CE ' HG11 ' A' ' 57' ' ' VAL . 3.9 mtt -131.44 140.06 49.52 Favored 'General case' 0 N--CA 1.464 0.225 0 CA-C-N 116.528 -0.305 . . . . 0.0 111.075 179.994 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 2.1 m -67.58 145.91 54.4 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 116.418 -0.355 . . . . 0.0 111.131 179.826 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 1.5 p90 -109.08 158.15 18.04 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.159 179.726 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -135.7 76.9 53.04 Favored Pre-proline 0 CA--C 1.532 0.264 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.587 179.677 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -54.09 -25.02 35.32 Favored 'Trans proline' 0 C--N 1.352 0.736 0 C-N-CA 122.982 2.454 . . . . 0.0 113.133 -179.99 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -52.95 -42.72 65.74 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-N 116.669 -0.241 . . . . 0.0 111.316 179.918 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 3.5 m-80 -133.01 15.69 4.22 Favored 'General case' 0 CA--C 1.541 0.615 0 N-CA-C 112.181 0.438 . . . . 0.0 112.181 -179.758 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 20' ' ' GLN . . . . . 0.491 ' C ' HD13 ' A' ' 36' ' ' LEU . 27.7 mt-30 56.08 75.26 0.35 Allowed 'General case' 0 N--CA 1.471 0.591 0 N-CA-C 111.959 0.355 . . . . 0.0 111.959 179.497 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 1.6 ptt? -163.01 147.95 11.58 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-N 116.431 -0.349 . . . . 0.0 111.26 179.191 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 7.5 m-85 -105.09 139.33 39.92 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-O 120.677 0.275 . . . . 0.0 110.973 179.675 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 75.5 p -132.44 158.25 42.51 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.57 -179.488 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 39.0 t80 -162.83 136.45 4.61 Favored Pre-proline 0 N--CA 1.465 0.276 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.908 179.619 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 41.7 Cg_endo -66.14 100.31 0.45 Allowed 'Trans proline' 0 C--N 1.35 0.617 0 C-N-CA 122.461 2.107 . . . . 0.0 112.32 179.725 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 26' ' ' CYS . . . . . 0.424 ' SG ' ' HD2' ' A' ' 27' ' ' PRO . 42.6 t -58.4 139.3 84.91 Favored Pre-proline 0 C--O 1.233 0.19 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.843 179.843 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 27' ' ' PRO . . . . . 0.424 ' HD2' ' SG ' ' A' ' 26' ' ' CYS . 65.1 Cg_exo -52.27 -26.53 27.33 Favored 'Trans proline' 0 C--N 1.349 0.596 0 C-N-CA 122.843 2.362 . . . . 0.0 113.038 179.844 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 28' ' ' CYS . . . . . 0.419 ' CB ' ' HB3' ' A' ' 51' ' ' CYS . 0.8 OUTLIER -68.19 -38.4 81.97 Favored 'General case' 0 CA--C 1.533 0.318 0 CA-C-O 120.472 0.177 . . . . 0.0 111.394 179.924 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 151.12 -45.28 0.64 Allowed Glycine 0 C--N 1.336 0.55 0 C-N-CA 120.827 -0.702 . . . . 0.0 112.999 -179.784 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 2.8 t70 -72.26 -178.21 2.41 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-N 116.677 0.239 . . . . 0.0 111.143 -179.845 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 8.2 ttm180 -118.93 125.37 49.3 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-O 120.673 0.273 . . . . 0.0 111.234 -179.86 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 32' ' ' PHE . . . . . 0.587 ' CE2' HD11 ' A' ' 55' ' ' ILE . 0.5 OUTLIER -64.84 154.33 37.48 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.243 179.858 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 20.8 pt20 -150.44 135.93 18.06 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.278 -179.92 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 2.8 tt -149.27 135.39 12.07 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.201 0 CA-C-N 116.425 -0.352 . . . . 0.0 111.219 179.428 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -86.2 140.93 29.71 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.83 179.963 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.686 ' O ' HD11 ' A' ' 64' ' ' LEU . 9.8 mp -58.03 -49.14 77.89 Favored 'General case' 0 C--O 1.232 0.152 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.676 179.699 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -58.05 -39.4 78.35 Favored 'General case' 0 CA--C 1.532 0.261 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.23 179.48 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -58.54 -46.79 86.09 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 116.571 -0.286 . . . . 0.0 110.834 179.809 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 8.9 mtm -59.82 -35.3 74.44 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.85 179.683 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -55.16 -42.91 73.74 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.923 179.511 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -60.38 -48.23 82.66 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-O 120.68 0.276 . . . . 0.0 110.81 179.712 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 149.62 54.76 0.01 OUTLIER Glycine 0 C--N 1.334 0.472 0 C-N-CA 120.954 -0.641 . . . . 0.0 112.663 179.775 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 2.3 tp10 -99.32 95.94 7.39 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-O 120.775 0.321 . . . . 0.0 111.047 179.971 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 13.4 mtmt -105.39 -36.89 7.03 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.078 179.75 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.462 HG13 ' O ' ' A' ' 45' ' ' VAL . 9.4 p -117.95 111.11 32.94 Favored 'Isoleucine or valine' 0 C--O 1.233 0.217 0 CA-C-O 121.037 0.446 . . . . 0.0 110.87 179.769 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -109.9 168.8 9.16 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-N 115.816 -0.629 . . . . 0.0 111.338 -179.552 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 12.0 p -130.83 140.44 48.68 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.254 0 CA-C-N 116.432 -0.349 . . . . 0.0 111.75 -179.352 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 40.6 t -76.64 136.82 67.21 Favored Pre-proline 0 N--CA 1.464 0.248 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.737 179.785 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_endo -83.03 20.7 1.12 Allowed 'Trans proline' 0 CA--C 1.537 0.627 0 C-N-CA 122.85 2.367 . . . . 0.0 113.203 179.796 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -129.0 -56.79 1.18 Allowed 'General case' 0 C--O 1.233 0.222 0 CA-C-N 116.682 -0.235 . . . . 0.0 110.419 179.516 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 51' ' ' CYS . . . . . 0.5 ' SG ' HD12 ' A' ' 53' ' ' LEU . 22.9 p -95.78 -24.16 16.62 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 116.473 -0.33 . . . . 0.0 111.777 179.49 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER 69.64 39.95 1.45 Allowed 'General case' 0 CA--C 1.534 0.344 0 CA-C-O 120.821 0.343 . . . . 0.0 111.368 -179.666 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.5 HD12 ' SG ' ' A' ' 51' ' ' CYS . 74.4 mt -98.07 127.78 44.21 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-N 116.433 -0.348 . . . . 0.0 110.606 179.62 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 54' ' ' MET . . . . . . . . . . . . . 9.4 mtt -82.61 136.24 34.86 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.963 -179.677 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.587 HD11 ' CE2' ' A' ' 32' ' ' PHE . 9.2 pt -136.75 152.61 29.1 Favored 'Isoleucine or valine' 0 C--O 1.234 0.25 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.908 -179.647 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -102.66 108.78 20.16 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.484 179.285 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.607 HG11 ' CE ' ' A' ' 13' ' ' MET . 0.0 OUTLIER -110.13 113.18 43.51 Favored 'Isoleucine or valine' 0 C--O 1.234 0.257 0 CA-C-O 120.793 0.33 . . . . 0.0 111.355 179.726 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.534 HG13 ' O ' ' A' ' 58' ' ' VAL . 8.1 p -81.88 88.2 1.84 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.265 0 CA-C-O 121.353 0.597 . . . . 0.0 110.772 179.821 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 51.0 p90 -80.02 155.27 27.68 Favored 'General case' 0 CA--C 1.531 0.249 0 CA-C-N 115.597 -0.729 . . . . 0.0 111.177 -179.568 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -103.54 145.91 29.32 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-O 120.891 0.377 . . . . 0.0 111.375 -179.875 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 5.8 tttp -87.94 -40.22 14.1 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.844 179.67 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 21.1 tt0 -56.42 -44.62 80.56 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.335 179.424 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 77.4 m-20 -63.0 -46.66 86.63 Favored 'General case' 0 N--CA 1.463 0.186 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.813 179.353 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.686 HD11 ' O ' ' A' ' 36' ' ' LEU . 0.5 OUTLIER -53.33 -45.89 69.24 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-N 116.635 -0.257 . . . . 0.0 111.327 179.971 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -58.0 -51.54 69.25 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-N 116.471 -0.332 . . . . 0.0 111.024 179.869 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 58.6 mt-10 -67.13 -46.36 74.34 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.889 179.767 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 5.2 m-85 -53.98 -31.91 52.35 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.62 179.637 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 1.7 t80 -59.09 -49.2 78.79 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-O 120.671 0.272 . . . . 0.0 110.804 179.935 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 34.8 mt-10 -83.93 -35.5 23.99 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.006 179.841 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 2.6 mm-40 -66.63 -30.31 70.55 Favored 'General case' 0 CA--C 1.533 0.29 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.67 179.765 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.465 0.285 0 CA-C-O 120.966 0.412 . . . . 0.0 111.991 -179.478 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 1.2 p . . . . . 0 N--CA 1.465 0.305 0 CA-C-O 120.627 0.251 . . . . 0.0 110.794 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 5' ' ' TYR . . . . . 0.544 ' CG ' HD11 ' A' ' 53' ' ' LEU . 2.8 m-85 -108.03 -73.74 0.68 Allowed 'General case' 0 C--O 1.233 0.226 0 CA-C-N 116.46 -0.337 . . . . 0.0 111.119 -179.968 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 8.9 p-10 -142.29 162.19 36.1 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.44 -179.515 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 -106.58 108.85 20.57 Favored 'General case' 0 CA--C 1.531 0.228 0 CA-C-N 115.857 -0.611 . . . . 0.0 110.976 -179.954 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 3.7 mp -93.73 150.14 4.07 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.23 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.215 179.95 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 4.0 tt0 -95.59 146.87 24.14 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.344 -179.734 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 2.9 tt -60.37 -33.19 53.08 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.296 0 CA-C-N 116.086 -0.507 . . . . 0.0 111.415 179.653 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 27.3 mt-10 -60.18 -35.24 74.93 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 116.464 -0.334 . . . . 0.0 110.892 179.532 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -96.44 37.22 1.28 Allowed 'General case' 0 CA--C 1.533 0.316 0 CA-C-O 120.804 0.335 . . . . 0.0 111.287 179.774 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 2.3 ttt -124.18 144.12 50.11 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.756 179.751 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 21.5 m -64.88 136.86 57.33 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.047 -179.788 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 19.7 p90 -105.89 131.04 53.68 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.009 179.771 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -118.65 91.8 42.82 Favored Pre-proline 0 C--N 1.33 -0.261 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.479 179.843 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 42.3 Cg_endo -70.82 -14.79 32.99 Favored 'Trans proline' 0 C--N 1.347 0.496 0 C-N-CA 122.598 2.199 . . . . 0.0 113.0 -179.932 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 -51.37 -35.26 37.79 Favored 'General case' 0 CA--C 1.533 0.319 0 N-CA-C 111.912 0.338 . . . . 0.0 111.912 -179.759 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 18.6 m-20 -148.71 26.67 0.91 Allowed 'General case' 0 CA--C 1.534 0.36 0 CA-C-N 116.624 -0.262 . . . . 0.0 111.579 -179.78 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 7.1 mt-30 55.02 69.84 0.69 Allowed 'General case' 0 CA--C 1.537 0.472 0 CA-C-O 120.921 0.391 . . . . 0.0 111.566 179.518 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 5.7 ptt? -151.52 167.49 27.87 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.938 179.577 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.526 ' HE1' HD21 ' A' ' 36' ' ' LEU . 17.4 m-85 -128.63 147.49 50.73 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 116.507 -0.315 . . . . 0.0 110.918 179.824 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 71.7 p -138.77 169.52 17.64 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.803 -179.615 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 47.6 t80 -163.54 137.09 4.4 Favored Pre-proline 0 N--CA 1.468 0.432 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.938 179.878 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -67.3 97.08 0.42 Allowed 'Trans proline' 0 C--N 1.352 0.713 0 C-N-CA 122.486 2.124 . . . . 0.0 112.11 179.446 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 26' ' ' CYS . . . . . 0.465 ' SG ' ' HD2' ' A' ' 27' ' ' PRO . 50.2 t -59.44 140.43 88.5 Favored Pre-proline 0 C--O 1.233 0.193 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.676 179.962 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 27' ' ' PRO . . . . . 0.465 ' HD2' ' SG ' ' A' ' 26' ' ' CYS . 74.5 Cg_exo -50.86 -27.75 21.54 Favored 'Trans proline' 0 C--N 1.349 0.591 0 C-N-CA 122.942 2.428 . . . . 0.0 113.098 179.928 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -71.48 -38.29 71.23 Favored 'General case' 0 CA--C 1.533 0.326 0 CA-C-O 120.485 0.183 . . . . 0.0 111.269 -179.905 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 149.45 -44.08 0.74 Allowed Glycine 0 C--N 1.337 0.6 0 C-N-CA 120.858 -0.687 . . . . 0.0 113.001 -179.971 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -68.26 176.85 2.55 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-O 120.84 0.352 . . . . 0.0 111.278 -179.716 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -118.43 128.82 54.98 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-N 116.492 -0.322 . . . . 0.0 110.998 -179.927 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 9.6 m-85 -62.54 160.13 14.44 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.859 179.671 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 10.5 pt20 -155.3 130.14 9.31 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-O 120.845 0.355 . . . . 0.0 111.401 -179.982 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 3.2 tt -157.3 124.19 0.56 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.281 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.904 179.707 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 32.0 m-85 -80.15 156.5 26.95 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.746 179.999 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.526 HD21 ' HE1' ' A' ' 22' ' ' PHE . 72.0 mt -58.73 -40.9 85.14 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.836 179.849 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -62.2 -35.22 78.21 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 116.447 -0.342 . . . . 0.0 111.408 179.675 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 18.1 m-20 -64.45 -60.08 3.58 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-O 120.862 0.363 . . . . 0.0 110.77 -179.943 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 13.7 ptp -60.18 -37.26 79.66 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.076 179.874 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 40' ' ' PHE . . . . . 0.428 ' HB2' ' CD2' ' A' ' 64' ' ' LEU . 23.2 t80 -59.8 -45.35 92.59 Favored 'General case' 0 CA--C 1.53 0.193 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.984 179.581 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -57.97 -42.2 84.53 Favored 'General case' 0 CA--C 1.532 0.251 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.005 179.799 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 149.78 65.73 0.01 OUTLIER Glycine 0 C--N 1.336 0.537 0 C-N-CA 120.773 -0.727 . . . . 0.0 113.086 179.632 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -120.01 156.63 30.51 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-O 120.655 0.264 . . . . 0.0 111.12 179.719 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 44' ' ' LYS . . . . . 0.554 ' HG3' HG23 ' A' ' 45' ' ' VAL . 0.2 OUTLIER -162.77 -46.8 0.04 OUTLIER 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.164 179.532 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.554 HG23 ' HG3' ' A' ' 44' ' ' LYS . 22.0 t -96.89 89.22 2.02 Favored 'Isoleucine or valine' 0 C--O 1.234 0.28 0 CA-C-O 120.892 0.377 . . . . 0.0 110.644 179.692 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -80.1 141.54 35.7 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.24 -179.583 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 7.9 m -110.09 127.24 67.14 Favored 'Isoleucine or valine' 0 C--O 1.232 0.174 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.464 -179.879 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 51.0 t -72.13 135.64 82.32 Favored Pre-proline 0 C--N 1.331 -0.227 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.792 179.806 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 87.0 Cg_endo -84.0 19.22 1.4 Allowed 'Trans proline' 0 CA--C 1.537 0.631 0 C-N-CA 122.734 2.289 . . . . 0.0 113.234 179.96 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 2.0 t -127.74 -57.86 1.25 Allowed 'General case' 0 C--O 1.232 0.176 0 CA-C-O 120.558 0.218 . . . . 0.0 110.649 179.538 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 19.6 p -98.7 -19.81 17.29 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-N 116.455 -0.339 . . . . 0.0 111.73 179.888 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER 67.81 39.28 2.68 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-O 121.081 0.467 . . . . 0.0 110.955 -179.895 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.557 HD23 HG23 ' A' ' 55' ' ' ILE . 9.1 tt -91.25 132.9 35.83 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.631 179.875 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 54' ' ' MET . . . . . . . . . . . . . 15.1 mtt -87.92 130.49 34.91 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.194 -179.664 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.557 HG23 HD23 ' A' ' 53' ' ' LEU . 3.2 pt -133.45 144.51 35.86 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.237 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.456 179.676 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -101.7 107.59 18.87 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.226 179.148 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.438 ' O ' HG13 ' A' ' 57' ' ' VAL . 11.6 p -107.98 117.1 52.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-O 120.943 0.402 . . . . 0.0 111.01 -179.821 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 13.9 p -79.99 135.54 25.25 Favored 'Isoleucine or valine' 0 C--O 1.236 0.347 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.662 -179.896 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 8.0 p90 -142.96 169.39 17.66 Favored 'General case' 0 C--O 1.235 0.299 0 CA-C-N 115.782 -0.645 . . . . 0.0 110.97 -179.084 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -138.06 171.07 14.95 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.175 179.615 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 7.6 mttp -96.78 23.01 7.47 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.324 179.746 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 4.6 mt-10 -94.35 -47.81 6.43 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.224 179.206 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 3.0 t70 -68.55 -35.95 78.12 Favored 'General case' 0 N--CA 1.462 0.126 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.213 179.529 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.428 ' CD2' ' HB2' ' A' ' 40' ' ' PHE . 0.7 OUTLIER -55.05 -53.61 53.6 Favored 'General case' 0 CA--C 1.532 0.279 0 CA-C-N 116.694 -0.23 . . . . 0.0 111.358 -179.895 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -59.57 -44.6 93.25 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-O 120.811 0.339 . . . . 0.0 110.934 179.573 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -64.45 -45.15 88.67 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-N 115.857 -0.61 . . . . 0.0 111.102 179.884 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 67' ' ' TYR . . . . . 0.448 ' HD2' HD11 ' A' ' 36' ' ' LEU . 1.2 t80 -72.11 -39.85 68.59 Favored 'General case' 0 CA--C 1.531 0.239 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.899 -179.764 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 15.4 t80 -62.5 -36.96 84.17 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-O 120.577 0.227 . . . . 0.0 110.86 179.924 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 32.4 mt-10 -78.11 -32.82 50.73 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.987 179.471 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 4.8 tt0 -114.23 40.4 2.52 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-N 116.546 -0.297 . . . . 0.0 111.492 -179.79 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.234 0.261 0 CA-C-O 120.986 0.422 . . . . 0.0 111.62 -179.942 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 4' ' ' THR . . . . . 0.51 HG21 ' CG ' ' A' ' 56' ' ' ASP . 0.8 OUTLIER . . . . . 0 N--CA 1.465 0.301 0 CA-C-O 120.772 0.32 . . . . 0.0 111.172 . . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 5' ' ' TYR . . . . . 0.597 ' CD1' HD11 ' A' ' 53' ' ' LEU . 61.2 m-85 -95.07 -35.26 11.99 Favored 'General case' 0 CA--C 1.53 0.197 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.523 179.991 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -155.04 174.1 15.65 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-O 120.812 0.339 . . . . 0.0 111.328 179.887 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 26.5 tt0 -130.8 114.33 15.2 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.649 -179.936 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.408 HG21 ' CE ' ' A' ' 13' ' ' MET . 27.8 mm -93.2 155.61 3.12 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.178 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.744 179.897 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 4.3 pm0 -119.1 145.97 45.49 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.171 -179.807 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 8.2 tp -59.21 -33.53 50.99 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.328 0 CA-C-N 116.277 -0.419 . . . . 0.0 111.168 179.595 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 8.4 mt-10 -65.68 -32.25 73.71 Favored 'General case' 0 CA--C 1.533 0.318 0 CA-C-N 116.461 -0.336 . . . . 0.0 111.155 179.445 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 11.0 t0 -98.63 40.32 1.2 Allowed 'General case' 0 CA--C 1.533 0.3 0 CA-C-O 120.97 0.414 . . . . 0.0 110.664 179.617 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 13' ' ' MET . . . . . 0.411 ' HG3' ' HB2' ' A' ' 24' ' ' TYR . 0.9 OUTLIER -131.83 163.96 27.11 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.937 179.803 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 5.8 m -96.62 119.93 36.0 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-N 116.43 -0.35 . . . . 0.0 110.824 -179.809 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 20.8 p90 -98.56 134.14 41.94 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.529 179.618 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 4.5 mt-10 -107.11 94.3 10.75 Favored Pre-proline 0 C--O 1.234 0.239 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.521 179.952 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -73.0 65.24 4.14 Favored 'Trans proline' 0 C--N 1.35 0.629 0 C-N-CA 122.936 2.424 . . . . 0.0 112.5 -179.553 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 5.4 pt-20 -135.92 -49.48 0.69 Allowed 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.676 -0.693 . . . . 0.0 111.062 179.991 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -135.54 32.19 3.07 Favored 'General case' 0 CA--C 1.535 0.382 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.384 179.865 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 20' ' ' GLN . . . . . 0.661 ' HG3' HD13 ' A' ' 36' ' ' LEU . 0.0 OUTLIER 55.48 59.29 3.98 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-O 121.037 0.446 . . . . 0.0 111.273 -179.995 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 10.6 ptm -143.14 163.28 33.3 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.989 179.791 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.579 ' CZ ' HG23 ' A' ' 34' ' ' ILE . 4.5 p90 -150.82 144.32 24.98 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.09 -179.997 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 23' ' ' THR . . . . . 0.441 HG22 ' HA ' ' A' ' 33' ' ' GLN . 76.4 p -134.62 167.35 20.98 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-N 115.987 -0.551 . . . . 0.0 111.689 -179.386 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 24' ' ' TYR . . . . . 0.411 ' HB2' ' HG3' ' A' ' 13' ' ' MET . 31.6 t80 -153.41 136.72 10.06 Favored Pre-proline 0 CA--C 1.531 0.239 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.937 -179.993 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo -66.58 101.94 0.57 Allowed 'Trans proline' 0 C--N 1.35 0.623 0 C-N-CA 122.706 2.27 . . . . 0.0 112.415 179.739 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 26' ' ' CYS . . . . . 0.419 ' SG ' ' HD2' ' A' ' 27' ' ' PRO . 41.8 t -62.82 139.23 97.21 Favored Pre-proline 0 C--O 1.232 0.184 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.605 179.688 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 27' ' ' PRO . . . . . 0.419 ' HD2' ' SG ' ' A' ' 26' ' ' CYS . 76.3 Cg_exo -51.44 -27.27 23.9 Favored 'Trans proline' 0 C--N 1.349 0.602 0 C-N-CA 122.847 2.365 . . . . 0.0 113.029 179.858 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 28' ' ' CYS . . . . . 0.422 ' CB ' ' HB3' ' A' ' 51' ' ' CYS . 0.8 OUTLIER -69.66 -36.88 76.43 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-N 116.849 -0.16 . . . . 0.0 111.425 179.947 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 148.53 -43.54 0.8 Allowed Glycine 0 C--N 1.337 0.599 0 C-N-CA 120.881 -0.676 . . . . 0.0 113.141 179.91 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -69.49 -177.77 1.26 Allowed 'General case' 0 N--CA 1.465 0.315 0 CA-C-O 120.841 0.353 . . . . 0.0 111.442 -179.686 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 1.4 tpp180 -121.74 118.53 29.31 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.033 -179.918 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 34.3 t80 -59.87 142.74 52.96 Favored 'General case' 0 CA--C 1.528 0.103 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.448 179.394 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 33' ' ' GLN . . . . . 0.441 ' HA ' HG22 ' A' ' 23' ' ' THR . 1.5 pt20 -135.81 143.97 45.46 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-N 116.539 -0.3 . . . . 0.0 111.214 -179.814 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.579 HG23 ' CZ ' ' A' ' 22' ' ' PHE . 8.2 tt -174.79 149.24 0.41 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.343 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.02 -179.953 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 64.9 m-85 -99.14 159.62 14.85 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.05 -179.806 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.661 HD13 ' HG3' ' A' ' 20' ' ' GLN . 7.9 mp -60.69 -44.27 96.73 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.728 179.831 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -57.9 -40.22 79.82 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.678 179.327 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -60.26 -42.37 95.22 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.521 179.292 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 4.5 mtp -91.55 33.41 1.01 Allowed 'General case' 0 CA--C 1.534 0.356 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.253 179.367 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 18.0 t80 -135.95 -47.32 0.66 Allowed 'General case' 0 C--O 1.233 0.207 0 CA-C-N 116.654 -0.248 . . . . 0.0 110.865 179.647 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 12.9 tt0 -58.69 -44.62 90.32 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.884 179.675 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 167.28 68.17 0.03 OUTLIER Glycine 0 C--N 1.335 0.492 0 C-N-CA 120.892 -0.671 . . . . 0.0 112.843 179.713 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -144.08 156.02 44.19 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-O 120.818 0.342 . . . . 0.0 111.439 -179.968 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 4.7 pttp -156.21 -47.35 0.08 Allowed 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 115.886 -0.597 . . . . 0.0 111.107 179.811 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.417 HG13 ' O ' ' A' ' 45' ' ' VAL . 10.5 p -103.74 120.36 53.72 Favored 'Isoleucine or valine' 0 C--O 1.233 0.211 0 CA-C-O 120.898 0.38 . . . . 0.0 110.797 179.735 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -111.99 173.83 6.17 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.162 -179.844 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 19.9 t -128.48 137.8 56.39 Favored 'Isoleucine or valine' 0 C--O 1.235 0.29 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.441 -179.669 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 43.8 t -78.6 136.12 59.79 Favored Pre-proline 0 C--O 1.233 0.222 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.679 179.624 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_endo -84.31 22.16 0.98 Allowed 'Trans proline' 0 C--N 1.349 0.595 0 C-N-CA 122.828 2.352 . . . . 0.0 113.339 179.951 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 36.4 m -131.26 -57.13 1.02 Allowed 'General case' 0 C--O 1.233 0.219 0 CA-C-O 120.507 0.194 . . . . 0.0 110.674 179.825 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 51' ' ' CYS . . . . . 0.422 ' HB3' ' CB ' ' A' ' 28' ' ' CYS . 19.2 p -95.68 -19.18 19.92 Favored 'General case' 0 CA--C 1.535 0.369 0 CA-C-N 116.489 -0.323 . . . . 0.0 111.615 179.441 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 1.7 m 62.97 40.83 8.96 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-O 121.061 0.457 . . . . 0.0 111.014 -179.728 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.597 HD11 ' CD1' ' A' ' 5' ' ' TYR . 7.1 tp -95.02 142.94 26.91 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.873 179.898 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 54' ' ' MET . . . . . . . . . . . . . 17.3 mtm -91.99 128.39 37.81 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.709 179.817 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 19.0 pt -137.62 139.41 43.25 Favored 'Isoleucine or valine' 0 C--O 1.233 0.227 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.452 -179.659 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 56' ' ' ASP . . . . . 0.51 ' CG ' HG21 ' A' ' 4' ' ' THR . 91.5 m-20 -99.06 90.13 4.5 Favored 'General case' 0 C--O 1.231 0.13 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.493 179.417 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.443 ' O ' HG13 ' A' ' 57' ' ' VAL . 9.4 p -86.79 114.54 26.22 Favored 'Isoleucine or valine' 0 C--O 1.233 0.216 0 CA-C-O 120.993 0.425 . . . . 0.0 110.759 179.697 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 14.3 p -79.71 142.79 13.49 Favored 'Isoleucine or valine' 0 C--O 1.233 0.213 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.269 -179.75 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 36.2 p90 -132.43 177.94 7.21 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.691 -179.827 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -121.87 -167.1 1.48 Allowed 'General case' 0 CA--C 1.534 0.331 0 CA-C-O 120.792 0.33 . . . . 0.0 110.789 179.781 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 4.7 mmtp -113.98 -44.99 3.1 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.288 179.255 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 7.7 mt-10 -61.71 -34.2 75.37 Favored 'General case' 0 CA--C 1.529 0.17 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.206 179.58 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 34.8 p30 -56.73 -32.6 65.7 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 116.843 -0.162 . . . . 0.0 111.25 179.582 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.626 ' HG ' HD23 ' A' ' 36' ' ' LEU . 1.3 mp -79.27 -53.29 7.1 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-O 120.658 0.266 . . . . 0.0 110.612 179.355 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -56.04 -38.92 71.22 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.814 179.473 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 26.9 tt0 -68.73 -40.53 79.86 Favored 'General case' 0 CA--C 1.531 0.242 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.776 179.335 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -68.38 -39.81 81.62 Favored 'General case' 0 CA--C 1.53 0.185 0 CA-C-N 116.525 -0.307 . . . . 0.0 111.628 179.842 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 6.0 m-85 -60.46 -41.81 94.89 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 116.773 -0.194 . . . . 0.0 111.081 -179.858 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 16.9 pt-20 -77.84 -33.56 52.2 Favored 'General case' 0 CA--C 1.533 0.322 0 CA-C-N 116.621 -0.263 . . . . 0.0 111.234 179.698 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -74.17 -51.79 14.46 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-O 120.605 0.24 . . . . 0.0 111.41 -179.951 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.233 0.197 0 CA-C-O 120.816 0.341 . . . . 0.0 111.358 -179.872 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 4' ' ' THR . . . . . 0.556 HG21 ' OD1' ' A' ' 56' ' ' ASP . 68.0 p . . . . . 0 N--CA 1.467 0.414 0 CA-C-O 120.756 0.313 . . . . 0.0 111.518 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 5' ' ' TYR . . . . . 0.507 ' HB2' HD11 ' A' ' 53' ' ' LEU . 10.8 t80 -104.93 -41.32 5.65 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.137 -179.992 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 6' ' ' ASP . . . . . 0.467 ' HB2' ' CD1' ' A' ' 5' ' ' TYR . 5.1 t70 -155.95 161.33 40.53 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-O 120.801 0.334 . . . . 0.0 111.633 -179.565 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -117.12 119.97 36.88 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.861 179.474 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.415 ' O ' ' HA ' ' A' ' 57' ' ' VAL . 3.7 mp -111.53 153.16 13.3 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.226 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.309 -179.581 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 9' ' ' GLU . . . . . 0.534 ' HA ' HG12 ' A' ' 58' ' ' VAL . 15.7 mt-10 -103.08 152.03 21.86 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.362 -179.841 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 1.1 tp -58.0 -35.35 51.8 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.297 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.253 179.508 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -63.37 -32.75 74.26 Favored 'General case' 0 CA--C 1.53 0.196 0 CA-C-N 116.544 -0.298 . . . . 0.0 111.151 179.544 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -96.18 36.79 1.29 Allowed 'General case' 0 CA--C 1.531 0.243 0 CA-C-O 120.762 0.315 . . . . 0.0 111.266 -179.987 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 13' ' ' MET . . . . . 0.422 ' HG3' ' HB2' ' A' ' 24' ' ' TYR . 7.6 ttt -127.31 140.84 51.93 Favored 'General case' 0 C--N 1.333 -0.128 0 CA-C-N 116.458 -0.337 . . . . 0.0 110.56 179.643 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 14' ' ' THR . . . . . 0.676 HG21 HH21 ' A' ' 31' ' ' ARG . 19.4 m -61.19 140.08 58.0 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.919 179.999 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 9.1 m-85 -105.14 135.28 46.79 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.772 -179.974 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -117.56 88.77 30.34 Favored Pre-proline 0 C--O 1.234 0.24 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.608 179.572 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 12.9 Cg_exo -70.7 65.16 2.36 Favored 'Trans proline' 0 C--N 1.349 0.556 0 C-N-CA 123.014 2.476 . . . . 0.0 112.47 -179.649 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 5.9 pt-20 -137.05 -51.89 0.67 Allowed 'General case' 0 C--O 1.232 0.177 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.909 179.945 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 70.8 m-20 -137.0 32.14 2.67 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-N 116.407 -0.36 . . . . 0.0 111.088 179.587 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 13.0 mm-40 56.87 61.9 2.45 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-O 120.917 0.389 . . . . 0.0 110.653 -179.861 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 3.8 ptm -134.26 150.41 51.01 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.957 -179.81 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.715 ' CE1' HD21 ' A' ' 36' ' ' LEU . 5.4 m-85 -122.99 126.86 47.97 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.659 -179.731 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 67.4 p -108.98 156.2 20.0 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.163 -179.87 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 24' ' ' TYR . . . . . 0.422 ' HB2' ' HG3' ' A' ' 13' ' ' MET . 64.8 t80 -148.12 107.34 3.65 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.54 179.824 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_exo -54.34 96.18 0.05 OUTLIER 'Trans proline' 0 C--N 1.348 0.551 0 C-N-CA 122.585 2.19 . . . . 0.0 111.95 -179.966 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 26' ' ' CYS . . . . . 0.451 ' SG ' ' HD2' ' A' ' 27' ' ' PRO . 46.4 t -63.46 139.19 97.55 Favored Pre-proline 0 C--O 1.233 0.225 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.909 -179.584 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 27' ' ' PRO . . . . . 0.451 ' HD2' ' SG ' ' A' ' 26' ' ' CYS . 10.1 Cg_endo -52.92 -23.3 20.72 Favored 'Trans proline' 0 C--N 1.349 0.554 0 C-N-CA 122.911 2.407 . . . . 0.0 112.834 179.745 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 6.1 p -59.43 -28.89 67.36 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-O 120.626 0.251 . . . . 0.0 111.222 179.839 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 125.11 4.74 7.03 Favored Glycine 0 CA--C 1.523 0.569 0 C-N-CA 120.988 -0.625 . . . . 0.0 113.6 179.976 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -119.91 -164.72 1.1 Allowed 'General case' 0 CA--C 1.534 0.341 0 CA-C-N 117.552 0.676 . . . . 0.0 111.424 -179.903 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 31' ' ' ARG . . . . . 0.676 HH21 HG21 ' A' ' 14' ' ' THR . 1.4 tpt180 -124.87 138.78 54.24 Favored 'General case' 0 C--O 1.232 0.155 0 CA-C-O 120.837 0.351 . . . . 0.0 111.561 -179.425 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 2.5 m-85 -81.29 165.16 21.66 Favored 'General case' 0 C--O 1.232 0.166 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.641 179.293 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 3.7 pt20 -155.46 122.92 5.56 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.438 -0.347 . . . . 0.0 111.009 179.785 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 4.3 tt -150.02 136.43 12.35 Favored 'Isoleucine or valine' 0 C--O 1.233 0.236 0 CA-C-N 116.308 -0.406 . . . . 0.0 111.141 -179.926 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 9.7 m-85 -96.39 156.5 16.31 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.011 -179.803 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.715 HD21 ' CE1' ' A' ' 22' ' ' PHE . 86.8 mt -63.64 -40.3 96.52 Favored 'General case' 0 N--CA 1.462 0.165 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.061 179.829 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 2.0 t0 -59.06 -35.76 73.89 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 116.499 -0.318 . . . . 0.0 111.361 179.928 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 9.7 m-20 -68.44 -58.53 4.2 Favored 'General case' 0 C--O 1.231 0.109 0 CA-C-O 120.828 0.347 . . . . 0.0 110.879 179.947 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 11.7 ptp -62.26 -34.03 75.75 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.527 -179.78 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 40' ' ' PHE . . . . . 0.403 ' HB2' ' CD2' ' A' ' 64' ' ' LEU . 22.4 t80 -60.21 -45.77 92.05 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 116.418 -0.355 . . . . 0.0 110.815 179.698 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 11.0 tt0 -57.93 -37.05 73.37 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.836 179.559 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 143.0 68.34 0.02 OUTLIER Glycine 0 C--N 1.334 0.426 0 C-N-CA 120.917 -0.659 . . . . 0.0 112.586 179.675 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -125.93 122.42 35.93 Favored 'General case' 0 N--CA 1.462 0.144 0 CA-C-O 120.7 0.286 . . . . 0.0 111.414 -179.769 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 14.0 mttt -118.68 -45.09 2.61 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.916 179.413 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.474 HG13 ' O ' ' A' ' 45' ' ' VAL . 10.6 p -104.55 114.52 44.37 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.182 0 CA-C-O 120.983 0.42 . . . . 0.0 110.98 179.904 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -106.92 151.45 25.25 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.947 -0.569 . . . . 0.0 111.433 -179.52 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 20.4 t -105.13 129.63 57.54 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.15 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.351 -179.893 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 50.2 t -69.43 135.35 88.65 Favored Pre-proline 0 N--CA 1.463 0.175 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.919 179.659 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 91.0 Cg_endo -83.9 19.05 1.42 Allowed 'Trans proline' 0 CA--C 1.535 0.537 0 C-N-CA 122.583 2.189 . . . . 0.0 113.118 179.953 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 1.9 m -129.1 -59.5 1.11 Allowed 'General case' 0 C--O 1.232 0.154 0 CA-C-O 120.412 0.148 . . . . 0.0 110.762 179.725 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 20.8 p -101.5 -14.2 17.6 Favored 'General case' 0 CA--C 1.535 0.377 0 N-CA-C 111.746 0.276 . . . . 0.0 111.746 179.789 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER 66.01 34.0 7.31 Favored 'General case' 0 CA--C 1.533 0.302 0 CA-C-O 120.848 0.356 . . . . 0.0 111.151 -179.98 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.507 HD11 ' HB2' ' A' ' 5' ' ' TYR . 16.8 tp -86.47 133.21 33.77 Favored 'General case' 0 C--O 1.232 0.14 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.709 179.76 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 54' ' ' MET . . . . . . . . . . . . . 15.3 mtt -82.72 129.9 35.04 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.696 179.995 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 3.0 pt -135.9 143.26 36.71 Favored 'Isoleucine or valine' 0 C--O 1.233 0.236 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.816 -179.474 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 56' ' ' ASP . . . . . 0.556 ' OD1' HG21 ' A' ' 4' ' ' THR . 30.1 m-20 -91.44 99.93 12.79 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.82 179.497 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.493 ' O ' HG13 ' A' ' 57' ' ' VAL . 10.2 p -105.19 110.52 31.23 Favored 'Isoleucine or valine' 0 C--O 1.234 0.262 0 CA-C-O 121.105 0.478 . . . . 0.0 110.927 179.723 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.534 HG12 ' HA ' ' A' ' 9' ' ' GLU . 12.3 p -82.05 138.14 19.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.407 -179.466 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 33.9 p90 -117.22 175.37 5.64 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.771 -0.65 . . . . 0.0 111.114 -179.683 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 60' ' ' ASP . . . . . 0.522 ' HB3' ' HB2' ' A' ' 63' ' ' ASP . 1.9 t70 -134.28 128.37 33.68 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.136 179.897 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 1.9 mptt -61.53 -42.35 98.69 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.638 179.514 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 23.5 mt-10 -63.95 -39.13 93.45 Favored 'General case' 0 C--O 1.232 0.137 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.328 179.187 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 63' ' ' ASP . . . . . 0.522 ' HB2' ' HB3' ' A' ' 60' ' ' ASP . 12.9 t70 -56.63 -45.02 81.77 Favored 'General case' 0 N--CA 1.462 0.126 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.886 179.331 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.639 ' HG ' HD22 ' A' ' 36' ' ' LEU . 1.1 mp -56.89 -55.62 32.18 Favored 'General case' 0 CA--C 1.529 0.151 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.517 -179.56 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -60.11 -46.91 88.02 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-N 116.673 -0.239 . . . . 0.0 111.483 -179.753 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 10.3 mm-40 -63.34 -42.62 98.94 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.901 179.877 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 33.9 t80 -69.91 -36.39 75.33 Favored 'General case' 0 CA--C 1.531 0.239 0 CA-C-N 116.481 -0.327 . . . . 0.0 111.149 179.599 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 2.2 t80 -55.7 -54.47 43.9 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-N 116.674 -0.239 . . . . 0.0 111.045 -179.882 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -69.83 -35.87 75.13 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.231 179.844 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 13.5 mt-10 -64.09 -38.37 90.81 Favored 'General case' 0 CA--C 1.53 0.179 0 CA-C-N 116.398 -0.365 . . . . 0.0 111.733 -179.831 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.233 0.194 0 N-CA-C 111.633 0.235 . . . . 0.0 111.633 -179.315 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 4' ' ' THR . . . . . 0.549 HG21 ' CG ' ' A' ' 56' ' ' ASP . 72.8 p . . . . . 0 N--CA 1.464 0.261 0 CA-C-O 120.91 0.386 . . . . 0.0 111.262 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 9.3 m-85 -105.89 -39.56 5.98 Favored 'General case' 0 CA--C 1.531 0.217 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.397 179.887 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -158.6 176.96 11.74 Favored 'General case' 0 C--O 1.235 0.299 0 CA-C-N 116.451 -0.341 . . . . 0.0 111.256 -179.91 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 2.2 pt-20 -123.14 151.37 42.19 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.906 -179.992 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 25.4 mt -133.2 149.59 31.67 Favored 'Isoleucine or valine' 0 C--O 1.232 0.181 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.254 -179.803 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 39.2 mt-10 -88.63 150.52 22.99 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.062 179.714 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 14.4 tt -56.86 -34.87 44.86 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.327 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.042 179.221 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -71.59 -44.13 65.03 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.106 179.573 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -53.06 -23.25 7.27 Favored 'General case' 0 N--CA 1.469 0.503 0 N-CA-C 112.026 0.38 . . . . 0.0 112.026 -179.973 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 13' ' ' MET . . . . . 0.403 ' CG ' ' HB2' ' A' ' 24' ' ' TYR . 4.8 ttm -88.42 137.53 32.24 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-N 116.791 -0.186 . . . . 0.0 110.708 179.867 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 29.4 m -60.62 145.27 49.65 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-O 120.735 0.302 . . . . 0.0 111.115 -179.945 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 16.3 p90 -104.84 144.27 31.99 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.272 179.992 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 9.0 mp0 -130.55 93.92 30.85 Favored Pre-proline 0 C--O 1.233 0.23 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.667 179.804 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -68.12 -17.0 45.5 Favored 'Trans proline' 0 C--N 1.349 0.576 0 C-N-CA 122.938 2.425 . . . . 0.0 112.86 179.585 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -54.35 -39.13 66.82 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 116.615 -0.266 . . . . 0.0 111.677 -179.96 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 2.1 m120 -144.7 20.03 1.66 Allowed 'General case' 0 CA--C 1.535 0.37 0 CA-C-N 116.431 -0.349 . . . . 0.0 111.839 -179.521 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 20' ' ' GLN . . . . . 0.439 ' C ' HD13 ' A' ' 36' ' ' LEU . 0.0 OUTLIER 55.68 79.32 0.16 Allowed 'General case' 0 C--O 1.234 0.237 0 CA-C-O 121.142 0.496 . . . . 0.0 111.288 179.636 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 3.2 ptt? -159.54 163.69 34.95 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.78 179.912 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 80.3 m-85 -123.58 118.78 28.12 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.617 179.792 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 14.7 p -105.46 152.03 23.52 Favored 'General case' 0 CA--C 1.53 0.184 0 CA-C-O 120.809 0.338 . . . . 0.0 111.145 -179.895 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 24' ' ' TYR . . . . . 0.403 ' HB2' ' CG ' ' A' ' 13' ' ' MET . 38.4 t80 -159.16 136.46 6.99 Favored Pre-proline 0 N--CA 1.463 0.198 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.018 -179.979 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -72.19 110.37 2.93 Favored 'Trans proline' 0 C--N 1.348 0.525 0 C-N-CA 122.496 2.131 . . . . 0.0 112.317 179.699 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 26' ' ' CYS . . . . . 0.46 ' SG ' ' HD2' ' A' ' 27' ' ' PRO . 51.5 t -77.63 140.14 63.57 Favored Pre-proline 0 C--O 1.233 0.209 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.463 179.56 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 27' ' ' PRO . . . . . 0.46 ' HD2' ' SG ' ' A' ' 26' ' ' CYS . 81.8 Cg_exo -49.41 -28.71 16.3 Favored 'Trans proline' 0 C--N 1.35 0.642 0 C-N-CA 123.041 2.494 . . . . 0.0 113.124 179.861 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 3.6 p -61.99 -29.83 70.53 Favored 'General case' 0 C--O 1.236 0.36 0 CA-C-O 120.657 0.265 . . . . 0.0 111.286 179.875 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 116.29 15.92 6.87 Favored Glycine 0 CA--C 1.525 0.696 0 C-N-CA 121.364 -0.446 . . . . 0.0 113.291 -179.894 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -120.11 -171.65 2.2 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-N 117.113 0.457 . . . . 0.0 111.056 -179.995 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 3.8 ttt180 -108.56 131.94 54.35 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-O 120.89 0.376 . . . . 0.0 111.367 -179.701 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 5.1 t80 -100.43 102.15 13.28 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.547 179.775 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 9.2 mt-30 -101.41 154.43 18.82 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.076 -179.781 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.409 HD13 ' HE3' ' A' ' 39' ' ' MET . 2.4 tt -161.98 123.48 0.31 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.254 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.044 179.674 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 1.3 t80 -76.1 145.11 40.26 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.829 -179.905 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.439 HD13 ' C ' ' A' ' 20' ' ' GLN . 10.1 mp -58.53 -42.78 88.56 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.852 179.714 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -60.21 -37.81 81.39 Favored 'General case' 0 N--CA 1.462 0.134 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.818 179.232 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -57.9 -52.02 67.21 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.866 179.715 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 39' ' ' MET . . . . . 0.409 ' HE3' HD13 ' A' ' 34' ' ' ILE . 7.8 mtt -67.61 -36.59 81.12 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 116.066 -0.516 . . . . 0.0 111.03 179.648 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 16.8 t80 -63.6 -42.5 98.23 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.975 179.732 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 3.0 tp10 -55.53 -35.5 65.71 Favored 'General case' 0 CA--C 1.532 0.269 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.195 179.68 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 139.42 54.91 0.05 OUTLIER Glycine 0 C--N 1.334 0.437 0 C-N-CA 121.15 -0.548 . . . . 0.0 112.433 179.669 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -103.65 150.68 23.78 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-O 120.87 0.367 . . . . 0.0 111.451 -179.711 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 87.0 mttt -147.02 -47.51 0.18 Allowed 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 115.894 -0.593 . . . . 0.0 111.226 179.905 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.509 HG22 ' OD1' ' A' ' 56' ' ' ASP . 15.7 t -107.54 99.97 9.72 Favored 'Isoleucine or valine' 0 C--O 1.233 0.21 0 CA-C-O 120.782 0.325 . . . . 0.0 110.799 179.985 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -88.1 148.49 24.43 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.202 -179.985 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 20.4 t -114.37 129.93 69.53 Favored 'Isoleucine or valine' 0 C--O 1.233 0.19 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.927 -179.902 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 48.9 t -68.87 136.48 89.89 Favored Pre-proline 0 N--CA 1.463 0.202 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.822 179.892 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 89.5 Cg_endo -83.5 19.43 1.34 Allowed 'Trans proline' 0 CA--C 1.536 0.58 0 C-N-CA 122.684 2.256 . . . . 0.0 113.084 179.854 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 43.0 t -128.03 -59.62 1.18 Allowed 'General case' 0 C--O 1.233 0.205 0 CA-C-O 120.57 0.224 . . . . 0.0 110.506 179.675 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 51' ' ' CYS . . . . . 0.785 ' SG ' HD23 ' A' ' 53' ' ' LEU . 22.9 p -101.16 -19.53 15.7 Favored 'General case' 0 CA--C 1.535 0.377 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.821 179.888 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 1.6 t 72.94 36.31 0.9 Allowed 'General case' 0 CA--C 1.535 0.375 0 CA-C-O 120.869 0.366 . . . . 0.0 111.039 -179.767 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.785 HD23 ' SG ' ' A' ' 51' ' ' CYS . 0.3 OUTLIER -67.66 155.59 38.84 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.835 179.742 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 54' ' ' MET . . . . . . . . . . . . . 15.2 mtt -112.01 114.12 26.82 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.697 -179.753 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.588 ' O ' HD12 ' A' ' 55' ' ' ILE . 2.8 pp -132.63 143.02 40.94 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.285 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.479 -179.658 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 56' ' ' ASP . . . . . 0.549 ' CG ' HG21 ' A' ' 4' ' ' THR . 45.8 m-20 -101.71 91.38 4.38 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.898 179.487 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 11.1 p -85.44 127.74 39.76 Favored 'Isoleucine or valine' 0 C--O 1.233 0.233 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.773 179.614 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 12.2 p -90.12 131.85 36.29 Favored 'Isoleucine or valine' 0 C--O 1.234 0.277 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.114 -179.871 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 54.2 p90 -112.22 143.46 43.24 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.818 -0.628 . . . . 0.0 111.103 -179.697 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 59.5 m-20 -104.39 -28.58 11.27 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.5 179.866 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 16.3 ttmt 63.82 26.05 14.24 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-O 120.937 0.399 . . . . 0.0 111.397 -179.777 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 20.4 tt0 -95.75 -39.43 9.87 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.531 179.479 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -74.29 -32.8 63.03 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-N 115.883 -0.598 . . . . 0.0 111.349 179.809 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.414 ' HG ' HD23 ' A' ' 36' ' ' LEU . 3.0 mp -54.85 -45.21 74.51 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-O 120.544 0.212 . . . . 0.0 111.114 -179.9 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -59.53 -38.62 81.48 Favored 'General case' 0 CA--C 1.532 0.28 0 CA-C-N 116.523 -0.308 . . . . 0.0 111.284 179.65 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 1.9 mm-40 -79.21 -40.84 29.73 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.236 179.726 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -64.8 -35.07 79.91 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 116.47 -0.332 . . . . 0.0 111.818 -179.827 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 2.9 m-85 -59.5 -36.07 75.36 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-O 120.582 0.23 . . . . 0.0 110.722 179.885 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 20.8 tt0 -87.54 -37.43 16.89 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.912 179.296 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 34.9 mt-10 -68.55 -40.87 80.49 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.752 -179.55 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 0.205 0 N-CA-C 111.565 0.209 . . . . 0.0 111.565 -179.56 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 6.8 ttt . . . . . 0 N--CA 1.489 1.509 0 CA-C-O 120.656 0.265 . . . . 0.0 111.579 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 15.4 m -109.72 -38.47 3.57 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.237 0 CA-C-N 116.588 -0.278 . . . . 0.0 111.298 179.778 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 1.3 m -130.66 119.08 21.89 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-N 116.591 -0.277 . . . . 0.0 110.682 179.852 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 13.7 p -147.49 143.91 28.19 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-N 116.398 -0.365 . . . . 0.0 111.342 -179.569 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' TYR . . . . . 0.597 ' CG ' HD11 ' A' ' 53' ' ' LEU . 12.1 m-85 -109.6 -38.45 5.42 Favored 'General case' 0 C--O 1.232 0.173 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.158 179.487 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 1.8 t0 -158.54 174.84 14.46 Favored 'General case' 0 C--O 1.236 0.352 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.047 179.888 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 34.0 mt-10 -130.45 127.5 39.38 Favored 'General case' 0 C--O 1.232 0.164 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.872 179.991 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.407 HG12 ' CE2' ' A' ' 24' ' ' TYR . 3.7 mp -109.88 155.45 11.08 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.181 -179.807 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 11.9 mp0 -111.49 146.88 36.48 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.257 -179.833 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 3.6 tt -62.64 -34.29 64.44 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.247 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.28 179.615 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 5.0 pt-20 -64.08 -32.4 73.94 Favored 'General case' 0 CA--C 1.531 0.239 0 CA-C-N 116.559 -0.291 . . . . 0.0 111.129 179.731 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 11.6 m-20 -96.7 37.62 1.27 Allowed 'General case' 0 CA--C 1.531 0.234 0 CA-C-O 120.839 0.352 . . . . 0.0 111.083 179.704 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -131.63 152.6 50.71 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.075 -179.952 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -81.05 166.07 21.09 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.935 179.925 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 3.1 m-85 -119.9 138.41 53.45 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.975 -179.765 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -107.89 90.05 6.04 Favored Pre-proline 0 C--O 1.234 0.265 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.718 179.685 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -73.1 64.44 4.22 Favored 'Trans proline' 0 C--N 1.35 0.614 0 C-N-CA 122.745 2.297 . . . . 0.0 112.937 -179.528 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' GLU . . . . . 0.401 ' HG3' ' HE2' ' A' ' 21' ' ' MET . 6.3 pt-20 -141.95 -46.45 0.35 Allowed 'General case' 0 CA--C 1.531 0.223 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.22 179.698 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 19' ' ' ASN . . . . . 0.512 ' HA ' HD12 ' A' ' 73' ' ' ILE . 3.5 m120 -139.36 29.49 2.2 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-N 116.572 -0.286 . . . . 0.0 111.449 179.692 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 20' ' ' GLN . . . . . 0.708 ' HB3' HD12 ' A' ' 36' ' ' LEU . 28.2 mt-30 56.52 68.62 0.83 Allowed 'General case' 0 C--O 1.234 0.244 0 CA-C-O 121.043 0.449 . . . . 0.0 111.664 179.448 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 21' ' ' MET . . . . . 0.401 ' HE2' ' HG3' ' A' ' 18' ' ' GLU . 3.8 ptt? -148.23 158.61 44.18 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.01 179.54 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.478 ' CE1' HD21 ' A' ' 36' ' ' LEU . 3.3 m-85 -110.13 159.44 17.34 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.685 179.91 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 34.4 p -134.35 150.06 50.9 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-O 120.941 0.401 . . . . 0.0 111.303 179.827 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' TYR . . . . . 0.407 ' CE2' HG12 ' A' ' 8' ' ' ILE . 31.5 t80 -155.69 102.07 2.17 Favored Pre-proline 0 C--N 1.333 -0.152 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.565 -179.87 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 62.6 Cg_exo -50.95 99.35 0.04 OUTLIER 'Trans proline' 0 C--N 1.349 0.574 0 C-N-CA 122.53 2.153 . . . . 0.0 112.116 -179.975 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 48.5 t -60.89 138.67 93.84 Favored Pre-proline 0 C--O 1.233 0.231 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.743 -179.618 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 80.2 Cg_exo -48.99 -26.45 10.24 Favored 'Trans proline' 0 C--N 1.351 0.667 0 C-N-CA 122.925 2.417 . . . . 0.0 113.025 179.796 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 4.3 p -59.5 -29.49 67.89 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-O 120.601 0.239 . . . . 0.0 111.352 179.661 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 123.2 7.5 7.02 Favored Glycine 0 CA--C 1.523 0.576 0 C-N-CA 121.207 -0.52 . . . . 0.0 113.445 179.94 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -114.09 -168.24 1.33 Allowed 'General case' 0 CA--C 1.532 0.262 0 CA-C-N 117.379 0.59 . . . . 0.0 111.158 -179.986 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 1.1 tpt180 -117.11 106.43 13.34 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-O 120.75 0.31 . . . . 0.0 110.91 -179.836 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -73.42 113.24 10.29 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.706 179.899 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 25.6 mt-30 -102.89 150.85 23.11 Favored 'General case' 0 N--CA 1.463 0.186 0 CA-C-N 116.435 -0.348 . . . . 0.0 111.146 -179.802 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.435 ' O ' HG23 ' A' ' 34' ' ' ILE . 0.9 OUTLIER -154.16 121.57 0.63 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.246 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.005 179.896 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 28.8 m-85 -81.92 148.14 28.9 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-N 116.374 -0.375 . . . . 0.0 111.144 -179.865 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.708 HD12 ' HB3' ' A' ' 20' ' ' GLN . 6.3 mt -67.85 -35.5 78.67 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.969 179.672 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 1.9 p-10 -66.22 -43.13 87.58 Favored 'General case' 0 CA--C 1.531 0.216 0 CA-C-N 116.372 -0.377 . . . . 0.0 110.825 179.481 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -62.81 -52.18 64.18 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-O 120.704 0.288 . . . . 0.0 111.053 -179.855 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 39' ' ' MET . . . . . 0.562 ' HG3' HD11 ' A' ' 64' ' ' LEU . 24.1 ptm -61.62 -27.67 68.82 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.36 179.97 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 40' ' ' PHE . . . . . 0.534 ' CD2' HD22 ' A' ' 64' ' ' LEU . 0.4 OUTLIER -55.58 -32.4 63.02 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 116.516 -0.311 . . . . 0.0 111.16 179.578 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 13.7 mt-10 -90.96 41.04 1.05 Allowed 'General case' 0 CA--C 1.532 0.285 0 CA-C-O 120.782 0.325 . . . . 0.0 111.484 179.9 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 60.09 64.81 3.84 Favored Glycine 0 C--N 1.334 0.434 0 C-N-CA 121.162 -0.542 . . . . 0.0 113.316 179.41 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 4.3 tt0 -121.62 98.93 6.19 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-O 120.927 0.394 . . . . 0.0 110.979 179.694 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -112.88 -33.78 5.97 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.804 179.856 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.431 HG23 ' O ' ' A' ' 45' ' ' VAL . 10.3 m -89.18 82.0 2.0 Favored 'Isoleucine or valine' 0 C--O 1.234 0.272 0 CA-C-O 121.037 0.446 . . . . 0.0 110.94 -179.977 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -91.09 147.0 23.38 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.274 -179.79 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 21.4 t -104.87 121.08 56.35 Favored 'Isoleucine or valine' 0 C--O 1.233 0.189 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.804 179.939 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 53.7 t -61.87 135.76 94.67 Favored Pre-proline 0 N--CA 1.463 0.223 0 CA-C-N 116.365 -0.379 . . . . 0.0 110.886 179.972 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 85.0 Cg_endo -84.32 20.25 1.24 Allowed 'Trans proline' 0 CA--C 1.534 0.495 0 C-N-CA 122.724 2.283 . . . . 0.0 113.167 179.926 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -129.81 -59.53 1.06 Allowed 'General case' 0 C--O 1.233 0.194 0 CA-C-O 120.516 0.198 . . . . 0.0 110.74 179.767 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 20.4 p -100.84 -17.29 16.94 Favored 'General case' 0 CA--C 1.532 0.261 0 CA-C-N 116.553 -0.294 . . . . 0.0 111.669 179.683 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER 67.43 36.56 3.8 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-O 120.911 0.386 . . . . 0.0 111.021 -179.889 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.597 HD11 ' CG ' ' A' ' 5' ' ' TYR . 9.8 tp -85.57 133.35 34.07 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.669 179.849 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 54' ' ' MET . . . . . . . . . . . . . 27.9 mtt -82.01 122.44 27.8 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.875 -179.801 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.486 ' O ' HD12 ' A' ' 55' ' ' ILE . 2.8 pp -131.33 143.34 40.93 Favored 'Isoleucine or valine' 0 C--O 1.234 0.26 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.008 179.884 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -109.39 92.21 3.96 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.622 -179.692 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 12.5 p -86.05 130.03 37.19 Favored 'Isoleucine or valine' 0 C--O 1.234 0.272 0 CA-C-N 116.099 -0.501 . . . . 0.0 111.002 -179.85 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 13.4 p -94.09 145.57 7.76 Favored 'Isoleucine or valine' 0 C--O 1.234 0.268 0 CA-C-N 116.057 -0.519 . . . . 0.0 111.103 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 22.3 p90 -131.89 146.77 52.31 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.153 179.879 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -89.26 -18.92 26.06 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.173 179.382 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 10.5 tttp 68.51 26.2 6.55 Favored 'General case' 0 CA--C 1.532 0.261 0 CA-C-O 120.835 0.35 . . . . 0.0 111.099 -179.688 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 4.4 tt0 -99.69 -62.52 1.23 Allowed 'General case' 0 C--O 1.232 0.165 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.351 179.644 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -62.03 -25.28 67.57 Favored 'General case' 0 N--CA 1.463 0.183 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.976 179.269 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.562 HD11 ' HG3' ' A' ' 39' ' ' MET . 0.2 OUTLIER -53.69 -38.31 64.09 Favored 'General case' 0 CA--C 1.53 0.203 0 CA-C-N 116.7 -0.227 . . . . 0.0 111.054 179.701 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -91.66 -37.64 12.92 Favored 'General case' 0 CA--C 1.53 0.208 0 CA-C-N 116.519 -0.309 . . . . 0.0 111.327 179.777 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 19.7 tt0 -66.22 -42.75 88.24 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-N 116.542 -0.299 . . . . 0.0 111.289 -179.937 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 23.3 t80 -57.92 -30.84 66.25 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.34 179.881 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' TYR . . . . . 0.423 ' HA ' ' NE2' ' A' ' 20' ' ' GLN . 4.2 m-85 -58.52 -35.29 72.05 Favored 'General case' 0 CA--C 1.528 0.117 0 CA-C-O 120.599 0.237 . . . . 0.0 110.725 179.745 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 18.4 mt-10 -81.88 -32.03 31.22 Favored 'General case' 0 C--O 1.232 0.152 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.888 179.394 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -69.4 -51.51 35.81 Favored 'General case' 0 N--CA 1.461 0.109 0 CA-C-N 116.486 -0.324 . . . . 0.0 111.208 179.921 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -71.49 154.01 41.81 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-N 116.363 -0.38 . . . . 0.0 111.358 -179.882 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -103.56 34.66 5.6 Favored Glycine 0 C--N 1.333 0.407 0 C-N-CA 120.982 -0.628 . . . . 0.0 112.715 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.512 HD12 ' HA ' ' A' ' 19' ' ' ASN . 16.4 tt -78.37 156.72 5.02 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.188 0 CA-C-O 120.6 0.238 . . . . 0.0 111.095 179.957 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 34.5 t60 -101.66 93.72 3.72 Favored Pre-proline 0 C--O 1.234 0.268 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.81 179.868 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_endo -68.34 160.15 50.26 Favored 'Trans proline' 0 C--N 1.347 0.498 0 C-N-CA 122.707 2.271 . . . . 0.0 112.483 -179.918 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' PRO . . . . . 0.44 ' O ' ' HB2' ' A' ' 77' ' ' GLU . 56.8 Cg_endo -70.26 168.52 21.97 Favored 'Trans proline' 0 C--N 1.348 0.508 0 C-N-CA 122.715 2.277 . . . . 0.0 112.239 179.869 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 77' ' ' GLU . . . . . 0.44 ' HB2' ' O ' ' A' ' 76' ' ' PRO . 5.0 mt-10 68.62 149.7 0.12 Allowed Pre-proline 0 N--CA 1.466 0.341 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.258 -179.895 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -71.78 157.63 54.87 Favored 'Trans proline' 0 C--N 1.346 0.432 0 C-N-CA 122.691 2.26 . . . . 0.0 112.523 179.897 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 4.0 mt -113.59 109.67 29.37 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.021 -179.908 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -97.2 126.88 42.69 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.086 179.962 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -104.58 109.25 21.09 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.054 179.9 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -142.93 132.77 24.04 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.078 -179.966 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.332 -0.179 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.125 179.832 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 84' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 75.1 mtp . . . . . 0 N--CA 1.489 1.491 0 CA-C-O 120.655 0.264 . . . . 0.0 111.203 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 6.6 m -108.35 133.96 51.7 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.197 0 CA-C-N 116.418 -0.355 . . . . 0.0 110.932 179.83 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 54.7 p -95.46 113.98 25.7 Favored 'General case' 0 CA--C 1.53 0.204 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.811 179.904 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 2.8 p 60.4 172.67 0.09 Allowed 'General case' 0 N--CA 1.47 0.561 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.487 -179.431 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' TYR . . . . . 0.577 ' CG ' HD11 ' A' ' 53' ' ' LEU . 17.1 m-85 -116.08 -38.11 3.69 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.707 -179.624 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 1.4 p30 -159.61 174.85 13.96 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-O 120.671 0.272 . . . . 0.0 111.015 -179.697 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -143.67 121.36 11.86 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.072 179.761 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 3.6 mp -115.36 151.99 17.05 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.178 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.271 -179.8 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 1.4 pm0 -91.12 156.14 18.11 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.359 -179.947 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 11.6 tt -63.78 -31.2 52.18 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.251 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.406 179.707 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 12.9 mt-10 -59.78 -33.58 71.88 Favored 'General case' 0 CA--C 1.531 0.249 0 CA-C-N 116.552 -0.295 . . . . 0.0 111.095 179.69 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -96.46 37.29 1.28 Allowed 'General case' 0 CA--C 1.534 0.335 0 CA-C-O 120.798 0.332 . . . . 0.0 111.211 179.815 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -131.65 134.19 45.7 Favored 'General case' 0 C--O 1.232 0.161 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.581 179.889 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 3.6 m -72.16 144.1 48.69 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-O 120.674 0.273 . . . . 0.0 110.782 179.977 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 13.5 p90 -111.84 141.92 44.87 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.001 179.923 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 29.3 mt-10 -117.75 82.9 17.1 Favored Pre-proline 0 C--O 1.233 0.224 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.741 179.916 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -54.76 -24.79 39.51 Favored 'Trans proline' 0 C--N 1.348 0.509 0 C-N-CA 122.814 2.342 . . . . 0.0 112.701 179.692 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -51.37 -38.09 51.51 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-N 116.55 -0.295 . . . . 0.0 111.32 179.729 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 46.3 m-20 -136.3 18.6 3.16 Favored 'General case' 0 CA--C 1.537 0.455 0 N-CA-C 111.927 0.343 . . . . 0.0 111.927 179.881 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' GLN . . . . . 0.463 HE21 ' HB3' ' A' ' 71' ' ' ALA . 39.7 mt-30 52.27 73.75 0.31 Allowed 'General case' 0 N--CA 1.467 0.392 0 N-CA-C 112.043 0.386 . . . . 0.0 112.043 179.399 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 21' ' ' MET . . . . . 0.416 ' HB3' ' CD2' ' A' ' 35' ' ' TYR . 3.7 ptt? -166.54 146.15 5.78 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.52 179.583 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 27.4 m-85 -90.16 157.05 17.92 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.808 179.548 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 19.1 p -147.46 136.52 22.27 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.19 179.762 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 58.3 t80 -139.82 136.02 17.07 Favored Pre-proline 0 C--N 1.332 -0.161 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.802 179.626 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo -67.48 101.7 0.66 Allowed 'Trans proline' 0 C--N 1.348 0.544 0 C-N-CA 122.528 2.152 . . . . 0.0 112.231 179.907 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' CYS . . . . . 0.412 ' SG ' ' HD2' ' A' ' 27' ' ' PRO . 37.2 t -61.95 137.6 95.48 Favored Pre-proline 0 C--O 1.233 0.197 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.696 179.868 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 27' ' ' PRO . . . . . 0.412 ' HD2' ' SG ' ' A' ' 26' ' ' CYS . 12.0 Cg_endo -56.46 -21.65 38.63 Favored 'Trans proline' 0 C--N 1.348 0.523 0 C-N-CA 122.611 2.207 . . . . 0.0 112.686 179.739 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -65.51 -37.88 88.07 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-O 120.507 0.194 . . . . 0.0 111.191 179.932 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 153.05 -44.13 0.62 Allowed Glycine 0 C--N 1.335 0.474 0 C-N-CA 120.692 -0.766 . . . . 0.0 113.13 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -84.36 179.43 7.44 Favored 'General case' 0 CA--C 1.532 0.256 0 CA-C-O 120.785 0.326 . . . . 0.0 111.253 -179.727 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 27.8 ttm180 -113.06 117.69 32.7 Favored 'General case' 0 C--O 1.232 0.159 0 CA-C-N 116.387 -0.369 . . . . 0.0 110.844 179.873 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' PHE . . . . . 0.548 ' HZ ' ' HB1' ' A' ' 46' ' ' ALA . 30.6 t80 -65.52 156.39 32.7 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.423 -179.838 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 15.8 pt20 -143.57 131.78 21.94 Favored 'General case' 0 CA--C 1.53 0.205 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.16 -179.971 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 7.0 tt -139.09 125.76 24.39 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.185 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.927 179.53 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' TYR . . . . . 0.416 ' CD2' ' HB3' ' A' ' 21' ' ' MET . 55.4 m-85 -80.24 151.2 29.76 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.345 -179.83 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 45.2 mt -61.34 -40.08 92.91 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.815 179.694 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 2.5 p-10 -63.02 -34.06 76.76 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.199 179.605 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -65.65 -58.94 4.52 Favored 'General case' 0 C--O 1.231 0.083 0 CA-C-O 120.799 0.333 . . . . 0.0 110.728 179.997 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' MET . . . . . 0.654 ' HG3' HD11 ' A' ' 64' ' ' LEU . 5.9 ptm -63.69 -34.38 77.73 Favored 'General case' 0 CA--C 1.53 0.202 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.277 179.991 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 46.4 t80 -57.44 -40.68 78.96 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 116.506 -0.316 . . . . 0.0 110.911 179.542 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 4.0 mt-10 -61.71 -35.4 77.94 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 116.538 -0.301 . . . . 0.0 110.982 179.541 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 137.45 46.6 0.08 OUTLIER Glycine 0 C--N 1.332 0.348 0 C-N-CA 120.95 -0.643 . . . . 0.0 112.625 179.86 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -104.07 115.96 31.36 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-O 120.669 0.271 . . . . 0.0 111.042 -179.954 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 2.4 ptpt -117.26 -40.37 3.09 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.216 179.943 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 5.0 m -101.71 101.13 11.68 Favored 'Isoleucine or valine' 0 C--O 1.232 0.172 0 CA-C-O 120.922 0.391 . . . . 0.0 111.249 -179.953 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.548 ' HB1' ' HZ ' ' A' ' 32' ' ' PHE . . . -99.5 167.77 10.4 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-N 115.987 -0.551 . . . . 0.0 111.404 -179.716 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 5.6 m -136.51 128.33 43.86 Favored 'Isoleucine or valine' 0 C--O 1.232 0.182 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.354 -179.83 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 46.1 t -66.22 136.1 95.17 Favored Pre-proline 0 N--CA 1.463 0.214 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.903 179.865 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_endo -83.57 20.11 1.24 Allowed 'Trans proline' 0 C--N 1.348 0.548 0 C-N-CA 122.692 2.262 . . . . 0.0 113.262 179.859 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -128.45 -56.25 1.23 Allowed 'General case' 0 C--O 1.232 0.156 0 CA-C-O 120.574 0.226 . . . . 0.0 110.502 179.658 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 20.1 p -100.83 -20.08 15.67 Favored 'General case' 0 CA--C 1.534 0.356 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.729 179.846 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 68.24 39.58 2.3 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-O 120.989 0.423 . . . . 0.0 110.896 -179.751 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.577 HD11 ' CG ' ' A' ' 5' ' ' TYR . 6.6 tp -86.44 129.77 34.74 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.816 179.948 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 54' ' ' MET . . . . . . . . . . . . . 28.0 mtm -83.02 131.08 35.19 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.845 -179.934 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 2.6 pp -142.27 145.88 23.16 Favored 'Isoleucine or valine' 0 C--O 1.233 0.204 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.62 -179.731 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -104.6 105.15 15.13 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.757 179.572 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.436 ' O ' HG13 ' A' ' 57' ' ' VAL . 12.9 p -105.51 118.23 52.62 Favored 'Isoleucine or valine' 0 C--O 1.233 0.213 0 CA-C-O 120.952 0.406 . . . . 0.0 111.101 179.793 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 14.6 p -86.22 139.32 17.55 Favored 'Isoleucine or valine' 0 C--O 1.233 0.232 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.045 -179.839 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 30.5 p90 -129.82 165.75 21.33 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.16 -179.649 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -128.43 178.83 6.01 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-N 116.024 -0.535 . . . . 0.0 111.039 -179.752 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 26.4 mttp -111.1 29.5 7.73 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.206 179.671 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 5.6 mt-10 -99.15 -70.27 0.73 Allowed 'General case' 0 C--O 1.232 0.147 0 CA-C-N 116.492 -0.322 . . . . 0.0 110.604 179.504 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 3.0 p30 -68.3 -37.7 80.88 Favored 'General case' 0 N--CA 1.463 0.175 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.6 179.432 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.654 HD11 ' HG3' ' A' ' 39' ' ' MET . 0.2 OUTLIER -56.11 -41.33 75.11 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-N 116.456 -0.338 . . . . 0.0 110.877 179.872 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -73.76 -38.64 64.65 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.35 179.654 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 10.3 mt-10 -71.94 -35.33 69.58 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 116.416 -0.356 . . . . 0.0 111.765 -179.678 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 7.4 m-85 -55.59 -28.32 54.38 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 116.623 -0.262 . . . . 0.0 111.345 -179.794 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 23.4 m-85 -60.66 -34.27 74.05 Favored 'General case' 0 CA--C 1.528 0.117 0 CA-C-N 116.651 -0.25 . . . . 0.0 110.562 179.707 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -90.55 -36.51 14.43 Favored 'General case' 0 CA--C 1.531 0.213 0 CA-C-N 116.284 -0.417 . . . . 0.0 110.993 179.445 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -71.12 -34.71 71.32 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 116.464 -0.335 . . . . 0.0 111.785 -179.648 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 71' ' ' ALA . . . . . 0.463 ' HB3' HE21 ' A' ' 20' ' ' GLN . . . -92.6 149.03 21.6 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-O 120.895 0.379 . . . . 0.0 111.295 -179.85 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -101.95 55.47 0.72 Allowed Glycine 0 C--N 1.333 0.387 0 C-N-CA 121.002 -0.618 . . . . 0.0 112.856 -179.821 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 1.1 tp -61.65 -32.87 54.99 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.26 0 CA-C-O 120.55 0.214 . . . . 0.0 111.452 179.799 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 4.3 m170 -106.68 87.89 3.1 Favored Pre-proline 0 C--O 1.232 0.172 0 CA-C-N 116.521 -0.308 . . . . 0.0 110.552 179.695 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_endo -69.63 111.32 2.75 Favored 'Trans proline' 0 C--N 1.348 0.54 0 C-N-CA 122.696 2.264 . . . . 0.0 112.576 -179.686 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -71.51 -178.55 3.06 Favored 'Trans proline' 0 C--N 1.348 0.533 0 C-N-CA 122.517 2.145 . . . . 0.0 112.407 179.819 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 77' ' ' GLU . . . . . 0.401 ' H ' ' HD2' ' A' ' 78' ' ' PRO . 0.9 OUTLIER -167.11 -60.12 0.01 OUTLIER Pre-proline 0 C--N 1.329 -0.287 0 CA-C-N 116.004 -0.543 . . . . 0.0 111.142 179.788 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 78' ' ' PRO . . . . . 0.401 ' HD2' ' H ' ' A' ' 77' ' ' GLU . 68.4 Cg_endo -73.07 65.26 4.21 Favored 'Trans proline' 0 C--N 1.35 0.62 0 C-N-CA 122.562 2.175 . . . . 0.0 112.352 179.885 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 2.0 pt -138.18 86.66 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.922 179.906 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . 57.76 75.27 0.38 Allowed 'General case' 0 C--O 1.234 0.243 0 CA-C-N 115.862 -0.608 . . . . 0.0 111.333 -179.709 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . 62.95 -174.37 0.15 Allowed 'General case' 0 C--O 1.234 0.246 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.454 179.99 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -170.26 136.13 1.36 Allowed 'General case' 0 C--O 1.233 0.211 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.279 -179.785 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.463 0.21 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.563 179.856 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 84' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.488 1.449 0 CA-C-O 120.676 0.274 . . . . 0.0 110.977 . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 20.7 t -97.38 142.73 13.76 Favored 'Isoleucine or valine' 0 C--O 1.232 0.183 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.442 -179.507 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 49.1 m -151.96 111.14 3.89 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.307 -179.927 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.64 HG21 ' CG ' ' A' ' 56' ' ' ASP . 0.9 OUTLIER -152.67 160.37 43.17 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-O 120.985 0.421 . . . . 0.0 111.511 -179.905 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 85.0 m-85 -105.04 -37.3 6.99 Favored 'General case' 0 CA--C 1.531 0.232 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.409 -179.945 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -157.14 175.67 13.75 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-N 116.534 -0.303 . . . . 0.0 111.247 -179.792 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 21.5 mt-10 -126.2 143.26 51.2 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 116.108 -0.497 . . . . 0.0 111.033 -179.921 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 22.8 mt -127.19 151.82 34.49 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.29 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.173 -179.886 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' GLU . . . . . 0.441 ' HG3' HG13 ' A' ' 58' ' ' VAL . 8.5 tt0 -104.97 142.89 33.98 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-N 116.515 -0.311 . . . . 0.0 110.953 179.756 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 41.2 pt -61.15 -32.81 53.82 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.305 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.34 179.82 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 16.8 tt0 -59.44 -33.19 70.97 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.841 179.613 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -97.01 36.89 1.36 Allowed 'General case' 0 CA--C 1.533 0.307 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.191 179.855 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 13.0 mtp -131.32 148.29 52.66 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.639 179.678 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 20.0 m -61.96 129.79 42.55 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.14 -179.816 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 21.1 p90 -93.53 124.39 37.49 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.716 179.593 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 -112.07 86.02 7.25 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.793 -179.881 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo -69.23 -16.99 40.18 Favored 'Trans proline' 0 C--N 1.347 0.499 0 C-N-CA 122.743 2.295 . . . . 0.0 112.942 -179.865 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -53.24 -37.49 62.12 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-N 116.712 -0.222 . . . . 0.0 111.15 179.739 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 25.8 m-20 -143.17 25.32 1.74 Allowed 'General case' 0 CA--C 1.533 0.303 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.718 179.902 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' GLN . . . . . 0.507 ' NE2' HG21 ' A' ' 73' ' ' ILE . 6.2 tt0 53.35 72.25 0.44 Allowed 'General case' 0 CA--C 1.534 0.329 0 CA-C-O 120.992 0.425 . . . . 0.0 111.648 179.513 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 21' ' ' MET . . . . . 0.434 ' HB3' ' CD2' ' A' ' 35' ' ' TYR . 5.7 ptt? -154.08 175.11 13.82 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.046 179.928 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 27.2 m-85 -137.4 138.65 40.08 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.131 179.879 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 79.6 p -130.82 156.64 44.66 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.273 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 45.7 t80 -156.53 136.01 8.22 Favored Pre-proline 0 N--CA 1.463 0.176 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.863 179.781 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -64.71 100.29 0.34 Allowed 'Trans proline' 0 C--N 1.35 0.616 0 C-N-CA 122.678 2.252 . . . . 0.0 112.37 179.839 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' CYS . . . . . 0.419 ' SG ' ' HD2' ' A' ' 27' ' ' PRO . 42.0 t -59.68 139.26 89.76 Favored Pre-proline 0 C--O 1.233 0.19 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.69 179.817 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 27' ' ' PRO . . . . . 0.419 ' HD2' ' SG ' ' A' ' 26' ' ' CYS . 75.2 Cg_exo -51.17 -26.09 18.87 Favored 'Trans proline' 0 C--N 1.348 0.548 0 C-N-CA 122.739 2.293 . . . . 0.0 112.951 179.887 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -68.53 -38.88 81.23 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-O 120.553 0.216 . . . . 0.0 111.279 -179.858 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 152.43 -45.95 0.59 Allowed Glycine 0 C--N 1.334 0.459 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.959 -179.904 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.3 t0 -73.17 -173.81 1.41 Allowed 'General case' 0 CA--C 1.533 0.303 0 CA-C-O 120.748 0.309 . . . . 0.0 111.156 -179.807 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 27.4 ttt180 -123.3 129.67 51.66 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-N 116.444 -0.343 . . . . 0.0 110.886 179.855 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 7.4 m-85 -65.09 161.98 17.8 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.987 179.822 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -151.76 127.92 10.49 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.221 179.8 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 3.6 tt -150.87 144.38 16.87 Favored 'Isoleucine or valine' 0 C--O 1.233 0.219 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.175 179.785 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' TYR . . . . . 0.434 ' CD2' ' HB3' ' A' ' 21' ' ' MET . 86.0 m-85 -105.29 157.47 17.28 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.869 -179.913 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.573 HD12 ' HG ' ' A' ' 64' ' ' LEU . 4.0 mm? -61.3 -33.85 74.25 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.936 179.768 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 8.2 t70 -68.13 -39.4 82.74 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.991 179.598 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -59.63 -56.43 22.04 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.1 -179.817 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 36.4 mtm -63.58 -31.27 72.39 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.947 179.618 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' PHE . . . . . 0.656 ' HB2' HD21 ' A' ' 64' ' ' LEU . 17.0 t80 -58.4 -46.32 86.64 Favored 'General case' 0 CA--C 1.529 0.148 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.912 179.604 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -58.18 -35.49 71.65 Favored 'General case' 0 N--CA 1.463 0.185 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.887 179.685 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 138.65 48.45 0.06 OUTLIER Glycine 0 C--N 1.333 0.386 0 C-N-CA 120.992 -0.623 . . . . 0.0 112.64 179.671 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -102.16 124.89 48.55 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-O 120.791 0.329 . . . . 0.0 110.946 -179.989 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 16.2 mttt -122.83 -43.91 2.23 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.968 179.897 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.486 HG13 ' O ' ' A' ' 45' ' ' VAL . 11.1 p -112.58 113.58 44.54 Favored 'Isoleucine or valine' 0 C--O 1.233 0.236 0 CA-C-O 121.001 0.429 . . . . 0.0 110.967 179.811 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -99.0 160.28 14.37 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.2 -179.648 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 7.5 m -116.81 124.42 72.86 Favored 'Isoleucine or valine' 0 C--O 1.233 0.2 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.367 -179.894 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 51.3 t -69.99 135.66 87.39 Favored Pre-proline 0 C--N 1.33 -0.252 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.868 179.875 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_endo -84.6 20.78 1.17 Allowed 'Trans proline' 0 CA--C 1.535 0.527 0 C-N-CA 122.714 2.276 . . . . 0.0 112.967 179.747 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -128.01 -57.67 1.24 Allowed 'General case' 0 CA--C 1.529 0.147 0 CA-C-O 120.587 0.232 . . . . 0.0 110.578 179.788 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 20.2 p -99.69 -20.45 16.28 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.817 179.946 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 2.1 t 67.29 40.02 2.86 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-O 120.921 0.391 . . . . 0.0 111.022 -179.857 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.52 ' CD2' HG23 ' A' ' 55' ' ' ILE . 8.5 tt -95.94 135.93 37.05 Favored 'General case' 0 C--O 1.232 0.178 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.625 179.805 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 54' ' ' MET . . . . . . . . . . . . . 12.3 mtt -89.39 128.45 35.92 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.128 -179.578 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.52 HG23 ' CD2' ' A' ' 53' ' ' LEU . 2.1 pp -135.14 132.09 52.72 Favored 'Isoleucine or valine' 0 C--O 1.233 0.221 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.474 179.922 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 56' ' ' ASP . . . . . 0.64 ' CG ' HG21 ' A' ' 4' ' ' THR . 74.1 m-20 -87.21 99.46 11.97 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.769 179.61 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.505 ' O ' HG13 ' A' ' 57' ' ' VAL . 13.3 p -93.18 113.38 27.97 Favored 'Isoleucine or valine' 0 C--O 1.233 0.228 0 CA-C-O 121.114 0.483 . . . . 0.0 111.126 179.943 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.441 HG13 ' HG3' ' A' ' 9' ' ' GLU . 11.7 p -81.64 135.5 24.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.867 -179.955 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 53.5 p90 -131.47 178.57 6.63 Favored 'General case' 0 CA--C 1.532 0.252 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.174 -179.722 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 1.6 t0 -126.29 159.91 31.8 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.893 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -79.99 -36.21 36.31 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.612 179.464 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -60.83 -36.73 79.83 Favored 'General case' 0 CA--C 1.528 0.114 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.088 179.967 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -55.16 -45.76 75.73 Favored 'General case' 0 N--CA 1.462 0.137 0 CA-C-N 116.474 -0.33 . . . . 0.0 111.145 179.747 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.656 HD21 ' HB2' ' A' ' 40' ' ' PHE . 3.7 mp -61.54 -55.89 26.03 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.626 -0.261 . . . . 0.0 110.915 179.812 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -56.73 -40.75 76.27 Favored 'General case' 0 N--CA 1.462 0.156 0 CA-C-N 116.484 -0.326 . . . . 0.0 111.083 179.736 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 30.0 mt-10 -67.43 -43.45 81.13 Favored 'General case' 0 CA--C 1.528 0.115 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.93 179.542 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 67' ' ' TYR . . . . . 0.405 ' CD1' ' HG3' ' A' ' 20' ' ' GLN . 0.3 OUTLIER -70.67 -40.15 73.13 Favored 'General case' 0 N--CA 1.463 0.183 0 CA-C-N 116.531 -0.304 . . . . 0.0 111.438 179.939 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 9.7 m-85 -59.21 -40.17 84.96 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 116.659 -0.246 . . . . 0.0 111.075 -179.744 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 16.8 mt-10 -81.24 -33.75 32.59 Favored 'General case' 0 CA--C 1.529 0.158 0 CA-C-N 116.577 -0.283 . . . . 0.0 111.101 179.886 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 29.1 mt-10 -73.44 -50.19 22.97 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-N 116.587 -0.279 . . . . 0.0 111.192 179.945 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -83.32 146.51 28.47 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-N 116.323 -0.398 . . . . 0.0 111.519 -179.572 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -101.27 46.5 1.29 Allowed Glycine 0 C--N 1.333 0.379 0 C-N-CA 120.993 -0.622 . . . . 0.0 112.571 179.825 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.507 HG21 ' NE2' ' A' ' 20' ' ' GLN . 8.5 tp -66.65 143.52 15.51 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.173 0 CA-C-O 120.8 0.333 . . . . 0.0 111.095 179.976 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 23.7 m80 -123.0 151.09 60.78 Favored Pre-proline 0 C--O 1.234 0.261 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.037 -179.857 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -54.18 161.3 5.33 Favored 'Trans proline' 0 C--N 1.351 0.69 0 C-N-CA 122.951 2.434 . . . . 0.0 112.698 179.779 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 42.0 Cg_endo -67.51 -38.36 14.77 Favored 'Trans proline' 0 C--N 1.35 0.62 0 C-N-CA 122.821 2.347 . . . . 0.0 112.836 -179.848 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 57.64 82.54 0.23 Allowed Pre-proline 0 N--CA 1.464 0.272 0 CA-C-O 120.952 0.406 . . . . 0.0 111.439 179.968 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.68 178.89 4.07 Favored 'Trans proline' 0 C--N 1.348 0.528 0 C-N-CA 123.013 2.475 . . . . 0.0 112.889 -179.834 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 2.0 pt -102.35 85.9 1.03 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.256 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.512 -179.861 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . 60.32 90.79 0.06 Allowed 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 115.776 -0.647 . . . . 0.0 111.586 179.815 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -103.46 35.25 2.65 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.6 179.832 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . 56.89 80.86 0.15 Allowed 'General case' 0 CA--C 1.533 0.303 0 CA-C-N 116.491 -0.322 . . . . 0.0 111.641 179.633 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.233 0.204 0 CA-C-O 120.985 0.421 . . . . 0.0 111.29 179.985 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 84' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 98.2 mtp . . . . . 0 N--CA 1.489 1.511 0 CA-C-O 120.797 0.332 . . . . 0.0 111.266 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 17.9 t -102.31 -41.29 7.81 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.301 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.139 179.984 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 9.0 p -79.22 133.52 36.68 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 116.475 -0.33 . . . . 0.0 111.254 -179.96 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 1.8 t -164.5 159.77 19.7 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.229 179.857 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 27.1 m-85 -103.88 -31.21 9.88 Favored 'General case' 0 CA--C 1.532 0.252 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.275 179.732 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 5.7 t70 -158.73 165.63 33.88 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-O 120.769 0.319 . . . . 0.0 111.566 -179.855 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 11.2 tt0 -136.41 115.05 11.98 Favored 'General case' 0 CA--C 1.53 0.195 0 CA-C-N 116.035 -0.529 . . . . 0.0 111.177 -179.774 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 3.9 mp -113.56 151.29 15.43 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.277 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.199 179.917 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 4.7 mt-10 -97.92 148.45 23.44 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.273 -179.927 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 14.3 tt -58.55 -31.43 43.63 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.305 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.36 179.668 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 26.4 mt-10 -63.13 -27.56 69.47 Favored 'General case' 0 CA--C 1.532 0.274 0 CA-C-N 116.597 -0.274 . . . . 0.0 111.302 179.634 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -95.09 36.14 1.23 Allowed 'General case' 0 CA--C 1.533 0.325 0 CA-C-O 120.696 0.284 . . . . 0.0 111.313 179.95 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -119.0 177.31 4.91 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-O 120.843 0.354 . . . . 0.0 110.959 179.715 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 1.6 m -108.49 85.69 2.15 Favored 'General case' 0 C--O 1.232 0.15 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.575 179.911 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 30.3 p90 -86.28 139.51 30.95 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.891 179.958 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 25.3 mt-10 -138.69 157.91 71.11 Favored Pre-proline 0 C--O 1.234 0.246 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.633 -179.606 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' PRO . . . . . 0.433 ' O ' HG22 ' A' ' 73' ' ' ILE . 25.8 Cg_exo -63.36 -11.95 28.16 Favored 'Trans proline' 0 C--N 1.351 0.686 0 C-N-CA 123.257 2.638 . . . . 0.0 112.914 179.391 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 3.1 pt-20 -66.17 82.99 0.08 Allowed 'General case' 0 C--O 1.233 0.197 0 CA-C-O 121.076 0.465 . . . . 0.0 110.843 -179.731 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 6.0 m-80 62.12 22.9 13.45 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-N 115.799 -0.637 . . . . 0.0 111.668 -179.503 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' GLN . . . . . 0.493 ' O ' HD23 ' A' ' 36' ' ' LEU . 0.8 OUTLIER 53.49 78.07 0.16 Allowed 'General case' 0 C--O 1.234 0.281 0 CA-C-O 121.067 0.461 . . . . 0.0 111.286 179.921 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 1.9 ppp? -133.71 143.5 48.54 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.674 179.842 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.546 ' CE1' HD22 ' A' ' 36' ' ' LEU . 0.9 OUTLIER -127.7 132.32 49.65 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.656 179.618 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 23' ' ' THR . . . . . 0.616 HG22 ' HA ' ' A' ' 33' ' ' GLN . 40.6 p -122.14 158.74 28.66 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.815 -178.929 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 61.1 t80 -139.9 137.22 18.05 Favored Pre-proline 0 CA--C 1.53 0.186 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.225 179.878 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 65.5 Cg_endo -73.44 100.94 1.3 Allowed 'Trans proline' 0 C--N 1.35 0.627 0 C-N-CA 122.768 2.312 . . . . 0.0 112.442 179.587 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' CYS . . . . . 0.44 ' SG ' ' HD2' ' A' ' 27' ' ' PRO . 53.1 t -68.69 140.21 91.76 Favored Pre-proline 0 C--O 1.233 0.229 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.705 179.786 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 27' ' ' PRO . . . . . 0.44 ' HD2' ' SG ' ' A' ' 26' ' ' CYS . 86.7 Cg_exo -48.89 -26.98 10.73 Favored 'Trans proline' 0 C--N 1.351 0.666 0 C-N-CA 122.916 2.411 . . . . 0.0 113.175 179.962 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 9.0 p -58.49 -28.92 65.83 Favored 'General case' 0 CA--C 1.533 0.321 0 CA-C-O 120.642 0.258 . . . . 0.0 111.433 -179.949 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 120.93 9.87 7.22 Favored Glycine 0 CA--C 1.523 0.57 0 C-N-CA 121.134 -0.555 . . . . 0.0 113.337 -179.823 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -122.42 -165.2 1.25 Allowed 'General case' 0 CA--C 1.535 0.375 0 CA-C-N 117.145 0.472 . . . . 0.0 110.935 179.972 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 3.8 ttt85 -137.85 117.16 12.73 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-O 120.515 0.198 . . . . 0.0 111.186 -179.73 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' PHE . . . . . 0.542 ' CZ ' ' HB1' ' A' ' 46' ' ' ALA . 76.4 t80 -70.63 151.96 44.4 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.225 179.896 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 33' ' ' GLN . . . . . 0.616 ' HA ' HG22 ' A' ' 23' ' ' THR . 3.6 pt20 -126.28 139.66 53.14 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.449 -179.939 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 12.0 tt -155.0 148.89 12.61 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.346 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.21 179.69 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 60.3 m-85 -100.67 155.77 17.7 Favored 'General case' 0 C--O 1.236 0.357 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.516 -179.695 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.82 HD12 ' HG ' ' A' ' 64' ' ' LEU . 3.2 mm? -61.67 -46.88 87.85 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.775 179.734 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -60.27 -36.55 78.08 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 116.495 -0.321 . . . . 0.0 110.995 179.647 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -57.19 -46.12 83.14 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.41 179.709 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 2.6 mtt -66.23 -28.81 69.02 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.321 179.582 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' PHE . . . . . 0.671 ' CE1' HD22 ' A' ' 64' ' ' LEU . 0.0 OUTLIER -56.53 -45.77 80.98 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-O 120.573 0.225 . . . . 0.0 111.046 179.906 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 10.6 mt-10 -59.91 -32.51 70.83 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 116.461 -0.336 . . . . 0.0 110.975 179.586 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 131.74 46.61 0.13 Allowed Glycine 0 C--N 1.333 0.394 0 C-N-CA 121.145 -0.55 . . . . 0.0 112.498 179.981 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -83.35 92.89 7.63 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-O 120.993 0.425 . . . . 0.0 110.888 -179.948 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 10.8 ptpt -107.33 -32.43 7.76 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.831 -0.622 . . . . 0.0 111.218 179.881 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.49 ' O ' HG13 ' A' ' 45' ' ' VAL . 7.6 p -121.58 108.98 23.47 Favored 'Isoleucine or valine' 0 C--O 1.233 0.214 0 CA-C-O 121.109 0.48 . . . . 0.0 110.874 179.796 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.542 ' HB1' ' CZ ' ' A' ' 32' ' ' PHE . . . -109.63 171.81 7.22 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.589 -179.361 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 19.1 t -128.91 119.43 49.48 Favored 'Isoleucine or valine' 0 C--O 1.232 0.145 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.036 -179.935 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 41.7 t -62.33 112.19 5.99 Favored Pre-proline 0 N--CA 1.463 0.199 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.452 179.683 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 31.1 Cg_exo -60.33 -17.82 49.2 Favored 'Trans proline' 0 C--N 1.347 0.484 0 C-N-CA 122.645 2.23 . . . . 0.0 113.346 -179.569 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 4.6 t -77.05 -65.17 0.98 Allowed 'General case' 0 CA--C 1.53 0.206 0 CA-C-O 120.416 0.15 . . . . 0.0 111.397 -179.738 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 22.6 p -92.18 -19.55 22.13 Favored 'General case' 0 N--CA 1.465 0.324 0 N-CA-C 112.195 0.442 . . . . 0.0 112.195 -179.426 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 72.96 36.4 0.88 Allowed 'General case' 0 CA--C 1.533 0.302 0 CA-C-O 120.886 0.374 . . . . 0.0 110.905 -179.609 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.604 HD23 HG23 ' A' ' 55' ' ' ILE . 6.4 tt -94.94 149.51 21.17 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.736 179.792 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 54' ' ' MET . . . . . . . . . . . . . 38.7 mtt -93.14 129.75 39.03 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-N 116.462 -0.335 . . . . 0.0 111.357 -179.487 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.604 HG23 HD23 ' A' ' 53' ' ' LEU . 2.5 pp -137.99 152.47 26.27 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.343 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.47 179.783 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 42.5 m-20 -108.7 107.63 18.16 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.64 179.067 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 14.5 p -99.43 125.63 52.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-O 120.967 0.413 . . . . 0.0 111.026 179.835 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 13.3 p -93.74 142.66 12.98 Favored 'Isoleucine or valine' 0 C--O 1.234 0.258 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.194 -179.88 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 3.0 p90 -131.03 144.39 51.42 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.623 -179.386 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -95.13 -22.67 17.72 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-N 115.997 -0.547 . . . . 0.0 112.028 -179.93 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 3.3 mttt 65.82 27.49 11.05 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-O 120.603 0.24 . . . . 0.0 111.412 -179.575 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 12.5 tt0 -95.47 -49.64 5.33 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-O 120.919 0.39 . . . . 0.0 110.104 179.474 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -66.51 -33.78 76.45 Favored 'General case' 0 N--CA 1.462 0.169 0 CA-C-N 115.746 -0.661 . . . . 0.0 111.129 179.577 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.82 ' HG ' HD12 ' A' ' 36' ' ' LEU . 0.2 OUTLIER -52.86 -34.62 55.17 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 116.679 -0.237 . . . . 0.0 111.495 -179.711 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -86.44 -48.73 8.17 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-N 116.663 -0.244 . . . . 0.0 111.56 -179.981 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 23.5 mt-10 -65.8 -54.17 30.54 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-O 120.664 0.268 . . . . 0.0 111.256 -179.674 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' TYR . . . . . 0.411 ' HA ' ' HB2' ' A' ' 70' ' ' GLU . 2.6 t80 -59.64 -23.69 63.25 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.3 179.412 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -57.27 -54.88 41.76 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-O 120.665 0.269 . . . . 0.0 110.962 179.834 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 37.1 mt-10 -79.97 -35.57 37.35 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.763 179.771 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' GLU . . . . . 0.411 ' HB2' ' HA ' ' A' ' 67' ' ' TYR . 25.0 mt-10 -62.84 -37.27 86.14 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.188 179.868 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -91.82 156.66 17.36 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-O 120.893 0.378 . . . . 0.0 111.353 -179.935 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -110.77 47.31 1.06 Allowed Glycine 0 C--N 1.332 0.345 0 CA-C-N 115.868 -0.605 . . . . 0.0 112.242 179.785 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.568 HD12 ' N ' ' A' ' 74' ' ' HIS . 2.7 pp -72.68 -28.51 27.8 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.214 0 N-CA-C 111.5 0.185 . . . . 0.0 111.5 -179.897 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 74' ' ' HIS . . . . . 0.568 ' N ' HD12 ' A' ' 73' ' ' ILE . 4.5 m170 -56.86 -60.32 9.83 Favored Pre-proline 0 CA--C 1.531 0.239 0 CA-C-N 116.769 -0.196 . . . . 0.0 111.045 179.896 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 75' ' ' PRO . . . . . 0.465 ' HA ' ' HD2' ' A' ' 76' ' ' PRO . 60.6 Cg_endo -72.1 109.27 2.66 Favored 'Trans proline' 0 C--N 1.351 0.676 0 C-N-CA 122.442 2.094 . . . . 0.0 112.263 179.662 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 76' ' ' PRO . . . . . 0.465 ' HD2' ' HA ' ' A' ' 75' ' ' PRO . 18.3 Cg_endo -61.48 -68.3 0.04 OUTLIER 'Trans proline' 0 C--N 1.35 0.645 0 C-N-CA 122.645 2.23 . . . . 0.0 112.633 -179.592 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 3.4 pt-20 -179.26 156.02 0.82 Allowed Pre-proline 0 N--CA 1.465 0.28 0 CA-C-N 116.628 -0.26 . . . . 0.0 110.476 179.759 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 78' ' ' PRO . . . . . 0.47 ' O ' HD13 ' A' ' 79' ' ' ILE . 39.6 Cg_exo -57.62 85.37 0.05 OUTLIER 'Trans proline' 0 C--N 1.351 0.662 0 C-N-CA 122.935 2.424 . . . . 0.0 112.566 -179.715 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.47 HD13 ' O ' ' A' ' 78' ' ' PRO . 24.2 mm -134.97 123.64 41.14 Favored 'Isoleucine or valine' 0 C--O 1.233 0.197 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.147 -179.705 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -119.75 -42.6 2.61 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.419 179.512 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -60.8 -53.43 57.48 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.727 -179.454 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 82' ' ' ALA . . . . . 0.402 ' HB3' HG21 ' A' ' 79' ' ' ILE . . . -68.57 101.34 1.26 Allowed 'General case' 0 C--O 1.232 0.176 0 CA-C-O 120.822 0.344 . . . . 0.0 111.05 -179.841 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.33 -0.254 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.084 -179.889 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 84' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.595 ' HG2' HG23 ' A' ' 2' ' ' VAL . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.646 0 N-CA-C 112.183 0.438 . . . . 0.0 112.183 . . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.595 HG23 ' HG2' ' A' ' 1' ' ' MET . 21.5 t -103.12 116.26 46.56 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.143 0 CA-C-O 120.59 0.233 . . . . 0.0 111.426 -179.694 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 1.2 m -167.79 80.25 0.18 Allowed 'General case' 0 CA--C 1.532 0.284 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.747 179.678 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.413 HG21 ' CG ' ' A' ' 56' ' ' ASP . 3.1 p 56.61 -171.51 0.08 Allowed 'General case' 0 N--CA 1.472 0.661 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.306 -179.353 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 5' ' ' TYR . . . . . 0.444 ' CG ' HD11 ' A' ' 53' ' ' LEU . 0.2 OUTLIER -111.64 -41.59 4.03 Favored 'General case' 0 CA--C 1.53 0.186 0 CA-C-N 116.517 -0.31 . . . . 0.0 111.311 -179.955 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -155.56 176.09 13.05 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-O 120.697 0.284 . . . . 0.0 111.207 -179.991 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' GLU . . . . . 0.562 ' O ' HD13 ' A' ' 8' ' ' ILE . 3.9 pt-20 -130.22 131.22 45.45 Favored 'General case' 0 CA--C 1.531 0.234 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.15 179.798 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.562 HD13 ' O ' ' A' ' 7' ' ' GLU . 26.5 mm -130.03 154.16 39.98 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.281 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.455 -179.812 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 9.7 mt-10 -103.78 148.22 26.36 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.062 179.843 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 33.8 pt -58.76 -32.43 46.72 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.325 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.347 179.537 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 4.4 mt-10 -60.45 -30.39 69.62 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.223 179.726 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 5.6 t0 -98.52 39.0 1.28 Allowed 'General case' 0 CA--C 1.532 0.278 0 CA-C-O 120.902 0.382 . . . . 0.0 111.038 179.727 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' MET . . . . . 0.415 ' HG2' ' HB2' ' A' ' 24' ' ' TYR . 0.1 OUTLIER -132.98 143.39 49.41 Favored 'General case' 0 C--O 1.232 0.172 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.585 179.833 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 1.2 m -62.18 121.12 12.3 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-O 120.734 0.302 . . . . 0.0 111.172 -179.582 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 20.8 p90 -87.76 125.44 34.43 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.695 179.597 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 -112.22 86.38 7.84 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.405 179.852 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 40.0 Cg_endo -67.45 -20.09 48.41 Favored 'Trans proline' 0 C--N 1.347 0.487 0 C-N-CA 122.673 2.248 . . . . 0.0 112.786 -179.989 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -53.33 -36.15 60.96 Favored 'General case' 0 CA--C 1.53 0.2 0 CA-C-N 116.591 -0.277 . . . . 0.0 111.337 179.884 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 3.0 t-20 -138.54 22.73 2.71 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-N 116.534 -0.303 . . . . 0.0 111.652 179.867 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 8.4 tt0 50.32 65.35 1.47 Allowed 'General case' 0 CA--C 1.534 0.347 0 CA-C-O 120.975 0.416 . . . . 0.0 111.454 179.916 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' MET . . . . . 0.467 ' HB3' ' CD1' ' A' ' 35' ' ' TYR . 23.3 ptt? -149.62 172.65 14.7 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.137 179.86 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.415 ' CD1' HD21 ' A' ' 36' ' ' LEU . 16.1 m-85 -130.3 134.29 47.1 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.026 179.86 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 11.8 p -130.53 136.29 48.8 Favored 'General case' 0 N--CA 1.462 0.162 0 CA-C-N 116.389 -0.368 . . . . 0.0 111.269 -179.893 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' TYR . . . . . 0.415 ' HB2' ' HG2' ' A' ' 13' ' ' MET . 32.7 t80 -139.38 137.46 19.02 Favored Pre-proline 0 C--N 1.333 -0.137 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.982 179.895 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -72.06 103.68 1.53 Allowed 'Trans proline' 0 C--N 1.348 0.517 0 C-N-CA 122.685 2.256 . . . . 0.0 112.507 179.924 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' CYS . . . . . 0.415 ' SG ' ' HD2' ' A' ' 27' ' ' PRO . 48.7 t -64.31 139.29 97.67 Favored Pre-proline 0 C--O 1.233 0.23 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.696 179.75 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 27' ' ' PRO . . . . . 0.415 ' HD2' ' SG ' ' A' ' 26' ' ' CYS . 71.0 Cg_exo -50.06 -26.01 13.82 Favored 'Trans proline' 0 C--N 1.352 0.713 0 C-N-CA 122.932 2.422 . . . . 0.0 113.237 179.844 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 7.7 p -57.94 -28.65 64.5 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-O 120.578 0.228 . . . . 0.0 111.434 179.944 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 122.84 6.79 7.62 Favored Glycine 0 CA--C 1.524 0.629 0 C-N-CA 121.096 -0.573 . . . . 0.0 113.513 -179.995 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -122.37 -173.33 2.65 Favored 'General case' 0 CA--C 1.532 0.252 0 CA-C-N 117.237 0.519 . . . . 0.0 111.001 179.954 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 7.1 ttm-85 -118.94 130.11 55.53 Favored 'General case' 0 N--CA 1.463 0.183 0 CA-C-O 120.807 0.337 . . . . 0.0 111.378 -179.854 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' PHE . . . . . 0.424 ' CZ ' ' HB1' ' A' ' 46' ' ' ALA . 64.6 t80 -91.84 157.48 16.85 Favored 'General case' 0 CA--C 1.529 0.164 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.917 179.673 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -140.13 129.3 23.72 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.067 179.749 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.47 ' O ' HG23 ' A' ' 34' ' ' ILE . 3.1 tt -139.06 115.65 10.24 Favored 'Isoleucine or valine' 0 C--O 1.234 0.254 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.986 179.626 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 35' ' ' TYR . . . . . 0.467 ' CD1' ' HB3' ' A' ' 21' ' ' MET . 41.6 m-85 -74.5 141.63 44.88 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.996 -179.88 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.624 ' O ' HD11 ' A' ' 64' ' ' LEU . 3.9 mm? -59.54 -38.29 80.65 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.006 179.686 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 1.2 p30 -60.88 -40.22 92.19 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 116.477 -0.329 . . . . 0.0 110.849 179.524 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 2.5 t70 -63.17 -39.56 95.02 Favored 'General case' 0 N--CA 1.462 0.134 0 CA-C-N 116.493 -0.321 . . . . 0.0 110.895 179.73 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' MET . . . . . 0.47 ' SD ' HD13 ' A' ' 36' ' ' LEU . 5.0 mtt -61.99 -29.49 70.29 Favored 'General case' 0 N--CA 1.463 0.187 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.115 179.604 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -57.13 -35.99 70.14 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 116.536 -0.302 . . . . 0.0 111.035 179.662 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 8.3 mt-10 -66.99 -34.4 77.67 Favored 'General case' 0 CA--C 1.531 0.234 0 CA-C-N 116.511 -0.313 . . . . 0.0 110.835 179.628 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 124.56 64.02 0.19 Allowed Glycine 0 C--N 1.335 0.49 0 C-N-CA 120.982 -0.628 . . . . 0.0 112.557 179.631 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 2.1 tp10 -104.25 105.93 16.25 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-O 120.729 0.3 . . . . 0.0 111.084 179.955 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -111.44 -33.79 6.3 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.044 179.431 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.446 HG22 ' OD1' ' A' ' 56' ' ' ASP . 18.8 t -115.96 87.68 1.07 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.273 0 CA-C-O 120.905 0.383 . . . . 0.0 110.659 179.752 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.424 ' HB1' ' CZ ' ' A' ' 32' ' ' PHE . . . -82.94 162.65 21.44 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.21 -179.796 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 11.6 p -121.38 122.95 68.63 Favored 'Isoleucine or valine' 0 C--O 1.233 0.206 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.083 179.926 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 49.3 t -63.04 135.43 96.22 Favored Pre-proline 0 C--N 1.331 -0.217 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.724 179.96 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 93.6 Cg_endo -83.3 19.76 1.28 Allowed 'Trans proline' 0 CA--C 1.535 0.555 0 C-N-CA 122.623 2.215 . . . . 0.0 113.307 -179.855 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -129.15 -57.19 1.16 Allowed 'General case' 0 C--O 1.233 0.188 0 CA-C-O 120.459 0.171 . . . . 0.0 110.628 179.661 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 17.9 p -101.68 -10.92 19.57 Favored 'General case' 0 N--CA 1.465 0.319 0 N-CA-C 111.956 0.354 . . . . 0.0 111.956 179.881 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 5.8 p 61.0 35.64 18.88 Favored 'General case' 0 CA--C 1.535 0.403 0 CA-C-O 120.842 0.354 . . . . 0.0 111.502 179.842 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.618 HD23 HG23 ' A' ' 55' ' ' ILE . 7.7 tt -89.07 134.6 33.94 Favored 'General case' 0 CA--C 1.53 0.2 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.534 179.748 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 54' ' ' MET . . . . . . . . . . . . . 20.4 mtt -84.6 135.79 34.04 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.062 -179.773 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.618 HG23 HD23 ' A' ' 53' ' ' LEU . 2.7 pt -138.81 137.56 42.68 Favored 'Isoleucine or valine' 0 C--O 1.234 0.261 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.751 -179.778 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 56' ' ' ASP . . . . . 0.446 ' OD1' HG22 ' A' ' 45' ' ' VAL . 55.5 m-20 -87.13 88.67 7.76 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.675 179.305 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.517 ' O ' HG13 ' A' ' 57' ' ' VAL . 14.2 p -88.38 112.47 23.86 Favored 'Isoleucine or valine' 0 C--O 1.234 0.263 0 CA-C-O 121.003 0.43 . . . . 0.0 111.004 179.901 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 14.4 p -86.72 127.72 40.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.935 179.997 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 29.1 p90 -124.82 177.76 5.84 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.936 -0.575 . . . . 0.0 111.114 -179.606 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -133.1 144.38 49.91 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.169 -179.807 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 8.1 tttt -74.88 -40.76 60.76 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.84 179.585 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 6.3 tt0 -58.03 -48.8 78.98 Favored 'General case' 0 N--CA 1.462 0.131 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.559 179.587 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -55.03 -50.15 69.78 Favored 'General case' 0 C--O 1.232 0.153 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.033 179.691 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.624 HD11 ' O ' ' A' ' 36' ' ' LEU . 0.3 OUTLIER -56.88 -40.32 75.98 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.132 179.976 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -61.27 -38.29 86.22 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-N 116.451 -0.34 . . . . 0.0 111.163 179.645 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -76.05 -47.46 24.62 Favored 'General case' 0 C--O 1.231 0.125 0 CA-C-N 116.474 -0.33 . . . . 0.0 111.075 179.639 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 6.5 m-85 -55.75 -32.75 63.68 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 116.468 -0.333 . . . . 0.0 111.384 179.876 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 1.8 t80 -59.09 -41.31 87.75 Favored 'General case' 0 C--O 1.232 0.184 0 CA-C-O 120.695 0.284 . . . . 0.0 110.713 179.644 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 6.4 tt0 -84.82 -38.94 18.94 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.803 179.447 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 4.9 tt0 -62.29 -39.69 93.79 Favored 'General case' 0 CA--C 1.529 0.169 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.252 -179.958 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -85.03 -39.22 18.28 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-N 116.597 -0.274 . . . . 0.0 111.132 179.729 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 64.12 62.04 5.53 Favored Glycine 0 C--N 1.336 0.573 0 C-N-CA 121.031 -0.604 . . . . 0.0 112.583 179.805 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 9.6 tp -56.28 -34.1 39.25 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.259 0 N-CA-C 111.886 0.328 . . . . 0.0 111.886 -179.881 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 35.0 m80 59.98 85.9 0.17 Allowed Pre-proline 0 N--CA 1.463 0.176 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.131 179.996 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 43.3 Cg_endo -68.22 109.98 2.12 Favored 'Trans proline' 0 C--N 1.346 0.436 0 C-N-CA 122.657 2.238 . . . . 0.0 112.42 -179.944 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 49.1 Cg_endo -69.41 138.12 38.16 Favored 'Trans proline' 0 C--N 1.351 0.675 0 C-N-CA 122.544 2.163 . . . . 0.0 111.933 179.755 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER 58.8 59.88 5.42 Favored Pre-proline 0 C--O 1.233 0.222 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.599 -179.547 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -71.69 58.0 2.53 Favored 'Trans proline' 0 C--N 1.35 0.615 0 C-N-CA 122.656 2.237 . . . . 0.0 112.535 -179.786 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 14.2 pt -151.04 30.47 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.53 0.184 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.311 179.953 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -88.8 92.86 9.38 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-O 120.808 0.337 . . . . 0.0 111.343 -179.581 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . 67.22 159.0 0.14 Allowed 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.669 179.828 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -166.86 169.9 12.76 Favored 'General case' 0 CA--C 1.53 0.206 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.744 -179.841 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.463 0.213 0 CA-C-N 115.88 -0.6 . . . . 0.0 111.558 179.764 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 84' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.489 1.519 0 CA-C-O 120.623 0.249 . . . . 0.0 111.204 . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.426 ' O ' HG12 ' A' ' 2' ' ' VAL . 10.6 t -106.86 43.58 0.18 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.316 0 CA-C-O 120.984 0.421 . . . . 0.0 110.911 179.798 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 56.05 82.71 0.1 Allowed 'General case' 0 CA--C 1.531 0.23 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.034 -179.964 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 2.4 p 63.13 173.11 0.15 Allowed 'General case' 0 N--CA 1.469 0.505 0 CA-C-N 115.599 -0.728 . . . . 0.0 111.432 -179.316 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' TYR . . . . . 0.414 ' CE1' HD21 ' A' ' 53' ' ' LEU . 7.9 m-85 -114.8 -37.33 4.24 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.747 -0.66 . . . . 0.0 111.381 -179.844 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -157.53 176.72 12.27 Favored 'General case' 0 C--O 1.236 0.344 0 CA-C-O 120.698 0.285 . . . . 0.0 111.094 179.752 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -122.7 140.94 52.31 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.966 179.802 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 25.0 mt -125.83 154.62 34.91 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.17 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.196 -179.811 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 17.1 mt-10 -109.04 150.62 27.52 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-N 116.345 -0.388 . . . . 0.0 111.108 179.957 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.665 HD11 ' CE2' ' A' ' 22' ' ' PHE . 16.5 tt -59.01 -28.88 39.93 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.292 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.58 179.697 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 20.5 mt-10 -58.26 -31.13 67.14 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-N 116.528 -0.305 . . . . 0.0 111.285 179.666 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -94.36 28.48 2.54 Favored 'General case' 0 CA--C 1.536 0.41 0 CA-C-N 116.695 -0.23 . . . . 0.0 111.41 179.643 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 1.4 ttp -122.75 167.56 13.33 Favored 'General case' 0 CA--C 1.53 0.176 0 CA-C-O 120.648 0.261 . . . . 0.0 111.234 -179.736 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -105.36 117.24 33.52 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.77 179.891 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 15' ' ' PHE . . . . . 0.513 ' HB3' ' CE2' ' A' ' 22' ' ' PHE . 37.2 p90 -96.0 147.78 23.34 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.974 179.826 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -144.43 150.25 47.13 Favored Pre-proline 0 N--CA 1.463 0.211 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.398 179.875 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 70.2 Cg_endo -73.8 -14.74 24.17 Favored 'Trans proline' 0 C--N 1.348 0.55 0 C-N-CA 123.056 2.504 . . . . 0.0 113.098 179.613 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -69.03 82.53 0.32 Allowed 'General case' 0 CA--C 1.53 0.185 0 CA-C-O 121.179 0.514 . . . . 0.0 110.868 -179.824 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 6.8 m-80 67.51 20.7 9.73 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 115.564 -0.744 . . . . 0.0 111.797 -179.556 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' GLN . . . . . 0.619 ' HG2' HD12 ' A' ' 36' ' ' LEU . 16.7 mt-30 54.14 77.54 0.19 Allowed 'General case' 0 CA--C 1.532 0.257 0 CA-C-O 120.854 0.359 . . . . 0.0 111.428 179.596 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -116.62 145.25 43.53 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.034 179.967 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.665 ' CE2' HD11 ' A' ' 10' ' ' ILE . 12.3 m-85 -125.92 94.86 4.23 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.654 -179.901 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 32.2 p -91.79 146.14 24.0 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.419 -179.49 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 23.0 t80 -142.59 137.18 15.09 Favored Pre-proline 0 CA--C 1.53 0.184 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.036 -179.942 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -65.32 100.02 0.37 Allowed 'Trans proline' 0 C--N 1.349 0.596 0 C-N-CA 122.694 2.263 . . . . 0.0 112.272 179.604 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' CYS . . . . . 0.403 ' SG ' ' HD2' ' A' ' 27' ' ' PRO . 48.1 t -65.94 139.01 96.56 Favored Pre-proline 0 C--O 1.233 0.229 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.699 179.903 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 27' ' ' PRO . . . . . 0.403 ' HD2' ' SG ' ' A' ' 26' ' ' CYS . 54.8 Cg_exo -53.25 -25.41 30.21 Favored 'Trans proline' 0 C--N 1.35 0.649 0 C-N-CA 122.82 2.346 . . . . 0.0 112.83 179.666 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -68.26 -38.54 81.86 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-O 120.451 0.167 . . . . 0.0 111.268 179.985 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 152.16 -47.47 0.56 Allowed Glycine 0 C--N 1.335 0.477 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.962 -179.987 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -76.74 -174.69 3.11 Favored 'General case' 0 CA--C 1.531 0.223 0 CA-C-O 120.694 0.283 . . . . 0.0 111.12 -179.783 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 12.3 mtt180 -122.36 137.41 54.87 Favored 'General case' 0 C--O 1.232 0.164 0 CA-C-O 120.829 0.347 . . . . 0.0 111.097 -179.853 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 9.1 m-85 -66.47 167.85 10.03 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.004 179.774 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 12.6 pt20 -154.18 97.64 2.06 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.114 -179.985 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 10.7 tt -123.97 151.52 28.94 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.216 0 CA-C-N 116.29 -0.413 . . . . 0.0 111.293 179.996 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 6.3 m-85 -102.53 152.69 20.86 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.839 -179.961 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.619 HD12 ' HG2' ' A' ' 20' ' ' GLN . 25.6 mt -61.6 -43.04 99.6 Favored 'General case' 0 N--CA 1.463 0.175 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.032 179.798 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -60.25 -38.13 82.53 Favored 'General case' 0 CA--C 1.53 0.187 0 CA-C-N 116.405 -0.362 . . . . 0.0 111.032 179.65 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -59.19 -57.04 14.79 Favored 'General case' 0 N--CA 1.462 0.158 0 CA-C-O 120.769 0.319 . . . . 0.0 110.81 179.711 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 47.6 mtm -61.32 -37.77 84.46 Favored 'General case' 0 N--CA 1.462 0.157 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.024 179.589 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 17.7 t80 -58.11 -38.7 76.96 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.999 179.586 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 1.3 tp10 -62.05 -45.13 94.9 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-N 116.507 -0.315 . . . . 0.0 110.761 179.576 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 152.29 48.34 0.02 OUTLIER Glycine 0 C--N 1.332 0.34 0 C-N-CA 120.979 -0.629 . . . . 0.0 112.694 179.627 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 1.1 tp10 -99.53 147.61 25.14 Favored 'General case' 0 C--O 1.231 0.106 0 CA-C-O 120.754 0.311 . . . . 0.0 110.99 179.921 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 7.9 mttt -149.37 -47.99 0.14 Allowed 'General case' 0 C--O 1.233 0.217 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.133 179.752 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.432 HG22 ' OD1' ' A' ' 56' ' ' ASP . 24.3 t -106.86 104.52 17.18 Favored 'Isoleucine or valine' 0 C--O 1.234 0.257 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.862 179.957 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -92.7 174.64 7.16 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.076 179.813 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 10.7 p -134.9 123.57 41.22 Favored 'Isoleucine or valine' 0 C--O 1.233 0.214 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.205 -179.954 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 48.3 t -70.31 135.77 86.66 Favored Pre-proline 0 C--N 1.332 -0.186 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.807 179.869 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_endo -84.13 20.94 1.13 Allowed 'Trans proline' 0 CA--C 1.536 0.581 0 C-N-CA 122.762 2.308 . . . . 0.0 113.077 179.682 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -128.71 -55.72 1.22 Allowed 'General case' 0 C--O 1.232 0.155 0 CA-C-N 116.67 -0.241 . . . . 0.0 110.626 179.903 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 18.6 p -98.31 -17.69 18.76 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.848 179.906 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 5.6 p 63.93 37.15 9.65 Favored 'General case' 0 CA--C 1.535 0.382 0 CA-C-O 120.987 0.422 . . . . 0.0 111.438 179.865 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.496 HD13 ' N ' ' A' ' 54' ' ' MET . 1.3 tm? -101.99 130.62 48.57 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.491 179.7 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 54' ' ' MET . . . . . 0.496 ' N ' HD13 ' A' ' 53' ' ' LEU . 60.6 mtm -83.95 135.18 34.56 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.836 179.997 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.463 ' O ' HD12 ' A' ' 55' ' ' ILE . 2.5 pp -137.51 134.35 46.42 Favored 'Isoleucine or valine' 0 C--O 1.233 0.23 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.564 -179.89 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 56' ' ' ASP . . . . . 0.432 ' OD1' HG22 ' A' ' 45' ' ' VAL . 20.1 m-20 -82.41 100.95 10.32 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.766 179.597 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.468 ' O ' HG13 ' A' ' 57' ' ' VAL . 13.5 p -104.02 116.66 48.22 Favored 'Isoleucine or valine' 0 C--O 1.233 0.227 0 CA-C-O 121.133 0.492 . . . . 0.0 111.179 179.9 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 12.4 p -87.55 137.53 20.82 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.939 -179.94 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 44.3 p90 -124.66 175.98 6.85 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.072 -179.67 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -114.02 155.94 24.99 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.144 -179.881 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 56.6 mttt -92.96 -44.44 8.43 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.742 179.674 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 16.2 pt-20 -57.84 -36.04 71.73 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 116.473 -0.33 . . . . 0.0 110.927 179.61 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -55.68 -53.3 58.3 Favored 'General case' 0 N--CA 1.461 0.125 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.67 179.523 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 3.0 mp -55.43 -39.35 70.14 Favored 'General case' 0 N--CA 1.462 0.159 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.211 179.631 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -58.76 -60.15 4.29 Favored 'General case' 0 CA--C 1.528 0.11 0 CA-C-N 116.507 -0.315 . . . . 0.0 111.173 179.885 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -63.72 -40.6 97.15 Favored 'General case' 0 N--CA 1.464 0.225 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.221 179.708 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 67' ' ' TYR . . . . . 0.617 ' O ' ' HB2' ' A' ' 71' ' ' ALA . 3.2 m-85 -63.16 -55.51 24.57 Favored 'General case' 0 C--O 1.227 -0.129 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.233 -179.82 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 3.0 t80 -61.56 -43.98 97.87 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 116.592 -0.276 . . . . 0.0 110.89 179.998 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 4.0 tt0 -58.11 -30.42 66.28 Favored 'General case' 0 CA--C 1.53 0.21 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.975 179.541 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -130.74 59.55 1.66 Allowed 'General case' 0 C--O 1.234 0.26 0 CA-C-O 120.839 0.352 . . . . 0.0 111.107 -179.927 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' ALA . . . . . 0.617 ' HB2' ' O ' ' A' ' 67' ' ' TYR . . . -135.54 139.38 43.89 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.536 179.926 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -97.02 48.23 1.6 Allowed Glycine 0 C--N 1.333 0.406 0 C-N-CA 121.081 -0.58 . . . . 0.0 112.309 179.515 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.414 HD13 ' NE2' ' A' ' 20' ' ' GLN . 36.4 pt -69.48 176.76 0.49 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.175 0 CA-C-O 120.671 0.272 . . . . 0.0 111.156 179.987 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -53.13 -59.85 8.15 Favored Pre-proline 0 CA--C 1.531 0.215 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.216 -179.987 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -73.74 111.15 3.23 Favored 'Trans proline' 0 C--N 1.352 0.739 0 C-N-CA 122.361 2.041 . . . . 0.0 112.342 179.605 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -71.54 -178.53 3.06 Favored 'Trans proline' 0 C--N 1.348 0.548 0 C-N-CA 122.68 2.254 . . . . 0.0 112.507 -179.912 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 5.6 tt0 -127.58 90.83 47.31 Favored Pre-proline 0 CA--C 1.531 0.237 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.089 179.989 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 41.1 Cg_endo -68.31 95.69 0.45 Allowed 'Trans proline' 0 C--N 1.346 0.43 0 C-N-CA 122.647 2.232 . . . . 0.0 112.424 179.987 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 1.8 pt -140.84 90.47 0.53 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.21 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.292 -179.722 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . 60.12 90.8 0.06 Allowed 'General case' 0 N--CA 1.465 0.302 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.504 179.934 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -106.47 163.13 13.11 Favored 'General case' 0 N--CA 1.463 0.207 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.548 -179.862 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -109.29 156.63 19.73 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.241 179.904 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.139 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.133 179.611 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 84' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 5.7 mtt . . . . . 0 N--CA 1.49 1.54 0 CA-C-O 120.525 0.202 . . . . 0.0 111.371 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.47 ' O ' HG23 ' A' ' 2' ' ' VAL . 30.9 m -66.8 113.52 2.98 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.275 0 CA-C-O 120.811 0.339 . . . . 0.0 111.17 -179.924 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 1.4 p -149.52 137.46 20.41 Favored 'General case' 0 CA--C 1.53 0.194 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.904 -179.538 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.48 HG22 ' O ' ' A' ' 54' ' ' MET . 0.2 OUTLIER 63.23 177.48 0.15 Allowed 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.982 -179.891 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 21.4 m-85 -105.58 -76.4 0.61 Allowed 'General case' 0 C--O 1.232 0.167 0 CA-C-N 116.48 -0.327 . . . . 0.0 111.176 -179.739 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -126.66 171.77 10.87 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.002 -179.813 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 4.6 pt-20 -132.64 136.31 46.41 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-N 116.405 -0.361 . . . . 0.0 111.014 179.654 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 3.7 mp -118.48 150.4 20.72 Favored 'Isoleucine or valine' 0 C--O 1.233 0.226 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.375 -179.605 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' GLU . . . . . 0.446 ' HA ' HG12 ' A' ' 58' ' ' VAL . 12.2 mt-10 -98.97 153.55 18.76 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.366 -179.905 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 1.1 tp -59.25 -32.61 48.65 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.286 0 CA-C-N 115.989 -0.55 . . . . 0.0 111.223 179.551 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -61.21 -33.17 73.04 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-N 116.551 -0.295 . . . . 0.0 110.998 179.514 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -96.91 37.37 1.31 Allowed 'General case' 0 C--O 1.234 0.27 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.177 179.816 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 13' ' ' MET . . . . . 0.516 ' HG2' ' CD1' ' A' ' 24' ' ' TYR . 3.3 mtp -125.75 150.09 48.02 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-N 116.407 -0.361 . . . . 0.0 110.887 179.798 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 7.3 m -96.7 113.57 25.14 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.766 179.679 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 24.2 p90 -80.38 130.18 35.0 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.517 179.632 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 3.9 tt0 -107.23 95.83 14.18 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.625 -179.949 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -72.87 60.84 3.72 Favored 'Trans proline' 0 C--N 1.347 0.492 0 C-N-CA 122.69 2.26 . . . . 0.0 112.58 -179.734 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 15.1 pt-20 -126.67 -45.27 1.63 Allowed 'General case' 0 C--O 1.233 0.189 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.876 179.915 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 2.2 t-20 -146.55 33.64 0.95 Allowed 'General case' 0 CA--C 1.532 0.276 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.066 179.636 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' GLN . . . . . 0.408 ' CG ' HG12 ' A' ' 73' ' ' ILE . 10.1 mt-30 57.9 57.75 3.98 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.222 179.851 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 21.8 ptm -136.62 151.44 49.33 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.672 179.658 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.611 ' HE1' HD23 ' A' ' 36' ' ' LEU . 7.6 m-85 -130.24 124.85 33.44 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.388 -179.899 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 23' ' ' THR . . . . . 0.767 HG22 ' HA ' ' A' ' 33' ' ' GLN . 64.3 p -120.24 137.5 54.18 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.952 -179.581 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 24' ' ' TYR . . . . . 0.516 ' CD1' ' HG2' ' A' ' 13' ' ' MET . 1.9 p90 -131.54 148.17 68.97 Favored Pre-proline 0 C--O 1.233 0.195 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.133 179.867 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_exo -52.52 124.72 15.81 Favored 'Trans proline' 0 C--N 1.349 0.584 0 C-N-CA 122.872 2.381 . . . . 0.0 112.774 -179.671 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' CYS . . . . . 0.491 ' SG ' ' HD2' ' A' ' 27' ' ' PRO . 50.5 t -94.9 141.21 22.98 Favored Pre-proline 0 C--N 1.33 -0.244 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.342 179.587 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 27' ' ' PRO . . . . . 0.491 ' HD2' ' SG ' ' A' ' 26' ' ' CYS . 87.6 Cg_exo -48.08 -30.11 13.63 Favored 'Trans proline' 0 C--N 1.349 0.578 0 C-N-CA 122.846 2.364 . . . . 0.0 113.192 179.914 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 28' ' ' CYS . . . . . 0.405 ' CB ' ' HB3' ' A' ' 51' ' ' CYS . 0.8 OUTLIER -76.96 -40.36 47.2 Favored 'General case' 0 CA--C 1.532 0.267 0 CA-C-N 116.818 -0.174 . . . . 0.0 111.32 179.986 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 151.77 -45.07 0.63 Allowed Glycine 0 C--N 1.335 0.516 0 C-N-CA 120.49 -0.862 . . . . 0.0 113.175 179.753 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 50.6 m-20 -67.33 -177.74 0.74 Allowed 'General case' 0 CA--C 1.532 0.271 0 CA-C-O 120.912 0.387 . . . . 0.0 111.123 -179.808 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -110.97 128.15 55.74 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.875 -179.716 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 15.0 m-85 -64.66 91.46 0.08 Allowed 'General case' 0 C--O 1.233 0.227 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.7 179.816 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' GLN . . . . . 0.767 ' HA ' HG22 ' A' ' 23' ' ' THR . 2.9 pt20 -80.13 125.86 30.36 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.228 -179.65 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 2.5 tt -161.26 133.77 1.09 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.207 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.066 179.723 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 71.3 m-85 -88.11 145.52 25.9 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.775 -179.947 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.611 HD23 ' HE1' ' A' ' 22' ' ' PHE . 4.1 pp -58.01 -33.38 68.88 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.215 179.74 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 37' ' ' ASP . . . . . 0.55 ' N ' HD12 ' A' ' 36' ' ' LEU . 1.2 p30 -65.3 -39.07 92.03 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 116.567 -0.288 . . . . 0.0 110.785 179.493 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -61.87 -46.95 87.19 Favored 'General case' 0 CA--C 1.528 0.116 0 CA-C-N 116.422 -0.353 . . . . 0.0 110.839 179.781 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 55.6 mtm -74.37 -33.1 62.98 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.176 179.825 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' PHE . . . . . 0.417 ' HB2' HD21 ' A' ' 64' ' ' LEU . 18.4 t80 -57.09 -38.27 73.09 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.029 -179.931 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 21.6 mt-10 -60.71 -37.18 80.83 Favored 'General case' 0 N--CA 1.462 0.147 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.889 179.548 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 145.56 47.62 0.03 OUTLIER Glycine 0 C--N 1.333 0.391 0 C-N-CA 120.94 -0.647 . . . . 0.0 112.69 179.794 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -112.56 148.2 35.02 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-O 120.741 0.305 . . . . 0.0 111.161 -179.845 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 22.8 mtmt -148.09 -48.24 0.16 Allowed 'General case' 0 CA--C 1.531 0.219 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.076 179.815 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.45 HG22 ' OD1' ' A' ' 56' ' ' ASP . 23.7 t -89.87 94.79 5.03 Favored 'Isoleucine or valine' 0 C--O 1.232 0.178 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.805 -179.985 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -91.6 159.18 16.03 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.188 -179.884 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 11.6 p -126.04 128.45 71.84 Favored 'Isoleucine or valine' 0 C--O 1.232 0.169 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.371 -179.904 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 42.0 t -71.21 136.73 84.32 Favored Pre-proline 0 CA--C 1.53 0.201 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.884 179.714 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 92.9 Cg_endo -82.8 20.35 1.16 Allowed 'Trans proline' 0 C--N 1.35 0.629 0 C-N-CA 122.751 2.301 . . . . 0.0 113.136 179.742 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 38.9 t -128.59 -58.11 1.18 Allowed 'General case' 0 C--O 1.232 0.153 0 N-CA-C 110.265 -0.272 . . . . 0.0 110.265 179.539 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' CYS . . . . . 0.816 ' SG ' HD23 ' A' ' 53' ' ' LEU . 20.7 p -94.26 -27.0 16.38 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.483 179.711 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 1.5 t 70.92 42.92 0.73 Allowed 'General case' 0 CA--C 1.532 0.275 0 CA-C-O 120.931 0.396 . . . . 0.0 110.968 -179.838 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.816 HD23 ' SG ' ' A' ' 51' ' ' CYS . 3.6 mm? -92.34 150.69 20.69 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.63 179.64 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 54' ' ' MET . . . . . 0.48 ' O ' HG22 ' A' ' 4' ' ' THR . 9.7 mtt -104.66 123.05 46.92 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.904 -179.791 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 2.6 pp -134.99 148.3 29.1 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.313 0 CA-C-N 116.363 -0.38 . . . . 0.0 111.842 -179.883 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' ASP . . . . . 0.45 ' OD1' HG22 ' A' ' 45' ' ' VAL . 32.1 m-20 -102.4 92.36 4.66 Favored 'General case' 0 CA--C 1.531 0.223 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.95 179.657 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 13.1 p -88.97 127.83 41.46 Favored 'Isoleucine or valine' 0 C--O 1.234 0.256 0 CA-C-O 120.851 0.357 . . . . 0.0 110.986 179.72 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.446 HG12 ' HA ' ' A' ' 9' ' ' GLU . 12.5 p -97.97 136.53 28.52 Favored 'Isoleucine or valine' 0 C--O 1.234 0.251 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.398 -179.837 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 16.1 p90 -123.82 170.12 10.88 Favored 'General case' 0 CA--C 1.53 0.184 0 CA-C-N 115.899 -0.591 . . . . 0.0 111.073 -179.966 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -107.63 160.13 15.93 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.106 179.734 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -89.17 -37.85 14.73 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.032 179.691 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -72.21 -38.83 68.91 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-N 116.618 -0.265 . . . . 0.0 111.171 179.944 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 88.7 m-20 -52.71 -41.65 64.11 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.001 -179.988 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.417 HD21 ' HB2' ' A' ' 40' ' ' PHE . 0.8 OUTLIER -63.7 -52.35 60.97 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.979 -179.933 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -57.47 -39.26 75.97 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-N 116.489 -0.323 . . . . 0.0 110.736 179.57 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -73.83 -46.43 45.15 Favored 'General case' 0 N--CA 1.461 0.124 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.273 179.67 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 9.3 t80 -60.61 -37.67 82.18 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 116.713 -0.221 . . . . 0.0 111.237 -179.946 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 13.9 t80 -58.29 -41.34 84.17 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-O 120.55 0.214 . . . . 0.0 110.813 179.742 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 9.5 mt-10 -87.93 -35.38 17.71 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.496 -179.801 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 -72.18 -33.37 67.63 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 116.65 -0.25 . . . . 0.0 111.583 -179.843 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -75.08 140.47 43.49 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-O 120.819 0.342 . . . . 0.0 111.329 -179.939 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -96.05 33.28 5.68 Favored Glycine 0 C--N 1.333 0.372 0 C-N-CA 121.027 -0.606 . . . . 0.0 112.297 179.475 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.408 HG12 ' CG ' ' A' ' 20' ' ' GLN . 1.7 pp -69.13 176.33 0.51 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.168 0 CA-C-O 120.841 0.353 . . . . 0.0 111.339 -179.851 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 57.4 m-70 -119.79 147.54 44.28 Favored Pre-proline 0 C--O 1.233 0.21 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.192 -179.729 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_endo -69.59 148.17 65.56 Favored 'Trans proline' 0 C--N 1.348 0.526 0 C-N-CA 122.717 2.278 . . . . 0.0 112.48 179.875 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 68.2 Cg_endo -73.88 84.84 1.41 Allowed 'Trans proline' 0 C--N 1.347 0.498 0 C-N-CA 122.789 2.326 . . . . 0.0 112.495 -179.845 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 77' ' ' GLU . . . . . 0.441 ' HB3' ' HD2' ' A' ' 78' ' ' PRO . 10.7 mt-10 67.52 164.51 0.13 Allowed Pre-proline 0 N--CA 1.467 0.377 0 CA-C-N 115.844 -0.616 . . . . 0.0 111.402 179.926 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 78' ' ' PRO . . . . . 0.441 ' HD2' ' HB3' ' A' ' 77' ' ' GLU . 46.9 Cg_exo -56.56 157.66 18.28 Favored 'Trans proline' 0 C--N 1.349 0.594 0 C-N-CA 122.833 2.355 . . . . 0.0 112.486 179.947 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.563 HD12 ' N ' ' A' ' 80' ' ' ALA . 2.2 pp -141.2 -46.43 0.23 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.206 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.86 179.974 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 80' ' ' ALA . . . . . 0.563 ' N ' HD12 ' A' ' 79' ' ' ILE . . . -144.65 30.92 1.19 Allowed 'General case' 0 N--CA 1.463 0.208 0 CA-C-O 120.771 0.32 . . . . 0.0 111.261 179.907 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -86.99 -33.87 19.45 Favored 'General case' 0 C--O 1.232 0.143 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.236 179.877 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -61.53 -38.31 86.94 Favored 'General case' 0 C--O 1.232 0.133 0 CA-C-N 116.42 -0.355 . . . . 0.0 111.339 179.929 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.174 0 CA-C-N 116.496 -0.32 . . . . 0.0 111.242 -179.999 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 84' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 19.0 mtt . . . . . 0 N--CA 1.49 1.549 0 CA-C-O 120.446 0.165 . . . . 0.0 111.333 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 9.9 m -128.56 147.6 33.05 Favored 'Isoleucine or valine' 0 C--O 1.233 0.232 0 CA-C-O 120.748 0.308 . . . . 0.0 111.675 179.974 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 8.9 p -140.74 34.84 1.79 Allowed 'General case' 0 CA--C 1.535 0.398 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.158 179.921 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.408 HG21 ' CG ' ' A' ' 56' ' ' ASP . 0.8 OUTLIER -101.47 171.89 7.31 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-O 120.906 0.384 . . . . 0.0 111.36 -179.963 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 15.3 m-85 -103.6 -36.2 8.01 Favored 'General case' 0 CA--C 1.53 0.194 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.381 179.849 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -158.78 171.45 20.05 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-O 120.701 0.286 . . . . 0.0 111.322 -179.97 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -127.54 140.5 52.09 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.005 -179.897 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 27.1 mm -120.48 156.01 23.61 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.254 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.926 -179.865 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 10.0 mt-10 -119.63 159.82 23.67 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-O 120.739 0.304 . . . . 0.0 111.323 179.848 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 11.5 tt -65.39 -30.95 51.77 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.351 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.481 179.37 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -60.02 -42.33 94.14 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-O 120.45 0.166 . . . . 0.0 111.331 -179.878 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 8.4 p-10 -98.09 37.05 1.47 Allowed 'General case' 0 CA--C 1.535 0.378 0 CA-C-O 120.824 0.345 . . . . 0.0 111.329 179.589 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -114.43 139.74 49.26 Favored 'General case' 0 C--O 1.233 0.236 0 N-CA-C 109.655 -0.498 . . . . 0.0 109.655 179.182 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 2.9 m -66.87 89.84 0.17 Allowed 'General case' 0 C--O 1.233 0.207 0 CA-C-O 120.86 0.362 . . . . 0.0 110.651 -179.649 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 52.1 p90 -80.2 127.71 32.66 Favored 'General case' 0 C--O 1.232 0.159 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.752 -179.979 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 5.8 mt-10 -109.1 93.92 13.93 Favored Pre-proline 0 C--O 1.236 0.346 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.347 179.845 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -71.64 64.77 3.05 Favored 'Trans proline' 0 C--N 1.346 0.398 0 C-N-CA 122.943 2.429 . . . . 0.0 112.351 -179.794 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 17.1 pt-20 -140.29 -45.86 0.42 Allowed 'General case' 0 CA--C 1.531 0.226 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.916 179.934 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 44.9 p30 -134.69 24.11 3.67 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.557 -179.998 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' GLN . . . . . 0.652 ' N ' HG21 ' A' ' 73' ' ' ILE . 0.2 OUTLIER 60.79 47.05 8.27 Favored 'General case' 0 C--O 1.235 0.325 0 CA-C-O 120.944 0.402 . . . . 0.0 111.053 179.983 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 20.2 ttt -114.77 143.13 45.56 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.919 -179.917 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.488 ' CD1' HD21 ' A' ' 36' ' ' LEU . 4.1 m-85 -127.92 104.34 7.75 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.702 179.649 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 23' ' ' THR . . . . . 0.412 HG22 ' HG2' ' A' ' 33' ' ' GLN . 22.5 p -107.88 179.27 4.27 Favored 'General case' 0 CA--C 1.531 0.216 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.01 -179.962 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 63.1 t80 -173.09 135.27 0.7 Allowed Pre-proline 0 N--CA 1.466 0.338 0 CA-C-N 116.63 -0.259 . . . . 0.0 111.211 179.712 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_endo -66.92 108.05 1.42 Allowed 'Trans proline' 0 C--N 1.349 0.6 0 C-N-CA 122.611 2.207 . . . . 0.0 112.447 179.832 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' CYS . . . . . 0.438 ' SG ' ' HD2' ' A' ' 27' ' ' PRO . 42.8 t -69.36 139.64 89.7 Favored Pre-proline 0 C--N 1.332 -0.187 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.517 179.704 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 27' ' ' PRO . . . . . 0.438 ' HD2' ' SG ' ' A' ' 26' ' ' CYS . 77.7 Cg_exo -51.59 -26.95 23.93 Favored 'Trans proline' 0 C--N 1.349 0.599 0 C-N-CA 122.92 2.413 . . . . 0.0 113.072 179.833 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 28' ' ' CYS . . . . . 0.403 ' CB ' ' HB3' ' A' ' 51' ' ' CYS . 0.8 OUTLIER -70.1 -38.59 75.7 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-N 116.894 -0.139 . . . . 0.0 111.36 -179.868 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 150.86 -43.31 0.71 Allowed Glycine 0 C--N 1.335 0.483 0 C-N-CA 120.869 -0.682 . . . . 0.0 112.91 -179.842 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -70.83 -174.44 0.92 Allowed 'General case' 0 CA--C 1.535 0.383 0 CA-C-O 120.668 0.271 . . . . 0.0 111.187 -179.77 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 18.6 ttm180 -126.96 122.37 34.35 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-O 120.706 0.289 . . . . 0.0 111.385 -179.689 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 4.4 m-85 -61.86 154.14 26.9 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.849 179.527 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' GLN . . . . . 0.412 ' HG2' HG22 ' A' ' 23' ' ' THR . 32.9 mt-30 -143.02 122.04 12.83 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-N 116.455 -0.338 . . . . 0.0 111.478 179.993 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 3.9 tt -151.2 123.12 1.12 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.24 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.896 179.451 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 44.5 m-85 -81.52 158.78 24.35 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.887 -179.916 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.84 HD12 ' HG ' ' A' ' 64' ' ' LEU . 4.0 mm? -59.53 -39.39 83.75 Favored 'General case' 0 N--CA 1.463 0.225 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.847 179.829 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -59.76 -42.59 93.58 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 116.468 -0.333 . . . . 0.0 110.98 179.543 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 33.9 m-20 -58.72 -46.11 88.09 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-O 120.857 0.36 . . . . 0.0 110.475 179.696 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 5.2 mmm -61.18 -35.71 77.88 Favored 'General case' 0 CA--C 1.529 0.17 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.808 179.518 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' PHE . . . . . 0.595 ' CD2' HD22 ' A' ' 64' ' ' LEU . 0.3 OUTLIER -54.35 -45.6 72.77 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 116.491 -0.322 . . . . 0.0 111.293 179.933 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 6.3 mt-10 -61.43 -46.47 89.96 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 116.585 -0.28 . . . . 0.0 110.892 179.875 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 132.09 52.63 0.09 OUTLIER Glycine 0 C--N 1.333 0.376 0 C-N-CA 120.977 -0.63 . . . . 0.0 112.609 179.807 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -106.32 95.88 6.08 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-O 120.941 0.401 . . . . 0.0 111.175 -179.938 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 5.0 ptpt -105.77 -32.92 8.18 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-N 115.843 -0.617 . . . . 0.0 111.064 179.62 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.547 HG13 ' O ' ' A' ' 45' ' ' VAL . 9.5 p -86.89 74.07 1.05 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.295 0 CA-C-O 121.456 0.646 . . . . 0.0 111.001 -179.915 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -81.5 136.32 35.63 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.718 -0.674 . . . . 0.0 111.101 -179.896 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 6.4 m -109.8 125.59 66.98 Favored 'Isoleucine or valine' 0 C--O 1.232 0.18 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.337 -179.985 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 50.3 t -68.8 135.68 90.05 Favored Pre-proline 0 C--O 1.233 0.229 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.84 179.893 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_endo -84.14 20.59 1.18 Allowed 'Trans proline' 0 C--N 1.349 0.59 0 C-N-CA 122.716 2.278 . . . . 0.0 113.217 179.698 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -128.55 -57.58 1.2 Allowed 'General case' 0 C--O 1.232 0.151 0 CA-C-O 120.59 0.233 . . . . 0.0 110.582 179.712 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 51' ' ' CYS . . . . . 0.403 ' HB3' ' CB ' ' A' ' 28' ' ' CYS . 19.1 p -95.35 -22.51 17.69 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-N 116.352 -0.386 . . . . 0.0 111.658 179.828 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 1.1 t 67.53 41.37 2.36 Favored 'General case' 0 CA--C 1.533 0.314 0 CA-C-O 120.981 0.42 . . . . 0.0 110.948 -179.841 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 7.0 tp -95.66 134.32 38.7 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.846 179.86 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' MET . . . . . . . . . . . . . 37.7 mtt -86.07 132.3 34.07 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.0 -179.94 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 2.5 pp -142.18 139.64 29.87 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.205 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.314 -179.899 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' ASP . . . . . 0.408 ' CG ' HG21 ' A' ' 4' ' ' THR . 67.3 m-20 -102.07 97.28 7.63 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.68 179.362 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 12.7 p -86.39 138.01 19.84 Favored 'Isoleucine or valine' 0 C--O 1.234 0.282 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.12 179.885 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 13.4 p -104.92 133.21 49.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.876 179.89 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 37.6 p90 -132.46 176.51 8.36 Favored 'General case' 0 CA--C 1.532 0.274 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.054 -179.397 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 2.5 t70 -122.3 147.69 45.93 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.457 179.968 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 15.0 tttm -83.68 -39.0 20.73 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.82 179.435 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 20.3 mt-10 -60.0 -42.29 93.94 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-N 116.481 -0.327 . . . . 0.0 110.397 179.514 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -64.6 -44.43 90.62 Favored 'General case' 0 CA--C 1.527 0.072 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.795 179.396 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.84 ' HG ' HD12 ' A' ' 36' ' ' LEU . 0.3 OUTLIER -58.25 -43.64 87.94 Favored 'General case' 0 N--CA 1.463 0.207 0 CA-C-N 116.679 -0.237 . . . . 0.0 110.946 179.841 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -65.11 -40.94 95.22 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-N 116.409 -0.359 . . . . 0.0 110.814 179.527 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 2.3 tp10 -72.35 -43.8 63.52 Favored 'General case' 0 CA--C 1.532 0.251 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.165 179.617 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 1.4 t80 -62.48 -36.56 82.88 Favored 'General case' 0 N--CA 1.464 0.273 0 N-CA-C 111.945 0.35 . . . . 0.0 111.945 -179.589 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -59.47 -38.73 81.56 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-O 120.676 0.274 . . . . 0.0 110.624 179.963 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 -86.69 -38.6 16.84 Favored 'General case' 0 CA--C 1.53 0.205 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.048 179.766 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 73.2 mt-10 -69.15 -38.81 78.99 Favored 'General case' 0 N--CA 1.465 0.306 0 N-CA-C 111.867 0.321 . . . . 0.0 111.867 -179.394 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -70.92 -47.06 61.17 Favored 'General case' 0 C--O 1.232 0.157 0 C-N-CA 121.245 -0.182 . . . . 0.0 111.401 -179.749 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 60.4 42.0 98.75 Favored Glycine 0 C--N 1.336 0.541 0 C-N-CA 120.852 -0.69 . . . . 0.0 112.573 -179.93 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.652 HG21 ' N ' ' A' ' 20' ' ' GLN . 2.8 pt -63.41 -31.59 53.43 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.258 0 N-CA-C 111.723 0.268 . . . . 0.0 111.723 -179.815 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 3.6 m-70 -73.13 -59.64 2.06 Favored Pre-proline 0 CA--C 1.532 0.287 0 CA-C-N 116.743 -0.208 . . . . 0.0 110.862 179.673 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 64.5 Cg_endo -73.81 110.64 3.12 Favored 'Trans proline' 0 C--N 1.352 0.743 0 C-N-CA 122.509 2.139 . . . . 0.0 112.7 179.843 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 76' ' ' PRO . . . . . 0.406 ' O ' ' HB2' ' A' ' 77' ' ' GLU . 57.1 Cg_endo -70.5 116.68 4.74 Favored 'Trans proline' 0 C--N 1.348 0.545 0 C-N-CA 122.708 2.272 . . . . 0.0 112.279 179.924 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 77' ' ' GLU . . . . . 0.406 ' HB2' ' O ' ' A' ' 76' ' ' PRO . 36.7 mt-10 67.33 163.55 0.13 Allowed Pre-proline 0 N--CA 1.468 0.427 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.288 -179.766 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -53.92 127.35 25.26 Favored 'Trans proline' 0 C--N 1.353 0.773 0 C-N-CA 122.853 2.369 . . . . 0.0 112.484 -179.861 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 15.5 tt -126.91 150.29 32.67 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.299 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.666 -179.513 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -151.87 170.87 18.75 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.346 -179.999 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -147.66 105.47 3.71 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-N 116.286 -0.416 . . . . 0.0 111.073 179.855 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -134.33 126.98 30.79 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.079 -179.998 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.156 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.948 179.762 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 84' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.488 1.469 0 CA-C-O 120.467 0.175 . . . . 0.0 111.304 . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.464 ' O ' HG13 ' A' ' 2' ' ' VAL . 11.5 p -82.46 117.89 29.21 Favored 'Isoleucine or valine' 0 C--O 1.233 0.189 0 CA-C-O 120.956 0.408 . . . . 0.0 111.246 -179.979 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 60.5 p -99.7 167.52 10.51 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.846 179.87 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -153.9 156.01 36.75 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.027 -179.97 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 25.7 m-85 -106.72 -74.04 0.67 Allowed 'General case' 0 C--O 1.232 0.166 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.325 -179.843 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -131.78 169.22 16.52 Favored 'General case' 0 C--O 1.234 0.279 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.152 -179.695 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 1.5 pt-20 -105.88 138.22 42.44 Favored 'General case' 0 C--O 1.232 0.166 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.234 179.987 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 31.3 mm -101.38 154.96 4.7 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.196 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.053 179.916 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 16.0 tt0 -109.18 130.3 55.49 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.947 179.94 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 18.7 tt -60.58 -31.3 48.65 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.262 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.244 179.632 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 3.1 tt0 -59.98 -31.81 70.25 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.107 179.543 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -96.26 37.12 1.27 Allowed 'General case' 0 CA--C 1.533 0.312 0 CA-C-O 120.81 0.338 . . . . 0.0 111.112 179.823 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' MET . . . . . 0.463 ' HE3' HG21 ' A' ' 57' ' ' VAL . 32.4 mtt -127.89 137.0 52.16 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-N 116.478 -0.328 . . . . 0.0 110.653 179.733 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 2.6 m -61.17 116.97 4.99 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.765 -179.847 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 23.5 p90 -86.44 134.05 33.72 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.904 -179.946 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -118.96 94.1 47.67 Favored Pre-proline 0 C--O 1.234 0.256 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.646 179.946 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_endo -68.34 -12.83 36.09 Favored 'Trans proline' 0 C--N 1.346 0.413 0 C-N-CA 122.76 2.307 . . . . 0.0 113.122 -179.926 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -54.75 -44.18 73.37 Favored 'General case' 0 CA--C 1.53 0.191 0 CA-C-N 116.812 -0.176 . . . . 0.0 111.138 -179.942 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 14.7 m-20 -144.85 24.3 1.51 Allowed 'General case' 0 CA--C 1.534 0.337 0 CA-C-N 116.435 -0.348 . . . . 0.0 111.555 179.723 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' GLN . . . . . 0.638 ' CG ' HD12 ' A' ' 36' ' ' LEU . 2.3 tp60 56.86 69.01 0.78 Allowed 'General case' 0 CA--C 1.532 0.285 0 CA-C-O 120.827 0.346 . . . . 0.0 111.7 179.561 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 11.7 ptp -141.89 150.15 41.15 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.352 -0.386 . . . . 0.0 111.139 179.662 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 7.7 m-85 -120.2 143.9 48.0 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.79 -179.941 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 58.0 p -126.68 146.69 50.1 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.232 -179.897 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 4.6 t80 -135.73 95.07 14.32 Favored Pre-proline 0 C--N 1.332 -0.177 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.605 179.815 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.415 ' HA ' ' HA ' ' A' ' 31' ' ' ARG . 54.4 Cg_exo -52.13 94.31 0.03 OUTLIER 'Trans proline' 0 C--N 1.349 0.59 0 C-N-CA 122.867 2.378 . . . . 0.0 112.309 -179.932 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 29.5 t -65.38 135.63 96.03 Favored Pre-proline 0 C--O 1.233 0.224 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.792 -179.778 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -60.17 -17.49 46.16 Favored 'Trans proline' 0 C--N 1.349 0.564 0 C-N-CA 122.731 2.288 . . . . 0.0 112.861 179.684 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 3.6 p -58.72 -30.33 67.37 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-O 120.556 0.217 . . . . 0.0 111.346 179.769 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 138.64 -15.28 3.37 Favored Glycine 0 CA--C 1.523 0.577 0 C-N-CA 120.945 -0.645 . . . . 0.0 113.28 -179.897 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 3.2 t0 -113.83 -166.55 1.1 Allowed 'General case' 0 CA--C 1.534 0.333 0 CA-C-N 117.036 0.418 . . . . 0.0 111.216 -179.804 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' ARG . . . . . 0.415 ' HA ' ' HA ' ' A' ' 25' ' ' PRO . 16.2 ttp-105 -129.32 153.62 47.67 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.059 -179.804 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -91.27 167.02 12.62 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-N 116.09 -0.504 . . . . 0.0 111.074 179.754 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -157.58 113.76 2.87 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.885 179.608 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.408 ' CD1' ' HG3' ' A' ' 39' ' ' MET . 5.3 tt -144.37 126.54 10.43 Favored 'Isoleucine or valine' 0 C--O 1.234 0.238 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.134 -179.876 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 37.2 m-85 -81.3 155.53 25.98 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.759 -179.994 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.638 HD12 ' CG ' ' A' ' 20' ' ' GLN . 24.2 mt -58.19 -37.33 74.55 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.055 179.762 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -59.57 -40.99 89.17 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 116.387 -0.37 . . . . 0.0 110.861 179.598 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 2.7 t0 -64.08 -39.16 93.45 Favored 'General case' 0 CA--C 1.528 0.112 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.565 179.525 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' MET . . . . . 0.408 ' HG3' ' CD1' ' A' ' 34' ' ' ILE . 28.2 mtm -93.1 30.94 1.52 Allowed 'General case' 0 CA--C 1.532 0.279 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.115 179.467 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 16.9 t80 -131.42 -47.32 0.98 Allowed 'General case' 0 C--O 1.232 0.181 0 CA-C-N 116.547 -0.297 . . . . 0.0 110.799 179.793 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 13.5 mt-10 -58.0 -36.95 73.39 Favored 'General case' 0 CA--C 1.53 0.179 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.17 179.731 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 151.87 68.26 0.01 OUTLIER Glycine 0 C--N 1.336 0.534 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.849 179.709 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 12.8 tt0 -130.37 157.91 41.28 Favored 'General case' 0 N--CA 1.462 0.152 0 CA-C-O 120.787 0.327 . . . . 0.0 111.436 179.966 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 1.8 mtmt -154.98 -45.98 0.08 Allowed 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.016 179.873 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 5.4 m -99.32 115.27 39.64 Favored 'Isoleucine or valine' 0 C--O 1.233 0.216 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.089 -179.99 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -109.15 149.99 28.53 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.152 -179.912 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 12.8 m -109.68 135.33 48.96 Favored 'Isoleucine or valine' 0 C--O 1.233 0.207 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.388 -179.898 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 50.8 t -75.94 135.96 70.29 Favored Pre-proline 0 C--O 1.233 0.229 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.018 -179.918 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 83.7 Cg_endo -83.91 19.17 1.4 Allowed 'Trans proline' 0 CA--C 1.535 0.573 0 C-N-CA 122.719 2.279 . . . . 0.0 113.127 179.639 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 36.3 t -128.41 -58.31 1.19 Allowed 'General case' 0 C--O 1.232 0.162 0 CA-C-N 116.746 -0.206 . . . . 0.0 110.572 179.789 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 21.0 p -103.39 -18.99 14.59 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 116.398 -0.364 . . . . 0.0 111.695 179.879 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER 70.03 37.13 1.78 Allowed 'General case' 0 CA--C 1.533 0.304 0 CA-C-O 120.788 0.328 . . . . 0.0 111.106 -179.802 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 7.6 mt -75.38 142.35 43.12 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-N 116.396 -0.366 . . . . 0.0 110.643 179.712 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' MET . . . . . . . . . . . . . 22.5 mtt -96.01 113.85 25.5 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.972 -179.58 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 2.7 pp -131.56 162.37 39.53 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.285 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.608 -179.538 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -119.5 95.74 4.91 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.032 179.995 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.463 HG21 ' HE3' ' A' ' 13' ' ' MET . 15.0 p -89.31 128.82 41.13 Favored 'Isoleucine or valine' 0 C--O 1.234 0.251 0 CA-C-O 120.937 0.399 . . . . 0.0 111.251 179.728 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 14.0 p -91.68 152.7 3.34 Favored 'Isoleucine or valine' 0 C--O 1.234 0.239 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.142 179.93 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 15.8 p90 -136.58 174.96 10.05 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.116 -179.651 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -133.43 142.77 48.47 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.321 179.939 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.74 -41.78 62.05 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.746 179.559 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -59.44 -41.03 88.66 Favored 'General case' 0 N--CA 1.462 0.139 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.624 179.427 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -70.42 -46.68 63.44 Favored 'General case' 0 CA--C 1.528 0.121 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.988 179.695 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.497 ' HG ' HD22 ' A' ' 36' ' ' LEU . 0.2 OUTLIER -56.93 -39.36 74.35 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.187 179.882 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -76.41 -46.44 27.15 Favored 'General case' 0 C--O 1.232 0.142 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.264 179.923 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 31.4 mt-10 -58.61 -47.05 85.66 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 116.43 -0.35 . . . . 0.0 110.924 179.817 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 3.3 m-85 -58.06 -32.62 68.19 Favored 'General case' 0 C--N 1.334 -0.105 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.299 179.742 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -59.57 -34.92 73.3 Favored 'General case' 0 CA--C 1.528 0.128 0 CA-C-O 120.626 0.251 . . . . 0.0 110.988 179.666 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -91.99 -35.42 13.98 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.028 179.719 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 13.9 mt-10 -68.92 -35.59 77.0 Favored 'General case' 0 CA--C 1.53 0.197 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.134 179.774 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 71' ' ' ALA . . . . . 0.495 ' HB3' HD12 ' A' ' 73' ' ' ILE . . . -98.77 152.38 19.76 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-O 120.859 0.362 . . . . 0.0 111.182 179.965 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -87.95 78.46 1.79 Allowed Glycine 0 C--N 1.334 0.427 0 C-N-CA 121.052 -0.594 . . . . 0.0 112.53 -179.928 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.6 HD13 ' H ' ' A' ' 73' ' ' ILE . 0.2 OUTLIER -137.9 140.17 41.31 Favored 'Isoleucine or valine' 0 C--O 1.233 0.225 0 CA-C-O 120.835 0.35 . . . . 0.0 111.298 -179.858 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 5.7 m-70 -104.03 160.04 27.35 Favored Pre-proline 0 C--N 1.33 -0.246 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.838 179.844 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_endo -69.5 110.85 2.6 Favored 'Trans proline' 0 C--N 1.348 0.533 0 C-N-CA 122.569 2.179 . . . . 0.0 112.371 179.988 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -70.39 166.59 27.88 Favored 'Trans proline' 0 C--N 1.347 0.462 0 C-N-CA 122.45 2.1 . . . . 0.0 112.201 179.799 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 3.2 mt-10 -114.96 86.42 13.46 Favored Pre-proline 0 C--N 1.331 -0.217 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.531 179.84 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -54.66 87.93 0.03 OUTLIER 'Trans proline' 0 C--N 1.352 0.731 0 C-N-CA 123.034 2.49 . . . . 0.0 112.446 -179.844 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 3.3 tt -111.37 -40.68 3.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 115.87 -0.604 . . . . 0.0 111.343 -179.71 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . 66.44 157.25 0.11 Allowed 'General case' 0 C--O 1.233 0.232 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.403 179.94 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -89.57 95.69 10.37 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.849 179.85 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . 62.0 76.49 0.37 Allowed 'General case' 0 C--O 1.234 0.271 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.269 -179.867 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.166 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.968 179.928 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 84' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 47.3 mtt . . . . . 0 N--CA 1.491 1.612 0 CA-C-O 120.398 0.142 . . . . 0.0 111.3 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 18.4 m -86.66 154.43 3.36 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.309 0 CA-C-O 120.664 0.269 . . . . 0.0 111.507 179.972 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 50.7 m -149.74 123.04 8.98 Favored 'General case' 0 CA--C 1.53 0.208 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.925 179.936 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.428 HG21 ' CG ' ' A' ' 56' ' ' ASP . 0.9 OUTLIER -110.02 160.95 15.98 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-O 120.98 0.419 . . . . 0.0 111.348 -179.814 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 5' ' ' TYR . . . . . 0.488 ' HB2' HD21 ' A' ' 53' ' ' LEU . 92.2 m-85 -107.87 -37.47 6.1 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-N 115.873 -0.603 . . . . 0.0 111.359 179.841 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -144.94 161.45 39.31 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-O 120.814 0.34 . . . . 0.0 111.393 179.923 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 7' ' ' GLU . . . . . 0.427 ' HG2' ' HB2' ' A' ' 56' ' ' ASP . 28.5 mt-10 -141.1 143.73 34.49 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.146 -179.888 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 3.8 mp -137.84 152.33 26.46 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.424 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.11 179.83 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -97.97 154.06 17.94 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 116.442 -0.345 . . . . 0.0 110.921 179.389 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.47 HD12 ' HA ' ' A' ' 59' ' ' PHE . 0.2 OUTLIER -54.65 -29.6 21.03 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.588 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.626 179.747 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 9.6 tt0 -56.25 -39.0 71.88 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-N 116.58 -0.282 . . . . 0.0 111.041 179.529 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -94.93 29.63 2.33 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-N 116.455 -0.339 . . . . 0.0 111.561 -179.817 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -114.71 136.69 52.79 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-O 120.577 0.227 . . . . 0.0 110.904 -179.961 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 25.6 m -71.8 102.54 2.87 Favored 'General case' 0 C--O 1.232 0.138 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.487 179.609 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 30.6 p90 -80.57 132.0 35.59 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.017 -179.788 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' GLU . . . . . 0.415 ' HB2' ' HG3' ' A' ' 21' ' ' MET . 53.2 mm-40 -108.95 95.08 16.17 Favored Pre-proline 0 C--O 1.234 0.28 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.618 179.916 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 67.0 Cg_endo -74.53 59.46 4.82 Favored 'Trans proline' 0 C--N 1.347 0.491 0 C-N-CA 122.615 2.21 . . . . 0.0 112.366 179.945 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -128.23 -49.19 1.31 Allowed 'General case' 0 CA--C 1.53 0.196 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.906 -179.914 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 16.0 m-80 -139.11 28.94 2.27 Favored 'General case' 0 CA--C 1.534 0.356 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.009 179.582 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' GLN . . . . . 0.81 ' HG2' HG21 ' A' ' 73' ' ' ILE . 3.6 mm100 58.88 61.91 2.03 Favored 'General case' 0 CA--C 1.535 0.401 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.609 179.489 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 21' ' ' MET . . . . . 0.415 ' HG3' ' HB2' ' A' ' 16' ' ' GLU . 20.8 ptp -134.7 141.18 46.46 Favored 'General case' 0 CA--C 1.531 0.227 0 CA-C-N 116.33 -0.396 . . . . 0.0 110.992 179.755 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 3.9 m-85 -111.23 125.68 54.06 Favored 'General case' 0 N--CA 1.463 0.176 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.492 179.713 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 29.6 p -117.27 160.85 20.44 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.329 -179.715 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 29.6 t80 -157.4 136.36 8.0 Favored Pre-proline 0 N--CA 1.463 0.175 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.018 -179.971 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -70.41 93.0 0.58 Allowed 'Trans proline' 0 C--N 1.347 0.448 0 C-N-CA 122.405 2.07 . . . . 0.0 111.989 179.421 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' CYS . . . . . 0.447 ' SG ' ' HD2' ' A' ' 27' ' ' PRO . 42.3 t -56.6 139.27 75.92 Favored Pre-proline 0 C--O 1.234 0.243 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.664 -179.968 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 27' ' ' PRO . . . . . 0.447 ' HD2' ' SG ' ' A' ' 26' ' ' CYS . 9.9 Cg_endo -53.23 -25.96 32.16 Favored 'Trans proline' 0 C--N 1.347 0.497 0 C-N-CA 122.926 2.418 . . . . 0.0 113.031 179.997 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 28' ' ' CYS . . . . . 0.411 ' CB ' ' HB3' ' A' ' 51' ' ' CYS . 0.6 OUTLIER -74.72 -39.43 61.9 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-O 120.461 0.172 . . . . 0.0 111.352 -179.898 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 150.04 -38.33 0.91 Allowed Glycine 0 C--N 1.334 0.467 0 C-N-CA 120.859 -0.686 . . . . 0.0 113.004 -179.802 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -72.04 -176.66 1.8 Allowed 'General case' 0 CA--C 1.533 0.321 0 CA-C-O 120.818 0.342 . . . . 0.0 111.215 -179.861 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 5.4 ttp-105 -116.7 123.67 47.8 Favored 'General case' 0 C--O 1.232 0.173 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.282 -179.375 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -73.65 99.95 3.23 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.643 179.534 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 9.7 mt-30 -92.98 136.39 33.3 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-N 116.474 -0.33 . . . . 0.0 111.208 -179.731 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.454 ' O ' HG23 ' A' ' 34' ' ' ILE . 1.0 OUTLIER -155.69 119.04 0.44 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.294 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.868 179.849 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 79.9 m-85 -81.86 159.07 23.8 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 116.444 -0.344 . . . . 0.0 110.934 -179.749 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.562 HD22 ' HG ' ' A' ' 64' ' ' LEU . 62.8 mt -55.16 -40.28 70.47 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.071 179.857 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 22.1 m-20 -60.38 -45.58 93.05 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-O 120.57 0.224 . . . . 0.0 110.555 179.395 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 64.5 m-20 -60.31 -43.52 96.28 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.139 179.132 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' MET . . . . . 0.424 ' HG2' ' HA ' ' A' ' 36' ' ' LEU . 1.8 ptm -90.77 36.79 0.91 Allowed 'General case' 0 CA--C 1.536 0.434 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.2 179.475 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 18.2 t80 -139.84 -49.89 0.48 Allowed 'General case' 0 CA--C 1.53 0.192 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.71 179.42 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 2.2 mm-40 -59.74 -35.88 75.47 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 116.526 -0.306 . . . . 0.0 110.911 179.613 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 140.59 52.28 0.04 OUTLIER Glycine 0 C--N 1.335 0.491 0 C-N-CA 120.951 -0.642 . . . . 0.0 113.015 179.568 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -129.03 102.3 6.44 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-O 120.796 0.332 . . . . 0.0 111.287 179.969 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.448 ' HG2' ' CE2' ' A' ' 59' ' ' PHE . 12.8 mttt -113.74 -34.98 5.31 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.02 179.723 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 29.7 t -79.12 79.11 0.9 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.238 0 CA-C-O 120.986 0.422 . . . . 0.0 110.565 179.849 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -87.56 151.54 22.91 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.333 -179.802 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 11.8 p -133.24 130.03 57.31 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.026 179.88 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 37.7 t -73.64 115.32 40.62 Favored Pre-proline 0 C--N 1.331 -0.238 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.312 179.859 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_exo -57.2 -21.63 44.32 Favored 'Trans proline' 0 CA--C 1.533 0.455 0 C-N-CA 122.703 2.269 . . . . 0.0 113.049 -179.996 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -76.25 -66.99 0.73 Allowed 'General case' 0 CA--C 1.533 0.294 0 N-CA-C 111.236 0.087 . . . . 0.0 111.236 -179.814 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 51' ' ' CYS . . . . . 0.411 ' HB3' ' CB ' ' A' ' 28' ' ' CYS . 27.4 p -81.7 -22.02 37.67 Favored 'General case' 0 N--CA 1.469 0.491 0 N-CA-C 111.991 0.367 . . . . 0.0 111.991 -179.826 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 1.3 t 69.65 37.88 1.81 Allowed 'General case' 0 CA--C 1.534 0.347 0 CA-C-O 120.802 0.334 . . . . 0.0 111.204 -179.762 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.488 HD21 ' HB2' ' A' ' 5' ' ' TYR . 2.8 tt -106.27 127.21 53.07 Favored 'General case' 0 CA--C 1.53 0.183 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.894 179.832 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 54' ' ' MET . . . . . . . . . . . . . 24.6 mtt -84.12 142.18 30.56 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.428 -179.467 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 2.8 pp -142.78 163.77 17.24 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.298 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.595 179.917 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' ASP . . . . . 0.428 ' CG ' HG21 ' A' ' 4' ' ' THR . 75.3 m-20 -115.9 106.91 14.34 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.704 179.03 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.462 ' O ' HG13 ' A' ' 57' ' ' VAL . 11.2 p -97.78 115.11 36.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-O 120.992 0.425 . . . . 0.0 110.624 179.59 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 14.4 p -81.95 125.46 39.75 Favored 'Isoleucine or valine' 0 C--O 1.233 0.199 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.032 -179.646 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' PHE . . . . . 0.47 ' HA ' HD12 ' A' ' 10' ' ' ILE . 11.3 p90 -136.7 167.61 21.09 Favored 'General case' 0 CA--C 1.531 0.218 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.465 -179.494 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 3.4 t0 -113.63 175.69 5.35 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.054 179.708 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 3.1 ttmt -100.23 -41.0 7.27 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.229 -179.958 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -59.36 -35.48 73.97 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 116.461 -0.336 . . . . 0.0 111.076 179.794 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 2.8 t0 -54.24 -43.27 70.76 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.168 -179.913 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.562 ' HG ' HD22 ' A' ' 36' ' ' LEU . 4.3 mp -60.22 -51.81 67.97 Favored 'General case' 0 N--CA 1.462 0.146 0 CA-C-N 116.444 -0.344 . . . . 0.0 110.903 179.877 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -53.84 -42.04 68.07 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-N 116.4 -0.363 . . . . 0.0 111.092 179.69 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 16.9 mm-40 -72.53 -41.28 66.03 Favored 'General case' 0 CA--C 1.528 0.132 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.018 179.579 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -61.0 -35.09 75.92 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 116.524 -0.307 . . . . 0.0 111.636 -179.877 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 3.8 m-85 -56.82 -52.19 66.03 Favored 'General case' 0 N--CA 1.462 0.154 0 CA-C-N 116.704 -0.226 . . . . 0.0 110.829 -179.967 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -75.59 -35.16 60.63 Favored 'General case' 0 CA--C 1.53 0.196 0 CA-C-N 116.542 -0.299 . . . . 0.0 111.013 179.711 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 1.8 mm-40 -61.0 -47.77 84.92 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-N 116.481 -0.327 . . . . 0.0 111.2 -179.958 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -81.91 149.8 28.06 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-O 120.842 0.353 . . . . 0.0 111.146 179.914 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -95.74 31.37 7.28 Favored Glycine 0 C--N 1.332 0.336 0 C-N-CA 121.127 -0.558 . . . . 0.0 112.499 179.7 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.81 HG21 ' HG2' ' A' ' 20' ' ' GLN . 2.2 pp -63.53 130.46 28.35 Favored 'Isoleucine or valine' 0 C--O 1.233 0.196 0 CA-C-O 120.718 0.294 . . . . 0.0 111.005 179.964 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -120.35 88.43 42.13 Favored Pre-proline 0 C--N 1.33 -0.242 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.93 -179.675 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 75' ' ' PRO . . . . . 0.58 ' HD3' HD12 ' A' ' 73' ' ' ILE . 52.6 Cg_exo -53.7 151.26 25.95 Favored 'Trans proline' 0 C--N 1.347 0.452 0 C-N-CA 122.859 2.373 . . . . 0.0 112.806 -179.873 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_endo -69.46 101.19 0.84 Allowed 'Trans proline' 0 C--N 1.349 0.596 0 C-N-CA 122.87 2.38 . . . . 0.0 112.585 -179.747 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 15.8 mt-10 -146.7 88.66 5.97 Favored Pre-proline 0 CA--C 1.534 0.347 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.139 -179.911 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_exo -56.55 153.97 32.83 Favored 'Trans proline' 0 C--N 1.35 0.654 0 C-N-CA 123.128 2.552 . . . . 0.0 113.004 -179.774 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 3.5 pt -137.1 30.69 0.65 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.433 0 CA-C-N 116.12 -0.491 . . . . 0.0 112.171 -179.856 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -162.21 130.73 4.16 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-O 120.673 0.273 . . . . 0.0 111.731 179.76 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -143.85 34.47 1.26 Allowed 'General case' 0 C--O 1.233 0.224 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.332 179.493 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -140.46 -58.07 0.53 Allowed 'General case' 0 CA--C 1.528 0.129 0 CA-C-N 116.499 -0.319 . . . . 0.0 111.108 179.712 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.106 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.019 179.839 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 84' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 13.0 mtm . . . . . 0 N--CA 1.491 1.582 0 CA-C-O 120.667 0.27 . . . . 0.0 111.178 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 11.1 p -132.22 130.98 60.95 Favored 'Isoleucine or valine' 0 C--O 1.233 0.225 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.146 -179.967 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 4.8 t -94.59 158.15 15.66 Favored 'General case' 0 C--O 1.232 0.184 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.873 179.944 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 81.8 p -149.65 144.02 25.88 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.377 -179.74 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' TYR . . . . . 0.517 ' CD1' HD11 ' A' ' 53' ' ' LEU . 18.7 m-85 -109.13 -38.89 5.43 Favored 'General case' 0 CA--C 1.531 0.217 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.198 179.702 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -157.02 175.14 14.49 Favored 'General case' 0 C--O 1.234 0.284 0 CA-C-N 116.484 -0.325 . . . . 0.0 111.244 179.881 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 2.6 pt-20 -135.24 125.98 27.25 Favored 'General case' 0 CA--C 1.53 0.189 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.122 179.856 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 4.6 mt -119.86 152.4 22.55 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.241 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.182 -179.745 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' GLU . . . . . 0.556 ' HA ' HG12 ' A' ' 58' ' ' VAL . 16.5 mt-10 -97.94 147.71 24.2 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.254 -179.998 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 8.0 tp -58.38 -31.37 42.74 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.238 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.138 179.476 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -59.32 -32.81 70.41 Favored 'General case' 0 CA--C 1.531 0.218 0 CA-C-N 116.551 -0.295 . . . . 0.0 110.934 179.603 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 5.5 t0 -97.57 36.09 1.55 Allowed 'General case' 0 CA--C 1.532 0.276 0 CA-C-O 120.914 0.387 . . . . 0.0 110.964 179.65 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -121.01 156.93 31.08 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.688 179.831 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 24.4 m -81.44 150.09 28.49 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.586 179.839 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 16.0 p90 -120.87 144.8 48.19 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.819 179.851 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -118.17 88.71 33.16 Favored Pre-proline 0 C--O 1.235 0.309 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.743 179.91 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 16.8 Cg_exo -68.27 72.47 0.85 Allowed 'Trans proline' 0 C--N 1.35 0.634 0 C-N-CA 122.98 2.453 . . . . 0.0 112.387 -179.711 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 1.1 pp20? -151.85 -50.39 0.11 Allowed 'General case' 0 C--O 1.233 0.212 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.992 179.907 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 20.8 m-20 -129.74 26.95 5.26 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-O 120.666 0.269 . . . . 0.0 111.223 179.495 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' GLN . . . . . 0.505 ' HG3' HD23 ' A' ' 36' ' ' LEU . 0.0 OUTLIER 56.82 54.64 6.96 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-O 120.992 0.425 . . . . 0.0 111.439 179.82 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 10.2 ptm -133.71 154.12 51.19 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.919 179.619 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 5.9 m-85 -119.06 147.69 43.85 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.081 -0.508 . . . . 0.0 111.052 -179.727 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' THR . . . . . 0.411 ' HA ' ' O ' ' A' ' 32' ' ' PHE . 20.5 p -123.35 173.79 7.74 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.141 -0.482 . . . . 0.0 111.209 179.918 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 60.8 t80 -172.12 99.83 0.37 Allowed Pre-proline 0 C--O 1.232 0.136 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.683 179.962 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_exo -51.21 99.76 0.04 OUTLIER 'Trans proline' 0 C--N 1.349 0.572 0 C-N-CA 122.684 2.256 . . . . 0.0 112.094 -179.905 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 45.9 t -60.53 138.38 92.63 Favored Pre-proline 0 C--N 1.331 -0.218 0 CA-C-N 116.053 -0.522 . . . . 0.0 110.776 -179.761 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 70.3 Cg_exo -51.84 -24.78 19.45 Favored 'Trans proline' 0 C--N 1.348 0.542 0 C-N-CA 122.695 2.263 . . . . 0.0 112.818 179.828 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 1.1 p -66.96 -37.96 85.24 Favored 'General case' 0 CA--C 1.533 0.305 0 CA-C-O 120.526 0.203 . . . . 0.0 111.221 179.902 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 151.88 -44.61 0.64 Allowed Glycine 0 C--N 1.335 0.498 0 C-N-CA 120.8 -0.714 . . . . 0.0 112.955 -179.996 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -72.34 -173.0 1.01 Allowed 'General case' 0 CA--C 1.532 0.278 0 CA-C-O 120.687 0.279 . . . . 0.0 111.337 -179.799 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 33.0 ttm180 -129.5 124.15 33.27 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-O 120.698 0.285 . . . . 0.0 111.052 -179.813 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 32' ' ' PHE . . . . . 0.411 ' O ' ' HA ' ' A' ' 23' ' ' THR . 1.8 m-85 -61.18 155.64 20.29 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.878 179.664 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 3.8 pt20 -147.16 112.02 5.38 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-N 116.376 -0.375 . . . . 0.0 111.15 179.763 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.404 ' CD1' ' HG2' ' A' ' 39' ' ' MET . 2.4 tt -140.48 134.91 35.0 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.955 179.904 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 8.5 m-85 -87.92 161.91 17.19 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.939 -179.811 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.505 HD23 ' HG3' ' A' ' 20' ' ' GLN . 4.0 mm? -60.63 -46.05 91.76 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.136 -179.991 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -60.57 -36.59 78.88 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-O 120.717 0.294 . . . . 0.0 110.769 179.425 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -60.68 -41.38 94.99 Favored 'General case' 0 C--N 1.334 -0.075 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.535 179.635 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 39' ' ' MET . . . . . 0.404 ' HG2' ' CD1' ' A' ' 34' ' ' ILE . 4.6 mmm -91.78 29.64 1.52 Allowed 'General case' 0 CA--C 1.535 0.401 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.089 179.303 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 40' ' ' PHE . . . . . 0.66 ' HB2' HD21 ' A' ' 64' ' ' LEU . 16.9 t80 -126.26 -43.54 1.78 Allowed 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 116.499 -0.318 . . . . 0.0 111.174 179.734 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -59.4 -68.13 0.31 Allowed 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 116.519 -0.31 . . . . 0.0 111.477 -179.467 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -169.62 55.76 0.2 Allowed Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.544 -0.836 . . . . 0.0 112.508 -179.761 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -110.15 160.31 16.59 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.834 0.35 . . . . 0.0 111.073 -179.866 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -163.83 -45.13 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.912 -0.585 . . . . 0.0 111.656 179.953 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.482 HG13 ' O ' ' A' ' 45' ' ' VAL . 8.9 p -116.67 112.68 40.36 Favored 'Isoleucine or valine' 0 C--O 1.233 0.224 0 CA-C-O 120.977 0.418 . . . . 0.0 111.101 -179.876 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -95.31 168.23 10.86 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.53 -179.589 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 18.6 t -139.74 125.79 22.29 Favored 'Isoleucine or valine' 0 C--O 1.232 0.173 0 CA-C-N 115.98 -0.554 . . . . 0.0 111.205 -179.855 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 42.5 t -73.73 114.58 33.7 Favored Pre-proline 0 C--N 1.331 -0.207 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.267 179.573 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_exo -59.24 -20.5 55.44 Favored 'Trans proline' 0 C--N 1.346 0.414 0 C-N-CA 122.569 2.179 . . . . 0.0 112.875 179.946 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -75.75 -67.32 0.68 Allowed 'General case' 0 CA--C 1.531 0.226 0 CA-C-N 116.789 -0.187 . . . . 0.0 111.316 -179.711 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 23.9 p -83.62 -22.42 32.23 Favored 'General case' 0 N--CA 1.466 0.37 0 N-CA-C 111.933 0.346 . . . . 0.0 111.933 -179.706 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER 70.79 39.42 1.08 Allowed 'General case' 0 CA--C 1.533 0.292 0 CA-C-O 120.891 0.377 . . . . 0.0 110.863 -179.678 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.517 HD11 ' CD1' ' A' ' 5' ' ' TYR . 7.4 tp -100.98 143.57 30.96 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.958 179.982 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 54' ' ' MET . . . . . . . . . . . . . 42.2 mtt -95.19 138.09 33.37 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.089 -179.827 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.426 ' O ' HG23 ' A' ' 45' ' ' VAL . 2.5 pp -148.08 145.07 18.86 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.259 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.653 -179.884 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -92.77 104.89 17.11 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.688 179.411 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.494 ' O ' HG13 ' A' ' 57' ' ' VAL . 13.4 p -108.42 112.96 42.61 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-O 121.036 0.446 . . . . 0.0 111.167 179.717 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.556 HG12 ' HA ' ' A' ' 9' ' ' GLU . 14.5 p -83.61 150.42 4.18 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.28 -179.759 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 47.2 p90 -119.36 177.84 4.76 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.224 -179.846 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 60' ' ' ASP . . . . . 0.426 ' O ' HD13 ' A' ' 64' ' ' LEU . 4.7 m-20 -121.96 172.83 7.92 Favored 'General case' 0 C--O 1.232 0.159 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.109 179.793 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 16.1 mmtt -105.6 -46.32 4.2 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.789 179.647 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -66.44 -40.75 89.66 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.894 179.774 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -57.94 -37.63 74.46 Favored 'General case' 0 N--CA 1.462 0.156 0 CA-C-N 116.554 -0.294 . . . . 0.0 111.203 179.913 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.66 HD21 ' HB2' ' A' ' 40' ' ' PHE . 0.4 OUTLIER -60.53 -41.0 93.53 Favored 'General case' 0 CA--C 1.53 0.189 0 CA-C-N 116.664 -0.244 . . . . 0.0 111.022 179.896 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -82.5 -42.96 17.77 Favored 'General case' 0 C--O 1.232 0.173 0 CA-C-N 116.485 -0.325 . . . . 0.0 111.015 179.687 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -61.18 -50.55 72.67 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.653 179.836 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 55.3 t80 -63.2 -31.86 73.12 Favored 'General case' 0 CA--C 1.53 0.196 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.331 179.649 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 2.0 t80 -61.93 -59.73 4.67 Favored 'General case' 0 C--O 1.232 0.143 0 CA-C-O 120.545 0.212 . . . . 0.0 110.851 179.918 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 2.1 tp10 -63.56 -35.33 80.14 Favored 'General case' 0 N--CA 1.462 0.17 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.388 -179.977 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 25.4 mt-10 -71.65 -36.47 70.69 Favored 'General case' 0 CA--C 1.53 0.179 0 CA-C-N 116.544 -0.298 . . . . 0.0 111.371 -179.893 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -79.61 -40.72 28.66 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 120.589 0.233 . . . . 0.0 111.353 180.0 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 66.1 62.22 4.86 Favored Glycine 0 C--N 1.335 0.528 0 C-N-CA 120.985 -0.626 . . . . 0.0 112.724 179.844 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 9.1 tp -58.08 -35.14 51.32 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.229 0 CA-C-O 120.556 0.217 . . . . 0.0 111.547 -179.991 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 9.7 m80 -98.41 149.41 35.71 Favored Pre-proline 0 C--O 1.234 0.237 0 CA-C-N 116.502 -0.317 . . . . 0.0 110.698 179.601 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo -53.83 152.72 21.94 Favored 'Trans proline' 0 C--N 1.35 0.635 0 C-N-CA 122.873 2.382 . . . . 0.0 112.665 -179.999 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 41.0 Cg_endo -67.02 -31.7 36.51 Favored 'Trans proline' 0 C--N 1.348 0.506 0 C-N-CA 122.526 2.15 . . . . 0.0 112.504 179.768 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 77' ' ' GLU . . . . . 0.609 ' O ' ' HB2' ' A' ' 81' ' ' ALA . 0.2 OUTLIER -141.67 87.16 10.32 Favored Pre-proline 0 C--O 1.232 0.168 0 CA-C-N 116.544 -0.298 . . . . 0.0 111.018 -179.981 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -69.98 -178.59 2.5 Favored 'Trans proline' 0 C--N 1.347 0.486 0 C-N-CA 122.576 2.184 . . . . 0.0 112.348 179.994 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 33.7 mt 68.44 102.35 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.339 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.618 -179.745 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . 60.08 37.6 20.96 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.075 -179.204 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 81' ' ' ALA . . . . . 0.609 ' HB2' ' O ' ' A' ' 77' ' ' GLU . . . -95.7 131.05 42.38 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.154 -179.965 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -80.23 164.67 23.06 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.114 179.893 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.331 -0.197 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.069 179.929 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 84' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 14.5 mtt . . . . . 0 N--CA 1.492 1.657 0 CA-C-O 120.654 0.264 . . . . 0.0 111.362 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 11.7 p -147.91 147.65 17.01 Favored 'Isoleucine or valine' 0 C--O 1.234 0.275 0 CA-C-N 116.558 -0.292 . . . . 0.0 111.28 -179.885 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 1.3 m -164.06 156.65 17.42 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.279 -179.918 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.437 HG21 ' CG ' ' A' ' 56' ' ' ASP . 0.8 OUTLIER -102.8 176.87 5.01 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.277 179.889 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 58.9 m-85 -98.95 -35.81 9.95 Favored 'General case' 0 CA--C 1.531 0.241 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.49 -179.891 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -158.85 173.55 16.36 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-O 120.759 0.314 . . . . 0.0 111.323 -179.92 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 2.7 tm-20 -138.58 122.72 18.03 Favored 'General case' 0 CA--C 1.531 0.24 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.879 -179.886 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 4.8 mt -126.21 152.36 33.5 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.338 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.114 -179.747 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 3.0 pt-20 -96.95 153.17 18.06 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.622 -179.99 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.464 HD13 ' CE ' ' A' ' 39' ' ' MET . 1.2 tp -62.99 -34.66 67.73 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.313 0 CA-C-N 115.947 -0.569 . . . . 0.0 111.36 179.58 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -58.74 -32.87 69.63 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-N 116.609 -0.269 . . . . 0.0 111.157 179.681 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -97.28 36.1 1.51 Allowed 'General case' 0 CA--C 1.537 0.47 0 CA-C-O 120.81 0.338 . . . . 0.0 111.311 179.783 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' MET . . . . . 0.409 ' HG3' ' HB2' ' A' ' 24' ' ' TYR . 1.7 ttt -121.54 148.83 43.98 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.888 179.787 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -69.33 126.93 31.3 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-O 120.826 0.346 . . . . 0.0 110.873 179.971 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 14.4 t80 -94.59 123.97 38.33 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.509 179.596 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 1.4 tp10 -108.96 92.1 10.2 Favored Pre-proline 0 C--O 1.234 0.256 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.314 179.499 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 64.3 Cg_endo -73.6 61.27 4.4 Favored 'Trans proline' 0 C--N 1.351 0.677 0 C-N-CA 122.793 2.329 . . . . 0.0 112.72 -179.44 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 19.1 pt-20 -131.44 -45.82 0.99 Allowed 'General case' 0 CA--C 1.533 0.302 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.885 179.772 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -141.71 32.13 1.63 Allowed 'General case' 0 CA--C 1.534 0.363 0 CA-C-N 116.515 -0.311 . . . . 0.0 111.057 179.406 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 91.3 mt-30 55.15 59.88 3.75 Favored 'General case' 0 C--O 1.236 0.363 0 CA-C-O 120.955 0.407 . . . . 0.0 111.413 179.931 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 9.6 ptp -130.41 148.72 52.25 Favored 'General case' 0 C--O 1.235 0.307 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.343 179.909 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 25.4 m-85 -124.6 102.89 7.84 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.896 179.994 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' THR . . . . . 0.415 HG22 ' HA ' ' A' ' 33' ' ' GLN . 66.9 p -101.54 166.83 10.5 Favored 'General case' 0 CA--C 1.532 0.261 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.84 -179.827 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 24' ' ' TYR . . . . . 0.409 ' HB2' ' HG3' ' A' ' 13' ' ' MET . 62.3 t80 -164.7 139.6 4.42 Favored Pre-proline 0 CA--C 1.531 0.235 0 CA-C-O 120.599 0.237 . . . . 0.0 111.377 179.774 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -53.2 121.79 10.03 Favored 'Trans proline' 0 C--N 1.352 0.724 0 C-N-CA 122.994 2.462 . . . . 0.0 113.144 -179.979 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' CYS . . . . . 0.461 ' SG ' ' HD2' ' A' ' 27' ' ' PRO . 42.1 t -90.64 140.3 26.57 Favored Pre-proline 0 C--N 1.331 -0.218 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.497 179.38 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 27' ' ' PRO . . . . . 0.461 ' HD2' ' SG ' ' A' ' 26' ' ' CYS . 73.8 Cg_exo -50.7 -27.82 20.92 Favored 'Trans proline' 0 C--N 1.349 0.587 0 C-N-CA 122.898 2.398 . . . . 0.0 113.026 179.536 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 28' ' ' CYS . . . . . 0.402 ' CB ' ' HB3' ' A' ' 51' ' ' CYS . 0.9 OUTLIER -69.51 -38.89 77.77 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-N 116.799 -0.182 . . . . 0.0 111.446 -179.959 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 151.92 -48.4 0.55 Allowed Glycine 0 C--N 1.336 0.57 0 C-N-CA 120.854 -0.689 . . . . 0.0 112.958 -179.933 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -73.96 -175.11 2.05 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-O 120.665 0.269 . . . . 0.0 110.966 179.984 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 19.5 mtt180 -118.72 134.66 54.98 Favored 'General case' 0 C--O 1.232 0.164 0 CA-C-O 120.677 0.275 . . . . 0.0 110.826 179.924 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 6.8 m-85 -62.23 168.0 3.7 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.811 179.653 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' GLN . . . . . 0.415 ' HA ' HG22 ' A' ' 23' ' ' THR . 5.8 tt0 -155.58 121.95 5.21 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-O 120.695 0.283 . . . . 0.0 111.274 179.882 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 5.8 tt -146.04 138.81 20.45 Favored 'Isoleucine or valine' 0 C--O 1.234 0.25 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.085 179.646 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 25.6 m-85 -95.58 155.49 16.72 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.993 179.992 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.838 HD22 ' HG ' ' A' ' 64' ' ' LEU . 87.9 mt -62.63 -39.84 95.11 Favored 'General case' 0 CA--C 1.53 0.199 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.016 179.72 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -66.2 -34.81 78.86 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 116.683 -0.235 . . . . 0.0 111.196 179.409 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -62.7 -57.99 9.06 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-O 120.918 0.389 . . . . 0.0 110.591 179.991 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 39' ' ' MET . . . . . 0.464 ' CE ' HD13 ' A' ' 10' ' ' ILE . 5.6 ptm -63.04 -34.62 77.97 Favored 'General case' 0 CA--C 1.534 0.343 0 CA-C-N 115.956 -0.565 . . . . 0.0 111.291 179.764 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 40' ' ' PHE . . . . . 0.405 ' HB2' ' CD2' ' A' ' 64' ' ' LEU . 31.6 t80 -61.14 -45.06 96.18 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-N 116.551 -0.295 . . . . 0.0 110.882 179.485 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 2.6 tp10 -56.0 -40.8 73.89 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.709 179.471 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 148.47 47.86 0.02 OUTLIER Glycine 0 C--N 1.335 0.49 0 C-N-CA 121.146 -0.55 . . . . 0.0 112.672 179.755 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 4.3 tt0 -112.4 123.19 49.73 Favored 'General case' 0 C--O 1.232 0.159 0 CA-C-O 120.826 0.346 . . . . 0.0 111.149 -179.795 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 19.4 mtmt -122.46 -43.75 2.27 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-N 115.917 -0.583 . . . . 0.0 111.026 179.726 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.483 HG13 ' O ' ' A' ' 45' ' ' VAL . 12.0 p -108.16 113.21 43.26 Favored 'Isoleucine or valine' 0 C--O 1.233 0.209 0 CA-C-O 121.011 0.434 . . . . 0.0 111.005 179.781 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -102.24 164.66 11.56 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.154 -179.815 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 11.6 p -124.49 129.09 73.93 Favored 'Isoleucine or valine' 0 C--O 1.233 0.207 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.227 -179.909 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 47.9 t -67.86 135.52 92.16 Favored Pre-proline 0 C--O 1.233 0.229 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.79 179.929 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 84.5 Cg_endo -83.54 21.09 1.08 Allowed 'Trans proline' 0 CA--C 1.537 0.639 0 C-N-CA 122.729 2.286 . . . . 0.0 113.056 179.777 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 7.7 t -129.07 -56.82 1.17 Allowed 'General case' 0 C--O 1.233 0.204 0 CA-C-N 116.615 -0.266 . . . . 0.0 110.512 179.768 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 51' ' ' CYS . . . . . 0.402 ' HB3' ' CB ' ' A' ' 28' ' ' CYS . 18.5 p -100.63 -10.59 20.79 Favored 'General case' 0 CA--C 1.538 0.481 0 N-CA-C 112.276 0.473 . . . . 0.0 112.276 179.924 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 6.5 p 60.24 35.85 20.87 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-O 120.863 0.363 . . . . 0.0 111.765 -179.903 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.599 HD23 HG23 ' A' ' 55' ' ' ILE . 6.6 tt -94.95 121.34 36.46 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.698 179.394 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 54' ' ' MET . . . . . . . . . . . . . 6.9 mtt -85.94 141.53 29.48 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.171 -179.712 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.599 HG23 HD23 ' A' ' 53' ' ' LEU . 3.8 pt -145.19 148.19 17.99 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.295 0 CA-C-N 115.934 -0.575 . . . . 0.0 111.495 179.997 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 56' ' ' ASP . . . . . 0.437 ' CG ' HG21 ' A' ' 4' ' ' THR . 72.3 m-20 -93.27 104.74 16.89 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.463 178.918 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.485 ' O ' HG13 ' A' ' 57' ' ' VAL . 12.5 p -100.22 112.37 32.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 121.057 0.456 . . . . 0.0 110.879 179.72 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 14.2 p -81.04 130.87 35.14 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.172 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.709 -179.852 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 42.1 p90 -133.41 176.96 8.06 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.29 -179.275 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 4.3 t70 -122.38 144.91 48.73 Favored 'General case' 0 N--CA 1.462 0.17 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.4 -179.923 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 11.7 mttp -76.7 -40.01 50.14 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.153 179.699 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 17.7 tt0 -58.43 -37.66 75.86 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 116.617 -0.265 . . . . 0.0 110.595 179.531 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 63' ' ' ASP . . . . . 0.478 ' HB3' ' CE2' ' A' ' 67' ' ' TYR . 3.4 m-20 -56.03 -43.87 78.2 Favored 'General case' 0 N--CA 1.463 0.19 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.954 179.425 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.838 ' HG ' HD22 ' A' ' 36' ' ' LEU . 3.0 mp -53.31 -53.41 51.4 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 116.469 -0.332 . . . . 0.0 111.185 179.987 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -56.24 -39.65 72.88 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 116.512 -0.313 . . . . 0.0 110.846 179.511 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -69.19 -39.74 78.49 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.05 179.367 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 67' ' ' TYR . . . . . 0.478 ' CE2' ' HB3' ' A' ' 63' ' ' ASP . 20.1 m-85 -69.12 -37.93 78.62 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 116.634 -0.257 . . . . 0.0 111.624 -179.861 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 5.7 m-85 -62.17 -38.25 88.35 Favored 'General case' 0 N--CA 1.463 0.211 0 C-N-CA 121.247 -0.181 . . . . 0.0 110.635 179.966 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -80.96 -36.26 31.13 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-N 116.48 -0.327 . . . . 0.0 111.084 179.262 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 5.7 mt-10 -72.28 -35.68 68.79 Favored 'General case' 0 N--CA 1.467 0.376 0 N-CA-C 111.681 0.252 . . . . 0.0 111.681 -179.834 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -87.42 -56.68 3.25 Favored 'General case' 0 C--O 1.233 0.215 0 N-CA-C 111.517 0.191 . . . . 0.0 111.517 -179.643 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 79.9 57.5 3.03 Favored Glycine 0 C--N 1.334 0.447 0 C-N-CA 120.89 -0.671 . . . . 0.0 112.782 179.98 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 10.7 tp -60.9 146.01 11.96 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.33 0 CA-C-O 120.753 0.311 . . . . 0.0 111.554 -179.932 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 55.4 m80 -99.15 160.83 26.64 Favored Pre-proline 0 C--O 1.234 0.262 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.796 179.511 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_exo -52.6 152.17 17.14 Favored 'Trans proline' 0 C--N 1.352 0.725 0 C-N-CA 122.928 2.418 . . . . 0.0 112.933 -179.779 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_endo -68.89 134.21 29.26 Favored 'Trans proline' 0 C--N 1.35 0.643 0 C-N-CA 122.685 2.257 . . . . 0.0 112.314 179.86 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER 61.18 86.11 0.16 Allowed Pre-proline 0 N--CA 1.466 0.327 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.258 -179.78 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_endo -68.61 111.32 2.53 Favored 'Trans proline' 0 C--N 1.349 0.563 0 C-N-CA 122.684 2.256 . . . . 0.0 112.312 179.949 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 21.4 mt 65.19 81.53 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.308 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.777 -179.651 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -104.78 92.91 4.46 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-N 115.801 -0.636 . . . . 0.0 111.281 -179.545 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . 69.29 151.83 0.09 Allowed 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.752 179.901 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . 63.61 100.78 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.511 -179.997 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.095 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.162 179.924 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 84' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 6.9 mtt . . . . . 0 N--CA 1.49 1.575 0 CA-C-O 120.68 0.276 . . . . 0.0 111.289 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 21.0 t -75.35 139.65 18.7 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.219 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.121 179.931 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 2.0 m -105.84 107.48 18.5 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.487 179.578 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.493 HG22 ' HA ' ' A' ' 55' ' ' ILE . 0.2 OUTLIER -153.35 178.73 9.46 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-N 116.262 -0.427 . . . . 0.0 111.477 -179.284 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 9.3 m-85 -106.68 -43.65 4.66 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.37 179.721 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 12.0 m-20 -151.74 175.53 12.31 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-O 120.782 0.325 . . . . 0.0 111.484 179.791 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 19.5 tt0 -128.0 122.62 32.73 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.443 179.514 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 28.5 mm -120.33 155.04 23.53 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.162 -179.584 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -112.55 150.98 30.56 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-N 116.308 -0.406 . . . . 0.0 111.292 179.867 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 2.8 tt -58.72 -31.89 45.38 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.331 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.239 179.576 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 17.8 mt-10 -66.24 -30.91 71.44 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-N 116.374 -0.375 . . . . 0.0 111.106 179.501 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 3.3 t70 -98.03 38.37 1.32 Allowed 'General case' 0 CA--C 1.533 0.313 0 CA-C-O 120.889 0.376 . . . . 0.0 111.052 179.816 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 1.8 mtp -128.39 156.17 43.56 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.782 179.778 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 8.7 m -87.4 108.2 18.89 Favored 'General case' 0 N--CA 1.462 0.15 0 CA-C-O 120.835 0.35 . . . . 0.0 110.952 -179.923 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' PHE . . . . . 0.419 ' HB3' ' CZ ' ' A' ' 22' ' ' PHE . 29.8 p90 -85.12 138.12 32.6 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.764 179.754 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 25.1 mt-10 -103.9 96.36 9.16 Favored Pre-proline 0 C--O 1.234 0.263 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.406 179.848 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -71.77 63.62 3.12 Favored 'Trans proline' 0 C--N 1.35 0.654 0 C-N-CA 122.812 2.342 . . . . 0.0 112.721 -179.497 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 7.1 pt-20 -135.14 -53.78 0.79 Allowed 'General case' 0 C--N 1.333 -0.144 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.741 179.535 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 71.6 m-20 -133.08 33.04 3.68 Favored 'General case' 0 CA--C 1.534 0.345 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.999 179.479 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' GLN . . . . . 0.546 ' OE1' HD11 ' A' ' 36' ' ' LEU . 25.4 mt-30 56.81 49.84 13.52 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-O 120.802 0.334 . . . . 0.0 111.287 179.936 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 9.6 ttp -122.62 157.18 32.72 Favored 'General case' 0 N--CA 1.463 0.176 0 CA-C-O 120.737 0.304 . . . . 0.0 111.161 -179.942 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.433 ' O ' ' HA ' ' A' ' 33' ' ' GLN . 5.8 m-85 -121.28 164.43 17.01 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.852 -179.988 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 25.6 p -144.59 150.93 38.29 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.095 179.487 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 86.5 t80 -145.38 95.91 4.95 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.243 179.282 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.403 ' HA ' ' HA ' ' A' ' 31' ' ' ARG . 53.1 Cg_exo -55.05 94.33 0.04 OUTLIER 'Trans proline' 0 C--N 1.349 0.559 0 C-N-CA 122.719 2.279 . . . . 0.0 111.832 179.967 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 26' ' ' CYS . . . . . 0.422 ' SG ' ' HD2' ' A' ' 27' ' ' PRO . 45.3 t -63.8 137.89 97.23 Favored Pre-proline 0 C--O 1.234 0.243 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.095 -179.306 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 27' ' ' PRO . . . . . 0.422 ' HD2' ' SG ' ' A' ' 26' ' ' CYS . 10.9 Cg_endo -54.84 -20.33 22.11 Favored 'Trans proline' 0 C--N 1.35 0.626 0 C-N-CA 122.906 2.404 . . . . 0.0 112.831 179.777 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 12.4 p -55.49 -29.31 58.55 Favored 'General case' 0 CA--C 1.535 0.378 0 CA-C-O 120.592 0.234 . . . . 0.0 111.398 179.68 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 125.55 5.43 6.52 Favored Glycine 0 CA--C 1.526 0.737 0 C-N-CA 121.143 -0.551 . . . . 0.0 113.692 179.836 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -126.55 -167.12 1.67 Allowed 'General case' 0 CA--C 1.536 0.408 0 CA-C-N 117.412 0.606 . . . . 0.0 111.324 -179.814 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 31' ' ' ARG . . . . . 0.403 ' HA ' ' HA ' ' A' ' 25' ' ' PRO . 8.6 ttm-85 -121.36 150.1 41.96 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-O 120.8 0.333 . . . . 0.0 111.506 -179.596 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 32' ' ' PHE . . . . . 0.474 ' HZ ' ' HB1' ' A' ' 46' ' ' ALA . 21.7 t80 -103.43 162.27 13.17 Favored 'General case' 0 CA--C 1.529 0.153 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.882 179.368 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 33' ' ' GLN . . . . . 0.433 ' HA ' ' O ' ' A' ' 22' ' ' PHE . 3.2 pt20 -149.7 115.64 5.66 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.879 179.65 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.427 HG21 ' HE2' ' A' ' 39' ' ' MET . 3.3 tt -130.71 128.3 62.92 Favored 'Isoleucine or valine' 0 C--O 1.234 0.245 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.062 179.989 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -80.23 123.53 28.02 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.054 -179.667 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.546 HD11 ' OE1' ' A' ' 20' ' ' GLN . 3.7 pp -61.28 -38.59 87.33 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.998 179.601 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 37' ' ' ASP . . . . . 0.537 ' N ' HD12 ' A' ' 36' ' ' LEU . 3.7 t70 -56.3 -46.37 79.83 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 116.503 -0.317 . . . . 0.0 110.801 179.538 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -65.92 -45.59 81.33 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.518 179.435 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 39' ' ' MET . . . . . 0.427 ' HE2' HG21 ' A' ' 34' ' ' ILE . 1.6 mtm -52.05 -25.62 9.02 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.852 179.687 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -53.97 -35.46 61.81 Favored 'General case' 0 N--CA 1.467 0.397 0 N-CA-C 111.559 0.207 . . . . 0.0 111.559 179.775 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 -58.44 -31.59 67.91 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-N 116.646 -0.252 . . . . 0.0 111.565 179.75 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 125.14 45.54 0.25 Allowed Glycine 0 C--N 1.335 0.509 0 C-N-CA 121.218 -0.515 . . . . 0.0 112.771 179.81 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -84.1 133.31 34.64 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-O 120.687 0.28 . . . . 0.0 110.908 179.996 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 3.4 ptpp? -126.54 -45.26 1.65 Allowed 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.385 -179.9 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 12.2 p -94.55 131.44 41.38 Favored 'Isoleucine or valine' 0 C--O 1.233 0.223 0 CA-C-N 116.418 -0.355 . . . . 0.0 110.715 179.797 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.474 ' HB1' ' HZ ' ' A' ' 32' ' ' PHE . . . -129.82 144.79 51.48 Favored 'General case' 0 C--O 1.234 0.288 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.109 -179.676 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 11.3 p -110.36 123.88 66.64 Favored 'Isoleucine or valine' 0 C--O 1.233 0.223 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.15 -179.828 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 52.5 t -62.2 134.72 94.72 Favored Pre-proline 0 N--CA 1.463 0.214 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.99 179.905 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 90.7 Cg_endo -84.98 24.55 0.76 Allowed 'Trans proline' 0 C--N 1.349 0.58 0 C-N-CA 122.713 2.275 . . . . 0.0 112.993 179.926 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 1.4 m -132.99 -60.29 0.87 Allowed 'General case' 0 CA--C 1.53 0.191 0 CA-C-N 116.503 -0.317 . . . . 0.0 110.586 -179.83 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 22.6 p -102.35 -13.98 17.1 Favored 'General case' 0 CA--C 1.537 0.462 0 N-CA-C 111.869 0.322 . . . . 0.0 111.869 179.494 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 6.4 t 66.82 34.28 5.6 Favored 'General case' 0 CA--C 1.534 0.365 0 CA-C-O 120.895 0.379 . . . . 0.0 111.286 -179.815 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.65 HD23 HG23 ' A' ' 55' ' ' ILE . 8.0 tt -85.21 134.27 34.15 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.604 179.663 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 54' ' ' MET . . . . . . . . . . . . . 40.7 mtm -82.79 133.0 35.15 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.198 -179.635 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.65 HG23 HD23 ' A' ' 53' ' ' LEU . 2.7 pt -138.68 151.07 23.85 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.394 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.853 -179.829 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 71.1 m-20 -97.02 88.47 4.52 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.741 179.297 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.472 ' O ' HG13 ' A' ' 57' ' ' VAL . 12.5 p -94.5 114.52 31.26 Favored 'Isoleucine or valine' 0 C--O 1.234 0.279 0 CA-C-O 121.063 0.458 . . . . 0.0 110.938 179.77 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 12.6 p -91.79 135.24 27.7 Favored 'Isoleucine or valine' 0 C--O 1.233 0.218 0 CA-C-N 115.967 -0.561 . . . . 0.0 110.974 -179.719 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 48.5 p90 -112.51 166.55 11.22 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.885 -179.52 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -131.16 137.74 49.14 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.215 179.774 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 17.0 mttp -68.43 -38.21 80.98 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.733 179.191 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 21.3 mt-10 -58.87 -52.99 63.35 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.427 179.266 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 38.4 m-20 -62.12 -43.04 99.72 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.993 179.505 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.464 HD23 HD13 ' A' ' 36' ' ' LEU . 0.8 OUTLIER -60.16 -53.43 57.77 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-O 120.607 0.242 . . . . 0.0 111.244 179.95 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -63.7 -39.25 93.84 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 116.422 -0.353 . . . . 0.0 111.149 179.867 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 26.7 tt0 -68.27 -41.29 81.26 Favored 'General case' 0 CA--C 1.532 0.285 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.9 179.476 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 19.9 t80 -66.24 -34.79 78.81 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.655 -179.994 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 68' ' ' TYR . . . . . 0.403 ' HA ' ' OE1' ' A' ' 20' ' ' GLN . 23.5 t80 -54.26 -41.96 69.41 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-O 120.732 0.301 . . . . 0.0 110.254 179.719 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 4.1 tt0 -83.6 -37.45 22.9 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.292 179.466 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -66.63 -32.96 74.62 Favored 'General case' 0 N--CA 1.467 0.403 0 N-CA-C 112.053 0.39 . . . . 0.0 112.053 -179.608 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -60.44 -63.18 1.39 Allowed 'General case' 0 N--CA 1.465 0.323 0 N-CA-C 111.863 0.32 . . . . 0.0 111.863 -179.322 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 90.65 35.78 7.17 Favored Glycine 0 C--N 1.334 0.418 0 C-N-CA 120.915 -0.659 . . . . 0.0 112.842 -179.816 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 17.9 tt -64.26 153.35 7.65 Favored 'Isoleucine or valine' 0 C--O 1.232 0.179 0 CA-C-O 120.623 0.249 . . . . 0.0 111.099 179.75 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 1.5 t-80 65.07 84.12 0.18 Allowed Pre-proline 0 C--O 1.233 0.23 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.328 -179.693 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -53.52 163.74 2.49 Favored 'Trans proline' 0 C--N 1.351 0.674 0 C-N-CA 123.023 2.482 . . . . 0.0 112.809 -179.607 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_exo -60.45 179.55 0.33 Allowed 'Trans proline' 0 C--N 1.35 0.631 0 C-N-CA 122.849 2.366 . . . . 0.0 112.495 179.858 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 77' ' ' GLU . . . . . 0.485 ' H ' ' HD2' ' A' ' 78' ' ' PRO . 2.3 mt-10 -160.94 -60.3 0.02 OUTLIER Pre-proline 0 C--N 1.33 -0.273 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.242 -179.874 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 78' ' ' PRO . . . . . 0.485 ' HD2' ' H ' ' A' ' 77' ' ' GLU . 57.8 Cg_endo -70.56 82.44 0.92 Allowed 'Trans proline' 0 C--N 1.352 0.762 0 C-N-CA 122.588 2.192 . . . . 0.0 112.633 -179.799 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 15.0 tt -66.37 150.32 11.04 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.247 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.249 179.886 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -65.4 -64.5 0.85 Allowed 'General case' 0 CA--C 1.531 0.229 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.052 179.871 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . 61.82 102.89 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.401 0 CA-C-N 116.387 -0.37 . . . . 0.0 111.796 179.574 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -130.86 -76.04 0.53 Allowed 'General case' 0 N--CA 1.464 0.227 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.434 179.758 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.128 0 CA-C-O 120.812 0.339 . . . . 0.0 111.132 -179.943 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 84' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.491 1.584 0 CA-C-O 120.599 0.238 . . . . 0.0 111.077 . . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 11.2 p -61.54 -32.46 53.57 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.219 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.273 179.55 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 5.1 m 61.83 177.43 0.12 Allowed 'General case' 0 C--O 1.233 0.219 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.672 -179.547 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 5.0 p 55.72 -173.44 0.06 Allowed 'General case' 0 CA--C 1.532 0.267 0 CA-C-O 120.875 0.369 . . . . 0.0 111.069 -179.838 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 11.6 m-85 -164.65 -40.84 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.123 179.755 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -145.83 169.99 17.45 Favored 'General case' 0 C--O 1.237 0.409 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.005 -179.798 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -123.98 112.11 16.81 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.873 -179.882 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.466 HG21 ' SD ' ' A' ' 13' ' ' MET . 27.8 mm -88.07 154.62 3.23 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.196 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.954 179.918 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 82.2 mt-10 -121.54 146.77 46.61 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-N 116.374 -0.376 . . . . 0.0 111.211 -179.983 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 8.1 tp -58.11 -34.95 50.67 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.344 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.124 179.501 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 6.6 tt0 -65.66 -34.61 78.6 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-N 116.496 -0.32 . . . . 0.0 110.878 179.46 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 22.1 m-20 -95.94 38.27 1.19 Allowed 'General case' 0 CA--C 1.531 0.238 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.226 179.766 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' MET . . . . . 0.466 ' SD ' HG21 ' A' ' 8' ' ' ILE . 0.6 OUTLIER -133.79 136.73 44.69 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.725 179.785 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 9.7 m -69.64 138.22 52.86 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.015 -179.841 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' PHE . . . . . 0.426 ' HB3' ' CE2' ' A' ' 22' ' ' PHE . 17.3 p90 -101.54 130.4 47.82 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.556 179.649 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 -109.23 90.82 8.68 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.733 179.795 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 69.9 Cg_endo -74.26 62.31 5.16 Favored 'Trans proline' 0 C--N 1.348 0.512 0 C-N-CA 122.776 2.317 . . . . 0.0 112.954 -179.786 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 4.8 pt-20 -132.68 -50.21 0.9 Allowed 'General case' 0 CA--C 1.531 0.224 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.757 179.47 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' ASN . . . . . 0.582 ' HA ' HD12 ' A' ' 73' ' ' ILE . 38.0 m-20 -136.46 32.03 2.82 Favored 'General case' 0 CA--C 1.534 0.345 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.23 179.512 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 20' ' ' GLN . . . . . 0.688 ' HB3' HD12 ' A' ' 36' ' ' LEU . 15.2 mt-30 56.67 67.38 1.0 Allowed 'General case' 0 CA--C 1.535 0.368 0 CA-C-O 121.06 0.457 . . . . 0.0 111.462 179.447 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 2.5 ptt? -146.99 158.64 43.98 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-N 116.013 -0.54 . . . . 0.0 111.092 179.674 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.509 ' CE1' HD21 ' A' ' 36' ' ' LEU . 17.4 m-85 -131.21 127.8 38.65 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.787 -179.967 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 23' ' ' THR . . . . . 0.42 ' HA ' ' O ' ' A' ' 32' ' ' PHE . 18.2 p -116.14 170.21 8.68 Favored 'General case' 0 CA--C 1.532 0.28 0 CA-C-O 120.828 0.347 . . . . 0.0 111.454 -179.877 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 57.8 t80 -163.23 136.29 4.31 Favored Pre-proline 0 N--CA 1.464 0.271 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.042 179.795 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 42.0 Cg_endo -66.59 103.38 0.68 Allowed 'Trans proline' 0 C--N 1.35 0.606 0 C-N-CA 122.555 2.17 . . . . 0.0 112.27 179.649 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' CYS . . . . . 0.461 ' SG ' ' HD2' ' A' ' 27' ' ' PRO . 42.7 t -66.89 139.63 95.76 Favored Pre-proline 0 C--O 1.233 0.215 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.551 179.786 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 27' ' ' PRO . . . . . 0.461 ' HD2' ' SG ' ' A' ' 26' ' ' CYS . 9.3 Cg_endo -53.64 -25.56 33.99 Favored 'Trans proline' 0 C--N 1.35 0.617 0 C-N-CA 122.928 2.419 . . . . 0.0 112.927 179.867 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 28' ' ' CYS . . . . . 0.401 ' CB ' ' HB3' ' A' ' 51' ' ' CYS . 0.8 OUTLIER -69.93 -38.03 76.07 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-O 120.51 0.195 . . . . 0.0 111.299 -179.978 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 150.37 -44.8 0.68 Allowed Glycine 0 C--N 1.336 0.541 0 C-N-CA 120.834 -0.698 . . . . 0.0 112.898 -179.922 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -71.09 -176.51 1.43 Allowed 'General case' 0 CA--C 1.534 0.333 0 CA-C-O 120.779 0.323 . . . . 0.0 111.169 -179.86 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 7.2 ttp180 -122.19 114.06 20.33 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-N 116.515 -0.312 . . . . 0.0 111.085 -179.886 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 32' ' ' PHE . . . . . 0.42 ' O ' ' HA ' ' A' ' 23' ' ' THR . 73.3 t80 -62.2 154.55 27.07 Favored 'General case' 0 N--CA 1.462 0.168 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.966 179.708 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 1.1 pt20 -147.47 144.12 28.37 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.231 179.994 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 2.8 tt -147.6 132.14 10.25 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.247 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.064 179.497 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 6.0 m-85 -90.41 139.54 30.58 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.944 -179.883 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.688 HD12 ' HB3' ' A' ' 20' ' ' GLN . 13.9 mt -59.57 -47.48 85.41 Favored 'General case' 0 N--CA 1.463 0.19 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.027 179.954 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -59.57 -38.5 81.32 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 116.587 -0.279 . . . . 0.0 110.78 179.339 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -66.73 -58.99 3.97 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.017 179.853 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 39' ' ' MET . . . . . 0.709 ' HG3' HD11 ' A' ' 64' ' ' LEU . 6.4 ptm -60.68 -32.58 71.79 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 116.462 -0.335 . . . . 0.0 111.556 -179.878 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 18.7 t80 -58.39 -37.05 74.49 Favored 'General case' 0 CA--C 1.533 0.318 0 CA-C-N 116.499 -0.318 . . . . 0.0 111.15 179.689 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 4.6 mt-10 -57.92 -38.14 75.34 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-O 120.668 0.271 . . . . 0.0 110.98 179.512 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 144.77 52.14 0.03 OUTLIER Glycine 0 C--N 1.334 0.46 0 C-N-CA 121.018 -0.611 . . . . 0.0 112.701 179.785 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -109.98 157.18 19.56 Favored 'General case' 0 C--O 1.232 0.15 0 CA-C-O 120.81 0.338 . . . . 0.0 111.237 -179.943 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -157.1 -47.14 0.07 Allowed 'General case' 0 CA--C 1.532 0.262 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.156 179.815 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 4.8 m -100.02 115.0 40.19 Favored 'Isoleucine or valine' 0 C--O 1.233 0.191 0 CA-C-O 120.84 0.352 . . . . 0.0 110.972 179.78 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -110.47 174.79 5.7 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.204 -179.854 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 11.3 m -133.48 121.18 40.81 Favored 'Isoleucine or valine' 0 C--O 1.233 0.209 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.186 -179.886 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 43.3 t -63.15 135.94 96.46 Favored Pre-proline 0 C--O 1.233 0.215 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.702 179.964 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 91.5 Cg_endo -83.15 19.87 1.26 Allowed 'Trans proline' 0 CA--C 1.537 0.645 0 C-N-CA 122.682 2.255 . . . . 0.0 113.212 179.972 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 29.8 t -128.35 -58.2 1.2 Allowed 'General case' 0 CA--C 1.529 0.152 0 CA-C-O 120.657 0.265 . . . . 0.0 110.521 179.644 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 51' ' ' CYS . . . . . 0.401 ' HB3' ' CB ' ' A' ' 28' ' ' CYS . 20.1 p -98.72 -20.2 17.07 Favored 'General case' 0 CA--C 1.533 0.327 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.826 179.93 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 1.1 t 67.46 39.48 2.88 Favored 'General case' 0 CA--C 1.534 0.327 0 CA-C-O 121.07 0.462 . . . . 0.0 110.904 -179.772 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 6.9 tp -88.08 131.68 34.58 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.711 179.814 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 54' ' ' MET . . . . . . . . . . . . . 41.1 mtt -85.14 123.99 31.29 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.618 -179.877 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 2.6 pp -134.06 142.16 41.89 Favored 'Isoleucine or valine' 0 C--O 1.234 0.249 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.621 -179.749 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -105.81 95.92 6.14 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.656 -179.909 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.415 ' HA ' ' O ' ' A' ' 8' ' ' ILE . 14.8 p -84.18 139.13 18.03 Favored 'Isoleucine or valine' 0 C--O 1.234 0.286 0 CA-C-O 120.941 0.4 . . . . 0.0 111.124 -179.954 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 12.1 p -111.26 123.02 66.75 Favored 'Isoleucine or valine' 0 C--O 1.234 0.264 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.862 179.703 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 32.3 p90 -129.32 176.83 7.63 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.025 -179.675 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -118.02 162.79 17.6 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.556 -179.898 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 22.8 mttt -87.82 -32.1 19.21 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.128 179.568 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -59.73 -54.55 45.05 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 116.587 -0.279 . . . . 0.0 110.835 179.882 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -61.28 -44.48 97.16 Favored 'General case' 0 N--CA 1.463 0.186 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.741 179.655 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.709 HD11 ' HG3' ' A' ' 39' ' ' MET . 0.2 OUTLIER -57.96 -41.31 82.64 Favored 'General case' 0 CA--C 1.529 0.157 0 CA-C-N 116.429 -0.35 . . . . 0.0 110.809 179.583 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -70.18 -39.45 75.24 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 116.441 -0.345 . . . . 0.0 111.241 179.763 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 31.1 mt-10 -70.51 -41.06 73.12 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.504 -179.808 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 67' ' ' TYR . . . . . 0.561 ' CD2' HD11 ' A' ' 36' ' ' LEU . 2.5 t80 -55.94 -30.84 62.3 Favored 'General case' 0 N--CA 1.465 0.275 0 CA-C-N 116.693 -0.231 . . . . 0.0 111.499 -179.958 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 68' ' ' TYR . . . . . 0.419 ' HA ' ' OE1' ' A' ' 20' ' ' GLN . 3.8 m-85 -58.85 -36.24 74.25 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-O 120.63 0.253 . . . . 0.0 110.589 179.665 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 7.8 tt0 -88.3 -36.32 16.73 Favored 'General case' 0 CA--C 1.531 0.242 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.943 179.334 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 4.5 mm-40 -66.23 -34.57 78.31 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.605 -179.705 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -67.63 143.88 55.81 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-O 120.86 0.362 . . . . 0.0 111.251 -179.838 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -96.06 28.24 13.58 Favored Glycine 0 CA--C 1.521 0.423 0 C-N-CA 121.05 -0.595 . . . . 0.0 112.804 179.959 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.582 HD12 ' HA ' ' A' ' 19' ' ' ASN . 11.7 tt -78.56 -34.52 17.94 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.314 0 CA-C-O 120.532 0.206 . . . . 0.0 111.364 179.971 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 10.6 m-70 -133.5 88.45 34.38 Favored Pre-proline 0 C--O 1.234 0.261 0 CA-C-O 120.79 0.329 . . . . 0.0 110.879 179.715 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.58 155.74 65.72 Favored 'Trans proline' 0 C--N 1.349 0.563 0 C-N-CA 122.842 2.362 . . . . 0.0 112.531 179.963 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -70.5 137.05 32.47 Favored 'Trans proline' 0 C--N 1.35 0.643 0 C-N-CA 122.826 2.351 . . . . 0.0 112.66 -179.9 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -169.18 152.61 5.14 Favored Pre-proline 0 CA--C 1.532 0.27 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.882 179.772 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -54.97 95.69 0.05 OUTLIER 'Trans proline' 0 C--N 1.352 0.75 0 C-N-CA 122.985 2.457 . . . . 0.0 112.565 -179.985 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 7.6 pt -105.43 -34.06 3.0 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.328 0 CA-C-N 116.022 -0.535 . . . . 0.0 111.825 -179.745 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -145.05 148.87 34.18 Favored 'General case' 0 C--O 1.234 0.284 0 CA-C-O 120.59 0.233 . . . . 0.0 111.135 -179.939 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -111.38 159.71 17.75 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.479 -179.757 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -135.44 148.57 49.34 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.139 179.925 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.463 0.219 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.59 179.882 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 84' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.3 mtp . . . . . 0 N--CA 1.49 1.549 0 CA-C-O 120.415 0.15 . . . . 0.0 111.379 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 11.6 p -64.73 -42.09 94.01 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.318 0 CA-C-N 116.787 -0.188 . . . . 0.0 111.429 179.93 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 22.9 m -109.58 -179.69 3.89 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-N 116.55 -0.295 . . . . 0.0 111.144 179.995 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.602 HG22 ' HB3' ' A' ' 54' ' ' MET . 58.4 p -64.48 168.04 6.31 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.249 179.915 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 5.7 m-85 -102.83 -50.3 3.57 Favored 'General case' 0 CA--C 1.529 0.163 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.173 179.628 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -154.88 176.49 12.43 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.383 179.702 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 15.3 pt-20 -123.76 135.56 53.9 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.765 179.422 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 3.5 mp -121.75 139.63 48.23 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.305 0 CA-C-N 116.462 -0.336 . . . . 0.0 110.827 -179.977 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' GLU . . . . . 0.48 ' HG3' HG13 ' A' ' 58' ' ' VAL . 3.2 tt0 -83.93 145.73 28.42 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.182 -179.871 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 9.7 tp -57.15 -33.81 43.89 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.314 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.184 179.586 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 -58.77 -34.58 71.59 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 116.569 -0.287 . . . . 0.0 111.087 179.307 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 54.2 m-20 -95.76 36.83 1.25 Allowed 'General case' 0 CA--C 1.535 0.367 0 CA-C-O 120.722 0.296 . . . . 0.0 111.342 179.591 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 3.1 ttt -120.2 146.49 45.98 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 116.582 -0.281 . . . . 0.0 110.802 179.779 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 1.5 m -68.95 126.03 28.5 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 116.519 -0.31 . . . . 0.0 110.765 179.876 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 2.8 p90 -105.14 157.58 17.17 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.04 179.885 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 23.6 mt-10 -139.97 83.27 16.33 Favored Pre-proline 0 C--O 1.235 0.292 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.675 179.98 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 70.4 Cg_exo -52.05 -28.75 33.7 Favored 'Trans proline' 0 C--N 1.349 0.554 0 C-N-CA 122.98 2.454 . . . . 0.0 112.731 179.919 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -52.36 -35.94 52.5 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-N 116.454 -0.339 . . . . 0.0 111.577 179.605 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 2.0 t-20 -141.85 29.39 1.7 Allowed 'General case' 0 CA--C 1.538 0.505 0 N-CA-C 111.721 0.267 . . . . 0.0 111.721 -179.92 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' GLN . . . . . 0.487 ' HB2' HD21 ' A' ' 36' ' ' LEU . 8.3 pt20 41.73 35.87 0.55 Allowed 'General case' 0 N--CA 1.475 0.792 0 N-CA-C 112.245 0.461 . . . . 0.0 112.245 -179.756 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 7.0 ttt -105.67 158.67 16.55 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.475 -179.601 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 23.1 m-85 -129.65 147.07 51.4 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-O 120.777 0.322 . . . . 0.0 111.187 179.587 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' THR . . . . . 0.427 HG22 ' O ' ' A' ' 32' ' ' PHE . 21.2 p -144.19 177.42 8.61 Favored 'General case' 0 CA--C 1.537 0.465 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.953 -179.98 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 38.7 t80 -171.68 134.79 0.89 Allowed Pre-proline 0 N--CA 1.47 0.559 0 CA-C-N 116.699 -0.228 . . . . 0.0 110.961 179.327 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -65.04 101.23 0.39 Allowed 'Trans proline' 0 C--N 1.352 0.724 0 C-N-CA 122.795 2.33 . . . . 0.0 112.902 -179.857 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' CYS . . . . . 0.435 ' SG ' ' HD2' ' A' ' 27' ' ' PRO . 46.7 t -66.18 139.53 96.5 Favored Pre-proline 0 C--O 1.233 0.232 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.729 179.598 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 27' ' ' PRO . . . . . 0.435 ' HD2' ' SG ' ' A' ' 26' ' ' CYS . 60.9 Cg_exo -52.61 -27.08 31.61 Favored 'Trans proline' 0 C--N 1.348 0.547 0 C-N-CA 122.748 2.299 . . . . 0.0 112.907 179.625 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -67.6 -38.53 84.11 Favored 'General case' 0 C--O 1.235 0.305 0 N-CA-C 111.61 0.226 . . . . 0.0 111.61 -179.99 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 152.32 -48.19 0.55 Allowed Glycine 0 C--N 1.336 0.571 0 C-N-CA 120.785 -0.721 . . . . 0.0 113.242 -179.788 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -75.89 -173.59 2.34 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-N 116.751 0.276 . . . . 0.0 111.137 -179.812 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 51.5 mtt180 -122.41 138.34 54.57 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-O 120.76 0.314 . . . . 0.0 111.185 -179.989 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 32' ' ' PHE . . . . . 0.427 ' O ' HG22 ' A' ' 23' ' ' THR . 45.0 m-85 -69.06 167.86 15.08 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.864 179.569 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 3.9 pp0? -152.17 138.16 18.16 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.22 179.594 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.445 HD13 ' HE2' ' A' ' 39' ' ' MET . 3.5 tt -173.98 127.87 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.531 0.238 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.033 179.659 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 76.5 m-85 -82.21 142.9 31.78 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.734 -179.81 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.514 HD13 HD23 ' A' ' 64' ' ' LEU . 3.9 pp -55.45 -35.22 65.22 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 116.389 -0.368 . . . . 0.0 111.231 179.645 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 37' ' ' ASP . . . . . 0.42 ' N ' HD12 ' A' ' 36' ' ' LEU . 0.9 OUTLIER -61.49 -45.6 93.55 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 116.534 -0.303 . . . . 0.0 111.016 179.678 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -61.12 -43.43 98.89 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-O 120.762 0.315 . . . . 0.0 110.731 179.453 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 39' ' ' MET . . . . . 0.445 ' HE2' HD13 ' A' ' 34' ' ' ILE . 3.6 mtt -59.75 -33.52 71.77 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.029 179.616 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -56.42 -39.88 73.78 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 116.534 -0.303 . . . . 0.0 110.991 179.533 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 21.9 mt-10 -65.57 -48.94 70.67 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 116.665 -0.243 . . . . 0.0 110.863 179.741 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 153.64 74.94 0.01 OUTLIER Glycine 0 C--N 1.336 0.535 0 C-N-CA 120.678 -0.772 . . . . 0.0 113.02 179.696 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 5.0 tp10 -128.66 96.71 4.47 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-O 120.858 0.361 . . . . 0.0 111.299 179.748 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 14.5 ptpt -111.86 -31.81 6.82 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.439 179.803 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 4.4 m -110.87 97.41 5.7 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.264 0 CA-C-O 120.953 0.406 . . . . 0.0 111.075 179.853 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -99.64 154.55 18.19 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.527 -179.574 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 11.2 p -118.56 139.23 46.59 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.244 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.313 -179.958 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 53.5 t -78.52 135.25 60.89 Favored Pre-proline 0 C--O 1.233 0.232 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.917 179.858 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_endo -83.96 19.7 1.32 Allowed 'Trans proline' 0 C--N 1.35 0.628 0 C-N-CA 122.692 2.261 . . . . 0.0 113.171 179.843 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 12.7 t -128.02 -59.26 1.19 Allowed 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 122.301 0.24 . . . . 0.0 110.41 179.607 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 19.4 p -95.76 -20.89 18.51 Favored 'General case' 0 N--CA 1.468 0.444 0 N-CA-C 112.073 0.397 . . . . 0.0 112.073 179.676 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 1.2 t 67.04 39.6 3.15 Favored 'General case' 0 CA--C 1.536 0.434 0 CA-C-O 120.901 0.382 . . . . 0.0 111.353 -179.683 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.585 HD23 HG23 ' A' ' 55' ' ' ILE . 8.0 tt -91.81 139.6 30.51 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.852 179.903 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 54' ' ' MET . . . . . 0.602 ' HB3' HG22 ' A' ' 4' ' ' THR . 53.1 mtp -88.24 128.11 35.46 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 116.396 -0.366 . . . . 0.0 111.3 -179.734 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.585 HG23 HD23 ' A' ' 53' ' ' LEU . 2.4 pt -132.26 139.08 50.95 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.259 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.492 179.937 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 22.0 m-20 -96.93 87.13 4.17 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 116.458 -0.337 . . . . 0.0 110.324 179.216 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.429 ' O ' HG13 ' A' ' 57' ' ' VAL . 12.6 p -93.13 114.15 29.35 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.251 0 CA-C-O 121.004 0.43 . . . . 0.0 111.079 -179.893 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.48 HG13 ' HG3' ' A' ' 9' ' ' GLU . 14.9 p -82.92 146.75 6.59 Favored 'Isoleucine or valine' 0 C--O 1.233 0.208 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.283 -179.539 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 47.5 p90 -121.9 170.1 10.13 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.267 -179.645 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -132.08 165.0 25.01 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.448 -179.914 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -99.83 -33.77 10.42 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.405 179.815 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 1.6 mm-40 -59.35 -60.31 4.06 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-O 120.471 0.176 . . . . 0.0 111.073 179.929 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -59.87 -44.49 94.14 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 116.608 -0.269 . . . . 0.0 110.86 179.733 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.514 HD23 HD13 ' A' ' 36' ' ' LEU . 0.7 OUTLIER -58.38 -45.34 88.49 Favored 'General case' 0 CA--C 1.53 0.211 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.036 179.734 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -62.77 -51.68 66.19 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.176 179.789 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 2.0 tp10 -59.57 -40.91 88.9 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-N 116.459 -0.337 . . . . 0.0 110.761 179.517 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 3.9 t80 -55.11 -36.18 65.45 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.435 179.544 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 1.6 t80 -55.9 -38.69 70.55 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-O 120.637 0.256 . . . . 0.0 110.58 179.791 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 4.2 tt0 -83.04 -37.24 24.17 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.73 179.091 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 8.1 mt-10 -65.76 -36.87 84.79 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 116.526 -0.306 . . . . 0.0 111.621 -179.802 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -75.82 142.72 42.18 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-O 120.811 0.338 . . . . 0.0 111.542 -179.893 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -92.57 26.81 12.36 Favored Glycine 0 CA--C 1.524 0.627 0 C-N-CA 121.032 -0.604 . . . . 0.0 113.077 179.705 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.466 HG21 ' OE1' ' A' ' 20' ' ' GLN . 2.6 tt -87.21 -33.19 6.66 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.274 0 CA-C-N 116.891 0.345 . . . . 0.0 111.574 179.931 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 5.5 t60 -113.3 91.64 20.13 Favored Pre-proline 0 CA--C 1.533 0.312 0 CA-C-O 120.66 0.267 . . . . 0.0 111.002 179.853 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_endo -68.59 152.36 74.71 Favored 'Trans proline' 0 C--N 1.352 0.74 0 C-N-CA 122.808 2.339 . . . . 0.0 112.636 -179.906 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 41.3 Cg_endo -68.61 -43.72 3.7 Favored 'Trans proline' 0 C--N 1.352 0.722 0 C-N-CA 122.627 2.218 . . . . 0.0 112.868 -179.864 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -106.95 147.94 36.03 Favored Pre-proline 0 C--O 1.233 0.215 0 CA-C-N 116.64 -0.254 . . . . 0.0 110.859 -179.997 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -70.89 116.53 4.71 Favored 'Trans proline' 0 C--N 1.351 0.66 0 C-N-CA 122.7 2.267 . . . . 0.0 112.476 -179.909 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 2.7 pp -133.96 23.47 1.19 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.486 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.962 179.979 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -142.68 146.53 34.5 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-O 120.648 0.261 . . . . 0.0 111.642 179.614 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -147.51 172.6 13.72 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.384 179.839 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -73.55 128.23 34.91 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-N 116.495 -0.32 . . . . 0.0 111.382 179.941 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.115 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.272 179.922 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 84' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 6.0 ptp . . . . . 0 N--CA 1.491 1.611 0 CA-C-O 120.709 0.29 . . . . 0.0 111.356 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 28.7 m -136.07 170.58 18.49 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.292 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.321 -179.869 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 3.5 m -129.05 31.36 4.91 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.025 179.647 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 3.1 p -91.8 150.11 21.25 Favored 'General case' 0 N--CA 1.464 0.275 0 CA-C-N 116.442 -0.345 . . . . 0.0 111.627 -179.797 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -107.89 -47.56 3.56 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.21 179.622 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -150.32 174.57 12.71 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.339 179.938 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 12.4 mt-10 -121.62 120.71 35.57 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.63 179.691 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.447 ' O ' ' HA ' ' A' ' 57' ' ' VAL . 3.6 mp -115.08 152.09 16.74 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.331 0 CA-C-N 116.441 -0.345 . . . . 0.0 111.33 -179.495 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 10.2 mt-10 -99.24 143.06 29.93 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 116.525 -0.307 . . . . 0.0 111.387 179.986 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 9.0 tp -59.32 -29.42 41.88 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.382 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.467 179.576 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 3.4 pt-20 -60.59 -28.67 68.67 Favored 'General case' 0 CA--C 1.533 0.325 0 CA-C-N 116.669 -0.241 . . . . 0.0 111.357 179.679 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -97.9 36.99 1.46 Allowed 'General case' 0 CA--C 1.535 0.392 0 CA-C-O 120.722 0.296 . . . . 0.0 111.248 179.756 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' MET . . . . . 0.607 ' CE ' HG11 ' A' ' 57' ' ' VAL . 3.9 mtt -131.44 140.06 49.52 Favored 'General case' 0 N--CA 1.464 0.225 0 CA-C-N 116.528 -0.305 . . . . 0.0 111.075 179.994 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 2.1 m -67.58 145.91 54.4 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 116.418 -0.355 . . . . 0.0 111.131 179.826 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 1.5 p90 -109.08 158.15 18.04 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.159 179.726 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -135.7 76.9 53.04 Favored Pre-proline 0 CA--C 1.532 0.264 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.587 179.677 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -54.09 -25.02 35.32 Favored 'Trans proline' 0 C--N 1.352 0.736 0 C-N-CA 122.982 2.454 . . . . 0.0 113.133 -179.99 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -52.95 -42.72 65.74 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-N 116.669 -0.241 . . . . 0.0 111.316 179.918 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 3.5 m-80 -133.01 15.69 4.22 Favored 'General case' 0 CA--C 1.541 0.615 0 N-CA-C 112.181 0.438 . . . . 0.0 112.181 -179.758 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' GLN . . . . . 0.491 ' C ' HD13 ' A' ' 36' ' ' LEU . 27.7 mt-30 56.08 75.26 0.35 Allowed 'General case' 0 N--CA 1.471 0.591 0 N-CA-C 111.959 0.355 . . . . 0.0 111.959 179.497 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 1.6 ptt? -163.01 147.95 11.58 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-N 116.431 -0.349 . . . . 0.0 111.26 179.191 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 7.5 m-85 -105.09 139.33 39.92 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-O 120.677 0.275 . . . . 0.0 110.973 179.675 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 75.5 p -132.44 158.25 42.51 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.57 -179.488 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 39.0 t80 -162.83 136.45 4.61 Favored Pre-proline 0 N--CA 1.465 0.276 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.908 179.619 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 41.7 Cg_endo -66.14 100.31 0.45 Allowed 'Trans proline' 0 C--N 1.35 0.617 0 C-N-CA 122.461 2.107 . . . . 0.0 112.32 179.725 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 26' ' ' CYS . . . . . 0.424 ' SG ' ' HD2' ' A' ' 27' ' ' PRO . 42.6 t -58.4 139.3 84.91 Favored Pre-proline 0 C--O 1.233 0.19 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.843 179.843 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 27' ' ' PRO . . . . . 0.424 ' HD2' ' SG ' ' A' ' 26' ' ' CYS . 65.1 Cg_exo -52.27 -26.53 27.33 Favored 'Trans proline' 0 C--N 1.349 0.596 0 C-N-CA 122.843 2.362 . . . . 0.0 113.038 179.844 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 28' ' ' CYS . . . . . 0.419 ' CB ' ' HB3' ' A' ' 51' ' ' CYS . 0.8 OUTLIER -68.19 -38.4 81.97 Favored 'General case' 0 CA--C 1.533 0.318 0 CA-C-O 120.472 0.177 . . . . 0.0 111.394 179.924 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 151.12 -45.28 0.64 Allowed Glycine 0 C--N 1.336 0.55 0 C-N-CA 120.827 -0.702 . . . . 0.0 112.999 -179.784 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 2.8 t70 -72.26 -178.21 2.41 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-N 116.677 0.239 . . . . 0.0 111.143 -179.845 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 8.2 ttm180 -118.93 125.37 49.3 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-O 120.673 0.273 . . . . 0.0 111.234 -179.86 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 32' ' ' PHE . . . . . 0.587 ' CE2' HD11 ' A' ' 55' ' ' ILE . 0.5 OUTLIER -64.84 154.33 37.48 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.243 179.858 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 20.8 pt20 -150.44 135.93 18.06 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.278 -179.92 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 2.8 tt -149.27 135.39 12.07 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.201 0 CA-C-N 116.425 -0.352 . . . . 0.0 111.219 179.428 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -86.2 140.93 29.71 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.83 179.963 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.686 ' O ' HD11 ' A' ' 64' ' ' LEU . 9.8 mp -58.03 -49.14 77.89 Favored 'General case' 0 C--O 1.232 0.152 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.676 179.699 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -58.05 -39.4 78.35 Favored 'General case' 0 CA--C 1.532 0.261 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.23 179.48 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -58.54 -46.79 86.09 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 116.571 -0.286 . . . . 0.0 110.834 179.809 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 8.9 mtm -59.82 -35.3 74.44 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.85 179.683 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -55.16 -42.91 73.74 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.923 179.511 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -60.38 -48.23 82.66 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-O 120.68 0.276 . . . . 0.0 110.81 179.712 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 149.62 54.76 0.01 OUTLIER Glycine 0 C--N 1.334 0.472 0 C-N-CA 120.954 -0.641 . . . . 0.0 112.663 179.775 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 2.3 tp10 -99.32 95.94 7.39 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-O 120.775 0.321 . . . . 0.0 111.047 179.971 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 13.4 mtmt -105.39 -36.89 7.03 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.078 179.75 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.462 HG13 ' O ' ' A' ' 45' ' ' VAL . 9.4 p -117.95 111.11 32.94 Favored 'Isoleucine or valine' 0 C--O 1.233 0.217 0 CA-C-O 121.037 0.446 . . . . 0.0 110.87 179.769 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -109.9 168.8 9.16 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-N 115.816 -0.629 . . . . 0.0 111.338 -179.552 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 12.0 p -130.83 140.44 48.68 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.254 0 CA-C-N 116.432 -0.349 . . . . 0.0 111.75 -179.352 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 40.6 t -76.64 136.82 67.21 Favored Pre-proline 0 N--CA 1.464 0.248 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.737 179.785 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_endo -83.03 20.7 1.12 Allowed 'Trans proline' 0 CA--C 1.537 0.627 0 C-N-CA 122.85 2.367 . . . . 0.0 113.203 179.796 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -129.0 -56.79 1.18 Allowed 'General case' 0 C--O 1.233 0.222 0 CA-C-N 116.682 -0.235 . . . . 0.0 110.419 179.516 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 51' ' ' CYS . . . . . 0.5 ' SG ' HD12 ' A' ' 53' ' ' LEU . 22.9 p -95.78 -24.16 16.62 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 116.473 -0.33 . . . . 0.0 111.777 179.49 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER 69.64 39.95 1.45 Allowed 'General case' 0 CA--C 1.534 0.344 0 CA-C-O 120.821 0.343 . . . . 0.0 111.368 -179.666 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.5 HD12 ' SG ' ' A' ' 51' ' ' CYS . 74.4 mt -98.07 127.78 44.21 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-N 116.433 -0.348 . . . . 0.0 110.606 179.62 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 54' ' ' MET . . . . . . . . . . . . . 9.4 mtt -82.61 136.24 34.86 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.963 -179.677 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.587 HD11 ' CE2' ' A' ' 32' ' ' PHE . 9.2 pt -136.75 152.61 29.1 Favored 'Isoleucine or valine' 0 C--O 1.234 0.25 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.908 -179.647 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -102.66 108.78 20.16 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.484 179.285 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.607 HG11 ' CE ' ' A' ' 13' ' ' MET . 0.0 OUTLIER -110.13 113.18 43.51 Favored 'Isoleucine or valine' 0 C--O 1.234 0.257 0 CA-C-O 120.793 0.33 . . . . 0.0 111.355 179.726 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.534 HG13 ' O ' ' A' ' 58' ' ' VAL . 8.1 p -81.88 88.2 1.84 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.265 0 CA-C-O 121.353 0.597 . . . . 0.0 110.772 179.821 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 51.0 p90 -80.02 155.27 27.68 Favored 'General case' 0 CA--C 1.531 0.249 0 CA-C-N 115.597 -0.729 . . . . 0.0 111.177 -179.568 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -103.54 145.91 29.32 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-O 120.891 0.377 . . . . 0.0 111.375 -179.875 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 5.8 tttp -87.94 -40.22 14.1 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.844 179.67 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 21.1 tt0 -56.42 -44.62 80.56 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.335 179.424 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 77.4 m-20 -63.0 -46.66 86.63 Favored 'General case' 0 N--CA 1.463 0.186 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.813 179.353 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.686 HD11 ' O ' ' A' ' 36' ' ' LEU . 0.5 OUTLIER -53.33 -45.89 69.24 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-N 116.635 -0.257 . . . . 0.0 111.327 179.971 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -58.0 -51.54 69.25 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-N 116.471 -0.332 . . . . 0.0 111.024 179.869 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 58.6 mt-10 -67.13 -46.36 74.34 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.889 179.767 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 5.2 m-85 -53.98 -31.91 52.35 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.62 179.637 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 1.7 t80 -59.09 -49.2 78.79 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-O 120.671 0.272 . . . . 0.0 110.804 179.935 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 34.8 mt-10 -83.93 -35.5 23.99 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.006 179.841 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 2.6 mm-40 -66.63 -30.31 70.55 Favored 'General case' 0 CA--C 1.533 0.29 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.67 179.765 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -62.71 167.2 4.7 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-O 120.966 0.412 . . . . 0.0 111.991 -179.478 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -108.36 38.67 3.22 Favored Glycine 0 C--N 1.334 0.469 0 C-N-CA 121.115 -0.564 . . . . 0.0 112.632 179.885 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 7.6 tt -66.59 140.36 19.61 Favored 'Isoleucine or valine' 0 C--O 1.232 0.17 0 CA-C-O 120.925 0.393 . . . . 0.0 111.379 -179.883 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 10.6 m-70 -72.02 -62.92 1.42 Allowed Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.097 -179.729 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 65.6 Cg_endo -72.93 110.41 3.03 Favored 'Trans proline' 0 C--N 1.351 0.691 0 C-N-CA 122.469 2.113 . . . . 0.0 112.613 179.864 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_endo -67.13 -56.57 0.23 Allowed 'Trans proline' 0 C--N 1.351 0.672 0 C-N-CA 122.421 2.081 . . . . 0.0 111.957 179.892 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -153.11 151.86 26.85 Favored Pre-proline 0 CA--C 1.532 0.26 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.22 179.247 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -54.74 146.92 52.63 Favored 'Trans proline' 0 C--N 1.349 0.576 0 C-N-CA 123.053 2.502 . . . . 0.0 112.702 -179.794 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 7.9 pt -102.84 -34.8 3.66 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.293 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.932 -179.843 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -105.42 112.16 25.16 Favored 'General case' 0 C--O 1.232 0.172 0 CA-C-O 120.746 0.308 . . . . 0.0 111.305 -179.884 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -81.11 172.38 13.76 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.561 -179.902 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -161.36 -50.54 0.04 OUTLIER 'General case' 0 CA--C 1.531 0.223 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.445 179.887 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.463 0.196 0 CA-C-O 120.903 0.383 . . . . 0.0 111.192 -179.901 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 84' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.9 ttt . . . . . 0 N--CA 1.488 1.466 0 CA-C-O 120.677 0.275 . . . . 0.0 111.047 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 11.8 p -75.59 147.24 8.27 Favored 'Isoleucine or valine' 0 C--O 1.234 0.241 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.268 -179.877 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 72.7 m -93.44 74.39 4.48 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.353 -179.621 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 1.2 p -151.96 163.41 39.33 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.794 179.711 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' TYR . . . . . 0.544 ' CG ' HD11 ' A' ' 53' ' ' LEU . 2.8 m-85 -108.03 -73.74 0.68 Allowed 'General case' 0 C--O 1.233 0.226 0 CA-C-N 116.46 -0.337 . . . . 0.0 111.119 -179.968 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 8.9 p-10 -142.29 162.19 36.1 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.44 -179.515 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 -106.58 108.85 20.57 Favored 'General case' 0 CA--C 1.531 0.228 0 CA-C-N 115.857 -0.611 . . . . 0.0 110.976 -179.954 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 3.7 mp -93.73 150.14 4.07 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.23 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.215 179.95 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 4.0 tt0 -95.59 146.87 24.14 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.344 -179.734 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 2.9 tt -60.37 -33.19 53.08 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.296 0 CA-C-N 116.086 -0.507 . . . . 0.0 111.415 179.653 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 27.3 mt-10 -60.18 -35.24 74.93 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 116.464 -0.334 . . . . 0.0 110.892 179.532 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -96.44 37.22 1.28 Allowed 'General case' 0 CA--C 1.533 0.316 0 CA-C-O 120.804 0.335 . . . . 0.0 111.287 179.774 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 2.3 ttt -124.18 144.12 50.11 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.756 179.751 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 21.5 m -64.88 136.86 57.33 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.047 -179.788 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 19.7 p90 -105.89 131.04 53.68 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.009 179.771 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -118.65 91.8 42.82 Favored Pre-proline 0 C--N 1.33 -0.261 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.479 179.843 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 42.3 Cg_endo -70.82 -14.79 32.99 Favored 'Trans proline' 0 C--N 1.347 0.496 0 C-N-CA 122.598 2.199 . . . . 0.0 113.0 -179.932 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 -51.37 -35.26 37.79 Favored 'General case' 0 CA--C 1.533 0.319 0 N-CA-C 111.912 0.338 . . . . 0.0 111.912 -179.759 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 18.6 m-20 -148.71 26.67 0.91 Allowed 'General case' 0 CA--C 1.534 0.36 0 CA-C-N 116.624 -0.262 . . . . 0.0 111.579 -179.78 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 7.1 mt-30 55.02 69.84 0.69 Allowed 'General case' 0 CA--C 1.537 0.472 0 CA-C-O 120.921 0.391 . . . . 0.0 111.566 179.518 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 5.7 ptt? -151.52 167.49 27.87 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.938 179.577 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.526 ' HE1' HD21 ' A' ' 36' ' ' LEU . 17.4 m-85 -128.63 147.49 50.73 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 116.507 -0.315 . . . . 0.0 110.918 179.824 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 71.7 p -138.77 169.52 17.64 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.803 -179.615 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 47.6 t80 -163.54 137.09 4.4 Favored Pre-proline 0 N--CA 1.468 0.432 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.938 179.878 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -67.3 97.08 0.42 Allowed 'Trans proline' 0 C--N 1.352 0.713 0 C-N-CA 122.486 2.124 . . . . 0.0 112.11 179.446 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 26' ' ' CYS . . . . . 0.465 ' SG ' ' HD2' ' A' ' 27' ' ' PRO . 50.2 t -59.44 140.43 88.5 Favored Pre-proline 0 C--O 1.233 0.193 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.676 179.962 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 27' ' ' PRO . . . . . 0.465 ' HD2' ' SG ' ' A' ' 26' ' ' CYS . 74.5 Cg_exo -50.86 -27.75 21.54 Favored 'Trans proline' 0 C--N 1.349 0.591 0 C-N-CA 122.942 2.428 . . . . 0.0 113.098 179.928 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -71.48 -38.29 71.23 Favored 'General case' 0 CA--C 1.533 0.326 0 CA-C-O 120.485 0.183 . . . . 0.0 111.269 -179.905 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 149.45 -44.08 0.74 Allowed Glycine 0 C--N 1.337 0.6 0 C-N-CA 120.858 -0.687 . . . . 0.0 113.001 -179.971 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -68.26 176.85 2.55 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-O 120.84 0.352 . . . . 0.0 111.278 -179.716 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -118.43 128.82 54.98 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-N 116.492 -0.322 . . . . 0.0 110.998 -179.927 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 9.6 m-85 -62.54 160.13 14.44 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.859 179.671 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 10.5 pt20 -155.3 130.14 9.31 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-O 120.845 0.355 . . . . 0.0 111.401 -179.982 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 3.2 tt -157.3 124.19 0.56 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.281 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.904 179.707 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 32.0 m-85 -80.15 156.5 26.95 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.746 179.999 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.526 HD21 ' HE1' ' A' ' 22' ' ' PHE . 72.0 mt -58.73 -40.9 85.14 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.836 179.849 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -62.2 -35.22 78.21 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 116.447 -0.342 . . . . 0.0 111.408 179.675 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 18.1 m-20 -64.45 -60.08 3.58 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-O 120.862 0.363 . . . . 0.0 110.77 -179.943 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 13.7 ptp -60.18 -37.26 79.66 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.076 179.874 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 40' ' ' PHE . . . . . 0.428 ' HB2' ' CD2' ' A' ' 64' ' ' LEU . 23.2 t80 -59.8 -45.35 92.59 Favored 'General case' 0 CA--C 1.53 0.193 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.984 179.581 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -57.97 -42.2 84.53 Favored 'General case' 0 CA--C 1.532 0.251 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.005 179.799 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 149.78 65.73 0.01 OUTLIER Glycine 0 C--N 1.336 0.537 0 C-N-CA 120.773 -0.727 . . . . 0.0 113.086 179.632 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -120.01 156.63 30.51 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-O 120.655 0.264 . . . . 0.0 111.12 179.719 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.554 ' HG3' HG23 ' A' ' 45' ' ' VAL . 0.2 OUTLIER -162.77 -46.8 0.04 OUTLIER 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.164 179.532 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.554 HG23 ' HG3' ' A' ' 44' ' ' LYS . 22.0 t -96.89 89.22 2.02 Favored 'Isoleucine or valine' 0 C--O 1.234 0.28 0 CA-C-O 120.892 0.377 . . . . 0.0 110.644 179.692 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -80.1 141.54 35.7 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.24 -179.583 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 7.9 m -110.09 127.24 67.14 Favored 'Isoleucine or valine' 0 C--O 1.232 0.174 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.464 -179.879 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 51.0 t -72.13 135.64 82.32 Favored Pre-proline 0 C--N 1.331 -0.227 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.792 179.806 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 87.0 Cg_endo -84.0 19.22 1.4 Allowed 'Trans proline' 0 CA--C 1.537 0.631 0 C-N-CA 122.734 2.289 . . . . 0.0 113.234 179.96 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 2.0 t -127.74 -57.86 1.25 Allowed 'General case' 0 C--O 1.232 0.176 0 CA-C-O 120.558 0.218 . . . . 0.0 110.649 179.538 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 19.6 p -98.7 -19.81 17.29 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-N 116.455 -0.339 . . . . 0.0 111.73 179.888 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER 67.81 39.28 2.68 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-O 121.081 0.467 . . . . 0.0 110.955 -179.895 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.557 HD23 HG23 ' A' ' 55' ' ' ILE . 9.1 tt -91.25 132.9 35.83 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.631 179.875 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 54' ' ' MET . . . . . . . . . . . . . 15.1 mtt -87.92 130.49 34.91 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.194 -179.664 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.557 HG23 HD23 ' A' ' 53' ' ' LEU . 3.2 pt -133.45 144.51 35.86 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.237 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.456 179.676 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -101.7 107.59 18.87 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.226 179.148 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.438 ' O ' HG13 ' A' ' 57' ' ' VAL . 11.6 p -107.98 117.1 52.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-O 120.943 0.402 . . . . 0.0 111.01 -179.821 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 13.9 p -79.99 135.54 25.25 Favored 'Isoleucine or valine' 0 C--O 1.236 0.347 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.662 -179.896 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 8.0 p90 -142.96 169.39 17.66 Favored 'General case' 0 C--O 1.235 0.299 0 CA-C-N 115.782 -0.645 . . . . 0.0 110.97 -179.084 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -138.06 171.07 14.95 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.175 179.615 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 7.6 mttp -96.78 23.01 7.47 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.324 179.746 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 4.6 mt-10 -94.35 -47.81 6.43 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.224 179.206 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 3.0 t70 -68.55 -35.95 78.12 Favored 'General case' 0 N--CA 1.462 0.126 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.213 179.529 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.428 ' CD2' ' HB2' ' A' ' 40' ' ' PHE . 0.7 OUTLIER -55.05 -53.61 53.6 Favored 'General case' 0 CA--C 1.532 0.279 0 CA-C-N 116.694 -0.23 . . . . 0.0 111.358 -179.895 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -59.57 -44.6 93.25 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-O 120.811 0.339 . . . . 0.0 110.934 179.573 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -64.45 -45.15 88.67 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-N 115.857 -0.61 . . . . 0.0 111.102 179.884 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 67' ' ' TYR . . . . . 0.448 ' HD2' HD11 ' A' ' 36' ' ' LEU . 1.2 t80 -72.11 -39.85 68.59 Favored 'General case' 0 CA--C 1.531 0.239 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.899 -179.764 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 15.4 t80 -62.5 -36.96 84.17 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-O 120.577 0.227 . . . . 0.0 110.86 179.924 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 32.4 mt-10 -78.11 -32.82 50.73 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.987 179.471 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 4.8 tt0 -114.23 40.4 2.52 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-N 116.546 -0.297 . . . . 0.0 111.492 -179.79 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -79.07 151.48 31.41 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-O 120.986 0.422 . . . . 0.0 111.62 -179.942 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -95.05 32.73 5.89 Favored Glycine 0 C--N 1.335 0.477 0 CA-C-N 115.694 -0.685 . . . . 0.0 112.82 179.693 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 4.6 tt -83.28 -35.7 12.1 Favored 'Isoleucine or valine' 0 C--O 1.233 0.236 0 CA-C-O 120.725 0.298 . . . . 0.0 111.143 179.862 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 22.4 p80 -87.14 146.61 40.68 Favored Pre-proline 0 CA--C 1.53 0.21 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.626 179.454 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -71.08 116.43 4.69 Favored 'Trans proline' 0 C--N 1.349 0.583 0 C-N-CA 122.741 2.294 . . . . 0.0 112.337 -179.747 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -60.18 171.59 3.03 Favored 'Trans proline' 0 C--N 1.351 0.667 0 C-N-CA 122.883 2.389 . . . . 0.0 112.772 -179.644 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 77' ' ' GLU . . . . . 0.401 ' HA ' ' HD3' ' A' ' 78' ' ' PRO . 1.8 mt-10 -94.17 148.36 35.0 Favored Pre-proline 0 C--O 1.232 0.156 0 CA-C-N 115.872 -0.604 . . . . 0.0 111.388 -179.873 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 78' ' ' PRO . . . . . 0.574 ' C ' HD12 ' A' ' 79' ' ' ILE . 39.3 Cg_exo -56.87 87.84 0.04 OUTLIER 'Trans proline' 0 C--N 1.352 0.755 0 C-N-CA 123.053 2.502 . . . . 0.0 112.725 179.926 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.574 HD12 ' C ' ' A' ' 78' ' ' PRO . 3.7 mp 66.86 133.93 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.338 0 CA-C-N 115.781 -0.645 . . . . 0.0 111.724 -179.971 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -130.83 -65.9 0.77 Allowed 'General case' 0 CA--C 1.53 0.21 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.478 179.89 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -101.75 -31.55 10.72 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 116.538 -0.301 . . . . 0.0 111.633 -179.717 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -60.23 115.2 3.33 Favored 'General case' 0 C--O 1.232 0.162 0 CA-C-N 116.463 -0.335 . . . . 0.0 111.272 -179.828 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.161 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.96 179.861 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 84' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 19.6 ptp . . . . . 0 N--CA 1.49 1.569 0 CA-C-O 120.703 0.287 . . . . 0.0 111.45 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 5.0 m -149.59 33.75 0.1 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.429 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.285 -179.952 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 61.75 -164.21 0.25 Allowed 'General case' 0 CA--C 1.536 0.419 0 CA-C-N 116.635 -0.257 . . . . 0.0 110.841 -179.665 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.51 HG21 ' CG ' ' A' ' 56' ' ' ASP . 0.8 OUTLIER -67.17 158.15 31.96 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-O 120.772 0.32 . . . . 0.0 111.172 179.963 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 5' ' ' TYR . . . . . 0.597 ' CD1' HD11 ' A' ' 53' ' ' LEU . 61.2 m-85 -95.07 -35.26 11.99 Favored 'General case' 0 CA--C 1.53 0.197 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.523 179.991 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -155.04 174.1 15.65 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-O 120.812 0.339 . . . . 0.0 111.328 179.887 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 26.5 tt0 -130.8 114.33 15.2 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.649 -179.936 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.408 HG21 ' CE ' ' A' ' 13' ' ' MET . 27.8 mm -93.2 155.61 3.12 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.178 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.744 179.897 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 4.3 pm0 -119.1 145.97 45.49 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.171 -179.807 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 8.2 tp -59.21 -33.53 50.99 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.328 0 CA-C-N 116.277 -0.419 . . . . 0.0 111.168 179.595 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 8.4 mt-10 -65.68 -32.25 73.71 Favored 'General case' 0 CA--C 1.533 0.318 0 CA-C-N 116.461 -0.336 . . . . 0.0 111.155 179.445 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 11.0 t0 -98.63 40.32 1.2 Allowed 'General case' 0 CA--C 1.533 0.3 0 CA-C-O 120.97 0.414 . . . . 0.0 110.664 179.617 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' MET . . . . . 0.411 ' HG3' ' HB2' ' A' ' 24' ' ' TYR . 0.9 OUTLIER -131.83 163.96 27.11 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.937 179.803 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 5.8 m -96.62 119.93 36.0 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-N 116.43 -0.35 . . . . 0.0 110.824 -179.809 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 20.8 p90 -98.56 134.14 41.94 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.529 179.618 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 4.5 mt-10 -107.11 94.3 10.75 Favored Pre-proline 0 C--O 1.234 0.239 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.521 179.952 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -73.0 65.24 4.14 Favored 'Trans proline' 0 C--N 1.35 0.629 0 C-N-CA 122.936 2.424 . . . . 0.0 112.5 -179.553 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 5.4 pt-20 -135.92 -49.48 0.69 Allowed 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.676 -0.693 . . . . 0.0 111.062 179.991 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -135.54 32.19 3.07 Favored 'General case' 0 CA--C 1.535 0.382 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.384 179.865 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 20' ' ' GLN . . . . . 0.661 ' HG3' HD13 ' A' ' 36' ' ' LEU . 0.2 OUTLIER 55.48 59.29 3.98 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-O 121.037 0.446 . . . . 0.0 111.273 -179.995 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 10.6 ptm -143.14 163.28 33.3 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.989 179.791 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.579 ' CZ ' HG23 ' A' ' 34' ' ' ILE . 4.5 p90 -150.82 144.32 24.98 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.09 -179.997 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 23' ' ' THR . . . . . 0.441 HG22 ' HA ' ' A' ' 33' ' ' GLN . 76.4 p -134.62 167.35 20.98 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-N 115.987 -0.551 . . . . 0.0 111.689 -179.386 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 24' ' ' TYR . . . . . 0.411 ' HB2' ' HG3' ' A' ' 13' ' ' MET . 31.6 t80 -153.41 136.72 10.06 Favored Pre-proline 0 CA--C 1.531 0.239 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.937 -179.993 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo -66.58 101.94 0.57 Allowed 'Trans proline' 0 C--N 1.35 0.623 0 C-N-CA 122.706 2.27 . . . . 0.0 112.415 179.739 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 26' ' ' CYS . . . . . 0.419 ' SG ' ' HD2' ' A' ' 27' ' ' PRO . 41.8 t -62.82 139.23 97.21 Favored Pre-proline 0 C--O 1.232 0.184 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.605 179.688 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 27' ' ' PRO . . . . . 0.419 ' HD2' ' SG ' ' A' ' 26' ' ' CYS . 76.3 Cg_exo -51.44 -27.27 23.9 Favored 'Trans proline' 0 C--N 1.349 0.602 0 C-N-CA 122.847 2.365 . . . . 0.0 113.029 179.858 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 28' ' ' CYS . . . . . 0.422 ' CB ' ' HB3' ' A' ' 51' ' ' CYS . 0.8 OUTLIER -69.66 -36.88 76.43 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-N 116.849 -0.16 . . . . 0.0 111.425 179.947 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 148.53 -43.54 0.8 Allowed Glycine 0 C--N 1.337 0.599 0 C-N-CA 120.881 -0.676 . . . . 0.0 113.141 179.91 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -69.49 -177.77 1.26 Allowed 'General case' 0 N--CA 1.465 0.315 0 CA-C-O 120.841 0.353 . . . . 0.0 111.442 -179.686 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 1.4 tpp180 -121.74 118.53 29.31 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.033 -179.918 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 34.3 t80 -59.87 142.74 52.96 Favored 'General case' 0 CA--C 1.528 0.103 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.448 179.394 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 33' ' ' GLN . . . . . 0.441 ' HA ' HG22 ' A' ' 23' ' ' THR . 1.5 pt20 -135.81 143.97 45.46 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-N 116.539 -0.3 . . . . 0.0 111.214 -179.814 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.579 HG23 ' CZ ' ' A' ' 22' ' ' PHE . 8.2 tt -174.79 149.24 0.41 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.343 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.02 -179.953 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 64.9 m-85 -99.14 159.62 14.85 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.05 -179.806 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.661 HD13 ' HG3' ' A' ' 20' ' ' GLN . 7.9 mp -60.69 -44.27 96.73 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.728 179.831 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -57.9 -40.22 79.82 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.678 179.327 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -60.26 -42.37 95.22 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.521 179.292 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 4.5 mtp -91.55 33.41 1.01 Allowed 'General case' 0 CA--C 1.534 0.356 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.253 179.367 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 18.0 t80 -135.95 -47.32 0.66 Allowed 'General case' 0 C--O 1.233 0.207 0 CA-C-N 116.654 -0.248 . . . . 0.0 110.865 179.647 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 12.9 tt0 -58.69 -44.62 90.32 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.884 179.675 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 167.28 68.17 0.03 OUTLIER Glycine 0 C--N 1.335 0.492 0 C-N-CA 120.892 -0.671 . . . . 0.0 112.843 179.713 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -144.08 156.02 44.19 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-O 120.818 0.342 . . . . 0.0 111.439 -179.968 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 4.7 pttp -156.21 -47.35 0.08 Allowed 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 115.886 -0.597 . . . . 0.0 111.107 179.811 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.417 HG13 ' O ' ' A' ' 45' ' ' VAL . 10.5 p -103.74 120.36 53.72 Favored 'Isoleucine or valine' 0 C--O 1.233 0.211 0 CA-C-O 120.898 0.38 . . . . 0.0 110.797 179.735 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -111.99 173.83 6.17 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.162 -179.844 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 19.9 t -128.48 137.8 56.39 Favored 'Isoleucine or valine' 0 C--O 1.235 0.29 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.441 -179.669 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 43.8 t -78.6 136.12 59.79 Favored Pre-proline 0 C--O 1.233 0.222 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.679 179.624 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_endo -84.31 22.16 0.98 Allowed 'Trans proline' 0 C--N 1.349 0.595 0 C-N-CA 122.828 2.352 . . . . 0.0 113.339 179.951 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 36.4 m -131.26 -57.13 1.02 Allowed 'General case' 0 C--O 1.233 0.219 0 CA-C-O 120.507 0.194 . . . . 0.0 110.674 179.825 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 51' ' ' CYS . . . . . 0.422 ' HB3' ' CB ' ' A' ' 28' ' ' CYS . 19.2 p -95.68 -19.18 19.92 Favored 'General case' 0 CA--C 1.535 0.369 0 CA-C-N 116.489 -0.323 . . . . 0.0 111.615 179.441 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 1.7 m 62.97 40.83 8.96 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-O 121.061 0.457 . . . . 0.0 111.014 -179.728 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.597 HD11 ' CD1' ' A' ' 5' ' ' TYR . 7.1 tp -95.02 142.94 26.91 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.873 179.898 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 54' ' ' MET . . . . . . . . . . . . . 17.3 mtm -91.99 128.39 37.81 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.709 179.817 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 19.0 pt -137.62 139.41 43.25 Favored 'Isoleucine or valine' 0 C--O 1.233 0.227 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.452 -179.659 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 56' ' ' ASP . . . . . 0.51 ' CG ' HG21 ' A' ' 4' ' ' THR . 91.5 m-20 -99.06 90.13 4.5 Favored 'General case' 0 C--O 1.231 0.13 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.493 179.417 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.443 ' O ' HG13 ' A' ' 57' ' ' VAL . 9.4 p -86.79 114.54 26.22 Favored 'Isoleucine or valine' 0 C--O 1.233 0.216 0 CA-C-O 120.993 0.425 . . . . 0.0 110.759 179.697 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 14.3 p -79.71 142.79 13.49 Favored 'Isoleucine or valine' 0 C--O 1.233 0.213 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.269 -179.75 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 36.2 p90 -132.43 177.94 7.21 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.691 -179.827 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -121.87 -167.1 1.48 Allowed 'General case' 0 CA--C 1.534 0.331 0 CA-C-O 120.792 0.33 . . . . 0.0 110.789 179.781 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 4.7 mmtp -113.98 -44.99 3.1 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.288 179.255 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 7.7 mt-10 -61.71 -34.2 75.37 Favored 'General case' 0 CA--C 1.529 0.17 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.206 179.58 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 34.8 p30 -56.73 -32.6 65.7 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 116.843 -0.162 . . . . 0.0 111.25 179.582 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.626 ' HG ' HD23 ' A' ' 36' ' ' LEU . 1.3 mp -79.27 -53.29 7.1 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-O 120.658 0.266 . . . . 0.0 110.612 179.355 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -56.04 -38.92 71.22 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.814 179.473 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 26.9 tt0 -68.73 -40.53 79.86 Favored 'General case' 0 CA--C 1.531 0.242 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.776 179.335 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 67' ' ' TYR . . . . . 0.524 ' HD2' HE21 ' A' ' 20' ' ' GLN . 0.1 OUTLIER -68.38 -39.81 81.62 Favored 'General case' 0 CA--C 1.53 0.185 0 CA-C-N 116.525 -0.307 . . . . 0.0 111.628 179.842 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 6.0 m-85 -60.46 -41.81 94.89 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 116.773 -0.194 . . . . 0.0 111.081 -179.858 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 16.9 pt-20 -77.84 -33.56 52.2 Favored 'General case' 0 CA--C 1.533 0.322 0 CA-C-N 116.621 -0.263 . . . . 0.0 111.234 179.698 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -74.17 -51.79 14.46 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-O 120.605 0.24 . . . . 0.0 111.41 -179.951 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -76.93 136.86 38.81 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-O 120.816 0.341 . . . . 0.0 111.358 -179.872 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -89.83 49.17 3.33 Favored Glycine 0 C--N 1.334 0.437 0 C-N-CA 121.09 -0.576 . . . . 0.0 112.935 179.995 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 1.1 tp -76.65 -36.72 27.84 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.234 0 CA-C-O 120.585 0.231 . . . . 0.0 111.128 179.7 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 1.8 t-80 -140.58 85.88 12.7 Favored Pre-proline 0 CA--C 1.531 0.237 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.889 179.78 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -70.07 154.7 66.25 Favored 'Trans proline' 0 C--N 1.348 0.515 0 C-N-CA 122.696 2.264 . . . . 0.0 112.438 179.918 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -54.09 133.54 55.79 Favored 'Trans proline' 0 C--N 1.351 0.706 0 C-N-CA 122.915 2.41 . . . . 0.0 112.641 -179.9 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 8.9 tt0 -168.09 85.91 0.73 Allowed Pre-proline 0 CA--C 1.534 0.328 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.245 -179.97 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_exo -58.53 171.98 1.67 Allowed 'Trans proline' 0 C--N 1.351 0.675 0 C-N-CA 123.006 2.47 . . . . 0.0 112.802 -179.966 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 24.7 mm -86.27 -42.88 16.07 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.232 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.408 -179.951 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -170.03 43.37 0.03 OUTLIER 'General case' 0 CA--C 1.533 0.322 0 CA-C-O 120.765 0.317 . . . . 0.0 111.194 179.531 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . 53.38 34.53 18.24 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.257 -179.621 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -86.59 -64.35 1.17 Allowed 'General case' 0 CA--C 1.531 0.25 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.578 -179.539 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.255 0 CA-C-O 120.976 0.417 . . . . 0.0 111.154 -179.98 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 84' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.488 1.459 0 CA-C-O 120.767 0.318 . . . . 0.0 111.376 . . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 28.6 m -104.06 165.58 3.29 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.186 0 CA-C-N 116.328 -0.397 . . . . 0.0 111.157 179.662 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 19.6 m -125.15 148.12 48.72 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.783 179.844 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.556 HG21 ' OD1' ' A' ' 56' ' ' ASP . 68.0 p -141.19 157.64 44.98 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-O 120.756 0.313 . . . . 0.0 111.518 -179.896 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 5' ' ' TYR . . . . . 0.507 ' HB2' HD11 ' A' ' 53' ' ' LEU . 10.8 t80 -104.93 -41.32 5.65 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.137 -179.992 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 6' ' ' ASP . . . . . 0.467 ' HB2' ' CD1' ' A' ' 5' ' ' TYR . 5.1 t70 -155.95 161.33 40.53 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-O 120.801 0.334 . . . . 0.0 111.633 -179.565 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -117.12 119.97 36.88 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.861 179.474 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.415 ' O ' ' HA ' ' A' ' 57' ' ' VAL . 3.7 mp -111.53 153.16 13.3 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.226 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.309 -179.581 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 9' ' ' GLU . . . . . 0.534 ' HA ' HG12 ' A' ' 58' ' ' VAL . 15.7 mt-10 -103.08 152.03 21.86 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.362 -179.841 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 1.1 tp -58.0 -35.35 51.8 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.297 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.253 179.508 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -63.37 -32.75 74.26 Favored 'General case' 0 CA--C 1.53 0.196 0 CA-C-N 116.544 -0.298 . . . . 0.0 111.151 179.544 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -96.18 36.79 1.29 Allowed 'General case' 0 CA--C 1.531 0.243 0 CA-C-O 120.762 0.315 . . . . 0.0 111.266 -179.987 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 13' ' ' MET . . . . . 0.422 ' HG3' ' HB2' ' A' ' 24' ' ' TYR . 7.6 ttt -127.31 140.84 51.93 Favored 'General case' 0 C--N 1.333 -0.128 0 CA-C-N 116.458 -0.337 . . . . 0.0 110.56 179.643 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 14' ' ' THR . . . . . 0.676 HG21 HH21 ' A' ' 31' ' ' ARG . 19.4 m -61.19 140.08 58.0 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.919 179.999 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 9.1 m-85 -105.14 135.28 46.79 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.772 -179.974 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -117.56 88.77 30.34 Favored Pre-proline 0 C--O 1.234 0.24 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.608 179.572 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 12.9 Cg_exo -70.7 65.16 2.36 Favored 'Trans proline' 0 C--N 1.349 0.556 0 C-N-CA 123.014 2.476 . . . . 0.0 112.47 -179.649 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 5.9 pt-20 -137.05 -51.89 0.67 Allowed 'General case' 0 C--O 1.232 0.177 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.909 179.945 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 19' ' ' ASN . . . . . 0.751 ' HA ' HD12 ' A' ' 73' ' ' ILE . 70.8 m-20 -137.0 32.14 2.67 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-N 116.407 -0.36 . . . . 0.0 111.088 179.587 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 13.0 mm-40 56.87 61.9 2.45 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-O 120.917 0.389 . . . . 0.0 110.653 -179.861 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 3.8 ptm -134.26 150.41 51.01 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.957 -179.81 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.715 ' CE1' HD21 ' A' ' 36' ' ' LEU . 5.4 m-85 -122.99 126.86 47.97 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.659 -179.731 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 67.4 p -108.98 156.2 20.0 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.163 -179.87 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 24' ' ' TYR . . . . . 0.422 ' HB2' ' HG3' ' A' ' 13' ' ' MET . 64.8 t80 -148.12 107.34 3.65 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.54 179.824 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_exo -54.34 96.18 0.05 OUTLIER 'Trans proline' 0 C--N 1.348 0.551 0 C-N-CA 122.585 2.19 . . . . 0.0 111.95 -179.966 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 26' ' ' CYS . . . . . 0.451 ' SG ' ' HD2' ' A' ' 27' ' ' PRO . 46.4 t -63.46 139.19 97.55 Favored Pre-proline 0 C--O 1.233 0.225 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.909 -179.584 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 27' ' ' PRO . . . . . 0.451 ' HD2' ' SG ' ' A' ' 26' ' ' CYS . 10.1 Cg_endo -52.92 -23.3 20.72 Favored 'Trans proline' 0 C--N 1.349 0.554 0 C-N-CA 122.911 2.407 . . . . 0.0 112.834 179.745 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 6.1 p -59.43 -28.89 67.36 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-O 120.626 0.251 . . . . 0.0 111.222 179.839 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 125.11 4.74 7.03 Favored Glycine 0 CA--C 1.523 0.569 0 C-N-CA 120.988 -0.625 . . . . 0.0 113.6 179.976 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -119.91 -164.72 1.1 Allowed 'General case' 0 CA--C 1.534 0.341 0 CA-C-N 117.552 0.676 . . . . 0.0 111.424 -179.903 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 31' ' ' ARG . . . . . 0.676 HH21 HG21 ' A' ' 14' ' ' THR . 1.4 tpt180 -124.87 138.78 54.24 Favored 'General case' 0 C--O 1.232 0.155 0 CA-C-O 120.837 0.351 . . . . 0.0 111.561 -179.425 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 2.5 m-85 -81.29 165.16 21.66 Favored 'General case' 0 C--O 1.232 0.166 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.641 179.293 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 3.7 pt20 -155.46 122.92 5.56 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.438 -0.347 . . . . 0.0 111.009 179.785 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 4.3 tt -150.02 136.43 12.35 Favored 'Isoleucine or valine' 0 C--O 1.233 0.236 0 CA-C-N 116.308 -0.406 . . . . 0.0 111.141 -179.926 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 9.7 m-85 -96.39 156.5 16.31 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.011 -179.803 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.715 HD21 ' CE1' ' A' ' 22' ' ' PHE . 86.8 mt -63.64 -40.3 96.52 Favored 'General case' 0 N--CA 1.462 0.165 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.061 179.829 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 2.0 t0 -59.06 -35.76 73.89 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 116.499 -0.318 . . . . 0.0 111.361 179.928 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 9.7 m-20 -68.44 -58.53 4.2 Favored 'General case' 0 C--O 1.231 0.109 0 CA-C-O 120.828 0.347 . . . . 0.0 110.879 179.947 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 11.7 ptp -62.26 -34.03 75.75 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.527 -179.78 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 40' ' ' PHE . . . . . 0.403 ' HB2' ' CD2' ' A' ' 64' ' ' LEU . 22.4 t80 -60.21 -45.77 92.05 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 116.418 -0.355 . . . . 0.0 110.815 179.698 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 11.0 tt0 -57.93 -37.05 73.37 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.836 179.559 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 143.0 68.34 0.02 OUTLIER Glycine 0 C--N 1.334 0.426 0 C-N-CA 120.917 -0.659 . . . . 0.0 112.586 179.675 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -125.93 122.42 35.93 Favored 'General case' 0 N--CA 1.462 0.144 0 CA-C-O 120.7 0.286 . . . . 0.0 111.414 -179.769 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 14.0 mttt -118.68 -45.09 2.61 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.916 179.413 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.474 HG13 ' O ' ' A' ' 45' ' ' VAL . 10.6 p -104.55 114.52 44.37 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.182 0 CA-C-O 120.983 0.42 . . . . 0.0 110.98 179.904 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -106.92 151.45 25.25 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.947 -0.569 . . . . 0.0 111.433 -179.52 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 20.4 t -105.13 129.63 57.54 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.15 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.351 -179.893 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 50.2 t -69.43 135.35 88.65 Favored Pre-proline 0 N--CA 1.463 0.175 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.919 179.659 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 91.0 Cg_endo -83.9 19.05 1.42 Allowed 'Trans proline' 0 CA--C 1.535 0.537 0 C-N-CA 122.583 2.189 . . . . 0.0 113.118 179.953 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 1.9 m -129.1 -59.5 1.11 Allowed 'General case' 0 C--O 1.232 0.154 0 CA-C-O 120.412 0.148 . . . . 0.0 110.762 179.725 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 20.8 p -101.5 -14.2 17.6 Favored 'General case' 0 CA--C 1.535 0.377 0 N-CA-C 111.746 0.276 . . . . 0.0 111.746 179.789 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER 66.01 34.0 7.31 Favored 'General case' 0 CA--C 1.533 0.302 0 CA-C-O 120.848 0.356 . . . . 0.0 111.151 -179.98 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.507 HD11 ' HB2' ' A' ' 5' ' ' TYR . 16.8 tp -86.47 133.21 33.77 Favored 'General case' 0 C--O 1.232 0.14 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.709 179.76 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 54' ' ' MET . . . . . . . . . . . . . 15.3 mtt -82.72 129.9 35.04 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.696 179.995 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 3.0 pt -135.9 143.26 36.71 Favored 'Isoleucine or valine' 0 C--O 1.233 0.236 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.816 -179.474 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 56' ' ' ASP . . . . . 0.556 ' OD1' HG21 ' A' ' 4' ' ' THR . 30.1 m-20 -91.44 99.93 12.79 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.82 179.497 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.493 ' O ' HG13 ' A' ' 57' ' ' VAL . 10.2 p -105.19 110.52 31.23 Favored 'Isoleucine or valine' 0 C--O 1.234 0.262 0 CA-C-O 121.105 0.478 . . . . 0.0 110.927 179.723 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.534 HG12 ' HA ' ' A' ' 9' ' ' GLU . 12.3 p -82.05 138.14 19.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.407 -179.466 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 33.9 p90 -117.22 175.37 5.64 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.771 -0.65 . . . . 0.0 111.114 -179.683 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 60' ' ' ASP . . . . . 0.522 ' HB3' ' HB2' ' A' ' 63' ' ' ASP . 1.9 t70 -134.28 128.37 33.68 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.136 179.897 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 1.9 mptt -61.53 -42.35 98.69 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.638 179.514 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 23.5 mt-10 -63.95 -39.13 93.45 Favored 'General case' 0 C--O 1.232 0.137 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.328 179.187 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 63' ' ' ASP . . . . . 0.522 ' HB2' ' HB3' ' A' ' 60' ' ' ASP . 12.9 t70 -56.63 -45.02 81.77 Favored 'General case' 0 N--CA 1.462 0.126 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.886 179.331 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.639 ' HG ' HD22 ' A' ' 36' ' ' LEU . 1.1 mp -56.89 -55.62 32.18 Favored 'General case' 0 CA--C 1.529 0.151 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.517 -179.56 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -60.11 -46.91 88.02 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-N 116.673 -0.239 . . . . 0.0 111.483 -179.753 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 10.3 mm-40 -63.34 -42.62 98.94 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.901 179.877 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 33.9 t80 -69.91 -36.39 75.33 Favored 'General case' 0 CA--C 1.531 0.239 0 CA-C-N 116.481 -0.327 . . . . 0.0 111.149 179.599 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 2.2 t80 -55.7 -54.47 43.9 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-N 116.674 -0.239 . . . . 0.0 111.045 -179.882 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -69.83 -35.87 75.13 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.231 179.844 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 13.5 mt-10 -64.09 -38.37 90.81 Favored 'General case' 0 CA--C 1.53 0.179 0 CA-C-N 116.398 -0.365 . . . . 0.0 111.733 -179.831 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -64.95 -61.57 2.08 Favored 'General case' 0 C--O 1.233 0.194 0 N-CA-C 111.633 0.235 . . . . 0.0 111.633 -179.315 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 91.3 37.54 6.21 Favored Glycine 0 C--N 1.334 0.429 0 C-N-CA 120.806 -0.711 . . . . 0.0 112.868 179.742 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.751 HD12 ' HA ' ' A' ' 19' ' ' ASN . 14.1 tt -73.38 141.48 16.23 Favored 'Isoleucine or valine' 0 C--O 1.233 0.226 0 CA-C-O 120.823 0.344 . . . . 0.0 111.201 179.944 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 27.6 t-80 -173.09 79.49 0.41 Allowed Pre-proline 0 C--N 1.33 -0.245 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.007 -179.909 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_exo -51.68 106.56 0.14 Allowed 'Trans proline' 0 C--N 1.35 0.631 0 C-N-CA 122.778 2.319 . . . . 0.0 112.366 179.948 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -68.73 -50.61 0.59 Allowed 'Trans proline' 0 C--N 1.349 0.567 0 C-N-CA 122.386 2.057 . . . . 0.0 112.442 -179.591 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -173.04 150.44 1.96 Allowed Pre-proline 0 C--O 1.234 0.251 0 CA-C-N 116.473 -0.331 . . . . 0.0 110.812 179.87 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 69.8 Cg_endo -73.41 179.62 5.35 Favored 'Trans proline' 0 C--N 1.349 0.555 0 C-N-CA 122.734 2.29 . . . . 0.0 112.539 -179.877 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.435 ' O ' HG22 ' A' ' 79' ' ' ILE . 13.7 mt -136.86 39.25 0.53 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.446 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.293 179.992 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -137.86 148.15 45.15 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-N 116.519 -0.31 . . . . 0.0 110.821 179.634 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -69.8 -69.22 0.36 Allowed 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 116.59 -0.277 . . . . 0.0 111.267 -179.862 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -109.58 -53.76 2.63 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 116.53 -0.305 . . . . 0.0 110.956 179.729 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.125 0 CA-C-O 121.002 0.43 . . . . 0.0 111.138 179.806 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 84' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.49 1.535 0 CA-C-O 120.658 0.266 . . . . 0.0 111.197 . . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 11.8 m -132.28 29.59 1.19 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.373 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.631 179.776 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 87.2 p -130.43 -179.32 5.2 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-O 120.625 0.25 . . . . 0.0 110.964 179.978 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.549 HG21 ' CG ' ' A' ' 56' ' ' ASP . 72.8 p -76.02 165.47 24.91 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-O 120.91 0.386 . . . . 0.0 111.262 -179.878 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 9.3 m-85 -105.89 -39.56 5.98 Favored 'General case' 0 CA--C 1.531 0.217 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.397 179.887 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -158.6 176.96 11.74 Favored 'General case' 0 C--O 1.235 0.299 0 CA-C-N 116.451 -0.341 . . . . 0.0 111.256 -179.91 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 2.2 pt-20 -123.14 151.37 42.19 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.906 -179.992 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 25.4 mt -133.2 149.59 31.67 Favored 'Isoleucine or valine' 0 C--O 1.232 0.181 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.254 -179.803 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 39.2 mt-10 -88.63 150.52 22.99 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.062 179.714 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 14.4 tt -56.86 -34.87 44.86 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.327 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.042 179.221 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -71.59 -44.13 65.03 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.106 179.573 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -53.06 -23.25 7.27 Favored 'General case' 0 N--CA 1.469 0.503 0 N-CA-C 112.026 0.38 . . . . 0.0 112.026 -179.973 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 13' ' ' MET . . . . . 0.403 ' CG ' ' HB2' ' A' ' 24' ' ' TYR . 4.8 ttm -88.42 137.53 32.24 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-N 116.791 -0.186 . . . . 0.0 110.708 179.867 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 29.4 m -60.62 145.27 49.65 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-O 120.735 0.302 . . . . 0.0 111.115 -179.945 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 16.3 p90 -104.84 144.27 31.99 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.272 179.992 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 9.0 mp0 -130.55 93.92 30.85 Favored Pre-proline 0 C--O 1.233 0.23 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.667 179.804 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -68.12 -17.0 45.5 Favored 'Trans proline' 0 C--N 1.349 0.576 0 C-N-CA 122.938 2.425 . . . . 0.0 112.86 179.585 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -54.35 -39.13 66.82 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 116.615 -0.266 . . . . 0.0 111.677 -179.96 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 2.1 m120 -144.7 20.03 1.66 Allowed 'General case' 0 CA--C 1.535 0.37 0 CA-C-N 116.431 -0.349 . . . . 0.0 111.839 -179.521 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 20' ' ' GLN . . . . . 0.447 ' OE1' ' HB ' ' A' ' 73' ' ' ILE . 0.0 OUTLIER 55.68 79.32 0.16 Allowed 'General case' 0 C--O 1.234 0.237 0 CA-C-O 121.142 0.496 . . . . 0.0 111.288 179.636 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 3.2 ptt? -159.54 163.69 34.95 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.78 179.912 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 80.3 m-85 -123.58 118.78 28.12 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.617 179.792 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 14.7 p -105.46 152.03 23.52 Favored 'General case' 0 CA--C 1.53 0.184 0 CA-C-O 120.809 0.338 . . . . 0.0 111.145 -179.895 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 24' ' ' TYR . . . . . 0.403 ' HB2' ' CG ' ' A' ' 13' ' ' MET . 38.4 t80 -159.16 136.46 6.99 Favored Pre-proline 0 N--CA 1.463 0.198 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.018 -179.979 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -72.19 110.37 2.93 Favored 'Trans proline' 0 C--N 1.348 0.525 0 C-N-CA 122.496 2.131 . . . . 0.0 112.317 179.699 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 26' ' ' CYS . . . . . 0.46 ' SG ' ' HD2' ' A' ' 27' ' ' PRO . 51.5 t -77.63 140.14 63.57 Favored Pre-proline 0 C--O 1.233 0.209 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.463 179.56 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 27' ' ' PRO . . . . . 0.46 ' HD2' ' SG ' ' A' ' 26' ' ' CYS . 81.8 Cg_exo -49.41 -28.71 16.3 Favored 'Trans proline' 0 C--N 1.35 0.642 0 C-N-CA 123.041 2.494 . . . . 0.0 113.124 179.861 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 3.6 p -61.99 -29.83 70.53 Favored 'General case' 0 C--O 1.236 0.36 0 CA-C-O 120.657 0.265 . . . . 0.0 111.286 179.875 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 116.29 15.92 6.87 Favored Glycine 0 CA--C 1.525 0.696 0 C-N-CA 121.364 -0.446 . . . . 0.0 113.291 -179.894 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -120.11 -171.65 2.2 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-N 117.113 0.457 . . . . 0.0 111.056 -179.995 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 3.8 ttt180 -108.56 131.94 54.35 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-O 120.89 0.376 . . . . 0.0 111.367 -179.701 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 5.1 t80 -100.43 102.15 13.28 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.547 179.775 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 9.2 mt-30 -101.41 154.43 18.82 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.076 -179.781 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.409 HD13 ' HE3' ' A' ' 39' ' ' MET . 2.4 tt -161.98 123.48 0.31 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.254 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.044 179.674 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 1.3 t80 -76.1 145.11 40.26 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.829 -179.905 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.439 HD13 ' C ' ' A' ' 20' ' ' GLN . 10.1 mp -58.53 -42.78 88.56 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.852 179.714 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -60.21 -37.81 81.39 Favored 'General case' 0 N--CA 1.462 0.134 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.818 179.232 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -57.9 -52.02 67.21 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.866 179.715 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 39' ' ' MET . . . . . 0.409 ' HE3' HD13 ' A' ' 34' ' ' ILE . 7.8 mtt -67.61 -36.59 81.12 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 116.066 -0.516 . . . . 0.0 111.03 179.648 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 16.8 t80 -63.6 -42.5 98.23 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.975 179.732 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 3.0 tp10 -55.53 -35.5 65.71 Favored 'General case' 0 CA--C 1.532 0.269 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.195 179.68 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 139.42 54.91 0.05 OUTLIER Glycine 0 C--N 1.334 0.437 0 C-N-CA 121.15 -0.548 . . . . 0.0 112.433 179.669 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -103.65 150.68 23.78 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-O 120.87 0.367 . . . . 0.0 111.451 -179.711 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 87.0 mttt -147.02 -47.51 0.18 Allowed 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 115.894 -0.593 . . . . 0.0 111.226 179.905 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.509 HG22 ' OD1' ' A' ' 56' ' ' ASP . 15.7 t -107.54 99.97 9.72 Favored 'Isoleucine or valine' 0 C--O 1.233 0.21 0 CA-C-O 120.782 0.325 . . . . 0.0 110.799 179.985 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -88.1 148.49 24.43 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.202 -179.985 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 20.4 t -114.37 129.93 69.53 Favored 'Isoleucine or valine' 0 C--O 1.233 0.19 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.927 -179.902 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 48.9 t -68.87 136.48 89.89 Favored Pre-proline 0 N--CA 1.463 0.202 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.822 179.892 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 89.5 Cg_endo -83.5 19.43 1.34 Allowed 'Trans proline' 0 CA--C 1.536 0.58 0 C-N-CA 122.684 2.256 . . . . 0.0 113.084 179.854 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 43.0 t -128.03 -59.62 1.18 Allowed 'General case' 0 C--O 1.233 0.205 0 CA-C-O 120.57 0.224 . . . . 0.0 110.506 179.675 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 51' ' ' CYS . . . . . 0.785 ' SG ' HD23 ' A' ' 53' ' ' LEU . 22.9 p -101.16 -19.53 15.7 Favored 'General case' 0 CA--C 1.535 0.377 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.821 179.888 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 1.6 t 72.94 36.31 0.9 Allowed 'General case' 0 CA--C 1.535 0.375 0 CA-C-O 120.869 0.366 . . . . 0.0 111.039 -179.767 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.785 HD23 ' SG ' ' A' ' 51' ' ' CYS . 0.3 OUTLIER -67.66 155.59 38.84 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.835 179.742 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 54' ' ' MET . . . . . . . . . . . . . 15.2 mtt -112.01 114.12 26.82 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.697 -179.753 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.588 ' O ' HD12 ' A' ' 55' ' ' ILE . 2.8 pp -132.63 143.02 40.94 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.285 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.479 -179.658 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 56' ' ' ASP . . . . . 0.549 ' CG ' HG21 ' A' ' 4' ' ' THR . 45.8 m-20 -101.71 91.38 4.38 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.898 179.487 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 11.1 p -85.44 127.74 39.76 Favored 'Isoleucine or valine' 0 C--O 1.233 0.233 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.773 179.614 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 12.2 p -90.12 131.85 36.29 Favored 'Isoleucine or valine' 0 C--O 1.234 0.277 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.114 -179.871 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 54.2 p90 -112.22 143.46 43.24 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.818 -0.628 . . . . 0.0 111.103 -179.697 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 59.5 m-20 -104.39 -28.58 11.27 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.5 179.866 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 16.3 ttmt 63.82 26.05 14.24 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-O 120.937 0.399 . . . . 0.0 111.397 -179.777 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 20.4 tt0 -95.75 -39.43 9.87 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.531 179.479 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -74.29 -32.8 63.03 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-N 115.883 -0.598 . . . . 0.0 111.349 179.809 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.414 ' HG ' HD23 ' A' ' 36' ' ' LEU . 3.0 mp -54.85 -45.21 74.51 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-O 120.544 0.212 . . . . 0.0 111.114 -179.9 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -59.53 -38.62 81.48 Favored 'General case' 0 CA--C 1.532 0.28 0 CA-C-N 116.523 -0.308 . . . . 0.0 111.284 179.65 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 1.9 mm-40 -79.21 -40.84 29.73 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.236 179.726 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -64.8 -35.07 79.91 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 116.47 -0.332 . . . . 0.0 111.818 -179.827 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 2.9 m-85 -59.5 -36.07 75.36 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-O 120.582 0.23 . . . . 0.0 110.722 179.885 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 20.8 tt0 -87.54 -37.43 16.89 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.912 179.296 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 34.9 mt-10 -68.55 -40.87 80.49 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.752 -179.55 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -89.77 -66.85 0.88 Allowed 'General case' 0 CA--C 1.53 0.205 0 N-CA-C 111.565 0.209 . . . . 0.0 111.565 -179.56 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 91.53 49.96 2.86 Favored Glycine 0 C--N 1.337 0.59 0 C-N-CA 121.033 -0.603 . . . . 0.0 112.94 -179.973 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.447 ' HB ' ' OE1' ' A' ' 20' ' ' GLN . 7.4 tp -66.37 144.03 15.07 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.246 0 CA-C-O 120.72 0.295 . . . . 0.0 111.115 179.86 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 32.1 m80 -81.22 157.58 70.62 Favored Pre-proline 0 C--O 1.234 0.268 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.127 179.97 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 38.6 Cg_endo -66.85 136.44 41.7 Favored 'Trans proline' 0 C--N 1.351 0.665 0 C-N-CA 122.682 2.255 . . . . 0.0 112.45 179.984 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 76' ' ' PRO . . . . . 0.409 ' O ' ' HD3' ' A' ' 78' ' ' PRO . 74.4 Cg_endo -74.87 -170.97 0.85 Allowed 'Trans proline' 0 C--N 1.349 0.556 0 C-N-CA 122.732 2.288 . . . . 0.0 112.282 179.844 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 18.5 mt-10 -112.12 90.39 13.64 Favored Pre-proline 0 C--O 1.233 0.204 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.66 179.69 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 78' ' ' PRO . . . . . 0.409 ' HD3' ' O ' ' A' ' 76' ' ' PRO . 54.4 Cg_exo -52.93 100.92 0.06 OUTLIER 'Trans proline' 0 C--N 1.35 0.63 0 C-N-CA 123.167 2.578 . . . . 0.0 112.903 -179.676 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.507 HD12 ' N ' ' A' ' 80' ' ' ALA . 2.1 pp -148.05 -45.2 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.532 0.255 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.682 179.62 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 80' ' ' ALA . . . . . 0.507 ' N ' HD12 ' A' ' 79' ' ' ILE . . . -122.51 122.79 39.74 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.642 -0.254 . . . . 0.0 110.88 -179.948 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -69.75 -69.98 0.31 Allowed 'General case' 0 N--CA 1.462 0.163 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.386 -179.605 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -145.79 151.54 38.11 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-O 120.729 0.299 . . . . 0.0 111.168 -179.984 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.233 0.21 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.427 -179.749 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 84' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 13.7 p . . . . . 0 C--O 1.234 0.257 0 CA-C-O 120.784 0.325 . . . . 0.0 111.342 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . 0.597 ' CG ' HD11 ' A' ' 53' ' ' LEU . 12.1 m-85 -109.6 -38.45 5.42 Favored 'General case' 0 C--O 1.232 0.173 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.158 179.487 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 1.8 t0 -158.54 174.84 14.46 Favored 'General case' 0 C--O 1.236 0.352 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.047 179.888 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 34.0 mt-10 -130.45 127.5 39.38 Favored 'General case' 0 C--O 1.232 0.164 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.872 179.991 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.407 HG12 ' CE2' ' A' ' 24' ' ' TYR . 3.7 mp -109.88 155.45 11.08 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.181 -179.807 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 11.9 mp0 -111.49 146.88 36.48 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.257 -179.833 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 3.6 tt -62.64 -34.29 64.44 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.247 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.28 179.615 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 5.0 pt-20 -64.08 -32.4 73.94 Favored 'General case' 0 CA--C 1.531 0.239 0 CA-C-N 116.559 -0.291 . . . . 0.0 111.129 179.731 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 11.6 m-20 -96.7 37.62 1.27 Allowed 'General case' 0 CA--C 1.531 0.234 0 CA-C-O 120.839 0.352 . . . . 0.0 111.083 179.704 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -131.63 152.6 50.71 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.075 -179.952 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -81.05 166.07 21.09 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.935 179.925 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 3.1 m-85 -119.9 138.41 53.45 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.975 -179.765 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -107.89 90.05 6.04 Favored Pre-proline 0 C--O 1.234 0.265 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.718 179.685 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -73.1 64.44 4.22 Favored 'Trans proline' 0 C--N 1.35 0.614 0 C-N-CA 122.745 2.297 . . . . 0.0 112.937 -179.528 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . 0.401 ' HG3' ' HE2' ' A' ' 21' ' ' MET . 6.3 pt-20 -141.95 -46.45 0.35 Allowed 'General case' 0 CA--C 1.531 0.223 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.22 179.698 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 3.5 m120 -139.36 29.49 2.2 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-N 116.572 -0.286 . . . . 0.0 111.449 179.692 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' GLN . . . . . 0.708 ' HB3' HD12 ' A' ' 36' ' ' LEU . 28.2 mt-30 56.52 68.62 0.83 Allowed 'General case' 0 C--O 1.234 0.244 0 CA-C-O 121.043 0.449 . . . . 0.0 111.664 179.448 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' MET . . . . . 0.401 ' HE2' ' HG3' ' A' ' 18' ' ' GLU . 3.8 ptt? -148.23 158.61 44.18 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.01 179.54 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.478 ' CE1' HD21 ' A' ' 36' ' ' LEU . 3.3 m-85 -110.13 159.44 17.34 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.685 179.91 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 34.4 p -134.35 150.06 50.9 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-O 120.941 0.401 . . . . 0.0 111.303 179.827 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' TYR . . . . . 0.407 ' CE2' HG12 ' A' ' 8' ' ' ILE . 31.5 t80 -155.69 102.07 2.17 Favored Pre-proline 0 C--N 1.333 -0.152 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.565 -179.87 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 62.6 Cg_exo -50.95 99.35 0.04 OUTLIER 'Trans proline' 0 C--N 1.349 0.574 0 C-N-CA 122.53 2.153 . . . . 0.0 112.116 -179.975 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 48.5 t -60.89 138.67 93.84 Favored Pre-proline 0 C--O 1.233 0.231 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.743 -179.618 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 80.2 Cg_exo -48.99 -26.45 10.24 Favored 'Trans proline' 0 C--N 1.351 0.667 0 C-N-CA 122.925 2.417 . . . . 0.0 113.025 179.796 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 4.3 p -59.5 -29.49 67.89 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-O 120.601 0.239 . . . . 0.0 111.352 179.661 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 123.2 7.5 7.02 Favored Glycine 0 CA--C 1.523 0.576 0 C-N-CA 121.207 -0.52 . . . . 0.0 113.445 179.94 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -114.09 -168.24 1.33 Allowed 'General case' 0 CA--C 1.532 0.262 0 CA-C-N 117.379 0.59 . . . . 0.0 111.158 -179.986 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 1.1 tpt180 -117.11 106.43 13.34 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-O 120.75 0.31 . . . . 0.0 110.91 -179.836 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -73.42 113.24 10.29 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.706 179.899 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 25.6 mt-30 -102.89 150.85 23.11 Favored 'General case' 0 N--CA 1.463 0.186 0 CA-C-N 116.435 -0.348 . . . . 0.0 111.146 -179.802 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.435 HG23 ' O ' ' A' ' 34' ' ' ILE . 0.9 OUTLIER -154.16 121.57 0.63 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.246 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.005 179.896 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 28.8 m-85 -81.92 148.14 28.9 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-N 116.374 -0.375 . . . . 0.0 111.144 -179.865 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.708 HD12 ' HB3' ' A' ' 20' ' ' GLN . 6.3 mt -67.85 -35.5 78.67 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.969 179.672 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 1.9 p-10 -66.22 -43.13 87.58 Favored 'General case' 0 CA--C 1.531 0.216 0 CA-C-N 116.372 -0.377 . . . . 0.0 110.825 179.481 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -62.81 -52.18 64.18 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-O 120.704 0.288 . . . . 0.0 111.053 -179.855 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' MET . . . . . 0.562 ' HG3' HD11 ' A' ' 64' ' ' LEU . 24.1 ptm -61.62 -27.67 68.82 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.36 179.97 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . 0.534 ' CD2' HD22 ' A' ' 64' ' ' LEU . 0.4 OUTLIER -55.58 -32.4 63.02 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 116.516 -0.311 . . . . 0.0 111.16 179.578 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 13.7 mt-10 -90.96 41.04 1.05 Allowed 'General case' 0 CA--C 1.532 0.285 0 CA-C-O 120.782 0.325 . . . . 0.0 111.484 179.9 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 60.09 64.81 3.84 Favored Glycine 0 C--N 1.334 0.434 0 C-N-CA 121.162 -0.542 . . . . 0.0 113.316 179.41 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 4.3 tt0 -121.62 98.93 6.19 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-O 120.927 0.394 . . . . 0.0 110.979 179.694 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -112.88 -33.78 5.97 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.804 179.856 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.431 HG23 ' O ' ' A' ' 45' ' ' VAL . 10.3 m -89.18 82.0 2.0 Favored 'Isoleucine or valine' 0 C--O 1.234 0.272 0 CA-C-O 121.037 0.446 . . . . 0.0 110.94 -179.977 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -91.09 147.0 23.38 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.274 -179.79 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 21.4 t -104.87 121.08 56.35 Favored 'Isoleucine or valine' 0 C--O 1.233 0.189 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.804 179.939 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 53.7 t -61.87 135.76 94.67 Favored Pre-proline 0 N--CA 1.463 0.223 0 CA-C-N 116.365 -0.379 . . . . 0.0 110.886 179.972 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 85.0 Cg_endo -84.32 20.25 1.24 Allowed 'Trans proline' 0 CA--C 1.534 0.495 0 C-N-CA 122.724 2.283 . . . . 0.0 113.167 179.926 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -129.81 -59.53 1.06 Allowed 'General case' 0 C--O 1.233 0.194 0 CA-C-O 120.516 0.198 . . . . 0.0 110.74 179.767 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 20.4 p -100.84 -17.29 16.94 Favored 'General case' 0 CA--C 1.532 0.261 0 CA-C-N 116.553 -0.294 . . . . 0.0 111.669 179.683 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER 67.43 36.56 3.8 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-O 120.911 0.386 . . . . 0.0 111.021 -179.889 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.597 HD11 ' CG ' ' A' ' 5' ' ' TYR . 9.8 tp -85.57 133.35 34.07 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.669 179.849 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' MET . . . . . . . . . . . . . 27.9 mtt -82.01 122.44 27.8 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.875 -179.801 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.486 ' O ' HD12 ' A' ' 55' ' ' ILE . 2.8 pp -131.33 143.34 40.93 Favored 'Isoleucine or valine' 0 C--O 1.234 0.26 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.008 179.884 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -109.39 92.21 3.96 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.622 -179.692 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 12.5 p -86.05 130.03 37.19 Favored 'Isoleucine or valine' 0 C--O 1.234 0.272 0 CA-C-N 116.099 -0.501 . . . . 0.0 111.002 -179.85 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 13.4 p -94.09 145.57 7.76 Favored 'Isoleucine or valine' 0 C--O 1.234 0.268 0 CA-C-N 116.057 -0.519 . . . . 0.0 111.103 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 22.3 p90 -131.89 146.77 52.31 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.153 179.879 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -89.26 -18.92 26.06 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.173 179.382 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 10.5 tttp 68.51 26.2 6.55 Favored 'General case' 0 CA--C 1.532 0.261 0 CA-C-O 120.835 0.35 . . . . 0.0 111.099 -179.688 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 4.4 tt0 -99.69 -62.52 1.23 Allowed 'General case' 0 C--O 1.232 0.165 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.351 179.644 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -62.03 -25.28 67.57 Favored 'General case' 0 N--CA 1.463 0.183 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.976 179.269 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.562 HD11 ' HG3' ' A' ' 39' ' ' MET . 0.2 OUTLIER -53.69 -38.31 64.09 Favored 'General case' 0 CA--C 1.53 0.203 0 CA-C-N 116.7 -0.227 . . . . 0.0 111.054 179.701 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -91.66 -37.64 12.92 Favored 'General case' 0 CA--C 1.53 0.208 0 CA-C-N 116.519 -0.309 . . . . 0.0 111.327 179.777 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 19.7 tt0 -66.22 -42.75 88.24 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-N 116.542 -0.299 . . . . 0.0 111.289 -179.937 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 23.3 t80 -57.92 -30.84 66.25 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.34 179.881 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . 0.423 ' HA ' ' NE2' ' A' ' 20' ' ' GLN . 4.2 m-85 -58.52 -35.29 72.05 Favored 'General case' 0 CA--C 1.528 0.117 0 CA-C-O 120.599 0.237 . . . . 0.0 110.725 179.745 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 18.4 mt-10 -81.88 -32.03 31.22 Favored 'General case' 0 C--O 1.232 0.152 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.888 179.394 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -69.4 -51.51 35.81 Favored 'General case' 0 N--CA 1.461 0.109 0 CA-C-N 116.486 -0.324 . . . . 0.0 111.208 179.921 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.233 0.203 0 CA-C-N 116.363 -0.38 . . . . 0.0 111.358 -179.882 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 2.8 p . . . . . 0 N--CA 1.47 0.561 0 CA-C-O 120.975 0.417 . . . . 0.0 111.487 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . 0.577 ' CG ' HD11 ' A' ' 53' ' ' LEU . 17.1 m-85 -116.08 -38.11 3.69 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.707 -179.624 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 1.4 p30 -159.61 174.85 13.96 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-O 120.671 0.272 . . . . 0.0 111.015 -179.697 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -143.67 121.36 11.86 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.072 179.761 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 3.6 mp -115.36 151.99 17.05 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.178 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.271 -179.8 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 1.4 pm0 -91.12 156.14 18.11 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.359 -179.947 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 11.6 tt -63.78 -31.2 52.18 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.251 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.406 179.707 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 12.9 mt-10 -59.78 -33.58 71.88 Favored 'General case' 0 CA--C 1.531 0.249 0 CA-C-N 116.552 -0.295 . . . . 0.0 111.095 179.69 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -96.46 37.29 1.28 Allowed 'General case' 0 CA--C 1.534 0.335 0 CA-C-O 120.798 0.332 . . . . 0.0 111.211 179.815 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -131.65 134.19 45.7 Favored 'General case' 0 C--O 1.232 0.161 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.581 179.889 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 3.6 m -72.16 144.1 48.69 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-O 120.674 0.273 . . . . 0.0 110.782 179.977 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 13.5 p90 -111.84 141.92 44.87 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.001 179.923 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 29.3 mt-10 -117.75 82.9 17.1 Favored Pre-proline 0 C--O 1.233 0.224 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.741 179.916 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -54.76 -24.79 39.51 Favored 'Trans proline' 0 C--N 1.348 0.509 0 C-N-CA 122.814 2.342 . . . . 0.0 112.701 179.692 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -51.37 -38.09 51.51 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-N 116.55 -0.295 . . . . 0.0 111.32 179.729 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 46.3 m-20 -136.3 18.6 3.16 Favored 'General case' 0 CA--C 1.537 0.455 0 N-CA-C 111.927 0.343 . . . . 0.0 111.927 179.881 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' GLN . . . . . 0.463 HE21 ' HB3' ' A' ' 71' ' ' ALA . 39.7 mt-30 52.27 73.75 0.31 Allowed 'General case' 0 N--CA 1.467 0.392 0 N-CA-C 112.043 0.386 . . . . 0.0 112.043 179.399 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' MET . . . . . 0.416 ' HB3' ' CD2' ' A' ' 35' ' ' TYR . 3.7 ptt? -166.54 146.15 5.78 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.52 179.583 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 27.4 m-85 -90.16 157.05 17.92 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.808 179.548 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 19.1 p -147.46 136.52 22.27 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.19 179.762 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 58.3 t80 -139.82 136.02 17.07 Favored Pre-proline 0 C--N 1.332 -0.161 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.802 179.626 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo -67.48 101.7 0.66 Allowed 'Trans proline' 0 C--N 1.348 0.544 0 C-N-CA 122.528 2.152 . . . . 0.0 112.231 179.907 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . 0.412 ' SG ' ' HD2' ' A' ' 27' ' ' PRO . 37.2 t -61.95 137.6 95.48 Favored Pre-proline 0 C--O 1.233 0.197 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.696 179.868 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . 0.412 ' HD2' ' SG ' ' A' ' 26' ' ' CYS . 12.0 Cg_endo -56.46 -21.65 38.63 Favored 'Trans proline' 0 C--N 1.348 0.523 0 C-N-CA 122.611 2.207 . . . . 0.0 112.686 179.739 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -65.51 -37.88 88.07 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-O 120.507 0.194 . . . . 0.0 111.191 179.932 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 153.05 -44.13 0.62 Allowed Glycine 0 C--N 1.335 0.474 0 C-N-CA 120.692 -0.766 . . . . 0.0 113.13 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -84.36 179.43 7.44 Favored 'General case' 0 CA--C 1.532 0.256 0 CA-C-O 120.785 0.326 . . . . 0.0 111.253 -179.727 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 27.8 ttm180 -113.06 117.69 32.7 Favored 'General case' 0 C--O 1.232 0.159 0 CA-C-N 116.387 -0.369 . . . . 0.0 110.844 179.873 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . 0.548 ' HZ ' ' HB1' ' A' ' 46' ' ' ALA . 30.6 t80 -65.52 156.39 32.7 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.423 -179.838 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 15.8 pt20 -143.57 131.78 21.94 Favored 'General case' 0 CA--C 1.53 0.205 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.16 -179.971 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 7.0 tt -139.09 125.76 24.39 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.185 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.927 179.53 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . 0.416 ' CD2' ' HB3' ' A' ' 21' ' ' MET . 55.4 m-85 -80.24 151.2 29.76 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.345 -179.83 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 45.2 mt -61.34 -40.08 92.91 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.815 179.694 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 2.5 p-10 -63.02 -34.06 76.76 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.199 179.605 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -65.65 -58.94 4.52 Favored 'General case' 0 C--O 1.231 0.083 0 CA-C-O 120.799 0.333 . . . . 0.0 110.728 179.997 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' MET . . . . . 0.654 ' HG3' HD11 ' A' ' 64' ' ' LEU . 5.9 ptm -63.69 -34.38 77.73 Favored 'General case' 0 CA--C 1.53 0.202 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.277 179.991 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 46.4 t80 -57.44 -40.68 78.96 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 116.506 -0.316 . . . . 0.0 110.911 179.542 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 4.0 mt-10 -61.71 -35.4 77.94 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 116.538 -0.301 . . . . 0.0 110.982 179.541 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 137.45 46.6 0.08 OUTLIER Glycine 0 C--N 1.332 0.348 0 C-N-CA 120.95 -0.643 . . . . 0.0 112.625 179.86 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -104.07 115.96 31.36 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-O 120.669 0.271 . . . . 0.0 111.042 -179.954 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 2.4 ptpt -117.26 -40.37 3.09 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.216 179.943 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 5.0 m -101.71 101.13 11.68 Favored 'Isoleucine or valine' 0 C--O 1.232 0.172 0 CA-C-O 120.922 0.391 . . . . 0.0 111.249 -179.953 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.548 ' HB1' ' HZ ' ' A' ' 32' ' ' PHE . . . -99.5 167.77 10.4 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-N 115.987 -0.551 . . . . 0.0 111.404 -179.716 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 5.6 m -136.51 128.33 43.86 Favored 'Isoleucine or valine' 0 C--O 1.232 0.182 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.354 -179.83 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 46.1 t -66.22 136.1 95.17 Favored Pre-proline 0 N--CA 1.463 0.214 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.903 179.865 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_endo -83.57 20.11 1.24 Allowed 'Trans proline' 0 C--N 1.348 0.548 0 C-N-CA 122.692 2.262 . . . . 0.0 113.262 179.859 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -128.45 -56.25 1.23 Allowed 'General case' 0 C--O 1.232 0.156 0 CA-C-O 120.574 0.226 . . . . 0.0 110.502 179.658 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 20.1 p -100.83 -20.08 15.67 Favored 'General case' 0 CA--C 1.534 0.356 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.729 179.846 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 68.24 39.58 2.3 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-O 120.989 0.423 . . . . 0.0 110.896 -179.751 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.577 HD11 ' CG ' ' A' ' 5' ' ' TYR . 6.6 tp -86.44 129.77 34.74 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.816 179.948 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' MET . . . . . . . . . . . . . 28.0 mtm -83.02 131.08 35.19 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.845 -179.934 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 2.6 pp -142.27 145.88 23.16 Favored 'Isoleucine or valine' 0 C--O 1.233 0.204 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.62 -179.731 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -104.6 105.15 15.13 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.757 179.572 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.436 HG13 ' O ' ' A' ' 57' ' ' VAL . 12.9 p -105.51 118.23 52.62 Favored 'Isoleucine or valine' 0 C--O 1.233 0.213 0 CA-C-O 120.952 0.406 . . . . 0.0 111.101 179.793 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 14.6 p -86.22 139.32 17.55 Favored 'Isoleucine or valine' 0 C--O 1.233 0.232 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.045 -179.839 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 30.5 p90 -129.82 165.75 21.33 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.16 -179.649 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -128.43 178.83 6.01 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-N 116.024 -0.535 . . . . 0.0 111.039 -179.752 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 26.4 mttp -111.1 29.5 7.73 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.206 179.671 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 5.6 mt-10 -99.15 -70.27 0.73 Allowed 'General case' 0 C--O 1.232 0.147 0 CA-C-N 116.492 -0.322 . . . . 0.0 110.604 179.504 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 3.0 p30 -68.3 -37.7 80.88 Favored 'General case' 0 N--CA 1.463 0.175 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.6 179.432 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.654 HD11 ' HG3' ' A' ' 39' ' ' MET . 0.2 OUTLIER -56.11 -41.33 75.11 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-N 116.456 -0.338 . . . . 0.0 110.877 179.872 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -73.76 -38.64 64.65 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.35 179.654 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 10.3 mt-10 -71.94 -35.33 69.58 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 116.416 -0.356 . . . . 0.0 111.765 -179.678 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 7.4 m-85 -55.59 -28.32 54.38 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 116.623 -0.262 . . . . 0.0 111.345 -179.794 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 23.4 m-85 -60.66 -34.27 74.05 Favored 'General case' 0 CA--C 1.528 0.117 0 CA-C-N 116.651 -0.25 . . . . 0.0 110.562 179.707 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -90.55 -36.51 14.43 Favored 'General case' 0 CA--C 1.531 0.213 0 CA-C-N 116.284 -0.417 . . . . 0.0 110.993 179.445 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -71.12 -34.71 71.32 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 116.464 -0.335 . . . . 0.0 111.785 -179.648 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . 0.463 ' HB3' HE21 ' A' ' 20' ' ' GLN . . . . . . . . 0 C--O 1.233 0.214 0 CA-C-O 120.895 0.379 . . . . 0.0 111.295 -179.85 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . 0.64 HG21 ' CG ' ' A' ' 56' ' ' ASP . 0.9 OUTLIER . . . . . 0 N--CA 1.464 0.264 0 CA-C-O 120.985 0.421 . . . . 0.0 111.511 . . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 85.0 m-85 -105.04 -37.3 6.99 Favored 'General case' 0 CA--C 1.531 0.232 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.409 -179.945 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -157.14 175.67 13.75 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-N 116.534 -0.303 . . . . 0.0 111.247 -179.792 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 21.5 mt-10 -126.2 143.26 51.2 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 116.108 -0.497 . . . . 0.0 111.033 -179.921 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 22.8 mt -127.19 151.82 34.49 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.29 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.173 -179.886 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . 0.441 ' HG3' HG13 ' A' ' 58' ' ' VAL . 8.5 tt0 -104.97 142.89 33.98 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-N 116.515 -0.311 . . . . 0.0 110.953 179.756 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 41.2 pt -61.15 -32.81 53.82 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.305 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.34 179.82 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 16.8 tt0 -59.44 -33.19 70.97 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.841 179.613 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -97.01 36.89 1.36 Allowed 'General case' 0 CA--C 1.533 0.307 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.191 179.855 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 13.0 mtp -131.32 148.29 52.66 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.639 179.678 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 20.0 m -61.96 129.79 42.55 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.14 -179.816 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 21.1 p90 -93.53 124.39 37.49 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.716 179.593 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 -112.07 86.02 7.25 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.793 -179.881 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo -69.23 -16.99 40.18 Favored 'Trans proline' 0 C--N 1.347 0.499 0 C-N-CA 122.743 2.295 . . . . 0.0 112.942 -179.865 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -53.24 -37.49 62.12 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-N 116.712 -0.222 . . . . 0.0 111.15 179.739 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 25.8 m-20 -143.17 25.32 1.74 Allowed 'General case' 0 CA--C 1.533 0.303 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.718 179.902 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' GLN . . . . . 0.442 ' HG2' HD23 ' A' ' 36' ' ' LEU . 6.2 tt0 53.35 72.25 0.44 Allowed 'General case' 0 CA--C 1.534 0.329 0 CA-C-O 120.992 0.425 . . . . 0.0 111.648 179.513 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' MET . . . . . 0.434 ' HB3' ' CD2' ' A' ' 35' ' ' TYR . 5.7 ptt? -154.08 175.11 13.82 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.046 179.928 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 27.2 m-85 -137.4 138.65 40.08 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.131 179.879 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 79.6 p -130.82 156.64 44.66 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.273 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 45.7 t80 -156.53 136.01 8.22 Favored Pre-proline 0 N--CA 1.463 0.176 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.863 179.781 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -64.71 100.29 0.34 Allowed 'Trans proline' 0 C--N 1.35 0.616 0 C-N-CA 122.678 2.252 . . . . 0.0 112.37 179.839 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . 0.419 ' SG ' ' HD2' ' A' ' 27' ' ' PRO . 42.0 t -59.68 139.26 89.76 Favored Pre-proline 0 C--O 1.233 0.19 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.69 179.817 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . 0.419 ' HD2' ' SG ' ' A' ' 26' ' ' CYS . 75.2 Cg_exo -51.17 -26.09 18.87 Favored 'Trans proline' 0 C--N 1.348 0.548 0 C-N-CA 122.739 2.293 . . . . 0.0 112.951 179.887 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -68.53 -38.88 81.23 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-O 120.553 0.216 . . . . 0.0 111.279 -179.858 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 152.43 -45.95 0.59 Allowed Glycine 0 C--N 1.334 0.459 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.959 -179.904 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.3 t0 -73.17 -173.81 1.41 Allowed 'General case' 0 CA--C 1.533 0.303 0 CA-C-O 120.748 0.309 . . . . 0.0 111.156 -179.807 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 27.4 ttt180 -123.3 129.67 51.66 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-N 116.444 -0.343 . . . . 0.0 110.886 179.855 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 7.4 m-85 -65.09 161.98 17.8 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.987 179.822 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -151.76 127.92 10.49 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.221 179.8 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 3.6 tt -150.87 144.38 16.87 Favored 'Isoleucine or valine' 0 C--O 1.233 0.219 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.175 179.785 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . 0.434 ' CD2' ' HB3' ' A' ' 21' ' ' MET . 86.0 m-85 -105.29 157.47 17.28 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.869 -179.913 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.573 HD12 ' HG ' ' A' ' 64' ' ' LEU . 4.0 mm? -61.3 -33.85 74.25 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.936 179.768 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 8.2 t70 -68.13 -39.4 82.74 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.991 179.598 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -59.63 -56.43 22.04 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.1 -179.817 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 36.4 mtm -63.58 -31.27 72.39 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.947 179.618 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . 0.656 ' HB2' HD21 ' A' ' 64' ' ' LEU . 17.0 t80 -58.4 -46.32 86.64 Favored 'General case' 0 CA--C 1.529 0.148 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.912 179.604 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -58.18 -35.49 71.65 Favored 'General case' 0 N--CA 1.463 0.185 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.887 179.685 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 138.65 48.45 0.06 OUTLIER Glycine 0 C--N 1.333 0.386 0 C-N-CA 120.992 -0.623 . . . . 0.0 112.64 179.671 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -102.16 124.89 48.55 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-O 120.791 0.329 . . . . 0.0 110.946 -179.989 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 16.2 mttt -122.83 -43.91 2.23 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.968 179.897 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.486 ' O ' HG13 ' A' ' 45' ' ' VAL . 11.1 p -112.58 113.58 44.54 Favored 'Isoleucine or valine' 0 C--O 1.233 0.236 0 CA-C-O 121.001 0.429 . . . . 0.0 110.967 179.811 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -99.0 160.28 14.37 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.2 -179.648 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 7.5 m -116.81 124.42 72.86 Favored 'Isoleucine or valine' 0 C--O 1.233 0.2 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.367 -179.894 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 51.3 t -69.99 135.66 87.39 Favored Pre-proline 0 C--N 1.33 -0.252 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.868 179.875 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_endo -84.6 20.78 1.17 Allowed 'Trans proline' 0 CA--C 1.535 0.527 0 C-N-CA 122.714 2.276 . . . . 0.0 112.967 179.747 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -128.01 -57.67 1.24 Allowed 'General case' 0 CA--C 1.529 0.147 0 CA-C-O 120.587 0.232 . . . . 0.0 110.578 179.788 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 20.2 p -99.69 -20.45 16.28 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.817 179.946 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 2.1 t 67.29 40.02 2.86 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-O 120.921 0.391 . . . . 0.0 111.022 -179.857 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.52 ' CD2' HG23 ' A' ' 55' ' ' ILE . 8.5 tt -95.94 135.93 37.05 Favored 'General case' 0 C--O 1.232 0.178 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.625 179.805 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' MET . . . . . . . . . . . . . 12.3 mtt -89.39 128.45 35.92 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.128 -179.578 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.52 HG23 ' CD2' ' A' ' 53' ' ' LEU . 2.1 pp -135.14 132.09 52.72 Favored 'Isoleucine or valine' 0 C--O 1.233 0.221 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.474 179.922 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . 0.64 ' CG ' HG21 ' A' ' 4' ' ' THR . 74.1 m-20 -87.21 99.46 11.97 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.769 179.61 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.505 HG13 ' O ' ' A' ' 57' ' ' VAL . 13.3 p -93.18 113.38 27.97 Favored 'Isoleucine or valine' 0 C--O 1.233 0.228 0 CA-C-O 121.114 0.483 . . . . 0.0 111.126 179.943 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.441 HG13 ' HG3' ' A' ' 9' ' ' GLU . 11.7 p -81.64 135.5 24.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.867 -179.955 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 53.5 p90 -131.47 178.57 6.63 Favored 'General case' 0 CA--C 1.532 0.252 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.174 -179.722 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 1.6 t0 -126.29 159.91 31.8 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.893 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -79.99 -36.21 36.31 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.612 179.464 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -60.83 -36.73 79.83 Favored 'General case' 0 CA--C 1.528 0.114 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.088 179.967 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -55.16 -45.76 75.73 Favored 'General case' 0 N--CA 1.462 0.137 0 CA-C-N 116.474 -0.33 . . . . 0.0 111.145 179.747 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.656 HD21 ' HB2' ' A' ' 40' ' ' PHE . 3.7 mp -61.54 -55.89 26.03 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.626 -0.261 . . . . 0.0 110.915 179.812 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -56.73 -40.75 76.27 Favored 'General case' 0 N--CA 1.462 0.156 0 CA-C-N 116.484 -0.326 . . . . 0.0 111.083 179.736 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 30.0 mt-10 -67.43 -43.45 81.13 Favored 'General case' 0 CA--C 1.528 0.115 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.93 179.542 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . 0.405 ' CD1' ' HG3' ' A' ' 20' ' ' GLN . 0.3 OUTLIER -70.67 -40.15 73.13 Favored 'General case' 0 N--CA 1.463 0.183 0 CA-C-N 116.531 -0.304 . . . . 0.0 111.438 179.939 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 9.7 m-85 -59.21 -40.17 84.96 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 116.659 -0.246 . . . . 0.0 111.075 -179.744 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 16.8 mt-10 -81.24 -33.75 32.59 Favored 'General case' 0 CA--C 1.529 0.158 0 CA-C-N 116.577 -0.283 . . . . 0.0 111.101 179.886 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 29.1 mt-10 -73.44 -50.19 22.97 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-N 116.587 -0.279 . . . . 0.0 111.192 179.945 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.169 0 CA-C-N 116.323 -0.398 . . . . 0.0 111.519 -179.572 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 1.8 t . . . . . 0 N--CA 1.465 0.277 0 CA-C-O 120.879 0.371 . . . . 0.0 111.229 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 27.1 m-85 -103.88 -31.21 9.88 Favored 'General case' 0 CA--C 1.532 0.252 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.275 179.732 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 5.7 t70 -158.73 165.63 33.88 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-O 120.769 0.319 . . . . 0.0 111.566 -179.855 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 11.2 tt0 -136.41 115.05 11.98 Favored 'General case' 0 CA--C 1.53 0.195 0 CA-C-N 116.035 -0.529 . . . . 0.0 111.177 -179.774 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 3.9 mp -113.56 151.29 15.43 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.277 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.199 179.917 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 4.7 mt-10 -97.92 148.45 23.44 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.273 -179.927 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 14.3 tt -58.55 -31.43 43.63 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.305 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.36 179.668 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 26.4 mt-10 -63.13 -27.56 69.47 Favored 'General case' 0 CA--C 1.532 0.274 0 CA-C-N 116.597 -0.274 . . . . 0.0 111.302 179.634 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -95.09 36.14 1.23 Allowed 'General case' 0 CA--C 1.533 0.325 0 CA-C-O 120.696 0.284 . . . . 0.0 111.313 179.95 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -119.0 177.31 4.91 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-O 120.843 0.354 . . . . 0.0 110.959 179.715 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 1.6 m -108.49 85.69 2.15 Favored 'General case' 0 C--O 1.232 0.15 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.575 179.911 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 30.3 p90 -86.28 139.51 30.95 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.891 179.958 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 25.3 mt-10 -138.69 157.91 71.11 Favored Pre-proline 0 C--O 1.234 0.246 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.633 -179.606 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 25.8 Cg_exo -63.36 -11.95 28.16 Favored 'Trans proline' 0 C--N 1.351 0.686 0 C-N-CA 123.257 2.638 . . . . 0.0 112.914 179.391 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 3.1 pt-20 -66.17 82.99 0.08 Allowed 'General case' 0 C--O 1.233 0.197 0 CA-C-O 121.076 0.465 . . . . 0.0 110.843 -179.731 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 6.0 m-80 62.12 22.9 13.45 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-N 115.799 -0.637 . . . . 0.0 111.668 -179.503 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' GLN . . . . . 0.493 ' O ' HD23 ' A' ' 36' ' ' LEU . 0.8 OUTLIER 53.49 78.07 0.16 Allowed 'General case' 0 C--O 1.234 0.281 0 CA-C-O 121.067 0.461 . . . . 0.0 111.286 179.921 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 1.9 ppp? -133.71 143.5 48.54 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.674 179.842 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.546 ' CE1' HD22 ' A' ' 36' ' ' LEU . 0.9 OUTLIER -127.7 132.32 49.65 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.656 179.618 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . 0.616 HG22 ' HA ' ' A' ' 33' ' ' GLN . 40.6 p -122.14 158.74 28.66 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.815 -178.929 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 61.1 t80 -139.9 137.22 18.05 Favored Pre-proline 0 CA--C 1.53 0.186 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.225 179.878 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 65.5 Cg_endo -73.44 100.94 1.3 Allowed 'Trans proline' 0 C--N 1.35 0.627 0 C-N-CA 122.768 2.312 . . . . 0.0 112.442 179.587 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . 0.44 ' SG ' ' HD2' ' A' ' 27' ' ' PRO . 53.1 t -68.69 140.21 91.76 Favored Pre-proline 0 C--O 1.233 0.229 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.705 179.786 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . 0.44 ' HD2' ' SG ' ' A' ' 26' ' ' CYS . 86.7 Cg_exo -48.89 -26.98 10.73 Favored 'Trans proline' 0 C--N 1.351 0.666 0 C-N-CA 122.916 2.411 . . . . 0.0 113.175 179.962 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 9.0 p -58.49 -28.92 65.83 Favored 'General case' 0 CA--C 1.533 0.321 0 CA-C-O 120.642 0.258 . . . . 0.0 111.433 -179.949 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 120.93 9.87 7.22 Favored Glycine 0 CA--C 1.523 0.57 0 C-N-CA 121.134 -0.555 . . . . 0.0 113.337 -179.823 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -122.42 -165.2 1.25 Allowed 'General case' 0 CA--C 1.535 0.375 0 CA-C-N 117.145 0.472 . . . . 0.0 110.935 179.972 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 3.8 ttt85 -137.85 117.16 12.73 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-O 120.515 0.198 . . . . 0.0 111.186 -179.73 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . 0.542 ' CZ ' ' HB1' ' A' ' 46' ' ' ALA . 76.4 t80 -70.63 151.96 44.4 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.225 179.896 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . 0.616 ' HA ' HG22 ' A' ' 23' ' ' THR . 3.6 pt20 -126.28 139.66 53.14 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.449 -179.939 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 12.0 tt -155.0 148.89 12.61 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.346 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.21 179.69 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 60.3 m-85 -100.67 155.77 17.7 Favored 'General case' 0 C--O 1.236 0.357 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.516 -179.695 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.82 HD12 ' HG ' ' A' ' 64' ' ' LEU . 3.2 mm? -61.67 -46.88 87.85 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.775 179.734 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -60.27 -36.55 78.08 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 116.495 -0.321 . . . . 0.0 110.995 179.647 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -57.19 -46.12 83.14 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.41 179.709 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 2.6 mtt -66.23 -28.81 69.02 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.321 179.582 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . 0.671 ' CE1' HD22 ' A' ' 64' ' ' LEU . 0.0 OUTLIER -56.53 -45.77 80.98 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-O 120.573 0.225 . . . . 0.0 111.046 179.906 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 10.6 mt-10 -59.91 -32.51 70.83 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 116.461 -0.336 . . . . 0.0 110.975 179.586 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 131.74 46.61 0.13 Allowed Glycine 0 C--N 1.333 0.394 0 C-N-CA 121.145 -0.55 . . . . 0.0 112.498 179.981 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -83.35 92.89 7.63 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-O 120.993 0.425 . . . . 0.0 110.888 -179.948 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 10.8 ptpt -107.33 -32.43 7.76 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.831 -0.622 . . . . 0.0 111.218 179.881 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.49 ' O ' HG13 ' A' ' 45' ' ' VAL . 7.6 p -121.58 108.98 23.47 Favored 'Isoleucine or valine' 0 C--O 1.233 0.214 0 CA-C-O 121.109 0.48 . . . . 0.0 110.874 179.796 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.542 ' HB1' ' CZ ' ' A' ' 32' ' ' PHE . . . -109.63 171.81 7.22 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.589 -179.361 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 19.1 t -128.91 119.43 49.48 Favored 'Isoleucine or valine' 0 C--O 1.232 0.145 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.036 -179.935 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 41.7 t -62.33 112.19 5.99 Favored Pre-proline 0 N--CA 1.463 0.199 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.452 179.683 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 31.1 Cg_exo -60.33 -17.82 49.2 Favored 'Trans proline' 0 C--N 1.347 0.484 0 C-N-CA 122.645 2.23 . . . . 0.0 113.346 -179.569 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 4.6 t -77.05 -65.17 0.98 Allowed 'General case' 0 CA--C 1.53 0.206 0 CA-C-O 120.416 0.15 . . . . 0.0 111.397 -179.738 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 22.6 p -92.18 -19.55 22.13 Favored 'General case' 0 N--CA 1.465 0.324 0 N-CA-C 112.195 0.442 . . . . 0.0 112.195 -179.426 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 72.96 36.4 0.88 Allowed 'General case' 0 CA--C 1.533 0.302 0 CA-C-O 120.886 0.374 . . . . 0.0 110.905 -179.609 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.604 HD23 HG23 ' A' ' 55' ' ' ILE . 6.4 tt -94.94 149.51 21.17 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.736 179.792 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' MET . . . . . . . . . . . . . 38.7 mtt -93.14 129.75 39.03 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-N 116.462 -0.335 . . . . 0.0 111.357 -179.487 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.604 HG23 HD23 ' A' ' 53' ' ' LEU . 2.5 pp -137.99 152.47 26.27 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.343 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.47 179.783 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 42.5 m-20 -108.7 107.63 18.16 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.64 179.067 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 14.5 p -99.43 125.63 52.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-O 120.967 0.413 . . . . 0.0 111.026 179.835 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 13.3 p -93.74 142.66 12.98 Favored 'Isoleucine or valine' 0 C--O 1.234 0.258 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.194 -179.88 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 3.0 p90 -131.03 144.39 51.42 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.623 -179.386 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -95.13 -22.67 17.72 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-N 115.997 -0.547 . . . . 0.0 112.028 -179.93 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 3.3 mttt 65.82 27.49 11.05 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-O 120.603 0.24 . . . . 0.0 111.412 -179.575 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 12.5 tt0 -95.47 -49.64 5.33 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-O 120.919 0.39 . . . . 0.0 110.104 179.474 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -66.51 -33.78 76.45 Favored 'General case' 0 N--CA 1.462 0.169 0 CA-C-N 115.746 -0.661 . . . . 0.0 111.129 179.577 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.82 ' HG ' HD12 ' A' ' 36' ' ' LEU . 0.2 OUTLIER -52.86 -34.62 55.17 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 116.679 -0.237 . . . . 0.0 111.495 -179.711 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -86.44 -48.73 8.17 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-N 116.663 -0.244 . . . . 0.0 111.56 -179.981 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 23.5 mt-10 -65.8 -54.17 30.54 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-O 120.664 0.268 . . . . 0.0 111.256 -179.674 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . 0.411 ' HA ' ' HB2' ' A' ' 70' ' ' GLU . 2.6 t80 -59.64 -23.69 63.25 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.3 179.412 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -57.27 -54.88 41.76 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-O 120.665 0.269 . . . . 0.0 110.962 179.834 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 37.1 mt-10 -79.97 -35.57 37.35 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.763 179.771 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . 0.411 ' HB2' ' HA ' ' A' ' 67' ' ' TYR . 25.0 mt-10 -62.84 -37.27 86.14 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.188 179.868 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.234 0.269 0 CA-C-O 120.893 0.378 . . . . 0.0 111.353 -179.935 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . 0.413 HG21 ' CG ' ' A' ' 56' ' ' ASP . 3.1 p . . . . . 0 N--CA 1.472 0.661 0 CA-C-O 120.781 0.324 . . . . 0.0 111.306 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . 0.444 ' CG ' HD11 ' A' ' 53' ' ' LEU . 0.2 OUTLIER -111.64 -41.59 4.03 Favored 'General case' 0 CA--C 1.53 0.186 0 CA-C-N 116.517 -0.31 . . . . 0.0 111.311 -179.955 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -155.56 176.09 13.05 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-O 120.697 0.284 . . . . 0.0 111.207 -179.991 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . 0.562 ' O ' HD13 ' A' ' 8' ' ' ILE . 3.9 pt-20 -130.22 131.22 45.45 Favored 'General case' 0 CA--C 1.531 0.234 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.15 179.798 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.562 HD13 ' O ' ' A' ' 7' ' ' GLU . 26.5 mm -130.03 154.16 39.98 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.281 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.455 -179.812 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 9.7 mt-10 -103.78 148.22 26.36 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.062 179.843 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 33.8 pt -58.76 -32.43 46.72 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.325 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.347 179.537 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 4.4 mt-10 -60.45 -30.39 69.62 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.223 179.726 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 5.6 t0 -98.52 39.0 1.28 Allowed 'General case' 0 CA--C 1.532 0.278 0 CA-C-O 120.902 0.382 . . . . 0.0 111.038 179.727 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' MET . . . . . 0.415 ' HG2' ' HB2' ' A' ' 24' ' ' TYR . 0.1 OUTLIER -132.98 143.39 49.41 Favored 'General case' 0 C--O 1.232 0.172 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.585 179.833 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 1.2 m -62.18 121.12 12.3 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-O 120.734 0.302 . . . . 0.0 111.172 -179.582 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 20.8 p90 -87.76 125.44 34.43 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.695 179.597 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 -112.22 86.38 7.84 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.405 179.852 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 40.0 Cg_endo -67.45 -20.09 48.41 Favored 'Trans proline' 0 C--N 1.347 0.487 0 C-N-CA 122.673 2.248 . . . . 0.0 112.786 -179.989 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -53.33 -36.15 60.96 Favored 'General case' 0 CA--C 1.53 0.2 0 CA-C-N 116.591 -0.277 . . . . 0.0 111.337 179.884 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 3.0 t-20 -138.54 22.73 2.71 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-N 116.534 -0.303 . . . . 0.0 111.652 179.867 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' GLN . . . . . 0.421 ' NE2' ' HA ' ' A' ' 68' ' ' TYR . 15.8 tt0 50.32 65.35 1.47 Allowed 'General case' 0 CA--C 1.534 0.347 0 CA-C-O 120.975 0.416 . . . . 0.0 111.454 179.916 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' MET . . . . . 0.467 ' HB3' ' CD1' ' A' ' 35' ' ' TYR . 23.3 ptt? -149.62 172.65 14.7 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.137 179.86 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.415 ' CD1' HD21 ' A' ' 36' ' ' LEU . 16.1 m-85 -130.3 134.29 47.1 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.026 179.86 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 11.8 p -130.53 136.29 48.8 Favored 'General case' 0 N--CA 1.462 0.162 0 CA-C-N 116.389 -0.368 . . . . 0.0 111.269 -179.893 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' TYR . . . . . 0.415 ' HB2' ' HG2' ' A' ' 13' ' ' MET . 32.7 t80 -139.38 137.46 19.02 Favored Pre-proline 0 C--N 1.333 -0.137 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.982 179.895 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -72.06 103.68 1.53 Allowed 'Trans proline' 0 C--N 1.348 0.517 0 C-N-CA 122.685 2.256 . . . . 0.0 112.507 179.924 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . 0.415 ' SG ' ' HD2' ' A' ' 27' ' ' PRO . 48.7 t -64.31 139.29 97.67 Favored Pre-proline 0 C--O 1.233 0.23 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.696 179.75 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . 0.415 ' HD2' ' SG ' ' A' ' 26' ' ' CYS . 71.0 Cg_exo -50.06 -26.01 13.82 Favored 'Trans proline' 0 C--N 1.352 0.713 0 C-N-CA 122.932 2.422 . . . . 0.0 113.237 179.844 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 7.7 p -57.94 -28.65 64.5 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-O 120.578 0.228 . . . . 0.0 111.434 179.944 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 122.84 6.79 7.62 Favored Glycine 0 CA--C 1.524 0.629 0 C-N-CA 121.096 -0.573 . . . . 0.0 113.513 -179.995 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -122.37 -173.33 2.65 Favored 'General case' 0 CA--C 1.532 0.252 0 CA-C-N 117.237 0.519 . . . . 0.0 111.001 179.954 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 7.1 ttm-85 -118.94 130.11 55.53 Favored 'General case' 0 N--CA 1.463 0.183 0 CA-C-O 120.807 0.337 . . . . 0.0 111.378 -179.854 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . 0.424 ' CZ ' ' HB1' ' A' ' 46' ' ' ALA . 64.6 t80 -91.84 157.48 16.85 Favored 'General case' 0 CA--C 1.529 0.164 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.917 179.673 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -140.13 129.3 23.72 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.067 179.749 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.47 HG23 ' O ' ' A' ' 34' ' ' ILE . 3.1 tt -139.06 115.65 10.24 Favored 'Isoleucine or valine' 0 C--O 1.234 0.254 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.986 179.626 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . 0.467 ' CD1' ' HB3' ' A' ' 21' ' ' MET . 41.6 m-85 -74.5 141.63 44.88 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.996 -179.88 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.624 ' O ' HD11 ' A' ' 64' ' ' LEU . 3.9 mm? -59.54 -38.29 80.65 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.006 179.686 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 1.2 p30 -60.88 -40.22 92.19 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 116.477 -0.329 . . . . 0.0 110.849 179.524 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 2.5 t70 -63.17 -39.56 95.02 Favored 'General case' 0 N--CA 1.462 0.134 0 CA-C-N 116.493 -0.321 . . . . 0.0 110.895 179.73 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' MET . . . . . 0.47 ' SD ' HD13 ' A' ' 36' ' ' LEU . 5.0 mtt -61.99 -29.49 70.29 Favored 'General case' 0 N--CA 1.463 0.187 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.115 179.604 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -57.13 -35.99 70.14 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 116.536 -0.302 . . . . 0.0 111.035 179.662 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 8.3 mt-10 -66.99 -34.4 77.67 Favored 'General case' 0 CA--C 1.531 0.234 0 CA-C-N 116.511 -0.313 . . . . 0.0 110.835 179.628 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 124.56 64.02 0.19 Allowed Glycine 0 C--N 1.335 0.49 0 C-N-CA 120.982 -0.628 . . . . 0.0 112.557 179.631 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 2.1 tp10 -104.25 105.93 16.25 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-O 120.729 0.3 . . . . 0.0 111.084 179.955 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -111.44 -33.79 6.3 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.044 179.431 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.446 HG22 ' OD1' ' A' ' 56' ' ' ASP . 18.8 t -115.96 87.68 1.07 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.273 0 CA-C-O 120.905 0.383 . . . . 0.0 110.659 179.752 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.424 ' HB1' ' CZ ' ' A' ' 32' ' ' PHE . . . -82.94 162.65 21.44 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.21 -179.796 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 11.6 p -121.38 122.95 68.63 Favored 'Isoleucine or valine' 0 C--O 1.233 0.206 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.083 179.926 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 49.3 t -63.04 135.43 96.22 Favored Pre-proline 0 C--N 1.331 -0.217 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.724 179.96 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 93.6 Cg_endo -83.3 19.76 1.28 Allowed 'Trans proline' 0 CA--C 1.535 0.555 0 C-N-CA 122.623 2.215 . . . . 0.0 113.307 -179.855 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -129.15 -57.19 1.16 Allowed 'General case' 0 C--O 1.233 0.188 0 CA-C-O 120.459 0.171 . . . . 0.0 110.628 179.661 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 17.9 p -101.68 -10.92 19.57 Favored 'General case' 0 N--CA 1.465 0.319 0 N-CA-C 111.956 0.354 . . . . 0.0 111.956 179.881 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 5.8 p 61.0 35.64 18.88 Favored 'General case' 0 CA--C 1.535 0.403 0 CA-C-O 120.842 0.354 . . . . 0.0 111.502 179.842 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.618 HD23 HG23 ' A' ' 55' ' ' ILE . 7.7 tt -89.07 134.6 33.94 Favored 'General case' 0 CA--C 1.53 0.2 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.534 179.748 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' MET . . . . . . . . . . . . . 20.4 mtt -84.6 135.79 34.04 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.062 -179.773 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.618 HG23 HD23 ' A' ' 53' ' ' LEU . 2.7 pt -138.81 137.56 42.68 Favored 'Isoleucine or valine' 0 C--O 1.234 0.261 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.751 -179.778 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . 0.446 ' OD1' HG22 ' A' ' 45' ' ' VAL . 55.5 m-20 -87.13 88.67 7.76 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.675 179.305 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.517 HG13 ' O ' ' A' ' 57' ' ' VAL . 14.2 p -88.38 112.47 23.86 Favored 'Isoleucine or valine' 0 C--O 1.234 0.263 0 CA-C-O 121.003 0.43 . . . . 0.0 111.004 179.901 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 14.4 p -86.72 127.72 40.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.935 179.997 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 29.1 p90 -124.82 177.76 5.84 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.936 -0.575 . . . . 0.0 111.114 -179.606 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -133.1 144.38 49.91 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.169 -179.807 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 8.1 tttt -74.88 -40.76 60.76 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.84 179.585 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 6.3 tt0 -58.03 -48.8 78.98 Favored 'General case' 0 N--CA 1.462 0.131 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.559 179.587 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -55.03 -50.15 69.78 Favored 'General case' 0 C--O 1.232 0.153 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.033 179.691 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.624 HD11 ' O ' ' A' ' 36' ' ' LEU . 0.3 OUTLIER -56.88 -40.32 75.98 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.132 179.976 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -61.27 -38.29 86.22 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-N 116.451 -0.34 . . . . 0.0 111.163 179.645 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -76.05 -47.46 24.62 Favored 'General case' 0 C--O 1.231 0.125 0 CA-C-N 116.474 -0.33 . . . . 0.0 111.075 179.639 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 6.5 m-85 -55.75 -32.75 63.68 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 116.468 -0.333 . . . . 0.0 111.384 179.876 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . 0.421 ' HA ' ' NE2' ' A' ' 20' ' ' GLN . 1.8 t80 -59.09 -41.31 87.75 Favored 'General case' 0 C--O 1.232 0.184 0 CA-C-O 120.695 0.284 . . . . 0.0 110.713 179.644 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 6.4 tt0 -84.82 -38.94 18.94 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.803 179.447 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 4.9 tt0 -62.29 -39.69 93.79 Favored 'General case' 0 CA--C 1.529 0.169 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.252 -179.958 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.233 0.194 0 CA-C-N 116.597 -0.274 . . . . 0.0 111.132 179.729 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 2.4 p . . . . . 0 N--CA 1.469 0.505 0 CA-C-O 121.201 0.524 . . . . 0.0 111.432 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . 0.414 ' CE1' HD21 ' A' ' 53' ' ' LEU . 7.9 m-85 -114.8 -37.33 4.24 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.747 -0.66 . . . . 0.0 111.381 -179.844 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -157.53 176.72 12.27 Favored 'General case' 0 C--O 1.236 0.344 0 CA-C-O 120.698 0.285 . . . . 0.0 111.094 179.752 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -122.7 140.94 52.31 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.966 179.802 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 25.0 mt -125.83 154.62 34.91 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.17 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.196 -179.811 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 17.1 mt-10 -109.04 150.62 27.52 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-N 116.345 -0.388 . . . . 0.0 111.108 179.957 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.665 HD11 ' CE2' ' A' ' 22' ' ' PHE . 16.5 tt -59.01 -28.88 39.93 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.292 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.58 179.697 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 20.5 mt-10 -58.26 -31.13 67.14 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-N 116.528 -0.305 . . . . 0.0 111.285 179.666 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -94.36 28.48 2.54 Favored 'General case' 0 CA--C 1.536 0.41 0 CA-C-N 116.695 -0.23 . . . . 0.0 111.41 179.643 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 1.4 ttp -122.75 167.56 13.33 Favored 'General case' 0 CA--C 1.53 0.176 0 CA-C-O 120.648 0.261 . . . . 0.0 111.234 -179.736 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -105.36 117.24 33.52 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.77 179.891 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . 0.513 ' HB3' ' CE2' ' A' ' 22' ' ' PHE . 37.2 p90 -96.0 147.78 23.34 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.974 179.826 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -144.43 150.25 47.13 Favored Pre-proline 0 N--CA 1.463 0.211 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.398 179.875 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 70.2 Cg_endo -73.8 -14.74 24.17 Favored 'Trans proline' 0 C--N 1.348 0.55 0 C-N-CA 123.056 2.504 . . . . 0.0 113.098 179.613 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -69.03 82.53 0.32 Allowed 'General case' 0 CA--C 1.53 0.185 0 CA-C-O 121.179 0.514 . . . . 0.0 110.868 -179.824 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 6.8 m-80 67.51 20.7 9.73 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 115.564 -0.744 . . . . 0.0 111.797 -179.556 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' GLN . . . . . 0.619 ' HG2' HD12 ' A' ' 36' ' ' LEU . 16.7 mt-30 54.14 77.54 0.19 Allowed 'General case' 0 CA--C 1.532 0.257 0 CA-C-O 120.854 0.359 . . . . 0.0 111.428 179.596 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -116.62 145.25 43.53 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.034 179.967 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.665 ' CE2' HD11 ' A' ' 10' ' ' ILE . 12.3 m-85 -125.92 94.86 4.23 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.654 -179.901 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 32.2 p -91.79 146.14 24.0 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.419 -179.49 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 23.0 t80 -142.59 137.18 15.09 Favored Pre-proline 0 CA--C 1.53 0.184 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.036 -179.942 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -65.32 100.02 0.37 Allowed 'Trans proline' 0 C--N 1.349 0.596 0 C-N-CA 122.694 2.263 . . . . 0.0 112.272 179.604 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . 0.403 ' SG ' ' HD2' ' A' ' 27' ' ' PRO . 48.1 t -65.94 139.01 96.56 Favored Pre-proline 0 C--O 1.233 0.229 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.699 179.903 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . 0.403 ' HD2' ' SG ' ' A' ' 26' ' ' CYS . 54.8 Cg_exo -53.25 -25.41 30.21 Favored 'Trans proline' 0 C--N 1.35 0.649 0 C-N-CA 122.82 2.346 . . . . 0.0 112.83 179.666 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -68.26 -38.54 81.86 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-O 120.451 0.167 . . . . 0.0 111.268 179.985 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 152.16 -47.47 0.56 Allowed Glycine 0 C--N 1.335 0.477 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.962 -179.987 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -76.74 -174.69 3.11 Favored 'General case' 0 CA--C 1.531 0.223 0 CA-C-O 120.694 0.283 . . . . 0.0 111.12 -179.783 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 12.3 mtt180 -122.36 137.41 54.87 Favored 'General case' 0 C--O 1.232 0.164 0 CA-C-O 120.829 0.347 . . . . 0.0 111.097 -179.853 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 9.1 m-85 -66.47 167.85 10.03 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.004 179.774 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 12.6 pt20 -154.18 97.64 2.06 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.114 -179.985 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 10.7 tt -123.97 151.52 28.94 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.216 0 CA-C-N 116.29 -0.413 . . . . 0.0 111.293 179.996 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 6.3 m-85 -102.53 152.69 20.86 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.839 -179.961 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.619 HD12 ' HG2' ' A' ' 20' ' ' GLN . 25.6 mt -61.6 -43.04 99.6 Favored 'General case' 0 N--CA 1.463 0.175 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.032 179.798 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -60.25 -38.13 82.53 Favored 'General case' 0 CA--C 1.53 0.187 0 CA-C-N 116.405 -0.362 . . . . 0.0 111.032 179.65 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -59.19 -57.04 14.79 Favored 'General case' 0 N--CA 1.462 0.158 0 CA-C-O 120.769 0.319 . . . . 0.0 110.81 179.711 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 47.6 mtm -61.32 -37.77 84.46 Favored 'General case' 0 N--CA 1.462 0.157 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.024 179.589 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 17.7 t80 -58.11 -38.7 76.96 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.999 179.586 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 1.3 tp10 -62.05 -45.13 94.9 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-N 116.507 -0.315 . . . . 0.0 110.761 179.576 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 152.29 48.34 0.02 OUTLIER Glycine 0 C--N 1.332 0.34 0 C-N-CA 120.979 -0.629 . . . . 0.0 112.694 179.627 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 1.1 tp10 -99.53 147.61 25.14 Favored 'General case' 0 C--O 1.231 0.106 0 CA-C-O 120.754 0.311 . . . . 0.0 110.99 179.921 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 7.9 mttt -149.37 -47.99 0.14 Allowed 'General case' 0 C--O 1.233 0.217 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.133 179.752 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.432 HG22 ' OD1' ' A' ' 56' ' ' ASP . 24.3 t -106.86 104.52 17.18 Favored 'Isoleucine or valine' 0 C--O 1.234 0.257 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.862 179.957 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -92.7 174.64 7.16 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.076 179.813 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 10.7 p -134.9 123.57 41.22 Favored 'Isoleucine or valine' 0 C--O 1.233 0.214 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.205 -179.954 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 48.3 t -70.31 135.77 86.66 Favored Pre-proline 0 C--N 1.332 -0.186 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.807 179.869 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_endo -84.13 20.94 1.13 Allowed 'Trans proline' 0 CA--C 1.536 0.581 0 C-N-CA 122.762 2.308 . . . . 0.0 113.077 179.682 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -128.71 -55.72 1.22 Allowed 'General case' 0 C--O 1.232 0.155 0 CA-C-N 116.67 -0.241 . . . . 0.0 110.626 179.903 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 18.6 p -98.31 -17.69 18.76 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.848 179.906 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 5.6 p 63.93 37.15 9.65 Favored 'General case' 0 CA--C 1.535 0.382 0 CA-C-O 120.987 0.422 . . . . 0.0 111.438 179.865 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.496 HD13 ' N ' ' A' ' 54' ' ' MET . 1.3 tm? -101.99 130.62 48.57 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.491 179.7 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' MET . . . . . 0.496 ' N ' HD13 ' A' ' 53' ' ' LEU . 60.6 mtm -83.95 135.18 34.56 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.836 179.997 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.463 ' O ' HD12 ' A' ' 55' ' ' ILE . 2.5 pp -137.51 134.35 46.42 Favored 'Isoleucine or valine' 0 C--O 1.233 0.23 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.564 -179.89 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . 0.432 ' OD1' HG22 ' A' ' 45' ' ' VAL . 20.1 m-20 -82.41 100.95 10.32 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.766 179.597 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.468 HG13 ' O ' ' A' ' 57' ' ' VAL . 13.5 p -104.02 116.66 48.22 Favored 'Isoleucine or valine' 0 C--O 1.233 0.227 0 CA-C-O 121.133 0.492 . . . . 0.0 111.179 179.9 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 12.4 p -87.55 137.53 20.82 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.939 -179.94 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 44.3 p90 -124.66 175.98 6.85 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.072 -179.67 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -114.02 155.94 24.99 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.144 -179.881 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 56.6 mttt -92.96 -44.44 8.43 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.742 179.674 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 16.2 pt-20 -57.84 -36.04 71.73 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 116.473 -0.33 . . . . 0.0 110.927 179.61 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -55.68 -53.3 58.3 Favored 'General case' 0 N--CA 1.461 0.125 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.67 179.523 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 3.0 mp -55.43 -39.35 70.14 Favored 'General case' 0 N--CA 1.462 0.159 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.211 179.631 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -58.76 -60.15 4.29 Favored 'General case' 0 CA--C 1.528 0.11 0 CA-C-N 116.507 -0.315 . . . . 0.0 111.173 179.885 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -63.72 -40.6 97.15 Favored 'General case' 0 N--CA 1.464 0.225 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.221 179.708 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . 0.617 ' O ' ' HB2' ' A' ' 71' ' ' ALA . 3.2 m-85 -63.16 -55.51 24.57 Favored 'General case' 0 C--O 1.227 -0.129 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.233 -179.82 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 3.0 t80 -61.56 -43.98 97.87 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 116.592 -0.276 . . . . 0.0 110.89 179.998 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 4.0 tt0 -58.11 -30.42 66.28 Favored 'General case' 0 CA--C 1.53 0.21 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.975 179.541 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -130.74 59.55 1.66 Allowed 'General case' 0 C--O 1.234 0.26 0 CA-C-O 120.839 0.352 . . . . 0.0 111.107 -179.927 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . 0.617 ' HB2' ' O ' ' A' ' 67' ' ' TYR . . . . . . . . 0 C--O 1.234 0.251 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.536 179.926 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . 0.48 HG22 ' O ' ' A' ' 54' ' ' MET . 0.2 OUTLIER . . . . . 0 N--CA 1.467 0.384 0 CA-C-O 120.747 0.308 . . . . 0.0 110.982 . . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 21.4 m-85 -105.58 -76.4 0.61 Allowed 'General case' 0 C--O 1.232 0.167 0 CA-C-N 116.48 -0.327 . . . . 0.0 111.176 -179.739 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -126.66 171.77 10.87 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.002 -179.813 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 4.6 pt-20 -132.64 136.31 46.41 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-N 116.405 -0.361 . . . . 0.0 111.014 179.654 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 3.7 mp -118.48 150.4 20.72 Favored 'Isoleucine or valine' 0 C--O 1.233 0.226 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.375 -179.605 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . 0.446 ' HA ' HG12 ' A' ' 58' ' ' VAL . 12.2 mt-10 -98.97 153.55 18.76 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.366 -179.905 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 1.1 tp -59.25 -32.61 48.65 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.286 0 CA-C-N 115.989 -0.55 . . . . 0.0 111.223 179.551 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -61.21 -33.17 73.04 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-N 116.551 -0.295 . . . . 0.0 110.998 179.514 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -96.91 37.37 1.31 Allowed 'General case' 0 C--O 1.234 0.27 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.177 179.816 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' MET . . . . . 0.516 ' HG2' ' CD1' ' A' ' 24' ' ' TYR . 3.3 mtp -125.75 150.09 48.02 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-N 116.407 -0.361 . . . . 0.0 110.887 179.798 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 7.3 m -96.7 113.57 25.14 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.766 179.679 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 24.2 p90 -80.38 130.18 35.0 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.517 179.632 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 3.9 tt0 -107.23 95.83 14.18 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.625 -179.949 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -72.87 60.84 3.72 Favored 'Trans proline' 0 C--N 1.347 0.492 0 C-N-CA 122.69 2.26 . . . . 0.0 112.58 -179.734 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 15.1 pt-20 -126.67 -45.27 1.63 Allowed 'General case' 0 C--O 1.233 0.189 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.876 179.915 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 2.2 t-20 -146.55 33.64 0.95 Allowed 'General case' 0 CA--C 1.532 0.276 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.066 179.636 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 10.1 mt-30 57.9 57.75 3.98 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.222 179.851 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 21.8 ptm -136.62 151.44 49.33 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.672 179.658 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.611 ' HE1' HD23 ' A' ' 36' ' ' LEU . 7.6 m-85 -130.24 124.85 33.44 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.388 -179.899 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . 0.767 HG22 ' HA ' ' A' ' 33' ' ' GLN . 64.3 p -120.24 137.5 54.18 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.952 -179.581 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' TYR . . . . . 0.516 ' CD1' ' HG2' ' A' ' 13' ' ' MET . 1.9 p90 -131.54 148.17 68.97 Favored Pre-proline 0 C--O 1.233 0.195 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.133 179.867 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_exo -52.52 124.72 15.81 Favored 'Trans proline' 0 C--N 1.349 0.584 0 C-N-CA 122.872 2.381 . . . . 0.0 112.774 -179.671 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . 0.491 ' SG ' ' HD2' ' A' ' 27' ' ' PRO . 50.5 t -94.9 141.21 22.98 Favored Pre-proline 0 C--N 1.33 -0.244 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.342 179.587 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . 0.491 ' HD2' ' SG ' ' A' ' 26' ' ' CYS . 87.6 Cg_exo -48.08 -30.11 13.63 Favored 'Trans proline' 0 C--N 1.349 0.578 0 C-N-CA 122.846 2.364 . . . . 0.0 113.192 179.914 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . 0.405 ' CB ' ' HB3' ' A' ' 51' ' ' CYS . 0.8 OUTLIER -76.96 -40.36 47.2 Favored 'General case' 0 CA--C 1.532 0.267 0 CA-C-N 116.818 -0.174 . . . . 0.0 111.32 179.986 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 151.77 -45.07 0.63 Allowed Glycine 0 C--N 1.335 0.516 0 C-N-CA 120.49 -0.862 . . . . 0.0 113.175 179.753 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 50.6 m-20 -67.33 -177.74 0.74 Allowed 'General case' 0 CA--C 1.532 0.271 0 CA-C-O 120.912 0.387 . . . . 0.0 111.123 -179.808 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -110.97 128.15 55.74 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.875 -179.716 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 15.0 m-85 -64.66 91.46 0.08 Allowed 'General case' 0 C--O 1.233 0.227 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.7 179.816 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . 0.767 ' HA ' HG22 ' A' ' 23' ' ' THR . 2.9 pt20 -80.13 125.86 30.36 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.228 -179.65 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 2.5 tt -161.26 133.77 1.09 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.207 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.066 179.723 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 71.3 m-85 -88.11 145.52 25.9 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.775 -179.947 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.611 HD23 ' HE1' ' A' ' 22' ' ' PHE . 4.1 pp -58.01 -33.38 68.88 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.215 179.74 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . 0.55 ' N ' HD12 ' A' ' 36' ' ' LEU . 1.2 p30 -65.3 -39.07 92.03 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 116.567 -0.288 . . . . 0.0 110.785 179.493 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -61.87 -46.95 87.19 Favored 'General case' 0 CA--C 1.528 0.116 0 CA-C-N 116.422 -0.353 . . . . 0.0 110.839 179.781 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 55.6 mtm -74.37 -33.1 62.98 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.176 179.825 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . 0.417 ' HB2' HD21 ' A' ' 64' ' ' LEU . 18.4 t80 -57.09 -38.27 73.09 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.029 -179.931 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 21.6 mt-10 -60.71 -37.18 80.83 Favored 'General case' 0 N--CA 1.462 0.147 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.889 179.548 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 145.56 47.62 0.03 OUTLIER Glycine 0 C--N 1.333 0.391 0 C-N-CA 120.94 -0.647 . . . . 0.0 112.69 179.794 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -112.56 148.2 35.02 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-O 120.741 0.305 . . . . 0.0 111.161 -179.845 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 22.8 mtmt -148.09 -48.24 0.16 Allowed 'General case' 0 CA--C 1.531 0.219 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.076 179.815 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.45 HG22 ' OD1' ' A' ' 56' ' ' ASP . 23.7 t -89.87 94.79 5.03 Favored 'Isoleucine or valine' 0 C--O 1.232 0.178 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.805 -179.985 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -91.6 159.18 16.03 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.188 -179.884 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 11.6 p -126.04 128.45 71.84 Favored 'Isoleucine or valine' 0 C--O 1.232 0.169 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.371 -179.904 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 42.0 t -71.21 136.73 84.32 Favored Pre-proline 0 CA--C 1.53 0.201 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.884 179.714 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 92.9 Cg_endo -82.8 20.35 1.16 Allowed 'Trans proline' 0 C--N 1.35 0.629 0 C-N-CA 122.751 2.301 . . . . 0.0 113.136 179.742 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 38.9 t -128.59 -58.11 1.18 Allowed 'General case' 0 C--O 1.232 0.153 0 N-CA-C 110.265 -0.272 . . . . 0.0 110.265 179.539 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' CYS . . . . . 0.816 ' SG ' HD23 ' A' ' 53' ' ' LEU . 20.7 p -94.26 -27.0 16.38 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.483 179.711 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 1.5 t 70.92 42.92 0.73 Allowed 'General case' 0 CA--C 1.532 0.275 0 CA-C-O 120.931 0.396 . . . . 0.0 110.968 -179.838 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.816 HD23 ' SG ' ' A' ' 51' ' ' CYS . 3.6 mm? -92.34 150.69 20.69 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.63 179.64 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' MET . . . . . 0.48 ' O ' HG22 ' A' ' 4' ' ' THR . 9.7 mtt -104.66 123.05 46.92 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.904 -179.791 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 2.6 pp -134.99 148.3 29.1 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.313 0 CA-C-N 116.363 -0.38 . . . . 0.0 111.842 -179.883 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . 0.45 ' OD1' HG22 ' A' ' 45' ' ' VAL . 32.1 m-20 -102.4 92.36 4.66 Favored 'General case' 0 CA--C 1.531 0.223 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.95 179.657 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 13.1 p -88.97 127.83 41.46 Favored 'Isoleucine or valine' 0 C--O 1.234 0.256 0 CA-C-O 120.851 0.357 . . . . 0.0 110.986 179.72 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.446 HG12 ' HA ' ' A' ' 9' ' ' GLU . 12.5 p -97.97 136.53 28.52 Favored 'Isoleucine or valine' 0 C--O 1.234 0.251 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.398 -179.837 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 16.1 p90 -123.82 170.12 10.88 Favored 'General case' 0 CA--C 1.53 0.184 0 CA-C-N 115.899 -0.591 . . . . 0.0 111.073 -179.966 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -107.63 160.13 15.93 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.106 179.734 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -89.17 -37.85 14.73 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.032 179.691 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -72.21 -38.83 68.91 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-N 116.618 -0.265 . . . . 0.0 111.171 179.944 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 88.7 m-20 -52.71 -41.65 64.11 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.001 -179.988 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.417 HD21 ' HB2' ' A' ' 40' ' ' PHE . 0.8 OUTLIER -63.7 -52.35 60.97 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.979 -179.933 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -57.47 -39.26 75.97 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-N 116.489 -0.323 . . . . 0.0 110.736 179.57 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -73.83 -46.43 45.15 Favored 'General case' 0 N--CA 1.461 0.124 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.273 179.67 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 9.3 t80 -60.61 -37.67 82.18 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 116.713 -0.221 . . . . 0.0 111.237 -179.946 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 13.9 t80 -58.29 -41.34 84.17 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-O 120.55 0.214 . . . . 0.0 110.813 179.742 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 9.5 mt-10 -87.93 -35.38 17.71 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.496 -179.801 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 -72.18 -33.37 67.63 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 116.65 -0.25 . . . . 0.0 111.583 -179.843 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.233 0.232 0 CA-C-O 120.819 0.342 . . . . 0.0 111.329 -179.939 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . 0.408 HG21 ' CG ' ' A' ' 56' ' ' ASP . 0.8 OUTLIER . . . . . 0 N--CA 1.464 0.262 0 CA-C-O 120.906 0.384 . . . . 0.0 111.36 . . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 15.3 m-85 -103.6 -36.2 8.01 Favored 'General case' 0 CA--C 1.53 0.194 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.381 179.849 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -158.78 171.45 20.05 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-O 120.701 0.286 . . . . 0.0 111.322 -179.97 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -127.54 140.5 52.09 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.005 -179.897 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 27.1 mm -120.48 156.01 23.61 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.254 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.926 -179.865 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 10.0 mt-10 -119.63 159.82 23.67 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-O 120.739 0.304 . . . . 0.0 111.323 179.848 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 11.5 tt -65.39 -30.95 51.77 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.351 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.481 179.37 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -60.02 -42.33 94.14 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-O 120.45 0.166 . . . . 0.0 111.331 -179.878 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 8.4 p-10 -98.09 37.05 1.47 Allowed 'General case' 0 CA--C 1.535 0.378 0 CA-C-O 120.824 0.345 . . . . 0.0 111.329 179.589 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -114.43 139.74 49.26 Favored 'General case' 0 C--O 1.233 0.236 0 N-CA-C 109.655 -0.498 . . . . 0.0 109.655 179.182 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 2.9 m -66.87 89.84 0.17 Allowed 'General case' 0 C--O 1.233 0.207 0 CA-C-O 120.86 0.362 . . . . 0.0 110.651 -179.649 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 52.1 p90 -80.2 127.71 32.66 Favored 'General case' 0 C--O 1.232 0.159 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.752 -179.979 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 5.8 mt-10 -109.1 93.92 13.93 Favored Pre-proline 0 C--O 1.236 0.346 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.347 179.845 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -71.64 64.77 3.05 Favored 'Trans proline' 0 C--N 1.346 0.398 0 C-N-CA 122.943 2.429 . . . . 0.0 112.351 -179.794 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 17.1 pt-20 -140.29 -45.86 0.42 Allowed 'General case' 0 CA--C 1.531 0.226 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.916 179.934 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 44.9 p30 -134.69 24.11 3.67 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.557 -179.998 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' GLN . . . . . 0.4 ' HG2' ' HB2' ' A' ' 36' ' ' LEU . 0.3 OUTLIER 60.79 47.05 8.27 Favored 'General case' 0 C--O 1.235 0.325 0 CA-C-O 120.944 0.402 . . . . 0.0 111.053 179.983 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 20.2 ttt -114.77 143.13 45.56 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.919 -179.917 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.488 ' CD1' HD21 ' A' ' 36' ' ' LEU . 4.1 m-85 -127.92 104.34 7.75 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.702 179.649 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . 0.412 HG22 ' HG2' ' A' ' 33' ' ' GLN . 22.5 p -107.88 179.27 4.27 Favored 'General case' 0 CA--C 1.531 0.216 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.01 -179.962 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 63.1 t80 -173.09 135.27 0.7 Allowed Pre-proline 0 N--CA 1.466 0.338 0 CA-C-N 116.63 -0.259 . . . . 0.0 111.211 179.712 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_endo -66.92 108.05 1.42 Allowed 'Trans proline' 0 C--N 1.349 0.6 0 C-N-CA 122.611 2.207 . . . . 0.0 112.447 179.832 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . 0.438 ' SG ' ' HD2' ' A' ' 27' ' ' PRO . 42.8 t -69.36 139.64 89.7 Favored Pre-proline 0 C--N 1.332 -0.187 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.517 179.704 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . 0.438 ' HD2' ' SG ' ' A' ' 26' ' ' CYS . 77.7 Cg_exo -51.59 -26.95 23.93 Favored 'Trans proline' 0 C--N 1.349 0.599 0 C-N-CA 122.92 2.413 . . . . 0.0 113.072 179.833 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . 0.403 ' CB ' ' HB3' ' A' ' 51' ' ' CYS . 0.8 OUTLIER -70.1 -38.59 75.7 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-N 116.894 -0.139 . . . . 0.0 111.36 -179.868 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 150.86 -43.31 0.71 Allowed Glycine 0 C--N 1.335 0.483 0 C-N-CA 120.869 -0.682 . . . . 0.0 112.91 -179.842 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -70.83 -174.44 0.92 Allowed 'General case' 0 CA--C 1.535 0.383 0 CA-C-O 120.668 0.271 . . . . 0.0 111.187 -179.77 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 18.6 ttm180 -126.96 122.37 34.35 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-O 120.706 0.289 . . . . 0.0 111.385 -179.689 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 4.4 m-85 -61.86 154.14 26.9 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.849 179.527 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . 0.412 ' HG2' HG22 ' A' ' 23' ' ' THR . 32.9 mt-30 -143.02 122.04 12.83 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-N 116.455 -0.338 . . . . 0.0 111.478 179.993 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 3.9 tt -151.2 123.12 1.12 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.24 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.896 179.451 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 44.5 m-85 -81.52 158.78 24.35 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.887 -179.916 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.84 HD12 ' HG ' ' A' ' 64' ' ' LEU . 4.0 mm? -59.53 -39.39 83.75 Favored 'General case' 0 N--CA 1.463 0.225 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.847 179.829 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -59.76 -42.59 93.58 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 116.468 -0.333 . . . . 0.0 110.98 179.543 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 33.9 m-20 -58.72 -46.11 88.09 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-O 120.857 0.36 . . . . 0.0 110.475 179.696 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 5.2 mmm -61.18 -35.71 77.88 Favored 'General case' 0 CA--C 1.529 0.17 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.808 179.518 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . 0.595 ' CD2' HD22 ' A' ' 64' ' ' LEU . 0.3 OUTLIER -54.35 -45.6 72.77 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 116.491 -0.322 . . . . 0.0 111.293 179.933 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 6.3 mt-10 -61.43 -46.47 89.96 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 116.585 -0.28 . . . . 0.0 110.892 179.875 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 132.09 52.63 0.09 OUTLIER Glycine 0 C--N 1.333 0.376 0 C-N-CA 120.977 -0.63 . . . . 0.0 112.609 179.807 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -106.32 95.88 6.08 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-O 120.941 0.401 . . . . 0.0 111.175 -179.938 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 5.0 ptpt -105.77 -32.92 8.18 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-N 115.843 -0.617 . . . . 0.0 111.064 179.62 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.547 ' O ' HG13 ' A' ' 45' ' ' VAL . 9.5 p -86.89 74.07 1.05 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.295 0 CA-C-O 121.456 0.646 . . . . 0.0 111.001 -179.915 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -81.5 136.32 35.63 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.718 -0.674 . . . . 0.0 111.101 -179.896 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 6.4 m -109.8 125.59 66.98 Favored 'Isoleucine or valine' 0 C--O 1.232 0.18 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.337 -179.985 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 50.3 t -68.8 135.68 90.05 Favored Pre-proline 0 C--O 1.233 0.229 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.84 179.893 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_endo -84.14 20.59 1.18 Allowed 'Trans proline' 0 C--N 1.349 0.59 0 C-N-CA 122.716 2.278 . . . . 0.0 113.217 179.698 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -128.55 -57.58 1.2 Allowed 'General case' 0 C--O 1.232 0.151 0 CA-C-O 120.59 0.233 . . . . 0.0 110.582 179.712 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' CYS . . . . . 0.403 ' HB3' ' CB ' ' A' ' 28' ' ' CYS . 19.1 p -95.35 -22.51 17.69 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-N 116.352 -0.386 . . . . 0.0 111.658 179.828 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 1.1 t 67.53 41.37 2.36 Favored 'General case' 0 CA--C 1.533 0.314 0 CA-C-O 120.981 0.42 . . . . 0.0 110.948 -179.841 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 7.0 tp -95.66 134.32 38.7 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.846 179.86 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' MET . . . . . . . . . . . . . 37.7 mtt -86.07 132.3 34.07 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.0 -179.94 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 2.5 pp -142.18 139.64 29.87 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.205 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.314 -179.899 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . 0.408 ' CG ' HG21 ' A' ' 4' ' ' THR . 67.3 m-20 -102.07 97.28 7.63 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.68 179.362 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 12.7 p -86.39 138.01 19.84 Favored 'Isoleucine or valine' 0 C--O 1.234 0.282 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.12 179.885 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 13.4 p -104.92 133.21 49.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.876 179.89 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 37.6 p90 -132.46 176.51 8.36 Favored 'General case' 0 CA--C 1.532 0.274 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.054 -179.397 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 2.5 t70 -122.3 147.69 45.93 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.457 179.968 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 15.0 tttm -83.68 -39.0 20.73 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.82 179.435 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 20.3 mt-10 -60.0 -42.29 93.94 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-N 116.481 -0.327 . . . . 0.0 110.397 179.514 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -64.6 -44.43 90.62 Favored 'General case' 0 CA--C 1.527 0.072 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.795 179.396 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.84 ' HG ' HD12 ' A' ' 36' ' ' LEU . 0.3 OUTLIER -58.25 -43.64 87.94 Favored 'General case' 0 N--CA 1.463 0.207 0 CA-C-N 116.679 -0.237 . . . . 0.0 110.946 179.841 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -65.11 -40.94 95.22 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-N 116.409 -0.359 . . . . 0.0 110.814 179.527 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 2.3 tp10 -72.35 -43.8 63.52 Favored 'General case' 0 CA--C 1.532 0.251 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.165 179.617 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 1.4 t80 -62.48 -36.56 82.88 Favored 'General case' 0 N--CA 1.464 0.273 0 N-CA-C 111.945 0.35 . . . . 0.0 111.945 -179.589 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -59.47 -38.73 81.56 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-O 120.676 0.274 . . . . 0.0 110.624 179.963 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 -86.69 -38.6 16.84 Favored 'General case' 0 CA--C 1.53 0.205 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.048 179.766 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 73.2 mt-10 -69.15 -38.81 78.99 Favored 'General case' 0 N--CA 1.465 0.306 0 N-CA-C 111.867 0.321 . . . . 0.0 111.867 -179.394 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.157 0 C-N-CA 121.245 -0.182 . . . . 0.0 111.401 -179.749 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--O 1.233 0.221 0 CA-C-O 120.722 0.296 . . . . 0.0 111.027 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 25.7 m-85 -106.72 -74.04 0.67 Allowed 'General case' 0 C--O 1.232 0.166 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.325 -179.843 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -131.78 169.22 16.52 Favored 'General case' 0 C--O 1.234 0.279 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.152 -179.695 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 1.5 pt-20 -105.88 138.22 42.44 Favored 'General case' 0 C--O 1.232 0.166 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.234 179.987 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 31.3 mm -101.38 154.96 4.7 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.196 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.053 179.916 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 16.0 tt0 -109.18 130.3 55.49 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.947 179.94 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 18.7 tt -60.58 -31.3 48.65 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.262 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.244 179.632 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 3.1 tt0 -59.98 -31.81 70.25 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.107 179.543 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -96.26 37.12 1.27 Allowed 'General case' 0 CA--C 1.533 0.312 0 CA-C-O 120.81 0.338 . . . . 0.0 111.112 179.823 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' MET . . . . . 0.463 ' HE3' HG21 ' A' ' 57' ' ' VAL . 32.4 mtt -127.89 137.0 52.16 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-N 116.478 -0.328 . . . . 0.0 110.653 179.733 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 2.6 m -61.17 116.97 4.99 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.765 -179.847 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 23.5 p90 -86.44 134.05 33.72 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.904 -179.946 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -118.96 94.1 47.67 Favored Pre-proline 0 C--O 1.234 0.256 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.646 179.946 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_endo -68.34 -12.83 36.09 Favored 'Trans proline' 0 C--N 1.346 0.413 0 C-N-CA 122.76 2.307 . . . . 0.0 113.122 -179.926 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -54.75 -44.18 73.37 Favored 'General case' 0 CA--C 1.53 0.191 0 CA-C-N 116.812 -0.176 . . . . 0.0 111.138 -179.942 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 14.7 m-20 -144.85 24.3 1.51 Allowed 'General case' 0 CA--C 1.534 0.337 0 CA-C-N 116.435 -0.348 . . . . 0.0 111.555 179.723 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' GLN . . . . . 0.638 ' CG ' HD12 ' A' ' 36' ' ' LEU . 2.3 tp60 56.86 69.01 0.78 Allowed 'General case' 0 CA--C 1.532 0.285 0 CA-C-O 120.827 0.346 . . . . 0.0 111.7 179.561 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 11.7 ptp -141.89 150.15 41.15 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.352 -0.386 . . . . 0.0 111.139 179.662 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 7.7 m-85 -120.2 143.9 48.0 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.79 -179.941 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 58.0 p -126.68 146.69 50.1 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.232 -179.897 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 4.6 t80 -135.73 95.07 14.32 Favored Pre-proline 0 C--N 1.332 -0.177 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.605 179.815 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . 0.415 ' HA ' ' HA ' ' A' ' 31' ' ' ARG . 54.4 Cg_exo -52.13 94.31 0.03 OUTLIER 'Trans proline' 0 C--N 1.349 0.59 0 C-N-CA 122.867 2.378 . . . . 0.0 112.309 -179.932 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 29.5 t -65.38 135.63 96.03 Favored Pre-proline 0 C--O 1.233 0.224 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.792 -179.778 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -60.17 -17.49 46.16 Favored 'Trans proline' 0 C--N 1.349 0.564 0 C-N-CA 122.731 2.288 . . . . 0.0 112.861 179.684 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 3.6 p -58.72 -30.33 67.37 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-O 120.556 0.217 . . . . 0.0 111.346 179.769 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 138.64 -15.28 3.37 Favored Glycine 0 CA--C 1.523 0.577 0 C-N-CA 120.945 -0.645 . . . . 0.0 113.28 -179.897 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 3.2 t0 -113.83 -166.55 1.1 Allowed 'General case' 0 CA--C 1.534 0.333 0 CA-C-N 117.036 0.418 . . . . 0.0 111.216 -179.804 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . 0.415 ' HA ' ' HA ' ' A' ' 25' ' ' PRO . 16.2 ttp-105 -129.32 153.62 47.67 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.059 -179.804 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -91.27 167.02 12.62 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-N 116.09 -0.504 . . . . 0.0 111.074 179.754 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -157.58 113.76 2.87 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.885 179.608 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.408 ' CD1' ' HG3' ' A' ' 39' ' ' MET . 5.3 tt -144.37 126.54 10.43 Favored 'Isoleucine or valine' 0 C--O 1.234 0.238 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.134 -179.876 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 37.2 m-85 -81.3 155.53 25.98 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.759 -179.994 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.638 HD12 ' CG ' ' A' ' 20' ' ' GLN . 24.2 mt -58.19 -37.33 74.55 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.055 179.762 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -59.57 -40.99 89.17 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 116.387 -0.37 . . . . 0.0 110.861 179.598 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 2.7 t0 -64.08 -39.16 93.45 Favored 'General case' 0 CA--C 1.528 0.112 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.565 179.525 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' MET . . . . . 0.408 ' HG3' ' CD1' ' A' ' 34' ' ' ILE . 28.2 mtm -93.1 30.94 1.52 Allowed 'General case' 0 CA--C 1.532 0.279 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.115 179.467 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 16.9 t80 -131.42 -47.32 0.98 Allowed 'General case' 0 C--O 1.232 0.181 0 CA-C-N 116.547 -0.297 . . . . 0.0 110.799 179.793 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 13.5 mt-10 -58.0 -36.95 73.39 Favored 'General case' 0 CA--C 1.53 0.179 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.17 179.731 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 151.87 68.26 0.01 OUTLIER Glycine 0 C--N 1.336 0.534 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.849 179.709 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 12.8 tt0 -130.37 157.91 41.28 Favored 'General case' 0 N--CA 1.462 0.152 0 CA-C-O 120.787 0.327 . . . . 0.0 111.436 179.966 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 1.8 mtmt -154.98 -45.98 0.08 Allowed 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.016 179.873 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 5.4 m -99.32 115.27 39.64 Favored 'Isoleucine or valine' 0 C--O 1.233 0.216 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.089 -179.99 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -109.15 149.99 28.53 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.152 -179.912 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 12.8 m -109.68 135.33 48.96 Favored 'Isoleucine or valine' 0 C--O 1.233 0.207 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.388 -179.898 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 50.8 t -75.94 135.96 70.29 Favored Pre-proline 0 C--O 1.233 0.229 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.018 -179.918 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 83.7 Cg_endo -83.91 19.17 1.4 Allowed 'Trans proline' 0 CA--C 1.535 0.573 0 C-N-CA 122.719 2.279 . . . . 0.0 113.127 179.639 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 36.3 t -128.41 -58.31 1.19 Allowed 'General case' 0 C--O 1.232 0.162 0 CA-C-N 116.746 -0.206 . . . . 0.0 110.572 179.789 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 21.0 p -103.39 -18.99 14.59 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 116.398 -0.364 . . . . 0.0 111.695 179.879 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER 70.03 37.13 1.78 Allowed 'General case' 0 CA--C 1.533 0.304 0 CA-C-O 120.788 0.328 . . . . 0.0 111.106 -179.802 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 7.6 mt -75.38 142.35 43.12 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-N 116.396 -0.366 . . . . 0.0 110.643 179.712 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' MET . . . . . . . . . . . . . 22.5 mtt -96.01 113.85 25.5 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.972 -179.58 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 2.7 pp -131.56 162.37 39.53 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.285 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.608 -179.538 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -119.5 95.74 4.91 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.032 179.995 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.463 HG21 ' HE3' ' A' ' 13' ' ' MET . 15.0 p -89.31 128.82 41.13 Favored 'Isoleucine or valine' 0 C--O 1.234 0.251 0 CA-C-O 120.937 0.399 . . . . 0.0 111.251 179.728 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 14.0 p -91.68 152.7 3.34 Favored 'Isoleucine or valine' 0 C--O 1.234 0.239 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.142 179.93 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 15.8 p90 -136.58 174.96 10.05 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.116 -179.651 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -133.43 142.77 48.47 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.321 179.939 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.74 -41.78 62.05 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.746 179.559 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -59.44 -41.03 88.66 Favored 'General case' 0 N--CA 1.462 0.139 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.624 179.427 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -70.42 -46.68 63.44 Favored 'General case' 0 CA--C 1.528 0.121 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.988 179.695 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.497 ' HG ' HD22 ' A' ' 36' ' ' LEU . 0.2 OUTLIER -56.93 -39.36 74.35 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.187 179.882 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -76.41 -46.44 27.15 Favored 'General case' 0 C--O 1.232 0.142 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.264 179.923 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 31.4 mt-10 -58.61 -47.05 85.66 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 116.43 -0.35 . . . . 0.0 110.924 179.817 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 3.3 m-85 -58.06 -32.62 68.19 Favored 'General case' 0 C--N 1.334 -0.105 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.299 179.742 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -59.57 -34.92 73.3 Favored 'General case' 0 CA--C 1.528 0.128 0 CA-C-O 120.626 0.251 . . . . 0.0 110.988 179.666 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -91.99 -35.42 13.98 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.028 179.719 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 13.9 mt-10 -68.92 -35.59 77.0 Favored 'General case' 0 CA--C 1.53 0.197 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.134 179.774 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.233 0.193 0 CA-C-O 120.859 0.362 . . . . 0.0 111.182 179.965 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . 0.428 HG21 ' CG ' ' A' ' 56' ' ' ASP . 0.9 OUTLIER . . . . . 0 N--CA 1.465 0.317 0 CA-C-O 120.98 0.419 . . . . 0.0 111.348 . . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . 0.488 ' HB2' HD21 ' A' ' 53' ' ' LEU . 92.2 m-85 -107.87 -37.47 6.1 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-N 115.873 -0.603 . . . . 0.0 111.359 179.841 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -144.94 161.45 39.31 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-O 120.814 0.34 . . . . 0.0 111.393 179.923 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . 0.427 ' HG2' ' HB2' ' A' ' 56' ' ' ASP . 28.5 mt-10 -141.1 143.73 34.49 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.146 -179.888 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 3.8 mp -137.84 152.33 26.46 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.424 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.11 179.83 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -97.97 154.06 17.94 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 116.442 -0.345 . . . . 0.0 110.921 179.389 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.47 HD12 ' HA ' ' A' ' 59' ' ' PHE . 0.2 OUTLIER -54.65 -29.6 21.03 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.588 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.626 179.747 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 9.6 tt0 -56.25 -39.0 71.88 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-N 116.58 -0.282 . . . . 0.0 111.041 179.529 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -94.93 29.63 2.33 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-N 116.455 -0.339 . . . . 0.0 111.561 -179.817 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -114.71 136.69 52.79 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-O 120.577 0.227 . . . . 0.0 110.904 -179.961 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 25.6 m -71.8 102.54 2.87 Favored 'General case' 0 C--O 1.232 0.138 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.487 179.609 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 30.6 p90 -80.57 132.0 35.59 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.017 -179.788 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . 0.415 ' HB2' ' HG3' ' A' ' 21' ' ' MET . 53.2 mm-40 -108.95 95.08 16.17 Favored Pre-proline 0 C--O 1.234 0.28 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.618 179.916 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 67.0 Cg_endo -74.53 59.46 4.82 Favored 'Trans proline' 0 C--N 1.347 0.491 0 C-N-CA 122.615 2.21 . . . . 0.0 112.366 179.945 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -128.23 -49.19 1.31 Allowed 'General case' 0 CA--C 1.53 0.196 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.906 -179.914 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 16.0 m-80 -139.11 28.94 2.27 Favored 'General case' 0 CA--C 1.534 0.356 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.009 179.582 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 3.9 mm-40 58.88 61.91 2.03 Favored 'General case' 0 CA--C 1.535 0.401 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.609 179.489 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' MET . . . . . 0.415 ' HG3' ' HB2' ' A' ' 16' ' ' GLU . 20.8 ptp -134.7 141.18 46.46 Favored 'General case' 0 CA--C 1.531 0.227 0 CA-C-N 116.33 -0.396 . . . . 0.0 110.992 179.755 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 3.9 m-85 -111.23 125.68 54.06 Favored 'General case' 0 N--CA 1.463 0.176 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.492 179.713 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 29.6 p -117.27 160.85 20.44 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.329 -179.715 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 29.6 t80 -157.4 136.36 8.0 Favored Pre-proline 0 N--CA 1.463 0.175 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.018 -179.971 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -70.41 93.0 0.58 Allowed 'Trans proline' 0 C--N 1.347 0.448 0 C-N-CA 122.405 2.07 . . . . 0.0 111.989 179.421 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . 0.447 ' SG ' ' HD2' ' A' ' 27' ' ' PRO . 42.3 t -56.6 139.27 75.92 Favored Pre-proline 0 C--O 1.234 0.243 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.664 -179.968 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . 0.447 ' HD2' ' SG ' ' A' ' 26' ' ' CYS . 9.9 Cg_endo -53.23 -25.96 32.16 Favored 'Trans proline' 0 C--N 1.347 0.497 0 C-N-CA 122.926 2.418 . . . . 0.0 113.031 179.997 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . 0.411 ' CB ' ' HB3' ' A' ' 51' ' ' CYS . 0.6 OUTLIER -74.72 -39.43 61.9 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-O 120.461 0.172 . . . . 0.0 111.352 -179.898 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 150.04 -38.33 0.91 Allowed Glycine 0 C--N 1.334 0.467 0 C-N-CA 120.859 -0.686 . . . . 0.0 113.004 -179.802 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -72.04 -176.66 1.8 Allowed 'General case' 0 CA--C 1.533 0.321 0 CA-C-O 120.818 0.342 . . . . 0.0 111.215 -179.861 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 5.4 ttp-105 -116.7 123.67 47.8 Favored 'General case' 0 C--O 1.232 0.173 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.282 -179.375 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -73.65 99.95 3.23 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.643 179.534 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 9.7 mt-30 -92.98 136.39 33.3 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-N 116.474 -0.33 . . . . 0.0 111.208 -179.731 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.454 HG23 ' O ' ' A' ' 34' ' ' ILE . 1.0 OUTLIER -155.69 119.04 0.44 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.294 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.868 179.849 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 79.9 m-85 -81.86 159.07 23.8 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 116.444 -0.344 . . . . 0.0 110.934 -179.749 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.562 HD22 ' HG ' ' A' ' 64' ' ' LEU . 62.8 mt -55.16 -40.28 70.47 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.071 179.857 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 22.1 m-20 -60.38 -45.58 93.05 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-O 120.57 0.224 . . . . 0.0 110.555 179.395 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 64.5 m-20 -60.31 -43.52 96.28 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.139 179.132 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' MET . . . . . 0.424 ' HG2' ' HA ' ' A' ' 36' ' ' LEU . 1.8 ptm -90.77 36.79 0.91 Allowed 'General case' 0 CA--C 1.536 0.434 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.2 179.475 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 18.2 t80 -139.84 -49.89 0.48 Allowed 'General case' 0 CA--C 1.53 0.192 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.71 179.42 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 2.2 mm-40 -59.74 -35.88 75.47 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 116.526 -0.306 . . . . 0.0 110.911 179.613 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 140.59 52.28 0.04 OUTLIER Glycine 0 C--N 1.335 0.491 0 C-N-CA 120.951 -0.642 . . . . 0.0 113.015 179.568 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -129.03 102.3 6.44 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-O 120.796 0.332 . . . . 0.0 111.287 179.969 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . 0.448 ' HG2' ' CE2' ' A' ' 59' ' ' PHE . 12.8 mttt -113.74 -34.98 5.31 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.02 179.723 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 29.7 t -79.12 79.11 0.9 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.238 0 CA-C-O 120.986 0.422 . . . . 0.0 110.565 179.849 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -87.56 151.54 22.91 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.333 -179.802 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 11.8 p -133.24 130.03 57.31 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.026 179.88 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 37.7 t -73.64 115.32 40.62 Favored Pre-proline 0 C--N 1.331 -0.238 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.312 179.859 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_exo -57.2 -21.63 44.32 Favored 'Trans proline' 0 CA--C 1.533 0.455 0 C-N-CA 122.703 2.269 . . . . 0.0 113.049 -179.996 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -76.25 -66.99 0.73 Allowed 'General case' 0 CA--C 1.533 0.294 0 N-CA-C 111.236 0.087 . . . . 0.0 111.236 -179.814 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' CYS . . . . . 0.411 ' HB3' ' CB ' ' A' ' 28' ' ' CYS . 27.4 p -81.7 -22.02 37.67 Favored 'General case' 0 N--CA 1.469 0.491 0 N-CA-C 111.991 0.367 . . . . 0.0 111.991 -179.826 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 1.3 t 69.65 37.88 1.81 Allowed 'General case' 0 CA--C 1.534 0.347 0 CA-C-O 120.802 0.334 . . . . 0.0 111.204 -179.762 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.488 HD21 ' HB2' ' A' ' 5' ' ' TYR . 2.8 tt -106.27 127.21 53.07 Favored 'General case' 0 CA--C 1.53 0.183 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.894 179.832 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' MET . . . . . . . . . . . . . 24.6 mtt -84.12 142.18 30.56 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.428 -179.467 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 2.8 pp -142.78 163.77 17.24 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.298 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.595 179.917 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . 0.428 ' CG ' HG21 ' A' ' 4' ' ' THR . 75.3 m-20 -115.9 106.91 14.34 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.704 179.03 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.462 HG13 ' O ' ' A' ' 57' ' ' VAL . 11.2 p -97.78 115.11 36.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-O 120.992 0.425 . . . . 0.0 110.624 179.59 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 14.4 p -81.95 125.46 39.75 Favored 'Isoleucine or valine' 0 C--O 1.233 0.199 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.032 -179.646 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . 0.47 ' HA ' HD12 ' A' ' 10' ' ' ILE . 11.3 p90 -136.7 167.61 21.09 Favored 'General case' 0 CA--C 1.531 0.218 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.465 -179.494 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 3.4 t0 -113.63 175.69 5.35 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.054 179.708 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 3.1 ttmt -100.23 -41.0 7.27 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.229 -179.958 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -59.36 -35.48 73.97 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 116.461 -0.336 . . . . 0.0 111.076 179.794 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 2.8 t0 -54.24 -43.27 70.76 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.168 -179.913 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.562 ' HG ' HD22 ' A' ' 36' ' ' LEU . 4.3 mp -60.22 -51.81 67.97 Favored 'General case' 0 N--CA 1.462 0.146 0 CA-C-N 116.444 -0.344 . . . . 0.0 110.903 179.877 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -53.84 -42.04 68.07 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-N 116.4 -0.363 . . . . 0.0 111.092 179.69 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 16.9 mm-40 -72.53 -41.28 66.03 Favored 'General case' 0 CA--C 1.528 0.132 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.018 179.579 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -61.0 -35.09 75.92 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 116.524 -0.307 . . . . 0.0 111.636 -179.877 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 3.8 m-85 -56.82 -52.19 66.03 Favored 'General case' 0 N--CA 1.462 0.154 0 CA-C-N 116.704 -0.226 . . . . 0.0 110.829 -179.967 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -75.59 -35.16 60.63 Favored 'General case' 0 CA--C 1.53 0.196 0 CA-C-N 116.542 -0.299 . . . . 0.0 111.013 179.711 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 1.8 mm-40 -61.0 -47.77 84.92 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-N 116.481 -0.327 . . . . 0.0 111.2 -179.958 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.233 0.186 0 CA-C-O 120.842 0.353 . . . . 0.0 111.146 179.914 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 81.8 p . . . . . 0 C--O 1.234 0.259 0 CA-C-O 120.719 0.295 . . . . 0.0 111.377 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . 0.517 ' CD1' HD11 ' A' ' 53' ' ' LEU . 18.7 m-85 -109.13 -38.89 5.43 Favored 'General case' 0 CA--C 1.531 0.217 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.198 179.702 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -157.02 175.14 14.49 Favored 'General case' 0 C--O 1.234 0.284 0 CA-C-N 116.484 -0.325 . . . . 0.0 111.244 179.881 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 2.6 pt-20 -135.24 125.98 27.25 Favored 'General case' 0 CA--C 1.53 0.189 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.122 179.856 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 4.6 mt -119.86 152.4 22.55 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.241 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.182 -179.745 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . 0.556 ' HA ' HG12 ' A' ' 58' ' ' VAL . 16.5 mt-10 -97.94 147.71 24.2 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.254 -179.998 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 8.0 tp -58.38 -31.37 42.74 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.238 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.138 179.476 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -59.32 -32.81 70.41 Favored 'General case' 0 CA--C 1.531 0.218 0 CA-C-N 116.551 -0.295 . . . . 0.0 110.934 179.603 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 5.5 t0 -97.57 36.09 1.55 Allowed 'General case' 0 CA--C 1.532 0.276 0 CA-C-O 120.914 0.387 . . . . 0.0 110.964 179.65 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -121.01 156.93 31.08 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.688 179.831 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 24.4 m -81.44 150.09 28.49 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.586 179.839 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 16.0 p90 -120.87 144.8 48.19 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.819 179.851 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -118.17 88.71 33.16 Favored Pre-proline 0 C--O 1.235 0.309 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.743 179.91 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 16.8 Cg_exo -68.27 72.47 0.85 Allowed 'Trans proline' 0 C--N 1.35 0.634 0 C-N-CA 122.98 2.453 . . . . 0.0 112.387 -179.711 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 1.1 pp20? -151.85 -50.39 0.11 Allowed 'General case' 0 C--O 1.233 0.212 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.992 179.907 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 20.8 m-20 -129.74 26.95 5.26 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-O 120.666 0.269 . . . . 0.0 111.223 179.495 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' GLN . . . . . 0.505 ' HG3' HD23 ' A' ' 36' ' ' LEU . 0.0 OUTLIER 56.82 54.64 6.96 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-O 120.992 0.425 . . . . 0.0 111.439 179.82 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 10.2 ptm -133.71 154.12 51.19 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.919 179.619 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 5.9 m-85 -119.06 147.69 43.85 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.081 -0.508 . . . . 0.0 111.052 -179.727 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . 0.411 ' HA ' ' O ' ' A' ' 32' ' ' PHE . 20.5 p -123.35 173.79 7.74 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.141 -0.482 . . . . 0.0 111.209 179.918 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 60.8 t80 -172.12 99.83 0.37 Allowed Pre-proline 0 C--O 1.232 0.136 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.683 179.962 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_exo -51.21 99.76 0.04 OUTLIER 'Trans proline' 0 C--N 1.349 0.572 0 C-N-CA 122.684 2.256 . . . . 0.0 112.094 -179.905 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 45.9 t -60.53 138.38 92.63 Favored Pre-proline 0 C--N 1.331 -0.218 0 CA-C-N 116.053 -0.522 . . . . 0.0 110.776 -179.761 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 70.3 Cg_exo -51.84 -24.78 19.45 Favored 'Trans proline' 0 C--N 1.348 0.542 0 C-N-CA 122.695 2.263 . . . . 0.0 112.818 179.828 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 1.1 p -66.96 -37.96 85.24 Favored 'General case' 0 CA--C 1.533 0.305 0 CA-C-O 120.526 0.203 . . . . 0.0 111.221 179.902 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 151.88 -44.61 0.64 Allowed Glycine 0 C--N 1.335 0.498 0 C-N-CA 120.8 -0.714 . . . . 0.0 112.955 -179.996 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -72.34 -173.0 1.01 Allowed 'General case' 0 CA--C 1.532 0.278 0 CA-C-O 120.687 0.279 . . . . 0.0 111.337 -179.799 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 33.0 ttm180 -129.5 124.15 33.27 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-O 120.698 0.285 . . . . 0.0 111.052 -179.813 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . 0.411 ' O ' ' HA ' ' A' ' 23' ' ' THR . 1.8 m-85 -61.18 155.64 20.29 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.878 179.664 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 3.8 pt20 -147.16 112.02 5.38 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-N 116.376 -0.375 . . . . 0.0 111.15 179.763 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.404 ' CD1' ' HG2' ' A' ' 39' ' ' MET . 2.4 tt -140.48 134.91 35.0 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.955 179.904 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 8.5 m-85 -87.92 161.91 17.19 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.939 -179.811 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.505 HD23 ' HG3' ' A' ' 20' ' ' GLN . 4.0 mm? -60.63 -46.05 91.76 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.136 -179.991 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -60.57 -36.59 78.88 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-O 120.717 0.294 . . . . 0.0 110.769 179.425 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -60.68 -41.38 94.99 Favored 'General case' 0 C--N 1.334 -0.075 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.535 179.635 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' MET . . . . . 0.404 ' HG2' ' CD1' ' A' ' 34' ' ' ILE . 4.6 mmm -91.78 29.64 1.52 Allowed 'General case' 0 CA--C 1.535 0.401 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.089 179.303 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . 0.66 ' HB2' HD21 ' A' ' 64' ' ' LEU . 16.9 t80 -126.26 -43.54 1.78 Allowed 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 116.499 -0.318 . . . . 0.0 111.174 179.734 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -59.4 -68.13 0.31 Allowed 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 116.519 -0.31 . . . . 0.0 111.477 -179.467 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -169.62 55.76 0.2 Allowed Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.544 -0.836 . . . . 0.0 112.508 -179.761 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -110.15 160.31 16.59 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.834 0.35 . . . . 0.0 111.073 -179.866 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -163.83 -45.13 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.912 -0.585 . . . . 0.0 111.656 179.953 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.482 ' O ' HG13 ' A' ' 45' ' ' VAL . 8.9 p -116.67 112.68 40.36 Favored 'Isoleucine or valine' 0 C--O 1.233 0.224 0 CA-C-O 120.977 0.418 . . . . 0.0 111.101 -179.876 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -95.31 168.23 10.86 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.53 -179.589 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 18.6 t -139.74 125.79 22.29 Favored 'Isoleucine or valine' 0 C--O 1.232 0.173 0 CA-C-N 115.98 -0.554 . . . . 0.0 111.205 -179.855 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 42.5 t -73.73 114.58 33.7 Favored Pre-proline 0 C--N 1.331 -0.207 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.267 179.573 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_exo -59.24 -20.5 55.44 Favored 'Trans proline' 0 C--N 1.346 0.414 0 C-N-CA 122.569 2.179 . . . . 0.0 112.875 179.946 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -75.75 -67.32 0.68 Allowed 'General case' 0 CA--C 1.531 0.226 0 CA-C-N 116.789 -0.187 . . . . 0.0 111.316 -179.711 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 23.9 p -83.62 -22.42 32.23 Favored 'General case' 0 N--CA 1.466 0.37 0 N-CA-C 111.933 0.346 . . . . 0.0 111.933 -179.706 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER 70.79 39.42 1.08 Allowed 'General case' 0 CA--C 1.533 0.292 0 CA-C-O 120.891 0.377 . . . . 0.0 110.863 -179.678 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.517 HD11 ' CD1' ' A' ' 5' ' ' TYR . 7.4 tp -100.98 143.57 30.96 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.958 179.982 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' MET . . . . . . . . . . . . . 42.2 mtt -95.19 138.09 33.37 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.089 -179.827 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.426 ' O ' HG23 ' A' ' 45' ' ' VAL . 2.5 pp -148.08 145.07 18.86 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.259 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.653 -179.884 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -92.77 104.89 17.11 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.688 179.411 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.494 HG13 ' O ' ' A' ' 57' ' ' VAL . 13.4 p -108.42 112.96 42.61 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-O 121.036 0.446 . . . . 0.0 111.167 179.717 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.556 HG12 ' HA ' ' A' ' 9' ' ' GLU . 14.5 p -83.61 150.42 4.18 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.28 -179.759 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 47.2 p90 -119.36 177.84 4.76 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.224 -179.846 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . 0.426 ' O ' HD13 ' A' ' 64' ' ' LEU . 4.7 m-20 -121.96 172.83 7.92 Favored 'General case' 0 C--O 1.232 0.159 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.109 179.793 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 16.1 mmtt -105.6 -46.32 4.2 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.789 179.647 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -66.44 -40.75 89.66 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.894 179.774 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -57.94 -37.63 74.46 Favored 'General case' 0 N--CA 1.462 0.156 0 CA-C-N 116.554 -0.294 . . . . 0.0 111.203 179.913 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.66 HD21 ' HB2' ' A' ' 40' ' ' PHE . 0.4 OUTLIER -60.53 -41.0 93.53 Favored 'General case' 0 CA--C 1.53 0.189 0 CA-C-N 116.664 -0.244 . . . . 0.0 111.022 179.896 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -82.5 -42.96 17.77 Favored 'General case' 0 C--O 1.232 0.173 0 CA-C-N 116.485 -0.325 . . . . 0.0 111.015 179.687 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -61.18 -50.55 72.67 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.653 179.836 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 55.3 t80 -63.2 -31.86 73.12 Favored 'General case' 0 CA--C 1.53 0.196 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.331 179.649 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 2.0 t80 -61.93 -59.73 4.67 Favored 'General case' 0 C--O 1.232 0.143 0 CA-C-O 120.545 0.212 . . . . 0.0 110.851 179.918 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 2.1 tp10 -63.56 -35.33 80.14 Favored 'General case' 0 N--CA 1.462 0.17 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.388 -179.977 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 25.4 mt-10 -71.65 -36.47 70.69 Favored 'General case' 0 CA--C 1.53 0.179 0 CA-C-N 116.544 -0.298 . . . . 0.0 111.371 -179.893 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.332 -0.176 0 CA-C-O 120.589 0.233 . . . . 0.0 111.353 180.0 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . 0.437 HG21 ' CG ' ' A' ' 56' ' ' ASP . 0.8 OUTLIER . . . . . 0 N--CA 1.465 0.32 0 CA-C-O 120.847 0.356 . . . . 0.0 111.277 . . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 58.9 m-85 -98.95 -35.81 9.95 Favored 'General case' 0 CA--C 1.531 0.241 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.49 -179.891 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -158.85 173.55 16.36 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-O 120.759 0.314 . . . . 0.0 111.323 -179.92 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 2.7 tm-20 -138.58 122.72 18.03 Favored 'General case' 0 CA--C 1.531 0.24 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.879 -179.886 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 4.8 mt -126.21 152.36 33.5 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.338 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.114 -179.747 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 3.0 pt-20 -96.95 153.17 18.06 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.622 -179.99 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.464 HD13 ' CE ' ' A' ' 39' ' ' MET . 1.2 tp -62.99 -34.66 67.73 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.313 0 CA-C-N 115.947 -0.569 . . . . 0.0 111.36 179.58 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -58.74 -32.87 69.63 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-N 116.609 -0.269 . . . . 0.0 111.157 179.681 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -97.28 36.1 1.51 Allowed 'General case' 0 CA--C 1.537 0.47 0 CA-C-O 120.81 0.338 . . . . 0.0 111.311 179.783 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' MET . . . . . 0.409 ' HG3' ' HB2' ' A' ' 24' ' ' TYR . 1.7 ttt -121.54 148.83 43.98 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.888 179.787 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -69.33 126.93 31.3 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-O 120.826 0.346 . . . . 0.0 110.873 179.971 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 14.4 t80 -94.59 123.97 38.33 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.509 179.596 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 1.4 tp10 -108.96 92.1 10.2 Favored Pre-proline 0 C--O 1.234 0.256 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.314 179.499 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 64.3 Cg_endo -73.6 61.27 4.4 Favored 'Trans proline' 0 C--N 1.351 0.677 0 C-N-CA 122.793 2.329 . . . . 0.0 112.72 -179.44 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 19.1 pt-20 -131.44 -45.82 0.99 Allowed 'General case' 0 CA--C 1.533 0.302 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.885 179.772 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -141.71 32.13 1.63 Allowed 'General case' 0 CA--C 1.534 0.363 0 CA-C-N 116.515 -0.311 . . . . 0.0 111.057 179.406 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 91.3 mt-30 55.15 59.88 3.75 Favored 'General case' 0 C--O 1.236 0.363 0 CA-C-O 120.955 0.407 . . . . 0.0 111.413 179.931 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 9.6 ptp -130.41 148.72 52.25 Favored 'General case' 0 C--O 1.235 0.307 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.343 179.909 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 25.4 m-85 -124.6 102.89 7.84 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.896 179.994 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . 0.415 HG22 ' HA ' ' A' ' 33' ' ' GLN . 66.9 p -101.54 166.83 10.5 Favored 'General case' 0 CA--C 1.532 0.261 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.84 -179.827 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' TYR . . . . . 0.409 ' HB2' ' HG3' ' A' ' 13' ' ' MET . 62.3 t80 -164.7 139.6 4.42 Favored Pre-proline 0 CA--C 1.531 0.235 0 CA-C-O 120.599 0.237 . . . . 0.0 111.377 179.774 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -53.2 121.79 10.03 Favored 'Trans proline' 0 C--N 1.352 0.724 0 C-N-CA 122.994 2.462 . . . . 0.0 113.144 -179.979 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . 0.461 ' SG ' ' HD2' ' A' ' 27' ' ' PRO . 42.1 t -90.64 140.3 26.57 Favored Pre-proline 0 C--N 1.331 -0.218 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.497 179.38 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . 0.461 ' HD2' ' SG ' ' A' ' 26' ' ' CYS . 73.8 Cg_exo -50.7 -27.82 20.92 Favored 'Trans proline' 0 C--N 1.349 0.587 0 C-N-CA 122.898 2.398 . . . . 0.0 113.026 179.536 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . 0.402 ' CB ' ' HB3' ' A' ' 51' ' ' CYS . 0.9 OUTLIER -69.51 -38.89 77.77 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-N 116.799 -0.182 . . . . 0.0 111.446 -179.959 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 151.92 -48.4 0.55 Allowed Glycine 0 C--N 1.336 0.57 0 C-N-CA 120.854 -0.689 . . . . 0.0 112.958 -179.933 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -73.96 -175.11 2.05 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-O 120.665 0.269 . . . . 0.0 110.966 179.984 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 19.5 mtt180 -118.72 134.66 54.98 Favored 'General case' 0 C--O 1.232 0.164 0 CA-C-O 120.677 0.275 . . . . 0.0 110.826 179.924 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 6.8 m-85 -62.23 168.0 3.7 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.811 179.653 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . 0.415 ' HA ' HG22 ' A' ' 23' ' ' THR . 5.8 tt0 -155.58 121.95 5.21 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-O 120.695 0.283 . . . . 0.0 111.274 179.882 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 5.8 tt -146.04 138.81 20.45 Favored 'Isoleucine or valine' 0 C--O 1.234 0.25 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.085 179.646 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 25.6 m-85 -95.58 155.49 16.72 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.993 179.992 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.838 HD22 ' HG ' ' A' ' 64' ' ' LEU . 87.9 mt -62.63 -39.84 95.11 Favored 'General case' 0 CA--C 1.53 0.199 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.016 179.72 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -66.2 -34.81 78.86 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 116.683 -0.235 . . . . 0.0 111.196 179.409 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -62.7 -57.99 9.06 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-O 120.918 0.389 . . . . 0.0 110.591 179.991 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' MET . . . . . 0.464 ' CE ' HD13 ' A' ' 10' ' ' ILE . 5.6 ptm -63.04 -34.62 77.97 Favored 'General case' 0 CA--C 1.534 0.343 0 CA-C-N 115.956 -0.565 . . . . 0.0 111.291 179.764 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . 0.405 ' HB2' ' CD2' ' A' ' 64' ' ' LEU . 31.6 t80 -61.14 -45.06 96.18 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-N 116.551 -0.295 . . . . 0.0 110.882 179.485 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 2.6 tp10 -56.0 -40.8 73.89 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.709 179.471 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 148.47 47.86 0.02 OUTLIER Glycine 0 C--N 1.335 0.49 0 C-N-CA 121.146 -0.55 . . . . 0.0 112.672 179.755 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 4.3 tt0 -112.4 123.19 49.73 Favored 'General case' 0 C--O 1.232 0.159 0 CA-C-O 120.826 0.346 . . . . 0.0 111.149 -179.795 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 19.4 mtmt -122.46 -43.75 2.27 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-N 115.917 -0.583 . . . . 0.0 111.026 179.726 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.483 ' O ' HG13 ' A' ' 45' ' ' VAL . 12.0 p -108.16 113.21 43.26 Favored 'Isoleucine or valine' 0 C--O 1.233 0.209 0 CA-C-O 121.011 0.434 . . . . 0.0 111.005 179.781 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -102.24 164.66 11.56 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.154 -179.815 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 11.6 p -124.49 129.09 73.93 Favored 'Isoleucine or valine' 0 C--O 1.233 0.207 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.227 -179.909 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 47.9 t -67.86 135.52 92.16 Favored Pre-proline 0 C--O 1.233 0.229 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.79 179.929 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 84.5 Cg_endo -83.54 21.09 1.08 Allowed 'Trans proline' 0 CA--C 1.537 0.639 0 C-N-CA 122.729 2.286 . . . . 0.0 113.056 179.777 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 7.7 t -129.07 -56.82 1.17 Allowed 'General case' 0 C--O 1.233 0.204 0 CA-C-N 116.615 -0.266 . . . . 0.0 110.512 179.768 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' CYS . . . . . 0.402 ' HB3' ' CB ' ' A' ' 28' ' ' CYS . 18.5 p -100.63 -10.59 20.79 Favored 'General case' 0 CA--C 1.538 0.481 0 N-CA-C 112.276 0.473 . . . . 0.0 112.276 179.924 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 6.5 p 60.24 35.85 20.87 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-O 120.863 0.363 . . . . 0.0 111.765 -179.903 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.599 HD23 HG23 ' A' ' 55' ' ' ILE . 6.6 tt -94.95 121.34 36.46 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.698 179.394 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' MET . . . . . . . . . . . . . 6.9 mtt -85.94 141.53 29.48 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.171 -179.712 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.599 HG23 HD23 ' A' ' 53' ' ' LEU . 3.8 pt -145.19 148.19 17.99 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.295 0 CA-C-N 115.934 -0.575 . . . . 0.0 111.495 179.997 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . 0.437 ' CG ' HG21 ' A' ' 4' ' ' THR . 72.3 m-20 -93.27 104.74 16.89 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.463 178.918 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.485 HG13 ' O ' ' A' ' 57' ' ' VAL . 12.5 p -100.22 112.37 32.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 121.057 0.456 . . . . 0.0 110.879 179.72 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 14.2 p -81.04 130.87 35.14 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.172 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.709 -179.852 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 42.1 p90 -133.41 176.96 8.06 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.29 -179.275 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 4.3 t70 -122.38 144.91 48.73 Favored 'General case' 0 N--CA 1.462 0.17 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.4 -179.923 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 11.7 mttp -76.7 -40.01 50.14 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.153 179.699 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 17.7 tt0 -58.43 -37.66 75.86 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 116.617 -0.265 . . . . 0.0 110.595 179.531 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . 0.478 ' HB3' ' CE2' ' A' ' 67' ' ' TYR . 3.4 m-20 -56.03 -43.87 78.2 Favored 'General case' 0 N--CA 1.463 0.19 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.954 179.425 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.838 ' HG ' HD22 ' A' ' 36' ' ' LEU . 3.0 mp -53.31 -53.41 51.4 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 116.469 -0.332 . . . . 0.0 111.185 179.987 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -56.24 -39.65 72.88 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 116.512 -0.313 . . . . 0.0 110.846 179.511 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -69.19 -39.74 78.49 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.05 179.367 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . 0.478 ' CE2' ' HB3' ' A' ' 63' ' ' ASP . 20.1 m-85 -69.12 -37.93 78.62 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 116.634 -0.257 . . . . 0.0 111.624 -179.861 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 5.7 m-85 -62.17 -38.25 88.35 Favored 'General case' 0 N--CA 1.463 0.211 0 C-N-CA 121.247 -0.181 . . . . 0.0 110.635 179.966 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -80.96 -36.26 31.13 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-N 116.48 -0.327 . . . . 0.0 111.084 179.262 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 5.7 mt-10 -72.28 -35.68 68.79 Favored 'General case' 0 N--CA 1.467 0.376 0 N-CA-C 111.681 0.252 . . . . 0.0 111.681 -179.834 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.233 0.215 0 N-CA-C 111.517 0.191 . . . . 0.0 111.517 -179.643 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . 0.493 HG22 ' HA ' ' A' ' 55' ' ' ILE . 0.2 OUTLIER . . . . . 0 N--CA 1.463 0.22 0 CA-C-O 120.769 0.319 . . . . 0.0 111.477 . . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 9.3 m-85 -106.68 -43.65 4.66 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.37 179.721 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 12.0 m-20 -151.74 175.53 12.31 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-O 120.782 0.325 . . . . 0.0 111.484 179.791 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 19.5 tt0 -128.0 122.62 32.73 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.443 179.514 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 28.5 mm -120.33 155.04 23.53 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.162 -179.584 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -112.55 150.98 30.56 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-N 116.308 -0.406 . . . . 0.0 111.292 179.867 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 2.8 tt -58.72 -31.89 45.38 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.331 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.239 179.576 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 17.8 mt-10 -66.24 -30.91 71.44 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-N 116.374 -0.375 . . . . 0.0 111.106 179.501 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 3.3 t70 -98.03 38.37 1.32 Allowed 'General case' 0 CA--C 1.533 0.313 0 CA-C-O 120.889 0.376 . . . . 0.0 111.052 179.816 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 1.8 mtp -128.39 156.17 43.56 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.782 179.778 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 8.7 m -87.4 108.2 18.89 Favored 'General case' 0 N--CA 1.462 0.15 0 CA-C-O 120.835 0.35 . . . . 0.0 110.952 -179.923 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . 0.419 ' HB3' ' CZ ' ' A' ' 22' ' ' PHE . 29.8 p90 -85.12 138.12 32.6 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.764 179.754 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 25.1 mt-10 -103.9 96.36 9.16 Favored Pre-proline 0 C--O 1.234 0.263 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.406 179.848 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -71.77 63.62 3.12 Favored 'Trans proline' 0 C--N 1.35 0.654 0 C-N-CA 122.812 2.342 . . . . 0.0 112.721 -179.497 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 7.1 pt-20 -135.14 -53.78 0.79 Allowed 'General case' 0 C--N 1.333 -0.144 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.741 179.535 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 71.6 m-20 -133.08 33.04 3.68 Favored 'General case' 0 CA--C 1.534 0.345 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.999 179.479 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' GLN . . . . . 0.546 ' OE1' HD11 ' A' ' 36' ' ' LEU . 25.4 mt-30 56.81 49.84 13.52 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-O 120.802 0.334 . . . . 0.0 111.287 179.936 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 9.6 ttp -122.62 157.18 32.72 Favored 'General case' 0 N--CA 1.463 0.176 0 CA-C-O 120.737 0.304 . . . . 0.0 111.161 -179.942 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.433 ' O ' ' HA ' ' A' ' 33' ' ' GLN . 5.8 m-85 -121.28 164.43 17.01 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.852 -179.988 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 25.6 p -144.59 150.93 38.29 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.095 179.487 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 86.5 t80 -145.38 95.91 4.95 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.243 179.282 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . 0.403 ' HA ' ' HA ' ' A' ' 31' ' ' ARG . 53.1 Cg_exo -55.05 94.33 0.04 OUTLIER 'Trans proline' 0 C--N 1.349 0.559 0 C-N-CA 122.719 2.279 . . . . 0.0 111.832 179.967 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . 0.422 ' SG ' ' HD2' ' A' ' 27' ' ' PRO . 45.3 t -63.8 137.89 97.23 Favored Pre-proline 0 C--O 1.234 0.243 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.095 -179.306 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . 0.422 ' HD2' ' SG ' ' A' ' 26' ' ' CYS . 10.9 Cg_endo -54.84 -20.33 22.11 Favored 'Trans proline' 0 C--N 1.35 0.626 0 C-N-CA 122.906 2.404 . . . . 0.0 112.831 179.777 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 12.4 p -55.49 -29.31 58.55 Favored 'General case' 0 CA--C 1.535 0.378 0 CA-C-O 120.592 0.234 . . . . 0.0 111.398 179.68 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 125.55 5.43 6.52 Favored Glycine 0 CA--C 1.526 0.737 0 C-N-CA 121.143 -0.551 . . . . 0.0 113.692 179.836 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -126.55 -167.12 1.67 Allowed 'General case' 0 CA--C 1.536 0.408 0 CA-C-N 117.412 0.606 . . . . 0.0 111.324 -179.814 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . 0.403 ' HA ' ' HA ' ' A' ' 25' ' ' PRO . 8.6 ttm-85 -121.36 150.1 41.96 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-O 120.8 0.333 . . . . 0.0 111.506 -179.596 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . 0.474 ' HZ ' ' HB1' ' A' ' 46' ' ' ALA . 21.7 t80 -103.43 162.27 13.17 Favored 'General case' 0 CA--C 1.529 0.153 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.882 179.368 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . 0.433 ' HA ' ' O ' ' A' ' 22' ' ' PHE . 3.2 pt20 -149.7 115.64 5.66 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.879 179.65 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.427 HG21 ' HE2' ' A' ' 39' ' ' MET . 3.3 tt -130.71 128.3 62.92 Favored 'Isoleucine or valine' 0 C--O 1.234 0.245 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.062 179.989 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -80.23 123.53 28.02 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.054 -179.667 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.546 HD11 ' OE1' ' A' ' 20' ' ' GLN . 3.7 pp -61.28 -38.59 87.33 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.998 179.601 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . 0.537 ' N ' HD12 ' A' ' 36' ' ' LEU . 3.7 t70 -56.3 -46.37 79.83 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 116.503 -0.317 . . . . 0.0 110.801 179.538 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -65.92 -45.59 81.33 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.518 179.435 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' MET . . . . . 0.427 ' HE2' HG21 ' A' ' 34' ' ' ILE . 1.6 mtm -52.05 -25.62 9.02 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.852 179.687 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -53.97 -35.46 61.81 Favored 'General case' 0 N--CA 1.467 0.397 0 N-CA-C 111.559 0.207 . . . . 0.0 111.559 179.775 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 -58.44 -31.59 67.91 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-N 116.646 -0.252 . . . . 0.0 111.565 179.75 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 125.14 45.54 0.25 Allowed Glycine 0 C--N 1.335 0.509 0 C-N-CA 121.218 -0.515 . . . . 0.0 112.771 179.81 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -84.1 133.31 34.64 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-O 120.687 0.28 . . . . 0.0 110.908 179.996 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 3.4 ptpp? -126.54 -45.26 1.65 Allowed 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.385 -179.9 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 12.2 p -94.55 131.44 41.38 Favored 'Isoleucine or valine' 0 C--O 1.233 0.223 0 CA-C-N 116.418 -0.355 . . . . 0.0 110.715 179.797 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.474 ' HB1' ' HZ ' ' A' ' 32' ' ' PHE . . . -129.82 144.79 51.48 Favored 'General case' 0 C--O 1.234 0.288 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.109 -179.676 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 11.3 p -110.36 123.88 66.64 Favored 'Isoleucine or valine' 0 C--O 1.233 0.223 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.15 -179.828 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 52.5 t -62.2 134.72 94.72 Favored Pre-proline 0 N--CA 1.463 0.214 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.99 179.905 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 90.7 Cg_endo -84.98 24.55 0.76 Allowed 'Trans proline' 0 C--N 1.349 0.58 0 C-N-CA 122.713 2.275 . . . . 0.0 112.993 179.926 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 1.4 m -132.99 -60.29 0.87 Allowed 'General case' 0 CA--C 1.53 0.191 0 CA-C-N 116.503 -0.317 . . . . 0.0 110.586 -179.83 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 22.6 p -102.35 -13.98 17.1 Favored 'General case' 0 CA--C 1.537 0.462 0 N-CA-C 111.869 0.322 . . . . 0.0 111.869 179.494 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 6.4 t 66.82 34.28 5.6 Favored 'General case' 0 CA--C 1.534 0.365 0 CA-C-O 120.895 0.379 . . . . 0.0 111.286 -179.815 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.65 HD23 HG23 ' A' ' 55' ' ' ILE . 8.0 tt -85.21 134.27 34.15 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.604 179.663 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' MET . . . . . . . . . . . . . 40.7 mtm -82.79 133.0 35.15 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.198 -179.635 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.65 HG23 HD23 ' A' ' 53' ' ' LEU . 2.7 pt -138.68 151.07 23.85 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.394 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.853 -179.829 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 71.1 m-20 -97.02 88.47 4.52 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.741 179.297 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.472 HG13 ' O ' ' A' ' 57' ' ' VAL . 12.5 p -94.5 114.52 31.26 Favored 'Isoleucine or valine' 0 C--O 1.234 0.279 0 CA-C-O 121.063 0.458 . . . . 0.0 110.938 179.77 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 12.6 p -91.79 135.24 27.7 Favored 'Isoleucine or valine' 0 C--O 1.233 0.218 0 CA-C-N 115.967 -0.561 . . . . 0.0 110.974 -179.719 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 48.5 p90 -112.51 166.55 11.22 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.885 -179.52 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -131.16 137.74 49.14 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.215 179.774 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 17.0 mttp -68.43 -38.21 80.98 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.733 179.191 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 21.3 mt-10 -58.87 -52.99 63.35 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.427 179.266 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 38.4 m-20 -62.12 -43.04 99.72 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.993 179.505 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.464 HD23 HD13 ' A' ' 36' ' ' LEU . 0.8 OUTLIER -60.16 -53.43 57.77 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-O 120.607 0.242 . . . . 0.0 111.244 179.95 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -63.7 -39.25 93.84 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 116.422 -0.353 . . . . 0.0 111.149 179.867 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 26.7 tt0 -68.27 -41.29 81.26 Favored 'General case' 0 CA--C 1.532 0.285 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.9 179.476 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 19.9 t80 -66.24 -34.79 78.81 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.655 -179.994 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . 0.403 ' HA ' ' OE1' ' A' ' 20' ' ' GLN . 23.5 t80 -54.26 -41.96 69.41 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-O 120.732 0.301 . . . . 0.0 110.254 179.719 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 4.1 tt0 -83.6 -37.45 22.9 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.292 179.466 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -66.63 -32.96 74.62 Favored 'General case' 0 N--CA 1.467 0.403 0 N-CA-C 112.053 0.39 . . . . 0.0 112.053 -179.608 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.465 0.323 0 N-CA-C 111.863 0.32 . . . . 0.0 111.863 -179.322 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 5.0 p . . . . . 0 CA--C 1.532 0.267 0 CA-C-O 120.875 0.369 . . . . 0.0 111.069 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 11.6 m-85 -164.65 -40.84 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.123 179.755 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -145.83 169.99 17.45 Favored 'General case' 0 C--O 1.237 0.409 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.005 -179.798 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -123.98 112.11 16.81 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.873 -179.882 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.466 HG21 ' SD ' ' A' ' 13' ' ' MET . 27.8 mm -88.07 154.62 3.23 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.196 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.954 179.918 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 82.2 mt-10 -121.54 146.77 46.61 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-N 116.374 -0.376 . . . . 0.0 111.211 -179.983 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 8.1 tp -58.11 -34.95 50.67 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.344 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.124 179.501 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 6.6 tt0 -65.66 -34.61 78.6 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-N 116.496 -0.32 . . . . 0.0 110.878 179.46 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 22.1 m-20 -95.94 38.27 1.19 Allowed 'General case' 0 CA--C 1.531 0.238 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.226 179.766 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' MET . . . . . 0.466 ' SD ' HG21 ' A' ' 8' ' ' ILE . 0.6 OUTLIER -133.79 136.73 44.69 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.725 179.785 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 9.7 m -69.64 138.22 52.86 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.015 -179.841 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . 0.426 ' HB3' ' CE2' ' A' ' 22' ' ' PHE . 17.3 p90 -101.54 130.4 47.82 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.556 179.649 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 -109.23 90.82 8.68 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.733 179.795 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 69.9 Cg_endo -74.26 62.31 5.16 Favored 'Trans proline' 0 C--N 1.348 0.512 0 C-N-CA 122.776 2.317 . . . . 0.0 112.954 -179.786 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 4.8 pt-20 -132.68 -50.21 0.9 Allowed 'General case' 0 CA--C 1.531 0.224 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.757 179.47 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 38.0 m-20 -136.46 32.03 2.82 Favored 'General case' 0 CA--C 1.534 0.345 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.23 179.512 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' GLN . . . . . 0.688 ' HB3' HD12 ' A' ' 36' ' ' LEU . 15.2 mt-30 56.67 67.38 1.0 Allowed 'General case' 0 CA--C 1.535 0.368 0 CA-C-O 121.06 0.457 . . . . 0.0 111.462 179.447 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 2.5 ptt? -146.99 158.64 43.98 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-N 116.013 -0.54 . . . . 0.0 111.092 179.674 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.509 ' CE1' HD21 ' A' ' 36' ' ' LEU . 17.4 m-85 -131.21 127.8 38.65 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.787 -179.967 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . 0.42 ' HA ' ' O ' ' A' ' 32' ' ' PHE . 18.2 p -116.14 170.21 8.68 Favored 'General case' 0 CA--C 1.532 0.28 0 CA-C-O 120.828 0.347 . . . . 0.0 111.454 -179.877 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 57.8 t80 -163.23 136.29 4.31 Favored Pre-proline 0 N--CA 1.464 0.271 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.042 179.795 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 42.0 Cg_endo -66.59 103.38 0.68 Allowed 'Trans proline' 0 C--N 1.35 0.606 0 C-N-CA 122.555 2.17 . . . . 0.0 112.27 179.649 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . 0.461 ' SG ' ' HD2' ' A' ' 27' ' ' PRO . 42.7 t -66.89 139.63 95.76 Favored Pre-proline 0 C--O 1.233 0.215 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.551 179.786 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . 0.461 ' HD2' ' SG ' ' A' ' 26' ' ' CYS . 9.3 Cg_endo -53.64 -25.56 33.99 Favored 'Trans proline' 0 C--N 1.35 0.617 0 C-N-CA 122.928 2.419 . . . . 0.0 112.927 179.867 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . 0.401 ' CB ' ' HB3' ' A' ' 51' ' ' CYS . 0.8 OUTLIER -69.93 -38.03 76.07 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-O 120.51 0.195 . . . . 0.0 111.299 -179.978 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 150.37 -44.8 0.68 Allowed Glycine 0 C--N 1.336 0.541 0 C-N-CA 120.834 -0.698 . . . . 0.0 112.898 -179.922 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -71.09 -176.51 1.43 Allowed 'General case' 0 CA--C 1.534 0.333 0 CA-C-O 120.779 0.323 . . . . 0.0 111.169 -179.86 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 7.2 ttp180 -122.19 114.06 20.33 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-N 116.515 -0.312 . . . . 0.0 111.085 -179.886 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . 0.42 ' O ' ' HA ' ' A' ' 23' ' ' THR . 73.3 t80 -62.2 154.55 27.07 Favored 'General case' 0 N--CA 1.462 0.168 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.966 179.708 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 1.1 pt20 -147.47 144.12 28.37 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.231 179.994 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 2.8 tt -147.6 132.14 10.25 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.247 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.064 179.497 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 6.0 m-85 -90.41 139.54 30.58 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.944 -179.883 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.688 HD12 ' HB3' ' A' ' 20' ' ' GLN . 13.9 mt -59.57 -47.48 85.41 Favored 'General case' 0 N--CA 1.463 0.19 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.027 179.954 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -59.57 -38.5 81.32 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 116.587 -0.279 . . . . 0.0 110.78 179.339 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -66.73 -58.99 3.97 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.017 179.853 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' MET . . . . . 0.709 ' HG3' HD11 ' A' ' 64' ' ' LEU . 6.4 ptm -60.68 -32.58 71.79 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 116.462 -0.335 . . . . 0.0 111.556 -179.878 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 18.7 t80 -58.39 -37.05 74.49 Favored 'General case' 0 CA--C 1.533 0.318 0 CA-C-N 116.499 -0.318 . . . . 0.0 111.15 179.689 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 4.6 mt-10 -57.92 -38.14 75.34 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-O 120.668 0.271 . . . . 0.0 110.98 179.512 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 144.77 52.14 0.03 OUTLIER Glycine 0 C--N 1.334 0.46 0 C-N-CA 121.018 -0.611 . . . . 0.0 112.701 179.785 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -109.98 157.18 19.56 Favored 'General case' 0 C--O 1.232 0.15 0 CA-C-O 120.81 0.338 . . . . 0.0 111.237 -179.943 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -157.1 -47.14 0.07 Allowed 'General case' 0 CA--C 1.532 0.262 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.156 179.815 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 4.8 m -100.02 115.0 40.19 Favored 'Isoleucine or valine' 0 C--O 1.233 0.191 0 CA-C-O 120.84 0.352 . . . . 0.0 110.972 179.78 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -110.47 174.79 5.7 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.204 -179.854 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 11.3 m -133.48 121.18 40.81 Favored 'Isoleucine or valine' 0 C--O 1.233 0.209 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.186 -179.886 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 43.3 t -63.15 135.94 96.46 Favored Pre-proline 0 C--O 1.233 0.215 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.702 179.964 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 91.5 Cg_endo -83.15 19.87 1.26 Allowed 'Trans proline' 0 CA--C 1.537 0.645 0 C-N-CA 122.682 2.255 . . . . 0.0 113.212 179.972 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 29.8 t -128.35 -58.2 1.2 Allowed 'General case' 0 CA--C 1.529 0.152 0 CA-C-O 120.657 0.265 . . . . 0.0 110.521 179.644 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' CYS . . . . . 0.401 ' HB3' ' CB ' ' A' ' 28' ' ' CYS . 20.1 p -98.72 -20.2 17.07 Favored 'General case' 0 CA--C 1.533 0.327 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.826 179.93 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 1.1 t 67.46 39.48 2.88 Favored 'General case' 0 CA--C 1.534 0.327 0 CA-C-O 121.07 0.462 . . . . 0.0 110.904 -179.772 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 6.9 tp -88.08 131.68 34.58 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.711 179.814 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' MET . . . . . . . . . . . . . 41.1 mtt -85.14 123.99 31.29 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.618 -179.877 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 2.6 pp -134.06 142.16 41.89 Favored 'Isoleucine or valine' 0 C--O 1.234 0.249 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.621 -179.749 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -105.81 95.92 6.14 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.656 -179.909 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.415 ' HA ' ' O ' ' A' ' 8' ' ' ILE . 14.8 p -84.18 139.13 18.03 Favored 'Isoleucine or valine' 0 C--O 1.234 0.286 0 CA-C-O 120.941 0.4 . . . . 0.0 111.124 -179.954 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 12.1 p -111.26 123.02 66.75 Favored 'Isoleucine or valine' 0 C--O 1.234 0.264 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.862 179.703 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 32.3 p90 -129.32 176.83 7.63 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.025 -179.675 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -118.02 162.79 17.6 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.556 -179.898 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 22.8 mttt -87.82 -32.1 19.21 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.128 179.568 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -59.73 -54.55 45.05 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 116.587 -0.279 . . . . 0.0 110.835 179.882 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -61.28 -44.48 97.16 Favored 'General case' 0 N--CA 1.463 0.186 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.741 179.655 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.709 HD11 ' HG3' ' A' ' 39' ' ' MET . 0.2 OUTLIER -57.96 -41.31 82.64 Favored 'General case' 0 CA--C 1.529 0.157 0 CA-C-N 116.429 -0.35 . . . . 0.0 110.809 179.583 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -70.18 -39.45 75.24 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 116.441 -0.345 . . . . 0.0 111.241 179.763 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 31.1 mt-10 -70.51 -41.06 73.12 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.504 -179.808 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . 0.561 ' CD2' HD11 ' A' ' 36' ' ' LEU . 2.5 t80 -55.94 -30.84 62.3 Favored 'General case' 0 N--CA 1.465 0.275 0 CA-C-N 116.693 -0.231 . . . . 0.0 111.499 -179.958 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . 0.419 ' HA ' ' OE1' ' A' ' 20' ' ' GLN . 3.8 m-85 -58.85 -36.24 74.25 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-O 120.63 0.253 . . . . 0.0 110.589 179.665 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 7.8 tt0 -88.3 -36.32 16.73 Favored 'General case' 0 CA--C 1.531 0.242 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.943 179.334 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 4.5 mm-40 -66.23 -34.57 78.31 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.605 -179.705 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.234 0.248 0 CA-C-O 120.86 0.362 . . . . 0.0 111.251 -179.838 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . 0.602 HG22 ' HB3' ' A' ' 54' ' ' MET . 58.4 p . . . . . 0 N--CA 1.468 0.449 0 CA-C-O 120.77 0.319 . . . . 0.0 111.249 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 5.7 m-85 -102.83 -50.3 3.57 Favored 'General case' 0 CA--C 1.529 0.163 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.173 179.628 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -154.88 176.49 12.43 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.383 179.702 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 15.3 pt-20 -123.76 135.56 53.9 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.765 179.422 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 3.5 mp -121.75 139.63 48.23 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.305 0 CA-C-N 116.462 -0.336 . . . . 0.0 110.827 -179.977 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . 0.48 ' HG3' HG13 ' A' ' 58' ' ' VAL . 3.2 tt0 -83.93 145.73 28.42 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.182 -179.871 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 9.7 tp -57.15 -33.81 43.89 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.314 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.184 179.586 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 -58.77 -34.58 71.59 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 116.569 -0.287 . . . . 0.0 111.087 179.307 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 54.2 m-20 -95.76 36.83 1.25 Allowed 'General case' 0 CA--C 1.535 0.367 0 CA-C-O 120.722 0.296 . . . . 0.0 111.342 179.591 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 3.1 ttt -120.2 146.49 45.98 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 116.582 -0.281 . . . . 0.0 110.802 179.779 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 1.5 m -68.95 126.03 28.5 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 116.519 -0.31 . . . . 0.0 110.765 179.876 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 2.8 p90 -105.14 157.58 17.17 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.04 179.885 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 23.6 mt-10 -139.97 83.27 16.33 Favored Pre-proline 0 C--O 1.235 0.292 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.675 179.98 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 70.4 Cg_exo -52.05 -28.75 33.7 Favored 'Trans proline' 0 C--N 1.349 0.554 0 C-N-CA 122.98 2.454 . . . . 0.0 112.731 179.919 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -52.36 -35.94 52.5 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-N 116.454 -0.339 . . . . 0.0 111.577 179.605 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 2.0 t-20 -141.85 29.39 1.7 Allowed 'General case' 0 CA--C 1.538 0.505 0 N-CA-C 111.721 0.267 . . . . 0.0 111.721 -179.92 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' GLN . . . . . 0.487 ' HB2' HD21 ' A' ' 36' ' ' LEU . 8.3 pt20 41.73 35.87 0.55 Allowed 'General case' 0 N--CA 1.475 0.792 0 N-CA-C 112.245 0.461 . . . . 0.0 112.245 -179.756 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 7.0 ttt -105.67 158.67 16.55 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.475 -179.601 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 23.1 m-85 -129.65 147.07 51.4 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-O 120.777 0.322 . . . . 0.0 111.187 179.587 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . 0.427 HG22 ' O ' ' A' ' 32' ' ' PHE . 21.2 p -144.19 177.42 8.61 Favored 'General case' 0 CA--C 1.537 0.465 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.953 -179.98 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 38.7 t80 -171.68 134.79 0.89 Allowed Pre-proline 0 N--CA 1.47 0.559 0 CA-C-N 116.699 -0.228 . . . . 0.0 110.961 179.327 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -65.04 101.23 0.39 Allowed 'Trans proline' 0 C--N 1.352 0.724 0 C-N-CA 122.795 2.33 . . . . 0.0 112.902 -179.857 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . 0.435 ' SG ' ' HD2' ' A' ' 27' ' ' PRO . 46.7 t -66.18 139.53 96.5 Favored Pre-proline 0 C--O 1.233 0.232 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.729 179.598 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . 0.435 ' HD2' ' SG ' ' A' ' 26' ' ' CYS . 60.9 Cg_exo -52.61 -27.08 31.61 Favored 'Trans proline' 0 C--N 1.348 0.547 0 C-N-CA 122.748 2.299 . . . . 0.0 112.907 179.625 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -67.6 -38.53 84.11 Favored 'General case' 0 C--O 1.235 0.305 0 N-CA-C 111.61 0.226 . . . . 0.0 111.61 -179.99 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 152.32 -48.19 0.55 Allowed Glycine 0 C--N 1.336 0.571 0 C-N-CA 120.785 -0.721 . . . . 0.0 113.242 -179.788 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -75.89 -173.59 2.34 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-N 116.751 0.276 . . . . 0.0 111.137 -179.812 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 51.5 mtt180 -122.41 138.34 54.57 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-O 120.76 0.314 . . . . 0.0 111.185 -179.989 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . 0.427 ' O ' HG22 ' A' ' 23' ' ' THR . 45.0 m-85 -69.06 167.86 15.08 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.864 179.569 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 3.9 pp0? -152.17 138.16 18.16 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.22 179.594 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.445 HD13 ' HE2' ' A' ' 39' ' ' MET . 3.5 tt -173.98 127.87 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.531 0.238 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.033 179.659 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 76.5 m-85 -82.21 142.9 31.78 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.734 -179.81 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.514 HD13 HD23 ' A' ' 64' ' ' LEU . 3.9 pp -55.45 -35.22 65.22 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 116.389 -0.368 . . . . 0.0 111.231 179.645 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . 0.42 ' N ' HD12 ' A' ' 36' ' ' LEU . 0.9 OUTLIER -61.49 -45.6 93.55 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 116.534 -0.303 . . . . 0.0 111.016 179.678 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -61.12 -43.43 98.89 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-O 120.762 0.315 . . . . 0.0 110.731 179.453 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' MET . . . . . 0.445 ' HE2' HD13 ' A' ' 34' ' ' ILE . 3.6 mtt -59.75 -33.52 71.77 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.029 179.616 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -56.42 -39.88 73.78 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 116.534 -0.303 . . . . 0.0 110.991 179.533 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 21.9 mt-10 -65.57 -48.94 70.67 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 116.665 -0.243 . . . . 0.0 110.863 179.741 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 153.64 74.94 0.01 OUTLIER Glycine 0 C--N 1.336 0.535 0 C-N-CA 120.678 -0.772 . . . . 0.0 113.02 179.696 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 5.0 tp10 -128.66 96.71 4.47 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-O 120.858 0.361 . . . . 0.0 111.299 179.748 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 14.5 ptpt -111.86 -31.81 6.82 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.439 179.803 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 4.4 m -110.87 97.41 5.7 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.264 0 CA-C-O 120.953 0.406 . . . . 0.0 111.075 179.853 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -99.64 154.55 18.19 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.527 -179.574 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 11.2 p -118.56 139.23 46.59 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.244 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.313 -179.958 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 53.5 t -78.52 135.25 60.89 Favored Pre-proline 0 C--O 1.233 0.232 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.917 179.858 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_endo -83.96 19.7 1.32 Allowed 'Trans proline' 0 C--N 1.35 0.628 0 C-N-CA 122.692 2.261 . . . . 0.0 113.171 179.843 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 12.7 t -128.02 -59.26 1.19 Allowed 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 122.301 0.24 . . . . 0.0 110.41 179.607 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 19.4 p -95.76 -20.89 18.51 Favored 'General case' 0 N--CA 1.468 0.444 0 N-CA-C 112.073 0.397 . . . . 0.0 112.073 179.676 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 1.2 t 67.04 39.6 3.15 Favored 'General case' 0 CA--C 1.536 0.434 0 CA-C-O 120.901 0.382 . . . . 0.0 111.353 -179.683 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.585 HD23 HG23 ' A' ' 55' ' ' ILE . 8.0 tt -91.81 139.6 30.51 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.852 179.903 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' MET . . . . . 0.602 ' HB3' HG22 ' A' ' 4' ' ' THR . 53.1 mtp -88.24 128.11 35.46 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 116.396 -0.366 . . . . 0.0 111.3 -179.734 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.585 HG23 HD23 ' A' ' 53' ' ' LEU . 2.4 pt -132.26 139.08 50.95 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.259 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.492 179.937 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 22.0 m-20 -96.93 87.13 4.17 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 116.458 -0.337 . . . . 0.0 110.324 179.216 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.429 HG13 ' O ' ' A' ' 57' ' ' VAL . 12.6 p -93.13 114.15 29.35 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.251 0 CA-C-O 121.004 0.43 . . . . 0.0 111.079 -179.893 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.48 HG13 ' HG3' ' A' ' 9' ' ' GLU . 14.9 p -82.92 146.75 6.59 Favored 'Isoleucine or valine' 0 C--O 1.233 0.208 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.283 -179.539 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 47.5 p90 -121.9 170.1 10.13 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.267 -179.645 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -132.08 165.0 25.01 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.448 -179.914 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -99.83 -33.77 10.42 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.405 179.815 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 1.6 mm-40 -59.35 -60.31 4.06 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-O 120.471 0.176 . . . . 0.0 111.073 179.929 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -59.87 -44.49 94.14 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 116.608 -0.269 . . . . 0.0 110.86 179.733 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.514 HD23 HD13 ' A' ' 36' ' ' LEU . 0.7 OUTLIER -58.38 -45.34 88.49 Favored 'General case' 0 CA--C 1.53 0.211 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.036 179.734 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -62.77 -51.68 66.19 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.176 179.789 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 2.0 tp10 -59.57 -40.91 88.9 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-N 116.459 -0.337 . . . . 0.0 110.761 179.517 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 3.9 t80 -55.11 -36.18 65.45 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.435 179.544 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 1.6 t80 -55.9 -38.69 70.55 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-O 120.637 0.256 . . . . 0.0 110.58 179.791 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 4.2 tt0 -83.04 -37.24 24.17 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.73 179.091 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 8.1 mt-10 -65.76 -36.87 84.79 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 116.526 -0.306 . . . . 0.0 111.621 -179.802 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.233 0.223 0 CA-C-O 120.811 0.338 . . . . 0.0 111.542 -179.893 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 3.1 p . . . . . 0 N--CA 1.464 0.275 0 CA-C-O 120.647 0.26 . . . . 0.0 111.627 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -107.89 -47.56 3.56 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.21 179.622 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -150.32 174.57 12.71 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.339 179.938 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 12.4 mt-10 -121.62 120.71 35.57 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.63 179.691 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.447 ' O ' ' HA ' ' A' ' 57' ' ' VAL . 3.6 mp -115.08 152.09 16.74 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.331 0 CA-C-N 116.441 -0.345 . . . . 0.0 111.33 -179.495 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 10.2 mt-10 -99.24 143.06 29.93 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 116.525 -0.307 . . . . 0.0 111.387 179.986 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 9.0 tp -59.32 -29.42 41.88 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.382 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.467 179.576 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 3.4 pt-20 -60.59 -28.67 68.67 Favored 'General case' 0 CA--C 1.533 0.325 0 CA-C-N 116.669 -0.241 . . . . 0.0 111.357 179.679 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -97.9 36.99 1.46 Allowed 'General case' 0 CA--C 1.535 0.392 0 CA-C-O 120.722 0.296 . . . . 0.0 111.248 179.756 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' MET . . . . . 0.607 ' CE ' HG11 ' A' ' 57' ' ' VAL . 3.9 mtt -131.44 140.06 49.52 Favored 'General case' 0 N--CA 1.464 0.225 0 CA-C-N 116.528 -0.305 . . . . 0.0 111.075 179.994 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 2.1 m -67.58 145.91 54.4 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 116.418 -0.355 . . . . 0.0 111.131 179.826 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 1.5 p90 -109.08 158.15 18.04 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.159 179.726 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -135.7 76.9 53.04 Favored Pre-proline 0 CA--C 1.532 0.264 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.587 179.677 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -54.09 -25.02 35.32 Favored 'Trans proline' 0 C--N 1.352 0.736 0 C-N-CA 122.982 2.454 . . . . 0.0 113.133 -179.99 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -52.95 -42.72 65.74 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-N 116.669 -0.241 . . . . 0.0 111.316 179.918 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 3.5 m-80 -133.01 15.69 4.22 Favored 'General case' 0 CA--C 1.541 0.615 0 N-CA-C 112.181 0.438 . . . . 0.0 112.181 -179.758 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' GLN . . . . . 0.491 ' C ' HD13 ' A' ' 36' ' ' LEU . 27.7 mt-30 56.08 75.26 0.35 Allowed 'General case' 0 N--CA 1.471 0.591 0 N-CA-C 111.959 0.355 . . . . 0.0 111.959 179.497 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 1.6 ptt? -163.01 147.95 11.58 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-N 116.431 -0.349 . . . . 0.0 111.26 179.191 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 7.5 m-85 -105.09 139.33 39.92 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-O 120.677 0.275 . . . . 0.0 110.973 179.675 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 75.5 p -132.44 158.25 42.51 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.57 -179.488 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 39.0 t80 -162.83 136.45 4.61 Favored Pre-proline 0 N--CA 1.465 0.276 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.908 179.619 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 41.7 Cg_endo -66.14 100.31 0.45 Allowed 'Trans proline' 0 C--N 1.35 0.617 0 C-N-CA 122.461 2.107 . . . . 0.0 112.32 179.725 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . 0.424 ' SG ' ' HD2' ' A' ' 27' ' ' PRO . 42.6 t -58.4 139.3 84.91 Favored Pre-proline 0 C--O 1.233 0.19 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.843 179.843 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . 0.424 ' HD2' ' SG ' ' A' ' 26' ' ' CYS . 65.1 Cg_exo -52.27 -26.53 27.33 Favored 'Trans proline' 0 C--N 1.349 0.596 0 C-N-CA 122.843 2.362 . . . . 0.0 113.038 179.844 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . 0.419 ' CB ' ' HB3' ' A' ' 51' ' ' CYS . 0.8 OUTLIER -68.19 -38.4 81.97 Favored 'General case' 0 CA--C 1.533 0.318 0 CA-C-O 120.472 0.177 . . . . 0.0 111.394 179.924 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 151.12 -45.28 0.64 Allowed Glycine 0 C--N 1.336 0.55 0 C-N-CA 120.827 -0.702 . . . . 0.0 112.999 -179.784 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 2.8 t70 -72.26 -178.21 2.41 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-N 116.677 0.239 . . . . 0.0 111.143 -179.845 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 8.2 ttm180 -118.93 125.37 49.3 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-O 120.673 0.273 . . . . 0.0 111.234 -179.86 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . 0.587 ' CE2' HD11 ' A' ' 55' ' ' ILE . 0.5 OUTLIER -64.84 154.33 37.48 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.243 179.858 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 20.8 pt20 -150.44 135.93 18.06 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.278 -179.92 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 2.8 tt -149.27 135.39 12.07 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.201 0 CA-C-N 116.425 -0.352 . . . . 0.0 111.219 179.428 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -86.2 140.93 29.71 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.83 179.963 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.686 ' O ' HD11 ' A' ' 64' ' ' LEU . 9.8 mp -58.03 -49.14 77.89 Favored 'General case' 0 C--O 1.232 0.152 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.676 179.699 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -58.05 -39.4 78.35 Favored 'General case' 0 CA--C 1.532 0.261 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.23 179.48 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -58.54 -46.79 86.09 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 116.571 -0.286 . . . . 0.0 110.834 179.809 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 8.9 mtm -59.82 -35.3 74.44 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.85 179.683 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -55.16 -42.91 73.74 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.923 179.511 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -60.38 -48.23 82.66 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-O 120.68 0.276 . . . . 0.0 110.81 179.712 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 149.62 54.76 0.01 OUTLIER Glycine 0 C--N 1.334 0.472 0 C-N-CA 120.954 -0.641 . . . . 0.0 112.663 179.775 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 2.3 tp10 -99.32 95.94 7.39 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-O 120.775 0.321 . . . . 0.0 111.047 179.971 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 13.4 mtmt -105.39 -36.89 7.03 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.078 179.75 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.462 ' O ' HG13 ' A' ' 45' ' ' VAL . 9.4 p -117.95 111.11 32.94 Favored 'Isoleucine or valine' 0 C--O 1.233 0.217 0 CA-C-O 121.037 0.446 . . . . 0.0 110.87 179.769 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -109.9 168.8 9.16 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-N 115.816 -0.629 . . . . 0.0 111.338 -179.552 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 12.0 p -130.83 140.44 48.68 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.254 0 CA-C-N 116.432 -0.349 . . . . 0.0 111.75 -179.352 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 40.6 t -76.64 136.82 67.21 Favored Pre-proline 0 N--CA 1.464 0.248 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.737 179.785 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_endo -83.03 20.7 1.12 Allowed 'Trans proline' 0 CA--C 1.537 0.627 0 C-N-CA 122.85 2.367 . . . . 0.0 113.203 179.796 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -129.0 -56.79 1.18 Allowed 'General case' 0 C--O 1.233 0.222 0 CA-C-N 116.682 -0.235 . . . . 0.0 110.419 179.516 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' CYS . . . . . 0.5 ' SG ' HD12 ' A' ' 53' ' ' LEU . 22.9 p -95.78 -24.16 16.62 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 116.473 -0.33 . . . . 0.0 111.777 179.49 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER 69.64 39.95 1.45 Allowed 'General case' 0 CA--C 1.534 0.344 0 CA-C-O 120.821 0.343 . . . . 0.0 111.368 -179.666 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.5 HD12 ' SG ' ' A' ' 51' ' ' CYS . 74.4 mt -98.07 127.78 44.21 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-N 116.433 -0.348 . . . . 0.0 110.606 179.62 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' MET . . . . . . . . . . . . . 9.4 mtt -82.61 136.24 34.86 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.963 -179.677 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.587 HD11 ' CE2' ' A' ' 32' ' ' PHE . 9.2 pt -136.75 152.61 29.1 Favored 'Isoleucine or valine' 0 C--O 1.234 0.25 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.908 -179.647 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -102.66 108.78 20.16 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.484 179.285 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.607 HG11 ' CE ' ' A' ' 13' ' ' MET . 0.0 OUTLIER -110.13 113.18 43.51 Favored 'Isoleucine or valine' 0 C--O 1.234 0.257 0 CA-C-O 120.793 0.33 . . . . 0.0 111.355 179.726 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.534 ' O ' HG13 ' A' ' 58' ' ' VAL . 8.1 p -81.88 88.2 1.84 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.265 0 CA-C-O 121.353 0.597 . . . . 0.0 110.772 179.821 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 51.0 p90 -80.02 155.27 27.68 Favored 'General case' 0 CA--C 1.531 0.249 0 CA-C-N 115.597 -0.729 . . . . 0.0 111.177 -179.568 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -103.54 145.91 29.32 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-O 120.891 0.377 . . . . 0.0 111.375 -179.875 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 5.8 tttp -87.94 -40.22 14.1 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.844 179.67 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 21.1 tt0 -56.42 -44.62 80.56 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.335 179.424 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 77.4 m-20 -63.0 -46.66 86.63 Favored 'General case' 0 N--CA 1.463 0.186 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.813 179.353 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.686 HD11 ' O ' ' A' ' 36' ' ' LEU . 0.5 OUTLIER -53.33 -45.89 69.24 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-N 116.635 -0.257 . . . . 0.0 111.327 179.971 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -58.0 -51.54 69.25 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-N 116.471 -0.332 . . . . 0.0 111.024 179.869 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 58.6 mt-10 -67.13 -46.36 74.34 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.889 179.767 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 5.2 m-85 -53.98 -31.91 52.35 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.62 179.637 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 1.7 t80 -59.09 -49.2 78.79 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-O 120.671 0.272 . . . . 0.0 110.804 179.935 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 34.8 mt-10 -83.93 -35.5 23.99 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.006 179.841 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 2.6 mm-40 -66.63 -30.31 70.55 Favored 'General case' 0 CA--C 1.533 0.29 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.67 179.765 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.465 0.285 0 CA-C-O 120.966 0.412 . . . . 0.0 111.991 -179.478 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 1.2 p . . . . . 0 N--CA 1.465 0.305 0 CA-C-O 120.627 0.251 . . . . 0.0 110.794 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . 0.544 ' CG ' HD11 ' A' ' 53' ' ' LEU . 2.8 m-85 -108.03 -73.74 0.68 Allowed 'General case' 0 C--O 1.233 0.226 0 CA-C-N 116.46 -0.337 . . . . 0.0 111.119 -179.968 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 8.9 p-10 -142.29 162.19 36.1 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.44 -179.515 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 -106.58 108.85 20.57 Favored 'General case' 0 CA--C 1.531 0.228 0 CA-C-N 115.857 -0.611 . . . . 0.0 110.976 -179.954 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 3.7 mp -93.73 150.14 4.07 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.23 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.215 179.95 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 4.0 tt0 -95.59 146.87 24.14 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.344 -179.734 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 2.9 tt -60.37 -33.19 53.08 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.296 0 CA-C-N 116.086 -0.507 . . . . 0.0 111.415 179.653 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 27.3 mt-10 -60.18 -35.24 74.93 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 116.464 -0.334 . . . . 0.0 110.892 179.532 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -96.44 37.22 1.28 Allowed 'General case' 0 CA--C 1.533 0.316 0 CA-C-O 120.804 0.335 . . . . 0.0 111.287 179.774 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 2.3 ttt -124.18 144.12 50.11 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.756 179.751 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 21.5 m -64.88 136.86 57.33 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.047 -179.788 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 19.7 p90 -105.89 131.04 53.68 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.009 179.771 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -118.65 91.8 42.82 Favored Pre-proline 0 C--N 1.33 -0.261 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.479 179.843 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 42.3 Cg_endo -70.82 -14.79 32.99 Favored 'Trans proline' 0 C--N 1.347 0.496 0 C-N-CA 122.598 2.199 . . . . 0.0 113.0 -179.932 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 -51.37 -35.26 37.79 Favored 'General case' 0 CA--C 1.533 0.319 0 N-CA-C 111.912 0.338 . . . . 0.0 111.912 -179.759 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 18.6 m-20 -148.71 26.67 0.91 Allowed 'General case' 0 CA--C 1.534 0.36 0 CA-C-N 116.624 -0.262 . . . . 0.0 111.579 -179.78 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 7.1 mt-30 55.02 69.84 0.69 Allowed 'General case' 0 CA--C 1.537 0.472 0 CA-C-O 120.921 0.391 . . . . 0.0 111.566 179.518 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 5.7 ptt? -151.52 167.49 27.87 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.938 179.577 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.526 ' HE1' HD21 ' A' ' 36' ' ' LEU . 17.4 m-85 -128.63 147.49 50.73 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 116.507 -0.315 . . . . 0.0 110.918 179.824 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 71.7 p -138.77 169.52 17.64 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.803 -179.615 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 47.6 t80 -163.54 137.09 4.4 Favored Pre-proline 0 N--CA 1.468 0.432 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.938 179.878 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -67.3 97.08 0.42 Allowed 'Trans proline' 0 C--N 1.352 0.713 0 C-N-CA 122.486 2.124 . . . . 0.0 112.11 179.446 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . 0.465 ' SG ' ' HD2' ' A' ' 27' ' ' PRO . 50.2 t -59.44 140.43 88.5 Favored Pre-proline 0 C--O 1.233 0.193 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.676 179.962 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . 0.465 ' HD2' ' SG ' ' A' ' 26' ' ' CYS . 74.5 Cg_exo -50.86 -27.75 21.54 Favored 'Trans proline' 0 C--N 1.349 0.591 0 C-N-CA 122.942 2.428 . . . . 0.0 113.098 179.928 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -71.48 -38.29 71.23 Favored 'General case' 0 CA--C 1.533 0.326 0 CA-C-O 120.485 0.183 . . . . 0.0 111.269 -179.905 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 149.45 -44.08 0.74 Allowed Glycine 0 C--N 1.337 0.6 0 C-N-CA 120.858 -0.687 . . . . 0.0 113.001 -179.971 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -68.26 176.85 2.55 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-O 120.84 0.352 . . . . 0.0 111.278 -179.716 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -118.43 128.82 54.98 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-N 116.492 -0.322 . . . . 0.0 110.998 -179.927 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 9.6 m-85 -62.54 160.13 14.44 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.859 179.671 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 10.5 pt20 -155.3 130.14 9.31 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-O 120.845 0.355 . . . . 0.0 111.401 -179.982 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 3.2 tt -157.3 124.19 0.56 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.281 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.904 179.707 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 32.0 m-85 -80.15 156.5 26.95 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.746 179.999 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.526 HD21 ' HE1' ' A' ' 22' ' ' PHE . 72.0 mt -58.73 -40.9 85.14 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.836 179.849 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -62.2 -35.22 78.21 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 116.447 -0.342 . . . . 0.0 111.408 179.675 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 18.1 m-20 -64.45 -60.08 3.58 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-O 120.862 0.363 . . . . 0.0 110.77 -179.943 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 13.7 ptp -60.18 -37.26 79.66 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.076 179.874 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . 0.428 ' HB2' ' CD2' ' A' ' 64' ' ' LEU . 23.2 t80 -59.8 -45.35 92.59 Favored 'General case' 0 CA--C 1.53 0.193 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.984 179.581 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -57.97 -42.2 84.53 Favored 'General case' 0 CA--C 1.532 0.251 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.005 179.799 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 149.78 65.73 0.01 OUTLIER Glycine 0 C--N 1.336 0.537 0 C-N-CA 120.773 -0.727 . . . . 0.0 113.086 179.632 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -120.01 156.63 30.51 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-O 120.655 0.264 . . . . 0.0 111.12 179.719 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . 0.554 ' HG3' HG23 ' A' ' 45' ' ' VAL . 0.2 OUTLIER -162.77 -46.8 0.04 OUTLIER 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.164 179.532 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.554 HG23 ' HG3' ' A' ' 44' ' ' LYS . 22.0 t -96.89 89.22 2.02 Favored 'Isoleucine or valine' 0 C--O 1.234 0.28 0 CA-C-O 120.892 0.377 . . . . 0.0 110.644 179.692 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -80.1 141.54 35.7 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.24 -179.583 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 7.9 m -110.09 127.24 67.14 Favored 'Isoleucine or valine' 0 C--O 1.232 0.174 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.464 -179.879 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 51.0 t -72.13 135.64 82.32 Favored Pre-proline 0 C--N 1.331 -0.227 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.792 179.806 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 87.0 Cg_endo -84.0 19.22 1.4 Allowed 'Trans proline' 0 CA--C 1.537 0.631 0 C-N-CA 122.734 2.289 . . . . 0.0 113.234 179.96 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 2.0 t -127.74 -57.86 1.25 Allowed 'General case' 0 C--O 1.232 0.176 0 CA-C-O 120.558 0.218 . . . . 0.0 110.649 179.538 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 19.6 p -98.7 -19.81 17.29 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-N 116.455 -0.339 . . . . 0.0 111.73 179.888 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER 67.81 39.28 2.68 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-O 121.081 0.467 . . . . 0.0 110.955 -179.895 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.557 HD23 HG23 ' A' ' 55' ' ' ILE . 9.1 tt -91.25 132.9 35.83 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.631 179.875 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' MET . . . . . . . . . . . . . 15.1 mtt -87.92 130.49 34.91 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.194 -179.664 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.557 HG23 HD23 ' A' ' 53' ' ' LEU . 3.2 pt -133.45 144.51 35.86 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.237 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.456 179.676 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -101.7 107.59 18.87 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.226 179.148 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.438 HG13 ' O ' ' A' ' 57' ' ' VAL . 11.6 p -107.98 117.1 52.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-O 120.943 0.402 . . . . 0.0 111.01 -179.821 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 13.9 p -79.99 135.54 25.25 Favored 'Isoleucine or valine' 0 C--O 1.236 0.347 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.662 -179.896 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 8.0 p90 -142.96 169.39 17.66 Favored 'General case' 0 C--O 1.235 0.299 0 CA-C-N 115.782 -0.645 . . . . 0.0 110.97 -179.084 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -138.06 171.07 14.95 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.175 179.615 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 7.6 mttp -96.78 23.01 7.47 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.324 179.746 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 4.6 mt-10 -94.35 -47.81 6.43 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.224 179.206 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 3.0 t70 -68.55 -35.95 78.12 Favored 'General case' 0 N--CA 1.462 0.126 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.213 179.529 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.428 ' CD2' ' HB2' ' A' ' 40' ' ' PHE . 0.7 OUTLIER -55.05 -53.61 53.6 Favored 'General case' 0 CA--C 1.532 0.279 0 CA-C-N 116.694 -0.23 . . . . 0.0 111.358 -179.895 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -59.57 -44.6 93.25 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-O 120.811 0.339 . . . . 0.0 110.934 179.573 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -64.45 -45.15 88.67 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-N 115.857 -0.61 . . . . 0.0 111.102 179.884 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . 0.448 ' HD2' HD11 ' A' ' 36' ' ' LEU . 1.2 t80 -72.11 -39.85 68.59 Favored 'General case' 0 CA--C 1.531 0.239 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.899 -179.764 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 15.4 t80 -62.5 -36.96 84.17 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-O 120.577 0.227 . . . . 0.0 110.86 179.924 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 32.4 mt-10 -78.11 -32.82 50.73 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.987 179.471 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 4.8 tt0 -114.23 40.4 2.52 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-N 116.546 -0.297 . . . . 0.0 111.492 -179.79 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.234 0.261 0 CA-C-O 120.986 0.422 . . . . 0.0 111.62 -179.942 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . 0.51 HG21 ' CG ' ' A' ' 56' ' ' ASP . 0.8 OUTLIER . . . . . 0 N--CA 1.465 0.301 0 CA-C-O 120.772 0.32 . . . . 0.0 111.172 . . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . 0.597 ' CD1' HD11 ' A' ' 53' ' ' LEU . 61.2 m-85 -95.07 -35.26 11.99 Favored 'General case' 0 CA--C 1.53 0.197 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.523 179.991 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -155.04 174.1 15.65 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-O 120.812 0.339 . . . . 0.0 111.328 179.887 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 26.5 tt0 -130.8 114.33 15.2 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.649 -179.936 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.408 HG21 ' CE ' ' A' ' 13' ' ' MET . 27.8 mm -93.2 155.61 3.12 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.178 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.744 179.897 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 4.3 pm0 -119.1 145.97 45.49 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.171 -179.807 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 8.2 tp -59.21 -33.53 50.99 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.328 0 CA-C-N 116.277 -0.419 . . . . 0.0 111.168 179.595 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 8.4 mt-10 -65.68 -32.25 73.71 Favored 'General case' 0 CA--C 1.533 0.318 0 CA-C-N 116.461 -0.336 . . . . 0.0 111.155 179.445 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 11.0 t0 -98.63 40.32 1.2 Allowed 'General case' 0 CA--C 1.533 0.3 0 CA-C-O 120.97 0.414 . . . . 0.0 110.664 179.617 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' MET . . . . . 0.411 ' HG3' ' HB2' ' A' ' 24' ' ' TYR . 0.9 OUTLIER -131.83 163.96 27.11 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.937 179.803 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 5.8 m -96.62 119.93 36.0 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-N 116.43 -0.35 . . . . 0.0 110.824 -179.809 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 20.8 p90 -98.56 134.14 41.94 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.529 179.618 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 4.5 mt-10 -107.11 94.3 10.75 Favored Pre-proline 0 C--O 1.234 0.239 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.521 179.952 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -73.0 65.24 4.14 Favored 'Trans proline' 0 C--N 1.35 0.629 0 C-N-CA 122.936 2.424 . . . . 0.0 112.5 -179.553 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 5.4 pt-20 -135.92 -49.48 0.69 Allowed 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.676 -0.693 . . . . 0.0 111.062 179.991 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -135.54 32.19 3.07 Favored 'General case' 0 CA--C 1.535 0.382 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.384 179.865 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' GLN . . . . . 0.661 ' HG3' HD13 ' A' ' 36' ' ' LEU . 0.0 OUTLIER 55.48 59.29 3.98 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-O 121.037 0.446 . . . . 0.0 111.273 -179.995 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 10.6 ptm -143.14 163.28 33.3 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.989 179.791 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.579 ' CZ ' HG23 ' A' ' 34' ' ' ILE . 4.5 p90 -150.82 144.32 24.98 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.09 -179.997 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . 0.441 HG22 ' HA ' ' A' ' 33' ' ' GLN . 76.4 p -134.62 167.35 20.98 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-N 115.987 -0.551 . . . . 0.0 111.689 -179.386 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' TYR . . . . . 0.411 ' HB2' ' HG3' ' A' ' 13' ' ' MET . 31.6 t80 -153.41 136.72 10.06 Favored Pre-proline 0 CA--C 1.531 0.239 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.937 -179.993 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo -66.58 101.94 0.57 Allowed 'Trans proline' 0 C--N 1.35 0.623 0 C-N-CA 122.706 2.27 . . . . 0.0 112.415 179.739 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . 0.419 ' SG ' ' HD2' ' A' ' 27' ' ' PRO . 41.8 t -62.82 139.23 97.21 Favored Pre-proline 0 C--O 1.232 0.184 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.605 179.688 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . 0.419 ' HD2' ' SG ' ' A' ' 26' ' ' CYS . 76.3 Cg_exo -51.44 -27.27 23.9 Favored 'Trans proline' 0 C--N 1.349 0.602 0 C-N-CA 122.847 2.365 . . . . 0.0 113.029 179.858 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . 0.422 ' CB ' ' HB3' ' A' ' 51' ' ' CYS . 0.8 OUTLIER -69.66 -36.88 76.43 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-N 116.849 -0.16 . . . . 0.0 111.425 179.947 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 148.53 -43.54 0.8 Allowed Glycine 0 C--N 1.337 0.599 0 C-N-CA 120.881 -0.676 . . . . 0.0 113.141 179.91 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -69.49 -177.77 1.26 Allowed 'General case' 0 N--CA 1.465 0.315 0 CA-C-O 120.841 0.353 . . . . 0.0 111.442 -179.686 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 1.4 tpp180 -121.74 118.53 29.31 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.033 -179.918 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 34.3 t80 -59.87 142.74 52.96 Favored 'General case' 0 CA--C 1.528 0.103 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.448 179.394 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . 0.441 ' HA ' HG22 ' A' ' 23' ' ' THR . 1.5 pt20 -135.81 143.97 45.46 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-N 116.539 -0.3 . . . . 0.0 111.214 -179.814 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.579 HG23 ' CZ ' ' A' ' 22' ' ' PHE . 8.2 tt -174.79 149.24 0.41 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.343 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.02 -179.953 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 64.9 m-85 -99.14 159.62 14.85 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.05 -179.806 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.661 HD13 ' HG3' ' A' ' 20' ' ' GLN . 7.9 mp -60.69 -44.27 96.73 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.728 179.831 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -57.9 -40.22 79.82 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.678 179.327 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -60.26 -42.37 95.22 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.521 179.292 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 4.5 mtp -91.55 33.41 1.01 Allowed 'General case' 0 CA--C 1.534 0.356 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.253 179.367 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 18.0 t80 -135.95 -47.32 0.66 Allowed 'General case' 0 C--O 1.233 0.207 0 CA-C-N 116.654 -0.248 . . . . 0.0 110.865 179.647 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 12.9 tt0 -58.69 -44.62 90.32 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.884 179.675 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 167.28 68.17 0.03 OUTLIER Glycine 0 C--N 1.335 0.492 0 C-N-CA 120.892 -0.671 . . . . 0.0 112.843 179.713 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -144.08 156.02 44.19 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-O 120.818 0.342 . . . . 0.0 111.439 -179.968 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 4.7 pttp -156.21 -47.35 0.08 Allowed 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 115.886 -0.597 . . . . 0.0 111.107 179.811 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.417 ' O ' HG13 ' A' ' 45' ' ' VAL . 10.5 p -103.74 120.36 53.72 Favored 'Isoleucine or valine' 0 C--O 1.233 0.211 0 CA-C-O 120.898 0.38 . . . . 0.0 110.797 179.735 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -111.99 173.83 6.17 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.162 -179.844 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 19.9 t -128.48 137.8 56.39 Favored 'Isoleucine or valine' 0 C--O 1.235 0.29 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.441 -179.669 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 43.8 t -78.6 136.12 59.79 Favored Pre-proline 0 C--O 1.233 0.222 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.679 179.624 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_endo -84.31 22.16 0.98 Allowed 'Trans proline' 0 C--N 1.349 0.595 0 C-N-CA 122.828 2.352 . . . . 0.0 113.339 179.951 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 36.4 m -131.26 -57.13 1.02 Allowed 'General case' 0 C--O 1.233 0.219 0 CA-C-O 120.507 0.194 . . . . 0.0 110.674 179.825 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' CYS . . . . . 0.422 ' HB3' ' CB ' ' A' ' 28' ' ' CYS . 19.2 p -95.68 -19.18 19.92 Favored 'General case' 0 CA--C 1.535 0.369 0 CA-C-N 116.489 -0.323 . . . . 0.0 111.615 179.441 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 1.7 m 62.97 40.83 8.96 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-O 121.061 0.457 . . . . 0.0 111.014 -179.728 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.597 HD11 ' CD1' ' A' ' 5' ' ' TYR . 7.1 tp -95.02 142.94 26.91 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.873 179.898 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' MET . . . . . . . . . . . . . 17.3 mtm -91.99 128.39 37.81 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.709 179.817 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 19.0 pt -137.62 139.41 43.25 Favored 'Isoleucine or valine' 0 C--O 1.233 0.227 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.452 -179.659 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . 0.51 ' CG ' HG21 ' A' ' 4' ' ' THR . 91.5 m-20 -99.06 90.13 4.5 Favored 'General case' 0 C--O 1.231 0.13 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.493 179.417 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.443 HG13 ' O ' ' A' ' 57' ' ' VAL . 9.4 p -86.79 114.54 26.22 Favored 'Isoleucine or valine' 0 C--O 1.233 0.216 0 CA-C-O 120.993 0.425 . . . . 0.0 110.759 179.697 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 14.3 p -79.71 142.79 13.49 Favored 'Isoleucine or valine' 0 C--O 1.233 0.213 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.269 -179.75 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 36.2 p90 -132.43 177.94 7.21 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.691 -179.827 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -121.87 -167.1 1.48 Allowed 'General case' 0 CA--C 1.534 0.331 0 CA-C-O 120.792 0.33 . . . . 0.0 110.789 179.781 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 4.7 mmtp -113.98 -44.99 3.1 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.288 179.255 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 7.7 mt-10 -61.71 -34.2 75.37 Favored 'General case' 0 CA--C 1.529 0.17 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.206 179.58 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 34.8 p30 -56.73 -32.6 65.7 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 116.843 -0.162 . . . . 0.0 111.25 179.582 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.626 ' HG ' HD23 ' A' ' 36' ' ' LEU . 1.3 mp -79.27 -53.29 7.1 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-O 120.658 0.266 . . . . 0.0 110.612 179.355 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -56.04 -38.92 71.22 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.814 179.473 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 26.9 tt0 -68.73 -40.53 79.86 Favored 'General case' 0 CA--C 1.531 0.242 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.776 179.335 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -68.38 -39.81 81.62 Favored 'General case' 0 CA--C 1.53 0.185 0 CA-C-N 116.525 -0.307 . . . . 0.0 111.628 179.842 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 6.0 m-85 -60.46 -41.81 94.89 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 116.773 -0.194 . . . . 0.0 111.081 -179.858 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 16.9 pt-20 -77.84 -33.56 52.2 Favored 'General case' 0 CA--C 1.533 0.322 0 CA-C-N 116.621 -0.263 . . . . 0.0 111.234 179.698 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -74.17 -51.79 14.46 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-O 120.605 0.24 . . . . 0.0 111.41 -179.951 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.233 0.197 0 CA-C-O 120.816 0.341 . . . . 0.0 111.358 -179.872 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . 0.556 HG21 ' OD1' ' A' ' 56' ' ' ASP . 68.0 p . . . . . 0 N--CA 1.467 0.414 0 CA-C-O 120.756 0.313 . . . . 0.0 111.518 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . 0.507 ' HB2' HD11 ' A' ' 53' ' ' LEU . 10.8 t80 -104.93 -41.32 5.65 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.137 -179.992 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . 0.467 ' HB2' ' CD1' ' A' ' 5' ' ' TYR . 5.1 t70 -155.95 161.33 40.53 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-O 120.801 0.334 . . . . 0.0 111.633 -179.565 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -117.12 119.97 36.88 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.861 179.474 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.415 ' O ' ' HA ' ' A' ' 57' ' ' VAL . 3.7 mp -111.53 153.16 13.3 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.226 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.309 -179.581 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . 0.534 ' HA ' HG12 ' A' ' 58' ' ' VAL . 15.7 mt-10 -103.08 152.03 21.86 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.362 -179.841 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 1.1 tp -58.0 -35.35 51.8 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.297 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.253 179.508 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -63.37 -32.75 74.26 Favored 'General case' 0 CA--C 1.53 0.196 0 CA-C-N 116.544 -0.298 . . . . 0.0 111.151 179.544 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -96.18 36.79 1.29 Allowed 'General case' 0 CA--C 1.531 0.243 0 CA-C-O 120.762 0.315 . . . . 0.0 111.266 -179.987 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' MET . . . . . 0.422 ' HG3' ' HB2' ' A' ' 24' ' ' TYR . 7.6 ttt -127.31 140.84 51.93 Favored 'General case' 0 C--N 1.333 -0.128 0 CA-C-N 116.458 -0.337 . . . . 0.0 110.56 179.643 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . 0.676 HG21 HH21 ' A' ' 31' ' ' ARG . 19.4 m -61.19 140.08 58.0 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.919 179.999 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 9.1 m-85 -105.14 135.28 46.79 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.772 -179.974 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -117.56 88.77 30.34 Favored Pre-proline 0 C--O 1.234 0.24 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.608 179.572 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 12.9 Cg_exo -70.7 65.16 2.36 Favored 'Trans proline' 0 C--N 1.349 0.556 0 C-N-CA 123.014 2.476 . . . . 0.0 112.47 -179.649 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 5.9 pt-20 -137.05 -51.89 0.67 Allowed 'General case' 0 C--O 1.232 0.177 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.909 179.945 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 70.8 m-20 -137.0 32.14 2.67 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-N 116.407 -0.36 . . . . 0.0 111.088 179.587 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 13.0 mm-40 56.87 61.9 2.45 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-O 120.917 0.389 . . . . 0.0 110.653 -179.861 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 3.8 ptm -134.26 150.41 51.01 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.957 -179.81 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.715 ' CE1' HD21 ' A' ' 36' ' ' LEU . 5.4 m-85 -122.99 126.86 47.97 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.659 -179.731 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 67.4 p -108.98 156.2 20.0 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.163 -179.87 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' TYR . . . . . 0.422 ' HB2' ' HG3' ' A' ' 13' ' ' MET . 64.8 t80 -148.12 107.34 3.65 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.54 179.824 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_exo -54.34 96.18 0.05 OUTLIER 'Trans proline' 0 C--N 1.348 0.551 0 C-N-CA 122.585 2.19 . . . . 0.0 111.95 -179.966 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . 0.451 ' SG ' ' HD2' ' A' ' 27' ' ' PRO . 46.4 t -63.46 139.19 97.55 Favored Pre-proline 0 C--O 1.233 0.225 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.909 -179.584 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . 0.451 ' HD2' ' SG ' ' A' ' 26' ' ' CYS . 10.1 Cg_endo -52.92 -23.3 20.72 Favored 'Trans proline' 0 C--N 1.349 0.554 0 C-N-CA 122.911 2.407 . . . . 0.0 112.834 179.745 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 6.1 p -59.43 -28.89 67.36 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-O 120.626 0.251 . . . . 0.0 111.222 179.839 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 125.11 4.74 7.03 Favored Glycine 0 CA--C 1.523 0.569 0 C-N-CA 120.988 -0.625 . . . . 0.0 113.6 179.976 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -119.91 -164.72 1.1 Allowed 'General case' 0 CA--C 1.534 0.341 0 CA-C-N 117.552 0.676 . . . . 0.0 111.424 -179.903 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . 0.676 HH21 HG21 ' A' ' 14' ' ' THR . 1.4 tpt180 -124.87 138.78 54.24 Favored 'General case' 0 C--O 1.232 0.155 0 CA-C-O 120.837 0.351 . . . . 0.0 111.561 -179.425 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 2.5 m-85 -81.29 165.16 21.66 Favored 'General case' 0 C--O 1.232 0.166 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.641 179.293 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 3.7 pt20 -155.46 122.92 5.56 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.438 -0.347 . . . . 0.0 111.009 179.785 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 4.3 tt -150.02 136.43 12.35 Favored 'Isoleucine or valine' 0 C--O 1.233 0.236 0 CA-C-N 116.308 -0.406 . . . . 0.0 111.141 -179.926 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 9.7 m-85 -96.39 156.5 16.31 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.011 -179.803 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.715 HD21 ' CE1' ' A' ' 22' ' ' PHE . 86.8 mt -63.64 -40.3 96.52 Favored 'General case' 0 N--CA 1.462 0.165 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.061 179.829 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 2.0 t0 -59.06 -35.76 73.89 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 116.499 -0.318 . . . . 0.0 111.361 179.928 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 9.7 m-20 -68.44 -58.53 4.2 Favored 'General case' 0 C--O 1.231 0.109 0 CA-C-O 120.828 0.347 . . . . 0.0 110.879 179.947 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 11.7 ptp -62.26 -34.03 75.75 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.527 -179.78 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . 0.403 ' HB2' ' CD2' ' A' ' 64' ' ' LEU . 22.4 t80 -60.21 -45.77 92.05 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 116.418 -0.355 . . . . 0.0 110.815 179.698 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 11.0 tt0 -57.93 -37.05 73.37 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.836 179.559 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 143.0 68.34 0.02 OUTLIER Glycine 0 C--N 1.334 0.426 0 C-N-CA 120.917 -0.659 . . . . 0.0 112.586 179.675 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -125.93 122.42 35.93 Favored 'General case' 0 N--CA 1.462 0.144 0 CA-C-O 120.7 0.286 . . . . 0.0 111.414 -179.769 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 14.0 mttt -118.68 -45.09 2.61 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.916 179.413 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.474 ' O ' HG13 ' A' ' 45' ' ' VAL . 10.6 p -104.55 114.52 44.37 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.182 0 CA-C-O 120.983 0.42 . . . . 0.0 110.98 179.904 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -106.92 151.45 25.25 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.947 -0.569 . . . . 0.0 111.433 -179.52 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 20.4 t -105.13 129.63 57.54 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.15 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.351 -179.893 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 50.2 t -69.43 135.35 88.65 Favored Pre-proline 0 N--CA 1.463 0.175 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.919 179.659 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 91.0 Cg_endo -83.9 19.05 1.42 Allowed 'Trans proline' 0 CA--C 1.535 0.537 0 C-N-CA 122.583 2.189 . . . . 0.0 113.118 179.953 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 1.9 m -129.1 -59.5 1.11 Allowed 'General case' 0 C--O 1.232 0.154 0 CA-C-O 120.412 0.148 . . . . 0.0 110.762 179.725 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 20.8 p -101.5 -14.2 17.6 Favored 'General case' 0 CA--C 1.535 0.377 0 N-CA-C 111.746 0.276 . . . . 0.0 111.746 179.789 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER 66.01 34.0 7.31 Favored 'General case' 0 CA--C 1.533 0.302 0 CA-C-O 120.848 0.356 . . . . 0.0 111.151 -179.98 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.507 HD11 ' HB2' ' A' ' 5' ' ' TYR . 16.8 tp -86.47 133.21 33.77 Favored 'General case' 0 C--O 1.232 0.14 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.709 179.76 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' MET . . . . . . . . . . . . . 15.3 mtt -82.72 129.9 35.04 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.696 179.995 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 3.0 pt -135.9 143.26 36.71 Favored 'Isoleucine or valine' 0 C--O 1.233 0.236 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.816 -179.474 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . 0.556 ' OD1' HG21 ' A' ' 4' ' ' THR . 30.1 m-20 -91.44 99.93 12.79 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.82 179.497 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.493 HG13 ' O ' ' A' ' 57' ' ' VAL . 10.2 p -105.19 110.52 31.23 Favored 'Isoleucine or valine' 0 C--O 1.234 0.262 0 CA-C-O 121.105 0.478 . . . . 0.0 110.927 179.723 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.534 HG12 ' HA ' ' A' ' 9' ' ' GLU . 12.3 p -82.05 138.14 19.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.407 -179.466 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 33.9 p90 -117.22 175.37 5.64 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.771 -0.65 . . . . 0.0 111.114 -179.683 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . 0.522 ' HB3' ' HB2' ' A' ' 63' ' ' ASP . 1.9 t70 -134.28 128.37 33.68 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.136 179.897 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 1.9 mptt -61.53 -42.35 98.69 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.638 179.514 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 23.5 mt-10 -63.95 -39.13 93.45 Favored 'General case' 0 C--O 1.232 0.137 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.328 179.187 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . 0.522 ' HB2' ' HB3' ' A' ' 60' ' ' ASP . 12.9 t70 -56.63 -45.02 81.77 Favored 'General case' 0 N--CA 1.462 0.126 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.886 179.331 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.639 ' HG ' HD22 ' A' ' 36' ' ' LEU . 1.1 mp -56.89 -55.62 32.18 Favored 'General case' 0 CA--C 1.529 0.151 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.517 -179.56 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -60.11 -46.91 88.02 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-N 116.673 -0.239 . . . . 0.0 111.483 -179.753 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 10.3 mm-40 -63.34 -42.62 98.94 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.901 179.877 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 33.9 t80 -69.91 -36.39 75.33 Favored 'General case' 0 CA--C 1.531 0.239 0 CA-C-N 116.481 -0.327 . . . . 0.0 111.149 179.599 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 2.2 t80 -55.7 -54.47 43.9 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-N 116.674 -0.239 . . . . 0.0 111.045 -179.882 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -69.83 -35.87 75.13 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.231 179.844 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 13.5 mt-10 -64.09 -38.37 90.81 Favored 'General case' 0 CA--C 1.53 0.179 0 CA-C-N 116.398 -0.365 . . . . 0.0 111.733 -179.831 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.233 0.194 0 N-CA-C 111.633 0.235 . . . . 0.0 111.633 -179.315 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . 0.549 HG21 ' CG ' ' A' ' 56' ' ' ASP . 72.8 p . . . . . 0 N--CA 1.464 0.261 0 CA-C-O 120.91 0.386 . . . . 0.0 111.262 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 9.3 m-85 -105.89 -39.56 5.98 Favored 'General case' 0 CA--C 1.531 0.217 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.397 179.887 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -158.6 176.96 11.74 Favored 'General case' 0 C--O 1.235 0.299 0 CA-C-N 116.451 -0.341 . . . . 0.0 111.256 -179.91 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 2.2 pt-20 -123.14 151.37 42.19 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.906 -179.992 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 25.4 mt -133.2 149.59 31.67 Favored 'Isoleucine or valine' 0 C--O 1.232 0.181 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.254 -179.803 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 39.2 mt-10 -88.63 150.52 22.99 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.062 179.714 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 14.4 tt -56.86 -34.87 44.86 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.327 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.042 179.221 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -71.59 -44.13 65.03 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.106 179.573 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -53.06 -23.25 7.27 Favored 'General case' 0 N--CA 1.469 0.503 0 N-CA-C 112.026 0.38 . . . . 0.0 112.026 -179.973 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' MET . . . . . 0.403 ' CG ' ' HB2' ' A' ' 24' ' ' TYR . 4.8 ttm -88.42 137.53 32.24 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-N 116.791 -0.186 . . . . 0.0 110.708 179.867 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 29.4 m -60.62 145.27 49.65 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-O 120.735 0.302 . . . . 0.0 111.115 -179.945 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 16.3 p90 -104.84 144.27 31.99 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.272 179.992 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 9.0 mp0 -130.55 93.92 30.85 Favored Pre-proline 0 C--O 1.233 0.23 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.667 179.804 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -68.12 -17.0 45.5 Favored 'Trans proline' 0 C--N 1.349 0.576 0 C-N-CA 122.938 2.425 . . . . 0.0 112.86 179.585 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -54.35 -39.13 66.82 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 116.615 -0.266 . . . . 0.0 111.677 -179.96 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 2.1 m120 -144.7 20.03 1.66 Allowed 'General case' 0 CA--C 1.535 0.37 0 CA-C-N 116.431 -0.349 . . . . 0.0 111.839 -179.521 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' GLN . . . . . 0.439 ' C ' HD13 ' A' ' 36' ' ' LEU . 0.0 OUTLIER 55.68 79.32 0.16 Allowed 'General case' 0 C--O 1.234 0.237 0 CA-C-O 121.142 0.496 . . . . 0.0 111.288 179.636 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 3.2 ptt? -159.54 163.69 34.95 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.78 179.912 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 80.3 m-85 -123.58 118.78 28.12 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.617 179.792 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 14.7 p -105.46 152.03 23.52 Favored 'General case' 0 CA--C 1.53 0.184 0 CA-C-O 120.809 0.338 . . . . 0.0 111.145 -179.895 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' TYR . . . . . 0.403 ' HB2' ' CG ' ' A' ' 13' ' ' MET . 38.4 t80 -159.16 136.46 6.99 Favored Pre-proline 0 N--CA 1.463 0.198 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.018 -179.979 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -72.19 110.37 2.93 Favored 'Trans proline' 0 C--N 1.348 0.525 0 C-N-CA 122.496 2.131 . . . . 0.0 112.317 179.699 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . 0.46 ' SG ' ' HD2' ' A' ' 27' ' ' PRO . 51.5 t -77.63 140.14 63.57 Favored Pre-proline 0 C--O 1.233 0.209 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.463 179.56 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . 0.46 ' HD2' ' SG ' ' A' ' 26' ' ' CYS . 81.8 Cg_exo -49.41 -28.71 16.3 Favored 'Trans proline' 0 C--N 1.35 0.642 0 C-N-CA 123.041 2.494 . . . . 0.0 113.124 179.861 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 3.6 p -61.99 -29.83 70.53 Favored 'General case' 0 C--O 1.236 0.36 0 CA-C-O 120.657 0.265 . . . . 0.0 111.286 179.875 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 116.29 15.92 6.87 Favored Glycine 0 CA--C 1.525 0.696 0 C-N-CA 121.364 -0.446 . . . . 0.0 113.291 -179.894 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -120.11 -171.65 2.2 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-N 117.113 0.457 . . . . 0.0 111.056 -179.995 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 3.8 ttt180 -108.56 131.94 54.35 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-O 120.89 0.376 . . . . 0.0 111.367 -179.701 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 5.1 t80 -100.43 102.15 13.28 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.547 179.775 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 9.2 mt-30 -101.41 154.43 18.82 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.076 -179.781 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.409 HD13 ' HE3' ' A' ' 39' ' ' MET . 2.4 tt -161.98 123.48 0.31 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.254 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.044 179.674 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 1.3 t80 -76.1 145.11 40.26 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.829 -179.905 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.439 HD13 ' C ' ' A' ' 20' ' ' GLN . 10.1 mp -58.53 -42.78 88.56 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.852 179.714 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -60.21 -37.81 81.39 Favored 'General case' 0 N--CA 1.462 0.134 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.818 179.232 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -57.9 -52.02 67.21 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.866 179.715 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' MET . . . . . 0.409 ' HE3' HD13 ' A' ' 34' ' ' ILE . 7.8 mtt -67.61 -36.59 81.12 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 116.066 -0.516 . . . . 0.0 111.03 179.648 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 16.8 t80 -63.6 -42.5 98.23 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.975 179.732 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 3.0 tp10 -55.53 -35.5 65.71 Favored 'General case' 0 CA--C 1.532 0.269 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.195 179.68 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 139.42 54.91 0.05 OUTLIER Glycine 0 C--N 1.334 0.437 0 C-N-CA 121.15 -0.548 . . . . 0.0 112.433 179.669 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -103.65 150.68 23.78 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-O 120.87 0.367 . . . . 0.0 111.451 -179.711 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 87.0 mttt -147.02 -47.51 0.18 Allowed 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 115.894 -0.593 . . . . 0.0 111.226 179.905 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.509 HG22 ' OD1' ' A' ' 56' ' ' ASP . 15.7 t -107.54 99.97 9.72 Favored 'Isoleucine or valine' 0 C--O 1.233 0.21 0 CA-C-O 120.782 0.325 . . . . 0.0 110.799 179.985 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -88.1 148.49 24.43 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.202 -179.985 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 20.4 t -114.37 129.93 69.53 Favored 'Isoleucine or valine' 0 C--O 1.233 0.19 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.927 -179.902 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 48.9 t -68.87 136.48 89.89 Favored Pre-proline 0 N--CA 1.463 0.202 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.822 179.892 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 89.5 Cg_endo -83.5 19.43 1.34 Allowed 'Trans proline' 0 CA--C 1.536 0.58 0 C-N-CA 122.684 2.256 . . . . 0.0 113.084 179.854 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 43.0 t -128.03 -59.62 1.18 Allowed 'General case' 0 C--O 1.233 0.205 0 CA-C-O 120.57 0.224 . . . . 0.0 110.506 179.675 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' CYS . . . . . 0.785 ' SG ' HD23 ' A' ' 53' ' ' LEU . 22.9 p -101.16 -19.53 15.7 Favored 'General case' 0 CA--C 1.535 0.377 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.821 179.888 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 1.6 t 72.94 36.31 0.9 Allowed 'General case' 0 CA--C 1.535 0.375 0 CA-C-O 120.869 0.366 . . . . 0.0 111.039 -179.767 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.785 HD23 ' SG ' ' A' ' 51' ' ' CYS . 0.3 OUTLIER -67.66 155.59 38.84 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.835 179.742 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' MET . . . . . . . . . . . . . 15.2 mtt -112.01 114.12 26.82 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.697 -179.753 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.588 ' O ' HD12 ' A' ' 55' ' ' ILE . 2.8 pp -132.63 143.02 40.94 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.285 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.479 -179.658 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . 0.549 ' CG ' HG21 ' A' ' 4' ' ' THR . 45.8 m-20 -101.71 91.38 4.38 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.898 179.487 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 11.1 p -85.44 127.74 39.76 Favored 'Isoleucine or valine' 0 C--O 1.233 0.233 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.773 179.614 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 12.2 p -90.12 131.85 36.29 Favored 'Isoleucine or valine' 0 C--O 1.234 0.277 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.114 -179.871 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 54.2 p90 -112.22 143.46 43.24 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.818 -0.628 . . . . 0.0 111.103 -179.697 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 59.5 m-20 -104.39 -28.58 11.27 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.5 179.866 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 16.3 ttmt 63.82 26.05 14.24 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-O 120.937 0.399 . . . . 0.0 111.397 -179.777 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 20.4 tt0 -95.75 -39.43 9.87 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.531 179.479 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -74.29 -32.8 63.03 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-N 115.883 -0.598 . . . . 0.0 111.349 179.809 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.414 ' HG ' HD23 ' A' ' 36' ' ' LEU . 3.0 mp -54.85 -45.21 74.51 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-O 120.544 0.212 . . . . 0.0 111.114 -179.9 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -59.53 -38.62 81.48 Favored 'General case' 0 CA--C 1.532 0.28 0 CA-C-N 116.523 -0.308 . . . . 0.0 111.284 179.65 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 1.9 mm-40 -79.21 -40.84 29.73 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.236 179.726 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -64.8 -35.07 79.91 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 116.47 -0.332 . . . . 0.0 111.818 -179.827 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 2.9 m-85 -59.5 -36.07 75.36 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-O 120.582 0.23 . . . . 0.0 110.722 179.885 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 20.8 tt0 -87.54 -37.43 16.89 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.912 179.296 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 34.9 mt-10 -68.55 -40.87 80.49 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.752 -179.55 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 0.205 0 N-CA-C 111.565 0.209 . . . . 0.0 111.565 -179.56 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 6.8 ttt . . . . . 0 N--CA 1.489 1.509 0 CA-C-O 120.656 0.265 . . . . 0.0 111.579 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 15.4 m -109.72 -38.47 3.57 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.237 0 CA-C-N 116.588 -0.278 . . . . 0.0 111.298 179.778 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 1.3 m -130.66 119.08 21.89 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-N 116.591 -0.277 . . . . 0.0 110.682 179.852 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 13.7 p -147.49 143.91 28.19 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-N 116.398 -0.365 . . . . 0.0 111.342 -179.569 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . 0.597 ' CG ' HD11 ' A' ' 53' ' ' LEU . 12.1 m-85 -109.6 -38.45 5.42 Favored 'General case' 0 C--O 1.232 0.173 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.158 179.487 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 1.8 t0 -158.54 174.84 14.46 Favored 'General case' 0 C--O 1.236 0.352 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.047 179.888 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 34.0 mt-10 -130.45 127.5 39.38 Favored 'General case' 0 C--O 1.232 0.164 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.872 179.991 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.407 HG12 ' CE2' ' A' ' 24' ' ' TYR . 3.7 mp -109.88 155.45 11.08 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.181 -179.807 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 11.9 mp0 -111.49 146.88 36.48 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.257 -179.833 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 3.6 tt -62.64 -34.29 64.44 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.247 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.28 179.615 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 5.0 pt-20 -64.08 -32.4 73.94 Favored 'General case' 0 CA--C 1.531 0.239 0 CA-C-N 116.559 -0.291 . . . . 0.0 111.129 179.731 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 11.6 m-20 -96.7 37.62 1.27 Allowed 'General case' 0 CA--C 1.531 0.234 0 CA-C-O 120.839 0.352 . . . . 0.0 111.083 179.704 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -131.63 152.6 50.71 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.075 -179.952 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -81.05 166.07 21.09 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.935 179.925 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 3.1 m-85 -119.9 138.41 53.45 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.975 -179.765 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -107.89 90.05 6.04 Favored Pre-proline 0 C--O 1.234 0.265 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.718 179.685 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -73.1 64.44 4.22 Favored 'Trans proline' 0 C--N 1.35 0.614 0 C-N-CA 122.745 2.297 . . . . 0.0 112.937 -179.528 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . 0.401 ' HG3' ' HE2' ' A' ' 21' ' ' MET . 6.3 pt-20 -141.95 -46.45 0.35 Allowed 'General case' 0 CA--C 1.531 0.223 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.22 179.698 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . 0.512 ' HA ' HD12 ' A' ' 73' ' ' ILE . 3.5 m120 -139.36 29.49 2.2 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-N 116.572 -0.286 . . . . 0.0 111.449 179.692 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . 0.708 ' HB3' HD12 ' A' ' 36' ' ' LEU . 28.2 mt-30 56.52 68.62 0.83 Allowed 'General case' 0 C--O 1.234 0.244 0 CA-C-O 121.043 0.449 . . . . 0.0 111.664 179.448 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . 0.401 ' HE2' ' HG3' ' A' ' 18' ' ' GLU . 3.8 ptt? -148.23 158.61 44.18 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.01 179.54 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.478 ' CE1' HD21 ' A' ' 36' ' ' LEU . 3.3 m-85 -110.13 159.44 17.34 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.685 179.91 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 34.4 p -134.35 150.06 50.9 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-O 120.941 0.401 . . . . 0.0 111.303 179.827 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . 0.407 ' CE2' HG12 ' A' ' 8' ' ' ILE . 31.5 t80 -155.69 102.07 2.17 Favored Pre-proline 0 C--N 1.333 -0.152 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.565 -179.87 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 62.6 Cg_exo -50.95 99.35 0.04 OUTLIER 'Trans proline' 0 C--N 1.349 0.574 0 C-N-CA 122.53 2.153 . . . . 0.0 112.116 -179.975 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 48.5 t -60.89 138.67 93.84 Favored Pre-proline 0 C--O 1.233 0.231 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.743 -179.618 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 80.2 Cg_exo -48.99 -26.45 10.24 Favored 'Trans proline' 0 C--N 1.351 0.667 0 C-N-CA 122.925 2.417 . . . . 0.0 113.025 179.796 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 4.3 p -59.5 -29.49 67.89 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-O 120.601 0.239 . . . . 0.0 111.352 179.661 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 123.2 7.5 7.02 Favored Glycine 0 CA--C 1.523 0.576 0 C-N-CA 121.207 -0.52 . . . . 0.0 113.445 179.94 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -114.09 -168.24 1.33 Allowed 'General case' 0 CA--C 1.532 0.262 0 CA-C-N 117.379 0.59 . . . . 0.0 111.158 -179.986 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 1.1 tpt180 -117.11 106.43 13.34 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-O 120.75 0.31 . . . . 0.0 110.91 -179.836 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -73.42 113.24 10.29 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.706 179.899 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 25.6 mt-30 -102.89 150.85 23.11 Favored 'General case' 0 N--CA 1.463 0.186 0 CA-C-N 116.435 -0.348 . . . . 0.0 111.146 -179.802 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.435 HG23 ' O ' ' A' ' 34' ' ' ILE . 0.9 OUTLIER -154.16 121.57 0.63 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.246 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.005 179.896 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 28.8 m-85 -81.92 148.14 28.9 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-N 116.374 -0.375 . . . . 0.0 111.144 -179.865 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.708 HD12 ' HB3' ' A' ' 20' ' ' GLN . 6.3 mt -67.85 -35.5 78.67 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.969 179.672 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 1.9 p-10 -66.22 -43.13 87.58 Favored 'General case' 0 CA--C 1.531 0.216 0 CA-C-N 116.372 -0.377 . . . . 0.0 110.825 179.481 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -62.81 -52.18 64.18 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-O 120.704 0.288 . . . . 0.0 111.053 -179.855 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' MET . . . . . 0.562 ' HG3' HD11 ' A' ' 64' ' ' LEU . 24.1 ptm -61.62 -27.67 68.82 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.36 179.97 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . 0.534 ' CD2' HD22 ' A' ' 64' ' ' LEU . 0.4 OUTLIER -55.58 -32.4 63.02 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 116.516 -0.311 . . . . 0.0 111.16 179.578 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 13.7 mt-10 -90.96 41.04 1.05 Allowed 'General case' 0 CA--C 1.532 0.285 0 CA-C-O 120.782 0.325 . . . . 0.0 111.484 179.9 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 60.09 64.81 3.84 Favored Glycine 0 C--N 1.334 0.434 0 C-N-CA 121.162 -0.542 . . . . 0.0 113.316 179.41 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 4.3 tt0 -121.62 98.93 6.19 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-O 120.927 0.394 . . . . 0.0 110.979 179.694 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -112.88 -33.78 5.97 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.804 179.856 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.431 HG23 ' O ' ' A' ' 45' ' ' VAL . 10.3 m -89.18 82.0 2.0 Favored 'Isoleucine or valine' 0 C--O 1.234 0.272 0 CA-C-O 121.037 0.446 . . . . 0.0 110.94 -179.977 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -91.09 147.0 23.38 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.274 -179.79 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 21.4 t -104.87 121.08 56.35 Favored 'Isoleucine or valine' 0 C--O 1.233 0.189 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.804 179.939 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 53.7 t -61.87 135.76 94.67 Favored Pre-proline 0 N--CA 1.463 0.223 0 CA-C-N 116.365 -0.379 . . . . 0.0 110.886 179.972 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 85.0 Cg_endo -84.32 20.25 1.24 Allowed 'Trans proline' 0 CA--C 1.534 0.495 0 C-N-CA 122.724 2.283 . . . . 0.0 113.167 179.926 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -129.81 -59.53 1.06 Allowed 'General case' 0 C--O 1.233 0.194 0 CA-C-O 120.516 0.198 . . . . 0.0 110.74 179.767 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 20.4 p -100.84 -17.29 16.94 Favored 'General case' 0 CA--C 1.532 0.261 0 CA-C-N 116.553 -0.294 . . . . 0.0 111.669 179.683 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER 67.43 36.56 3.8 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-O 120.911 0.386 . . . . 0.0 111.021 -179.889 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.597 HD11 ' CG ' ' A' ' 5' ' ' TYR . 9.8 tp -85.57 133.35 34.07 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.669 179.849 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' MET . . . . . . . . . . . . . 27.9 mtt -82.01 122.44 27.8 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.875 -179.801 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.486 ' O ' HD12 ' A' ' 55' ' ' ILE . 2.8 pp -131.33 143.34 40.93 Favored 'Isoleucine or valine' 0 C--O 1.234 0.26 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.008 179.884 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -109.39 92.21 3.96 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.622 -179.692 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 12.5 p -86.05 130.03 37.19 Favored 'Isoleucine or valine' 0 C--O 1.234 0.272 0 CA-C-N 116.099 -0.501 . . . . 0.0 111.002 -179.85 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 13.4 p -94.09 145.57 7.76 Favored 'Isoleucine or valine' 0 C--O 1.234 0.268 0 CA-C-N 116.057 -0.519 . . . . 0.0 111.103 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 22.3 p90 -131.89 146.77 52.31 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.153 179.879 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -89.26 -18.92 26.06 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.173 179.382 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 10.5 tttp 68.51 26.2 6.55 Favored 'General case' 0 CA--C 1.532 0.261 0 CA-C-O 120.835 0.35 . . . . 0.0 111.099 -179.688 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 4.4 tt0 -99.69 -62.52 1.23 Allowed 'General case' 0 C--O 1.232 0.165 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.351 179.644 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -62.03 -25.28 67.57 Favored 'General case' 0 N--CA 1.463 0.183 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.976 179.269 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.562 HD11 ' HG3' ' A' ' 39' ' ' MET . 0.2 OUTLIER -53.69 -38.31 64.09 Favored 'General case' 0 CA--C 1.53 0.203 0 CA-C-N 116.7 -0.227 . . . . 0.0 111.054 179.701 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -91.66 -37.64 12.92 Favored 'General case' 0 CA--C 1.53 0.208 0 CA-C-N 116.519 -0.309 . . . . 0.0 111.327 179.777 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 19.7 tt0 -66.22 -42.75 88.24 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-N 116.542 -0.299 . . . . 0.0 111.289 -179.937 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 23.3 t80 -57.92 -30.84 66.25 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.34 179.881 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . 0.423 ' HA ' ' NE2' ' A' ' 20' ' ' GLN . 4.2 m-85 -58.52 -35.29 72.05 Favored 'General case' 0 CA--C 1.528 0.117 0 CA-C-O 120.599 0.237 . . . . 0.0 110.725 179.745 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 18.4 mt-10 -81.88 -32.03 31.22 Favored 'General case' 0 C--O 1.232 0.152 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.888 179.394 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -69.4 -51.51 35.81 Favored 'General case' 0 N--CA 1.461 0.109 0 CA-C-N 116.486 -0.324 . . . . 0.0 111.208 179.921 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -71.49 154.01 41.81 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-N 116.363 -0.38 . . . . 0.0 111.358 -179.882 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -103.56 34.66 5.6 Favored Glycine 0 C--N 1.333 0.407 0 C-N-CA 120.982 -0.628 . . . . 0.0 112.715 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.512 HD12 ' HA ' ' A' ' 19' ' ' ASN . 16.4 tt -78.37 156.72 5.02 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.188 0 CA-C-O 120.6 0.238 . . . . 0.0 111.095 179.957 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 34.5 t60 -101.66 93.72 3.72 Favored Pre-proline 0 C--O 1.234 0.268 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.81 179.868 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_endo -68.34 160.15 50.26 Favored 'Trans proline' 0 C--N 1.347 0.498 0 C-N-CA 122.707 2.271 . . . . 0.0 112.483 -179.918 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . 0.44 ' O ' ' HB2' ' A' ' 77' ' ' GLU . 56.8 Cg_endo -70.26 168.52 21.97 Favored 'Trans proline' 0 C--N 1.348 0.508 0 C-N-CA 122.715 2.277 . . . . 0.0 112.239 179.869 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . 0.44 ' HB2' ' O ' ' A' ' 76' ' ' PRO . 5.0 mt-10 68.62 149.7 0.12 Allowed Pre-proline 0 N--CA 1.466 0.341 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.258 -179.895 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -71.78 157.63 54.87 Favored 'Trans proline' 0 C--N 1.346 0.432 0 C-N-CA 122.691 2.26 . . . . 0.0 112.523 179.897 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 4.0 mt -113.59 109.67 29.37 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.021 -179.908 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -97.2 126.88 42.69 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.086 179.962 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -104.58 109.25 21.09 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.054 179.9 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -142.93 132.77 24.04 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.078 -179.966 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.332 -0.179 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.125 179.832 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 75.1 mtp . . . . . 0 N--CA 1.489 1.491 0 CA-C-O 120.655 0.264 . . . . 0.0 111.203 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 6.6 m -108.35 133.96 51.7 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.197 0 CA-C-N 116.418 -0.355 . . . . 0.0 110.932 179.83 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 54.7 p -95.46 113.98 25.7 Favored 'General case' 0 CA--C 1.53 0.204 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.811 179.904 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 2.8 p 60.4 172.67 0.09 Allowed 'General case' 0 N--CA 1.47 0.561 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.487 -179.431 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . 0.577 ' CG ' HD11 ' A' ' 53' ' ' LEU . 17.1 m-85 -116.08 -38.11 3.69 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.707 -179.624 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 1.4 p30 -159.61 174.85 13.96 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-O 120.671 0.272 . . . . 0.0 111.015 -179.697 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -143.67 121.36 11.86 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.072 179.761 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 3.6 mp -115.36 151.99 17.05 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.178 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.271 -179.8 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 1.4 pm0 -91.12 156.14 18.11 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.359 -179.947 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 11.6 tt -63.78 -31.2 52.18 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.251 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.406 179.707 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 12.9 mt-10 -59.78 -33.58 71.88 Favored 'General case' 0 CA--C 1.531 0.249 0 CA-C-N 116.552 -0.295 . . . . 0.0 111.095 179.69 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -96.46 37.29 1.28 Allowed 'General case' 0 CA--C 1.534 0.335 0 CA-C-O 120.798 0.332 . . . . 0.0 111.211 179.815 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -131.65 134.19 45.7 Favored 'General case' 0 C--O 1.232 0.161 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.581 179.889 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 3.6 m -72.16 144.1 48.69 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-O 120.674 0.273 . . . . 0.0 110.782 179.977 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 13.5 p90 -111.84 141.92 44.87 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.001 179.923 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 29.3 mt-10 -117.75 82.9 17.1 Favored Pre-proline 0 C--O 1.233 0.224 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.741 179.916 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -54.76 -24.79 39.51 Favored 'Trans proline' 0 C--N 1.348 0.509 0 C-N-CA 122.814 2.342 . . . . 0.0 112.701 179.692 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -51.37 -38.09 51.51 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-N 116.55 -0.295 . . . . 0.0 111.32 179.729 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 46.3 m-20 -136.3 18.6 3.16 Favored 'General case' 0 CA--C 1.537 0.455 0 N-CA-C 111.927 0.343 . . . . 0.0 111.927 179.881 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . 0.463 HE21 ' HB3' ' A' ' 71' ' ' ALA . 39.7 mt-30 52.27 73.75 0.31 Allowed 'General case' 0 N--CA 1.467 0.392 0 N-CA-C 112.043 0.386 . . . . 0.0 112.043 179.399 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . 0.416 ' HB3' ' CD2' ' A' ' 35' ' ' TYR . 3.7 ptt? -166.54 146.15 5.78 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.52 179.583 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 27.4 m-85 -90.16 157.05 17.92 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.808 179.548 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 19.1 p -147.46 136.52 22.27 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.19 179.762 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 58.3 t80 -139.82 136.02 17.07 Favored Pre-proline 0 C--N 1.332 -0.161 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.802 179.626 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo -67.48 101.7 0.66 Allowed 'Trans proline' 0 C--N 1.348 0.544 0 C-N-CA 122.528 2.152 . . . . 0.0 112.231 179.907 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . 0.412 ' SG ' ' HD2' ' A' ' 27' ' ' PRO . 37.2 t -61.95 137.6 95.48 Favored Pre-proline 0 C--O 1.233 0.197 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.696 179.868 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . 0.412 ' HD2' ' SG ' ' A' ' 26' ' ' CYS . 12.0 Cg_endo -56.46 -21.65 38.63 Favored 'Trans proline' 0 C--N 1.348 0.523 0 C-N-CA 122.611 2.207 . . . . 0.0 112.686 179.739 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -65.51 -37.88 88.07 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-O 120.507 0.194 . . . . 0.0 111.191 179.932 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 153.05 -44.13 0.62 Allowed Glycine 0 C--N 1.335 0.474 0 C-N-CA 120.692 -0.766 . . . . 0.0 113.13 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -84.36 179.43 7.44 Favored 'General case' 0 CA--C 1.532 0.256 0 CA-C-O 120.785 0.326 . . . . 0.0 111.253 -179.727 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 27.8 ttm180 -113.06 117.69 32.7 Favored 'General case' 0 C--O 1.232 0.159 0 CA-C-N 116.387 -0.369 . . . . 0.0 110.844 179.873 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . 0.548 ' HZ ' ' HB1' ' A' ' 46' ' ' ALA . 30.6 t80 -65.52 156.39 32.7 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.423 -179.838 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 15.8 pt20 -143.57 131.78 21.94 Favored 'General case' 0 CA--C 1.53 0.205 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.16 -179.971 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 7.0 tt -139.09 125.76 24.39 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.185 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.927 179.53 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . 0.416 ' CD2' ' HB3' ' A' ' 21' ' ' MET . 55.4 m-85 -80.24 151.2 29.76 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.345 -179.83 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 45.2 mt -61.34 -40.08 92.91 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.815 179.694 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 2.5 p-10 -63.02 -34.06 76.76 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.199 179.605 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -65.65 -58.94 4.52 Favored 'General case' 0 C--O 1.231 0.083 0 CA-C-O 120.799 0.333 . . . . 0.0 110.728 179.997 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' MET . . . . . 0.654 ' HG3' HD11 ' A' ' 64' ' ' LEU . 5.9 ptm -63.69 -34.38 77.73 Favored 'General case' 0 CA--C 1.53 0.202 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.277 179.991 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 46.4 t80 -57.44 -40.68 78.96 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 116.506 -0.316 . . . . 0.0 110.911 179.542 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 4.0 mt-10 -61.71 -35.4 77.94 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 116.538 -0.301 . . . . 0.0 110.982 179.541 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 137.45 46.6 0.08 OUTLIER Glycine 0 C--N 1.332 0.348 0 C-N-CA 120.95 -0.643 . . . . 0.0 112.625 179.86 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -104.07 115.96 31.36 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-O 120.669 0.271 . . . . 0.0 111.042 -179.954 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 2.4 ptpt -117.26 -40.37 3.09 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.216 179.943 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 5.0 m -101.71 101.13 11.68 Favored 'Isoleucine or valine' 0 C--O 1.232 0.172 0 CA-C-O 120.922 0.391 . . . . 0.0 111.249 -179.953 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.548 ' HB1' ' HZ ' ' A' ' 32' ' ' PHE . . . -99.5 167.77 10.4 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-N 115.987 -0.551 . . . . 0.0 111.404 -179.716 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 5.6 m -136.51 128.33 43.86 Favored 'Isoleucine or valine' 0 C--O 1.232 0.182 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.354 -179.83 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 46.1 t -66.22 136.1 95.17 Favored Pre-proline 0 N--CA 1.463 0.214 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.903 179.865 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_endo -83.57 20.11 1.24 Allowed 'Trans proline' 0 C--N 1.348 0.548 0 C-N-CA 122.692 2.262 . . . . 0.0 113.262 179.859 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -128.45 -56.25 1.23 Allowed 'General case' 0 C--O 1.232 0.156 0 CA-C-O 120.574 0.226 . . . . 0.0 110.502 179.658 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 20.1 p -100.83 -20.08 15.67 Favored 'General case' 0 CA--C 1.534 0.356 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.729 179.846 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 68.24 39.58 2.3 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-O 120.989 0.423 . . . . 0.0 110.896 -179.751 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.577 HD11 ' CG ' ' A' ' 5' ' ' TYR . 6.6 tp -86.44 129.77 34.74 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.816 179.948 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' MET . . . . . . . . . . . . . 28.0 mtm -83.02 131.08 35.19 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.845 -179.934 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 2.6 pp -142.27 145.88 23.16 Favored 'Isoleucine or valine' 0 C--O 1.233 0.204 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.62 -179.731 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -104.6 105.15 15.13 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.757 179.572 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.436 HG13 ' O ' ' A' ' 57' ' ' VAL . 12.9 p -105.51 118.23 52.62 Favored 'Isoleucine or valine' 0 C--O 1.233 0.213 0 CA-C-O 120.952 0.406 . . . . 0.0 111.101 179.793 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 14.6 p -86.22 139.32 17.55 Favored 'Isoleucine or valine' 0 C--O 1.233 0.232 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.045 -179.839 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 30.5 p90 -129.82 165.75 21.33 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.16 -179.649 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -128.43 178.83 6.01 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-N 116.024 -0.535 . . . . 0.0 111.039 -179.752 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 26.4 mttp -111.1 29.5 7.73 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.206 179.671 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 5.6 mt-10 -99.15 -70.27 0.73 Allowed 'General case' 0 C--O 1.232 0.147 0 CA-C-N 116.492 -0.322 . . . . 0.0 110.604 179.504 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 3.0 p30 -68.3 -37.7 80.88 Favored 'General case' 0 N--CA 1.463 0.175 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.6 179.432 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.654 HD11 ' HG3' ' A' ' 39' ' ' MET . 0.2 OUTLIER -56.11 -41.33 75.11 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-N 116.456 -0.338 . . . . 0.0 110.877 179.872 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -73.76 -38.64 64.65 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.35 179.654 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 10.3 mt-10 -71.94 -35.33 69.58 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 116.416 -0.356 . . . . 0.0 111.765 -179.678 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 7.4 m-85 -55.59 -28.32 54.38 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 116.623 -0.262 . . . . 0.0 111.345 -179.794 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 23.4 m-85 -60.66 -34.27 74.05 Favored 'General case' 0 CA--C 1.528 0.117 0 CA-C-N 116.651 -0.25 . . . . 0.0 110.562 179.707 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -90.55 -36.51 14.43 Favored 'General case' 0 CA--C 1.531 0.213 0 CA-C-N 116.284 -0.417 . . . . 0.0 110.993 179.445 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -71.12 -34.71 71.32 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 116.464 -0.335 . . . . 0.0 111.785 -179.648 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . 0.463 ' HB3' HE21 ' A' ' 20' ' ' GLN . . . -92.6 149.03 21.6 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-O 120.895 0.379 . . . . 0.0 111.295 -179.85 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -101.95 55.47 0.72 Allowed Glycine 0 C--N 1.333 0.387 0 C-N-CA 121.002 -0.618 . . . . 0.0 112.856 -179.821 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 1.1 tp -61.65 -32.87 54.99 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.26 0 CA-C-O 120.55 0.214 . . . . 0.0 111.452 179.799 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 4.3 m170 -106.68 87.89 3.1 Favored Pre-proline 0 C--O 1.232 0.172 0 CA-C-N 116.521 -0.308 . . . . 0.0 110.552 179.695 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_endo -69.63 111.32 2.75 Favored 'Trans proline' 0 C--N 1.348 0.54 0 C-N-CA 122.696 2.264 . . . . 0.0 112.576 -179.686 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -71.51 -178.55 3.06 Favored 'Trans proline' 0 C--N 1.348 0.533 0 C-N-CA 122.517 2.145 . . . . 0.0 112.407 179.819 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . 0.401 ' H ' ' HD2' ' A' ' 78' ' ' PRO . 0.9 OUTLIER -167.11 -60.12 0.01 OUTLIER Pre-proline 0 C--N 1.329 -0.287 0 CA-C-N 116.004 -0.543 . . . . 0.0 111.142 179.788 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . 0.401 ' HD2' ' H ' ' A' ' 77' ' ' GLU . 68.4 Cg_endo -73.07 65.26 4.21 Favored 'Trans proline' 0 C--N 1.35 0.62 0 C-N-CA 122.562 2.175 . . . . 0.0 112.352 179.885 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 2.0 pt -138.18 86.66 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.922 179.906 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . 57.76 75.27 0.38 Allowed 'General case' 0 C--O 1.234 0.243 0 CA-C-N 115.862 -0.608 . . . . 0.0 111.333 -179.709 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . 62.95 -174.37 0.15 Allowed 'General case' 0 C--O 1.234 0.246 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.454 179.99 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -170.26 136.13 1.36 Allowed 'General case' 0 C--O 1.233 0.211 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.279 -179.785 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.463 0.21 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.563 179.856 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.488 1.449 0 CA-C-O 120.676 0.274 . . . . 0.0 110.977 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 20.7 t -97.38 142.73 13.76 Favored 'Isoleucine or valine' 0 C--O 1.232 0.183 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.442 -179.507 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 49.1 m -151.96 111.14 3.89 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.307 -179.927 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.64 HG21 ' CG ' ' A' ' 56' ' ' ASP . 0.9 OUTLIER -152.67 160.37 43.17 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-O 120.985 0.421 . . . . 0.0 111.511 -179.905 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 85.0 m-85 -105.04 -37.3 6.99 Favored 'General case' 0 CA--C 1.531 0.232 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.409 -179.945 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -157.14 175.67 13.75 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-N 116.534 -0.303 . . . . 0.0 111.247 -179.792 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 21.5 mt-10 -126.2 143.26 51.2 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 116.108 -0.497 . . . . 0.0 111.033 -179.921 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 22.8 mt -127.19 151.82 34.49 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.29 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.173 -179.886 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . 0.441 ' HG3' HG13 ' A' ' 58' ' ' VAL . 8.5 tt0 -104.97 142.89 33.98 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-N 116.515 -0.311 . . . . 0.0 110.953 179.756 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 41.2 pt -61.15 -32.81 53.82 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.305 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.34 179.82 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 16.8 tt0 -59.44 -33.19 70.97 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.841 179.613 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -97.01 36.89 1.36 Allowed 'General case' 0 CA--C 1.533 0.307 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.191 179.855 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 13.0 mtp -131.32 148.29 52.66 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.639 179.678 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 20.0 m -61.96 129.79 42.55 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.14 -179.816 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 21.1 p90 -93.53 124.39 37.49 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.716 179.593 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 -112.07 86.02 7.25 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.793 -179.881 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo -69.23 -16.99 40.18 Favored 'Trans proline' 0 C--N 1.347 0.499 0 C-N-CA 122.743 2.295 . . . . 0.0 112.942 -179.865 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -53.24 -37.49 62.12 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-N 116.712 -0.222 . . . . 0.0 111.15 179.739 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 25.8 m-20 -143.17 25.32 1.74 Allowed 'General case' 0 CA--C 1.533 0.303 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.718 179.902 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . 0.507 ' NE2' HG21 ' A' ' 73' ' ' ILE . 6.2 tt0 53.35 72.25 0.44 Allowed 'General case' 0 CA--C 1.534 0.329 0 CA-C-O 120.992 0.425 . . . . 0.0 111.648 179.513 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . 0.434 ' HB3' ' CD2' ' A' ' 35' ' ' TYR . 5.7 ptt? -154.08 175.11 13.82 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.046 179.928 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 27.2 m-85 -137.4 138.65 40.08 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.131 179.879 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 79.6 p -130.82 156.64 44.66 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.273 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 45.7 t80 -156.53 136.01 8.22 Favored Pre-proline 0 N--CA 1.463 0.176 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.863 179.781 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -64.71 100.29 0.34 Allowed 'Trans proline' 0 C--N 1.35 0.616 0 C-N-CA 122.678 2.252 . . . . 0.0 112.37 179.839 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . 0.419 ' SG ' ' HD2' ' A' ' 27' ' ' PRO . 42.0 t -59.68 139.26 89.76 Favored Pre-proline 0 C--O 1.233 0.19 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.69 179.817 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . 0.419 ' HD2' ' SG ' ' A' ' 26' ' ' CYS . 75.2 Cg_exo -51.17 -26.09 18.87 Favored 'Trans proline' 0 C--N 1.348 0.548 0 C-N-CA 122.739 2.293 . . . . 0.0 112.951 179.887 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -68.53 -38.88 81.23 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-O 120.553 0.216 . . . . 0.0 111.279 -179.858 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 152.43 -45.95 0.59 Allowed Glycine 0 C--N 1.334 0.459 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.959 -179.904 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.3 t0 -73.17 -173.81 1.41 Allowed 'General case' 0 CA--C 1.533 0.303 0 CA-C-O 120.748 0.309 . . . . 0.0 111.156 -179.807 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 27.4 ttt180 -123.3 129.67 51.66 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-N 116.444 -0.343 . . . . 0.0 110.886 179.855 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 7.4 m-85 -65.09 161.98 17.8 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.987 179.822 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -151.76 127.92 10.49 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.221 179.8 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 3.6 tt -150.87 144.38 16.87 Favored 'Isoleucine or valine' 0 C--O 1.233 0.219 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.175 179.785 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . 0.434 ' CD2' ' HB3' ' A' ' 21' ' ' MET . 86.0 m-85 -105.29 157.47 17.28 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.869 -179.913 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.573 HD12 ' HG ' ' A' ' 64' ' ' LEU . 4.0 mm? -61.3 -33.85 74.25 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.936 179.768 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 8.2 t70 -68.13 -39.4 82.74 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.991 179.598 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -59.63 -56.43 22.04 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.1 -179.817 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 36.4 mtm -63.58 -31.27 72.39 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.947 179.618 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . 0.656 ' HB2' HD21 ' A' ' 64' ' ' LEU . 17.0 t80 -58.4 -46.32 86.64 Favored 'General case' 0 CA--C 1.529 0.148 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.912 179.604 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -58.18 -35.49 71.65 Favored 'General case' 0 N--CA 1.463 0.185 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.887 179.685 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 138.65 48.45 0.06 OUTLIER Glycine 0 C--N 1.333 0.386 0 C-N-CA 120.992 -0.623 . . . . 0.0 112.64 179.671 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -102.16 124.89 48.55 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-O 120.791 0.329 . . . . 0.0 110.946 -179.989 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 16.2 mttt -122.83 -43.91 2.23 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.968 179.897 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.486 ' O ' HG13 ' A' ' 45' ' ' VAL . 11.1 p -112.58 113.58 44.54 Favored 'Isoleucine or valine' 0 C--O 1.233 0.236 0 CA-C-O 121.001 0.429 . . . . 0.0 110.967 179.811 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -99.0 160.28 14.37 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.2 -179.648 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 7.5 m -116.81 124.42 72.86 Favored 'Isoleucine or valine' 0 C--O 1.233 0.2 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.367 -179.894 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 51.3 t -69.99 135.66 87.39 Favored Pre-proline 0 C--N 1.33 -0.252 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.868 179.875 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_endo -84.6 20.78 1.17 Allowed 'Trans proline' 0 CA--C 1.535 0.527 0 C-N-CA 122.714 2.276 . . . . 0.0 112.967 179.747 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -128.01 -57.67 1.24 Allowed 'General case' 0 CA--C 1.529 0.147 0 CA-C-O 120.587 0.232 . . . . 0.0 110.578 179.788 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 20.2 p -99.69 -20.45 16.28 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.817 179.946 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 2.1 t 67.29 40.02 2.86 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-O 120.921 0.391 . . . . 0.0 111.022 -179.857 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.52 ' CD2' HG23 ' A' ' 55' ' ' ILE . 8.5 tt -95.94 135.93 37.05 Favored 'General case' 0 C--O 1.232 0.178 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.625 179.805 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' MET . . . . . . . . . . . . . 12.3 mtt -89.39 128.45 35.92 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.128 -179.578 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.52 HG23 ' CD2' ' A' ' 53' ' ' LEU . 2.1 pp -135.14 132.09 52.72 Favored 'Isoleucine or valine' 0 C--O 1.233 0.221 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.474 179.922 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . 0.64 ' CG ' HG21 ' A' ' 4' ' ' THR . 74.1 m-20 -87.21 99.46 11.97 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.769 179.61 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.505 HG13 ' O ' ' A' ' 57' ' ' VAL . 13.3 p -93.18 113.38 27.97 Favored 'Isoleucine or valine' 0 C--O 1.233 0.228 0 CA-C-O 121.114 0.483 . . . . 0.0 111.126 179.943 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.441 HG13 ' HG3' ' A' ' 9' ' ' GLU . 11.7 p -81.64 135.5 24.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.867 -179.955 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 53.5 p90 -131.47 178.57 6.63 Favored 'General case' 0 CA--C 1.532 0.252 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.174 -179.722 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 1.6 t0 -126.29 159.91 31.8 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.893 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -79.99 -36.21 36.31 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.612 179.464 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -60.83 -36.73 79.83 Favored 'General case' 0 CA--C 1.528 0.114 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.088 179.967 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -55.16 -45.76 75.73 Favored 'General case' 0 N--CA 1.462 0.137 0 CA-C-N 116.474 -0.33 . . . . 0.0 111.145 179.747 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.656 HD21 ' HB2' ' A' ' 40' ' ' PHE . 3.7 mp -61.54 -55.89 26.03 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.626 -0.261 . . . . 0.0 110.915 179.812 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -56.73 -40.75 76.27 Favored 'General case' 0 N--CA 1.462 0.156 0 CA-C-N 116.484 -0.326 . . . . 0.0 111.083 179.736 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 30.0 mt-10 -67.43 -43.45 81.13 Favored 'General case' 0 CA--C 1.528 0.115 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.93 179.542 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . 0.405 ' CD1' ' HG3' ' A' ' 20' ' ' GLN . 0.3 OUTLIER -70.67 -40.15 73.13 Favored 'General case' 0 N--CA 1.463 0.183 0 CA-C-N 116.531 -0.304 . . . . 0.0 111.438 179.939 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 9.7 m-85 -59.21 -40.17 84.96 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 116.659 -0.246 . . . . 0.0 111.075 -179.744 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 16.8 mt-10 -81.24 -33.75 32.59 Favored 'General case' 0 CA--C 1.529 0.158 0 CA-C-N 116.577 -0.283 . . . . 0.0 111.101 179.886 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 29.1 mt-10 -73.44 -50.19 22.97 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-N 116.587 -0.279 . . . . 0.0 111.192 179.945 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -83.32 146.51 28.47 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-N 116.323 -0.398 . . . . 0.0 111.519 -179.572 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -101.27 46.5 1.29 Allowed Glycine 0 C--N 1.333 0.379 0 C-N-CA 120.993 -0.622 . . . . 0.0 112.571 179.825 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.507 HG21 ' NE2' ' A' ' 20' ' ' GLN . 8.5 tp -66.65 143.52 15.51 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.173 0 CA-C-O 120.8 0.333 . . . . 0.0 111.095 179.976 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 23.7 m80 -123.0 151.09 60.78 Favored Pre-proline 0 C--O 1.234 0.261 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.037 -179.857 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -54.18 161.3 5.33 Favored 'Trans proline' 0 C--N 1.351 0.69 0 C-N-CA 122.951 2.434 . . . . 0.0 112.698 179.779 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 42.0 Cg_endo -67.51 -38.36 14.77 Favored 'Trans proline' 0 C--N 1.35 0.62 0 C-N-CA 122.821 2.347 . . . . 0.0 112.836 -179.848 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 57.64 82.54 0.23 Allowed Pre-proline 0 N--CA 1.464 0.272 0 CA-C-O 120.952 0.406 . . . . 0.0 111.439 179.968 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.68 178.89 4.07 Favored 'Trans proline' 0 C--N 1.348 0.528 0 C-N-CA 123.013 2.475 . . . . 0.0 112.889 -179.834 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 2.0 pt -102.35 85.9 1.03 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.256 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.512 -179.861 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . 60.32 90.79 0.06 Allowed 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 115.776 -0.647 . . . . 0.0 111.586 179.815 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -103.46 35.25 2.65 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.6 179.832 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . 56.89 80.86 0.15 Allowed 'General case' 0 CA--C 1.533 0.303 0 CA-C-N 116.491 -0.322 . . . . 0.0 111.641 179.633 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.233 0.204 0 CA-C-O 120.985 0.421 . . . . 0.0 111.29 179.985 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 98.2 mtp . . . . . 0 N--CA 1.489 1.511 0 CA-C-O 120.797 0.332 . . . . 0.0 111.266 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 17.9 t -102.31 -41.29 7.81 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.301 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.139 179.984 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 9.0 p -79.22 133.52 36.68 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 116.475 -0.33 . . . . 0.0 111.254 -179.96 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 1.8 t -164.5 159.77 19.7 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.229 179.857 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 27.1 m-85 -103.88 -31.21 9.88 Favored 'General case' 0 CA--C 1.532 0.252 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.275 179.732 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 5.7 t70 -158.73 165.63 33.88 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-O 120.769 0.319 . . . . 0.0 111.566 -179.855 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 11.2 tt0 -136.41 115.05 11.98 Favored 'General case' 0 CA--C 1.53 0.195 0 CA-C-N 116.035 -0.529 . . . . 0.0 111.177 -179.774 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 3.9 mp -113.56 151.29 15.43 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.277 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.199 179.917 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 4.7 mt-10 -97.92 148.45 23.44 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.273 -179.927 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 14.3 tt -58.55 -31.43 43.63 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.305 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.36 179.668 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 26.4 mt-10 -63.13 -27.56 69.47 Favored 'General case' 0 CA--C 1.532 0.274 0 CA-C-N 116.597 -0.274 . . . . 0.0 111.302 179.634 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -95.09 36.14 1.23 Allowed 'General case' 0 CA--C 1.533 0.325 0 CA-C-O 120.696 0.284 . . . . 0.0 111.313 179.95 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -119.0 177.31 4.91 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-O 120.843 0.354 . . . . 0.0 110.959 179.715 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 1.6 m -108.49 85.69 2.15 Favored 'General case' 0 C--O 1.232 0.15 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.575 179.911 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 30.3 p90 -86.28 139.51 30.95 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.891 179.958 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 25.3 mt-10 -138.69 157.91 71.11 Favored Pre-proline 0 C--O 1.234 0.246 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.633 -179.606 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . 0.433 ' O ' HG22 ' A' ' 73' ' ' ILE . 25.8 Cg_exo -63.36 -11.95 28.16 Favored 'Trans proline' 0 C--N 1.351 0.686 0 C-N-CA 123.257 2.638 . . . . 0.0 112.914 179.391 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 3.1 pt-20 -66.17 82.99 0.08 Allowed 'General case' 0 C--O 1.233 0.197 0 CA-C-O 121.076 0.465 . . . . 0.0 110.843 -179.731 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 6.0 m-80 62.12 22.9 13.45 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-N 115.799 -0.637 . . . . 0.0 111.668 -179.503 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . 0.493 ' O ' HD23 ' A' ' 36' ' ' LEU . 0.8 OUTLIER 53.49 78.07 0.16 Allowed 'General case' 0 C--O 1.234 0.281 0 CA-C-O 121.067 0.461 . . . . 0.0 111.286 179.921 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 1.9 ppp? -133.71 143.5 48.54 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.674 179.842 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.546 ' CE1' HD22 ' A' ' 36' ' ' LEU . 0.9 OUTLIER -127.7 132.32 49.65 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.656 179.618 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . 0.616 HG22 ' HA ' ' A' ' 33' ' ' GLN . 40.6 p -122.14 158.74 28.66 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.815 -178.929 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 61.1 t80 -139.9 137.22 18.05 Favored Pre-proline 0 CA--C 1.53 0.186 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.225 179.878 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 65.5 Cg_endo -73.44 100.94 1.3 Allowed 'Trans proline' 0 C--N 1.35 0.627 0 C-N-CA 122.768 2.312 . . . . 0.0 112.442 179.587 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . 0.44 ' SG ' ' HD2' ' A' ' 27' ' ' PRO . 53.1 t -68.69 140.21 91.76 Favored Pre-proline 0 C--O 1.233 0.229 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.705 179.786 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . 0.44 ' HD2' ' SG ' ' A' ' 26' ' ' CYS . 86.7 Cg_exo -48.89 -26.98 10.73 Favored 'Trans proline' 0 C--N 1.351 0.666 0 C-N-CA 122.916 2.411 . . . . 0.0 113.175 179.962 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 9.0 p -58.49 -28.92 65.83 Favored 'General case' 0 CA--C 1.533 0.321 0 CA-C-O 120.642 0.258 . . . . 0.0 111.433 -179.949 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 120.93 9.87 7.22 Favored Glycine 0 CA--C 1.523 0.57 0 C-N-CA 121.134 -0.555 . . . . 0.0 113.337 -179.823 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -122.42 -165.2 1.25 Allowed 'General case' 0 CA--C 1.535 0.375 0 CA-C-N 117.145 0.472 . . . . 0.0 110.935 179.972 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 3.8 ttt85 -137.85 117.16 12.73 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-O 120.515 0.198 . . . . 0.0 111.186 -179.73 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . 0.542 ' CZ ' ' HB1' ' A' ' 46' ' ' ALA . 76.4 t80 -70.63 151.96 44.4 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.225 179.896 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . 0.616 ' HA ' HG22 ' A' ' 23' ' ' THR . 3.6 pt20 -126.28 139.66 53.14 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.449 -179.939 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 12.0 tt -155.0 148.89 12.61 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.346 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.21 179.69 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 60.3 m-85 -100.67 155.77 17.7 Favored 'General case' 0 C--O 1.236 0.357 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.516 -179.695 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.82 HD12 ' HG ' ' A' ' 64' ' ' LEU . 3.2 mm? -61.67 -46.88 87.85 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.775 179.734 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -60.27 -36.55 78.08 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 116.495 -0.321 . . . . 0.0 110.995 179.647 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -57.19 -46.12 83.14 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.41 179.709 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 2.6 mtt -66.23 -28.81 69.02 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.321 179.582 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . 0.671 ' CE1' HD22 ' A' ' 64' ' ' LEU . 0.0 OUTLIER -56.53 -45.77 80.98 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-O 120.573 0.225 . . . . 0.0 111.046 179.906 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 10.6 mt-10 -59.91 -32.51 70.83 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 116.461 -0.336 . . . . 0.0 110.975 179.586 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 131.74 46.61 0.13 Allowed Glycine 0 C--N 1.333 0.394 0 C-N-CA 121.145 -0.55 . . . . 0.0 112.498 179.981 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -83.35 92.89 7.63 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-O 120.993 0.425 . . . . 0.0 110.888 -179.948 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 10.8 ptpt -107.33 -32.43 7.76 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.831 -0.622 . . . . 0.0 111.218 179.881 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.49 ' O ' HG13 ' A' ' 45' ' ' VAL . 7.6 p -121.58 108.98 23.47 Favored 'Isoleucine or valine' 0 C--O 1.233 0.214 0 CA-C-O 121.109 0.48 . . . . 0.0 110.874 179.796 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.542 ' HB1' ' CZ ' ' A' ' 32' ' ' PHE . . . -109.63 171.81 7.22 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.589 -179.361 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 19.1 t -128.91 119.43 49.48 Favored 'Isoleucine or valine' 0 C--O 1.232 0.145 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.036 -179.935 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 41.7 t -62.33 112.19 5.99 Favored Pre-proline 0 N--CA 1.463 0.199 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.452 179.683 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 31.1 Cg_exo -60.33 -17.82 49.2 Favored 'Trans proline' 0 C--N 1.347 0.484 0 C-N-CA 122.645 2.23 . . . . 0.0 113.346 -179.569 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 4.6 t -77.05 -65.17 0.98 Allowed 'General case' 0 CA--C 1.53 0.206 0 CA-C-O 120.416 0.15 . . . . 0.0 111.397 -179.738 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 22.6 p -92.18 -19.55 22.13 Favored 'General case' 0 N--CA 1.465 0.324 0 N-CA-C 112.195 0.442 . . . . 0.0 112.195 -179.426 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 72.96 36.4 0.88 Allowed 'General case' 0 CA--C 1.533 0.302 0 CA-C-O 120.886 0.374 . . . . 0.0 110.905 -179.609 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.604 HD23 HG23 ' A' ' 55' ' ' ILE . 6.4 tt -94.94 149.51 21.17 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.736 179.792 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' MET . . . . . . . . . . . . . 38.7 mtt -93.14 129.75 39.03 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-N 116.462 -0.335 . . . . 0.0 111.357 -179.487 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.604 HG23 HD23 ' A' ' 53' ' ' LEU . 2.5 pp -137.99 152.47 26.27 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.343 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.47 179.783 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 42.5 m-20 -108.7 107.63 18.16 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.64 179.067 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 14.5 p -99.43 125.63 52.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-O 120.967 0.413 . . . . 0.0 111.026 179.835 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 13.3 p -93.74 142.66 12.98 Favored 'Isoleucine or valine' 0 C--O 1.234 0.258 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.194 -179.88 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 3.0 p90 -131.03 144.39 51.42 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.623 -179.386 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -95.13 -22.67 17.72 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-N 115.997 -0.547 . . . . 0.0 112.028 -179.93 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 3.3 mttt 65.82 27.49 11.05 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-O 120.603 0.24 . . . . 0.0 111.412 -179.575 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 12.5 tt0 -95.47 -49.64 5.33 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-O 120.919 0.39 . . . . 0.0 110.104 179.474 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -66.51 -33.78 76.45 Favored 'General case' 0 N--CA 1.462 0.169 0 CA-C-N 115.746 -0.661 . . . . 0.0 111.129 179.577 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.82 ' HG ' HD12 ' A' ' 36' ' ' LEU . 0.2 OUTLIER -52.86 -34.62 55.17 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 116.679 -0.237 . . . . 0.0 111.495 -179.711 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -86.44 -48.73 8.17 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-N 116.663 -0.244 . . . . 0.0 111.56 -179.981 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 23.5 mt-10 -65.8 -54.17 30.54 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-O 120.664 0.268 . . . . 0.0 111.256 -179.674 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . 0.411 ' HA ' ' HB2' ' A' ' 70' ' ' GLU . 2.6 t80 -59.64 -23.69 63.25 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.3 179.412 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -57.27 -54.88 41.76 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-O 120.665 0.269 . . . . 0.0 110.962 179.834 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 37.1 mt-10 -79.97 -35.57 37.35 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.763 179.771 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . 0.411 ' HB2' ' HA ' ' A' ' 67' ' ' TYR . 25.0 mt-10 -62.84 -37.27 86.14 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.188 179.868 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -91.82 156.66 17.36 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-O 120.893 0.378 . . . . 0.0 111.353 -179.935 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -110.77 47.31 1.06 Allowed Glycine 0 C--N 1.332 0.345 0 CA-C-N 115.868 -0.605 . . . . 0.0 112.242 179.785 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.568 HD12 ' N ' ' A' ' 74' ' ' HIS . 2.7 pp -72.68 -28.51 27.8 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.214 0 N-CA-C 111.5 0.185 . . . . 0.0 111.5 -179.897 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' HIS . . . . . 0.568 ' N ' HD12 ' A' ' 73' ' ' ILE . 4.5 m170 -56.86 -60.32 9.83 Favored Pre-proline 0 CA--C 1.531 0.239 0 CA-C-N 116.769 -0.196 . . . . 0.0 111.045 179.896 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . 0.465 ' HA ' ' HD2' ' A' ' 76' ' ' PRO . 60.6 Cg_endo -72.1 109.27 2.66 Favored 'Trans proline' 0 C--N 1.351 0.676 0 C-N-CA 122.442 2.094 . . . . 0.0 112.263 179.662 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . 0.465 ' HD2' ' HA ' ' A' ' 75' ' ' PRO . 18.3 Cg_endo -61.48 -68.3 0.04 OUTLIER 'Trans proline' 0 C--N 1.35 0.645 0 C-N-CA 122.645 2.23 . . . . 0.0 112.633 -179.592 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 3.4 pt-20 -179.26 156.02 0.82 Allowed Pre-proline 0 N--CA 1.465 0.28 0 CA-C-N 116.628 -0.26 . . . . 0.0 110.476 179.759 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . 0.47 ' O ' HD13 ' A' ' 79' ' ' ILE . 39.6 Cg_exo -57.62 85.37 0.05 OUTLIER 'Trans proline' 0 C--N 1.351 0.662 0 C-N-CA 122.935 2.424 . . . . 0.0 112.566 -179.715 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.47 HD13 ' O ' ' A' ' 78' ' ' PRO . 24.2 mm -134.97 123.64 41.14 Favored 'Isoleucine or valine' 0 C--O 1.233 0.197 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.147 -179.705 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -119.75 -42.6 2.61 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.419 179.512 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -60.8 -53.43 57.48 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.727 -179.454 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . 0.402 ' HB3' HG21 ' A' ' 79' ' ' ILE . . . -68.57 101.34 1.26 Allowed 'General case' 0 C--O 1.232 0.176 0 CA-C-O 120.822 0.344 . . . . 0.0 111.05 -179.841 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.33 -0.254 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.084 -179.889 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.595 ' HG2' HG23 ' A' ' 2' ' ' VAL . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.646 0 N-CA-C 112.183 0.438 . . . . 0.0 112.183 . . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.595 HG23 ' HG2' ' A' ' 1' ' ' MET . 21.5 t -103.12 116.26 46.56 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.143 0 CA-C-O 120.59 0.233 . . . . 0.0 111.426 -179.694 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 1.2 m -167.79 80.25 0.18 Allowed 'General case' 0 CA--C 1.532 0.284 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.747 179.678 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.413 HG21 ' CG ' ' A' ' 56' ' ' ASP . 3.1 p 56.61 -171.51 0.08 Allowed 'General case' 0 N--CA 1.472 0.661 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.306 -179.353 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . 0.444 ' CG ' HD11 ' A' ' 53' ' ' LEU . 0.2 OUTLIER -111.64 -41.59 4.03 Favored 'General case' 0 CA--C 1.53 0.186 0 CA-C-N 116.517 -0.31 . . . . 0.0 111.311 -179.955 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -155.56 176.09 13.05 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-O 120.697 0.284 . . . . 0.0 111.207 -179.991 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . 0.562 ' O ' HD13 ' A' ' 8' ' ' ILE . 3.9 pt-20 -130.22 131.22 45.45 Favored 'General case' 0 CA--C 1.531 0.234 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.15 179.798 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.562 HD13 ' O ' ' A' ' 7' ' ' GLU . 26.5 mm -130.03 154.16 39.98 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.281 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.455 -179.812 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 9.7 mt-10 -103.78 148.22 26.36 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.062 179.843 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 33.8 pt -58.76 -32.43 46.72 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.325 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.347 179.537 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 4.4 mt-10 -60.45 -30.39 69.62 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.223 179.726 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 5.6 t0 -98.52 39.0 1.28 Allowed 'General case' 0 CA--C 1.532 0.278 0 CA-C-O 120.902 0.382 . . . . 0.0 111.038 179.727 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . 0.415 ' HG2' ' HB2' ' A' ' 24' ' ' TYR . 0.1 OUTLIER -132.98 143.39 49.41 Favored 'General case' 0 C--O 1.232 0.172 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.585 179.833 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 1.2 m -62.18 121.12 12.3 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-O 120.734 0.302 . . . . 0.0 111.172 -179.582 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 20.8 p90 -87.76 125.44 34.43 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.695 179.597 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 -112.22 86.38 7.84 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.405 179.852 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 40.0 Cg_endo -67.45 -20.09 48.41 Favored 'Trans proline' 0 C--N 1.347 0.487 0 C-N-CA 122.673 2.248 . . . . 0.0 112.786 -179.989 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -53.33 -36.15 60.96 Favored 'General case' 0 CA--C 1.53 0.2 0 CA-C-N 116.591 -0.277 . . . . 0.0 111.337 179.884 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 3.0 t-20 -138.54 22.73 2.71 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-N 116.534 -0.303 . . . . 0.0 111.652 179.867 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . 0.421 ' NE2' ' HA ' ' A' ' 68' ' ' TYR . 15.8 tt0 50.32 65.35 1.47 Allowed 'General case' 0 CA--C 1.534 0.347 0 CA-C-O 120.975 0.416 . . . . 0.0 111.454 179.916 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . 0.467 ' HB3' ' CD1' ' A' ' 35' ' ' TYR . 23.3 ptt? -149.62 172.65 14.7 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.137 179.86 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.415 ' CD1' HD21 ' A' ' 36' ' ' LEU . 16.1 m-85 -130.3 134.29 47.1 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.026 179.86 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 11.8 p -130.53 136.29 48.8 Favored 'General case' 0 N--CA 1.462 0.162 0 CA-C-N 116.389 -0.368 . . . . 0.0 111.269 -179.893 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . 0.415 ' HB2' ' HG2' ' A' ' 13' ' ' MET . 32.7 t80 -139.38 137.46 19.02 Favored Pre-proline 0 C--N 1.333 -0.137 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.982 179.895 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -72.06 103.68 1.53 Allowed 'Trans proline' 0 C--N 1.348 0.517 0 C-N-CA 122.685 2.256 . . . . 0.0 112.507 179.924 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . 0.415 ' SG ' ' HD2' ' A' ' 27' ' ' PRO . 48.7 t -64.31 139.29 97.67 Favored Pre-proline 0 C--O 1.233 0.23 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.696 179.75 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . 0.415 ' HD2' ' SG ' ' A' ' 26' ' ' CYS . 71.0 Cg_exo -50.06 -26.01 13.82 Favored 'Trans proline' 0 C--N 1.352 0.713 0 C-N-CA 122.932 2.422 . . . . 0.0 113.237 179.844 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 7.7 p -57.94 -28.65 64.5 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-O 120.578 0.228 . . . . 0.0 111.434 179.944 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 122.84 6.79 7.62 Favored Glycine 0 CA--C 1.524 0.629 0 C-N-CA 121.096 -0.573 . . . . 0.0 113.513 -179.995 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -122.37 -173.33 2.65 Favored 'General case' 0 CA--C 1.532 0.252 0 CA-C-N 117.237 0.519 . . . . 0.0 111.001 179.954 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 7.1 ttm-85 -118.94 130.11 55.53 Favored 'General case' 0 N--CA 1.463 0.183 0 CA-C-O 120.807 0.337 . . . . 0.0 111.378 -179.854 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . 0.424 ' CZ ' ' HB1' ' A' ' 46' ' ' ALA . 64.6 t80 -91.84 157.48 16.85 Favored 'General case' 0 CA--C 1.529 0.164 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.917 179.673 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -140.13 129.3 23.72 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.067 179.749 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.47 HG23 ' O ' ' A' ' 34' ' ' ILE . 3.1 tt -139.06 115.65 10.24 Favored 'Isoleucine or valine' 0 C--O 1.234 0.254 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.986 179.626 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . 0.467 ' CD1' ' HB3' ' A' ' 21' ' ' MET . 41.6 m-85 -74.5 141.63 44.88 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.996 -179.88 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.624 ' O ' HD11 ' A' ' 64' ' ' LEU . 3.9 mm? -59.54 -38.29 80.65 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.006 179.686 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 1.2 p30 -60.88 -40.22 92.19 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 116.477 -0.329 . . . . 0.0 110.849 179.524 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 2.5 t70 -63.17 -39.56 95.02 Favored 'General case' 0 N--CA 1.462 0.134 0 CA-C-N 116.493 -0.321 . . . . 0.0 110.895 179.73 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' MET . . . . . 0.47 ' SD ' HD13 ' A' ' 36' ' ' LEU . 5.0 mtt -61.99 -29.49 70.29 Favored 'General case' 0 N--CA 1.463 0.187 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.115 179.604 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -57.13 -35.99 70.14 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 116.536 -0.302 . . . . 0.0 111.035 179.662 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 8.3 mt-10 -66.99 -34.4 77.67 Favored 'General case' 0 CA--C 1.531 0.234 0 CA-C-N 116.511 -0.313 . . . . 0.0 110.835 179.628 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 124.56 64.02 0.19 Allowed Glycine 0 C--N 1.335 0.49 0 C-N-CA 120.982 -0.628 . . . . 0.0 112.557 179.631 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 2.1 tp10 -104.25 105.93 16.25 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-O 120.729 0.3 . . . . 0.0 111.084 179.955 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -111.44 -33.79 6.3 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.044 179.431 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.446 HG22 ' OD1' ' A' ' 56' ' ' ASP . 18.8 t -115.96 87.68 1.07 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.273 0 CA-C-O 120.905 0.383 . . . . 0.0 110.659 179.752 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.424 ' HB1' ' CZ ' ' A' ' 32' ' ' PHE . . . -82.94 162.65 21.44 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.21 -179.796 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 11.6 p -121.38 122.95 68.63 Favored 'Isoleucine or valine' 0 C--O 1.233 0.206 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.083 179.926 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 49.3 t -63.04 135.43 96.22 Favored Pre-proline 0 C--N 1.331 -0.217 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.724 179.96 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 93.6 Cg_endo -83.3 19.76 1.28 Allowed 'Trans proline' 0 CA--C 1.535 0.555 0 C-N-CA 122.623 2.215 . . . . 0.0 113.307 -179.855 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -129.15 -57.19 1.16 Allowed 'General case' 0 C--O 1.233 0.188 0 CA-C-O 120.459 0.171 . . . . 0.0 110.628 179.661 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 17.9 p -101.68 -10.92 19.57 Favored 'General case' 0 N--CA 1.465 0.319 0 N-CA-C 111.956 0.354 . . . . 0.0 111.956 179.881 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 5.8 p 61.0 35.64 18.88 Favored 'General case' 0 CA--C 1.535 0.403 0 CA-C-O 120.842 0.354 . . . . 0.0 111.502 179.842 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.618 HD23 HG23 ' A' ' 55' ' ' ILE . 7.7 tt -89.07 134.6 33.94 Favored 'General case' 0 CA--C 1.53 0.2 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.534 179.748 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' MET . . . . . . . . . . . . . 20.4 mtt -84.6 135.79 34.04 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.062 -179.773 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.618 HG23 HD23 ' A' ' 53' ' ' LEU . 2.7 pt -138.81 137.56 42.68 Favored 'Isoleucine or valine' 0 C--O 1.234 0.261 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.751 -179.778 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . 0.446 ' OD1' HG22 ' A' ' 45' ' ' VAL . 55.5 m-20 -87.13 88.67 7.76 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.675 179.305 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.517 HG13 ' O ' ' A' ' 57' ' ' VAL . 14.2 p -88.38 112.47 23.86 Favored 'Isoleucine or valine' 0 C--O 1.234 0.263 0 CA-C-O 121.003 0.43 . . . . 0.0 111.004 179.901 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 14.4 p -86.72 127.72 40.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.935 179.997 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 29.1 p90 -124.82 177.76 5.84 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.936 -0.575 . . . . 0.0 111.114 -179.606 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -133.1 144.38 49.91 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.169 -179.807 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 8.1 tttt -74.88 -40.76 60.76 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.84 179.585 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 6.3 tt0 -58.03 -48.8 78.98 Favored 'General case' 0 N--CA 1.462 0.131 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.559 179.587 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -55.03 -50.15 69.78 Favored 'General case' 0 C--O 1.232 0.153 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.033 179.691 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.624 HD11 ' O ' ' A' ' 36' ' ' LEU . 0.3 OUTLIER -56.88 -40.32 75.98 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.132 179.976 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -61.27 -38.29 86.22 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-N 116.451 -0.34 . . . . 0.0 111.163 179.645 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -76.05 -47.46 24.62 Favored 'General case' 0 C--O 1.231 0.125 0 CA-C-N 116.474 -0.33 . . . . 0.0 111.075 179.639 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 6.5 m-85 -55.75 -32.75 63.68 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 116.468 -0.333 . . . . 0.0 111.384 179.876 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . 0.421 ' HA ' ' NE2' ' A' ' 20' ' ' GLN . 1.8 t80 -59.09 -41.31 87.75 Favored 'General case' 0 C--O 1.232 0.184 0 CA-C-O 120.695 0.284 . . . . 0.0 110.713 179.644 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 6.4 tt0 -84.82 -38.94 18.94 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.803 179.447 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 4.9 tt0 -62.29 -39.69 93.79 Favored 'General case' 0 CA--C 1.529 0.169 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.252 -179.958 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -85.03 -39.22 18.28 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-N 116.597 -0.274 . . . . 0.0 111.132 179.729 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 64.12 62.04 5.53 Favored Glycine 0 C--N 1.336 0.573 0 C-N-CA 121.031 -0.604 . . . . 0.0 112.583 179.805 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 9.6 tp -56.28 -34.1 39.25 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.259 0 N-CA-C 111.886 0.328 . . . . 0.0 111.886 -179.881 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 35.0 m80 59.98 85.9 0.17 Allowed Pre-proline 0 N--CA 1.463 0.176 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.131 179.996 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 43.3 Cg_endo -68.22 109.98 2.12 Favored 'Trans proline' 0 C--N 1.346 0.436 0 C-N-CA 122.657 2.238 . . . . 0.0 112.42 -179.944 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 49.1 Cg_endo -69.41 138.12 38.16 Favored 'Trans proline' 0 C--N 1.351 0.675 0 C-N-CA 122.544 2.163 . . . . 0.0 111.933 179.755 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER 58.8 59.88 5.42 Favored Pre-proline 0 C--O 1.233 0.222 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.599 -179.547 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -71.69 58.0 2.53 Favored 'Trans proline' 0 C--N 1.35 0.615 0 C-N-CA 122.656 2.237 . . . . 0.0 112.535 -179.786 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 14.2 pt -151.04 30.47 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.53 0.184 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.311 179.953 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -88.8 92.86 9.38 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-O 120.808 0.337 . . . . 0.0 111.343 -179.581 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . 67.22 159.0 0.14 Allowed 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.669 179.828 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -166.86 169.9 12.76 Favored 'General case' 0 CA--C 1.53 0.206 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.744 -179.841 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.463 0.213 0 CA-C-N 115.88 -0.6 . . . . 0.0 111.558 179.764 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.489 1.519 0 CA-C-O 120.623 0.249 . . . . 0.0 111.204 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.426 ' O ' HG12 ' A' ' 2' ' ' VAL . 10.6 t -106.86 43.58 0.18 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.316 0 CA-C-O 120.984 0.421 . . . . 0.0 110.911 179.798 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 56.05 82.71 0.1 Allowed 'General case' 0 CA--C 1.531 0.23 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.034 -179.964 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 2.4 p 63.13 173.11 0.15 Allowed 'General case' 0 N--CA 1.469 0.505 0 CA-C-N 115.599 -0.728 . . . . 0.0 111.432 -179.316 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . 0.414 ' CE1' HD21 ' A' ' 53' ' ' LEU . 7.9 m-85 -114.8 -37.33 4.24 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.747 -0.66 . . . . 0.0 111.381 -179.844 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -157.53 176.72 12.27 Favored 'General case' 0 C--O 1.236 0.344 0 CA-C-O 120.698 0.285 . . . . 0.0 111.094 179.752 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -122.7 140.94 52.31 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.966 179.802 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 25.0 mt -125.83 154.62 34.91 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.17 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.196 -179.811 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 17.1 mt-10 -109.04 150.62 27.52 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-N 116.345 -0.388 . . . . 0.0 111.108 179.957 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.665 HD11 ' CE2' ' A' ' 22' ' ' PHE . 16.5 tt -59.01 -28.88 39.93 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.292 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.58 179.697 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 20.5 mt-10 -58.26 -31.13 67.14 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-N 116.528 -0.305 . . . . 0.0 111.285 179.666 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -94.36 28.48 2.54 Favored 'General case' 0 CA--C 1.536 0.41 0 CA-C-N 116.695 -0.23 . . . . 0.0 111.41 179.643 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 1.4 ttp -122.75 167.56 13.33 Favored 'General case' 0 CA--C 1.53 0.176 0 CA-C-O 120.648 0.261 . . . . 0.0 111.234 -179.736 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -105.36 117.24 33.52 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.77 179.891 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . 0.513 ' HB3' ' CE2' ' A' ' 22' ' ' PHE . 37.2 p90 -96.0 147.78 23.34 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.974 179.826 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -144.43 150.25 47.13 Favored Pre-proline 0 N--CA 1.463 0.211 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.398 179.875 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 70.2 Cg_endo -73.8 -14.74 24.17 Favored 'Trans proline' 0 C--N 1.348 0.55 0 C-N-CA 123.056 2.504 . . . . 0.0 113.098 179.613 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -69.03 82.53 0.32 Allowed 'General case' 0 CA--C 1.53 0.185 0 CA-C-O 121.179 0.514 . . . . 0.0 110.868 -179.824 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 6.8 m-80 67.51 20.7 9.73 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 115.564 -0.744 . . . . 0.0 111.797 -179.556 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . 0.619 ' HG2' HD12 ' A' ' 36' ' ' LEU . 16.7 mt-30 54.14 77.54 0.19 Allowed 'General case' 0 CA--C 1.532 0.257 0 CA-C-O 120.854 0.359 . . . . 0.0 111.428 179.596 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -116.62 145.25 43.53 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.034 179.967 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.665 ' CE2' HD11 ' A' ' 10' ' ' ILE . 12.3 m-85 -125.92 94.86 4.23 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.654 -179.901 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 32.2 p -91.79 146.14 24.0 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.419 -179.49 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 23.0 t80 -142.59 137.18 15.09 Favored Pre-proline 0 CA--C 1.53 0.184 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.036 -179.942 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -65.32 100.02 0.37 Allowed 'Trans proline' 0 C--N 1.349 0.596 0 C-N-CA 122.694 2.263 . . . . 0.0 112.272 179.604 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . 0.403 ' SG ' ' HD2' ' A' ' 27' ' ' PRO . 48.1 t -65.94 139.01 96.56 Favored Pre-proline 0 C--O 1.233 0.229 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.699 179.903 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . 0.403 ' HD2' ' SG ' ' A' ' 26' ' ' CYS . 54.8 Cg_exo -53.25 -25.41 30.21 Favored 'Trans proline' 0 C--N 1.35 0.649 0 C-N-CA 122.82 2.346 . . . . 0.0 112.83 179.666 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -68.26 -38.54 81.86 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-O 120.451 0.167 . . . . 0.0 111.268 179.985 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 152.16 -47.47 0.56 Allowed Glycine 0 C--N 1.335 0.477 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.962 -179.987 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -76.74 -174.69 3.11 Favored 'General case' 0 CA--C 1.531 0.223 0 CA-C-O 120.694 0.283 . . . . 0.0 111.12 -179.783 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 12.3 mtt180 -122.36 137.41 54.87 Favored 'General case' 0 C--O 1.232 0.164 0 CA-C-O 120.829 0.347 . . . . 0.0 111.097 -179.853 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 9.1 m-85 -66.47 167.85 10.03 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.004 179.774 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 12.6 pt20 -154.18 97.64 2.06 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.114 -179.985 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 10.7 tt -123.97 151.52 28.94 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.216 0 CA-C-N 116.29 -0.413 . . . . 0.0 111.293 179.996 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 6.3 m-85 -102.53 152.69 20.86 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.839 -179.961 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.619 HD12 ' HG2' ' A' ' 20' ' ' GLN . 25.6 mt -61.6 -43.04 99.6 Favored 'General case' 0 N--CA 1.463 0.175 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.032 179.798 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -60.25 -38.13 82.53 Favored 'General case' 0 CA--C 1.53 0.187 0 CA-C-N 116.405 -0.362 . . . . 0.0 111.032 179.65 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -59.19 -57.04 14.79 Favored 'General case' 0 N--CA 1.462 0.158 0 CA-C-O 120.769 0.319 . . . . 0.0 110.81 179.711 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 47.6 mtm -61.32 -37.77 84.46 Favored 'General case' 0 N--CA 1.462 0.157 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.024 179.589 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 17.7 t80 -58.11 -38.7 76.96 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.999 179.586 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 1.3 tp10 -62.05 -45.13 94.9 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-N 116.507 -0.315 . . . . 0.0 110.761 179.576 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 152.29 48.34 0.02 OUTLIER Glycine 0 C--N 1.332 0.34 0 C-N-CA 120.979 -0.629 . . . . 0.0 112.694 179.627 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 1.1 tp10 -99.53 147.61 25.14 Favored 'General case' 0 C--O 1.231 0.106 0 CA-C-O 120.754 0.311 . . . . 0.0 110.99 179.921 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 7.9 mttt -149.37 -47.99 0.14 Allowed 'General case' 0 C--O 1.233 0.217 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.133 179.752 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.432 HG22 ' OD1' ' A' ' 56' ' ' ASP . 24.3 t -106.86 104.52 17.18 Favored 'Isoleucine or valine' 0 C--O 1.234 0.257 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.862 179.957 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -92.7 174.64 7.16 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.076 179.813 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 10.7 p -134.9 123.57 41.22 Favored 'Isoleucine or valine' 0 C--O 1.233 0.214 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.205 -179.954 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 48.3 t -70.31 135.77 86.66 Favored Pre-proline 0 C--N 1.332 -0.186 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.807 179.869 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_endo -84.13 20.94 1.13 Allowed 'Trans proline' 0 CA--C 1.536 0.581 0 C-N-CA 122.762 2.308 . . . . 0.0 113.077 179.682 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -128.71 -55.72 1.22 Allowed 'General case' 0 C--O 1.232 0.155 0 CA-C-N 116.67 -0.241 . . . . 0.0 110.626 179.903 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 18.6 p -98.31 -17.69 18.76 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.848 179.906 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 5.6 p 63.93 37.15 9.65 Favored 'General case' 0 CA--C 1.535 0.382 0 CA-C-O 120.987 0.422 . . . . 0.0 111.438 179.865 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.496 HD13 ' N ' ' A' ' 54' ' ' MET . 1.3 tm? -101.99 130.62 48.57 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.491 179.7 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' MET . . . . . 0.496 ' N ' HD13 ' A' ' 53' ' ' LEU . 60.6 mtm -83.95 135.18 34.56 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.836 179.997 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.463 ' O ' HD12 ' A' ' 55' ' ' ILE . 2.5 pp -137.51 134.35 46.42 Favored 'Isoleucine or valine' 0 C--O 1.233 0.23 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.564 -179.89 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . 0.432 ' OD1' HG22 ' A' ' 45' ' ' VAL . 20.1 m-20 -82.41 100.95 10.32 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.766 179.597 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.468 HG13 ' O ' ' A' ' 57' ' ' VAL . 13.5 p -104.02 116.66 48.22 Favored 'Isoleucine or valine' 0 C--O 1.233 0.227 0 CA-C-O 121.133 0.492 . . . . 0.0 111.179 179.9 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 12.4 p -87.55 137.53 20.82 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.939 -179.94 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 44.3 p90 -124.66 175.98 6.85 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.072 -179.67 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -114.02 155.94 24.99 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.144 -179.881 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 56.6 mttt -92.96 -44.44 8.43 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.742 179.674 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 16.2 pt-20 -57.84 -36.04 71.73 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 116.473 -0.33 . . . . 0.0 110.927 179.61 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -55.68 -53.3 58.3 Favored 'General case' 0 N--CA 1.461 0.125 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.67 179.523 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 3.0 mp -55.43 -39.35 70.14 Favored 'General case' 0 N--CA 1.462 0.159 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.211 179.631 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -58.76 -60.15 4.29 Favored 'General case' 0 CA--C 1.528 0.11 0 CA-C-N 116.507 -0.315 . . . . 0.0 111.173 179.885 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -63.72 -40.6 97.15 Favored 'General case' 0 N--CA 1.464 0.225 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.221 179.708 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . 0.617 ' O ' ' HB2' ' A' ' 71' ' ' ALA . 3.2 m-85 -63.16 -55.51 24.57 Favored 'General case' 0 C--O 1.227 -0.129 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.233 -179.82 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 3.0 t80 -61.56 -43.98 97.87 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 116.592 -0.276 . . . . 0.0 110.89 179.998 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 4.0 tt0 -58.11 -30.42 66.28 Favored 'General case' 0 CA--C 1.53 0.21 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.975 179.541 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -130.74 59.55 1.66 Allowed 'General case' 0 C--O 1.234 0.26 0 CA-C-O 120.839 0.352 . . . . 0.0 111.107 -179.927 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . 0.617 ' HB2' ' O ' ' A' ' 67' ' ' TYR . . . -135.54 139.38 43.89 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.536 179.926 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -97.02 48.23 1.6 Allowed Glycine 0 C--N 1.333 0.406 0 C-N-CA 121.081 -0.58 . . . . 0.0 112.309 179.515 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.414 HD13 ' NE2' ' A' ' 20' ' ' GLN . 36.4 pt -69.48 176.76 0.49 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.175 0 CA-C-O 120.671 0.272 . . . . 0.0 111.156 179.987 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -53.13 -59.85 8.15 Favored Pre-proline 0 CA--C 1.531 0.215 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.216 -179.987 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -73.74 111.15 3.23 Favored 'Trans proline' 0 C--N 1.352 0.739 0 C-N-CA 122.361 2.041 . . . . 0.0 112.342 179.605 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -71.54 -178.53 3.06 Favored 'Trans proline' 0 C--N 1.348 0.548 0 C-N-CA 122.68 2.254 . . . . 0.0 112.507 -179.912 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 5.6 tt0 -127.58 90.83 47.31 Favored Pre-proline 0 CA--C 1.531 0.237 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.089 179.989 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 41.1 Cg_endo -68.31 95.69 0.45 Allowed 'Trans proline' 0 C--N 1.346 0.43 0 C-N-CA 122.647 2.232 . . . . 0.0 112.424 179.987 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 1.8 pt -140.84 90.47 0.53 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.21 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.292 -179.722 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . 60.12 90.8 0.06 Allowed 'General case' 0 N--CA 1.465 0.302 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.504 179.934 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -106.47 163.13 13.11 Favored 'General case' 0 N--CA 1.463 0.207 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.548 -179.862 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -109.29 156.63 19.73 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.241 179.904 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.139 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.133 179.611 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 5.7 mtt . . . . . 0 N--CA 1.49 1.54 0 CA-C-O 120.525 0.202 . . . . 0.0 111.371 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.47 ' O ' HG23 ' A' ' 2' ' ' VAL . 30.9 m -66.8 113.52 2.98 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.275 0 CA-C-O 120.811 0.339 . . . . 0.0 111.17 -179.924 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 1.4 p -149.52 137.46 20.41 Favored 'General case' 0 CA--C 1.53 0.194 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.904 -179.538 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.48 HG22 ' O ' ' A' ' 54' ' ' MET . 0.2 OUTLIER 63.23 177.48 0.15 Allowed 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.982 -179.891 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 21.4 m-85 -105.58 -76.4 0.61 Allowed 'General case' 0 C--O 1.232 0.167 0 CA-C-N 116.48 -0.327 . . . . 0.0 111.176 -179.739 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -126.66 171.77 10.87 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.002 -179.813 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 4.6 pt-20 -132.64 136.31 46.41 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-N 116.405 -0.361 . . . . 0.0 111.014 179.654 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 3.7 mp -118.48 150.4 20.72 Favored 'Isoleucine or valine' 0 C--O 1.233 0.226 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.375 -179.605 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . 0.446 ' HA ' HG12 ' A' ' 58' ' ' VAL . 12.2 mt-10 -98.97 153.55 18.76 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.366 -179.905 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 1.1 tp -59.25 -32.61 48.65 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.286 0 CA-C-N 115.989 -0.55 . . . . 0.0 111.223 179.551 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -61.21 -33.17 73.04 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-N 116.551 -0.295 . . . . 0.0 110.998 179.514 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -96.91 37.37 1.31 Allowed 'General case' 0 C--O 1.234 0.27 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.177 179.816 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . 0.516 ' HG2' ' CD1' ' A' ' 24' ' ' TYR . 3.3 mtp -125.75 150.09 48.02 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-N 116.407 -0.361 . . . . 0.0 110.887 179.798 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 7.3 m -96.7 113.57 25.14 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.766 179.679 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 24.2 p90 -80.38 130.18 35.0 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.517 179.632 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 3.9 tt0 -107.23 95.83 14.18 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.625 -179.949 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -72.87 60.84 3.72 Favored 'Trans proline' 0 C--N 1.347 0.492 0 C-N-CA 122.69 2.26 . . . . 0.0 112.58 -179.734 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 15.1 pt-20 -126.67 -45.27 1.63 Allowed 'General case' 0 C--O 1.233 0.189 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.876 179.915 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 2.2 t-20 -146.55 33.64 0.95 Allowed 'General case' 0 CA--C 1.532 0.276 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.066 179.636 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . 0.408 ' CG ' HG12 ' A' ' 73' ' ' ILE . 10.1 mt-30 57.9 57.75 3.98 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.222 179.851 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 21.8 ptm -136.62 151.44 49.33 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.672 179.658 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.611 ' HE1' HD23 ' A' ' 36' ' ' LEU . 7.6 m-85 -130.24 124.85 33.44 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.388 -179.899 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . 0.767 HG22 ' HA ' ' A' ' 33' ' ' GLN . 64.3 p -120.24 137.5 54.18 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.952 -179.581 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . 0.516 ' CD1' ' HG2' ' A' ' 13' ' ' MET . 1.9 p90 -131.54 148.17 68.97 Favored Pre-proline 0 C--O 1.233 0.195 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.133 179.867 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_exo -52.52 124.72 15.81 Favored 'Trans proline' 0 C--N 1.349 0.584 0 C-N-CA 122.872 2.381 . . . . 0.0 112.774 -179.671 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . 0.491 ' SG ' ' HD2' ' A' ' 27' ' ' PRO . 50.5 t -94.9 141.21 22.98 Favored Pre-proline 0 C--N 1.33 -0.244 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.342 179.587 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . 0.491 ' HD2' ' SG ' ' A' ' 26' ' ' CYS . 87.6 Cg_exo -48.08 -30.11 13.63 Favored 'Trans proline' 0 C--N 1.349 0.578 0 C-N-CA 122.846 2.364 . . . . 0.0 113.192 179.914 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . 0.405 ' CB ' ' HB3' ' A' ' 51' ' ' CYS . 0.8 OUTLIER -76.96 -40.36 47.2 Favored 'General case' 0 CA--C 1.532 0.267 0 CA-C-N 116.818 -0.174 . . . . 0.0 111.32 179.986 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 151.77 -45.07 0.63 Allowed Glycine 0 C--N 1.335 0.516 0 C-N-CA 120.49 -0.862 . . . . 0.0 113.175 179.753 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 50.6 m-20 -67.33 -177.74 0.74 Allowed 'General case' 0 CA--C 1.532 0.271 0 CA-C-O 120.912 0.387 . . . . 0.0 111.123 -179.808 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -110.97 128.15 55.74 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.875 -179.716 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 15.0 m-85 -64.66 91.46 0.08 Allowed 'General case' 0 C--O 1.233 0.227 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.7 179.816 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . 0.767 ' HA ' HG22 ' A' ' 23' ' ' THR . 2.9 pt20 -80.13 125.86 30.36 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.228 -179.65 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 2.5 tt -161.26 133.77 1.09 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.207 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.066 179.723 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 71.3 m-85 -88.11 145.52 25.9 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.775 -179.947 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.611 HD23 ' HE1' ' A' ' 22' ' ' PHE . 4.1 pp -58.01 -33.38 68.88 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.215 179.74 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . 0.55 ' N ' HD12 ' A' ' 36' ' ' LEU . 1.2 p30 -65.3 -39.07 92.03 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 116.567 -0.288 . . . . 0.0 110.785 179.493 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -61.87 -46.95 87.19 Favored 'General case' 0 CA--C 1.528 0.116 0 CA-C-N 116.422 -0.353 . . . . 0.0 110.839 179.781 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 55.6 mtm -74.37 -33.1 62.98 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.176 179.825 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . 0.417 ' HB2' HD21 ' A' ' 64' ' ' LEU . 18.4 t80 -57.09 -38.27 73.09 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.029 -179.931 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 21.6 mt-10 -60.71 -37.18 80.83 Favored 'General case' 0 N--CA 1.462 0.147 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.889 179.548 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 145.56 47.62 0.03 OUTLIER Glycine 0 C--N 1.333 0.391 0 C-N-CA 120.94 -0.647 . . . . 0.0 112.69 179.794 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -112.56 148.2 35.02 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-O 120.741 0.305 . . . . 0.0 111.161 -179.845 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 22.8 mtmt -148.09 -48.24 0.16 Allowed 'General case' 0 CA--C 1.531 0.219 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.076 179.815 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.45 HG22 ' OD1' ' A' ' 56' ' ' ASP . 23.7 t -89.87 94.79 5.03 Favored 'Isoleucine or valine' 0 C--O 1.232 0.178 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.805 -179.985 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -91.6 159.18 16.03 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.188 -179.884 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 11.6 p -126.04 128.45 71.84 Favored 'Isoleucine or valine' 0 C--O 1.232 0.169 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.371 -179.904 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 42.0 t -71.21 136.73 84.32 Favored Pre-proline 0 CA--C 1.53 0.201 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.884 179.714 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 92.9 Cg_endo -82.8 20.35 1.16 Allowed 'Trans proline' 0 C--N 1.35 0.629 0 C-N-CA 122.751 2.301 . . . . 0.0 113.136 179.742 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 38.9 t -128.59 -58.11 1.18 Allowed 'General case' 0 C--O 1.232 0.153 0 N-CA-C 110.265 -0.272 . . . . 0.0 110.265 179.539 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' CYS . . . . . 0.816 ' SG ' HD23 ' A' ' 53' ' ' LEU . 20.7 p -94.26 -27.0 16.38 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.483 179.711 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 1.5 t 70.92 42.92 0.73 Allowed 'General case' 0 CA--C 1.532 0.275 0 CA-C-O 120.931 0.396 . . . . 0.0 110.968 -179.838 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.816 HD23 ' SG ' ' A' ' 51' ' ' CYS . 3.6 mm? -92.34 150.69 20.69 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.63 179.64 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' MET . . . . . 0.48 ' O ' HG22 ' A' ' 4' ' ' THR . 9.7 mtt -104.66 123.05 46.92 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.904 -179.791 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 2.6 pp -134.99 148.3 29.1 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.313 0 CA-C-N 116.363 -0.38 . . . . 0.0 111.842 -179.883 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . 0.45 ' OD1' HG22 ' A' ' 45' ' ' VAL . 32.1 m-20 -102.4 92.36 4.66 Favored 'General case' 0 CA--C 1.531 0.223 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.95 179.657 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 13.1 p -88.97 127.83 41.46 Favored 'Isoleucine or valine' 0 C--O 1.234 0.256 0 CA-C-O 120.851 0.357 . . . . 0.0 110.986 179.72 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.446 HG12 ' HA ' ' A' ' 9' ' ' GLU . 12.5 p -97.97 136.53 28.52 Favored 'Isoleucine or valine' 0 C--O 1.234 0.251 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.398 -179.837 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 16.1 p90 -123.82 170.12 10.88 Favored 'General case' 0 CA--C 1.53 0.184 0 CA-C-N 115.899 -0.591 . . . . 0.0 111.073 -179.966 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -107.63 160.13 15.93 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.106 179.734 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -89.17 -37.85 14.73 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.032 179.691 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -72.21 -38.83 68.91 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-N 116.618 -0.265 . . . . 0.0 111.171 179.944 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 88.7 m-20 -52.71 -41.65 64.11 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.001 -179.988 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.417 HD21 ' HB2' ' A' ' 40' ' ' PHE . 0.8 OUTLIER -63.7 -52.35 60.97 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.979 -179.933 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -57.47 -39.26 75.97 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-N 116.489 -0.323 . . . . 0.0 110.736 179.57 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -73.83 -46.43 45.15 Favored 'General case' 0 N--CA 1.461 0.124 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.273 179.67 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 9.3 t80 -60.61 -37.67 82.18 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 116.713 -0.221 . . . . 0.0 111.237 -179.946 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 13.9 t80 -58.29 -41.34 84.17 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-O 120.55 0.214 . . . . 0.0 110.813 179.742 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 9.5 mt-10 -87.93 -35.38 17.71 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.496 -179.801 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 -72.18 -33.37 67.63 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 116.65 -0.25 . . . . 0.0 111.583 -179.843 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -75.08 140.47 43.49 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-O 120.819 0.342 . . . . 0.0 111.329 -179.939 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -96.05 33.28 5.68 Favored Glycine 0 C--N 1.333 0.372 0 C-N-CA 121.027 -0.606 . . . . 0.0 112.297 179.475 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.408 HG12 ' CG ' ' A' ' 20' ' ' GLN . 1.7 pp -69.13 176.33 0.51 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.168 0 CA-C-O 120.841 0.353 . . . . 0.0 111.339 -179.851 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 57.4 m-70 -119.79 147.54 44.28 Favored Pre-proline 0 C--O 1.233 0.21 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.192 -179.729 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_endo -69.59 148.17 65.56 Favored 'Trans proline' 0 C--N 1.348 0.526 0 C-N-CA 122.717 2.278 . . . . 0.0 112.48 179.875 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 68.2 Cg_endo -73.88 84.84 1.41 Allowed 'Trans proline' 0 C--N 1.347 0.498 0 C-N-CA 122.789 2.326 . . . . 0.0 112.495 -179.845 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . 0.441 ' HB3' ' HD2' ' A' ' 78' ' ' PRO . 10.7 mt-10 67.52 164.51 0.13 Allowed Pre-proline 0 N--CA 1.467 0.377 0 CA-C-N 115.844 -0.616 . . . . 0.0 111.402 179.926 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . 0.441 ' HD2' ' HB3' ' A' ' 77' ' ' GLU . 46.9 Cg_exo -56.56 157.66 18.28 Favored 'Trans proline' 0 C--N 1.349 0.594 0 C-N-CA 122.833 2.355 . . . . 0.0 112.486 179.947 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.563 HD12 ' N ' ' A' ' 80' ' ' ALA . 2.2 pp -141.2 -46.43 0.23 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.206 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.86 179.974 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . 0.563 ' N ' HD12 ' A' ' 79' ' ' ILE . . . -144.65 30.92 1.19 Allowed 'General case' 0 N--CA 1.463 0.208 0 CA-C-O 120.771 0.32 . . . . 0.0 111.261 179.907 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -86.99 -33.87 19.45 Favored 'General case' 0 C--O 1.232 0.143 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.236 179.877 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -61.53 -38.31 86.94 Favored 'General case' 0 C--O 1.232 0.133 0 CA-C-N 116.42 -0.355 . . . . 0.0 111.339 179.929 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.174 0 CA-C-N 116.496 -0.32 . . . . 0.0 111.242 -179.999 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 19.0 mtt . . . . . 0 N--CA 1.49 1.549 0 CA-C-O 120.446 0.165 . . . . 0.0 111.333 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 9.9 m -128.56 147.6 33.05 Favored 'Isoleucine or valine' 0 C--O 1.233 0.232 0 CA-C-O 120.748 0.308 . . . . 0.0 111.675 179.974 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 8.9 p -140.74 34.84 1.79 Allowed 'General case' 0 CA--C 1.535 0.398 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.158 179.921 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.408 HG21 ' CG ' ' A' ' 56' ' ' ASP . 0.8 OUTLIER -101.47 171.89 7.31 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-O 120.906 0.384 . . . . 0.0 111.36 -179.963 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 15.3 m-85 -103.6 -36.2 8.01 Favored 'General case' 0 CA--C 1.53 0.194 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.381 179.849 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -158.78 171.45 20.05 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-O 120.701 0.286 . . . . 0.0 111.322 -179.97 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -127.54 140.5 52.09 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.005 -179.897 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 27.1 mm -120.48 156.01 23.61 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.254 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.926 -179.865 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 10.0 mt-10 -119.63 159.82 23.67 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-O 120.739 0.304 . . . . 0.0 111.323 179.848 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 11.5 tt -65.39 -30.95 51.77 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.351 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.481 179.37 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -60.02 -42.33 94.14 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-O 120.45 0.166 . . . . 0.0 111.331 -179.878 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 8.4 p-10 -98.09 37.05 1.47 Allowed 'General case' 0 CA--C 1.535 0.378 0 CA-C-O 120.824 0.345 . . . . 0.0 111.329 179.589 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -114.43 139.74 49.26 Favored 'General case' 0 C--O 1.233 0.236 0 N-CA-C 109.655 -0.498 . . . . 0.0 109.655 179.182 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 2.9 m -66.87 89.84 0.17 Allowed 'General case' 0 C--O 1.233 0.207 0 CA-C-O 120.86 0.362 . . . . 0.0 110.651 -179.649 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 52.1 p90 -80.2 127.71 32.66 Favored 'General case' 0 C--O 1.232 0.159 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.752 -179.979 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 5.8 mt-10 -109.1 93.92 13.93 Favored Pre-proline 0 C--O 1.236 0.346 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.347 179.845 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -71.64 64.77 3.05 Favored 'Trans proline' 0 C--N 1.346 0.398 0 C-N-CA 122.943 2.429 . . . . 0.0 112.351 -179.794 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 17.1 pt-20 -140.29 -45.86 0.42 Allowed 'General case' 0 CA--C 1.531 0.226 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.916 179.934 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 44.9 p30 -134.69 24.11 3.67 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.557 -179.998 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . 0.652 ' N ' HG21 ' A' ' 73' ' ' ILE . 0.3 OUTLIER 60.79 47.05 8.27 Favored 'General case' 0 C--O 1.235 0.325 0 CA-C-O 120.944 0.402 . . . . 0.0 111.053 179.983 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 20.2 ttt -114.77 143.13 45.56 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.919 -179.917 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.488 ' CD1' HD21 ' A' ' 36' ' ' LEU . 4.1 m-85 -127.92 104.34 7.75 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.702 179.649 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . 0.412 HG22 ' HG2' ' A' ' 33' ' ' GLN . 22.5 p -107.88 179.27 4.27 Favored 'General case' 0 CA--C 1.531 0.216 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.01 -179.962 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 63.1 t80 -173.09 135.27 0.7 Allowed Pre-proline 0 N--CA 1.466 0.338 0 CA-C-N 116.63 -0.259 . . . . 0.0 111.211 179.712 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_endo -66.92 108.05 1.42 Allowed 'Trans proline' 0 C--N 1.349 0.6 0 C-N-CA 122.611 2.207 . . . . 0.0 112.447 179.832 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . 0.438 ' SG ' ' HD2' ' A' ' 27' ' ' PRO . 42.8 t -69.36 139.64 89.7 Favored Pre-proline 0 C--N 1.332 -0.187 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.517 179.704 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . 0.438 ' HD2' ' SG ' ' A' ' 26' ' ' CYS . 77.7 Cg_exo -51.59 -26.95 23.93 Favored 'Trans proline' 0 C--N 1.349 0.599 0 C-N-CA 122.92 2.413 . . . . 0.0 113.072 179.833 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . 0.403 ' CB ' ' HB3' ' A' ' 51' ' ' CYS . 0.8 OUTLIER -70.1 -38.59 75.7 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-N 116.894 -0.139 . . . . 0.0 111.36 -179.868 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 150.86 -43.31 0.71 Allowed Glycine 0 C--N 1.335 0.483 0 C-N-CA 120.869 -0.682 . . . . 0.0 112.91 -179.842 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -70.83 -174.44 0.92 Allowed 'General case' 0 CA--C 1.535 0.383 0 CA-C-O 120.668 0.271 . . . . 0.0 111.187 -179.77 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 18.6 ttm180 -126.96 122.37 34.35 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-O 120.706 0.289 . . . . 0.0 111.385 -179.689 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 4.4 m-85 -61.86 154.14 26.9 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.849 179.527 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . 0.412 ' HG2' HG22 ' A' ' 23' ' ' THR . 32.9 mt-30 -143.02 122.04 12.83 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-N 116.455 -0.338 . . . . 0.0 111.478 179.993 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 3.9 tt -151.2 123.12 1.12 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.24 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.896 179.451 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 44.5 m-85 -81.52 158.78 24.35 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.887 -179.916 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.84 HD12 ' HG ' ' A' ' 64' ' ' LEU . 4.0 mm? -59.53 -39.39 83.75 Favored 'General case' 0 N--CA 1.463 0.225 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.847 179.829 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -59.76 -42.59 93.58 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 116.468 -0.333 . . . . 0.0 110.98 179.543 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 33.9 m-20 -58.72 -46.11 88.09 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-O 120.857 0.36 . . . . 0.0 110.475 179.696 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 5.2 mmm -61.18 -35.71 77.88 Favored 'General case' 0 CA--C 1.529 0.17 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.808 179.518 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . 0.595 ' CD2' HD22 ' A' ' 64' ' ' LEU . 0.3 OUTLIER -54.35 -45.6 72.77 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 116.491 -0.322 . . . . 0.0 111.293 179.933 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 6.3 mt-10 -61.43 -46.47 89.96 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 116.585 -0.28 . . . . 0.0 110.892 179.875 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 132.09 52.63 0.09 OUTLIER Glycine 0 C--N 1.333 0.376 0 C-N-CA 120.977 -0.63 . . . . 0.0 112.609 179.807 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -106.32 95.88 6.08 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-O 120.941 0.401 . . . . 0.0 111.175 -179.938 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 5.0 ptpt -105.77 -32.92 8.18 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-N 115.843 -0.617 . . . . 0.0 111.064 179.62 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.547 ' O ' HG13 ' A' ' 45' ' ' VAL . 9.5 p -86.89 74.07 1.05 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.295 0 CA-C-O 121.456 0.646 . . . . 0.0 111.001 -179.915 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -81.5 136.32 35.63 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.718 -0.674 . . . . 0.0 111.101 -179.896 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 6.4 m -109.8 125.59 66.98 Favored 'Isoleucine or valine' 0 C--O 1.232 0.18 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.337 -179.985 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 50.3 t -68.8 135.68 90.05 Favored Pre-proline 0 C--O 1.233 0.229 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.84 179.893 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_endo -84.14 20.59 1.18 Allowed 'Trans proline' 0 C--N 1.349 0.59 0 C-N-CA 122.716 2.278 . . . . 0.0 113.217 179.698 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -128.55 -57.58 1.2 Allowed 'General case' 0 C--O 1.232 0.151 0 CA-C-O 120.59 0.233 . . . . 0.0 110.582 179.712 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' CYS . . . . . 0.403 ' HB3' ' CB ' ' A' ' 28' ' ' CYS . 19.1 p -95.35 -22.51 17.69 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-N 116.352 -0.386 . . . . 0.0 111.658 179.828 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 1.1 t 67.53 41.37 2.36 Favored 'General case' 0 CA--C 1.533 0.314 0 CA-C-O 120.981 0.42 . . . . 0.0 110.948 -179.841 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 7.0 tp -95.66 134.32 38.7 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.846 179.86 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' MET . . . . . . . . . . . . . 37.7 mtt -86.07 132.3 34.07 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.0 -179.94 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 2.5 pp -142.18 139.64 29.87 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.205 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.314 -179.899 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . 0.408 ' CG ' HG21 ' A' ' 4' ' ' THR . 67.3 m-20 -102.07 97.28 7.63 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.68 179.362 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 12.7 p -86.39 138.01 19.84 Favored 'Isoleucine or valine' 0 C--O 1.234 0.282 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.12 179.885 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 13.4 p -104.92 133.21 49.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.876 179.89 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 37.6 p90 -132.46 176.51 8.36 Favored 'General case' 0 CA--C 1.532 0.274 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.054 -179.397 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 2.5 t70 -122.3 147.69 45.93 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.457 179.968 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 15.0 tttm -83.68 -39.0 20.73 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.82 179.435 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 20.3 mt-10 -60.0 -42.29 93.94 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-N 116.481 -0.327 . . . . 0.0 110.397 179.514 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -64.6 -44.43 90.62 Favored 'General case' 0 CA--C 1.527 0.072 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.795 179.396 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.84 ' HG ' HD12 ' A' ' 36' ' ' LEU . 0.3 OUTLIER -58.25 -43.64 87.94 Favored 'General case' 0 N--CA 1.463 0.207 0 CA-C-N 116.679 -0.237 . . . . 0.0 110.946 179.841 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -65.11 -40.94 95.22 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-N 116.409 -0.359 . . . . 0.0 110.814 179.527 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 2.3 tp10 -72.35 -43.8 63.52 Favored 'General case' 0 CA--C 1.532 0.251 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.165 179.617 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 1.4 t80 -62.48 -36.56 82.88 Favored 'General case' 0 N--CA 1.464 0.273 0 N-CA-C 111.945 0.35 . . . . 0.0 111.945 -179.589 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -59.47 -38.73 81.56 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-O 120.676 0.274 . . . . 0.0 110.624 179.963 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 -86.69 -38.6 16.84 Favored 'General case' 0 CA--C 1.53 0.205 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.048 179.766 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 73.2 mt-10 -69.15 -38.81 78.99 Favored 'General case' 0 N--CA 1.465 0.306 0 N-CA-C 111.867 0.321 . . . . 0.0 111.867 -179.394 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -70.92 -47.06 61.17 Favored 'General case' 0 C--O 1.232 0.157 0 C-N-CA 121.245 -0.182 . . . . 0.0 111.401 -179.749 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 60.4 42.0 98.75 Favored Glycine 0 C--N 1.336 0.541 0 C-N-CA 120.852 -0.69 . . . . 0.0 112.573 -179.93 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.652 HG21 ' N ' ' A' ' 20' ' ' GLN . 2.8 pt -63.41 -31.59 53.43 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.258 0 N-CA-C 111.723 0.268 . . . . 0.0 111.723 -179.815 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 3.6 m-70 -73.13 -59.64 2.06 Favored Pre-proline 0 CA--C 1.532 0.287 0 CA-C-N 116.743 -0.208 . . . . 0.0 110.862 179.673 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 64.5 Cg_endo -73.81 110.64 3.12 Favored 'Trans proline' 0 C--N 1.352 0.743 0 C-N-CA 122.509 2.139 . . . . 0.0 112.7 179.843 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . 0.406 ' O ' ' HB2' ' A' ' 77' ' ' GLU . 57.1 Cg_endo -70.5 116.68 4.74 Favored 'Trans proline' 0 C--N 1.348 0.545 0 C-N-CA 122.708 2.272 . . . . 0.0 112.279 179.924 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . 0.406 ' HB2' ' O ' ' A' ' 76' ' ' PRO . 36.7 mt-10 67.33 163.55 0.13 Allowed Pre-proline 0 N--CA 1.468 0.427 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.288 -179.766 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -53.92 127.35 25.26 Favored 'Trans proline' 0 C--N 1.353 0.773 0 C-N-CA 122.853 2.369 . . . . 0.0 112.484 -179.861 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 15.5 tt -126.91 150.29 32.67 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.299 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.666 -179.513 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -151.87 170.87 18.75 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.346 -179.999 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -147.66 105.47 3.71 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-N 116.286 -0.416 . . . . 0.0 111.073 179.855 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -134.33 126.98 30.79 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.079 -179.998 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.156 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.948 179.762 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.488 1.469 0 CA-C-O 120.467 0.175 . . . . 0.0 111.304 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.464 HG13 ' O ' ' A' ' 2' ' ' VAL . 11.5 p -82.46 117.89 29.21 Favored 'Isoleucine or valine' 0 C--O 1.233 0.189 0 CA-C-O 120.956 0.408 . . . . 0.0 111.246 -179.979 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 60.5 p -99.7 167.52 10.51 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.846 179.87 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -153.9 156.01 36.75 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.027 -179.97 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 25.7 m-85 -106.72 -74.04 0.67 Allowed 'General case' 0 C--O 1.232 0.166 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.325 -179.843 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -131.78 169.22 16.52 Favored 'General case' 0 C--O 1.234 0.279 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.152 -179.695 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 1.5 pt-20 -105.88 138.22 42.44 Favored 'General case' 0 C--O 1.232 0.166 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.234 179.987 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 31.3 mm -101.38 154.96 4.7 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.196 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.053 179.916 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 16.0 tt0 -109.18 130.3 55.49 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.947 179.94 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 18.7 tt -60.58 -31.3 48.65 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.262 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.244 179.632 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 3.1 tt0 -59.98 -31.81 70.25 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.107 179.543 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -96.26 37.12 1.27 Allowed 'General case' 0 CA--C 1.533 0.312 0 CA-C-O 120.81 0.338 . . . . 0.0 111.112 179.823 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . 0.463 ' HE3' HG21 ' A' ' 57' ' ' VAL . 32.4 mtt -127.89 137.0 52.16 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-N 116.478 -0.328 . . . . 0.0 110.653 179.733 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 2.6 m -61.17 116.97 4.99 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.765 -179.847 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 23.5 p90 -86.44 134.05 33.72 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.904 -179.946 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -118.96 94.1 47.67 Favored Pre-proline 0 C--O 1.234 0.256 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.646 179.946 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_endo -68.34 -12.83 36.09 Favored 'Trans proline' 0 C--N 1.346 0.413 0 C-N-CA 122.76 2.307 . . . . 0.0 113.122 -179.926 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -54.75 -44.18 73.37 Favored 'General case' 0 CA--C 1.53 0.191 0 CA-C-N 116.812 -0.176 . . . . 0.0 111.138 -179.942 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 14.7 m-20 -144.85 24.3 1.51 Allowed 'General case' 0 CA--C 1.534 0.337 0 CA-C-N 116.435 -0.348 . . . . 0.0 111.555 179.723 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . 0.638 ' CG ' HD12 ' A' ' 36' ' ' LEU . 2.3 tp60 56.86 69.01 0.78 Allowed 'General case' 0 CA--C 1.532 0.285 0 CA-C-O 120.827 0.346 . . . . 0.0 111.7 179.561 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 11.7 ptp -141.89 150.15 41.15 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.352 -0.386 . . . . 0.0 111.139 179.662 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 7.7 m-85 -120.2 143.9 48.0 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.79 -179.941 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 58.0 p -126.68 146.69 50.1 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.232 -179.897 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 4.6 t80 -135.73 95.07 14.32 Favored Pre-proline 0 C--N 1.332 -0.177 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.605 179.815 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.415 ' HA ' ' HA ' ' A' ' 31' ' ' ARG . 54.4 Cg_exo -52.13 94.31 0.03 OUTLIER 'Trans proline' 0 C--N 1.349 0.59 0 C-N-CA 122.867 2.378 . . . . 0.0 112.309 -179.932 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 29.5 t -65.38 135.63 96.03 Favored Pre-proline 0 C--O 1.233 0.224 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.792 -179.778 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -60.17 -17.49 46.16 Favored 'Trans proline' 0 C--N 1.349 0.564 0 C-N-CA 122.731 2.288 . . . . 0.0 112.861 179.684 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 3.6 p -58.72 -30.33 67.37 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-O 120.556 0.217 . . . . 0.0 111.346 179.769 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 138.64 -15.28 3.37 Favored Glycine 0 CA--C 1.523 0.577 0 C-N-CA 120.945 -0.645 . . . . 0.0 113.28 -179.897 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 3.2 t0 -113.83 -166.55 1.1 Allowed 'General case' 0 CA--C 1.534 0.333 0 CA-C-N 117.036 0.418 . . . . 0.0 111.216 -179.804 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . 0.415 ' HA ' ' HA ' ' A' ' 25' ' ' PRO . 16.2 ttp-105 -129.32 153.62 47.67 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.059 -179.804 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -91.27 167.02 12.62 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-N 116.09 -0.504 . . . . 0.0 111.074 179.754 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -157.58 113.76 2.87 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.885 179.608 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.408 ' CD1' ' HG3' ' A' ' 39' ' ' MET . 5.3 tt -144.37 126.54 10.43 Favored 'Isoleucine or valine' 0 C--O 1.234 0.238 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.134 -179.876 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 37.2 m-85 -81.3 155.53 25.98 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.759 -179.994 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.638 HD12 ' CG ' ' A' ' 20' ' ' GLN . 24.2 mt -58.19 -37.33 74.55 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.055 179.762 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -59.57 -40.99 89.17 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 116.387 -0.37 . . . . 0.0 110.861 179.598 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 2.7 t0 -64.08 -39.16 93.45 Favored 'General case' 0 CA--C 1.528 0.112 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.565 179.525 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' MET . . . . . 0.408 ' HG3' ' CD1' ' A' ' 34' ' ' ILE . 28.2 mtm -93.1 30.94 1.52 Allowed 'General case' 0 CA--C 1.532 0.279 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.115 179.467 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 16.9 t80 -131.42 -47.32 0.98 Allowed 'General case' 0 C--O 1.232 0.181 0 CA-C-N 116.547 -0.297 . . . . 0.0 110.799 179.793 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 13.5 mt-10 -58.0 -36.95 73.39 Favored 'General case' 0 CA--C 1.53 0.179 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.17 179.731 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 151.87 68.26 0.01 OUTLIER Glycine 0 C--N 1.336 0.534 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.849 179.709 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 12.8 tt0 -130.37 157.91 41.28 Favored 'General case' 0 N--CA 1.462 0.152 0 CA-C-O 120.787 0.327 . . . . 0.0 111.436 179.966 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 1.8 mtmt -154.98 -45.98 0.08 Allowed 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.016 179.873 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 5.4 m -99.32 115.27 39.64 Favored 'Isoleucine or valine' 0 C--O 1.233 0.216 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.089 -179.99 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -109.15 149.99 28.53 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.152 -179.912 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 12.8 m -109.68 135.33 48.96 Favored 'Isoleucine or valine' 0 C--O 1.233 0.207 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.388 -179.898 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 50.8 t -75.94 135.96 70.29 Favored Pre-proline 0 C--O 1.233 0.229 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.018 -179.918 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 83.7 Cg_endo -83.91 19.17 1.4 Allowed 'Trans proline' 0 CA--C 1.535 0.573 0 C-N-CA 122.719 2.279 . . . . 0.0 113.127 179.639 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 36.3 t -128.41 -58.31 1.19 Allowed 'General case' 0 C--O 1.232 0.162 0 CA-C-N 116.746 -0.206 . . . . 0.0 110.572 179.789 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 21.0 p -103.39 -18.99 14.59 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 116.398 -0.364 . . . . 0.0 111.695 179.879 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER 70.03 37.13 1.78 Allowed 'General case' 0 CA--C 1.533 0.304 0 CA-C-O 120.788 0.328 . . . . 0.0 111.106 -179.802 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 7.6 mt -75.38 142.35 43.12 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-N 116.396 -0.366 . . . . 0.0 110.643 179.712 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' MET . . . . . . . . . . . . . 22.5 mtt -96.01 113.85 25.5 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.972 -179.58 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 2.7 pp -131.56 162.37 39.53 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.285 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.608 -179.538 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -119.5 95.74 4.91 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.032 179.995 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.463 HG21 ' HE3' ' A' ' 13' ' ' MET . 15.0 p -89.31 128.82 41.13 Favored 'Isoleucine or valine' 0 C--O 1.234 0.251 0 CA-C-O 120.937 0.399 . . . . 0.0 111.251 179.728 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 14.0 p -91.68 152.7 3.34 Favored 'Isoleucine or valine' 0 C--O 1.234 0.239 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.142 179.93 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 15.8 p90 -136.58 174.96 10.05 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.116 -179.651 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -133.43 142.77 48.47 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.321 179.939 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.74 -41.78 62.05 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.746 179.559 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -59.44 -41.03 88.66 Favored 'General case' 0 N--CA 1.462 0.139 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.624 179.427 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -70.42 -46.68 63.44 Favored 'General case' 0 CA--C 1.528 0.121 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.988 179.695 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.497 ' HG ' HD22 ' A' ' 36' ' ' LEU . 0.2 OUTLIER -56.93 -39.36 74.35 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.187 179.882 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -76.41 -46.44 27.15 Favored 'General case' 0 C--O 1.232 0.142 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.264 179.923 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 31.4 mt-10 -58.61 -47.05 85.66 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 116.43 -0.35 . . . . 0.0 110.924 179.817 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 3.3 m-85 -58.06 -32.62 68.19 Favored 'General case' 0 C--N 1.334 -0.105 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.299 179.742 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -59.57 -34.92 73.3 Favored 'General case' 0 CA--C 1.528 0.128 0 CA-C-O 120.626 0.251 . . . . 0.0 110.988 179.666 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -91.99 -35.42 13.98 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.028 179.719 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 13.9 mt-10 -68.92 -35.59 77.0 Favored 'General case' 0 CA--C 1.53 0.197 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.134 179.774 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . 0.495 ' HB3' HD12 ' A' ' 73' ' ' ILE . . . -98.77 152.38 19.76 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-O 120.859 0.362 . . . . 0.0 111.182 179.965 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -87.95 78.46 1.79 Allowed Glycine 0 C--N 1.334 0.427 0 C-N-CA 121.052 -0.594 . . . . 0.0 112.53 -179.928 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.6 ' H ' HD13 ' A' ' 73' ' ' ILE . 0.2 OUTLIER -137.9 140.17 41.31 Favored 'Isoleucine or valine' 0 C--O 1.233 0.225 0 CA-C-O 120.835 0.35 . . . . 0.0 111.298 -179.858 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 5.7 m-70 -104.03 160.04 27.35 Favored Pre-proline 0 C--N 1.33 -0.246 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.838 179.844 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_endo -69.5 110.85 2.6 Favored 'Trans proline' 0 C--N 1.348 0.533 0 C-N-CA 122.569 2.179 . . . . 0.0 112.371 179.988 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -70.39 166.59 27.88 Favored 'Trans proline' 0 C--N 1.347 0.462 0 C-N-CA 122.45 2.1 . . . . 0.0 112.201 179.799 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 3.2 mt-10 -114.96 86.42 13.46 Favored Pre-proline 0 C--N 1.331 -0.217 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.531 179.84 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -54.66 87.93 0.03 OUTLIER 'Trans proline' 0 C--N 1.352 0.731 0 C-N-CA 123.034 2.49 . . . . 0.0 112.446 -179.844 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 3.3 tt -111.37 -40.68 3.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 115.87 -0.604 . . . . 0.0 111.343 -179.71 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . 66.44 157.25 0.11 Allowed 'General case' 0 C--O 1.233 0.232 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.403 179.94 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -89.57 95.69 10.37 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.849 179.85 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . 62.0 76.49 0.37 Allowed 'General case' 0 C--O 1.234 0.271 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.269 -179.867 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.166 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.968 179.928 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 47.3 mtt . . . . . 0 N--CA 1.491 1.612 0 CA-C-O 120.398 0.142 . . . . 0.0 111.3 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 18.4 m -86.66 154.43 3.36 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.309 0 CA-C-O 120.664 0.269 . . . . 0.0 111.507 179.972 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 50.7 m -149.74 123.04 8.98 Favored 'General case' 0 CA--C 1.53 0.208 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.925 179.936 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.428 HG21 ' CG ' ' A' ' 56' ' ' ASP . 0.9 OUTLIER -110.02 160.95 15.98 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-O 120.98 0.419 . . . . 0.0 111.348 -179.814 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . 0.488 ' HB2' HD21 ' A' ' 53' ' ' LEU . 92.2 m-85 -107.87 -37.47 6.1 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-N 115.873 -0.603 . . . . 0.0 111.359 179.841 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -144.94 161.45 39.31 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-O 120.814 0.34 . . . . 0.0 111.393 179.923 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . 0.427 ' HG2' ' HB2' ' A' ' 56' ' ' ASP . 28.5 mt-10 -141.1 143.73 34.49 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.146 -179.888 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 3.8 mp -137.84 152.33 26.46 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.424 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.11 179.83 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -97.97 154.06 17.94 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 116.442 -0.345 . . . . 0.0 110.921 179.389 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.47 HD12 ' HA ' ' A' ' 59' ' ' PHE . 0.2 OUTLIER -54.65 -29.6 21.03 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.588 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.626 179.747 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 9.6 tt0 -56.25 -39.0 71.88 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-N 116.58 -0.282 . . . . 0.0 111.041 179.529 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -94.93 29.63 2.33 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-N 116.455 -0.339 . . . . 0.0 111.561 -179.817 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -114.71 136.69 52.79 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-O 120.577 0.227 . . . . 0.0 110.904 -179.961 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 25.6 m -71.8 102.54 2.87 Favored 'General case' 0 C--O 1.232 0.138 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.487 179.609 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 30.6 p90 -80.57 132.0 35.59 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.017 -179.788 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . 0.415 ' HB2' ' HG3' ' A' ' 21' ' ' MET . 53.2 mm-40 -108.95 95.08 16.17 Favored Pre-proline 0 C--O 1.234 0.28 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.618 179.916 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 67.0 Cg_endo -74.53 59.46 4.82 Favored 'Trans proline' 0 C--N 1.347 0.491 0 C-N-CA 122.615 2.21 . . . . 0.0 112.366 179.945 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -128.23 -49.19 1.31 Allowed 'General case' 0 CA--C 1.53 0.196 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.906 -179.914 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 16.0 m-80 -139.11 28.94 2.27 Favored 'General case' 0 CA--C 1.534 0.356 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.009 179.582 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . 0.81 ' HG2' HG21 ' A' ' 73' ' ' ILE . 3.9 mm-40 58.88 61.91 2.03 Favored 'General case' 0 CA--C 1.535 0.401 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.609 179.489 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . 0.415 ' HG3' ' HB2' ' A' ' 16' ' ' GLU . 20.8 ptp -134.7 141.18 46.46 Favored 'General case' 0 CA--C 1.531 0.227 0 CA-C-N 116.33 -0.396 . . . . 0.0 110.992 179.755 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 3.9 m-85 -111.23 125.68 54.06 Favored 'General case' 0 N--CA 1.463 0.176 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.492 179.713 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 29.6 p -117.27 160.85 20.44 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.329 -179.715 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 29.6 t80 -157.4 136.36 8.0 Favored Pre-proline 0 N--CA 1.463 0.175 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.018 -179.971 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -70.41 93.0 0.58 Allowed 'Trans proline' 0 C--N 1.347 0.448 0 C-N-CA 122.405 2.07 . . . . 0.0 111.989 179.421 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . 0.447 ' SG ' ' HD2' ' A' ' 27' ' ' PRO . 42.3 t -56.6 139.27 75.92 Favored Pre-proline 0 C--O 1.234 0.243 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.664 -179.968 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . 0.447 ' HD2' ' SG ' ' A' ' 26' ' ' CYS . 9.9 Cg_endo -53.23 -25.96 32.16 Favored 'Trans proline' 0 C--N 1.347 0.497 0 C-N-CA 122.926 2.418 . . . . 0.0 113.031 179.997 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . 0.411 ' CB ' ' HB3' ' A' ' 51' ' ' CYS . 0.6 OUTLIER -74.72 -39.43 61.9 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-O 120.461 0.172 . . . . 0.0 111.352 -179.898 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 150.04 -38.33 0.91 Allowed Glycine 0 C--N 1.334 0.467 0 C-N-CA 120.859 -0.686 . . . . 0.0 113.004 -179.802 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -72.04 -176.66 1.8 Allowed 'General case' 0 CA--C 1.533 0.321 0 CA-C-O 120.818 0.342 . . . . 0.0 111.215 -179.861 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 5.4 ttp-105 -116.7 123.67 47.8 Favored 'General case' 0 C--O 1.232 0.173 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.282 -179.375 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -73.65 99.95 3.23 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.643 179.534 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 9.7 mt-30 -92.98 136.39 33.3 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-N 116.474 -0.33 . . . . 0.0 111.208 -179.731 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.454 HG23 ' O ' ' A' ' 34' ' ' ILE . 1.0 OUTLIER -155.69 119.04 0.44 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.294 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.868 179.849 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 79.9 m-85 -81.86 159.07 23.8 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 116.444 -0.344 . . . . 0.0 110.934 -179.749 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.562 HD22 ' HG ' ' A' ' 64' ' ' LEU . 62.8 mt -55.16 -40.28 70.47 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.071 179.857 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 22.1 m-20 -60.38 -45.58 93.05 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-O 120.57 0.224 . . . . 0.0 110.555 179.395 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 64.5 m-20 -60.31 -43.52 96.28 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.139 179.132 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' MET . . . . . 0.424 ' HG2' ' HA ' ' A' ' 36' ' ' LEU . 1.8 ptm -90.77 36.79 0.91 Allowed 'General case' 0 CA--C 1.536 0.434 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.2 179.475 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 18.2 t80 -139.84 -49.89 0.48 Allowed 'General case' 0 CA--C 1.53 0.192 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.71 179.42 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 2.2 mm-40 -59.74 -35.88 75.47 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 116.526 -0.306 . . . . 0.0 110.911 179.613 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 140.59 52.28 0.04 OUTLIER Glycine 0 C--N 1.335 0.491 0 C-N-CA 120.951 -0.642 . . . . 0.0 113.015 179.568 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -129.03 102.3 6.44 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-O 120.796 0.332 . . . . 0.0 111.287 179.969 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.448 ' HG2' ' CE2' ' A' ' 59' ' ' PHE . 12.8 mttt -113.74 -34.98 5.31 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.02 179.723 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 29.7 t -79.12 79.11 0.9 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.238 0 CA-C-O 120.986 0.422 . . . . 0.0 110.565 179.849 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -87.56 151.54 22.91 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.333 -179.802 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 11.8 p -133.24 130.03 57.31 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.026 179.88 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 37.7 t -73.64 115.32 40.62 Favored Pre-proline 0 C--N 1.331 -0.238 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.312 179.859 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_exo -57.2 -21.63 44.32 Favored 'Trans proline' 0 CA--C 1.533 0.455 0 C-N-CA 122.703 2.269 . . . . 0.0 113.049 -179.996 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -76.25 -66.99 0.73 Allowed 'General case' 0 CA--C 1.533 0.294 0 N-CA-C 111.236 0.087 . . . . 0.0 111.236 -179.814 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' CYS . . . . . 0.411 ' HB3' ' CB ' ' A' ' 28' ' ' CYS . 27.4 p -81.7 -22.02 37.67 Favored 'General case' 0 N--CA 1.469 0.491 0 N-CA-C 111.991 0.367 . . . . 0.0 111.991 -179.826 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 1.3 t 69.65 37.88 1.81 Allowed 'General case' 0 CA--C 1.534 0.347 0 CA-C-O 120.802 0.334 . . . . 0.0 111.204 -179.762 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.488 HD21 ' HB2' ' A' ' 5' ' ' TYR . 2.8 tt -106.27 127.21 53.07 Favored 'General case' 0 CA--C 1.53 0.183 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.894 179.832 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' MET . . . . . . . . . . . . . 24.6 mtt -84.12 142.18 30.56 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.428 -179.467 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 2.8 pp -142.78 163.77 17.24 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.298 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.595 179.917 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . 0.428 ' CG ' HG21 ' A' ' 4' ' ' THR . 75.3 m-20 -115.9 106.91 14.34 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.704 179.03 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.462 HG13 ' O ' ' A' ' 57' ' ' VAL . 11.2 p -97.78 115.11 36.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-O 120.992 0.425 . . . . 0.0 110.624 179.59 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 14.4 p -81.95 125.46 39.75 Favored 'Isoleucine or valine' 0 C--O 1.233 0.199 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.032 -179.646 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . 0.47 ' HA ' HD12 ' A' ' 10' ' ' ILE . 11.3 p90 -136.7 167.61 21.09 Favored 'General case' 0 CA--C 1.531 0.218 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.465 -179.494 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 3.4 t0 -113.63 175.69 5.35 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.054 179.708 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 3.1 ttmt -100.23 -41.0 7.27 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.229 -179.958 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -59.36 -35.48 73.97 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 116.461 -0.336 . . . . 0.0 111.076 179.794 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 2.8 t0 -54.24 -43.27 70.76 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.168 -179.913 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.562 ' HG ' HD22 ' A' ' 36' ' ' LEU . 4.3 mp -60.22 -51.81 67.97 Favored 'General case' 0 N--CA 1.462 0.146 0 CA-C-N 116.444 -0.344 . . . . 0.0 110.903 179.877 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -53.84 -42.04 68.07 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-N 116.4 -0.363 . . . . 0.0 111.092 179.69 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 16.9 mm-40 -72.53 -41.28 66.03 Favored 'General case' 0 CA--C 1.528 0.132 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.018 179.579 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -61.0 -35.09 75.92 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 116.524 -0.307 . . . . 0.0 111.636 -179.877 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 3.8 m-85 -56.82 -52.19 66.03 Favored 'General case' 0 N--CA 1.462 0.154 0 CA-C-N 116.704 -0.226 . . . . 0.0 110.829 -179.967 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -75.59 -35.16 60.63 Favored 'General case' 0 CA--C 1.53 0.196 0 CA-C-N 116.542 -0.299 . . . . 0.0 111.013 179.711 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 1.8 mm-40 -61.0 -47.77 84.92 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-N 116.481 -0.327 . . . . 0.0 111.2 -179.958 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -81.91 149.8 28.06 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-O 120.842 0.353 . . . . 0.0 111.146 179.914 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -95.74 31.37 7.28 Favored Glycine 0 C--N 1.332 0.336 0 C-N-CA 121.127 -0.558 . . . . 0.0 112.499 179.7 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.81 HG21 ' HG2' ' A' ' 20' ' ' GLN . 2.2 pp -63.53 130.46 28.35 Favored 'Isoleucine or valine' 0 C--O 1.233 0.196 0 CA-C-O 120.718 0.294 . . . . 0.0 111.005 179.964 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -120.35 88.43 42.13 Favored Pre-proline 0 C--N 1.33 -0.242 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.93 -179.675 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . 0.58 ' HD3' HD12 ' A' ' 73' ' ' ILE . 52.6 Cg_exo -53.7 151.26 25.95 Favored 'Trans proline' 0 C--N 1.347 0.452 0 C-N-CA 122.859 2.373 . . . . 0.0 112.806 -179.873 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_endo -69.46 101.19 0.84 Allowed 'Trans proline' 0 C--N 1.349 0.596 0 C-N-CA 122.87 2.38 . . . . 0.0 112.585 -179.747 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 15.8 mt-10 -146.7 88.66 5.97 Favored Pre-proline 0 CA--C 1.534 0.347 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.139 -179.911 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_exo -56.55 153.97 32.83 Favored 'Trans proline' 0 C--N 1.35 0.654 0 C-N-CA 123.128 2.552 . . . . 0.0 113.004 -179.774 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 3.5 pt -137.1 30.69 0.65 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.433 0 CA-C-N 116.12 -0.491 . . . . 0.0 112.171 -179.856 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -162.21 130.73 4.16 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-O 120.673 0.273 . . . . 0.0 111.731 179.76 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -143.85 34.47 1.26 Allowed 'General case' 0 C--O 1.233 0.224 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.332 179.493 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -140.46 -58.07 0.53 Allowed 'General case' 0 CA--C 1.528 0.129 0 CA-C-N 116.499 -0.319 . . . . 0.0 111.108 179.712 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.106 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.019 179.839 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 13.0 mtm . . . . . 0 N--CA 1.491 1.582 0 CA-C-O 120.667 0.27 . . . . 0.0 111.178 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 11.1 p -132.22 130.98 60.95 Favored 'Isoleucine or valine' 0 C--O 1.233 0.225 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.146 -179.967 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 4.8 t -94.59 158.15 15.66 Favored 'General case' 0 C--O 1.232 0.184 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.873 179.944 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 81.8 p -149.65 144.02 25.88 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.377 -179.74 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . 0.517 ' CD1' HD11 ' A' ' 53' ' ' LEU . 18.7 m-85 -109.13 -38.89 5.43 Favored 'General case' 0 CA--C 1.531 0.217 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.198 179.702 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -157.02 175.14 14.49 Favored 'General case' 0 C--O 1.234 0.284 0 CA-C-N 116.484 -0.325 . . . . 0.0 111.244 179.881 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 2.6 pt-20 -135.24 125.98 27.25 Favored 'General case' 0 CA--C 1.53 0.189 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.122 179.856 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 4.6 mt -119.86 152.4 22.55 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.241 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.182 -179.745 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . 0.556 ' HA ' HG12 ' A' ' 58' ' ' VAL . 16.5 mt-10 -97.94 147.71 24.2 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.254 -179.998 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 8.0 tp -58.38 -31.37 42.74 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.238 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.138 179.476 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -59.32 -32.81 70.41 Favored 'General case' 0 CA--C 1.531 0.218 0 CA-C-N 116.551 -0.295 . . . . 0.0 110.934 179.603 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 5.5 t0 -97.57 36.09 1.55 Allowed 'General case' 0 CA--C 1.532 0.276 0 CA-C-O 120.914 0.387 . . . . 0.0 110.964 179.65 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -121.01 156.93 31.08 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.688 179.831 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 24.4 m -81.44 150.09 28.49 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.586 179.839 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 16.0 p90 -120.87 144.8 48.19 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.819 179.851 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -118.17 88.71 33.16 Favored Pre-proline 0 C--O 1.235 0.309 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.743 179.91 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 16.8 Cg_exo -68.27 72.47 0.85 Allowed 'Trans proline' 0 C--N 1.35 0.634 0 C-N-CA 122.98 2.453 . . . . 0.0 112.387 -179.711 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 1.1 pp20? -151.85 -50.39 0.11 Allowed 'General case' 0 C--O 1.233 0.212 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.992 179.907 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 20.8 m-20 -129.74 26.95 5.26 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-O 120.666 0.269 . . . . 0.0 111.223 179.495 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . 0.505 ' HG3' HD23 ' A' ' 36' ' ' LEU . 0.0 OUTLIER 56.82 54.64 6.96 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-O 120.992 0.425 . . . . 0.0 111.439 179.82 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 10.2 ptm -133.71 154.12 51.19 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.919 179.619 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 5.9 m-85 -119.06 147.69 43.85 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.081 -0.508 . . . . 0.0 111.052 -179.727 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . 0.411 ' HA ' ' O ' ' A' ' 32' ' ' PHE . 20.5 p -123.35 173.79 7.74 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.141 -0.482 . . . . 0.0 111.209 179.918 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 60.8 t80 -172.12 99.83 0.37 Allowed Pre-proline 0 C--O 1.232 0.136 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.683 179.962 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_exo -51.21 99.76 0.04 OUTLIER 'Trans proline' 0 C--N 1.349 0.572 0 C-N-CA 122.684 2.256 . . . . 0.0 112.094 -179.905 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 45.9 t -60.53 138.38 92.63 Favored Pre-proline 0 C--N 1.331 -0.218 0 CA-C-N 116.053 -0.522 . . . . 0.0 110.776 -179.761 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 70.3 Cg_exo -51.84 -24.78 19.45 Favored 'Trans proline' 0 C--N 1.348 0.542 0 C-N-CA 122.695 2.263 . . . . 0.0 112.818 179.828 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 1.1 p -66.96 -37.96 85.24 Favored 'General case' 0 CA--C 1.533 0.305 0 CA-C-O 120.526 0.203 . . . . 0.0 111.221 179.902 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 151.88 -44.61 0.64 Allowed Glycine 0 C--N 1.335 0.498 0 C-N-CA 120.8 -0.714 . . . . 0.0 112.955 -179.996 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -72.34 -173.0 1.01 Allowed 'General case' 0 CA--C 1.532 0.278 0 CA-C-O 120.687 0.279 . . . . 0.0 111.337 -179.799 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 33.0 ttm180 -129.5 124.15 33.27 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-O 120.698 0.285 . . . . 0.0 111.052 -179.813 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . 0.411 ' O ' ' HA ' ' A' ' 23' ' ' THR . 1.8 m-85 -61.18 155.64 20.29 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.878 179.664 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 3.8 pt20 -147.16 112.02 5.38 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-N 116.376 -0.375 . . . . 0.0 111.15 179.763 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.404 ' CD1' ' HG2' ' A' ' 39' ' ' MET . 2.4 tt -140.48 134.91 35.0 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.955 179.904 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 8.5 m-85 -87.92 161.91 17.19 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.939 -179.811 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.505 HD23 ' HG3' ' A' ' 20' ' ' GLN . 4.0 mm? -60.63 -46.05 91.76 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.136 -179.991 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -60.57 -36.59 78.88 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-O 120.717 0.294 . . . . 0.0 110.769 179.425 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -60.68 -41.38 94.99 Favored 'General case' 0 C--N 1.334 -0.075 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.535 179.635 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' MET . . . . . 0.404 ' HG2' ' CD1' ' A' ' 34' ' ' ILE . 4.6 mmm -91.78 29.64 1.52 Allowed 'General case' 0 CA--C 1.535 0.401 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.089 179.303 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . 0.66 ' HB2' HD21 ' A' ' 64' ' ' LEU . 16.9 t80 -126.26 -43.54 1.78 Allowed 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 116.499 -0.318 . . . . 0.0 111.174 179.734 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -59.4 -68.13 0.31 Allowed 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 116.519 -0.31 . . . . 0.0 111.477 -179.467 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -169.62 55.76 0.2 Allowed Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.544 -0.836 . . . . 0.0 112.508 -179.761 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -110.15 160.31 16.59 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.834 0.35 . . . . 0.0 111.073 -179.866 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -163.83 -45.13 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.912 -0.585 . . . . 0.0 111.656 179.953 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.482 ' O ' HG13 ' A' ' 45' ' ' VAL . 8.9 p -116.67 112.68 40.36 Favored 'Isoleucine or valine' 0 C--O 1.233 0.224 0 CA-C-O 120.977 0.418 . . . . 0.0 111.101 -179.876 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -95.31 168.23 10.86 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.53 -179.589 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 18.6 t -139.74 125.79 22.29 Favored 'Isoleucine or valine' 0 C--O 1.232 0.173 0 CA-C-N 115.98 -0.554 . . . . 0.0 111.205 -179.855 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 42.5 t -73.73 114.58 33.7 Favored Pre-proline 0 C--N 1.331 -0.207 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.267 179.573 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_exo -59.24 -20.5 55.44 Favored 'Trans proline' 0 C--N 1.346 0.414 0 C-N-CA 122.569 2.179 . . . . 0.0 112.875 179.946 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -75.75 -67.32 0.68 Allowed 'General case' 0 CA--C 1.531 0.226 0 CA-C-N 116.789 -0.187 . . . . 0.0 111.316 -179.711 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 23.9 p -83.62 -22.42 32.23 Favored 'General case' 0 N--CA 1.466 0.37 0 N-CA-C 111.933 0.346 . . . . 0.0 111.933 -179.706 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER 70.79 39.42 1.08 Allowed 'General case' 0 CA--C 1.533 0.292 0 CA-C-O 120.891 0.377 . . . . 0.0 110.863 -179.678 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.517 HD11 ' CD1' ' A' ' 5' ' ' TYR . 7.4 tp -100.98 143.57 30.96 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.958 179.982 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' MET . . . . . . . . . . . . . 42.2 mtt -95.19 138.09 33.37 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.089 -179.827 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.426 ' O ' HG23 ' A' ' 45' ' ' VAL . 2.5 pp -148.08 145.07 18.86 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.259 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.653 -179.884 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -92.77 104.89 17.11 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.688 179.411 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.494 HG13 ' O ' ' A' ' 57' ' ' VAL . 13.4 p -108.42 112.96 42.61 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-O 121.036 0.446 . . . . 0.0 111.167 179.717 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.556 HG12 ' HA ' ' A' ' 9' ' ' GLU . 14.5 p -83.61 150.42 4.18 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.28 -179.759 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 47.2 p90 -119.36 177.84 4.76 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.224 -179.846 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . 0.426 ' O ' HD13 ' A' ' 64' ' ' LEU . 4.7 m-20 -121.96 172.83 7.92 Favored 'General case' 0 C--O 1.232 0.159 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.109 179.793 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 16.1 mmtt -105.6 -46.32 4.2 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.789 179.647 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -66.44 -40.75 89.66 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.894 179.774 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -57.94 -37.63 74.46 Favored 'General case' 0 N--CA 1.462 0.156 0 CA-C-N 116.554 -0.294 . . . . 0.0 111.203 179.913 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.66 HD21 ' HB2' ' A' ' 40' ' ' PHE . 0.4 OUTLIER -60.53 -41.0 93.53 Favored 'General case' 0 CA--C 1.53 0.189 0 CA-C-N 116.664 -0.244 . . . . 0.0 111.022 179.896 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -82.5 -42.96 17.77 Favored 'General case' 0 C--O 1.232 0.173 0 CA-C-N 116.485 -0.325 . . . . 0.0 111.015 179.687 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -61.18 -50.55 72.67 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.653 179.836 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 55.3 t80 -63.2 -31.86 73.12 Favored 'General case' 0 CA--C 1.53 0.196 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.331 179.649 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 2.0 t80 -61.93 -59.73 4.67 Favored 'General case' 0 C--O 1.232 0.143 0 CA-C-O 120.545 0.212 . . . . 0.0 110.851 179.918 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 2.1 tp10 -63.56 -35.33 80.14 Favored 'General case' 0 N--CA 1.462 0.17 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.388 -179.977 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 25.4 mt-10 -71.65 -36.47 70.69 Favored 'General case' 0 CA--C 1.53 0.179 0 CA-C-N 116.544 -0.298 . . . . 0.0 111.371 -179.893 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -79.61 -40.72 28.66 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 120.589 0.233 . . . . 0.0 111.353 180.0 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 66.1 62.22 4.86 Favored Glycine 0 C--N 1.335 0.528 0 C-N-CA 120.985 -0.626 . . . . 0.0 112.724 179.844 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 9.1 tp -58.08 -35.14 51.32 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.229 0 CA-C-O 120.556 0.217 . . . . 0.0 111.547 -179.991 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 9.7 m80 -98.41 149.41 35.71 Favored Pre-proline 0 C--O 1.234 0.237 0 CA-C-N 116.502 -0.317 . . . . 0.0 110.698 179.601 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo -53.83 152.72 21.94 Favored 'Trans proline' 0 C--N 1.35 0.635 0 C-N-CA 122.873 2.382 . . . . 0.0 112.665 -179.999 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 41.0 Cg_endo -67.02 -31.7 36.51 Favored 'Trans proline' 0 C--N 1.348 0.506 0 C-N-CA 122.526 2.15 . . . . 0.0 112.504 179.768 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . 0.609 ' O ' ' HB2' ' A' ' 81' ' ' ALA . 0.2 OUTLIER -141.67 87.16 10.32 Favored Pre-proline 0 C--O 1.232 0.168 0 CA-C-N 116.544 -0.298 . . . . 0.0 111.018 -179.981 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -69.98 -178.59 2.5 Favored 'Trans proline' 0 C--N 1.347 0.486 0 C-N-CA 122.576 2.184 . . . . 0.0 112.348 179.994 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 33.7 mt 68.44 102.35 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.339 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.618 -179.745 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . 60.08 37.6 20.96 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.075 -179.204 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . 0.609 ' HB2' ' O ' ' A' ' 77' ' ' GLU . . . -95.7 131.05 42.38 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.154 -179.965 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -80.23 164.67 23.06 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.114 179.893 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.331 -0.197 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.069 179.929 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 14.5 mtt . . . . . 0 N--CA 1.492 1.657 0 CA-C-O 120.654 0.264 . . . . 0.0 111.362 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 11.7 p -147.91 147.65 17.01 Favored 'Isoleucine or valine' 0 C--O 1.234 0.275 0 CA-C-N 116.558 -0.292 . . . . 0.0 111.28 -179.885 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 1.3 m -164.06 156.65 17.42 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.279 -179.918 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.437 HG21 ' CG ' ' A' ' 56' ' ' ASP . 0.8 OUTLIER -102.8 176.87 5.01 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.277 179.889 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 58.9 m-85 -98.95 -35.81 9.95 Favored 'General case' 0 CA--C 1.531 0.241 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.49 -179.891 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -158.85 173.55 16.36 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-O 120.759 0.314 . . . . 0.0 111.323 -179.92 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 2.7 tm-20 -138.58 122.72 18.03 Favored 'General case' 0 CA--C 1.531 0.24 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.879 -179.886 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 4.8 mt -126.21 152.36 33.5 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.338 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.114 -179.747 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 3.0 pt-20 -96.95 153.17 18.06 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.622 -179.99 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.464 HD13 ' CE ' ' A' ' 39' ' ' MET . 1.2 tp -62.99 -34.66 67.73 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.313 0 CA-C-N 115.947 -0.569 . . . . 0.0 111.36 179.58 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -58.74 -32.87 69.63 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-N 116.609 -0.269 . . . . 0.0 111.157 179.681 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -97.28 36.1 1.51 Allowed 'General case' 0 CA--C 1.537 0.47 0 CA-C-O 120.81 0.338 . . . . 0.0 111.311 179.783 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . 0.409 ' HG3' ' HB2' ' A' ' 24' ' ' TYR . 1.7 ttt -121.54 148.83 43.98 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.888 179.787 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -69.33 126.93 31.3 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-O 120.826 0.346 . . . . 0.0 110.873 179.971 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 14.4 t80 -94.59 123.97 38.33 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.509 179.596 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 1.4 tp10 -108.96 92.1 10.2 Favored Pre-proline 0 C--O 1.234 0.256 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.314 179.499 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 64.3 Cg_endo -73.6 61.27 4.4 Favored 'Trans proline' 0 C--N 1.351 0.677 0 C-N-CA 122.793 2.329 . . . . 0.0 112.72 -179.44 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 19.1 pt-20 -131.44 -45.82 0.99 Allowed 'General case' 0 CA--C 1.533 0.302 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.885 179.772 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -141.71 32.13 1.63 Allowed 'General case' 0 CA--C 1.534 0.363 0 CA-C-N 116.515 -0.311 . . . . 0.0 111.057 179.406 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 91.3 mt-30 55.15 59.88 3.75 Favored 'General case' 0 C--O 1.236 0.363 0 CA-C-O 120.955 0.407 . . . . 0.0 111.413 179.931 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 9.6 ptp -130.41 148.72 52.25 Favored 'General case' 0 C--O 1.235 0.307 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.343 179.909 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 25.4 m-85 -124.6 102.89 7.84 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.896 179.994 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . 0.415 HG22 ' HA ' ' A' ' 33' ' ' GLN . 66.9 p -101.54 166.83 10.5 Favored 'General case' 0 CA--C 1.532 0.261 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.84 -179.827 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . 0.409 ' HB2' ' HG3' ' A' ' 13' ' ' MET . 62.3 t80 -164.7 139.6 4.42 Favored Pre-proline 0 CA--C 1.531 0.235 0 CA-C-O 120.599 0.237 . . . . 0.0 111.377 179.774 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -53.2 121.79 10.03 Favored 'Trans proline' 0 C--N 1.352 0.724 0 C-N-CA 122.994 2.462 . . . . 0.0 113.144 -179.979 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . 0.461 ' SG ' ' HD2' ' A' ' 27' ' ' PRO . 42.1 t -90.64 140.3 26.57 Favored Pre-proline 0 C--N 1.331 -0.218 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.497 179.38 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . 0.461 ' HD2' ' SG ' ' A' ' 26' ' ' CYS . 73.8 Cg_exo -50.7 -27.82 20.92 Favored 'Trans proline' 0 C--N 1.349 0.587 0 C-N-CA 122.898 2.398 . . . . 0.0 113.026 179.536 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . 0.402 ' CB ' ' HB3' ' A' ' 51' ' ' CYS . 0.9 OUTLIER -69.51 -38.89 77.77 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-N 116.799 -0.182 . . . . 0.0 111.446 -179.959 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 151.92 -48.4 0.55 Allowed Glycine 0 C--N 1.336 0.57 0 C-N-CA 120.854 -0.689 . . . . 0.0 112.958 -179.933 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -73.96 -175.11 2.05 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-O 120.665 0.269 . . . . 0.0 110.966 179.984 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 19.5 mtt180 -118.72 134.66 54.98 Favored 'General case' 0 C--O 1.232 0.164 0 CA-C-O 120.677 0.275 . . . . 0.0 110.826 179.924 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 6.8 m-85 -62.23 168.0 3.7 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.811 179.653 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . 0.415 ' HA ' HG22 ' A' ' 23' ' ' THR . 5.8 tt0 -155.58 121.95 5.21 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-O 120.695 0.283 . . . . 0.0 111.274 179.882 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 5.8 tt -146.04 138.81 20.45 Favored 'Isoleucine or valine' 0 C--O 1.234 0.25 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.085 179.646 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 25.6 m-85 -95.58 155.49 16.72 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.993 179.992 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.838 HD22 ' HG ' ' A' ' 64' ' ' LEU . 87.9 mt -62.63 -39.84 95.11 Favored 'General case' 0 CA--C 1.53 0.199 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.016 179.72 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -66.2 -34.81 78.86 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 116.683 -0.235 . . . . 0.0 111.196 179.409 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -62.7 -57.99 9.06 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-O 120.918 0.389 . . . . 0.0 110.591 179.991 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' MET . . . . . 0.464 ' CE ' HD13 ' A' ' 10' ' ' ILE . 5.6 ptm -63.04 -34.62 77.97 Favored 'General case' 0 CA--C 1.534 0.343 0 CA-C-N 115.956 -0.565 . . . . 0.0 111.291 179.764 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . 0.405 ' HB2' ' CD2' ' A' ' 64' ' ' LEU . 31.6 t80 -61.14 -45.06 96.18 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-N 116.551 -0.295 . . . . 0.0 110.882 179.485 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 2.6 tp10 -56.0 -40.8 73.89 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.709 179.471 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 148.47 47.86 0.02 OUTLIER Glycine 0 C--N 1.335 0.49 0 C-N-CA 121.146 -0.55 . . . . 0.0 112.672 179.755 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 4.3 tt0 -112.4 123.19 49.73 Favored 'General case' 0 C--O 1.232 0.159 0 CA-C-O 120.826 0.346 . . . . 0.0 111.149 -179.795 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 19.4 mtmt -122.46 -43.75 2.27 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-N 115.917 -0.583 . . . . 0.0 111.026 179.726 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.483 ' O ' HG13 ' A' ' 45' ' ' VAL . 12.0 p -108.16 113.21 43.26 Favored 'Isoleucine or valine' 0 C--O 1.233 0.209 0 CA-C-O 121.011 0.434 . . . . 0.0 111.005 179.781 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -102.24 164.66 11.56 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.154 -179.815 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 11.6 p -124.49 129.09 73.93 Favored 'Isoleucine or valine' 0 C--O 1.233 0.207 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.227 -179.909 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 47.9 t -67.86 135.52 92.16 Favored Pre-proline 0 C--O 1.233 0.229 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.79 179.929 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 84.5 Cg_endo -83.54 21.09 1.08 Allowed 'Trans proline' 0 CA--C 1.537 0.639 0 C-N-CA 122.729 2.286 . . . . 0.0 113.056 179.777 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 7.7 t -129.07 -56.82 1.17 Allowed 'General case' 0 C--O 1.233 0.204 0 CA-C-N 116.615 -0.266 . . . . 0.0 110.512 179.768 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' CYS . . . . . 0.402 ' HB3' ' CB ' ' A' ' 28' ' ' CYS . 18.5 p -100.63 -10.59 20.79 Favored 'General case' 0 CA--C 1.538 0.481 0 N-CA-C 112.276 0.473 . . . . 0.0 112.276 179.924 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 6.5 p 60.24 35.85 20.87 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-O 120.863 0.363 . . . . 0.0 111.765 -179.903 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.599 HD23 HG23 ' A' ' 55' ' ' ILE . 6.6 tt -94.95 121.34 36.46 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.698 179.394 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' MET . . . . . . . . . . . . . 6.9 mtt -85.94 141.53 29.48 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.171 -179.712 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.599 HG23 HD23 ' A' ' 53' ' ' LEU . 3.8 pt -145.19 148.19 17.99 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.295 0 CA-C-N 115.934 -0.575 . . . . 0.0 111.495 179.997 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . 0.437 ' CG ' HG21 ' A' ' 4' ' ' THR . 72.3 m-20 -93.27 104.74 16.89 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.463 178.918 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.485 HG13 ' O ' ' A' ' 57' ' ' VAL . 12.5 p -100.22 112.37 32.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 121.057 0.456 . . . . 0.0 110.879 179.72 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 14.2 p -81.04 130.87 35.14 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.172 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.709 -179.852 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 42.1 p90 -133.41 176.96 8.06 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.29 -179.275 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 4.3 t70 -122.38 144.91 48.73 Favored 'General case' 0 N--CA 1.462 0.17 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.4 -179.923 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 11.7 mttp -76.7 -40.01 50.14 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.153 179.699 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 17.7 tt0 -58.43 -37.66 75.86 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 116.617 -0.265 . . . . 0.0 110.595 179.531 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . 0.478 ' HB3' ' CE2' ' A' ' 67' ' ' TYR . 3.4 m-20 -56.03 -43.87 78.2 Favored 'General case' 0 N--CA 1.463 0.19 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.954 179.425 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.838 ' HG ' HD22 ' A' ' 36' ' ' LEU . 3.0 mp -53.31 -53.41 51.4 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 116.469 -0.332 . . . . 0.0 111.185 179.987 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -56.24 -39.65 72.88 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 116.512 -0.313 . . . . 0.0 110.846 179.511 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -69.19 -39.74 78.49 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.05 179.367 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . 0.478 ' CE2' ' HB3' ' A' ' 63' ' ' ASP . 20.1 m-85 -69.12 -37.93 78.62 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 116.634 -0.257 . . . . 0.0 111.624 -179.861 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 5.7 m-85 -62.17 -38.25 88.35 Favored 'General case' 0 N--CA 1.463 0.211 0 C-N-CA 121.247 -0.181 . . . . 0.0 110.635 179.966 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -80.96 -36.26 31.13 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-N 116.48 -0.327 . . . . 0.0 111.084 179.262 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 5.7 mt-10 -72.28 -35.68 68.79 Favored 'General case' 0 N--CA 1.467 0.376 0 N-CA-C 111.681 0.252 . . . . 0.0 111.681 -179.834 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -87.42 -56.68 3.25 Favored 'General case' 0 C--O 1.233 0.215 0 N-CA-C 111.517 0.191 . . . . 0.0 111.517 -179.643 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 79.9 57.5 3.03 Favored Glycine 0 C--N 1.334 0.447 0 C-N-CA 120.89 -0.671 . . . . 0.0 112.782 179.98 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 10.7 tp -60.9 146.01 11.96 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.33 0 CA-C-O 120.753 0.311 . . . . 0.0 111.554 -179.932 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 55.4 m80 -99.15 160.83 26.64 Favored Pre-proline 0 C--O 1.234 0.262 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.796 179.511 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_exo -52.6 152.17 17.14 Favored 'Trans proline' 0 C--N 1.352 0.725 0 C-N-CA 122.928 2.418 . . . . 0.0 112.933 -179.779 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_endo -68.89 134.21 29.26 Favored 'Trans proline' 0 C--N 1.35 0.643 0 C-N-CA 122.685 2.257 . . . . 0.0 112.314 179.86 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER 61.18 86.11 0.16 Allowed Pre-proline 0 N--CA 1.466 0.327 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.258 -179.78 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_endo -68.61 111.32 2.53 Favored 'Trans proline' 0 C--N 1.349 0.563 0 C-N-CA 122.684 2.256 . . . . 0.0 112.312 179.949 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 21.4 mt 65.19 81.53 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.308 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.777 -179.651 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -104.78 92.91 4.46 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-N 115.801 -0.636 . . . . 0.0 111.281 -179.545 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . 69.29 151.83 0.09 Allowed 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.752 179.901 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . 63.61 100.78 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.511 -179.997 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.095 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.162 179.924 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 6.9 mtt . . . . . 0 N--CA 1.49 1.575 0 CA-C-O 120.68 0.276 . . . . 0.0 111.289 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 21.0 t -75.35 139.65 18.7 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.219 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.121 179.931 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 2.0 m -105.84 107.48 18.5 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.487 179.578 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.493 HG22 ' HA ' ' A' ' 55' ' ' ILE . 0.2 OUTLIER -153.35 178.73 9.46 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-N 116.262 -0.427 . . . . 0.0 111.477 -179.284 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 9.3 m-85 -106.68 -43.65 4.66 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.37 179.721 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 12.0 m-20 -151.74 175.53 12.31 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-O 120.782 0.325 . . . . 0.0 111.484 179.791 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 19.5 tt0 -128.0 122.62 32.73 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.443 179.514 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 28.5 mm -120.33 155.04 23.53 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.162 -179.584 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -112.55 150.98 30.56 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-N 116.308 -0.406 . . . . 0.0 111.292 179.867 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 2.8 tt -58.72 -31.89 45.38 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.331 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.239 179.576 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 17.8 mt-10 -66.24 -30.91 71.44 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-N 116.374 -0.375 . . . . 0.0 111.106 179.501 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 3.3 t70 -98.03 38.37 1.32 Allowed 'General case' 0 CA--C 1.533 0.313 0 CA-C-O 120.889 0.376 . . . . 0.0 111.052 179.816 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 1.8 mtp -128.39 156.17 43.56 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.782 179.778 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 8.7 m -87.4 108.2 18.89 Favored 'General case' 0 N--CA 1.462 0.15 0 CA-C-O 120.835 0.35 . . . . 0.0 110.952 -179.923 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . 0.419 ' HB3' ' CZ ' ' A' ' 22' ' ' PHE . 29.8 p90 -85.12 138.12 32.6 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.764 179.754 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 25.1 mt-10 -103.9 96.36 9.16 Favored Pre-proline 0 C--O 1.234 0.263 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.406 179.848 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -71.77 63.62 3.12 Favored 'Trans proline' 0 C--N 1.35 0.654 0 C-N-CA 122.812 2.342 . . . . 0.0 112.721 -179.497 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 7.1 pt-20 -135.14 -53.78 0.79 Allowed 'General case' 0 C--N 1.333 -0.144 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.741 179.535 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 71.6 m-20 -133.08 33.04 3.68 Favored 'General case' 0 CA--C 1.534 0.345 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.999 179.479 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . 0.546 ' OE1' HD11 ' A' ' 36' ' ' LEU . 25.4 mt-30 56.81 49.84 13.52 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-O 120.802 0.334 . . . . 0.0 111.287 179.936 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 9.6 ttp -122.62 157.18 32.72 Favored 'General case' 0 N--CA 1.463 0.176 0 CA-C-O 120.737 0.304 . . . . 0.0 111.161 -179.942 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.433 ' O ' ' HA ' ' A' ' 33' ' ' GLN . 5.8 m-85 -121.28 164.43 17.01 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.852 -179.988 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 25.6 p -144.59 150.93 38.29 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.095 179.487 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 86.5 t80 -145.38 95.91 4.95 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.243 179.282 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.403 ' HA ' ' HA ' ' A' ' 31' ' ' ARG . 53.1 Cg_exo -55.05 94.33 0.04 OUTLIER 'Trans proline' 0 C--N 1.349 0.559 0 C-N-CA 122.719 2.279 . . . . 0.0 111.832 179.967 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . 0.422 ' SG ' ' HD2' ' A' ' 27' ' ' PRO . 45.3 t -63.8 137.89 97.23 Favored Pre-proline 0 C--O 1.234 0.243 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.095 -179.306 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . 0.422 ' HD2' ' SG ' ' A' ' 26' ' ' CYS . 10.9 Cg_endo -54.84 -20.33 22.11 Favored 'Trans proline' 0 C--N 1.35 0.626 0 C-N-CA 122.906 2.404 . . . . 0.0 112.831 179.777 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 12.4 p -55.49 -29.31 58.55 Favored 'General case' 0 CA--C 1.535 0.378 0 CA-C-O 120.592 0.234 . . . . 0.0 111.398 179.68 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 125.55 5.43 6.52 Favored Glycine 0 CA--C 1.526 0.737 0 C-N-CA 121.143 -0.551 . . . . 0.0 113.692 179.836 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -126.55 -167.12 1.67 Allowed 'General case' 0 CA--C 1.536 0.408 0 CA-C-N 117.412 0.606 . . . . 0.0 111.324 -179.814 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . 0.403 ' HA ' ' HA ' ' A' ' 25' ' ' PRO . 8.6 ttm-85 -121.36 150.1 41.96 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-O 120.8 0.333 . . . . 0.0 111.506 -179.596 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . 0.474 ' HZ ' ' HB1' ' A' ' 46' ' ' ALA . 21.7 t80 -103.43 162.27 13.17 Favored 'General case' 0 CA--C 1.529 0.153 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.882 179.368 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . 0.433 ' HA ' ' O ' ' A' ' 22' ' ' PHE . 3.2 pt20 -149.7 115.64 5.66 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.879 179.65 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.427 HG21 ' HE2' ' A' ' 39' ' ' MET . 3.3 tt -130.71 128.3 62.92 Favored 'Isoleucine or valine' 0 C--O 1.234 0.245 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.062 179.989 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -80.23 123.53 28.02 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.054 -179.667 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.546 HD11 ' OE1' ' A' ' 20' ' ' GLN . 3.7 pp -61.28 -38.59 87.33 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.998 179.601 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . 0.537 ' N ' HD12 ' A' ' 36' ' ' LEU . 3.7 t70 -56.3 -46.37 79.83 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 116.503 -0.317 . . . . 0.0 110.801 179.538 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -65.92 -45.59 81.33 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.518 179.435 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' MET . . . . . 0.427 ' HE2' HG21 ' A' ' 34' ' ' ILE . 1.6 mtm -52.05 -25.62 9.02 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.852 179.687 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -53.97 -35.46 61.81 Favored 'General case' 0 N--CA 1.467 0.397 0 N-CA-C 111.559 0.207 . . . . 0.0 111.559 179.775 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 -58.44 -31.59 67.91 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-N 116.646 -0.252 . . . . 0.0 111.565 179.75 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 125.14 45.54 0.25 Allowed Glycine 0 C--N 1.335 0.509 0 C-N-CA 121.218 -0.515 . . . . 0.0 112.771 179.81 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -84.1 133.31 34.64 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-O 120.687 0.28 . . . . 0.0 110.908 179.996 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 3.4 ptpp? -126.54 -45.26 1.65 Allowed 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.385 -179.9 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 12.2 p -94.55 131.44 41.38 Favored 'Isoleucine or valine' 0 C--O 1.233 0.223 0 CA-C-N 116.418 -0.355 . . . . 0.0 110.715 179.797 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.474 ' HB1' ' HZ ' ' A' ' 32' ' ' PHE . . . -129.82 144.79 51.48 Favored 'General case' 0 C--O 1.234 0.288 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.109 -179.676 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 11.3 p -110.36 123.88 66.64 Favored 'Isoleucine or valine' 0 C--O 1.233 0.223 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.15 -179.828 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 52.5 t -62.2 134.72 94.72 Favored Pre-proline 0 N--CA 1.463 0.214 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.99 179.905 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 90.7 Cg_endo -84.98 24.55 0.76 Allowed 'Trans proline' 0 C--N 1.349 0.58 0 C-N-CA 122.713 2.275 . . . . 0.0 112.993 179.926 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 1.4 m -132.99 -60.29 0.87 Allowed 'General case' 0 CA--C 1.53 0.191 0 CA-C-N 116.503 -0.317 . . . . 0.0 110.586 -179.83 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 22.6 p -102.35 -13.98 17.1 Favored 'General case' 0 CA--C 1.537 0.462 0 N-CA-C 111.869 0.322 . . . . 0.0 111.869 179.494 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 6.4 t 66.82 34.28 5.6 Favored 'General case' 0 CA--C 1.534 0.365 0 CA-C-O 120.895 0.379 . . . . 0.0 111.286 -179.815 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.65 HD23 HG23 ' A' ' 55' ' ' ILE . 8.0 tt -85.21 134.27 34.15 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.604 179.663 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' MET . . . . . . . . . . . . . 40.7 mtm -82.79 133.0 35.15 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.198 -179.635 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.65 HG23 HD23 ' A' ' 53' ' ' LEU . 2.7 pt -138.68 151.07 23.85 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.394 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.853 -179.829 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 71.1 m-20 -97.02 88.47 4.52 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.741 179.297 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.472 HG13 ' O ' ' A' ' 57' ' ' VAL . 12.5 p -94.5 114.52 31.26 Favored 'Isoleucine or valine' 0 C--O 1.234 0.279 0 CA-C-O 121.063 0.458 . . . . 0.0 110.938 179.77 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 12.6 p -91.79 135.24 27.7 Favored 'Isoleucine or valine' 0 C--O 1.233 0.218 0 CA-C-N 115.967 -0.561 . . . . 0.0 110.974 -179.719 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 48.5 p90 -112.51 166.55 11.22 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.885 -179.52 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -131.16 137.74 49.14 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.215 179.774 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 17.0 mttp -68.43 -38.21 80.98 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.733 179.191 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 21.3 mt-10 -58.87 -52.99 63.35 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.427 179.266 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 38.4 m-20 -62.12 -43.04 99.72 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.993 179.505 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.464 HD23 HD13 ' A' ' 36' ' ' LEU . 0.8 OUTLIER -60.16 -53.43 57.77 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-O 120.607 0.242 . . . . 0.0 111.244 179.95 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -63.7 -39.25 93.84 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 116.422 -0.353 . . . . 0.0 111.149 179.867 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 26.7 tt0 -68.27 -41.29 81.26 Favored 'General case' 0 CA--C 1.532 0.285 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.9 179.476 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 19.9 t80 -66.24 -34.79 78.81 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.655 -179.994 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . 0.403 ' HA ' ' OE1' ' A' ' 20' ' ' GLN . 23.5 t80 -54.26 -41.96 69.41 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-O 120.732 0.301 . . . . 0.0 110.254 179.719 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 4.1 tt0 -83.6 -37.45 22.9 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.292 179.466 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -66.63 -32.96 74.62 Favored 'General case' 0 N--CA 1.467 0.403 0 N-CA-C 112.053 0.39 . . . . 0.0 112.053 -179.608 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -60.44 -63.18 1.39 Allowed 'General case' 0 N--CA 1.465 0.323 0 N-CA-C 111.863 0.32 . . . . 0.0 111.863 -179.322 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 90.65 35.78 7.17 Favored Glycine 0 C--N 1.334 0.418 0 C-N-CA 120.915 -0.659 . . . . 0.0 112.842 -179.816 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 17.9 tt -64.26 153.35 7.65 Favored 'Isoleucine or valine' 0 C--O 1.232 0.179 0 CA-C-O 120.623 0.249 . . . . 0.0 111.099 179.75 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 1.5 t-80 65.07 84.12 0.18 Allowed Pre-proline 0 C--O 1.233 0.23 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.328 -179.693 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -53.52 163.74 2.49 Favored 'Trans proline' 0 C--N 1.351 0.674 0 C-N-CA 123.023 2.482 . . . . 0.0 112.809 -179.607 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_exo -60.45 179.55 0.33 Allowed 'Trans proline' 0 C--N 1.35 0.631 0 C-N-CA 122.849 2.366 . . . . 0.0 112.495 179.858 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . 0.485 ' H ' ' HD2' ' A' ' 78' ' ' PRO . 2.3 mt-10 -160.94 -60.3 0.02 OUTLIER Pre-proline 0 C--N 1.33 -0.273 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.242 -179.874 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . 0.485 ' HD2' ' H ' ' A' ' 77' ' ' GLU . 57.8 Cg_endo -70.56 82.44 0.92 Allowed 'Trans proline' 0 C--N 1.352 0.762 0 C-N-CA 122.588 2.192 . . . . 0.0 112.633 -179.799 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 15.0 tt -66.37 150.32 11.04 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.247 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.249 179.886 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -65.4 -64.5 0.85 Allowed 'General case' 0 CA--C 1.531 0.229 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.052 179.871 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . 61.82 102.89 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.401 0 CA-C-N 116.387 -0.37 . . . . 0.0 111.796 179.574 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -130.86 -76.04 0.53 Allowed 'General case' 0 N--CA 1.464 0.227 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.434 179.758 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.128 0 CA-C-O 120.812 0.339 . . . . 0.0 111.132 -179.943 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.491 1.584 0 CA-C-O 120.599 0.238 . . . . 0.0 111.077 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 11.2 p -61.54 -32.46 53.57 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.219 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.273 179.55 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 5.1 m 61.83 177.43 0.12 Allowed 'General case' 0 C--O 1.233 0.219 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.672 -179.547 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 5.0 p 55.72 -173.44 0.06 Allowed 'General case' 0 CA--C 1.532 0.267 0 CA-C-O 120.875 0.369 . . . . 0.0 111.069 -179.838 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 11.6 m-85 -164.65 -40.84 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.123 179.755 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -145.83 169.99 17.45 Favored 'General case' 0 C--O 1.237 0.409 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.005 -179.798 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -123.98 112.11 16.81 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.873 -179.882 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.466 HG21 ' SD ' ' A' ' 13' ' ' MET . 27.8 mm -88.07 154.62 3.23 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.196 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.954 179.918 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 82.2 mt-10 -121.54 146.77 46.61 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-N 116.374 -0.376 . . . . 0.0 111.211 -179.983 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 8.1 tp -58.11 -34.95 50.67 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.344 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.124 179.501 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 6.6 tt0 -65.66 -34.61 78.6 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-N 116.496 -0.32 . . . . 0.0 110.878 179.46 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 22.1 m-20 -95.94 38.27 1.19 Allowed 'General case' 0 CA--C 1.531 0.238 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.226 179.766 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . 0.466 ' SD ' HG21 ' A' ' 8' ' ' ILE . 0.6 OUTLIER -133.79 136.73 44.69 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.725 179.785 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 9.7 m -69.64 138.22 52.86 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.015 -179.841 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . 0.426 ' HB3' ' CE2' ' A' ' 22' ' ' PHE . 17.3 p90 -101.54 130.4 47.82 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.556 179.649 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 -109.23 90.82 8.68 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.733 179.795 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 69.9 Cg_endo -74.26 62.31 5.16 Favored 'Trans proline' 0 C--N 1.348 0.512 0 C-N-CA 122.776 2.317 . . . . 0.0 112.954 -179.786 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 4.8 pt-20 -132.68 -50.21 0.9 Allowed 'General case' 0 CA--C 1.531 0.224 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.757 179.47 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . 0.582 ' HA ' HD12 ' A' ' 73' ' ' ILE . 38.0 m-20 -136.46 32.03 2.82 Favored 'General case' 0 CA--C 1.534 0.345 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.23 179.512 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . 0.688 ' HB3' HD12 ' A' ' 36' ' ' LEU . 15.2 mt-30 56.67 67.38 1.0 Allowed 'General case' 0 CA--C 1.535 0.368 0 CA-C-O 121.06 0.457 . . . . 0.0 111.462 179.447 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 2.5 ptt? -146.99 158.64 43.98 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-N 116.013 -0.54 . . . . 0.0 111.092 179.674 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.509 ' CE1' HD21 ' A' ' 36' ' ' LEU . 17.4 m-85 -131.21 127.8 38.65 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.787 -179.967 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . 0.42 ' HA ' ' O ' ' A' ' 32' ' ' PHE . 18.2 p -116.14 170.21 8.68 Favored 'General case' 0 CA--C 1.532 0.28 0 CA-C-O 120.828 0.347 . . . . 0.0 111.454 -179.877 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 57.8 t80 -163.23 136.29 4.31 Favored Pre-proline 0 N--CA 1.464 0.271 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.042 179.795 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 42.0 Cg_endo -66.59 103.38 0.68 Allowed 'Trans proline' 0 C--N 1.35 0.606 0 C-N-CA 122.555 2.17 . . . . 0.0 112.27 179.649 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . 0.461 ' SG ' ' HD2' ' A' ' 27' ' ' PRO . 42.7 t -66.89 139.63 95.76 Favored Pre-proline 0 C--O 1.233 0.215 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.551 179.786 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . 0.461 ' HD2' ' SG ' ' A' ' 26' ' ' CYS . 9.3 Cg_endo -53.64 -25.56 33.99 Favored 'Trans proline' 0 C--N 1.35 0.617 0 C-N-CA 122.928 2.419 . . . . 0.0 112.927 179.867 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . 0.401 ' CB ' ' HB3' ' A' ' 51' ' ' CYS . 0.8 OUTLIER -69.93 -38.03 76.07 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-O 120.51 0.195 . . . . 0.0 111.299 -179.978 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 150.37 -44.8 0.68 Allowed Glycine 0 C--N 1.336 0.541 0 C-N-CA 120.834 -0.698 . . . . 0.0 112.898 -179.922 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -71.09 -176.51 1.43 Allowed 'General case' 0 CA--C 1.534 0.333 0 CA-C-O 120.779 0.323 . . . . 0.0 111.169 -179.86 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 7.2 ttp180 -122.19 114.06 20.33 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-N 116.515 -0.312 . . . . 0.0 111.085 -179.886 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . 0.42 ' O ' ' HA ' ' A' ' 23' ' ' THR . 73.3 t80 -62.2 154.55 27.07 Favored 'General case' 0 N--CA 1.462 0.168 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.966 179.708 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 1.1 pt20 -147.47 144.12 28.37 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.231 179.994 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 2.8 tt -147.6 132.14 10.25 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.247 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.064 179.497 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 6.0 m-85 -90.41 139.54 30.58 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.944 -179.883 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.688 HD12 ' HB3' ' A' ' 20' ' ' GLN . 13.9 mt -59.57 -47.48 85.41 Favored 'General case' 0 N--CA 1.463 0.19 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.027 179.954 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -59.57 -38.5 81.32 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 116.587 -0.279 . . . . 0.0 110.78 179.339 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -66.73 -58.99 3.97 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.017 179.853 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' MET . . . . . 0.709 ' HG3' HD11 ' A' ' 64' ' ' LEU . 6.4 ptm -60.68 -32.58 71.79 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 116.462 -0.335 . . . . 0.0 111.556 -179.878 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 18.7 t80 -58.39 -37.05 74.49 Favored 'General case' 0 CA--C 1.533 0.318 0 CA-C-N 116.499 -0.318 . . . . 0.0 111.15 179.689 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 4.6 mt-10 -57.92 -38.14 75.34 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-O 120.668 0.271 . . . . 0.0 110.98 179.512 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 144.77 52.14 0.03 OUTLIER Glycine 0 C--N 1.334 0.46 0 C-N-CA 121.018 -0.611 . . . . 0.0 112.701 179.785 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -109.98 157.18 19.56 Favored 'General case' 0 C--O 1.232 0.15 0 CA-C-O 120.81 0.338 . . . . 0.0 111.237 -179.943 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -157.1 -47.14 0.07 Allowed 'General case' 0 CA--C 1.532 0.262 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.156 179.815 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 4.8 m -100.02 115.0 40.19 Favored 'Isoleucine or valine' 0 C--O 1.233 0.191 0 CA-C-O 120.84 0.352 . . . . 0.0 110.972 179.78 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -110.47 174.79 5.7 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.204 -179.854 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 11.3 m -133.48 121.18 40.81 Favored 'Isoleucine or valine' 0 C--O 1.233 0.209 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.186 -179.886 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 43.3 t -63.15 135.94 96.46 Favored Pre-proline 0 C--O 1.233 0.215 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.702 179.964 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 91.5 Cg_endo -83.15 19.87 1.26 Allowed 'Trans proline' 0 CA--C 1.537 0.645 0 C-N-CA 122.682 2.255 . . . . 0.0 113.212 179.972 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 29.8 t -128.35 -58.2 1.2 Allowed 'General case' 0 CA--C 1.529 0.152 0 CA-C-O 120.657 0.265 . . . . 0.0 110.521 179.644 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' CYS . . . . . 0.401 ' HB3' ' CB ' ' A' ' 28' ' ' CYS . 20.1 p -98.72 -20.2 17.07 Favored 'General case' 0 CA--C 1.533 0.327 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.826 179.93 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 1.1 t 67.46 39.48 2.88 Favored 'General case' 0 CA--C 1.534 0.327 0 CA-C-O 121.07 0.462 . . . . 0.0 110.904 -179.772 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 6.9 tp -88.08 131.68 34.58 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.711 179.814 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' MET . . . . . . . . . . . . . 41.1 mtt -85.14 123.99 31.29 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.618 -179.877 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 2.6 pp -134.06 142.16 41.89 Favored 'Isoleucine or valine' 0 C--O 1.234 0.249 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.621 -179.749 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -105.81 95.92 6.14 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.656 -179.909 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.415 ' HA ' ' O ' ' A' ' 8' ' ' ILE . 14.8 p -84.18 139.13 18.03 Favored 'Isoleucine or valine' 0 C--O 1.234 0.286 0 CA-C-O 120.941 0.4 . . . . 0.0 111.124 -179.954 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 12.1 p -111.26 123.02 66.75 Favored 'Isoleucine or valine' 0 C--O 1.234 0.264 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.862 179.703 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 32.3 p90 -129.32 176.83 7.63 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.025 -179.675 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -118.02 162.79 17.6 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.556 -179.898 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 22.8 mttt -87.82 -32.1 19.21 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.128 179.568 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -59.73 -54.55 45.05 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 116.587 -0.279 . . . . 0.0 110.835 179.882 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -61.28 -44.48 97.16 Favored 'General case' 0 N--CA 1.463 0.186 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.741 179.655 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.709 HD11 ' HG3' ' A' ' 39' ' ' MET . 0.2 OUTLIER -57.96 -41.31 82.64 Favored 'General case' 0 CA--C 1.529 0.157 0 CA-C-N 116.429 -0.35 . . . . 0.0 110.809 179.583 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -70.18 -39.45 75.24 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 116.441 -0.345 . . . . 0.0 111.241 179.763 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 31.1 mt-10 -70.51 -41.06 73.12 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.504 -179.808 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . 0.561 ' CD2' HD11 ' A' ' 36' ' ' LEU . 2.5 t80 -55.94 -30.84 62.3 Favored 'General case' 0 N--CA 1.465 0.275 0 CA-C-N 116.693 -0.231 . . . . 0.0 111.499 -179.958 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . 0.419 ' HA ' ' OE1' ' A' ' 20' ' ' GLN . 3.8 m-85 -58.85 -36.24 74.25 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-O 120.63 0.253 . . . . 0.0 110.589 179.665 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 7.8 tt0 -88.3 -36.32 16.73 Favored 'General case' 0 CA--C 1.531 0.242 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.943 179.334 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 4.5 mm-40 -66.23 -34.57 78.31 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.605 -179.705 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -67.63 143.88 55.81 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-O 120.86 0.362 . . . . 0.0 111.251 -179.838 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -96.06 28.24 13.58 Favored Glycine 0 CA--C 1.521 0.423 0 C-N-CA 121.05 -0.595 . . . . 0.0 112.804 179.959 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.582 HD12 ' HA ' ' A' ' 19' ' ' ASN . 11.7 tt -78.56 -34.52 17.94 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.314 0 CA-C-O 120.532 0.206 . . . . 0.0 111.364 179.971 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 10.6 m-70 -133.5 88.45 34.38 Favored Pre-proline 0 C--O 1.234 0.261 0 CA-C-O 120.79 0.329 . . . . 0.0 110.879 179.715 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.58 155.74 65.72 Favored 'Trans proline' 0 C--N 1.349 0.563 0 C-N-CA 122.842 2.362 . . . . 0.0 112.531 179.963 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -70.5 137.05 32.47 Favored 'Trans proline' 0 C--N 1.35 0.643 0 C-N-CA 122.826 2.351 . . . . 0.0 112.66 -179.9 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -169.18 152.61 5.14 Favored Pre-proline 0 CA--C 1.532 0.27 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.882 179.772 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -54.97 95.69 0.05 OUTLIER 'Trans proline' 0 C--N 1.352 0.75 0 C-N-CA 122.985 2.457 . . . . 0.0 112.565 -179.985 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 7.6 pt -105.43 -34.06 3.0 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.328 0 CA-C-N 116.022 -0.535 . . . . 0.0 111.825 -179.745 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -145.05 148.87 34.18 Favored 'General case' 0 C--O 1.234 0.284 0 CA-C-O 120.59 0.233 . . . . 0.0 111.135 -179.939 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -111.38 159.71 17.75 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.479 -179.757 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -135.44 148.57 49.34 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.139 179.925 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.463 0.219 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.59 179.882 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.3 mtp . . . . . 0 N--CA 1.49 1.549 0 CA-C-O 120.415 0.15 . . . . 0.0 111.379 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 11.6 p -64.73 -42.09 94.01 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.318 0 CA-C-N 116.787 -0.188 . . . . 0.0 111.429 179.93 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 22.9 m -109.58 -179.69 3.89 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-N 116.55 -0.295 . . . . 0.0 111.144 179.995 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.602 HG22 ' HB3' ' A' ' 54' ' ' MET . 58.4 p -64.48 168.04 6.31 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.249 179.915 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 5.7 m-85 -102.83 -50.3 3.57 Favored 'General case' 0 CA--C 1.529 0.163 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.173 179.628 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -154.88 176.49 12.43 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.383 179.702 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 15.3 pt-20 -123.76 135.56 53.9 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.765 179.422 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 3.5 mp -121.75 139.63 48.23 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.305 0 CA-C-N 116.462 -0.336 . . . . 0.0 110.827 -179.977 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . 0.48 ' HG3' HG13 ' A' ' 58' ' ' VAL . 3.2 tt0 -83.93 145.73 28.42 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.182 -179.871 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 9.7 tp -57.15 -33.81 43.89 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.314 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.184 179.586 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 -58.77 -34.58 71.59 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 116.569 -0.287 . . . . 0.0 111.087 179.307 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 54.2 m-20 -95.76 36.83 1.25 Allowed 'General case' 0 CA--C 1.535 0.367 0 CA-C-O 120.722 0.296 . . . . 0.0 111.342 179.591 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 3.1 ttt -120.2 146.49 45.98 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 116.582 -0.281 . . . . 0.0 110.802 179.779 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 1.5 m -68.95 126.03 28.5 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 116.519 -0.31 . . . . 0.0 110.765 179.876 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 2.8 p90 -105.14 157.58 17.17 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.04 179.885 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 23.6 mt-10 -139.97 83.27 16.33 Favored Pre-proline 0 C--O 1.235 0.292 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.675 179.98 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 70.4 Cg_exo -52.05 -28.75 33.7 Favored 'Trans proline' 0 C--N 1.349 0.554 0 C-N-CA 122.98 2.454 . . . . 0.0 112.731 179.919 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -52.36 -35.94 52.5 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-N 116.454 -0.339 . . . . 0.0 111.577 179.605 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 2.0 t-20 -141.85 29.39 1.7 Allowed 'General case' 0 CA--C 1.538 0.505 0 N-CA-C 111.721 0.267 . . . . 0.0 111.721 -179.92 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . 0.487 ' HB2' HD21 ' A' ' 36' ' ' LEU . 8.3 pt20 41.73 35.87 0.55 Allowed 'General case' 0 N--CA 1.475 0.792 0 N-CA-C 112.245 0.461 . . . . 0.0 112.245 -179.756 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 7.0 ttt -105.67 158.67 16.55 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.475 -179.601 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 23.1 m-85 -129.65 147.07 51.4 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-O 120.777 0.322 . . . . 0.0 111.187 179.587 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . 0.427 HG22 ' O ' ' A' ' 32' ' ' PHE . 21.2 p -144.19 177.42 8.61 Favored 'General case' 0 CA--C 1.537 0.465 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.953 -179.98 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 38.7 t80 -171.68 134.79 0.89 Allowed Pre-proline 0 N--CA 1.47 0.559 0 CA-C-N 116.699 -0.228 . . . . 0.0 110.961 179.327 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -65.04 101.23 0.39 Allowed 'Trans proline' 0 C--N 1.352 0.724 0 C-N-CA 122.795 2.33 . . . . 0.0 112.902 -179.857 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . 0.435 ' SG ' ' HD2' ' A' ' 27' ' ' PRO . 46.7 t -66.18 139.53 96.5 Favored Pre-proline 0 C--O 1.233 0.232 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.729 179.598 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . 0.435 ' HD2' ' SG ' ' A' ' 26' ' ' CYS . 60.9 Cg_exo -52.61 -27.08 31.61 Favored 'Trans proline' 0 C--N 1.348 0.547 0 C-N-CA 122.748 2.299 . . . . 0.0 112.907 179.625 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -67.6 -38.53 84.11 Favored 'General case' 0 C--O 1.235 0.305 0 N-CA-C 111.61 0.226 . . . . 0.0 111.61 -179.99 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 152.32 -48.19 0.55 Allowed Glycine 0 C--N 1.336 0.571 0 C-N-CA 120.785 -0.721 . . . . 0.0 113.242 -179.788 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -75.89 -173.59 2.34 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-N 116.751 0.276 . . . . 0.0 111.137 -179.812 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 51.5 mtt180 -122.41 138.34 54.57 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-O 120.76 0.314 . . . . 0.0 111.185 -179.989 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . 0.427 ' O ' HG22 ' A' ' 23' ' ' THR . 45.0 m-85 -69.06 167.86 15.08 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.864 179.569 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 3.9 pp0? -152.17 138.16 18.16 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.22 179.594 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.445 HD13 ' HE2' ' A' ' 39' ' ' MET . 3.5 tt -173.98 127.87 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.531 0.238 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.033 179.659 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 76.5 m-85 -82.21 142.9 31.78 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.734 -179.81 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.514 HD13 HD23 ' A' ' 64' ' ' LEU . 3.9 pp -55.45 -35.22 65.22 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 116.389 -0.368 . . . . 0.0 111.231 179.645 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . 0.42 ' N ' HD12 ' A' ' 36' ' ' LEU . 0.9 OUTLIER -61.49 -45.6 93.55 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 116.534 -0.303 . . . . 0.0 111.016 179.678 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -61.12 -43.43 98.89 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-O 120.762 0.315 . . . . 0.0 110.731 179.453 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' MET . . . . . 0.445 ' HE2' HD13 ' A' ' 34' ' ' ILE . 3.6 mtt -59.75 -33.52 71.77 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.029 179.616 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -56.42 -39.88 73.78 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 116.534 -0.303 . . . . 0.0 110.991 179.533 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 21.9 mt-10 -65.57 -48.94 70.67 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 116.665 -0.243 . . . . 0.0 110.863 179.741 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 153.64 74.94 0.01 OUTLIER Glycine 0 C--N 1.336 0.535 0 C-N-CA 120.678 -0.772 . . . . 0.0 113.02 179.696 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 5.0 tp10 -128.66 96.71 4.47 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-O 120.858 0.361 . . . . 0.0 111.299 179.748 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 14.5 ptpt -111.86 -31.81 6.82 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.439 179.803 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 4.4 m -110.87 97.41 5.7 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.264 0 CA-C-O 120.953 0.406 . . . . 0.0 111.075 179.853 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -99.64 154.55 18.19 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.527 -179.574 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 11.2 p -118.56 139.23 46.59 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.244 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.313 -179.958 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 53.5 t -78.52 135.25 60.89 Favored Pre-proline 0 C--O 1.233 0.232 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.917 179.858 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_endo -83.96 19.7 1.32 Allowed 'Trans proline' 0 C--N 1.35 0.628 0 C-N-CA 122.692 2.261 . . . . 0.0 113.171 179.843 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 12.7 t -128.02 -59.26 1.19 Allowed 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 122.301 0.24 . . . . 0.0 110.41 179.607 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 19.4 p -95.76 -20.89 18.51 Favored 'General case' 0 N--CA 1.468 0.444 0 N-CA-C 112.073 0.397 . . . . 0.0 112.073 179.676 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 1.2 t 67.04 39.6 3.15 Favored 'General case' 0 CA--C 1.536 0.434 0 CA-C-O 120.901 0.382 . . . . 0.0 111.353 -179.683 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.585 HD23 HG23 ' A' ' 55' ' ' ILE . 8.0 tt -91.81 139.6 30.51 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.852 179.903 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' MET . . . . . 0.602 ' HB3' HG22 ' A' ' 4' ' ' THR . 53.1 mtp -88.24 128.11 35.46 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 116.396 -0.366 . . . . 0.0 111.3 -179.734 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.585 HG23 HD23 ' A' ' 53' ' ' LEU . 2.4 pt -132.26 139.08 50.95 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.259 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.492 179.937 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 22.0 m-20 -96.93 87.13 4.17 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 116.458 -0.337 . . . . 0.0 110.324 179.216 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.429 HG13 ' O ' ' A' ' 57' ' ' VAL . 12.6 p -93.13 114.15 29.35 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.251 0 CA-C-O 121.004 0.43 . . . . 0.0 111.079 -179.893 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.48 HG13 ' HG3' ' A' ' 9' ' ' GLU . 14.9 p -82.92 146.75 6.59 Favored 'Isoleucine or valine' 0 C--O 1.233 0.208 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.283 -179.539 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 47.5 p90 -121.9 170.1 10.13 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.267 -179.645 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -132.08 165.0 25.01 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.448 -179.914 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -99.83 -33.77 10.42 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.405 179.815 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 1.6 mm-40 -59.35 -60.31 4.06 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-O 120.471 0.176 . . . . 0.0 111.073 179.929 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -59.87 -44.49 94.14 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 116.608 -0.269 . . . . 0.0 110.86 179.733 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.514 HD23 HD13 ' A' ' 36' ' ' LEU . 0.7 OUTLIER -58.38 -45.34 88.49 Favored 'General case' 0 CA--C 1.53 0.211 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.036 179.734 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -62.77 -51.68 66.19 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.176 179.789 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 2.0 tp10 -59.57 -40.91 88.9 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-N 116.459 -0.337 . . . . 0.0 110.761 179.517 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 3.9 t80 -55.11 -36.18 65.45 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.435 179.544 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 1.6 t80 -55.9 -38.69 70.55 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-O 120.637 0.256 . . . . 0.0 110.58 179.791 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 4.2 tt0 -83.04 -37.24 24.17 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.73 179.091 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 8.1 mt-10 -65.76 -36.87 84.79 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 116.526 -0.306 . . . . 0.0 111.621 -179.802 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -75.82 142.72 42.18 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-O 120.811 0.338 . . . . 0.0 111.542 -179.893 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -92.57 26.81 12.36 Favored Glycine 0 CA--C 1.524 0.627 0 C-N-CA 121.032 -0.604 . . . . 0.0 113.077 179.705 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.466 HG21 ' OE1' ' A' ' 20' ' ' GLN . 2.6 tt -87.21 -33.19 6.66 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.274 0 CA-C-N 116.891 0.345 . . . . 0.0 111.574 179.931 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 5.5 t60 -113.3 91.64 20.13 Favored Pre-proline 0 CA--C 1.533 0.312 0 CA-C-O 120.66 0.267 . . . . 0.0 111.002 179.853 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_endo -68.59 152.36 74.71 Favored 'Trans proline' 0 C--N 1.352 0.74 0 C-N-CA 122.808 2.339 . . . . 0.0 112.636 -179.906 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 41.3 Cg_endo -68.61 -43.72 3.7 Favored 'Trans proline' 0 C--N 1.352 0.722 0 C-N-CA 122.627 2.218 . . . . 0.0 112.868 -179.864 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -106.95 147.94 36.03 Favored Pre-proline 0 C--O 1.233 0.215 0 CA-C-N 116.64 -0.254 . . . . 0.0 110.859 -179.997 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -70.89 116.53 4.71 Favored 'Trans proline' 0 C--N 1.351 0.66 0 C-N-CA 122.7 2.267 . . . . 0.0 112.476 -179.909 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 2.7 pp -133.96 23.47 1.19 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.486 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.962 179.979 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -142.68 146.53 34.5 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-O 120.648 0.261 . . . . 0.0 111.642 179.614 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -147.51 172.6 13.72 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.384 179.839 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -73.55 128.23 34.91 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-N 116.495 -0.32 . . . . 0.0 111.382 179.941 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.115 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.272 179.922 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 6.0 ptp . . . . . 0 N--CA 1.491 1.611 0 CA-C-O 120.709 0.29 . . . . 0.0 111.356 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 28.7 m -136.07 170.58 18.49 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.292 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.321 -179.869 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 3.5 m -129.05 31.36 4.91 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.025 179.647 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 3.1 p -91.8 150.11 21.25 Favored 'General case' 0 N--CA 1.464 0.275 0 CA-C-N 116.442 -0.345 . . . . 0.0 111.627 -179.797 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -107.89 -47.56 3.56 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.21 179.622 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -150.32 174.57 12.71 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.339 179.938 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 12.4 mt-10 -121.62 120.71 35.57 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.63 179.691 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.447 ' O ' ' HA ' ' A' ' 57' ' ' VAL . 3.6 mp -115.08 152.09 16.74 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.331 0 CA-C-N 116.441 -0.345 . . . . 0.0 111.33 -179.495 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 10.2 mt-10 -99.24 143.06 29.93 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 116.525 -0.307 . . . . 0.0 111.387 179.986 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 9.0 tp -59.32 -29.42 41.88 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.382 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.467 179.576 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 3.4 pt-20 -60.59 -28.67 68.67 Favored 'General case' 0 CA--C 1.533 0.325 0 CA-C-N 116.669 -0.241 . . . . 0.0 111.357 179.679 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -97.9 36.99 1.46 Allowed 'General case' 0 CA--C 1.535 0.392 0 CA-C-O 120.722 0.296 . . . . 0.0 111.248 179.756 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . 0.607 ' CE ' HG11 ' A' ' 57' ' ' VAL . 3.9 mtt -131.44 140.06 49.52 Favored 'General case' 0 N--CA 1.464 0.225 0 CA-C-N 116.528 -0.305 . . . . 0.0 111.075 179.994 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 2.1 m -67.58 145.91 54.4 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 116.418 -0.355 . . . . 0.0 111.131 179.826 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 1.5 p90 -109.08 158.15 18.04 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.159 179.726 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -135.7 76.9 53.04 Favored Pre-proline 0 CA--C 1.532 0.264 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.587 179.677 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -54.09 -25.02 35.32 Favored 'Trans proline' 0 C--N 1.352 0.736 0 C-N-CA 122.982 2.454 . . . . 0.0 113.133 -179.99 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -52.95 -42.72 65.74 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-N 116.669 -0.241 . . . . 0.0 111.316 179.918 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 3.5 m-80 -133.01 15.69 4.22 Favored 'General case' 0 CA--C 1.541 0.615 0 N-CA-C 112.181 0.438 . . . . 0.0 112.181 -179.758 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . 0.491 ' C ' HD13 ' A' ' 36' ' ' LEU . 27.7 mt-30 56.08 75.26 0.35 Allowed 'General case' 0 N--CA 1.471 0.591 0 N-CA-C 111.959 0.355 . . . . 0.0 111.959 179.497 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 1.6 ptt? -163.01 147.95 11.58 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-N 116.431 -0.349 . . . . 0.0 111.26 179.191 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 7.5 m-85 -105.09 139.33 39.92 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-O 120.677 0.275 . . . . 0.0 110.973 179.675 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 75.5 p -132.44 158.25 42.51 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.57 -179.488 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 39.0 t80 -162.83 136.45 4.61 Favored Pre-proline 0 N--CA 1.465 0.276 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.908 179.619 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 41.7 Cg_endo -66.14 100.31 0.45 Allowed 'Trans proline' 0 C--N 1.35 0.617 0 C-N-CA 122.461 2.107 . . . . 0.0 112.32 179.725 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . 0.424 ' SG ' ' HD2' ' A' ' 27' ' ' PRO . 42.6 t -58.4 139.3 84.91 Favored Pre-proline 0 C--O 1.233 0.19 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.843 179.843 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . 0.424 ' HD2' ' SG ' ' A' ' 26' ' ' CYS . 65.1 Cg_exo -52.27 -26.53 27.33 Favored 'Trans proline' 0 C--N 1.349 0.596 0 C-N-CA 122.843 2.362 . . . . 0.0 113.038 179.844 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . 0.419 ' CB ' ' HB3' ' A' ' 51' ' ' CYS . 0.8 OUTLIER -68.19 -38.4 81.97 Favored 'General case' 0 CA--C 1.533 0.318 0 CA-C-O 120.472 0.177 . . . . 0.0 111.394 179.924 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 151.12 -45.28 0.64 Allowed Glycine 0 C--N 1.336 0.55 0 C-N-CA 120.827 -0.702 . . . . 0.0 112.999 -179.784 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 2.8 t70 -72.26 -178.21 2.41 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-N 116.677 0.239 . . . . 0.0 111.143 -179.845 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 8.2 ttm180 -118.93 125.37 49.3 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-O 120.673 0.273 . . . . 0.0 111.234 -179.86 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . 0.587 ' CE2' HD11 ' A' ' 55' ' ' ILE . 0.5 OUTLIER -64.84 154.33 37.48 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.243 179.858 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 20.8 pt20 -150.44 135.93 18.06 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.278 -179.92 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 2.8 tt -149.27 135.39 12.07 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.201 0 CA-C-N 116.425 -0.352 . . . . 0.0 111.219 179.428 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -86.2 140.93 29.71 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.83 179.963 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.686 ' O ' HD11 ' A' ' 64' ' ' LEU . 9.8 mp -58.03 -49.14 77.89 Favored 'General case' 0 C--O 1.232 0.152 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.676 179.699 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -58.05 -39.4 78.35 Favored 'General case' 0 CA--C 1.532 0.261 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.23 179.48 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -58.54 -46.79 86.09 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 116.571 -0.286 . . . . 0.0 110.834 179.809 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 8.9 mtm -59.82 -35.3 74.44 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.85 179.683 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -55.16 -42.91 73.74 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.923 179.511 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -60.38 -48.23 82.66 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-O 120.68 0.276 . . . . 0.0 110.81 179.712 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 149.62 54.76 0.01 OUTLIER Glycine 0 C--N 1.334 0.472 0 C-N-CA 120.954 -0.641 . . . . 0.0 112.663 179.775 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 2.3 tp10 -99.32 95.94 7.39 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-O 120.775 0.321 . . . . 0.0 111.047 179.971 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 13.4 mtmt -105.39 -36.89 7.03 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.078 179.75 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.462 ' O ' HG13 ' A' ' 45' ' ' VAL . 9.4 p -117.95 111.11 32.94 Favored 'Isoleucine or valine' 0 C--O 1.233 0.217 0 CA-C-O 121.037 0.446 . . . . 0.0 110.87 179.769 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -109.9 168.8 9.16 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-N 115.816 -0.629 . . . . 0.0 111.338 -179.552 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 12.0 p -130.83 140.44 48.68 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.254 0 CA-C-N 116.432 -0.349 . . . . 0.0 111.75 -179.352 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 40.6 t -76.64 136.82 67.21 Favored Pre-proline 0 N--CA 1.464 0.248 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.737 179.785 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_endo -83.03 20.7 1.12 Allowed 'Trans proline' 0 CA--C 1.537 0.627 0 C-N-CA 122.85 2.367 . . . . 0.0 113.203 179.796 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -129.0 -56.79 1.18 Allowed 'General case' 0 C--O 1.233 0.222 0 CA-C-N 116.682 -0.235 . . . . 0.0 110.419 179.516 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' CYS . . . . . 0.5 ' SG ' HD12 ' A' ' 53' ' ' LEU . 22.9 p -95.78 -24.16 16.62 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 116.473 -0.33 . . . . 0.0 111.777 179.49 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER 69.64 39.95 1.45 Allowed 'General case' 0 CA--C 1.534 0.344 0 CA-C-O 120.821 0.343 . . . . 0.0 111.368 -179.666 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.5 HD12 ' SG ' ' A' ' 51' ' ' CYS . 74.4 mt -98.07 127.78 44.21 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-N 116.433 -0.348 . . . . 0.0 110.606 179.62 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' MET . . . . . . . . . . . . . 9.4 mtt -82.61 136.24 34.86 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.963 -179.677 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.587 HD11 ' CE2' ' A' ' 32' ' ' PHE . 9.2 pt -136.75 152.61 29.1 Favored 'Isoleucine or valine' 0 C--O 1.234 0.25 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.908 -179.647 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -102.66 108.78 20.16 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.484 179.285 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.607 HG11 ' CE ' ' A' ' 13' ' ' MET . 0.0 OUTLIER -110.13 113.18 43.51 Favored 'Isoleucine or valine' 0 C--O 1.234 0.257 0 CA-C-O 120.793 0.33 . . . . 0.0 111.355 179.726 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.534 ' O ' HG13 ' A' ' 58' ' ' VAL . 8.1 p -81.88 88.2 1.84 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.265 0 CA-C-O 121.353 0.597 . . . . 0.0 110.772 179.821 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 51.0 p90 -80.02 155.27 27.68 Favored 'General case' 0 CA--C 1.531 0.249 0 CA-C-N 115.597 -0.729 . . . . 0.0 111.177 -179.568 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -103.54 145.91 29.32 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-O 120.891 0.377 . . . . 0.0 111.375 -179.875 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 5.8 tttp -87.94 -40.22 14.1 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.844 179.67 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 21.1 tt0 -56.42 -44.62 80.56 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.335 179.424 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 77.4 m-20 -63.0 -46.66 86.63 Favored 'General case' 0 N--CA 1.463 0.186 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.813 179.353 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.686 HD11 ' O ' ' A' ' 36' ' ' LEU . 0.5 OUTLIER -53.33 -45.89 69.24 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-N 116.635 -0.257 . . . . 0.0 111.327 179.971 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -58.0 -51.54 69.25 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-N 116.471 -0.332 . . . . 0.0 111.024 179.869 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 58.6 mt-10 -67.13 -46.36 74.34 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.889 179.767 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 5.2 m-85 -53.98 -31.91 52.35 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.62 179.637 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 1.7 t80 -59.09 -49.2 78.79 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-O 120.671 0.272 . . . . 0.0 110.804 179.935 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 34.8 mt-10 -83.93 -35.5 23.99 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.006 179.841 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 2.6 mm-40 -66.63 -30.31 70.55 Favored 'General case' 0 CA--C 1.533 0.29 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.67 179.765 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -62.71 167.2 4.7 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-O 120.966 0.412 . . . . 0.0 111.991 -179.478 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -108.36 38.67 3.22 Favored Glycine 0 C--N 1.334 0.469 0 C-N-CA 121.115 -0.564 . . . . 0.0 112.632 179.885 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 7.6 tt -66.59 140.36 19.61 Favored 'Isoleucine or valine' 0 C--O 1.232 0.17 0 CA-C-O 120.925 0.393 . . . . 0.0 111.379 -179.883 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 10.6 m-70 -72.02 -62.92 1.42 Allowed Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.097 -179.729 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 65.6 Cg_endo -72.93 110.41 3.03 Favored 'Trans proline' 0 C--N 1.351 0.691 0 C-N-CA 122.469 2.113 . . . . 0.0 112.613 179.864 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_endo -67.13 -56.57 0.23 Allowed 'Trans proline' 0 C--N 1.351 0.672 0 C-N-CA 122.421 2.081 . . . . 0.0 111.957 179.892 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -153.11 151.86 26.85 Favored Pre-proline 0 CA--C 1.532 0.26 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.22 179.247 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -54.74 146.92 52.63 Favored 'Trans proline' 0 C--N 1.349 0.576 0 C-N-CA 123.053 2.502 . . . . 0.0 112.702 -179.794 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 7.9 pt -102.84 -34.8 3.66 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.293 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.932 -179.843 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -105.42 112.16 25.16 Favored 'General case' 0 C--O 1.232 0.172 0 CA-C-O 120.746 0.308 . . . . 0.0 111.305 -179.884 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -81.11 172.38 13.76 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.561 -179.902 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -161.36 -50.54 0.04 OUTLIER 'General case' 0 CA--C 1.531 0.223 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.445 179.887 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.463 0.196 0 CA-C-O 120.903 0.383 . . . . 0.0 111.192 -179.901 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.9 ttt . . . . . 0 N--CA 1.488 1.466 0 CA-C-O 120.677 0.275 . . . . 0.0 111.047 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 11.8 p -75.59 147.24 8.27 Favored 'Isoleucine or valine' 0 C--O 1.234 0.241 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.268 -179.877 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 72.7 m -93.44 74.39 4.48 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.353 -179.621 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 1.2 p -151.96 163.41 39.33 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.794 179.711 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . 0.544 ' CG ' HD11 ' A' ' 53' ' ' LEU . 2.8 m-85 -108.03 -73.74 0.68 Allowed 'General case' 0 C--O 1.233 0.226 0 CA-C-N 116.46 -0.337 . . . . 0.0 111.119 -179.968 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 8.9 p-10 -142.29 162.19 36.1 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.44 -179.515 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 -106.58 108.85 20.57 Favored 'General case' 0 CA--C 1.531 0.228 0 CA-C-N 115.857 -0.611 . . . . 0.0 110.976 -179.954 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 3.7 mp -93.73 150.14 4.07 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.23 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.215 179.95 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 4.0 tt0 -95.59 146.87 24.14 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.344 -179.734 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 2.9 tt -60.37 -33.19 53.08 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.296 0 CA-C-N 116.086 -0.507 . . . . 0.0 111.415 179.653 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 27.3 mt-10 -60.18 -35.24 74.93 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 116.464 -0.334 . . . . 0.0 110.892 179.532 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -96.44 37.22 1.28 Allowed 'General case' 0 CA--C 1.533 0.316 0 CA-C-O 120.804 0.335 . . . . 0.0 111.287 179.774 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 2.3 ttt -124.18 144.12 50.11 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.756 179.751 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 21.5 m -64.88 136.86 57.33 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.047 -179.788 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 19.7 p90 -105.89 131.04 53.68 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.009 179.771 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -118.65 91.8 42.82 Favored Pre-proline 0 C--N 1.33 -0.261 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.479 179.843 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 42.3 Cg_endo -70.82 -14.79 32.99 Favored 'Trans proline' 0 C--N 1.347 0.496 0 C-N-CA 122.598 2.199 . . . . 0.0 113.0 -179.932 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 -51.37 -35.26 37.79 Favored 'General case' 0 CA--C 1.533 0.319 0 N-CA-C 111.912 0.338 . . . . 0.0 111.912 -179.759 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 18.6 m-20 -148.71 26.67 0.91 Allowed 'General case' 0 CA--C 1.534 0.36 0 CA-C-N 116.624 -0.262 . . . . 0.0 111.579 -179.78 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 7.1 mt-30 55.02 69.84 0.69 Allowed 'General case' 0 CA--C 1.537 0.472 0 CA-C-O 120.921 0.391 . . . . 0.0 111.566 179.518 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 5.7 ptt? -151.52 167.49 27.87 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.938 179.577 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.526 ' HE1' HD21 ' A' ' 36' ' ' LEU . 17.4 m-85 -128.63 147.49 50.73 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 116.507 -0.315 . . . . 0.0 110.918 179.824 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 71.7 p -138.77 169.52 17.64 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.803 -179.615 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 47.6 t80 -163.54 137.09 4.4 Favored Pre-proline 0 N--CA 1.468 0.432 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.938 179.878 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -67.3 97.08 0.42 Allowed 'Trans proline' 0 C--N 1.352 0.713 0 C-N-CA 122.486 2.124 . . . . 0.0 112.11 179.446 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . 0.465 ' SG ' ' HD2' ' A' ' 27' ' ' PRO . 50.2 t -59.44 140.43 88.5 Favored Pre-proline 0 C--O 1.233 0.193 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.676 179.962 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . 0.465 ' HD2' ' SG ' ' A' ' 26' ' ' CYS . 74.5 Cg_exo -50.86 -27.75 21.54 Favored 'Trans proline' 0 C--N 1.349 0.591 0 C-N-CA 122.942 2.428 . . . . 0.0 113.098 179.928 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -71.48 -38.29 71.23 Favored 'General case' 0 CA--C 1.533 0.326 0 CA-C-O 120.485 0.183 . . . . 0.0 111.269 -179.905 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 149.45 -44.08 0.74 Allowed Glycine 0 C--N 1.337 0.6 0 C-N-CA 120.858 -0.687 . . . . 0.0 113.001 -179.971 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -68.26 176.85 2.55 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-O 120.84 0.352 . . . . 0.0 111.278 -179.716 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -118.43 128.82 54.98 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-N 116.492 -0.322 . . . . 0.0 110.998 -179.927 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 9.6 m-85 -62.54 160.13 14.44 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.859 179.671 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 10.5 pt20 -155.3 130.14 9.31 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-O 120.845 0.355 . . . . 0.0 111.401 -179.982 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 3.2 tt -157.3 124.19 0.56 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.281 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.904 179.707 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 32.0 m-85 -80.15 156.5 26.95 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.746 179.999 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.526 HD21 ' HE1' ' A' ' 22' ' ' PHE . 72.0 mt -58.73 -40.9 85.14 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.836 179.849 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -62.2 -35.22 78.21 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 116.447 -0.342 . . . . 0.0 111.408 179.675 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 18.1 m-20 -64.45 -60.08 3.58 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-O 120.862 0.363 . . . . 0.0 110.77 -179.943 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 13.7 ptp -60.18 -37.26 79.66 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.076 179.874 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . 0.428 ' HB2' ' CD2' ' A' ' 64' ' ' LEU . 23.2 t80 -59.8 -45.35 92.59 Favored 'General case' 0 CA--C 1.53 0.193 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.984 179.581 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -57.97 -42.2 84.53 Favored 'General case' 0 CA--C 1.532 0.251 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.005 179.799 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 149.78 65.73 0.01 OUTLIER Glycine 0 C--N 1.336 0.537 0 C-N-CA 120.773 -0.727 . . . . 0.0 113.086 179.632 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -120.01 156.63 30.51 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-O 120.655 0.264 . . . . 0.0 111.12 179.719 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.554 ' HG3' HG23 ' A' ' 45' ' ' VAL . 0.2 OUTLIER -162.77 -46.8 0.04 OUTLIER 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.164 179.532 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.554 HG23 ' HG3' ' A' ' 44' ' ' LYS . 22.0 t -96.89 89.22 2.02 Favored 'Isoleucine or valine' 0 C--O 1.234 0.28 0 CA-C-O 120.892 0.377 . . . . 0.0 110.644 179.692 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -80.1 141.54 35.7 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.24 -179.583 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 7.9 m -110.09 127.24 67.14 Favored 'Isoleucine or valine' 0 C--O 1.232 0.174 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.464 -179.879 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 51.0 t -72.13 135.64 82.32 Favored Pre-proline 0 C--N 1.331 -0.227 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.792 179.806 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 87.0 Cg_endo -84.0 19.22 1.4 Allowed 'Trans proline' 0 CA--C 1.537 0.631 0 C-N-CA 122.734 2.289 . . . . 0.0 113.234 179.96 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 2.0 t -127.74 -57.86 1.25 Allowed 'General case' 0 C--O 1.232 0.176 0 CA-C-O 120.558 0.218 . . . . 0.0 110.649 179.538 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 19.6 p -98.7 -19.81 17.29 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-N 116.455 -0.339 . . . . 0.0 111.73 179.888 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER 67.81 39.28 2.68 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-O 121.081 0.467 . . . . 0.0 110.955 -179.895 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.557 HD23 HG23 ' A' ' 55' ' ' ILE . 9.1 tt -91.25 132.9 35.83 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.631 179.875 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' MET . . . . . . . . . . . . . 15.1 mtt -87.92 130.49 34.91 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.194 -179.664 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.557 HG23 HD23 ' A' ' 53' ' ' LEU . 3.2 pt -133.45 144.51 35.86 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.237 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.456 179.676 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -101.7 107.59 18.87 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.226 179.148 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.438 HG13 ' O ' ' A' ' 57' ' ' VAL . 11.6 p -107.98 117.1 52.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-O 120.943 0.402 . . . . 0.0 111.01 -179.821 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 13.9 p -79.99 135.54 25.25 Favored 'Isoleucine or valine' 0 C--O 1.236 0.347 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.662 -179.896 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 8.0 p90 -142.96 169.39 17.66 Favored 'General case' 0 C--O 1.235 0.299 0 CA-C-N 115.782 -0.645 . . . . 0.0 110.97 -179.084 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -138.06 171.07 14.95 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.175 179.615 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 7.6 mttp -96.78 23.01 7.47 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.324 179.746 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 4.6 mt-10 -94.35 -47.81 6.43 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.224 179.206 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 3.0 t70 -68.55 -35.95 78.12 Favored 'General case' 0 N--CA 1.462 0.126 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.213 179.529 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.428 ' CD2' ' HB2' ' A' ' 40' ' ' PHE . 0.7 OUTLIER -55.05 -53.61 53.6 Favored 'General case' 0 CA--C 1.532 0.279 0 CA-C-N 116.694 -0.23 . . . . 0.0 111.358 -179.895 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -59.57 -44.6 93.25 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-O 120.811 0.339 . . . . 0.0 110.934 179.573 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -64.45 -45.15 88.67 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-N 115.857 -0.61 . . . . 0.0 111.102 179.884 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . 0.448 ' HD2' HD11 ' A' ' 36' ' ' LEU . 1.2 t80 -72.11 -39.85 68.59 Favored 'General case' 0 CA--C 1.531 0.239 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.899 -179.764 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 15.4 t80 -62.5 -36.96 84.17 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-O 120.577 0.227 . . . . 0.0 110.86 179.924 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 32.4 mt-10 -78.11 -32.82 50.73 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.987 179.471 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 4.8 tt0 -114.23 40.4 2.52 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-N 116.546 -0.297 . . . . 0.0 111.492 -179.79 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -79.07 151.48 31.41 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-O 120.986 0.422 . . . . 0.0 111.62 -179.942 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -95.05 32.73 5.89 Favored Glycine 0 C--N 1.335 0.477 0 CA-C-N 115.694 -0.685 . . . . 0.0 112.82 179.693 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 4.6 tt -83.28 -35.7 12.1 Favored 'Isoleucine or valine' 0 C--O 1.233 0.236 0 CA-C-O 120.725 0.298 . . . . 0.0 111.143 179.862 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 22.4 p80 -87.14 146.61 40.68 Favored Pre-proline 0 CA--C 1.53 0.21 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.626 179.454 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -71.08 116.43 4.69 Favored 'Trans proline' 0 C--N 1.349 0.583 0 C-N-CA 122.741 2.294 . . . . 0.0 112.337 -179.747 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -60.18 171.59 3.03 Favored 'Trans proline' 0 C--N 1.351 0.667 0 C-N-CA 122.883 2.389 . . . . 0.0 112.772 -179.644 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . 0.401 ' HA ' ' HD3' ' A' ' 78' ' ' PRO . 1.8 mt-10 -94.17 148.36 35.0 Favored Pre-proline 0 C--O 1.232 0.156 0 CA-C-N 115.872 -0.604 . . . . 0.0 111.388 -179.873 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . 0.574 ' C ' HD12 ' A' ' 79' ' ' ILE . 39.3 Cg_exo -56.87 87.84 0.04 OUTLIER 'Trans proline' 0 C--N 1.352 0.755 0 C-N-CA 123.053 2.502 . . . . 0.0 112.725 179.926 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.574 HD12 ' C ' ' A' ' 78' ' ' PRO . 3.7 mp 66.86 133.93 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.338 0 CA-C-N 115.781 -0.645 . . . . 0.0 111.724 -179.971 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -130.83 -65.9 0.77 Allowed 'General case' 0 CA--C 1.53 0.21 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.478 179.89 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -101.75 -31.55 10.72 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 116.538 -0.301 . . . . 0.0 111.633 -179.717 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -60.23 115.2 3.33 Favored 'General case' 0 C--O 1.232 0.162 0 CA-C-N 116.463 -0.335 . . . . 0.0 111.272 -179.828 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.161 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.96 179.861 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 19.6 ptp . . . . . 0 N--CA 1.49 1.569 0 CA-C-O 120.703 0.287 . . . . 0.0 111.45 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 5.0 m -149.59 33.75 0.1 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.429 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.285 -179.952 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 61.75 -164.21 0.25 Allowed 'General case' 0 CA--C 1.536 0.419 0 CA-C-N 116.635 -0.257 . . . . 0.0 110.841 -179.665 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.51 HG21 ' CG ' ' A' ' 56' ' ' ASP . 0.8 OUTLIER -67.17 158.15 31.96 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-O 120.772 0.32 . . . . 0.0 111.172 179.963 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . 0.597 ' CD1' HD11 ' A' ' 53' ' ' LEU . 61.2 m-85 -95.07 -35.26 11.99 Favored 'General case' 0 CA--C 1.53 0.197 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.523 179.991 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -155.04 174.1 15.65 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-O 120.812 0.339 . . . . 0.0 111.328 179.887 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 26.5 tt0 -130.8 114.33 15.2 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.649 -179.936 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.408 HG21 ' CE ' ' A' ' 13' ' ' MET . 27.8 mm -93.2 155.61 3.12 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.178 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.744 179.897 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 4.3 pm0 -119.1 145.97 45.49 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.171 -179.807 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 8.2 tp -59.21 -33.53 50.99 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.328 0 CA-C-N 116.277 -0.419 . . . . 0.0 111.168 179.595 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 8.4 mt-10 -65.68 -32.25 73.71 Favored 'General case' 0 CA--C 1.533 0.318 0 CA-C-N 116.461 -0.336 . . . . 0.0 111.155 179.445 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 11.0 t0 -98.63 40.32 1.2 Allowed 'General case' 0 CA--C 1.533 0.3 0 CA-C-O 120.97 0.414 . . . . 0.0 110.664 179.617 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . 0.411 ' HG3' ' HB2' ' A' ' 24' ' ' TYR . 0.9 OUTLIER -131.83 163.96 27.11 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.937 179.803 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 5.8 m -96.62 119.93 36.0 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-N 116.43 -0.35 . . . . 0.0 110.824 -179.809 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 20.8 p90 -98.56 134.14 41.94 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.529 179.618 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 4.5 mt-10 -107.11 94.3 10.75 Favored Pre-proline 0 C--O 1.234 0.239 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.521 179.952 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -73.0 65.24 4.14 Favored 'Trans proline' 0 C--N 1.35 0.629 0 C-N-CA 122.936 2.424 . . . . 0.0 112.5 -179.553 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 5.4 pt-20 -135.92 -49.48 0.69 Allowed 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.676 -0.693 . . . . 0.0 111.062 179.991 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -135.54 32.19 3.07 Favored 'General case' 0 CA--C 1.535 0.382 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.384 179.865 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . 0.661 ' HG3' HD13 ' A' ' 36' ' ' LEU . 0.0 OUTLIER 55.48 59.29 3.98 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-O 121.037 0.446 . . . . 0.0 111.273 -179.995 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 10.6 ptm -143.14 163.28 33.3 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.989 179.791 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.579 ' CZ ' HG23 ' A' ' 34' ' ' ILE . 4.5 p90 -150.82 144.32 24.98 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.09 -179.997 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . 0.441 HG22 ' HA ' ' A' ' 33' ' ' GLN . 76.4 p -134.62 167.35 20.98 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-N 115.987 -0.551 . . . . 0.0 111.689 -179.386 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . 0.411 ' HB2' ' HG3' ' A' ' 13' ' ' MET . 31.6 t80 -153.41 136.72 10.06 Favored Pre-proline 0 CA--C 1.531 0.239 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.937 -179.993 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo -66.58 101.94 0.57 Allowed 'Trans proline' 0 C--N 1.35 0.623 0 C-N-CA 122.706 2.27 . . . . 0.0 112.415 179.739 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . 0.419 ' SG ' ' HD2' ' A' ' 27' ' ' PRO . 41.8 t -62.82 139.23 97.21 Favored Pre-proline 0 C--O 1.232 0.184 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.605 179.688 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . 0.419 ' HD2' ' SG ' ' A' ' 26' ' ' CYS . 76.3 Cg_exo -51.44 -27.27 23.9 Favored 'Trans proline' 0 C--N 1.349 0.602 0 C-N-CA 122.847 2.365 . . . . 0.0 113.029 179.858 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . 0.422 ' CB ' ' HB3' ' A' ' 51' ' ' CYS . 0.8 OUTLIER -69.66 -36.88 76.43 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-N 116.849 -0.16 . . . . 0.0 111.425 179.947 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 148.53 -43.54 0.8 Allowed Glycine 0 C--N 1.337 0.599 0 C-N-CA 120.881 -0.676 . . . . 0.0 113.141 179.91 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -69.49 -177.77 1.26 Allowed 'General case' 0 N--CA 1.465 0.315 0 CA-C-O 120.841 0.353 . . . . 0.0 111.442 -179.686 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 1.4 tpp180 -121.74 118.53 29.31 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.033 -179.918 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 34.3 t80 -59.87 142.74 52.96 Favored 'General case' 0 CA--C 1.528 0.103 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.448 179.394 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . 0.441 ' HA ' HG22 ' A' ' 23' ' ' THR . 1.5 pt20 -135.81 143.97 45.46 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-N 116.539 -0.3 . . . . 0.0 111.214 -179.814 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.579 HG23 ' CZ ' ' A' ' 22' ' ' PHE . 8.2 tt -174.79 149.24 0.41 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.343 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.02 -179.953 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 64.9 m-85 -99.14 159.62 14.85 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.05 -179.806 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.661 HD13 ' HG3' ' A' ' 20' ' ' GLN . 7.9 mp -60.69 -44.27 96.73 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.728 179.831 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -57.9 -40.22 79.82 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.678 179.327 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -60.26 -42.37 95.22 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.521 179.292 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 4.5 mtp -91.55 33.41 1.01 Allowed 'General case' 0 CA--C 1.534 0.356 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.253 179.367 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 18.0 t80 -135.95 -47.32 0.66 Allowed 'General case' 0 C--O 1.233 0.207 0 CA-C-N 116.654 -0.248 . . . . 0.0 110.865 179.647 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 12.9 tt0 -58.69 -44.62 90.32 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.884 179.675 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 167.28 68.17 0.03 OUTLIER Glycine 0 C--N 1.335 0.492 0 C-N-CA 120.892 -0.671 . . . . 0.0 112.843 179.713 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -144.08 156.02 44.19 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-O 120.818 0.342 . . . . 0.0 111.439 -179.968 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 4.7 pttp -156.21 -47.35 0.08 Allowed 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 115.886 -0.597 . . . . 0.0 111.107 179.811 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.417 ' O ' HG13 ' A' ' 45' ' ' VAL . 10.5 p -103.74 120.36 53.72 Favored 'Isoleucine or valine' 0 C--O 1.233 0.211 0 CA-C-O 120.898 0.38 . . . . 0.0 110.797 179.735 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -111.99 173.83 6.17 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.162 -179.844 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 19.9 t -128.48 137.8 56.39 Favored 'Isoleucine or valine' 0 C--O 1.235 0.29 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.441 -179.669 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 43.8 t -78.6 136.12 59.79 Favored Pre-proline 0 C--O 1.233 0.222 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.679 179.624 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_endo -84.31 22.16 0.98 Allowed 'Trans proline' 0 C--N 1.349 0.595 0 C-N-CA 122.828 2.352 . . . . 0.0 113.339 179.951 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 36.4 m -131.26 -57.13 1.02 Allowed 'General case' 0 C--O 1.233 0.219 0 CA-C-O 120.507 0.194 . . . . 0.0 110.674 179.825 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' CYS . . . . . 0.422 ' HB3' ' CB ' ' A' ' 28' ' ' CYS . 19.2 p -95.68 -19.18 19.92 Favored 'General case' 0 CA--C 1.535 0.369 0 CA-C-N 116.489 -0.323 . . . . 0.0 111.615 179.441 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 1.7 m 62.97 40.83 8.96 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-O 121.061 0.457 . . . . 0.0 111.014 -179.728 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.597 HD11 ' CD1' ' A' ' 5' ' ' TYR . 7.1 tp -95.02 142.94 26.91 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.873 179.898 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' MET . . . . . . . . . . . . . 17.3 mtm -91.99 128.39 37.81 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.709 179.817 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 19.0 pt -137.62 139.41 43.25 Favored 'Isoleucine or valine' 0 C--O 1.233 0.227 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.452 -179.659 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . 0.51 ' CG ' HG21 ' A' ' 4' ' ' THR . 91.5 m-20 -99.06 90.13 4.5 Favored 'General case' 0 C--O 1.231 0.13 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.493 179.417 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.443 HG13 ' O ' ' A' ' 57' ' ' VAL . 9.4 p -86.79 114.54 26.22 Favored 'Isoleucine or valine' 0 C--O 1.233 0.216 0 CA-C-O 120.993 0.425 . . . . 0.0 110.759 179.697 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 14.3 p -79.71 142.79 13.49 Favored 'Isoleucine or valine' 0 C--O 1.233 0.213 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.269 -179.75 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 36.2 p90 -132.43 177.94 7.21 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.691 -179.827 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -121.87 -167.1 1.48 Allowed 'General case' 0 CA--C 1.534 0.331 0 CA-C-O 120.792 0.33 . . . . 0.0 110.789 179.781 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 4.7 mmtp -113.98 -44.99 3.1 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.288 179.255 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 7.7 mt-10 -61.71 -34.2 75.37 Favored 'General case' 0 CA--C 1.529 0.17 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.206 179.58 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 34.8 p30 -56.73 -32.6 65.7 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 116.843 -0.162 . . . . 0.0 111.25 179.582 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.626 ' HG ' HD23 ' A' ' 36' ' ' LEU . 1.3 mp -79.27 -53.29 7.1 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-O 120.658 0.266 . . . . 0.0 110.612 179.355 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -56.04 -38.92 71.22 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.814 179.473 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 26.9 tt0 -68.73 -40.53 79.86 Favored 'General case' 0 CA--C 1.531 0.242 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.776 179.335 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -68.38 -39.81 81.62 Favored 'General case' 0 CA--C 1.53 0.185 0 CA-C-N 116.525 -0.307 . . . . 0.0 111.628 179.842 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 6.0 m-85 -60.46 -41.81 94.89 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 116.773 -0.194 . . . . 0.0 111.081 -179.858 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 16.9 pt-20 -77.84 -33.56 52.2 Favored 'General case' 0 CA--C 1.533 0.322 0 CA-C-N 116.621 -0.263 . . . . 0.0 111.234 179.698 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -74.17 -51.79 14.46 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-O 120.605 0.24 . . . . 0.0 111.41 -179.951 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -76.93 136.86 38.81 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-O 120.816 0.341 . . . . 0.0 111.358 -179.872 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -89.83 49.17 3.33 Favored Glycine 0 C--N 1.334 0.437 0 C-N-CA 121.09 -0.576 . . . . 0.0 112.935 179.995 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.43 HG21 ' NE2' ' A' ' 20' ' ' GLN . 1.1 tp -76.65 -36.72 27.84 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.234 0 CA-C-O 120.585 0.231 . . . . 0.0 111.128 179.7 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 1.8 t-80 -140.58 85.88 12.7 Favored Pre-proline 0 CA--C 1.531 0.237 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.889 179.78 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -70.07 154.7 66.25 Favored 'Trans proline' 0 C--N 1.348 0.515 0 C-N-CA 122.696 2.264 . . . . 0.0 112.438 179.918 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -54.09 133.54 55.79 Favored 'Trans proline' 0 C--N 1.351 0.706 0 C-N-CA 122.915 2.41 . . . . 0.0 112.641 -179.9 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 8.9 tt0 -168.09 85.91 0.73 Allowed Pre-proline 0 CA--C 1.534 0.328 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.245 -179.97 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_exo -58.53 171.98 1.67 Allowed 'Trans proline' 0 C--N 1.351 0.675 0 C-N-CA 123.006 2.47 . . . . 0.0 112.802 -179.966 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 24.7 mm -86.27 -42.88 16.07 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.232 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.408 -179.951 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -170.03 43.37 0.03 OUTLIER 'General case' 0 CA--C 1.533 0.322 0 CA-C-O 120.765 0.317 . . . . 0.0 111.194 179.531 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . 53.38 34.53 18.24 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.257 -179.621 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -86.59 -64.35 1.17 Allowed 'General case' 0 CA--C 1.531 0.25 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.578 -179.539 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.255 0 CA-C-O 120.976 0.417 . . . . 0.0 111.154 -179.98 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.488 1.459 0 CA-C-O 120.767 0.318 . . . . 0.0 111.376 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 28.6 m -104.06 165.58 3.29 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.186 0 CA-C-N 116.328 -0.397 . . . . 0.0 111.157 179.662 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 19.6 m -125.15 148.12 48.72 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.783 179.844 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.556 HG21 ' OD1' ' A' ' 56' ' ' ASP . 68.0 p -141.19 157.64 44.98 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-O 120.756 0.313 . . . . 0.0 111.518 -179.896 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . 0.507 ' HB2' HD11 ' A' ' 53' ' ' LEU . 10.8 t80 -104.93 -41.32 5.65 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.137 -179.992 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . 0.467 ' HB2' ' CD1' ' A' ' 5' ' ' TYR . 5.1 t70 -155.95 161.33 40.53 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-O 120.801 0.334 . . . . 0.0 111.633 -179.565 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -117.12 119.97 36.88 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.861 179.474 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.415 ' O ' ' HA ' ' A' ' 57' ' ' VAL . 3.7 mp -111.53 153.16 13.3 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.226 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.309 -179.581 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . 0.534 ' HA ' HG12 ' A' ' 58' ' ' VAL . 15.7 mt-10 -103.08 152.03 21.86 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.362 -179.841 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 1.1 tp -58.0 -35.35 51.8 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.297 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.253 179.508 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -63.37 -32.75 74.26 Favored 'General case' 0 CA--C 1.53 0.196 0 CA-C-N 116.544 -0.298 . . . . 0.0 111.151 179.544 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -96.18 36.79 1.29 Allowed 'General case' 0 CA--C 1.531 0.243 0 CA-C-O 120.762 0.315 . . . . 0.0 111.266 -179.987 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . 0.422 ' HG3' ' HB2' ' A' ' 24' ' ' TYR . 7.6 ttt -127.31 140.84 51.93 Favored 'General case' 0 C--N 1.333 -0.128 0 CA-C-N 116.458 -0.337 . . . . 0.0 110.56 179.643 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 0.676 HG21 HH21 ' A' ' 31' ' ' ARG . 19.4 m -61.19 140.08 58.0 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.919 179.999 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 9.1 m-85 -105.14 135.28 46.79 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.772 -179.974 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -117.56 88.77 30.34 Favored Pre-proline 0 C--O 1.234 0.24 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.608 179.572 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 12.9 Cg_exo -70.7 65.16 2.36 Favored 'Trans proline' 0 C--N 1.349 0.556 0 C-N-CA 123.014 2.476 . . . . 0.0 112.47 -179.649 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 5.9 pt-20 -137.05 -51.89 0.67 Allowed 'General case' 0 C--O 1.232 0.177 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.909 179.945 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . 0.751 ' HA ' HD12 ' A' ' 73' ' ' ILE . 70.8 m-20 -137.0 32.14 2.67 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-N 116.407 -0.36 . . . . 0.0 111.088 179.587 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 13.0 mm-40 56.87 61.9 2.45 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-O 120.917 0.389 . . . . 0.0 110.653 -179.861 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 3.8 ptm -134.26 150.41 51.01 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.957 -179.81 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.715 ' CE1' HD21 ' A' ' 36' ' ' LEU . 5.4 m-85 -122.99 126.86 47.97 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.659 -179.731 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 67.4 p -108.98 156.2 20.0 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.163 -179.87 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . 0.422 ' HB2' ' HG3' ' A' ' 13' ' ' MET . 64.8 t80 -148.12 107.34 3.65 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.54 179.824 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_exo -54.34 96.18 0.05 OUTLIER 'Trans proline' 0 C--N 1.348 0.551 0 C-N-CA 122.585 2.19 . . . . 0.0 111.95 -179.966 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . 0.451 ' SG ' ' HD2' ' A' ' 27' ' ' PRO . 46.4 t -63.46 139.19 97.55 Favored Pre-proline 0 C--O 1.233 0.225 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.909 -179.584 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . 0.451 ' HD2' ' SG ' ' A' ' 26' ' ' CYS . 10.1 Cg_endo -52.92 -23.3 20.72 Favored 'Trans proline' 0 C--N 1.349 0.554 0 C-N-CA 122.911 2.407 . . . . 0.0 112.834 179.745 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 6.1 p -59.43 -28.89 67.36 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-O 120.626 0.251 . . . . 0.0 111.222 179.839 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 125.11 4.74 7.03 Favored Glycine 0 CA--C 1.523 0.569 0 C-N-CA 120.988 -0.625 . . . . 0.0 113.6 179.976 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -119.91 -164.72 1.1 Allowed 'General case' 0 CA--C 1.534 0.341 0 CA-C-N 117.552 0.676 . . . . 0.0 111.424 -179.903 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . 0.676 HH21 HG21 ' A' ' 14' ' ' THR . 1.4 tpt180 -124.87 138.78 54.24 Favored 'General case' 0 C--O 1.232 0.155 0 CA-C-O 120.837 0.351 . . . . 0.0 111.561 -179.425 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 2.5 m-85 -81.29 165.16 21.66 Favored 'General case' 0 C--O 1.232 0.166 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.641 179.293 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 3.7 pt20 -155.46 122.92 5.56 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.438 -0.347 . . . . 0.0 111.009 179.785 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 4.3 tt -150.02 136.43 12.35 Favored 'Isoleucine or valine' 0 C--O 1.233 0.236 0 CA-C-N 116.308 -0.406 . . . . 0.0 111.141 -179.926 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 9.7 m-85 -96.39 156.5 16.31 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.011 -179.803 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.715 HD21 ' CE1' ' A' ' 22' ' ' PHE . 86.8 mt -63.64 -40.3 96.52 Favored 'General case' 0 N--CA 1.462 0.165 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.061 179.829 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 2.0 t0 -59.06 -35.76 73.89 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 116.499 -0.318 . . . . 0.0 111.361 179.928 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 9.7 m-20 -68.44 -58.53 4.2 Favored 'General case' 0 C--O 1.231 0.109 0 CA-C-O 120.828 0.347 . . . . 0.0 110.879 179.947 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 11.7 ptp -62.26 -34.03 75.75 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.527 -179.78 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . 0.403 ' HB2' ' CD2' ' A' ' 64' ' ' LEU . 22.4 t80 -60.21 -45.77 92.05 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 116.418 -0.355 . . . . 0.0 110.815 179.698 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 11.0 tt0 -57.93 -37.05 73.37 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.836 179.559 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 143.0 68.34 0.02 OUTLIER Glycine 0 C--N 1.334 0.426 0 C-N-CA 120.917 -0.659 . . . . 0.0 112.586 179.675 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -125.93 122.42 35.93 Favored 'General case' 0 N--CA 1.462 0.144 0 CA-C-O 120.7 0.286 . . . . 0.0 111.414 -179.769 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 14.0 mttt -118.68 -45.09 2.61 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.916 179.413 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.474 ' O ' HG13 ' A' ' 45' ' ' VAL . 10.6 p -104.55 114.52 44.37 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.182 0 CA-C-O 120.983 0.42 . . . . 0.0 110.98 179.904 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -106.92 151.45 25.25 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.947 -0.569 . . . . 0.0 111.433 -179.52 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 20.4 t -105.13 129.63 57.54 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.15 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.351 -179.893 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 50.2 t -69.43 135.35 88.65 Favored Pre-proline 0 N--CA 1.463 0.175 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.919 179.659 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 91.0 Cg_endo -83.9 19.05 1.42 Allowed 'Trans proline' 0 CA--C 1.535 0.537 0 C-N-CA 122.583 2.189 . . . . 0.0 113.118 179.953 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 1.9 m -129.1 -59.5 1.11 Allowed 'General case' 0 C--O 1.232 0.154 0 CA-C-O 120.412 0.148 . . . . 0.0 110.762 179.725 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 20.8 p -101.5 -14.2 17.6 Favored 'General case' 0 CA--C 1.535 0.377 0 N-CA-C 111.746 0.276 . . . . 0.0 111.746 179.789 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER 66.01 34.0 7.31 Favored 'General case' 0 CA--C 1.533 0.302 0 CA-C-O 120.848 0.356 . . . . 0.0 111.151 -179.98 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.507 HD11 ' HB2' ' A' ' 5' ' ' TYR . 16.8 tp -86.47 133.21 33.77 Favored 'General case' 0 C--O 1.232 0.14 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.709 179.76 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' MET . . . . . . . . . . . . . 15.3 mtt -82.72 129.9 35.04 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.696 179.995 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 3.0 pt -135.9 143.26 36.71 Favored 'Isoleucine or valine' 0 C--O 1.233 0.236 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.816 -179.474 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . 0.556 ' OD1' HG21 ' A' ' 4' ' ' THR . 30.1 m-20 -91.44 99.93 12.79 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.82 179.497 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.493 HG13 ' O ' ' A' ' 57' ' ' VAL . 10.2 p -105.19 110.52 31.23 Favored 'Isoleucine or valine' 0 C--O 1.234 0.262 0 CA-C-O 121.105 0.478 . . . . 0.0 110.927 179.723 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.534 HG12 ' HA ' ' A' ' 9' ' ' GLU . 12.3 p -82.05 138.14 19.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.407 -179.466 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 33.9 p90 -117.22 175.37 5.64 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.771 -0.65 . . . . 0.0 111.114 -179.683 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . 0.522 ' HB3' ' HB2' ' A' ' 63' ' ' ASP . 1.9 t70 -134.28 128.37 33.68 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.136 179.897 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 1.9 mptt -61.53 -42.35 98.69 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.638 179.514 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 23.5 mt-10 -63.95 -39.13 93.45 Favored 'General case' 0 C--O 1.232 0.137 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.328 179.187 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . 0.522 ' HB2' ' HB3' ' A' ' 60' ' ' ASP . 12.9 t70 -56.63 -45.02 81.77 Favored 'General case' 0 N--CA 1.462 0.126 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.886 179.331 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.639 ' HG ' HD22 ' A' ' 36' ' ' LEU . 1.1 mp -56.89 -55.62 32.18 Favored 'General case' 0 CA--C 1.529 0.151 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.517 -179.56 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -60.11 -46.91 88.02 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-N 116.673 -0.239 . . . . 0.0 111.483 -179.753 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 10.3 mm-40 -63.34 -42.62 98.94 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.901 179.877 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 33.9 t80 -69.91 -36.39 75.33 Favored 'General case' 0 CA--C 1.531 0.239 0 CA-C-N 116.481 -0.327 . . . . 0.0 111.149 179.599 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 2.2 t80 -55.7 -54.47 43.9 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-N 116.674 -0.239 . . . . 0.0 111.045 -179.882 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -69.83 -35.87 75.13 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.231 179.844 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 13.5 mt-10 -64.09 -38.37 90.81 Favored 'General case' 0 CA--C 1.53 0.179 0 CA-C-N 116.398 -0.365 . . . . 0.0 111.733 -179.831 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -64.95 -61.57 2.08 Favored 'General case' 0 C--O 1.233 0.194 0 N-CA-C 111.633 0.235 . . . . 0.0 111.633 -179.315 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 91.3 37.54 6.21 Favored Glycine 0 C--N 1.334 0.429 0 C-N-CA 120.806 -0.711 . . . . 0.0 112.868 179.742 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.751 HD12 ' HA ' ' A' ' 19' ' ' ASN . 14.1 tt -73.38 141.48 16.23 Favored 'Isoleucine or valine' 0 C--O 1.233 0.226 0 CA-C-O 120.823 0.344 . . . . 0.0 111.201 179.944 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 27.6 t-80 -173.09 79.49 0.41 Allowed Pre-proline 0 C--N 1.33 -0.245 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.007 -179.909 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_exo -51.68 106.56 0.14 Allowed 'Trans proline' 0 C--N 1.35 0.631 0 C-N-CA 122.778 2.319 . . . . 0.0 112.366 179.948 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -68.73 -50.61 0.59 Allowed 'Trans proline' 0 C--N 1.349 0.567 0 C-N-CA 122.386 2.057 . . . . 0.0 112.442 -179.591 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -173.04 150.44 1.96 Allowed Pre-proline 0 C--O 1.234 0.251 0 CA-C-N 116.473 -0.331 . . . . 0.0 110.812 179.87 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 69.8 Cg_endo -73.41 179.62 5.35 Favored 'Trans proline' 0 C--N 1.349 0.555 0 C-N-CA 122.734 2.29 . . . . 0.0 112.539 -179.877 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.435 HG22 ' O ' ' A' ' 79' ' ' ILE . 13.7 mt -136.86 39.25 0.53 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.446 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.293 179.992 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -137.86 148.15 45.15 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-N 116.519 -0.31 . . . . 0.0 110.821 179.634 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -69.8 -69.22 0.36 Allowed 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 116.59 -0.277 . . . . 0.0 111.267 -179.862 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -109.58 -53.76 2.63 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 116.53 -0.305 . . . . 0.0 110.956 179.729 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.125 0 CA-C-O 121.002 0.43 . . . . 0.0 111.138 179.806 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.49 1.535 0 CA-C-O 120.658 0.266 . . . . 0.0 111.197 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 11.8 m -132.28 29.59 1.19 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.373 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.631 179.776 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 87.2 p -130.43 -179.32 5.2 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-O 120.625 0.25 . . . . 0.0 110.964 179.978 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.549 HG21 ' CG ' ' A' ' 56' ' ' ASP . 72.8 p -76.02 165.47 24.91 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-O 120.91 0.386 . . . . 0.0 111.262 -179.878 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 9.3 m-85 -105.89 -39.56 5.98 Favored 'General case' 0 CA--C 1.531 0.217 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.397 179.887 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -158.6 176.96 11.74 Favored 'General case' 0 C--O 1.235 0.299 0 CA-C-N 116.451 -0.341 . . . . 0.0 111.256 -179.91 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 2.2 pt-20 -123.14 151.37 42.19 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.906 -179.992 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 25.4 mt -133.2 149.59 31.67 Favored 'Isoleucine or valine' 0 C--O 1.232 0.181 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.254 -179.803 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 39.2 mt-10 -88.63 150.52 22.99 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.062 179.714 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 14.4 tt -56.86 -34.87 44.86 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.327 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.042 179.221 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -71.59 -44.13 65.03 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.106 179.573 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -53.06 -23.25 7.27 Favored 'General case' 0 N--CA 1.469 0.503 0 N-CA-C 112.026 0.38 . . . . 0.0 112.026 -179.973 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . 0.403 ' CG ' ' HB2' ' A' ' 24' ' ' TYR . 4.8 ttm -88.42 137.53 32.24 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-N 116.791 -0.186 . . . . 0.0 110.708 179.867 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 29.4 m -60.62 145.27 49.65 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-O 120.735 0.302 . . . . 0.0 111.115 -179.945 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 16.3 p90 -104.84 144.27 31.99 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.272 179.992 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 9.0 mp0 -130.55 93.92 30.85 Favored Pre-proline 0 C--O 1.233 0.23 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.667 179.804 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -68.12 -17.0 45.5 Favored 'Trans proline' 0 C--N 1.349 0.576 0 C-N-CA 122.938 2.425 . . . . 0.0 112.86 179.585 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -54.35 -39.13 66.82 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 116.615 -0.266 . . . . 0.0 111.677 -179.96 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 2.1 m120 -144.7 20.03 1.66 Allowed 'General case' 0 CA--C 1.535 0.37 0 CA-C-N 116.431 -0.349 . . . . 0.0 111.839 -179.521 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . 0.447 ' OE1' ' HB ' ' A' ' 73' ' ' ILE . 0.0 OUTLIER 55.68 79.32 0.16 Allowed 'General case' 0 C--O 1.234 0.237 0 CA-C-O 121.142 0.496 . . . . 0.0 111.288 179.636 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 3.2 ptt? -159.54 163.69 34.95 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.78 179.912 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 80.3 m-85 -123.58 118.78 28.12 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.617 179.792 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 14.7 p -105.46 152.03 23.52 Favored 'General case' 0 CA--C 1.53 0.184 0 CA-C-O 120.809 0.338 . . . . 0.0 111.145 -179.895 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . 0.403 ' HB2' ' CG ' ' A' ' 13' ' ' MET . 38.4 t80 -159.16 136.46 6.99 Favored Pre-proline 0 N--CA 1.463 0.198 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.018 -179.979 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -72.19 110.37 2.93 Favored 'Trans proline' 0 C--N 1.348 0.525 0 C-N-CA 122.496 2.131 . . . . 0.0 112.317 179.699 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . 0.46 ' SG ' ' HD2' ' A' ' 27' ' ' PRO . 51.5 t -77.63 140.14 63.57 Favored Pre-proline 0 C--O 1.233 0.209 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.463 179.56 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . 0.46 ' HD2' ' SG ' ' A' ' 26' ' ' CYS . 81.8 Cg_exo -49.41 -28.71 16.3 Favored 'Trans proline' 0 C--N 1.35 0.642 0 C-N-CA 123.041 2.494 . . . . 0.0 113.124 179.861 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 3.6 p -61.99 -29.83 70.53 Favored 'General case' 0 C--O 1.236 0.36 0 CA-C-O 120.657 0.265 . . . . 0.0 111.286 179.875 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 116.29 15.92 6.87 Favored Glycine 0 CA--C 1.525 0.696 0 C-N-CA 121.364 -0.446 . . . . 0.0 113.291 -179.894 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -120.11 -171.65 2.2 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-N 117.113 0.457 . . . . 0.0 111.056 -179.995 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 3.8 ttt180 -108.56 131.94 54.35 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-O 120.89 0.376 . . . . 0.0 111.367 -179.701 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 5.1 t80 -100.43 102.15 13.28 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.547 179.775 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 9.2 mt-30 -101.41 154.43 18.82 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.076 -179.781 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.409 HD13 ' HE3' ' A' ' 39' ' ' MET . 2.4 tt -161.98 123.48 0.31 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.254 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.044 179.674 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 1.3 t80 -76.1 145.11 40.26 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.829 -179.905 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.439 HD13 ' C ' ' A' ' 20' ' ' GLN . 10.1 mp -58.53 -42.78 88.56 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.852 179.714 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -60.21 -37.81 81.39 Favored 'General case' 0 N--CA 1.462 0.134 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.818 179.232 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -57.9 -52.02 67.21 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.866 179.715 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' MET . . . . . 0.409 ' HE3' HD13 ' A' ' 34' ' ' ILE . 7.8 mtt -67.61 -36.59 81.12 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 116.066 -0.516 . . . . 0.0 111.03 179.648 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 16.8 t80 -63.6 -42.5 98.23 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.975 179.732 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 3.0 tp10 -55.53 -35.5 65.71 Favored 'General case' 0 CA--C 1.532 0.269 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.195 179.68 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 139.42 54.91 0.05 OUTLIER Glycine 0 C--N 1.334 0.437 0 C-N-CA 121.15 -0.548 . . . . 0.0 112.433 179.669 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -103.65 150.68 23.78 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-O 120.87 0.367 . . . . 0.0 111.451 -179.711 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 87.0 mttt -147.02 -47.51 0.18 Allowed 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 115.894 -0.593 . . . . 0.0 111.226 179.905 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.509 HG22 ' OD1' ' A' ' 56' ' ' ASP . 15.7 t -107.54 99.97 9.72 Favored 'Isoleucine or valine' 0 C--O 1.233 0.21 0 CA-C-O 120.782 0.325 . . . . 0.0 110.799 179.985 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -88.1 148.49 24.43 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.202 -179.985 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 20.4 t -114.37 129.93 69.53 Favored 'Isoleucine or valine' 0 C--O 1.233 0.19 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.927 -179.902 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 48.9 t -68.87 136.48 89.89 Favored Pre-proline 0 N--CA 1.463 0.202 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.822 179.892 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 89.5 Cg_endo -83.5 19.43 1.34 Allowed 'Trans proline' 0 CA--C 1.536 0.58 0 C-N-CA 122.684 2.256 . . . . 0.0 113.084 179.854 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 43.0 t -128.03 -59.62 1.18 Allowed 'General case' 0 C--O 1.233 0.205 0 CA-C-O 120.57 0.224 . . . . 0.0 110.506 179.675 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' CYS . . . . . 0.785 ' SG ' HD23 ' A' ' 53' ' ' LEU . 22.9 p -101.16 -19.53 15.7 Favored 'General case' 0 CA--C 1.535 0.377 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.821 179.888 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 1.6 t 72.94 36.31 0.9 Allowed 'General case' 0 CA--C 1.535 0.375 0 CA-C-O 120.869 0.366 . . . . 0.0 111.039 -179.767 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.785 HD23 ' SG ' ' A' ' 51' ' ' CYS . 0.3 OUTLIER -67.66 155.59 38.84 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.835 179.742 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' MET . . . . . . . . . . . . . 15.2 mtt -112.01 114.12 26.82 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.697 -179.753 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.588 ' O ' HD12 ' A' ' 55' ' ' ILE . 2.8 pp -132.63 143.02 40.94 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.285 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.479 -179.658 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . 0.549 ' CG ' HG21 ' A' ' 4' ' ' THR . 45.8 m-20 -101.71 91.38 4.38 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.898 179.487 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 11.1 p -85.44 127.74 39.76 Favored 'Isoleucine or valine' 0 C--O 1.233 0.233 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.773 179.614 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 12.2 p -90.12 131.85 36.29 Favored 'Isoleucine or valine' 0 C--O 1.234 0.277 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.114 -179.871 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 54.2 p90 -112.22 143.46 43.24 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.818 -0.628 . . . . 0.0 111.103 -179.697 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 59.5 m-20 -104.39 -28.58 11.27 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.5 179.866 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 16.3 ttmt 63.82 26.05 14.24 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-O 120.937 0.399 . . . . 0.0 111.397 -179.777 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 20.4 tt0 -95.75 -39.43 9.87 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.531 179.479 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -74.29 -32.8 63.03 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-N 115.883 -0.598 . . . . 0.0 111.349 179.809 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.414 ' HG ' HD23 ' A' ' 36' ' ' LEU . 3.0 mp -54.85 -45.21 74.51 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-O 120.544 0.212 . . . . 0.0 111.114 -179.9 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -59.53 -38.62 81.48 Favored 'General case' 0 CA--C 1.532 0.28 0 CA-C-N 116.523 -0.308 . . . . 0.0 111.284 179.65 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 1.9 mm-40 -79.21 -40.84 29.73 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.236 179.726 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -64.8 -35.07 79.91 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 116.47 -0.332 . . . . 0.0 111.818 -179.827 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 2.9 m-85 -59.5 -36.07 75.36 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-O 120.582 0.23 . . . . 0.0 110.722 179.885 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 20.8 tt0 -87.54 -37.43 16.89 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.912 179.296 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 34.9 mt-10 -68.55 -40.87 80.49 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.752 -179.55 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -89.77 -66.85 0.88 Allowed 'General case' 0 CA--C 1.53 0.205 0 N-CA-C 111.565 0.209 . . . . 0.0 111.565 -179.56 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 91.53 49.96 2.86 Favored Glycine 0 C--N 1.337 0.59 0 C-N-CA 121.033 -0.603 . . . . 0.0 112.94 -179.973 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.447 ' HB ' ' OE1' ' A' ' 20' ' ' GLN . 7.4 tp -66.37 144.03 15.07 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.246 0 CA-C-O 120.72 0.295 . . . . 0.0 111.115 179.86 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 32.1 m80 -81.22 157.58 70.62 Favored Pre-proline 0 C--O 1.234 0.268 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.127 179.97 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 38.6 Cg_endo -66.85 136.44 41.7 Favored 'Trans proline' 0 C--N 1.351 0.665 0 C-N-CA 122.682 2.255 . . . . 0.0 112.45 179.984 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . 0.409 ' O ' ' HD3' ' A' ' 78' ' ' PRO . 74.4 Cg_endo -74.87 -170.97 0.85 Allowed 'Trans proline' 0 C--N 1.349 0.556 0 C-N-CA 122.732 2.288 . . . . 0.0 112.282 179.844 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 18.5 mt-10 -112.12 90.39 13.64 Favored Pre-proline 0 C--O 1.233 0.204 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.66 179.69 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . 0.409 ' HD3' ' O ' ' A' ' 76' ' ' PRO . 54.4 Cg_exo -52.93 100.92 0.06 OUTLIER 'Trans proline' 0 C--N 1.35 0.63 0 C-N-CA 123.167 2.578 . . . . 0.0 112.903 -179.676 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.507 HD12 ' N ' ' A' ' 80' ' ' ALA . 2.1 pp -148.05 -45.2 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.532 0.255 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.682 179.62 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . 0.507 ' N ' HD12 ' A' ' 79' ' ' ILE . . . -122.51 122.79 39.74 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.642 -0.254 . . . . 0.0 110.88 -179.948 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -69.75 -69.98 0.31 Allowed 'General case' 0 N--CA 1.462 0.163 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.386 -179.605 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -145.79 151.54 38.11 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-O 120.729 0.299 . . . . 0.0 111.168 -179.984 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.233 0.21 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.427 -179.749 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 stop_ save_